
<html lang="en"     class="pb-page"  data-request-id="5c11536c-d50b-41d3-80d7-677649c343e8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-4;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b01514;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors" /></meta><meta name="dc.Creator" content="F. Anthony  Romero" /></meta><meta name="dc.Creator" content="Alexander M.  Taylor" /></meta><meta name="dc.Creator" content="Terry D.  Crawford" /></meta><meta name="dc.Creator" content="Vickie  Tsui" /></meta><meta name="dc.Creator" content="Alexandre  Côté" /></meta><meta name="dc.Creator" content="Steven  Magnuson" /></meta><meta name="dc.Description" content="Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as “readers” that ultimately determine the functional..." /></meta><meta name="Description" content="Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as “readers” that ultimately determine the functional..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 1, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01514" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01514" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01514" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01514" /></link>
        
    
    

<title>Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01514" /></meta><meta property="og:title" content="Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0028.jpeg" /></meta><meta property="og:description" content="Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as “readers” that ultimately determine the functional outcome of the post-translational modification. Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncology and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain. More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B. Such novel inhibitors can be used to probe the physiological function of these non-BET bromodomains and further understanding of their role in certain disease states. Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biological tools, as well as our perspective on the field." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01514"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01514">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01514&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01514&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01514&amp;href=/doi/10.1021/acs.jmedchem.5b01514" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1271-1298</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01502" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.5b01507" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+Anthony++Romero">F. Anthony Romero</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+M.++Taylor">Alexander M. Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry+D.++Crawford">Terry D. Crawford</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vickie++Tsui">Vickie Tsui</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexandre++C%C3%B4t%C3%A9">Alexandre Côté</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Magnuson">Steven Magnuson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Discovery Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Constellation Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +1-650-467-6384. E-mail: <a href="/cdn-cgi/l/email-protection#aedcc1c3cbdcc180c8dccfc0c5eec9cbc0cb80cdc1c3"><span class="__cf_email__" data-cfemail="3e4c51535b4c5110584c5f50557e595b505b105d5153">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01514&amp;href=/doi/10.1021%2Facs.jmedchem.5b01514" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1271–1298</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 16, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 September 2015</li><li><span class="item_label"><b>Published</b> online</span>1 December 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01514" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01514</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1271%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DF.%2BAnthony%2BRomero%252C%2BAlexander%2BM.%2BTaylor%252C%2BTerry%2BD.%2BCrawford%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D4%26contentID%3Dacs.jmedchem.5b01514%26title%3DDisrupting%2BAcetyl-Lysine%2BRecognition%253A%2BProgress%2Bin%2Bthe%2BDevelopment%2Bof%2BBromodomain%2BInhibitors%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1298%26publicationDate%3DFebruary%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01514"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5415</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">132</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01514" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Anthony Romero&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;M. Taylor&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;D. Crawford&quot;},{&quot;first_name&quot;:&quot;Vickie&quot;,&quot;last_name&quot;:&quot;Tsui&quot;},{&quot;first_name&quot;:&quot;Alexandre&quot;,&quot;last_name&quot;:&quot;Côté&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Magnuson&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;1271-1298&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01514&quot;},&quot;abstract&quot;:&quot;Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as “readers” that ultimately determine the functional outcome of the post-translational modification. Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncology and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain. More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B. Such novel inhibitors can be used to probe the physiological function of these non-BET bromodomains and further understanding of their role in certain disease states. Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biological tools, as well as our perspective on the field.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01514&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01514" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01514&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01514" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01514&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01514" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01514&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01514&amp;href=/doi/10.1021/acs.jmedchem.5b01514" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01514" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01514" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01514%26sid%3Dliteratum%253Aachs%26pmid%3D26572217%26genre%3Darticle%26aulast%3DRomero%26date%3D2016%26atitle%3DDisrupting%2BAcetyl-Lysine%2BRecognition%253A%2BProgress%2Bin%2Bthe%2BDevelopment%2Bof%2BBromodomain%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D4%26spage%3D1271%26epage%3D1298%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/jmcmar.2016.59.issue-4/20160225/jmcmar.2016.59.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as “readers” that ultimately determine the functional outcome of the post-translational modification. Because the initial discovery of selective BET inhibitors have helped define the role of that protein family in oncology and inflammation, BET bromodomains have continued to garner the most attention of any other bromodomain. More recently, non-BET bromodomain inhibitors that are potent and selective have been disclosed for ATAD2, CBP, BRD7/9, BRPF, BRPF/TRIM24, CECR2, SMARCA4, and BAZ2A/B. Such novel inhibitors can be used to probe the physiological function of these non-BET bromodomains and further understanding of their role in certain disease states. Here, we provide an update to the progress in identifying selective bromodomain inhibitors and their use as biological tools, as well as our perspective on the field.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/59/4"><issue-title>Epigenetics</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One of the most widely studied histone post-translational modification (PTM) is acetylation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Histones are covalently modified at the ε-amino group of lysines by histone acetyltransferases (HATs), thereby neutralizing the positive charge and thus interfering with the histone–DNA interaction essential for nucleosome stability.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Since Allfrey’s discovery of histone acetylation in 1964,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> it is now understood that the interplay of acetylation and deacetylation of chromatin plays a critical role in transcription.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Key to this process is the ability of “readers” to recognize specific PTMs that ultimately determine the functional outcome of the PTM.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Three readers (bromodomain,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> double PHD finger,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and pleckstrin homology domain)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> that recognize acetylated lysine (KAc) have been identified and the bromodomain is the most thoroughly characterized of the three.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Bromodomains were first identified in <i>Drosphilia</i> (<i>brahma</i> gene),<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and their function remained largely unknown until it was discovered that bromodomains bind acetyl-lysine.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> To date, 61 bromodomains have been identified, and these domains consist of roughly 110 amino acid residues.<a onclick="showRef(event, 'ref7 ref11 ref14'); return false;" href="javascript:void(0);" class="ref ref7 ref11 ref14">(7, 11, 14)</a> Initially, the concept of targeting a bromodomain was thought to be challenging because it would involve inhibiting a protein–peptide interaction, but this changed in 2010 when two potent and selective bromodomain inhibitors were shown to bind in the KAc binding groove. The molecules <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> which was identified from an earlier Mitsubishi patent,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and <b>2</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> which was identified at GSK through phenotypic screening, were shown to inhibit the function of members of the bromodomain and extra terminal domain family (BET). This family is characterized by dual bromodomains and consists of BRD2, BRD3, BRD4, and BRDT. Since these disclosures, there has been a significant amount of work on developing BET inhibitors and on understanding the role of BET proteins in various disease states that include oncology, inflammation, immunology, and cardiovascular disease.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> While much of the focus of bromodomain inhibition research has targeted the BET family, there is now quite a bit of interest in non-BET bromodomains. This interest has culminated in recent reports describing potent and selective inhibitors that should help define the physiological role of these proteins.<a onclick="showRef(event, 'ref7 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref7 ref19 ref20 ref21">(7, 19-21)</a> Literature reports related to bromodomains increased steadily from 1992 to 2010 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> After the simultaneous publication of the papers describing <b>1</b> and <b>2</b> in 2010, there was a significant increase in publications. Herein, we will describe the recent progress on both BET and non-BET bromodomain inhibitors, with an eye toward their application to understanding the physiological significance of these bromodomains.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> (JQ1) and <b>2</b> (I-BET762).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Number of bromodomain publications per calendar year.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Structural Features of Bromodomains</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Following the trend in number of publications, bromodomain structures in the Protein Data Bank (PDB) have increased significantly in the past few years, and many of these reported structures include small molecules bound in the KAc binding site. This site is located at one end of a four-helical bundle bromodomain, away from both the C- and N-termini (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). Acetylated-lysine and most of the known small molecule ligands form a hydrogen bond with the side chain of a conserved asparagine residue located at the beginning of the BC loop [Asn140 in the case of BRD4(1)], and a water-mediated hydrogen bond with the hydroxyl of a conserved tyrosine located on the ZA loop [Tyr97 in BRD4(1)] (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). Deeper in the back of this binding pocket, a network of water molecules is observed that is conserved across various bromodomains. In many of the structures, this network extends to a channel framed by the ZA loop that is termed the ZA channel. The ZA channel can be used to enhance potency and selectivity, as can the adjacent region known as the “WPF shelf” in BET based on the conservation of the WPF motif in BET family members.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The “WPF shelf” is not a general term for non-BET bromodomains because they lack the sequence conservation. Although the phenylalanine is nearly invariant, the other two residues can vary in size, hydrophobicity, or effects on backbone conformational properties (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). These differences may make the “WPF shelf” a productive area to explore to achieve selectivity depending on the desired on- and off-targets. Another important specificity determinant is the so-called “gatekeeper” residue (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Located at the start of the C helix, it defines the shape of one side of the entrance into the KAc binding site. For example, the Tyr222 gatekeeper of BRD9 forms what resembles a flat floor, allowing the aromatic motifs of the three BRD9 inhibitors to π-stack with the receptor (see <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> and BRD9 section for further discussion). These aromatic interactions augment the interactions seen with the conserved Asn216 and Tyr173.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overview of the bromodomain binding site. Compound <b>3</b> is shown in complex with BRD4(1) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q">4Z1Q</a>). (A) Structure of compound <b>3</b>. (B) Cartoon representation of chain A of the bromodomain, showing the 4-helix bundle and the ligand-binding site. (C) Close-up view of the binding site: the ligand is shown in beige, and the protein is depicted as a ribbon covered with a gray molecular surface. Key amino acid side chains are shown; these and important structural features are labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Aligned Amino Acid Compositions for WPF Motif and Gatekeeper Residues of Selected Bromodomains</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" align="center">bromodomain</th><th class="rowsep1 colsep0" colspan="3" align="center">WPF motif residues</th><th class="rowsep1 colsep0" align="center">gatekeeper</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4(1)</td><td class="colsep0 rowsep0" align="center">Trp</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Ile</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD4(2)</td><td class="colsep0 rowsep0" align="center">Trp</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Val</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CBP</td><td class="colsep0 rowsep0" align="center">Leu</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Val</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRIM24</td><td class="colsep0 rowsep0" align="center">Leu</td><td class="colsep0 rowsep0" align="center">Ala</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Val</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRD9</td><td class="colsep0 rowsep0" align="center">Gly</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Tyr</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CECR2</td><td class="colsep0 rowsep0" align="center">Trp</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Tyr</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRPF1</td><td class="colsep0 rowsep0" align="center">Asn</td><td class="colsep0 rowsep0" align="center">Ile</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Phe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BRPF3</td><td class="colsep0 rowsep0" align="center">His</td><td class="colsep0 rowsep0" align="center">Ile</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Phe</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PCAF</td><td class="colsep0 rowsep0" align="center">Trp</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Tyr</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAZ2B</td><td class="colsep0 rowsep0" align="center">Trp</td><td class="colsep0 rowsep0" align="center">Pro</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Ile</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ATAD2</td><td class="colsep0 rowsep0" align="center">Arg</td><td class="colsep0 rowsep0" align="center">Val</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Ile</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SMARCA4 (BRG1)</td><td class="colsep0 rowsep0" align="center">Glu</td><td class="colsep0 rowsep0" align="center">Val</td><td class="colsep0 rowsep0" align="center">Phe</td><td class="colsep0 rowsep0" align="center">Ile</td></tr></tbody></table></div></div><div class="NLM_p">The growing number of publicly available bromodomain crystal structures warrants a caution in the analysis and interpretation of such structures. Most bromodomains pack in the crystal lattice such that the KAc binding sites from two asymmetric subunits are directly interacting with each other. This is not automatically displayed by most programs; however, many programs allow the generation of symmetry mates that enable the evaluation of potential artifacts due to packing interactions. An example is shown for CBP (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>) in which the side chain conformation of Arg1173 wraps (cyan) around and makes π–π interactions with tetrahydroquinoline part of the ligand <b>4</b>. However, examination of a neighboring symmetry mate (gray) shows that the arginine also makes multiple interactions with glutamic acids in the crystal lattice, leading one to question the biological relevance of this observed conformation or the interpretation of a ligand/Arg interaction.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Another example in which the ligand conformations are affected by different packing within the asymmetric subunit and between symmetry mates will be discussed in the section on TRIM24.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>4</b> bound to CBP (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYW">4NYW</a>). (A) Structure of compound <b>4</b>. (B) Chain A is shown in cyan, with its bound ligand shown in beige. The neighboring symmetry mate, as generated by PyMol (Schrodinger, Inc.), is shown in gray. The interactions between two glutamic acids (both direct and water-mediated) from the symmetry mate and Arg1173 of the parent subunit are depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">CBP Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cAMP response element binding protein (CREBBP, CBP, KAT3A) and a highly homologous paralogue, adenoviral E1A binding protein (EP300, p300, KAT3B), are large multidomain proteins,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> each contain a bromodomain that has been shown to recognize p53 acetylated at K382 following DNA damage.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> CBP and p300 have been implicated as potential oncology targets.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> Recently, Liu et al. implicated p300 in cancer immunology, demonstrating that p300 is critical for Foxp3<sup>+</sup> regulatory T cell (T<sub>reg</sub>) function and homeostasis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> These cells play a critical role in limiting host autoimmunity and act as master regulators of the immune system. Liu and co-workers observed a significant decrease in Foxp3<sup>+</sup> T<sub>reg</sub> cells in p300 conditional knockout mice relative to wild-type mice, as well as significantly decreased tumor growth. While this effect was observed from knocking out the entire multidomain protein, it remained unclear whether inhibition of specific domains (e.g., the HAT domain or the bromodomain) would have the same effect. Genentech (GNE) and Constellation Pharmaceuticals (CPI) have subsequently disclosed the use of bromodomain inhibitors for cancer immunotherapy.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> They exemplify a CBP/p300 bromodomain inhibitor that not only reduces numbers of Foxp3<sup>+</sup> T<sub>reg</sub> cells but also reduces the expression of other immune checkpoint receptors such as LAG3, TIM3, and CTLA4. In addition, GNE and CPI disclose that similar effects are seen using a recently disclosed CBP inhibitor (compound <b>4</b>; <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref24 ref31'); return false;" href="javascript:void(0);" class="ref ref24 ref31">(24, 31)</a> It is clear that the development of potent and selective CBP bromodomain inhibitors will help further elucidate the role of CBP in tumor immune responses and other oncology indications.</div><div class="NLM_p">Pioneering work toward identifying CBP inhibitors was initially reported by Zhou et al. and Hewings et al. Although compounds <b>5</b> (MS2126),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>6</b> (MS7972),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><b>7</b> (Ischemin),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and compound <b>8</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> have micromolar affinity (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), these studies set the stage for targeting the CBP bromodomain with more potent small molecule inhibitors. These early compounds have been reviewed elsewhere in detail,<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> and the discussion that follows will focus on the potent and selective CBP inhibitors that have been reported after these initial disclosures.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of some of the first reported CBP inhibitors (<b>5</b>–<b>8</b>) with their reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structural Genomics Consortium (SGC) CBP Inhibitors</h3><div class="NLM_p">During the course of identifying compound <b>8</b>, Hewings et al. discovered that <i>N</i>-methyl pyrrolidinone (NMP) binds to CBP with a 2.3 mM affinity and high ligand efficiency (LE).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Following up on this discovery with the screening of NMP analogues, Rooney et al. identified 3-methyl-3,4-dihydroquinazolin-2(1<i>H</i>)-one (<b>9</b>, IC<sub>50</sub> = 29.4 μM, LE = 0.51) as an attractive starting point (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> They were aware that <b>9</b> was susceptible to benzylic oxidation,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> so they addressed this concern by exploring benzoxazinone- and dihydroquinoxalinone-based cores. The combination of the dihydroquinoxalinone core and optimization at the 5-position, using an amide library, led to compound <b>4</b> (IC<sub>50</sub> = 323 nM, ITC <i>K</i><sub>d</sub> = 390 nM). This compound is the first disclosed example of a CBP inhibitor with submicromolar affinity. A co-crystal structure of compound <b>4</b> with the bromodomain of CBP revealed that the tetrahydroquinoline (THQ) moiety binds in the LPF shelf region (corresponding to the WPF shelf of BRD4; <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), sandwiched between Pro1110 and Arg1173. It is clear that gaining the interaction to the LPF shelf contributes significantly to its potency. Compound <b>4</b> was shown to be selective for CBP over several bromodomains, however, only moderate selectivity (4-fold) was observed for CBP over BRD4. In a cellular context using a fluorescence recovery after photobleaching (FRAP) assay (see <a class="ref internalNav" href="#sec1_11_6" aria-label="Assessing Target Engagement/Cellular Activity">Assessing Target Engagement/Cellular Activity</a> section for explanation of FRAP), compound <b>4</b> was able to displace the CBP bromodomain from chromatin in U2OS cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Recently developed potent CBP inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>. Initial starting points for the optimization of these inhibitors (when known) are shown at left of arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Soon after this publication, a detailed account of the development of the SGC-nominated probe <b>11</b> (SGC-CBP30) was disclosed (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> Earlier investigations of isoxazolylbenzimidazoles as selective BET inhibitors revealed that fragment <b>10</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> showed similar potency for both BRD4 (IC<sub>50</sub> = 6.3 μM) and CBP (IC<sub>50</sub> = 4 μM) and demonstrated the potential to add substitutents to the N-1 position of the benzimidazole for further potency optimization. Hay et al. began to explore the ZA channel by substituting at C-2 and to target the LPF shelf by introducing modifications at N-1. A crystal structure of an unoptimized compound revealed a flipped binding mode in which the substituents in the C-2 position were directed to the LPF shelf, and substituents at the N-2 position were interacting with the ZA channel. Further optimization unveiled <b>11</b> (IC<sub>50</sub> = 69 nM, ITC <i>K</i><sub>d</sub> = 21 nM). Co-crystallization of <b>11</b> with the CBP bromodomain showed that the chlorophenyl ring interacts with Arg1173 in a manner similar to the interaction of the THQ ring of compound <b>4</b>. Selectivity of <b>11</b> over non-BET bromodomains was good, and moderate selectivity was obtained over BRD4 (40-fold), an improvement of 10-fold compared to compound <b>4</b>. The utility of this compound was examined in FRAP and p53 luciferase reporter assays. Compound <b>11</b> inhibited p53 activity with an IC<sub>50</sub> of 1.5 μM. Recently Hammitzsh et al. found that <b>11</b> suppresses human Th17 responses.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> While pan-BET inhibitors elicit a similar phenotype with broad effects on gene expression, <b>11</b> was shown to have a more narrow effect. This indicates that CBP inhibitors have the potential to have more nuanced therapeutic effects than BET inhibitors. In vitro ADME suggested that <b>11</b> would not be effective as an in vivo probe, and undoubtedly a compound that could be tested in vivo would be very helpful in clarifying the potential of therapeutic targeting of CBP.</div><div class="NLM_p last">Another CBP probe, <b>12</b><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (I-CBP112, IC<sub>50</sub> = 170 nM, ITC <i>K</i><sub>d</sub> = 151 nM), has been released on the SGC web site, but the detailed optimization of this compound has not been disclosed (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). This probe has a unique benzoxazepine core with the carbonyl of the ethylamide binding Asn1168, the piperidine binding in the BC loop and the diemethoxy phenyl positioned over the LPF shelf (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NR6">4NR6</a>). This compound is the first of the CBP inhibitors to have a group binding in the BC loop region, where the piperidine mostly points out to solvent. As noted above, the importance of the “WPF shelf” (or LPF shelf in this case) is a common theme among bromodomain inhibitors; this region appears to play an important role for <b>12</b>, in that important interactions are observed with the dimethoxyphenyl sandwiched between Pro1110 and Arg1173. This hydrophobic shelf appears to be critical not only for potency but also for selectivity against other bromodomains, and it is often different among the various bromodomains, as described above (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In the FRAP assay, <b>12</b> accelerated fluorescence recovery at 1 μM. Good selectivity was reported in a BLI assay against several bromodomains, although the SGC Web site does disclose that weak cross-reactivity was only noted for the BET family.</div></div><div id="sec1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> University of Zurich CBP Inhibitors</h3><div class="NLM_p">Recently, Nevado and Caflisch and co-workers have published back-to-back papers describing their work on identifying potent and selective CBP inhibitors.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Using an in silico approach, the authors identified an acyl benzamide (<i>K</i><sub>d</sub> = 29 μM, LE = 0.27) as a hit. Structurally similar analogues were purchased and screened that resulted in the identification of compound <b>13</b> (<i>K</i><sub>d</sub> = 5 μM, LE = 0.36) as a more efficient starting point (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Modeling suggested the fumaric acid interacted with Arg1173. In pursuit of optimizing this area, the fumaric acid side chain was replaced with a benzoic acid, which resulted in a 6-fold increase in potency. Further substitution on the benzoic acid moiety led to compounds <b>14</b> (<i>K</i><sub>d</sub> = 170 nM, ITC <i>K</i><sub>d</sub> = 300 nM) and <b>15</b> (<i>K</i><sub>d</sub> = 400 nM, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Selectivity was measured against several of the BET family members and each compound showed moderate selectivity for CBP. In the BRD4(1) assay compound <b>14</b> showed a potency of ∼10 μM, providing a 60-fold selectivity window. The methyl ester of compound <b>15</b> was found to have low micromolar GI<sub>50</sub> values against ML2 and MOLM-13 cell lines. These results may indicate a path forward for CBP inhibitors to treat acute myeloid leukemia.</div><div class="NLM_p last">Since the initial discovery of early CBP inhibitors by Zhou et al., there has been much progress in identifying potent and selective inhibitors. It is clear that starting from ligand-efficient fragments can readily yield nanomolar inhibitors. The SGC and others have made significant progress in developing potent and selective CBP inhibitors, but it remains to be seen if lack of high selectivity over BET bromodomains will confound results when trying to isolate the role of CBP. Inhibition of the BET family bromodomains produces pronounced phenotypes, and there is little shift in cellular potency from the measured biochemical IC<sub>50</sub>s against BRD4 (representative BET BRD).<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Although 60-fold or even 100-fold biochemical selectivity appears reasonable, this still may not be enough to tease apart CBP-associated phenotypes from those of BET inhibition. One of the key struggles going forward in this field is identifying potent and selective CBP inhibitors devoid of BET activity, in addition to the challenge mentioned above of identifying a probe suitable for in vivo studies.</div></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">BAZ2A/B Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Little is known about the function of BAZ2A/B (bromodomain adjacent to zinc finger domain, 2A/B), although it is known to be a member of the nuclear remodeling complex (NoRC).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Elevated expression levels of BAZ2A have been observed in prostate cancer,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which has sparked interest in the development of probe compounds for use a chemical genetic tools.</div><div id="sec1_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> SGC BAZ2A/B Inhibitors</h3><div class="NLM_p">The SGC has recently published two papers describing BAZ2A/B inhibitors. Drouin et al. reported the first BAZ2A/B inhibitor <b>16</b> (BAZ-ICR, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Virtual screening of putative bromodomain inhibitors led to the discovery of this trisubstituted imidazole scaffold. The crystal structure of compound <b>16</b> bound to BAZ2B shows that the <i>N</i>-methyl pyrazole, directly attached to the central imidazole, serves as the KAc mimetic. Interestingly, the pendant ethyl-linked electron rich <i>N</i>-methyl pyrazole folds back to form an intramolecular π-stacking interaction with the electron-poor benzonitrile. In addition, the nitrile also forms a hydrogen bond to Leu1891 while the pyrazole hydrogen bonds to Asn1894. Compound <b>16</b> showed moderate potency (ITC BAZ2A/BAZ2B <i>K</i><sub>d</sub>s of 110 and 170 nM) while displaying good selectivity when assayed against a broad panel of 47 bromodomains, with the lone exception of CECR2 (ITC <i>K</i><sub>d</sub> = 1.55 μM). Compound <b>16</b> also showed cellular activity in a FRAP assay.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. BAZ2A/B bromodomain inhibitors and their reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The second BAZ2A/B probe from the SGC that was developed by GlaxoSmithKline (GSK), <b>17</b> (GSK2801, <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), evolved from a hit containing a keto-indolizine in which the methyl ketone functions as the KAc mimetic.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Incorporation of an <i>ortho</i>-methyl sulfone on the phenyl ring attached to the indolizine core induces a nonplanar orientation of the two rings that is well tolerated by BAZ2B but not by BRD2 due to the smaller binding pocket dimensions of the latter bromodomain. The propyl ether on the other side of the core reaches into the ZA/BC pocket, providing a small increase in potency and apparently imparting selectivity over BRD9 based on AlphaScreen data (BRD9 IC<sub>50</sub> > 50 μM vs 24 μM without the propyl ether). Subsequent ITC analysis, however, indicated the selectivity window of <b>17</b> was narrower than originally observed in the AlphaScreen (BAZ2A/BAZ2B ITC <i>K</i><sub>d</sub>s of 260 and 140 nM, BRD9 ITC <i>K</i><sub>d</sub> of 1.1 μM). While <b>17</b> may not have ideal selectivity for phenotypic screening, it provides an alternate scaffold to <b>16</b> and is therefore potentially highly useful by comparison with <b>16</b> in identifying true on-target effects. Also, because the selective BRD7/9 inhibitor <b>22</b> is derived from the same scaffold as <b>17</b>, compound <b>22</b> provides an opportunity to identify any confounding BRD7/9-driven phenotypes.</div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">BRD7/9 Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The function of BRD9 (bromodomain-containing protein 9) is unknown, although its overexpression has been associated with several disease areas, including cervical cancers and nonsmall cell lung cancer.<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> Interestingly, proteomic analysis has identified BRD9 as a subunit in the mammalian BAF SWI/SNF complex.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> In contrast, the highly similar bromodomain-containing protein 7 (BRD7) is a subunit of the PBAF SWI/SNF complex,<a onclick="showRef(event, 'ref51 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref53">(51, 53)</a> and may play a role in recruiting specific transcription factors.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> It has been proposed that BRD7 is a tumor suppressor and, accordingly, BRD7 has been found to be down-regulated in cancer cells.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></div><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> SGC BRD7/9 Inhibitors</h3><div class="NLM_p">The SGC previously reported nonselective BRD9 inhibitors,<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> and the utility of these compounds in phenotypic studies was limited by their binding to BET bromodomains. Since the initial reports, these authors have identified three distinct potent and selective BRD7/9 dual inhibitors. The first of these selective inhibitors that was developed by the University of Oxford, <b>20</b> (LP99, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), was derived from 1-methylquinolone (<b>18</b>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The <i>N</i>-methyl pyridone served as the KAc mimetic, forming a single hydrogen bond to the conserved Asn106, while the quinolone core forms a π-stacking interaction with the Tyr106 gatekeeper. Addition of a valerolactam directed into the hydrophobic ZA channel enabled a scaffold that could be further substituted to interact with the active site. Investigation of substitution on the valerolactam yielded <b>19</b> (ITC <i>K</i><sub>d</sub> = 493 nM, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). A crystal structure of <b>19</b> bound to BRD9 revealed that the phenyl moiety was oriented into the hydrophobic pocket of BRD9 (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>A). Further optimization of substitution on the phenyl ring of <b>19</b> resulted in <b>20</b> (ITC <i>K</i><sub>d</sub> = 99 nM). Compound <b>20</b> was found to be selective against a panel of 48 bromodomians, with only BRD9 and paralogue BRD7 showing significant binding when assayed by DSF in the presence of 10 μM compound.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Recently developed, potent BRD9 inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>. Initial starting points for the optimization of these inhibitors are shown left of arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Co-crystal structures comparing the binding mode of BRD7/9 bromodomain inhibitors. (A) <b>19</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z6I">4Z6I</a>], (B) <b>22</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9V">5E9V</a>], and (C) <b>24</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UIW">4UIW</a>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The second SGC probe, compound <b>22</b> (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), utilized the keto-indolizine scaffold that was first incorporated in the BAZ2A/B chemical probe <b>17</b>.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> As observed with BAZ2A/B, the ketone forms the necessary hydrogen bonding interaction with Asn100 (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>B). The binding is further strengthened by a π-stacking interaction between the indolizine core and Tyr106 and possibly by a second interaction to the Asn100 through a nonclassical hydrogen bond interaction between the asparagine carbonyl and hydrogen at the indolizine C7 position. Hay et al. placed a 2-pyridyl at the 1-position of the indolizine, yielding <b>21</b>, a compound with BRD9 activity and equivalent BAZ2B activity as measured by an AlphaScreen assay. Subsequent conversion of the pyridine to an imidazo[1,2-<i>a</i>]pyridine and incorporation of a morpholine at the 7-position afforded compound <b>22</b>. This compound retained BRD9 affinity (DSF Δ<i>T</i><sub>m</sub> 4.5 °C, IC<sub>50</sub> = 126 nM, ITC <i>K</i><sub>d</sub> = 68 nM), demonstrated selectivity against other bromodomain family members, including BAZ2A/B, and showed activity in a FRAP cellular assay (1 μM).</div><div class="NLM_p last">Lastly, the SGC Web site has been updated with a new chemical probe for BRD7/9, BI-9564, that was developed by Boehringer-Ingelheim.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The structure is not yet disclosed, but it is noted that the compound was discovered through fragment-based screening and optimization. BI-9564 binds to BRD9 and BRD7 with <i>K</i><sub>d</sub> values of 14 and 239 nM, respectively, as measured by ITC. Interestingly, the affinities for BET bromodomains are reported to be >100 μM. In addition, BI-9564 is reported to have cellular activity in a FRAP assay (1 μM). There does appear to be some off-target binding to CECR2 (ITC <i>K</i><sub>d</sub> = 258 nM), but this does not translate into the cellular setting.</div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> GlaxoSmithKline BRD9 Inhibitor</h3><div class="NLM_p">Theodoulou et al. from GSK identified <b>24</b> (I-BRD9, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>), a broadly selective BRD9 inhibitor that is, to date, the only published tool compound published with significant selectivity for BRD9 over BRD7.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The initial thienopyridone scaffold (<b>23</b>) was identified through screening of internal GSK compounds with the <i>N</i>-methyl pyridone functioning as the KAc mimetic. BRD4 selectivity was improved upon through the introduction of an amidine group at the 2-position of the thienopyridone core (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>C). This appendage makes a direct hydrogen bond to the Ile53 of BRD9 that mitigates the potential offending carbonyl–carbonyl interaction observed between Ile53 and the amide of <b>23</b>, increasing BRD9 potency, while the authors hypothesize that the amidine is less tolerated in the more hydrophobic pocket of BRD4. Also contributing to overall selectivity was the electron-deficient <i>m</i>-trifluoromethylbenzene that fills the ZA channel, as well as increasing steric bulk of the pyridone by replacing the <i>N</i>-methyl substituent with <i>N</i>-ethyl. This optimization yielded <b>24</b> (IC<sub>50</sub> = 50 nM) that is selective over BRD4 (IC<sub>50</sub> = 5,000 nM). Selectivity was further assessed by BROMO<i>scan</i> screening, and the results showed that <b>24</b> is >200-fold selective for BRD9 (<i>K</i><sub>d</sub> = 2 nM) over BRD7 (<i>K</i><sub>d</sub> = 398 nM), a surprising result given the high degree of homology between the two paralogues. The authors provide a rationale for the BRD7/9 selectivity that is based on rather conservative residue differences. In BRD9, GPP shelf Gly43 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) and ZA channel Ala46 create a slightly larger pocket compared to their BRD7 equivalent Ala154 and Ser157, allowing an optimal fit of the inhibitor to the binding pocket of BRD9. The selectivity over BRD7 allows investigators to explore the phenotypic effects of BRD9 inhibitors without contamination from BRD7 inhibition.</div><div class="NLM_p last">The phenotypic effects of either dual BRD7/9 or BRD9 inhibitors have proven intriguing. Scientists at GSK studied the gene expression changes induced by <b>24</b> along with a BET inhibitor and found that genes such as CLEC1, FES, SAMSN1, and DUSP6 were selectively and strongly down-regulated by the BRD9 inhibitor. These genes have been implicated in cancer and immunological pathways. Compound <b>20</b> was found to inhibit the secretion of IL-6 from cultured THP-1 cells, and a patent application by Genentech and Constellation disclosed that the inhibition of BRD7/9 bromodomains (structures not disclosed) results in inhibition of IL-4, IL-5, and IL-13 production by human Th2 cells.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The reduction of these cytokines suggests BRD7/9 bromodomain inhibitors may have a role in treatment of inflammatory conditions.</div></div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">ATAD2 Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ATAD2 (ATPase family, AAA domain containing 2) is overexpressed in a wide variety of cancers, including prostate and triple-negative breast.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> Interestingly, ATAD2 binds the MYC protein, stimulates MYC-dependent transcriptional activity and may contribute to the development of aggressive cancers.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> It has been suggested that inhibitors of ATAD2 could be novel oncology treatments, although the specific role of the bromodomain in ATAD2 function is currently unclear.</div><div id="sec1_5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> GlaxoSmithKline ATAD2 Inhibitor</h3><div class="NLM_p">While there is interest in the biological function of ATAD2, the ATAD2 bromodomain is considered one of the most difficult-to-drug members of the family.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Compared to other bromodomains, the ATAD2 pocket is quite shallow. This suggests that gaining selectivity for ATAD2 over other bromodomains would be a significant challenge. Harner et al. disclosed NMR fragment screen hits that bound to ATAD2 with <i>K</i><sub>d</sub>s ranging from 350–600 μM and with ligand efficiencies ranging from 0.25–0.32.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Not surprisingly, the most efficient fragments were from scaffolds that are also found among strong binders to other bromodomains. A single-digit micromolar ATAD2 inhibitor (<b>26</b>, IC<sub>50</sub> = 1.3 μM, LE = 0.30, <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>) based on a 3-methylquinolinone fragment hit (<b>25</b>) was recently reported by Demont et al.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Key to optimization of <b>25</b> was replacing the flexible dimethylamino ethyl with a 4-aminopiperidine, providing a rigidified conformation to interact with Asp1071, as well as incorporating a 3-pyridyl ring that forms a direct hydrogen bond to Asp1014. Compound <b>26</b> was moderately potent against ATAD2 but had equivalent affinity for BET bromodomains. In a recent follow-up paper, Bamborough et al. focused on increasing ATAD2 potency while decreasing BRD4 potency.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The authors surmised that targeting the more polar and flexible RVF shelf in ATAD2 (Arg1007, Val1008, and Phe1009) might be productive in gaining both potency and selectivity over BRD4, which has a more hydrophobic WPF shelf. Substitution at C3 of the piperidine allowed access to the RVF shelf. Optimization in this area led to ether-linked cyclic sulfone <b>27</b> (ATAD2 IC<sub>50</sub> = 130 nM, BRD4 IC<sub>50</sub> = 16 μM) with nanomolar potency and impressive selectivity over BRD4 (>100-fold). An additional example was compound <b>28</b>, in which the main naphthyridone core was replaced with a quinolinone core (ATAD2 IC<sub>50</sub> = 158 nM, BRD4 IC<sub>50</sub> = 4 μM). The crystal structure of <b>28</b> bound to ATAD2 showed that instead of hydrogen bonding with Arg1007 from the RVF shelf of ATAD2, the cyclic sulfone makes an interaction instead with Arg1077 on helix 7 and potentially clashes with the corresponding WPF shelf residues on BRD4 (Met149 and W81; <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>), imparting selectivity over BRD4. Because compounds <b>27</b> and <b>28</b> had poor permeability, several analogues were made in an attempt to improve this property. One of these analogues, compound <b>29</b> had better permeability at the expense of ATAD2 potency and BRD4 selectivity (ATAD2 IC<sub>50</sub> = 316 nM, BRD4 IC<sub>50</sub> = 8 μM). Compound <b>29</b> was further evaluated and is very selective against other bromodomain family members, except for TAF1(2) and CECR2. As discussed above for CBP and other bromodomain inhibitors, optimizing the interaction with the “WPF shelf” region of ATAD2 (RVF shelf) appears crucial for obtaining both potency and selectivity. While the authors of these ATAD2 publications were unable to identify one optimal molecule in terms of potency, selectivity, and permeability, they did indicate that a subsequent publication would describe a more selective and cell-permeable ATAD2 probe compound.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. ATAD2 inhibitors and their reported IC<sub>50</sub>. Initial starting point and progression to potent compounds is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Co-crystal structure of <b>28</b> (gray) with ATAD2 (teal) [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A83">5A83</a>]; the apo structure of BRD4(1) [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LYI">4LYI</a>] is overlaid in brown. Distances are shown between the sulfone of <b>28</b> and residues in BRD4(1) that may result in steric clashing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">CECR2 Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Recently, the SGC has declared a CECR2 (cat eye syndrome chromosome region, candidate 2) bromodomain probe, NVS-1, but they have not yet released the structure.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> NVS-1 (IC<sub>50</sub> = 0.047 μM, ITC <i>K</i><sub>d</sub> = 0.080 μM) was developed by Novartis and is reported to be a highly potent and selective probe that is active in the cellular FRAP assay. However, it is noted that this compound is poorly soluble, so cellular experiments requiring high concentrations may not be feasible.</div></div><div id="sec1_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">SMARCA4 (BRG1) Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A), also known as BRG1, has been implicated in lung cancer and in other tumor types.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> In addition, SMARCA4 may play a role in sensitivity and resistance to anticancer drugs.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">The SGC has disclosed the SMARCA4 bromodomain inhibitor <b>30</b> (PF1-3, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) developed by Pfizer, but the design of the probe and a description of its optimization has yet to be published.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Compound <b>30</b> binds with high affinity to SMARCA2/4 as well as to the fifth bromodomain of Polybromo 1, [PBRM1(5)] (ITC <i>K</i><sub>d</sub> of 89 nM and 48 nM for SMARCA4 and PBRM1(5), respectively. In a panel of 15 bromodomains assayed by DSF, only SMARCA2, SMARCA4, and PB1(5) showed significant <i>T</i><sub>m</sub> shifts (Δ<i>T</i><sub>m</sub> 6.5, 5.1, and 7.5 °C, respectively). Compound <b>30</b> showed activity in a FRAP-recovery SMARCA2 cellular assay. More recently, Vangamundi et al. showed that inhibition of the SMARCA2 bromodomain fails to display an antiproliferative phenotype.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SMARCA4 (BRG1) bromodomain inhibitor and its reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">BRPF1 Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The BRPF1 (bromodomain and PHD finger containing 1) protein is part of the BRPF family that also includes BRD1 (aka BRPF2) and BRPF3. BRPF proteins are a component of the MYST family histone acetyltransferase (HAT) complexes<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> in which they bridge the subunit ING5 and hEAF6 to the HAT-containing transcriptional coactivators, MOZ/MORF.<a onclick="showRef(event, 'ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79">(77-79)</a> While some biological functions have been linked to different subunits of the tetrameric complex,<a onclick="showRef(event, 'ref77 ref80'); return false;" href="javascript:void(0);" class="ref ref77 ref80">(77, 80)</a> including the BRPF proteins,<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> little is known about the precise role of the bromodomain itself within either the full-length proteins or the HAT complexes. In an attempt to establish a robust target–phenotype correlation and ultimately evaluate the therapeutic potential of BRPF1 bromodomain inhibition, small-molecule inhibitors have been sought. In addition to reports of selective BRPF1 inhibitors, others have disclosed pan-BRPF (BRPF1/2/3) bromodomain inhibitors, each of which selectivity type could prove valuable as chemical tools.</div><div id="sec1_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> GlaxoSmithKline BRPF1 Inhibitor</h3><div class="NLM_p">Identified in the context of a BRD4 drug discovery program, a highly ligand efficient 1,3-benzimidazolone fragment demonstrated promising activity in a BRPF1 assay (IC<sub>50</sub> = 10 μM, LE = 0.47) and was selected by Demont et al. as a starting point to develop a inhibitor of the BRPF bromodomain family.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> After assembling and testing 1,3-benzimidazolone analogues, compound <b>31</b> (BRPF1 IC<sub>50</sub> = 79 nM) was discovered (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Apart from its attractive potency, <b>31</b> appears to be selective for BRPF1 over multiple other bromodomains, including BRD4(1) (IC<sub>50</sub> > 50 μM). Unexpectedly, selectivity for BRPF1 over BRPF2 (100-fold) and BRPF3 (>1000-fold) was observed. Subtle differences, close to the KAc binding pocket and, more precisely, the substitution of BRPF1 Pro658 by Ser592 in BRPF2 and Asn619 in BRPF3, are believed to contribute to the observed selectivity. The co-crystal structure of <b>31</b> bound to BRPF1 reveals a hydrophobic interaction between Pro658 and the 1,3-benzimidazolone, whereas examination of the apo structure of BRPF2 suggests this type of hydrophobic interaction would not be possible (<a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>). The complex structure confirmed the interaction of the C2 carbonyl with the conserved Asn708 and, through water, with Tyr665 in BRPF1. Additionally, the co-crystal structure revealed that the <i>N</i>1-methyl (piperidine side) is buried in the back of the KAc binding pocket while the <i>N</i>3-methyl (benzamide side) is exposed to solvent. This binding mode is consistent with the SAR data that show a greater loss of potency for the <i>N</i>1-desmethyl (250-fold) than for the <i>N</i>3-desmethyl (8-fold). In a cellular context (BRET assay), compound <b>31</b> exhibited a dose–response curve with a 0.98 μM IC<sub>50</sub>.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. BRPF bromodomain inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Comparison of BRPF1/<b>31</b> (yellow, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UYE">4UYE</a>) co-crystal structure with the apo structure of BRPF2 (teal, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RCW">3RCW</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> SGC BRPF Inhibitors</h3><div class="NLM_p">To date, the SGC and their collaborators have reported three bromodomain inhibitors for the BRPF family bromodomains. Two of these, <b>32</b> (PFI-4)<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and <b>33</b> (OF-1),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> are close analogues of compound <b>31</b>, having the same 1,3-benzimidazolone motif. The third SGC compound, <b>34</b> (NI-57),<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> is based on a new quinolinone scaffold (<a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>). Although biochemical data may suggest a slight potency advantage for <b>32</b> (BRPF1 IC<sub>50</sub> = 45 nM, ITC <i>K</i><sub>d</sub> = 13 nM) compared to compound <b>31</b>, the latter has been more extensively profiled and also shows slightly better selectivity over BRPF2/3.</div><div class="NLM_p">Compound <b>33</b> is classified as a pan-BRPF bromodomain inhibitor based on binding to both BRPF1 (ITC <i>K</i><sub>d</sub> = 100 nM) and BRPF2 (ITC <i>K</i><sub>d</sub> = 500 nM) and, to a lesser extent, BRPF3 (ITC <i>K</i><sub>d</sub> = 2,400 nM). This compound is reported to have >100-fold selectivity for BRPF1 over other bromodomains tested, with the exception of TRIM24 (50% inhibition at 20 μM) and, more importantly, BRD4 (39-fold). In cellular contexts, <b>33</b> showed evidence of cellular target engagement at 1 μM in a full-length BRPF1B thermal shift assay and at 5 μM in a BRPF2 FRAP assay.</div><div class="NLM_p last">Lastly, the University of College London has developed the BRPF bromodomain probe <b>34</b>. Similar to <b>33</b>, <b>34</b> is a pan-BRPF inhibitor with cellular activity (BRPF1 ITC <i>K</i><sub>d</sub> = 31 nM, BRPF2 <i>K</i><sub>d</sub> = 110 nM and BRPF3 <i>K</i><sub>d</sub> = 410 nM). Interestingly, <b>34</b>, which shows some structural similarity to the BET inhibitor PFI-1 (<b>40</b>, <a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>), does not appear to bind significantly to BRD4 yet does interact with the BRD9 bromodomain (32-fold selectivity for BRPF1). An important advantage of having two distinct scaffolds for interrogating the role of pan-BRPF inhibition in human diseases, as in the case of <b>34</b> and <b>33</b>, is that they decrease the likelihood of having the same off-target profile and, therefore, increasing the confidence in the target-phenotype correlation.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div></div></div><div id="sec1_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Dual TRIM24 and BRPF Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">TRIM24 (aka TIF-1α, tripartite motif 24 protein) is a multidomain protein characterized by an adjacent PHD finger and bromodomain, as well as by other auxiliary domains, including a RING finger motif. Tsai et al. reported that both the PHD finger and the bromodomain function as a cooperative unit that respectively recognize unmodified H3K4 and H3K23ac on the same histone tail.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> TRIM24 is known to deregulate the retinoic acid-signaling pathway<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> and to interact with estrogen receptors<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> to promote tumor development. High TRIM24 levels have also been observed in multiple cancer cell lines,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89, 90)</a> and overexpression has been concurrently associated with a poor prognosis in breast cancer patients.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> In an advance that will help both to understand the complex mechanism by which TRIM24 regulates cancer and to better dissect the biological function of each domain, chemical probes derived from a 1,3-benzimidazolone scaffold have recently been published by two independent groups.</div><div id="sec1_9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> SGC TRIM24/BRPF Inhibitor</h3><div class="NLM_p">In 2015, the SGC and their collaborators reported compound <b>35</b> (<a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>) as a dual TRIM24 (IC<sub>50</sub> = 430 nM, ITC <i>K</i><sub>d</sub> = 222 nM) and BRPF1 (IC<sub>50</sub> = 340 nM, ITC <i>K</i><sub>d</sub> = 137 nM) inhibitor.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Although there is meaningful potency against BRPF2 (IC<sub>50</sub> = 1750 nM, ITC <i>K</i><sub>d</sub> = 1,100 nM) and BRPF3 (IC<sub>50</sub> = ∼7 μM), the selectivity over the other bromodomains tested in a thermal shift assay, including BET family members and CBP, appears to be good. A co-crystal structure of <b>35</b> bound to a TRIM24 PHD/bromodomain construct confirmed the binding of the ligand in the KAc channel of the bromodomain, where the 1,3-benzimidazolone moiety forms a canonical hydrogen bond with Asn980 and a water mediated hydrogen bond with Tyr935. In a cellular context (FRAP assay), compound <b>35</b> was able to displace the full-length TRIM24 protein from chromatin at 1 μM, but failed to show any effect with the full-length BRPF1 protein under similar conditions. However, when using a construct expressing three tandem copies of the BRPF1 bromodomain, evidence of cellular target engagement was found. When tested against a small panel of cancer cell lines, compound <b>35</b> showed only modest cytotoxicity (GI<sub>50</sub> > 10 μM). It is unclear whether TRIM24/BRPF1 inhibition simply has little effect on cellular viability, whether the weak phenotype is the consequence of modest cellular potency of the compound or whether testing a larger panel of cell lines would reveal greater effects.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Dual TRIM24/BRPF bromodomain inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> The University of Texas MD Anderson Cancer Center TRIM24/BRPF Inhibitor</h3><div class="NLM_p">Concurrent to the SGC work, research conducted by Palmer et al. led to the discovery of <b>36</b> (IACS-9571, <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>), a more potent TRIM24 bromodomain inhibitor (IC<sub>50</sub> = 8 nM, ITC <i>K</i><sub>d</sub> = 31 nM).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Having first identified multiple indolinones, tetrahydroquinolin-2-one, and 1,3-benzimidazolone as initial hits, the team eventually concentrated their efforts on the latter series. The SAR revealed a wide tolerance of substitutions around the arylsulfonamide and, therefore, this position was used to modulate physical properties. Alternatively, using the vector offered by <i>meta</i> substitution (rather than the <i>para</i> position on the phenoxy group) increased the potency by about 10-fold. Guided by co-crystal structures, the team then examined 3,5-disubstituted analogues as a strategy to simultaneously target two productive vectors. Indeed, the co-crystal structure of <b>37</b> (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>) reveals that these two substitutions could occupy either what the authors referred to as the “upper pocket” (chain A) or the ZA channel (chain B; <a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>). Also shown in the figures are packing interactions between the ligand in chain A with chain B (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>B) and between chain B and its symmetry mate (<a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a>C). These interactions may render the conformations observed in the structures artifactual, and it is therefore difficult to assess which, if either, is the biologically relevant conformation. This bidirectional design, combined with the introduction of a basic amine on one of the substituents to form a salt-bridge interaction with Asp926, led to a significant increase in potency. More importantly, the cellular activity was improved; <b>36</b> demonstrates a TRIM24 EC<sub>50</sub> of 50 nM in an AlphaLisa cellular target-engagement assay. While <b>36</b> lacks selectivity against the BRPF family, in particular BRPF1 (ITC <i>K</i><sub>d</sub> = 14 nM), good selectivity is observed over other bromodomains, including BRD4 (<i>K</i><sub>d</sub> > 10 μM). In the context of future in vivo studies, the pharmacokinetic profile of this compound was evaluated in mice and appears to be reasonable (clearance approximately half the rate of hepatic blood flow, iv terminal half-life of 0.7 h and bioavailability of 29%).</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Crystal structure of <b>37</b> bound to TRIM24 [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YBM">4YBM</a>] showing different crystal contacts and inhibitor conformations for the two copies of TRIM24 in the asymmetric unit. (A) Structure of <b>37</b>. (B) Chain A is depicted in gray, with the “upper pocket” shaded orange. In pink is the surface of TRIM24 from chain B in the asymmetric subunit. The ZA channel is purple. (C) Chain B is depicted in gray, with the “upper pocket” shaded orange. In green is the symmetry mate closest to chain B. The ZA channel is purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">BPTF Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87578" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87578" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Although a highly potent and selective BPTF (bromodomain PHD finger transcription factor) inhibitor has yet to be disclosed, Urick et al. recently discovered a weak BPTF bromodomain inhibitor, <b>38</b> (AU1, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>), through <sup>19</sup>F NMR screening.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Compound <b>38 (</b>ITC <i>K</i><sub>d</sub> = 2.8 μM) shows modest BPTF activity and appears to be selective for BPTF over BRD4, but potency against other bromodomains is not reported. The authors investigated the effect of <b>38</b> in BPTF-mediated gene regulation and found that it does interfere with the MOBKL3 regulatory region, suggesting that the BPTF bromodomain is crucial for gene regulation. Compound <b>38</b> may provide a reasonable starting point for developing a BPTF probe; however, the poor ligand efficiency (LE = 0.23) for this compound suggests that it could be a challenging lead to optimize.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. BPTF bromodomain inhibitor and its reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">BET Bromodomain Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66765" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66765" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The influential disclosures of the BET inhibitors <b>1</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and <b>2</b><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> [followed shortly thereafter by <b>39</b> (I-BET151)<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> and <b>40</b> (PFI-1)<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a>] sparked tremendous academic and industrial interest in inhibitors of the BET family (BRD2, BRD3, BRD4, and BRDT) bromodomains and the phenotypes they elicit (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>). Spurred on by the ever-increasing number of reports relating small-molecule BET inhibition to phenotypes as varied as cancer cell proliferation<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and suppression of inflammatory response,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> drug discovery researchers over the last three years have reported far more inhibitors of BET bromodomains than of all other bromodomains combined. Many of the reported compounds have been used as chemical genetic probes to continue to explore phenotypes and understand the molecular role of BET inhibition. BRD4 and the BET family have also been used as a platform to develop new methods of characterizing cellular target engagement. In perhaps the greatest sign of the importance of BET bromodomain inhibition, a few compounds have progressed to human clinical trials in cancer indications, where promising results have been reported.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> In this section, we present highlights of BET chemical matter, screening methods, and new phenotypes reported since 2012.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Seminal BET bromodomain inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">BET inhibitors can be categorized based on their KAc mimic (e.g., triazole, dimethylisoxazole, and pyridone-like), leaving only a few compounds that do not fit into these categories (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>). To a large extent, the seminal BET inhibitors <b>1</b>, <b>2</b>, <b>39</b>, and <b>40</b> are archetypical of some of these categories and likely inspired and informed other groups as they explored BET bromodomain inhibitor space. While the KAc binding site of the BET bromodomains is highly homologous to that of other bromodomain-containing proteins (e.g., CREBBP, BRD9, and SMARCA4), selectivity has been achieved in a number of different ways, especially by taking advantage of differences in the gatekeeper and WPF shelf residues.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Key interactions for (A) triazole <b>2</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3P5O">3P5O</a>), (B) dimethylisoxazole <b>39</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZYU">3ZYU</a>), and (C) pyridone-like <b>40</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E96">4E96</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Triazole-Derived Binding Motifs</h3><div class="NLM_p">The first widely recognized BET bromodomain inhibitors reported were the triazole-based diazepines <b>1</b> and <b>2</b>. A closely related compound is <b>41</b> (OTX015, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>), the rights to which were acquired in 2012 by OncoEthix from Mitsubishi Tanabe. Differing only in the substituent at the amide side chain from <b>1</b> (which itself was identified based on insights from Mitsubishi’s original patent),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> compound <b>41</b> has since been developed for human dosing<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> and has seen application in a number of clinical trials for oncology indications (see below for further discussion). As is evident from co-crystal structures of <b>1</b> or <b>2</b> bound to BRD4(1), the triazole is a good KAc mimic because of its ability to engage both Asn140 and Tyr97 and to orient a methyl group into the back water pocket (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>A). Combined with thiophene or benzene rings, the diazepine structure optimally positions the pendant chlorophenyl ring to fill space in the hydrophobic region over the gatekeeper. Taken together, these features make an attractive template that has been the inspiration for a number of groups in their efforts to develop different BET inhibitors.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Selected recently reported triazole-derived BET inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Perhaps the closest analogues of <b>1</b> were described by Concert Pharmaceuticals, whose various deuterated molecules incorporated the heavy atom at key sites of oxidative metabolism to affect plasma exposure by way of the kinetic isotope effect.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_p">In another example of a related series, Bayer published a patent application describing BET inhibitors that preserved the [5–7–5] fused ring system of the Mitsubishi thienotriazolodiazepines but replaced the dimethylthiophene with an 1,2-dimethyl pyrrole.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Some of the resulting compounds, such as <b>42</b> [BRD4(1) IC<sub>50</sub> = 20 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>] showed growth inhibition in multiple cell lines. The same group also found that potency could be maintained by replacing the amides at the 4-position with heterocycles.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Around the same time, Bayer disclosed another series of BET inhibitors that maintain the [6–7–5] fused ring system of <b>2</b> but replaced the connecting imine in the azepine with an alkene, as represented by compound <b>43</b> (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Although no co-crystal structures of <b>43</b> have been released, the compound is clearly able to engage in productive binding interactions with the BET bromodomains, as it is potent both biochemically [BRD4(1) IC<sub>50</sub> = 20 nM] and in leukemia cells (MOLM-13, EC<sub>50</sub> = 120 nM).</div><div class="NLM_p">The team at Constellation found that an isoxazole KAc mimetic (originating from an aminoisoxazole fragment identified through a fragment screen) could be merged with the benzodiazepine motif to make highly potent compounds such as <b>44</b> [BRD4(1) IC<sub>50</sub> = 14 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>]. Compound <b>44</b> was active against a number of hematological cell lines (e.g., MV4-11 GI<sub>50</sub> = 15 nM), which translated into efficacy when dosed PO QD in a mouse xenograft model.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> CPI-0610, CPI’s clinical BET inhibitor, is derived from this isoxazolobenzazepine series and its structure was recently revealed at the 2015 AACR annual meeting but has yet to be disclosed in print literature.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> CPI later reported that BRD4 activity could be maintained and in vivo metabolism reduced even when the carboxamide substituent was pared back to a methyl group.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">Returning to the triazole motif, CPI determined that the acetyl recognition site would tolerate disubstitution at the 4-position.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Synthetically challenging compounds like trisubstituted cyclopropane <b>45</b> [BRD4(1) IC<sub>50</sub> = 500 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>] (and related cyclobutanes and oxetanes) recapitulated the same key interactions as <b>1</b> and <b>2</b>, with the spiro substituent at the 4-position causing no apparent undesirable clash with the binding site.</div><div class="NLM_p">In a subsequent report, the same group replaced the imine of the diazepine scaffold with an aniline. The approach generated potent bromodomain inhibitors such as compound <b>3</b> [BRD4(1) IC<sub>50</sub> = 15 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>].<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> In a crystal structure of compound <b>3</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) bound to BRD4(1), the compound adopted the requisite cup-shaped conformation, allowing it to interact with Asn140/Tyr97 and position the chlorophenyl tail group in the hydrophobic region near the gatekeeper and the border of the WPF shelf. Compound <b>3</b> had reasonable metabolic stability and, when dosed orally in mice, reduced IL-6 release in a dose-dependent manner following stimulation with lipopolysaccharide. These in vivo data indicate that it is possible to modulate an inflammatory response through BET bromodomain inhibition.</div><div class="NLM_p">CPI reported a different series of triazole-based binders in 2012 in a patent application disclosing substituted triazolopyridazines.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> A structurally related series based on a triazole fused to a phthalazine body had been previously reported by the SGC but suffered from poor potency and selectivity over the bromodomains of CBP and BRD9, likely because of suboptimal positioning of the WPF shelf binding motif.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> An example is compound <b>46</b> [BRD4(1) IC<sub>50</sub> < 500 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>], in which the <i>N</i>-methyl and <i>N</i>-α-methylbenzyl moieties fill the ZA channel and cover the WPF shelf. The biochemical activity of these compounds translated well into <i>MYC</i> mRNA suppression and IL-6 release cellular assays. A group at Boehringer-Ingelheim explored similar compounds with various <i>N</i>-linked saturated heterocycles instead of the urea.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a></div><div class="NLM_p">Workers at Incyte found that the <i>N</i>-methyl aniline group of compounds like <b>46</b> could effectively be tied back into a heterocycle and still maintain potency.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> One such example, <b>47</b> [BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>], was reported to be active in a myeloma cell line (KMS.12.BM, EC<sub>50</sub> < 1 μM).</div><div class="NLM_p last">In a different approach, a group at Boehringer-Ingelheim incorporated a biaryl motif into the body of their BET inhibitor to cover the top of the WPF shelf, with a short alkyl chain substituent extends from the side of the inhibitor and lies just over the gatekeeper.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Resulting triazolopyrazine compounds such as <b>48</b> (<a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a>) were quite potent [BRD4(1) IC<sub>50</sub> = 9 nM].</div></div><div id="sec1_11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Isoxazole-Binding Motifs</h3><div class="NLM_p">The Asn140/Tyr97 KAc mimetic that has received the most attention in recent years has been the dimethylisoxazole based on the prototypical <b>39</b>. Co-crystal structures of dimethylisoxazole-based inhibitors bound to the BET bromodomains show that the oxygen of the isoxazole engages in a hydrogen bond with the NH<sub>2</sub> of Asn140, leaving the heterocycle nitrogen poised to interact through water with Tyr97 and the 3-methyl substituent to fill the space of the acetyl lysine substrate (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>B). The 5-methyl substituent remains in close proximity to the Asn140 carbonyl and likely contributes to binding via a noncanonical H-bonding interaction. These ideal interactions, along with the potential of the dimethylisoxazole unit to be incorporated into more modular syntheses than those of the diazepines, have likely contributed to its popularity as a KAc binding motif. Bradner and co-workers recently reported a fluorous-tagged multicomponent approach that yields dimethylisoxazole BRD4 inhibitors, albeit of modest potency and off-target bromodomain selectivity.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">In the design of dimethylisoxazole-based BET inhibitors, some groups have chosen to stay close to the tricyclic core of <b>39</b>. For example, Aurigene reported a series of imidazoquinoline derivatives typified by compound <b>49</b> (IC<sub>50</sub> < 200 nM, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>), in which the heterotricycle forms the core of the inhibitor, allowing for imidazole <i>N</i>-linked alkyl- and aryl-heterocycles to serve as the WPF shelf binders.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Piramal took a similar approach with compounds like <b>50</b> [BRD4(1) IC<sub>50</sub> < 300 nM, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>, active in a MOLM-13 leukemia cell line], where the imidazolone of <b>39</b> was converted to an imidazolylidene cyanamide.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Epigenetix reported modifying the same imidazolone to an oxazolone.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Modeling of compounds bound to either bromodomains 1 and 2 of BRD4 allowed Wang and co-workers at the University of Michigan to replace the [5–6–6] core of <b>39</b> with a [6–5–6] ring system, resulting in a “γ-carboline” series exemplified by <b>51</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Compound <b>51</b> was biochemically potent against both bromodomain 1 and 2 of BRD4, with <i>K</i><sub>i</sub>s ranging from 3 to 25 nM, and it showed activity against the MV4-11 cell line (GI<sub>50</sub> = 25 nM). Interestingly, <b>51</b> also demonstrated submicromolar activity against the bromodomain of CBP (<i>K</i><sub>d</sub> = 670 nM). Other compounds from the same series showed strong efficacy when dosed at 40 mpk QD PO in an MV4-11 mouse xenograft model (H187 human small cell lung carcinoma) without causing body weight loss.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Researchers at Bristol-Myers Squibb also pursued a γ-carboline series, although its substitution pattern suggests that the binding mode in the bromodomain is flipped relative to that of <b>51</b>. For instance, with compounds such as <b>52</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>), the ring nitrogen of the carbazole is used to position benzyl<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> or sulfonamido<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> tail groups that interact with the hydrophobic region of BET. Compound <b>52</b> was used to show efficacy in a small cell lung carcinoma mouse xenograft model when dosed PO at 15 mpk BID.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Selected recently reported dimethylisoxazole-based BET inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Moving away from <b>39</b>, a number of other groups have determined that a tricyclic core is not required to link the KAc mimic with the WPF shelf-binding element. For example, a fragment-based effort reported by the SGC resulted in a series of substituted phenyl-dimethylisoxazoles that demonstrated a BRD4(1) IC<sub>50</sub> of 380 nM and submicromolar activity against MV4-11 cells but only ∼2-fold selectivity over the bromodomain of CBP.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Researchers at Gilead developed more potent, axially chiral BET inhibitors based on a benzimidazolone core. This is represented by compound <b>53</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>), which displayed a BRD4(1) IC<sub>50</sub> of 14 nM and a GI<sub>50</sub> of 10 nM in a multiple myeloma cell line (MM1.s) known to be sensitive to BET inhibition.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> In other work from Gilead, quinolines and quinolinones made up the core of the BET inhibitor, with sulfonamide WPF shelf binders at the 6-position.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Around the same time, a group at Zenith determined that the dimethylisoxazole could be combined with a benzimidazole body such that <i>N</i>-substituted aryl and aliphatic heterocycles could serve as WPF shelf binders.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Compound <b>54</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>), representative of this design, demonstrated a BRD4(1) IC<sub>50</sub> < 300 nM. Zenith also disclosed BET inhibitors with a 4-substituted benzimidazole core that oriented heteroaryl groups into the WPF shelf.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Biaryl compounds from that patent filing demonstrated in vivo activity, including in mouse cancer xenograft studies with OCi-3 leukemia cells and MM1.s multiple myeloma cells in an inflammation model and on the T cell release of various cytokines in T cells. Teams at the SGC<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> and Plexxikon<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> each investigated [5–6] heterocycles as suitable cores but looked at different connectivity relative to the benzimidazoles of Gilead and Zenith (compound <b>55</b>, <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>). Similarly, a team at Beigene determined that 3,3-disubstituted oxindoles could orient aryl heterocycles over the WPF shelf.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> A representative compound, <b>56</b>, was potent against the BET family [BRD4(1) IC<sub>50</sub> = 8 nM] and demonstrated an EC<sub>50</sub> of 34 nM in an MV4-11 cellular assay. Workers at Boehringer-Ingelheim disclosed bromodomain inhibitors with the same oxindole core but with two carbon attachments at the 3-position.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> They also expanded the five-member oxindole ring to a six-membered ring, creating compounds with a disubstituted dihydroquinazolinone core.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Representatives of that series, such as <b>57</b> [BRD4(1) IC<sub>50</sub> = 34 nM], shown in <a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>, took advantage of defined stereochemistry to orient the phenyl group into the hydrophobic region. Finally, Incyte researchers used a unique fused tricyclic scaffold.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Compounds such as <b>58</b> (<a class="ref internalNav" href="#fig21" aria-label="Figure 21">Figure 21</a>) from this series demonstrated low nanomolar activity against BRD4(1), which translated into submicromolar activity in a cellular assay of <i>MYC</i> transcription repression.</div></div><div id="sec1_11_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Pyridone-Binding Motifs</h3><div class="NLM_p"><i>N</i>-Methyl pyridones and a wide variety of derivatives have been reported by several groups. These bind bromodomains with high affinities because of their ability to recapitulate many of the same interactions with Asn140 and Tyr97 as seen for other scaffolds. For example, co-crystal structures of compounds related to compounds <b>59</b>, <b>60</b>, and <b>61</b> show the pyridone carbonyl forming a direct H-bond with Asn140 and an interaction with Tyr97 through a water molecule (<a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>C). The <i>N</i>-methyl group fills the back of the KAc binding pocket.</div><div class="NLM_p">In some of the first descriptions of this motif, researchers at AbbVie reported 4-aryl-substituted pyrrolopyridones (with<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> and without<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> substitution on the pyrrole ring) that achieved low nanomolar and even subnanomolar activity against the BRD4 bromodomains. For example, the BRD4(1) IC<sub>50</sub> for compound <b>59</b> (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>) was measured to be 3 nM, which translated into a GI<sub>50</sub> of 1 nM for MX-1 cells. Related compounds have shown efficacy in mouse tumor xenograft models and in in vivo IL-6 release models of inflammation.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><div class="NLM_p">Around the same time, a team at GSK also disclosed fused pyridones that incorporated either a furan [<b>60</b>, BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>]<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> or thiophene [<b>61</b>, BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>] ring.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> In both cases, the fused pyridone served as the KAc mimetic, and a heteroaryl group interacted with the WPF shelf to position an ether-linked cyclo-alkane or -arene over the gatekeeper residue. Interestingly, some of the pyrrolopyridones reported by AbbVie are more than 150-fold selective for BRD4(2) over BRD4(1). In contrast, GSK’s furopyridone <b>60</b> is reported to be at least 100-fold selective for BRD4(1) over BRD4(2). In general, selectivity for either the first or second bromodomain of BRD4 holds true for all the other members of the BET family, suggesting that these compounds can be used to investigate the contributions of individual bromodomains to pan-BET family inhibition-mediated phenotypes and toxicities.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0023.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Recently reported BET inhibitors with pyridone-derived KAc mimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AbbVie later disclosed that the fused pyrrolopyridone group could be deconstructed to its pyridone core and still retain low nanomolar activity.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> However, they subsequently found that macrocyclization between the pyridone and the gatekeeper-binding motif afforded more potent compounds, such as <b>62</b> [BRD4(1) IC<sub>50</sub> = 2 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>], with the cyclization presumably promoting the active conformation.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> In an in vivo mouse model of inflammation, <b>62</b> was found to reduce IL-6 release by 83% following lipopolysaccharide stimulation. AbbVie also found that the pyrrolopyridone could be cyclized onto the moiety that covered the gatekeeper residue while maintaining potency and physicochemical properties consistent with oral dosing. For example, fused polycyclic pyrrolopyridone <b>63</b> [BRD4(1) IC<sub>50</sub> = 0.7 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>], with a sulfone-substituted phenyl core and fluorophenyl lipophilic binding element, bound BRD4(1) and BRD4(2) equally. Compound <b>63</b> reduced tumor growth by 95% after 21 days of QD dosing at 1 mpk in a multiple myeloma mouse xenograft model (animals showed no weight loss).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div><div class="NLM_p">Interestingly, the team at AbbVie also found that the methyl group of the pyridone could be moved to the pyrrole nitrogen, accompanied by a corresponding shift of the aryl group.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> Presumably, the binding mode of the pyrrolopyridone flips to position the methyl group in the same place as the methyl of the acetyl group of the natural substrate. Representative compound <b>64</b> [BRD4(1) IC<sub>50</sub> = 1 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>] was used in a mouse xenograft model of multiple myeloma, where it showed 79% tumor growth inhibition following 21 days of QD dosing at 2.5 mpk. A related isoindolone series was also explored, in which the pyrrole connectivity was rearranged and the pyridone was partially reduced to form compounds like <b>65</b> (<a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>). The compound proved efficacious in a mouse xenograft model of multiple myeloma, albeit at substantially higher doses than pyrrolopyridone <b>59</b>.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">A group at Novartis arrived at a different series of <i>N</i>-methylpyridone BET inhibitors.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Researchers there took a modular approach in which they coupled a pyrrolopyrrolone with multiple different potential KAc mimetics, including dimethylisoxazole, 1,2,4-triazole, 1,2,3 triazole, and <i>N</i>-methylpyridone. Some of the resulting compounds, like <b>66</b> [BRD4(1) IC<sub>50</sub> = 85 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>], inhibited growth of MV4-11 and THP cells and proved not only to bind BRD4 but also to be submicromolar inhibitors of the CBP bromodomain.</div><div class="NLM_p">Benzimidazoles and their derivatives have also been pursued as the core of potent BET inhibitors. Incyte reported a series linked to the KAc binding group at either the 4-<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> or 5-position<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> that apply a substituted aryl ether as the WPF shelf binding element. Researchers at Boehringer-Ingelheim combined 2-substituted benzimidazoles with an additional nitrogen in the KAc mimetic to create compounds like <b>67</b> [BRD4(1) IC<sub>50</sub> = 8 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>].<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a></div><div class="NLM_p last">Finally, workers at Quanticel explored a benzo fusion to the pyridone and arrived at compounds like <b>68</b> [BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>], which is similar to the AbbVie compound <b>59</b>.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div></div><div id="sec1_11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Other Motifs</h3><div class="NLM_p">Although many of the BET bromodomain inhibitors disclosed in recent years have been derived from the seminal work on one of the scaffolds described above, a few drug discovery groups have been successful at developing different chemical matter. Most, but not all, of these compounds satisfy the Asn140/Tyr97 interaction with some sort of carbonyl-based KAc mimetic group, as is the case with <b>40</b> that applies a dihydroquinazolinone core. The [6–6] ring system positions a methyl substituent in the back of the KAc pocket and an arylsulfonamide over the gatekeeper, which together lead to its BRD4(1) IC<sub>50</sub> of 220 nM. A related oxindole series, with compounds like <b>69</b> [BRD4(1) IC<sub>50</sub> < 150 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>], was more recently reported by Orion.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0024.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Recently reported BET inhibitors with less common KAc binding motifs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With their disclosure of hydropyridopyrazinone and hydroquinoxalinone analogues, a group at Bayer identified a different class of KAc mimetic motif with a substitution pattern different than that of <b>40</b>.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Structurally similar to reported kinase inhibitor <b>80</b> (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>),<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> compounds such as <b>70</b> (<a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>) bind Asn140/Tyr97 through their carbonyl, employing the fused heterocycle as the core and the fluorophenyl group as the lipophilic binding element. The core pyrimidine and aniline linker would be expected to make through-water hydrogen bonds with Gln85 and Pro82 based on the co-crystal structure of <b>80</b> bound to BRD4(1).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Compounds from this series were active both biochemically and against a panel of leukemia and myeloma cell lines.</div><div class="NLM_p">A group at GSK found that the carbonyl group of the KAc mimetic, in compounds like <b>71</b>, could be moved out of the [6–6] ring system into an acyl moiety while maintaining potency. Optimization of this template eventually led to I-BET726 [aka GSK1324726A, 4-((2<i>S</i>,4<i>R</i>)-1-acetyl-4-(4-chlorophenylamino)-2-methyl-1,2,3,4-tetrahydroquinolin-6-yl)benzoic acid].<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> In compounds like <b>71</b> [BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>], the <i>N</i>-acyl group serves as the Asn140/Tyr97-proximal KAc mimetic, positioning 4-anilino substituents to serve as the lipophilic binding group.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a></div><div class="NLM_p">In further work, Forma Therapeutics also took advantage of an <i>N</i>-acyl KAc mimetic group, employing a substituted tetrahydroquinoxaline core.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> In compounds like <b>72</b> [BRD4(1) IC<sub>50</sub> < 100 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>], a substituted pyrazole is positioned to make edge/face interactions with Trp81 in the WPF shelf, and the arylcarbamate interacts with the Ile146 gatekeeper. Analogues containing a tetrahydroquinoline core with 5-aryloxy substituents were also found to be competent BET bromodomain inhibitors.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">In an interesting twist on the diazepine motif of some of the early BET bromodomain inhibitors, the group at Bayer disclosed, in 2014, dihydrobenzodiazepine carboxamides exemplified by <b>73</b> [BRD4(1) IC<sub>50</sub> = 20 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>].<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Showing growth inhibition of multiple cancer lines, these compounds likely bind Asn140/Tyr97 through the methyl carboxamide, positioning the 4-methyl substituent in the water pocket and orienting the substituted aryl group as the lipophilic binding element.</div><div class="NLM_p">Around the same time, researchers at AbbVie described a series of 3-carboxamide pyrrole-based BET inhibitors.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> This class of compounds [represented by <b>74</b>, BRD4(1) IC<sub>50</sub> = 78 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>] appears to represent a deconstructed version of AbbVie’s pyrrolopyridone series (<b>65</b>, <a class="ref internalNav" href="#fig22" aria-label="Figure 22">Figure 22</a>) in which all the main binding elements are conserved. Compound <b>74</b> showed activity against a breast cancer cell line (EC<sub>50</sub> = 170 nM). A group at Freiburg University identified similar chemical matter in which an acyl moiety serves as the KAc mimetic and contains a substituted acetanilide, although many of these compounds demonstrated only a modest selectivity over other bromodomains, such as CBP.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a></div><div class="NLM_p">At the Icahn School of Medicine at Mount Sinai, Zhou and co-workers reported a different series of BET inhibitors with unique structural features [e.g., <b>75</b>, BRD4(1) IC<sub>50</sub> < 1 μM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>].<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Although the binding mode of these compounds was not described, one could presume they interact with Asn140 via the carbonyl group of the vinylogous amide, which would position the α-methyl group found in the most potent representatives in the water pocket.</div><div class="NLM_p">Zenith/Resverlogix have described a number of compounds related to <b>76</b> [RVX-208, BRD4(1) ITC <i>K</i><sub>d</sub> = 1,100 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>], now in human clinical trials. Compound <b>76</b> is an inhibitor of ApoA1 production that was discovered by phenotypic screening and later determined to act through BET bromodomain inhibition.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> In this class of compounds, a quinazolinone serves as the KAc binding group and core, interacting with Asn140/Tyr97 via the carbonyl and through-water with the 5-methoxy substituent. Interestingly, <b>76</b> has no WPF shelf binding element and, instead, extends a substituted aryl moiety toward the BC loop, where there are substantial differences between the residues in BRD4(1) and BRD4(2). Perhaps because of the different interactions in that region, compounds in this class show greater potency toward all second bromodomains of BET-class proteins than toward the first bromodomains [<b>76</b>, BRD4(2) ITC <i>K</i><sub>d</sub> = 140 nM].<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> The in vitro activity of <b>76</b> and its relatives translates well into cellular potency, with many compounds from this series showing activity in assays of mRNA transcript reduction and suppression of IL-6 release following LPS stimulation.</div><div class="NLM_p">Noguchi-Yachide and co-workers recently determined that benzoylated adenine derivatives are capable of binding BET bromodomains, although, with the exception of <b>77</b> (BRD4(1) IC<sub>50</sub> = 430 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>), most compounds from this series displayed only modest potency.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> No binding mode was reported for this series, but a related series of amino purines has been reported to bind the BRD9 bromodomain through a purine nitrogen.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p last">Finally, in one of the only examples of a KAc mimetic that is not a triazole, isoxazole, or carbonyl, Zhou and co-workers described a series of diazabenzenes that interact with the conserved Asn via hydrogen bond with a phenol.<a onclick="showRef(event, 'ref300'); return false;" href="javascript:void(0);" class="ref ref300">(158)</a> Compound <b>78</b> [BRD4(1) IC<sub>50</sub> < 85 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>] applies an extended diazabenzene system as the body with no formal lipophilic shelf binding element. Instead, a co-crystal structure shows that the heteroaryl sulfonamide covers Trp81 and makes water-mediated contacts between a diaza nitrogen and Pro82. Compound <b>78</b> was shown to be >25-fold selective over the non-BET bromodomains tested and inhibited cellular IL-6 release (IL-6 EC<sub>50</sub> = 4.9 μM), albeit with a ∼100-fold potency shift relative to biochemical assays. These data establish the scaffold as a structurally unique inhibitor of BET bromodomains.</div></div><div id="sec1_11_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biophysical and Computational Identification of BET Inhibitors</h3><div class="NLM_p">Given the tremendous interest in BET biology and how well-behaved its bromodomains are in biochemical assays, the target has emerged as a platform from which to explore new approaches for the identification of inhibitor starting points. For example, Pomerantz and co-workers have established <sup>19</sup>F NMR as a paradigm for finding bromodomain ligands.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(159)</a> They found that the bromodomains of BRD4, BRDT, or BPTF expressed in the presence of fluorine-labeled tyrosine or tryptophan led to stable <sup>19</sup>F NMR-active constructs with negligible difference in their structure or ability to bind known ligands like <b>1</b>. Importantly, several of the fluorine resonances shifted measurably upon addition of <b>1</b>, indicating that they could serve as a readout of ligands binding in the KAc recognition site. It was also found that a second fluorine-labeled bromodomain could be observed simultaneously, which allowed the group to screen for selective binders. In a proof of concept screen, 229 small molecules from a kinase inhibitor set were evaluated at 100 μM against BRD4(1) and BPTF bromodomains, resulting in the identification of novel classes of selective binders for each of the BET and BPTF bromodomains.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> ITC and fluorescence polarization assays with the wild-type domains yielded <i>K</i><sub>d</sub>s and <i>K</i><sub>i</sub>s for the new ligands ranging from 0.3–13 μM, demonstrating the utility of this approach.</div><div class="NLM_p">Because of the structural rigidity of the isolated bromodomain and the large number of high quality co-crystal structures bound to inhibitors, computational approaches have seemed a natural fit to identify new inhibitors. To that end, Zhao and Caflisch recently reported on a fragment-based docking approach that led to the identification of biophysically validated chemical matter.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(160)</a> Using their anchor-based library tailoring technique, they decomposed millions of compounds from the ZINC library into rigid fragments. These were then filtered based on molecular properties such as size and rotatable bonds before being docked into the BRD4(1) bromodomain. Parent compounds that contained at least one of the anchor fragments prioritized through this method were then docked and further evaluated in various molecular dynamics simulations to yield 24 compounds, four of which showed BRD4(1) Δ<i>T</i><sub>m</sub> > 1 °C in a DSF assay. Co-crystal structures were reported for two of the compounds [BRD4(1) IC<sub>50</sub> ≅ 7 μM], each of which contained a carbonyl that bound Asn140.</div><div class="NLM_p">A group teamed with the SGC took a virtual approach to fragment screening, in which they drew upon a library of KAc mimics, fragments based on known bromodomain binders, and topology-based similarity searches for their docking studies.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(161)</a> The team took several steps to rule out false positives, including the elimination of poses with compounds in obviously high-energy conformations. This resulted in 250 promising compounds, six of which showed meaningful activity in a biochemical assay and four of which were co-crystallized with BRD4(1). Of the four compounds, two had pyridone-like KAc mimetics, while the others (a quinoline and a triazole) demonstrated novel interactions with Asn140/Tyr97.</div><div class="NLM_p">Fragments were also the focus of a study by Shen and co-workers, in which a library of ∼500 compounds with physicochemical properties favorable for drug discovery were docked using Glide into a co-crystal structure of <b>1</b>.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(162)</a> Requiring a hydrogen-bonding interaction with Asn140, the group identified 41 fragments for crystallography experiments and obtained nine co-crystal structures. Among the fragments was a substituted thiazolidinone, a relatively ligand-efficient KAc binding motif that had not been described previously. Subsequent addition of an arylsulfonamide to interact with the Ile gatekeeper residue increased the potency and resulted in compounds like <b>79</b> [BRD4(1) IC<sub>50</sub> = 230 nM, <a class="ref internalNav" href="#fig23" aria-label="Figure 23">Figure 23</a>], which displayed weak HT-29 antiproliferative activity.</div><div class="NLM_p last">Finally, a group from Zenith and Albany Molecular used Glide to screen a database of millions of known compounds in silico against protein models based on the complex of <b>76</b> and BRD4(1).<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(163)</a> Importantly, a water molecule that bridges an H-bonding interaction between most known BRD4 bromodomain ligands and Tyr97of BRD4(1) was treated as a structural water in the workflow. This virtual screen resulted in 153 prioritized compounds representing 82 scaffolds. Subsequent in vitro characterization in a TR-FRET assay identified a number of inhibitors of modest potency, including a quinoxalinone scaffold [BRD4(1) IC<sub>50</sub> = 9 μM] that formed a bidentate hydrogen bonding interaction with Asn140 in a co-crystal structure.</div></div><div id="sec1_11_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Assessing Target Engagement/Cellular Activity</h3><div class="NLM_p">Because of the increasing interest in using small molecule inhibitors to explore the phenotypic implications of disrupting BET bromodomains and because of the lack (until recently) of an unequivocal proximal gene or other pathway readouts connected to most of the bromodomain-containing targets, a great deal of work in recent years has gone into developing methods for assessing the cellular activity of small molecule bromodomain inhibitors.</div><div class="NLM_p">In one approach, a team at the SGC adapted the concept of fluorescence recovery after photobleaching (FRAP) to the analysis of bromodomain binding.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(164)</a> They found that when a small section of the nucleus of cells expressing green fluorescent protein linked to either BRD4(1) or BRD4(2) mutated at Asn140 was irradiated with a high power laser pulse, bleaching the fluorescence of all molecules in that section, the fluorescence pattern returned to baseline more quickly in the cells with the mutant construct than the nonmutant one. This faster return to baseline for the mutant construct is consistent with its greater mobility within the nucleus due to a weakened ability to localize to chromatin. Experiments with <b>1</b> and <b>40</b> using the native construct resulted in recovery half-lives indistinguishable from those of the mutant constructs, providing support for the full engagement of the bromodomain by the inhibitors at the concentrations tested. Importantly, this approach allows for an assessment of whether inhibition of a bromodomain is sufficient to displace a full-length, multidomain protein from chromatin. The data from the SGC suggest that is the case for the BET proteins but not, for example, for CBP. Displacement from chromatin is clearly not the only requirement for a meaningful phenotype, however, because recent reports have implicated CBP bromodomain inhibition in the suppression of the IL-17 cytokine, for example.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">A method disclosed by a team at Constellation and Genentech also took advantage of changes in fluorescence pattern to assess target engagement.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(165)</a> As depicted in <a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>A, cells expressing a Zs-green fluorescent protein linked to a bromodomain display a relatively diffuse fluorescence pattern throughout the nucleus, reflecting the distribution pattern of the bromodomain. Application of a small molecule bromodomain inhibitor was found to disrupt the fluorescence pattern and lead to the formation of highly fluorescent punctate structures or “dots”, presumably due to aggregation of the Zs-green fusions following their displacement from chromatin. Quantification of the formation of the dots at different concentrations of inhibitor allowed for a measure of target engagement.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0025.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Schematic representation of the (A) dot assay and (B) BRET assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another approach, Promega Corporation developed a bioluminescence resonance energy transfer (BRET) assay that has also proven useful in evaluating the cellular activity of BET and other bromodomain inhibitors (<a class="ref internalNav" href="#fig24" aria-label="Figure 24">Figure 24</a>B).<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(166)</a> In their assay, cells express a protein domain of interest [e.g., BRD4(1)] fused to a bioluminescent reporter such as nanoluciferase. In the presence of a tracer construct comprising an acetylated lysine tail coupled to a fluorophore, BRET takes place following irradiation of the system at an appropriate wavelength. Application of a small molecule causes a quantifiable loss in BRET signal, consistent with a disruption of the bromodomain/tracer recognition and cellular target engagement. Importantly, it has been found that the acetylated lysine of the tracer piece can be replaced by a validated small molecule inhibitor, which can lead to a substantial improvement in signal.</div><div class="NLM_p">Researchers at Bayer<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(167)</a> and DiscoveRx Corporation<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(168)</a> independently took a very different approach toward assessing compound activity in cells based on the ability of a small molecule to bind a target peptide and provide measurable protection from proteolytic degradation in cells. In proof of concept experiments with BRD4, the teams showed that <b>1</b> increased the half-life of a truncated bromodomain linked to a readout peptide, consistent with cellular target engagement. The increased levels of the target could be quantified either by β-galactosidase fragment complementation or TR-FRET, either of which was amenable to a high-throughput screening format.</div><div class="NLM_p last">As with any biological assay, each of these methods described has strengths and limitations, but having multiple approaches available is invaluable to researchers taking a chemical genetics approach toward target validation. Comparable results from orthogonal assays help make an unambiguous determination of target engagement, which has been highlighted as a key element in the meaningful application of a small molecule probe.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(169)</a></div></div><div id="sec1_11_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Chemical Biology and Genetic Applications of BET Inhibitors</h3><div class="NLM_p">The report of potent and selective compounds like <b>1</b> and <b>2</b>, combined with the interest in decoupling the roles of the different bromodomains of BET family members, has led a number of groups to modify BET bromodomain inhibitors into tools for use in chemical biology studies.</div><div class="NLM_p">In an example disclosed in 2013, Coferon described compounds that would engage both bromodomains of the BET proteins simultaneously, with the goal of effecting greater release of BET from chromatin and, possibly, a stronger phenotype.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(170)</a> Their strategy relied entirely on using other reported bromodomain inhibitors, connected by a variety of linkers at different sites around the molecules, and many of the resulting compounds were very potent. It was not immediately apparent whether the dimeric inhibitors were substantially more potent than their monomeric counterparts (or even whether they were engaging both bromodomains, as intended), but the approach did identify compounds with a MV4-11 GI<sub>50</sub> below 30 nM. A later disclosure focused on developing monomeric BET inhibitors that could dimerize spontaneously in aqueous solution to achieve the same effect.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(171)</a></div><div class="NLM_p">Recently, Crews and co-workers at Yale described an intriguing application of bromodomain inhibitors to effect the degradation of the BET family by the proteasome.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(172)</a> Having grown out of their longstanding effort to link specific inhibitors to a so-called “degradation module”, this approach tethered <b>41</b> to pomalidomide (which was recently shown to bind cereblon, a substrate adaptor for a cullin-type ubiquitin ligase complex; <a class="ref internalNav" href="#fig25" aria-label="Figure 25">Figure 25</a>).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(173)</a> The group demonstrated that the resulting hybrids were still capable of binding their individual protein targets but caused them to colocalize in cells and degrade BRD4 in an ubiquitin-dependent manner. As expected, levels of MYC decreased, which led to apoptosis in BET-dependent cell lines. Bradner and co-workers created similar hybrid compounds and extended the concept to a mouse xenograft study in which they showed efficacy against a MYC-driven patient-derived cell line.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(174)</a> Ciulli and co-workers also reported using a BET bromodomain inhibitor hybrid to elicit proteasomal degradation, targeting, instead, the VHL component of the ubiquitin ligase complex.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(175)</a> Curiously, these latter compounds degraded BRD4 more effectively than either BRD2 or BRD3, which raises the possibility of examining the role of the individual members of the BET family to the observed phenotypes, although their initial experiments suggest that BRD4 ablation alone is sufficient to reduce MYC expression analogous to application of <b>1</b>.</div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0026.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Compound <b>41</b> (blue) tethered to pomalidomide (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same group also reported modifying <b>2</b> to take a “bump and hole” approach to deconvoluting the different contributions of the bromodomains of the BET family.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(176)</a> Hypothesizing that an α-substituent on the acetamide side chain might clash with the highly conserved residue Leu94, they found a substantial shape complementarity between an ethyl derivative and the appropriate Leu94 mutant bromodomains. FRAP studies confirmed that the effects translated into cells.</div><div class="NLM_p last">Also of note is a report from a team at Pfizer on the application of BRD4(1) inhibitors that incorporate a photolabile tropone (which was found to be a competent KAc mimetic) and pendant alkyne. The probes allowed for the direct photolabeling and pull down of their targets, which could be used to study off-target binding.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(177)</a> Finally, Young, Bradner, and co-workers used JQ1-derived compounds as capture reagents; followed by DNA sequencing, allowing for the determination of the genomic targets of small molecules.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(178)</a></div></div><div id="sec1_11_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> BET Bromodomain/Kinase Dual Inhibition</h3><div class="NLM_p">In part because of the potential of synergistic polypharmacology between BET bromodomain inhibitors and kinases known to be active against hematological cancer cell lines<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(179)</a> and in part because of the similarity between the KAc binding groups that engage Asn140/Tyr97 in bromodomains and known hinge binders in kinase inhibitors, several groups have investigated whether dual bromodomain/kinase inhibitors can be identified.</div><div class="NLM_p">PI3K has been the focus of some of the efforts to develop dual inhibitors, spurred on by reports of a synergistic biological activity between inhibitors targeting that kinase and BET inhibitors.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(180)</a> In one of the first reports toward this end, a group at Cellzome identified PI3 kinase inhibitors <b>81</b> and <b>82</b>, shown in <a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>, as binders of BRD4(1) but not BRD4(2).<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(181)</a> Co-crystal structures established that the two chromenone-based compounds bind the bromodomain in a mode similar to <b>76</b>, and they also recapitulated cellular activity in established cancer and inflammation cellular models.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Some reported BET bromodomain/kinase dual inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using an alpha screen of BRD4(1), a group at the SGC determined that a number of compounds from a set of known kinase inhibitors bound the bromodomain.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(182)</a> Around the same time, separate crystallization studies established the binding modes of more than a dozen, including some with submicromolar potency, such as the PLK1 inhibitor <b>80</b> (<a class="ref internalNav" href="#fig26" aria-label="Figure 26">Figure 26</a>), a dihydroquinoxaline related to <b>70</b>.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Although <b>80</b> had some activity against one of the bromodomains of TAF1, it was, in general, selective for the BET family. Fletcher and co-workers at the University of Maryland later undertook a structure–activity relationship study of <b>80</b> binding to BRD4(1) and corroborated many of the key binding interactions suggested from the co-crystal structure.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(183)</a> Despite optimization of potency to single-digit nanomolar levels on both targets, dual inhibitors were not more active in a GI<sub>50</sub> assay against MV4-11 cells (GI<sub>50</sub> = 19 nM), although further testing in a broader cell panel or in vivo studies are necessary to determine whether dual bromodomain/kinase inhibitors display increased efficacy.</div><div class="NLM_p last">Interestingly, while dual bromodomain/kinase inhibition has been intentionally targeted, there have been few reports of efforts to develop potent poly bromodomain inhibitors to investigate the biological implications of displacing multiple bromodomain-containing proteins from chromatin at once.</div></div><div id="sec1_11_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Selected New Biological Phenotypes Elucidated With Small Molecule Probes</h3><div class="NLM_p">As mentioned above, certain BET bromodomain-driven phenotypes, including growth inhibition of a number of hematological cancer cell lines and suppression of inflammatory response pathways, have been well established, and there is increasing understanding of the mechanisms behind them.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(184)</a> Recent years have seen an explosion of reports on various aspects of BET-driven biology, and while a thorough review of the literature is beyond the scope of this perspective, a few highlights are worth mentioning.</div><div class="NLM_p">Several groups have investigated whether BET bromodomain inhibition has the potential for application to cancers outside of leukemia and lymphoma. For example, an shRNA screen in an ovarian carcinoma cell line implicated BRD4 as a new potential therapeutic target.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(185)</a> Pharmacologic treatment with <b>1</b> recapitulated the shRNA results in that cell line, and it inhibited growth in other ovarian cancer cell lines in a pattern that correlated with suppression of MYC expression. In a study in cells derived from castration-resistant prostate cancer, Chinnaiyan and co-workers at the University of Michigan found that BET bromodomain inhibition with <b>1</b> disrupted androgen receptor signaling, leading to growth inhibition of cells and activity in a mouse xenograft model.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(186)</a> In another promising report of expanded indications for BET bromodomain-based therapy, a transcriptional analysis of malignant peripheral nerve sheath tumors implicated the involvement of BRD4 in cell growth.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(187)</a> Again, <b>1</b> was used to demonstrate efficacy in a mouse xenograft model of the disease.</div><div class="NLM_p">There have also been some reports of increased activity when the BET bromodomains are inhibited in the context of other therapeutics, even beyond the kinase inhibitors discussed above. One study revealed that <b>1</b>, <b>39</b>, and <b>40</b> all acted in synergy with the immunomodulatory drug lenalidomide in a model of an aggressive non-Hodgkin lymphoma.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(188)</a> Combination therapy also demonstrated increased efficacy in vivo. Furthermore, whereas <b>1</b> itself was not sufficient to inhibit tumor growth in a xenograft model of osteocarcoma, combination therapy with rapamycin was markedly more effective.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(189)</a></div><div class="NLM_p last">Outside of cancer, there are indications that BET plays a role in viral life cycles, including a report in 2012, which demonstrated that the application of either BRD4 shRNA or <b>1</b> induced HIV out of a latent state in T cells<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(190)</a> and provided evidence that BRD4 is involved with the initiation of DNA replication in human papilloma virus.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(191)</a> Finally, BET bromodomain inhibition by <b>1</b> has been demonstrated to suppress the expression of DUX4, a transcriptional activator believed to be a driver of facioscapulohumeral muscular dystrophy,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(192)</a> and treatment with <b>39</b> reduced graft-versus-host disease in an animal model of bone marrow transplantation.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(193)</a></div></div><div id="sec1_11_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Clinical Applications of BET Inhibitors</h3><div class="NLM_p">As the most- and longest-studied bromodomains, it is perhaps not surprising that BET inhibitors lead the other bromodomains in the clinic. While the first clinical trials of BET inhibitors (<b>76</b>) have focused on cardiovascular outcomes, the other molecules are being used initially in the oncology setting (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Undoubtedly, scientists, medical professionals, patients, and industry watchers will be closely following this highly competitive field.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Summary of BET Inhibitors in Clinical Trials for Oncology Indications</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">company</th><th class="colsep0 rowsep0" align="center">molecule</th><th class="colsep0 rowsep0" align="center">most advanced clinical phase</th><th class="colsep0 rowsep0" align="center">solid tumors or heme malignancies</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OncoEthix/Merck</td><td class="colsep0 rowsep0" align="left"><b>41</b> (OTX-015)</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK</td><td class="colsep0 rowsep0" align="left"><b>2</b> (GSK-525762)</td><td class="colsep0 rowsep0" align="center">1/2</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Constellation</td><td class="colsep0 rowsep0" align="left">CPI-0610</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">heme malignancies</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tensha</td><td class="colsep0 rowsep0" align="left">TEN-010</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bayer</td><td class="colsep0 rowsep0" align="left">BAY 123809</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gilead</td><td class="colsep0 rowsep0" align="left">GS-5829</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Incyte</td><td class="colsep0 rowsep0" align="left">INCB054329</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AbbVie</td><td class="colsep0 rowsep0" align="left">ABBV-075</td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">both</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS</td><td class="colsep0 rowsep0" align="left">BMS-9861158</td><td class="colsep0 rowsep0" align="center">1/2a</td><td class="colsep0 rowsep0" align="left">solid tumors</td></tr></tbody></table></div></div><div class="NLM_p">Leading the way in oncology is <b>41</b>. The first of the trials initiated by OncoEthix (ClinicalTrials.gov identifier: NCT01713582) was a dose-finding study for patients with acute leukemia and other hematological malignancies. This trial started in December 2012, and interim results were presented at the 2014 AACR Annual Meeting<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(194)</a> and the 56th ASH Annual Meeting.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(195)</a> More recently, final results of the dose-finding effort were reported at the 13th International Congress on Targeted Anticancer Therapies (TAT).<a onclick="showRef(event, 'ref195 ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref195 ref196 ref197">(196-198)</a> Oral PK of the compound was found to be linear up to 120 mg. In acute leukemia (AL) patients, the maximum tolerated dose (MTD) was found to be 120 mg with dose limiting toxicities of diarrhea and fatigue at 160 mg. Prevalent grade 1/2 gastrointestinal adverse events that limited compliance were noted at 120 mg. In patients with other hematological malignancies (OHM), the MTD was found to be 80 mg and the dose limiting toxicity (DLT) was thrombocytopenia. Grades 3 and 4 thrombocytopenia was observed in multiple patients at doses of 80 mg of QD and above. Platelet levels did recover during a dosing holiday, and as development of <b>41</b> proceeds, a discontinuous dosing schedule will be employed with a recommended dose of 80 mg. It remains to be seen is how effectively <b>41</b> can be combined with other therapies given the required dose holiday. In addition to PK and safety, clinicians were able to monitor patients for signs of efficacy. Responses were observed in AML and lymphoma patients, and, given this early clinical success, Merck and OncoEthix are proceeding with a number of other trials. In October 2014, a phase Ib trial was initiated that will examine <b>41</b> in patients with advanced solid tumors (ClinicalTrials.gov identifier: NCT02259114). The tumor types will include NUT midline carcinoma, triple-negative breast cancer, nonsmall cell lung cancer with rearranged ALK gene/fusion protein or KRAS mutation, castration-resistant prostate cancer, and pancreatic ductal adenocarcinoma. In November 2014, Merck/Oncoethix initiated a phase IIa trial in patients with recurrent glioblastoma multiforme (ClinicalTrials.gov identifier: NCT02296476). After dose escalation to determine the MTD, the expansion cohort will assess efficacy as measured by progression-free survival. Lastly, investigators are planning to assess <b>41</b> in combination with azacitidine in patients with newly diagnosed AML that are not candidates for standard intensive induction therapy (ClinicalTrials.gov identifier: NCT02303782).</div><div class="NLM_p">GSK has also been active in the clinic with their BET inhibitor, <b>2</b> (GSK-525762). In May 2012, they initiated a study to investigate safety, PK, PD, and clinical activity of their molecule in a number of solid tumors including NUT midline carcinoma, small-cell lung cancer, nonsmall cell lung cancer, colorectal cancer, neuroblastoma, castration-resistant prostate cancer, triple-negative breast cancer, estrogen receptor positive breast cancer, and MYC-driven solid tumor subjects (ClinicalTrials.gov identifier: NCT01587703). That their initial study is being conducted in such a large and diverse group of patients speaks not only to the broad range of tumor types where BET therapy may be beneficial but also to the difficulty in choosing a patient group on the basis of a predictive biomarker. In addition to the clinical trial in solid tumors, GSK initiated a study in patients with relapsed, refractory hematologic malignancies (ClinicalTrials.gov identifier: NCT01943851).</div><div class="NLM_p">CPI has focused their initial clinical efforts with CPI-0610 on heme malignancies, starting three separate trials in collaboration with The Leukemia and Lymphoma Society. The first trial, started in September 2013, is being run in patients with progressive lymphoma and intended to explore PK, safety, and pharmacodynamics markers (ClinicalTrials.gov identifier: NCT01949883). Less than a year later, they initiated a trial in patients with acute leukemia, myelodysplastic syndrome, or myelodysplastic/myeloproliferative neoplasms (ClinicalTrials.gov identifier: NCT02158858) and a trial in patients with previously treated multiple myeloma (ClinicalTrials.gov identifier: NCT02157636). Outcome measures in these two more recent trials are similar to those being evaluated in their first study.</div><div class="NLM_p">In addition to the three molecules discussed already in this section, phase I clinical trials have also been initiated for a number of other molecules whose structures have not yet been disclosed. TEN-010 (structure not disclosed), being investigated by Tensha Therapeutics, is known to be closely related to <b>1</b> in structure. Tensha has initiated a trial in patients with acute myeloid leukemia and myelodysplatic syndrome (ClinicalTrials.gov identifier: NCT02308761) and another in patients with advanced solid tumors where TEN-010 is being administered subcutaneously (ClinicalTrials.gov identifier: NCT01987362). Bayer has started their first trial in all-comers with solid tumors and lymphoma with BAY 1238097 (structure not disclosed; ClinicalTrials.gov identifier: NCT02369029), and Gilead is testing GS-5829 (structure not disclosed) in patients in a similarly broad patient population (ClinicalTrials.gov identifier: NCT02392611). Similarly, Incyte is testing INCB054329 (structure not disclosed) in patients with any advanced solid malignancy or lymphoma (ClinicalTrials.gov identifier: NCT02431260), while AbbVie is focusing study of ABBV-075 (structure not disclosed) in patients with breast cancer, nonsmall cell lung cancer, acute myeloid leukemia, or multiple myeloma (ClinicalTrials.gov identifier: NCT02391480). Lastly, BMS is initially testing BMS-986l158 (structure not disclosed) only in patients with solid tumors (ClinicalTrials.gov identifier: NCT02419417) but will be dosing it alone and in combination with paclitaxel in both the dose escalation and expansion parts of the study. With the exception of the TEN-010 study in patients with solid tumors, all of the trials mentioned in this paragraph started in 2015 as these companies make efforts to catch up to the clinical studies that are further ahead.</div><div class="NLM_p last">Outside of oncology, Resverlogix is pioneering the clinical investigation of BET inhibitor <b>76</b> in a number of cardiovascular indications including atherosclerosis (ClinicalTrials.gov identifier: NCT01058018), coronary artery disease (ClinicalTrials.gov identifier: NCT01067820), dyslipidemia (ClinicalTrials.gov identifier: NCT01423188), and type II diabetes (ClinicalTrials.gov identifier: NCT01728467). The results of these completed phase II trials were reviewed previously,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> but the most promising finding was that, upon pooling data, a statistically significant reduction of major adverse cardiovascular events (MACE) was observed in patients receiving <b>76</b> compared to placebo. With these results, Resverlogix has moved forward with plans to conduct a phase III study.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(199)</a> The study design has been submitted to the European Regulatory Authority, and initiation is planned for late 2015. The primary end point of this trial, appropriately named BETonMACE, will be designed to show a relative risk reduction of MACE in high risk cardiovascular and diabetes mellitus patients.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13624" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13624" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Since the disclosure of <b>1</b> and <b>2</b>, there has been significant progress in the development of bromodomain inhibitors. The BET family has seen an explosion of new chemical matter, and this is not surprising as several BET inhibitors are currently progressing in the clinic for oncology and cardiovascular indications. As the results for these clinical trials are disclosed, positive data will bring much enthusiasm to this field of bromodomain inhibition. Some of the most exciting progress over the past few years has been in the development of non-BET bromodomain inhibitors. These new probes should aid in the understanding of the physiological function of the targeted bromodomain and its relevance in certain disease states. One of the key challenges in non-BET bromodomain probe identification is selectivity. Because the biology is not well understood for many of these bromodomains, contamination of off-target bromodomain activity (as well as other off-targets) can easily confound results. Gaining selectivity against the BET bromodomains has been of utmost importance because inhibition of BET produces very strong and broad phenotypes. A recurring theme in the development of potent and selective non-BET BRD inhibitors is targeting the “WPF shelf” and “gatekeeper” regions. As discussed above, this area of the binding site often differs substantially among bromodomains. For instance, in the development of CBP and ATAD2 inhibitors, the “WPF shelf” region proved vital for gaining selectivity over BET. While the KAc mimetic moiety that binds the conserved Asn is requisite for high potency, the “WPF shelf” and “gatekeeper” regions are also proving to be a key for driving selectivity and potency. Examination of published crystal structures revealed the impact of crystal packing on the conformation seen in the ligand and even protein conformations. These packing interactions near the ligand-binding site can affect the biological relevance of the observed conformations; therefore, caution needs to be taken in the interpretation of the structures or even in the design of crystallography constructs. Significant progress has been made in developing BET and non-BET bromodomain inhibitors. While there has been progress in identifying chemical probes for various bromodomains, there still remain bromodomains (e.g., TAF, WDR9, BRD8, ZMYND11, ASH1L) for which no chemical matter has been identified. In general, the non-BET bromodomain field has lagged behind that of the BET research, and it will be interesting to see whether therapeutically relevant targets are discovered and validated with in vivo tool compounds.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01514" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Anthony Romero</span> - <span class="hlFld-Affiliation affiliation">Discovery
Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#186a77757d6a77367e6a797673587f7d767d367b7775"><span class="__cf_email__" data-cfemail="eb9984868e9984c58d998a8580ab8c8e858ec5888486">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander M. Taylor</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry D. Crawford</span> - <span class="hlFld-Affiliation affiliation">Discovery
Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vickie Tsui</span> - <span class="hlFld-Affiliation affiliation">Discovery
Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandre Côté</span> - <span class="hlFld-Affiliation affiliation">Constellation
Pharmaceuticals, Inc. 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Magnuson</span> - <span class="hlFld-Affiliation affiliation">Discovery
Chemistry, Genentech, Inc. 1 DNA Way, South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="27" class="article__inlineFigure"><h2 class="fig-label">F. Anthony Romero</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3475-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>F. Anthony Romero</b> is a medicinal chemist at Genentech in South San Francisco, California. He earned his A.B. from Occidental College and Ph.D. from the University of Kansas under Prof. Gary Grunewald. He did a postdoctoral fellowship at The Scripps Research Institute with Prof. Dale Boger and worked at Merck prior to joining Genentech.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Alexander M. Taylor</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3480-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alexander M. Taylor</b> is a medicinal chemist at Constellation Pharmaceuticals in Cambridge, Massachusetts. He received a B.Sc. in chemistry from Vanderbilt University in Nashville, Tennessee and worked with Bernd Giese at the University of Basel in Switzerland before joining the group of Prof. Stuart Schreiber in the chemistry department at Harvard University for his Ph.D. work. He conducted postdoctoral research with Prof. Stephen Buchwald at MIT before joining Constellation Pharmaceuticals.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Terry D. Crawford</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3485-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Terry D. Crawford</b> is a medicinal chemist at Genentech in South San Francisco, California. He earned his B.Sc. from the University of Nebraska, Lincoln, and worked at Pfizer prior to joining Genentech.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Vickie Tsui</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3490-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vickie Tsui</b> is a computational chemist at Genentech in South San Francisco, California. She earned her B.Sc. from Yale University and her Ph.D. from The Scripps Research Institute under Prof. David Case.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Alexandre Côté</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3495-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Alexandre Côté</b> is a medicinal chemist at Constellation Pharmaceuticals in Cambridge, Massachusetts. He earned his B.Sc. degree from Université Laval and his M.Sc. and Ph.D. degrees from Université de Montréal under the supervision of Prof. André B. Charette. He did a postdoctoral fellowship at Princeton University with Prof. Erik J. Sorensen and worked at Pharmacor and Infinity Pharmaceuticals prior to joining Constellation Pharmaceuticals.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Steven Magnuson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=BIO-d3231e3500-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Steven Magnuson</b> is a medicinal chemist at Genentech in South San Francisco, California. He earned his B.Sc. from the University of British Columbia and his Ph.D. from the University of Alberta with Prof. Derek Clive. He did a postdoctoral fellowship at Columbia University with Prof. Samuel Danishefsky and worked at Bayer prior to joining Genentech.</p></figure></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">AACR</td><td class="NLM_def"><p class="first last">American Association of Cancer Research</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">AML</td><td class="NLM_def"><p class="first last">acute myeloid leukemia</p></td></tr><tr><td class="NLM_term">ASH</td><td class="NLM_def"><p class="first last">American Society of Hematology</p></td></tr><tr><td class="NLM_term">ATAD2</td><td class="NLM_def"><p class="first last">ATPase family, AAA domain containing 2</p></td></tr><tr><td class="NLM_term">BAF</td><td class="NLM_def"><p class="first last">BRG1- or HRBM-associated factors</p></td></tr><tr><td class="NLM_term">BAZ2A/B</td><td class="NLM_def"><p class="first last">bromodomain adjacent to zinc finger domain, 2A/B</p></td></tr><tr><td class="NLM_term">BET</td><td class="NLM_def"><p class="first last">bromodomain and extra C-terminal domain</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">bis in die, twice a day</p></td></tr><tr><td class="NLM_term">BLI</td><td class="NLM_def"><p class="first last">biolayer interferometry</p></td></tr><tr><td class="NLM_term">BMS</td><td class="NLM_def"><p class="first last">Bristol-Myers Squibb</p></td></tr><tr><td class="NLM_term">BPTF</td><td class="NLM_def"><p class="first last">bromodomain PHD finger transcription factor</p></td></tr><tr><td class="NLM_term">BRD</td><td class="NLM_def"><p class="first last">bromodomain</p></td></tr><tr><td class="NLM_term">BRD(X)</td><td class="NLM_def"><p class="first last">bromodomain-containing protein X (X = 2, 3, or 4)</p></td></tr><tr><td class="NLM_term">BRD4-BD1</td><td class="NLM_def"><p class="first last">the first bromodomain of the bromodomain-containing protein 4</p></td></tr><tr><td class="NLM_term">BRD7</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 7</p></td></tr><tr><td class="NLM_term">BRD9</td><td class="NLM_def"><p class="first last">bromodomain-containing protein 9</p></td></tr><tr><td class="NLM_term">BRDT</td><td class="NLM_def"><p class="first last">bromodomain testis-specific protein</p></td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">BRG1</td><td class="NLM_def"><p class="first last">brahma related gene 1</p></td></tr><tr><td class="NLM_term">BRPF(X)</td><td class="NLM_def"><p class="first last">bromodomain and PHD finger containing (X = 1, 2, 3)</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate response element binding protein binding protein</p></td></tr><tr><td class="NLM_term">CECR2</td><td class="NLM_def"><p class="first last">at eye syndrome critical region protein 2</p></td></tr><tr><td class="NLM_term">CLEC1</td><td class="NLM_def"><p class="first last">C-type lectin domain family 1</p></td></tr><tr><td class="NLM_term">CPI</td><td class="NLM_def"><p class="first last">Constellation Pharmaceuticals</p></td></tr><tr><td class="NLM_term">CTLA4</td><td class="NLM_def"><p class="first last">cytotoxic T-lymphocyte-associated protein 4</p></td></tr><tr><td class="NLM_term">DHQ</td><td class="NLM_def"><p class="first last">3-methyl-3,4-dihydroquinazolin-2(1<i>H</i>)-one</p></td></tr><tr><td class="NLM_term">DLT</td><td class="NLM_def"><p class="first last">dose limiting toxicity</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">DNA</p></td></tr><tr><td class="NLM_term">DUSP6</td><td class="NLM_def"><p class="first last">dual specificity phosphatase 6</p></td></tr><tr><td class="NLM_term">FES</td><td class="NLM_def"><p class="first last">FES proto-oncogene, tyrosine kinase</p></td></tr><tr><td class="NLM_term">FoxP3</td><td class="NLM_def"><p class="first last">forkhead box P3</p></td></tr><tr><td class="NLM_term">FRAP</td><td class="NLM_def"><p class="first last">fluorescence recovery after photobleaching</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">GNE</td><td class="NLM_def"><p class="first last">Genentech</p></td></tr><tr><td class="NLM_term">GSK</td><td class="NLM_def"><p class="first last">GlaxoSmithKline</p></td></tr><tr><td class="NLM_term">H3K23ac</td><td class="NLM_def"><p class="first last">histone 3 acetylated lysine 23</p></td></tr><tr><td class="NLM_term">H3K4</td><td class="NLM_def"><p class="first last">histone 3 lysine 4</p></td></tr><tr><td class="NLM_term">HAT</td><td class="NLM_def"><p class="first last">histone acetyltransferases</p></td></tr><tr><td class="NLM_term">IL-X</td><td class="NLM_def"><p class="first last">interleukin-X (X = 4,5, 6, 13)</p></td></tr><tr><td class="NLM_term">ISWI</td><td class="NLM_def"><p class="first last">imitation switch chromatin remodeling complex</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal calorimetry</p></td></tr><tr><td class="NLM_term">i.v</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">KAc</td><td class="NLM_def"><p class="first last">acetylated lysine</p></td></tr><tr><td class="NLM_term">LAG3</td><td class="NLM_def"><p class="first last">lymphocyte-activation gene 3</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">milligrams per kilogram</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl pyrrolidine</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NoRC</td><td class="NLM_def"><p class="first last">nucleolar remodeling complex</p></td></tr><tr><td class="NLM_term">NUT</td><td class="NLM_def"><p class="first last">nuclear protein in testis</p></td></tr><tr><td class="NLM_term">PB1(5)</td><td class="NLM_def"><p class="first last">fifth subunit of polybromo 1</p></td></tr><tr><td class="NLM_term">PBAF</td><td class="NLM_def"><p class="first last">polybromo-associated BRG1- or HRBM-associated factors</p></td></tr><tr><td class="NLM_term">PCAF</td><td class="NLM_def"><p class="first last">p300/CBP-associated factor</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PHD</td><td class="NLM_def"><p class="first last">plant homeodomain</p></td></tr><tr><td class="NLM_term">PI3 kinase</td><td class="NLM_def"><p class="first last">phosphatidylinositol-4,5-bisphosphate 3-kinase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">per os, by mouth</p></td></tr><tr><td class="NLM_term">PTM</td><td class="NLM_def"><p class="first last">post-translational modification</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">quaque die, one a day</p></td></tr><tr><td class="NLM_term">RNA</td><td class="NLM_def"><p class="first last">ribonucleic acid</p></td></tr><tr><td class="NLM_term">SAMSN1</td><td class="NLM_def"><p class="first last">SAM domain</p></td></tr><tr><td class="NLM_term">SH3</td><td class="NLM_def"><p class="first last">domain and nuclear localization signals</p></td></tr><tr><td class="NLM_term">SGC</td><td class="NLM_def"><p class="first last">Structural Genomics Consortium</p></td></tr><tr><td class="NLM_term">shRNA</td><td class="NLM_def"><p class="first last">short hairpin ribonucleic acid</p></td></tr><tr><td class="NLM_term">SMARCA(X)</td><td class="NLM_def"><p class="first last">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member X (X = 2, 4)</p></td></tr><tr><td class="NLM_term">SWI/SNF</td><td class="NLM_def"><p class="first last">switch/sucrose nonfermentable</p></td></tr><tr><td class="NLM_term">TAT</td><td class="NLM_def"><p class="first last">targeted anticancer therapies</p></td></tr><tr><td class="NLM_term">Th2</td><td class="NLM_def"><p class="first last">type 2 helper T cell</p></td></tr><tr><td class="NLM_term">THQ</td><td class="NLM_def"><p class="first last">tetrahydroquinoline</p></td></tr><tr><td class="NLM_term">TIM3</td><td class="NLM_def"><p class="first last">T-cell immunoglobulin domain and mucin domain 3</p></td></tr><tr><td class="NLM_term">T<sub>reg</sub></td><td class="NLM_def"><p class="first last">regulatory T cells</p></td></tr><tr><td class="NLM_term">TRIM24</td><td class="NLM_def"><p class="first last">tripartite motif 24 protein</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52061" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52061" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 199 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Verdone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caserta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, E. D.</span><span> </span><span class="NLM_article-title">Role of Histone Acetylation in the Control of Gene Expression</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1139/o05-041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1139%2Fo05-041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=15959560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=344-353&author=L.+Verdoneauthor=M.+Casertaauthor=E.+D.+Mauro&title=Role+of+Histone+Acetylation+in+the+Control+of+Gene+Expression&doi=10.1139%2Fo05-041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of histone acetylation in the control of gene expression</span></div><div class="casAuthors">Verdone, Loredana; Caserta, Micaela; Di Mauro, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-353</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Histone proteins play structural and functional roles in all nuclear processes.  They undergo different types of covalent modifications, defined in their ensemble as epigenetic because changes in DNA sequences are not involved.  Histone acetylation emerges as a central switch that allows interconversion between permissive and repressive chromatin domains in terms of transcriptional competence.  The mechanisms underlying the histone acetylation-dependent control of gene expression include a direct effect on the stability of nucleosomal arrays and the creation of docking sites for the binding of regulatory proteins.  Histone acetyltransferases and deacetylases are, resp., the enzymes devoted to the addn. and removal of acetyl groups from lysine residues on the histone N-terminal tails.  The enzymes exert fundamental roles in developmental processes and their deregulation has been linked to the progression of diverse human disorders, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra07s9zdBpF7Vg90H21EOLACvtfcHk0lhGYpEKqTT_eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFClsbo%253D&md5=4f3d8b79f8cac35e7b0b553028ce96c5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1139%2Fo05-041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo05-041%26sid%3Dliteratum%253Aachs%26aulast%3DVerdone%26aufirst%3DL.%26aulast%3DCaserta%26aufirst%3DM.%26aulast%3DMauro%26aufirst%3DE.%2BD.%26atitle%3DRole%2520of%2520Histone%2520Acetylation%2520in%2520the%2520Control%2520of%2520Gene%2520Expression%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2005%26volume%3D83%26spage%3D344%26epage%3D353%26doi%3D10.1139%2Fo05-041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Workman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, R. E.</span><span> </span><span class="NLM_article-title">Alteration of Nucleosome Structure as a Mechanism of Transcriptional Regulation</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.67.1.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1146%2Fannurev.biochem.67.1.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=9759497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=545-579&author=J.+L.+Workmanauthor=R.+E.+Kingston&title=Alteration+of+Nucleosome+Structure+as+a+Mechanism+of+Transcriptional+Regulation&doi=10.1146%2Fannurev.biochem.67.1.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of nucleosome structure as a mechanism of transcriptional regulation</span></div><div class="casAuthors">Workman, J. L.; Kingston, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-579</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 270 refs.  The nucleosome, which is the primary building block of chromatin, is not a static structure: It can adopt alternative conformations.  Changes in soln. conditions or changes in histone acetylation state cause nucleosomes and nucleosomal arrays to behave with altered biophys. properties.  Distinct subpopulations of nucleosomes isolated from cells have chromatog. properties and nuclease sensitivity different from those of bulk nucleosomes.  Recently, proteins that were initially identified as necessary for transcriptional regulation have been shown to alter nucleosomal structure.  These proteins are found in three types of multiprotein complexes that can acetylate nucleosomes, deacetylate nucleosomes, or alter nucleosome structure in an ATP-dependent manner.  The direct modification of nucleosome structure by these complexes is likely to play a central role in appropriate regulation of eukaryotic genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpflCcssvuburVg90H21EOLACvtfcHk0lgyi24mqiR5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsbw%253D&md5=6dceb9de82a66dd5360a1183b33a3365</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.545%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DJ.%2BL.%26aulast%3DKingston%26aufirst%3DR.%2BE.%26atitle%3DAlteration%2520of%2520Nucleosome%2520Structure%2520as%2520a%2520Mechanism%2520of%2520Transcriptional%2520Regulation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D545%26epage%3D579%26doi%3D10.1146%2Fannurev.biochem.67.1.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Allfrey, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulkner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirsky, A. E.</span><span> </span><span class="NLM_article-title">Acetylation and Methylation of Histones and Their Possible Role in the Regulation of RNA Synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1073/pnas.51.5.786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.51.5.786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=14172992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaF2cXktlekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1964&pages=786-794&author=V.+G.+Allfreyauthor=R.+Faulknerauthor=A.+E.+Mirsky&title=Acetylation+and+Methylation+of+Histones+and+Their+Possible+Role+in+the+Regulation+of+RNA+Synthesis&doi=10.1073%2Fpnas.51.5.786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation and methylation of histones and their possible role in the regulation of ribonucleic acid (RNA) synthesis</span></div><div class="casAuthors">Allfrey, V. G.; Faulkner, R.; Mirsky, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">786-94</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Isolated calf thymus nuclei was incubated with 14C-labeled Na acetate.  Evidence that acetate was incorporated as acetyl groups attached to histones included: (1) following chromatography the label was eluted together with basic proteins; (2) acetyl-labeled histones were sepd. by electrophoresis; (3) acetate-14C was not removed from histones by org. solvents; (4) over 75% of the label remained after histones were treated with trichloroacetic acid.  Most extensive acetate uptake occurred with arginine-rich histones.  Puromycin did not inhibit the acetylation, indicating histones were modified by acetylation after completion of the polypeptide chain.  Acetylation lowered the histone effectiveness as inhibitor of the RNA polymerase reaction, and a dynamic and reversible mechanism was suggested for activation as well as repression of RNA synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL5QIm_JdO1bVg90H21EOLACvtfcHk0lgyi24mqiR5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXktlekurg%253D&md5=7a80f7a8a12636d4bc47930ee5eff217</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.51.5.786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.51.5.786%26sid%3Dliteratum%253Aachs%26aulast%3DAllfrey%26aufirst%3DV.%2BG.%26aulast%3DFaulkner%26aufirst%3DR.%26aulast%3DMirsky%26aufirst%3DA.%2BE.%26atitle%3DAcetylation%2520and%2520Methylation%2520of%2520Histones%2520and%2520Their%2520Possible%2520Role%2520in%2520the%2520Regulation%2520of%2520RNA%2520Synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1964%26volume%3D51%26spage%3D786%26epage%3D794%26doi%3D10.1073%2Fpnas.51.5.786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Jenuwein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Translating the Histone Code</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1126/science.1063127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1063127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=11498575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1074-1080&author=T.+Jenuweinauthor=C.+D.+Allis&title=Translating+the+Histone+Code&doi=10.1126%2Fscience.1063127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Translating the histone code</span></div><div class="casAuthors">Jenuwein, Thomas; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5532</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The review.  Chromatin, the physiol. template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone amino termini, thereby regulating access to the underlying DNA.  Distinct histone amino-terminal modifications can generate synergistic or antagonistic interaction affinities for chromatin-assocd. proteins, which in turn dictate dynamic transitions between transcriptionally active or transcriptionally silent chromatin states.  The combinatorial nature of histone amino-terminal modifications thus reveals a "histone code" that considerably extends the information potential of the genetic code.  We propose that this epigenetic marking system represents a fundamental regulatory mechanism that has an impact on most, if not all; chromatin-templated processes, with far-reaching consequences for cell fate decisions and both normal and pathol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFyHNepKcUbVg90H21EOLACvtfcHk0lgyi24mqiR5oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D&md5=021dcd98a5e5bf2ed7eedef1897b2269</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1063127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1063127%26sid%3Dliteratum%253Aachs%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DTranslating%2520the%2520Histone%2520Code%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1074%26epage%3D1080%26doi%3D10.1126%2Fscience.1063127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The Language of Covalent Histone Modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/47412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+Language+of+Covalent+Histone+Modifications&doi=10.1038%2F47412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2ebdzK3WA7WLJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520Language%2520of%2520Covalent%2520Histone%2520Modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45%26doi%3D10.1038%2F47412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Dhalluin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure and Ligand of a Histone Acetyltransferase Bromodomain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/20974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2F20974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10365964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=491-496&author=C.+Dhalluinauthor=J.+E.+Carlsonauthor=L.+Zengauthor=C.+Heauthor=A.+K.+Aggarwalauthor=M.-M.+Zhou&title=Structure+and+Ligand+of+a+Histone+Acetyltransferase+Bromodomain&doi=10.1038%2F20974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and ligand of a histone acetyltransferase bromodomain</span></div><div class="casAuthors">Dhalluin, Christophe; Carlson, Justin E.; Zeng, Lei; He, Cheng; Aggarwal, Aneel K.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6735</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone acetylation is important in chromatin remodelling and gene activation.  Nearly all known histone-acetyltransferase (HAT)-assocd. transcriptional co-activators contain bromodomains, which are ∼110-amino-acid modules found in many chromatin-assocd. proteins.  Despite the wide occurrence of these bromodomains, their three-dimensional structure and binding partners remain unknown.  Here we report the soln. structure of the bromodomain of the HAT co-activator P/CAF (p300/CBP-assocd. factor).  The structure reveals an unusual left-handed up-and-down four-helix bundle.  In addn., we show by a combination of structural and site-directed mutagenesis studies that bromodomains can interact specifically with acetylated lysine, making them the first known protein modules to do so.  The nature of the recognition of acetyl-lysine by the P/CAF bromodomain is similar to that of acetyl-CoA by histone acetyltransferase.  Thus, the bromodomain is functionally linked to the HAT activity of co-activators in the regulation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTbwcjeBG_rVg90H21EOLACvtfcHk0ljiIUz3xlvKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D&md5=ff1063ba81d81b431065dd6e3751ba79</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F20974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20974%26sid%3Dliteratum%253Aachs%26aulast%3DDhalluin%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DAggarwal%26aufirst%3DA.%2BK.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure%2520and%2520Ligand%2520of%2520a%2520Histone%2520Acetyltransferase%2520Bromodomain%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D491%26epage%3D496%26doi%3D10.1038%2F20974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting Bromodomains: Epigenetic Readers of Lysine Acetylation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nrd4286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnrd4286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24751816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=337-356&author=P.+Filippakopoulosauthor=S.+Knapp&title=Targeting+Bromodomains%3A+Epigenetic+Readers+of+Lysine+Acetylation&doi=10.1038%2Fnrd4286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bromodomains: epigenetic readers of lysine acetylation</span></div><div class="casAuthors">Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-356</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant acetylation levels have been linked to the development of several diseases.  Acetyl-lysine modifications create docking sites for bromodomains, which are small interaction modules found on diverse proteins, some of which have a key role in the acetylation-dependent assembly of transcriptional regulator complexes.  These complexes can then initiate transcriptional programs that result in phenotypic changes.  The recent discovery of potent and highly specific inhibitors for the BET (bromodomain and extra-terminal) family of bromodomains has stimulated intensive research activity in diverse therapeutic areas, particularly in oncol., where BET proteins regulate the expression of key oncogenes and anti-apoptotic proteins.  In addn., targeting BET bromodomains could hold potential for the treatment of inflammation and viral infection.  Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOSIcwBJKj4LVg90H21EOLACvtfcHk0ljiIUz3xlvKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D&md5=77049c82ce6a19b4685e3b7950399a07</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4286%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520Bromodomains%253A%2520Epigenetic%2520Readers%2520of%2520Lysine%2520Acetylation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D337%26epage%3D356%26doi%3D10.1038%2Fnrd4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lange, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaynak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonjes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottbauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelilah-Seyfried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, S.</span><span> </span><span class="NLM_article-title">Regulation of Muscle Development by DPF3, a Novel Histone Acetylation and Methylation Reader of the BAF Chromatin Remodeling Complex</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1101/gad.471408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1101%2Fgad.471408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18765789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2370-2384&author=M.+Langeauthor=B.+Kaynakauthor=U.+B.+Forsterauthor=M.+Tonjesauthor=J.+J.+Fischerauthor=C.+Grimmauthor=J.+Schlesingerauthor=S.+Justauthor=I.+Dunkelauthor=T.+Kruegerauthor=S.+Mebusauthor=H.+Lehrachauthor=R.+Lurzauthor=J.+Gobomauthor=W.+Rottbauerauthor=S.+Abdelilah-Seyfriedauthor=S.+Sperling&title=Regulation+of+Muscle+Development+by+DPF3%2C+a+Novel+Histone+Acetylation+and+Methylation+Reader+of+the+BAF+Chromatin+Remodeling+Complex&doi=10.1101%2Fgad.471408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span></div><div class="casAuthors">Lange, Martin; Kaynak, Bogac; Forster, Ulrike B.; Toenjes, Martje; Fischer, Jenny J.; Grimm, Christina; Schlesinger, Jenny; Just, Steffen; Dunkel, Ilona; Krueger, Tammo; Mebus, Siegrun; Lehrach, Hans; Lurz, Rudi; Gobom, Johan; Rottbauer, Wolfgang; Abdelilah-Seyfried, Salim; Sperling, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2370-2384</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Chromatin remodeling and histone modifications facilitate access of transcription factors to DNA by promoting the unwinding and destabilization of histone-DNA interactions.  We present DPF3, a new epigenetic key factor for heart and muscle development characterized by a double PHD finger.  DPF3 is assocd. with the BAF chromatin remodeling complex and binds methylated and acetylated lysine residues of histone 3 and 4.  Thus, DPF3 may represent the first plant homeodomains that bind acetylated lysines, a feature previously only shown for the bromodomain.  During development Dpf3 is expressed in the heart and somites of mouse, chicken, and zebrafish.  Morpholino knockdown of dpf3 in zebrafish leads to incomplete cardiac looping and severely reduced ventricular contractility, with disassembled muscular fibers caused by transcriptional deregulation of structural and regulatory proteins.  Promoter anal. identified Dpf3 as a novel downstream target of Mef2a.  Taken together, DPF3 adds a further layer of complexity to the BAF complex by representing a tissue-specific anchor between histone acetylations as well as methylations and chromatin remodeling.  Furthermore, this shows that plant homeodomain proteins play a yet unexplored role in recruiting chromatin remodeling complexes to acetylated histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKDUoXByUL7Vg90H21EOLACvtfcHk0ljiIUz3xlvKAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI&md5=173473acf1587d33492b8cee1fa16f88</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fgad.471408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.471408%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DM.%26aulast%3DKaynak%26aufirst%3DB.%26aulast%3DForster%26aufirst%3DU.%2BB.%26aulast%3DTonjes%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DJ.%2BJ.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DSchlesinger%26aufirst%3DJ.%26aulast%3DJust%26aufirst%3DS.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DMebus%26aufirst%3DS.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DGobom%26aufirst%3DJ.%26aulast%3DRottbauer%26aufirst%3DW.%26aulast%3DAbdelilah-Seyfried%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Muscle%2520Development%2520by%2520DPF3%252C%2520a%2520Novel%2520Histone%2520Acetylation%2520and%2520Methylation%2520Reader%2520of%2520the%2520BAF%2520Chromatin%2520Remodeling%2520Complex%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D2370%26epage%3D2384%26doi%3D10.1101%2Fgad.471408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Mechanism and Regulation of Acetylated Histone Binding by the Tandem PHD Finger of DPF3b</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1038/nature09139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20613843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=258-262&author=L.+Zengauthor=Q.+Zhangauthor=S.+Liauthor=A.+N.+Plotnikovauthor=M.+J.+Walshauthor=M.-M.+Zhou&title=Mechanism+and+Regulation+of+Acetylated+Histone+Binding+by+the+Tandem+PHD+Finger+of+DPF3b&doi=10.1038%2Fnature09139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span></div><div class="casAuthors">Zeng, Lei; Zhang, Qiang; Li, SiDe; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7303</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context.  Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains.  Recently, a tandem plant homeodomain (PHD) finger (PHD1-PHD2, or PHD12) of human DPF3b, which functions in assocn. with the BAF chromatin remodeling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner, making it the first alternative to bromodomains for acetyl-lysine binding.  Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b.  Our three-dimensional soln. structures and biochem. anal. of DPF3b highlight the mol. basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac).  Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c.  Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs304GNjB0LVg90H21EOLACvtfcHk0litkiYNJpF_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D&md5=48807136d91002d7454db72c56ece898</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature09139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09139%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DMechanism%2520and%2520Regulation%2520of%2520Acetylated%2520Histone%2520Binding%2520by%2520the%2520Tandem%2520PHD%2520Finger%2520of%2520DPF3b%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature09139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botuyan, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mer, G.</span><span> </span><span class="NLM_article-title">Structural Basis for Recognition of H3K56-Acetylated Histone H3-H4 by the Chaperone Rtt106</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1038/nature10861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature10861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=104-107&author=D.+Suauthor=Q.+Huauthor=Q.+Liauthor=J.+R.+Thompsonauthor=G.+Cuiauthor=A.+Fazlyauthor=B.+A.+Daviesauthor=M.+V.+Botuyanauthor=Z.+Zhangauthor=G.+Mer&title=Structural+Basis+for+Recognition+of+H3K56-Acetylated+Histone+H3-H4+by+the+Chaperone+Rtt106&doi=10.1038%2Fnature10861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10861%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DFazly%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DB.%2BA.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DStructural%2520Basis%2520for%2520Recognition%2520of%2520H3K56-Acetylated%2520Histone%2520H3-H4%2520by%2520the%2520Chaperone%2520Rtt106%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D104%26epage%3D107%26doi%3D10.1038%2Fnature10861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.-P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+M%C3%BCllerauthor=T.+Pawsonauthor=A.-C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+Recognition+and+Large-Scale+Structural+Analysis+of+the+Human+Bromodomain+Family&doi=10.1016%2Fj.cell.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0litkiYNJpF_tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.-P.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520Recognition%2520and%2520Large-Scale%2520Structural%2520Analysis%2520of%2520the%2520Human%2520Bromodomain%2520Family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231%26doi%3D10.1016%2Fj.cell.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tamkun, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuring, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattatucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennison, J. A.</span><span> </span><span class="NLM_article-title">Brahma: a Regulator of Drosophila Homeotic Genes Structurally Related to the Yeast Transcriptional Activator SNF2/SWl2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1016/0092-8674(92)90191-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2F0092-8674%2892%2990191-E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1992&pages=561-572&author=J.+W.+Tamkunauthor=R.+Deuringauthor=M.+P.+Scottauthor=M.+Kissingerauthor=A.+M.+Pattatucciauthor=T.+C.+Kaufmanauthor=J.+A.+Kennison&title=Brahma%3A+a+Regulator+of+Drosophila+Homeotic+Genes+Structurally+Related+to+the+Yeast+Transcriptional+Activator+SNF2%2FSWl2&doi=10.1016%2F0092-8674%2892%2990191-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990191-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990191-E%26sid%3Dliteratum%253Aachs%26aulast%3DTamkun%26aufirst%3DJ.%2BW.%26aulast%3DDeuring%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DKissinger%26aufirst%3DM.%26aulast%3DPattatucci%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DT.%2BC.%26aulast%3DKennison%26aufirst%3DJ.%2BA.%26atitle%3DBrahma%253A%2520a%2520Regulator%2520of%2520Drosophila%2520Homeotic%2520Genes%2520Structurally%2520Related%2520to%2520the%2520Yeast%2520Transcriptional%2520Activator%2520SNF2%252FSWl2%26jtitle%3DCell%26date%3D1992%26volume%3D68%26spage%3D561%26epage%3D572%26doi%3D10.1016%2F0092-8674%2892%2990191-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Haynes, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winston, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowsdale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawid, I. B.</span><span> </span><span class="NLM_article-title">The Bromodomain: a Conserved Sequence Found in Human, <i>Drosophila</i> And Yeast Proteins</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="refDoi"> DOI: 10.1093/nar/20.10.2603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Fnar%2F20.10.2603" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1992&pages=2603&author=S.+R.+Haynesauthor=C.+Dollardauthor=F.+Winstonauthor=S.+Beckauthor=J.+Trowsdaleauthor=I.+B.+Dawid&title=The+Bromodomain%3A+a+Conserved+Sequence+Found+in+Human%2C+Drosophila+And+Yeast+Proteins&doi=10.1093%2Fnar%2F20.10.2603"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F20.10.2603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F20.10.2603%26sid%3Dliteratum%253Aachs%26aulast%3DHaynes%26aufirst%3DS.%2BR.%26aulast%3DDollard%26aufirst%3DC.%26aulast%3DWinston%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DTrowsdale%26aufirst%3DJ.%26aulast%3DDawid%26aufirst%3DI.%2BB.%26atitle%3DThe%2520Bromodomain%253A%2520a%2520Conserved%2520Sequence%2520Found%2520in%2520Human%252C%2520Drosophila%2520And%2520Yeast%2520Proteins%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1992%26volume%3D20%26spage%3D2603%26doi%3D10.1093%2Fnar%2F20.10.2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic Protein Families: a New Frontier for Drug Discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1038/nrd3674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnrd3674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22498752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+Protein+Families%3A+a+New+Frontier+for+Drug+Discovery&doi=10.1038%2Fnrd3674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic protein families: a new frontier for drug discovery</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V.; Lee, Kevin; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases.  At the mol. level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones.  Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-contg. proteins and proteins that bind to methylated histones.  These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains.  In this article, we discuss the known links with disease, basic mol. mechanisms of action and recent progress in the pharmacol. modulation of each class of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcD99eCigNtLVg90H21EOLACvtfcHk0ljEjX7YmvBBnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D&md5=eb82034466a43107aa74a18ccf6d29f5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3674%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520Protein%2520Families%253A%2520a%2520New%2520Frontier%2520for%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400%26doi%3D10.1038%2Fnrd3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective Inhibition of BET Bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span><span class="refDoi"> DOI: 10.1038/nature09504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=N.+La+Thangueauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+Inhibition+of+BET+Bromodomains&doi=10.1038%2Fnature09504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0ljEjX7YmvBBnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%2BThangue%26aufirst%3DN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520Inhibition%2520of%2520BET%2520Bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073%26doi%3D10.1038%2Fnature09504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sueoka, H.; Ehara, S.; Kobayashi, H.; Arichi, T.; Komatsu, T.</span><span> </span><span class="NLM_article-title">Thienotraizolodiazepine Compounds and Their Pharmaceutical Use</span>. US5712274,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Sueoka&author=S.+Ehara&author=H.+Kobayashi&author=T.+Arichi&author=T.+Komatsu&title=Thienotraizolodiazepine+Compounds+and+Their+Pharmaceutical+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSueoka%26aufirst%3DH.%26atitle%3DThienotraizolodiazepine%2520Compounds%2520and%2520Their%2520Pharmaceutical%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of Inflammation by a Synthetic Histone Mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1038/nature09589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.-W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+Inflammation+by+a+Synthetic+Histone+Mimic&doi=10.1038%2Fnature09589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0licHy3rodTlJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520Inflammation%2520by%2520a%2520Synthetic%2520Histone%2520Mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature09589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.2174/1568026615666150302110135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.2174%2F1568026615666150302110135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25732788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-794&author=L.+Yuauthor=Z.+Wangauthor=Z.+Zhangauthor=X.+Renauthor=X.+Luauthor=K.+Ding&title=Small-Molecule+BET+Inhibitors+in+Clinical+and+Preclinical+Development+and+Their+Therapeutic+Potential&doi=10.2174%2F1568026615666150302110135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span></div><div class="casAuthors">Yu, Lei; Wang, Zhen; Zhang, Zhang; Ren, Xiaomei; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">776-794</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation is a pivotal mechanism in chromatin processes and the regulation of gene transcription.  The acetylated lysine residues of histones are exclusively recognized by bromodomains (BRDs) known as epigenetic reader.  Proteins contg. BRDs undergo a post-translational modification (PTM) with development of cellular signaling and disease biol.  The bromo and extra-terminal (BET) proteins are the second subfamily, which play important roles in cellular proliferation, cell cycle progression and chromatin compaction.  Recently, a variety of small mols. have been reported to interact with the BET family proteins and accelerate the validation of BET proteins as druggable targets for treatment of cancers, inflammation and related diseases.  In this review, we will summarize the small-mol. inhibitors in clin. and preclin. studies of the BET family bromodomains and their medicinal implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk52FOUPlX8bVg90H21EOLACvtfcHk0licHy3rodTlJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D&md5=802bf7b832d46c2b18ef6ac77eda1445</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302110135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302110135%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DSmall-Molecule%2520BET%2520Inhibitors%2520in%2520Clinical%2520and%2520Preclinical%2520Development%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D794%26doi%3D10.2174%2F1568026615666150302110135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain–Acetyl-Lysine Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span><span class="refDoi"> DOI: 10.1021/jm300915b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+C.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+Development+and+Application+of+Small+Molecule+Inhibitors+of+Bromodomain%E2%80%93Acetyl-Lysine+Interactions&doi=10.1021%2Fjm300915b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Hewings, David S.; Rooney, Timothy P. C.; Jennings, Laura E.; Hay, Duncan A.; Schofield, Christopher J.; Brennan, Paul E.; Knapp, Stefan; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9393-9413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery.  These acetyl-lysine (KAc) reader domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information.  By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners.  There has been intense activity in developing potent and selective small mol. probes that disrupt the interaction between a given bromodomain and KAc.  Rapid success has been achieved with the BET family of bromodomains, and a no. of potent and selective probes have been reported.  These compds. have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets.  Herein, we review the biol. of the bromodomains and discuss the SAR for the existing small mol. probes.  The biol. that has been enabled by these compds. is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8pl0pnLXruLVg90H21EOLACvtfcHk0li8xYqtyLFCVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ&md5=486a87abb406c4c833404ccce61c1389</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520Development%2520and%2520Application%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520Bromodomain%25E2%2580%2593Acetyl-Lysine%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413%26doi%3D10.1021%2Fjm300915b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Brand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Measures, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Bromodomain–Acetyl-Lysine Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1021/cb500996u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500996u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=22-39&author=M.+Brandauthor=A.+M.+Measuresauthor=B.+G.+Wilsonauthor=W.+A.+Cortopassiauthor=R.+Alexanderauthor=M.+H%C3%B6ssauthor=D.+S.+Hewingsauthor=T.+P.+C.+Rooneyauthor=R.+S.+Patonauthor=S.+J.+Conway&title=Small+Molecule+Inhibitors+of+Bromodomain%E2%80%93Acetyl-Lysine+Interactions&doi=10.1021%2Fcb500996u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Brand, Michael; Measures, Angelina R.; Wilson, Brian G.; Cortopassi, Wilian A.; Alexander, Rikki; Hoss, Matthias; Hewings, David S.; Rooney, Timothy P. C.; Paton, Robert S.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-39</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains are protein modules that bind to acetylated lysine residues.  Their interaction with histone proteins suggests that they function as "readers" of histone lysine acetylation, a component of the proposed "histone code".  Bromodomain-contg. proteins are often found as components of larger protein complexes with roles in fundamental cellular process including transcription.  The publication of two potent ligands for the BET bromodomains in 2010 demonstrated that small mols. can inhibit the bromodomain-acetyl-lysine protein-protein interaction.  These mols. display strong phenotypic effects in a no. of cell lines and affect a range of cancers in vivo.  This work stimulated intense interest in developing further ligands for the BET bromodomains and the design of ligands for non-BET bromodomains.  Here we review the recent progress in the field with particular attention paid to ligand design, the assays employed in early ligand discovery, and the use of computational approaches to inform ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JZtWpBpqS7Vg90H21EOLACvtfcHk0li8xYqtyLFCVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGktQ%253D%253D&md5=e40e85fc300109654712a00de400c8ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcb500996u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500996u%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DM.%26aulast%3DMeasures%26aufirst%3DA.%2BM.%26aulast%3DWilson%26aufirst%3DB.%2BG.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DH%25C3%25B6ss%26aufirst%3DM.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Bromodomain%25E2%2580%2593Acetyl-Lysine%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D22%26epage%3D39%26doi%3D10.1021%2Fcb500996u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Gallenkamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelato, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinmann, H.</span><span> </span><span class="NLM_article-title">Bromodomains and Their Pharmacological Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1002/cmdc.201300434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fcmdc.201300434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24497428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=438-464&author=D.+Gallenkampauthor=K.+A.+Gelatoauthor=B.+Haendlerauthor=H.+Weinmann&title=Bromodomains+and+Their+Pharmacological+Inhibitors&doi=10.1002%2Fcmdc.201300434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomains and Their Pharmacological Inhibitors</span></div><div class="casAuthors">Gallenkamp, Daniel; Gelato, Kathy A.; Haendler, Bernard; Weinmann, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">438-464</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Over 60 bromodomains belonging to proteins with very different functions have been identified in humans.  Several of them interact with acetylated lysine residues, leading to the recruitment and stabilization of protein complexes.  The bromodomain and extra-terminal domain (BET) proteins contain tandem bromodomains which bind to acetylated histones and are thereby implicated in a no. of DNA-centered processes, including the regulation of gene expression.  The recent identification of inhibitors of BET and non-BET bromodomains is one of the few examples in which effective blockade of a protein-protein interaction can be achieved with a small mol.  This has led to major strides in the understanding of the function of bromodomain-contg. proteins and their involvement in diseases such as cancer and inflammation.  Indeed, BET bromodomain inhibitors are now being clin. evaluated for the treatment of hematol. tumors and have also been tested in clin. trials for the relatively rare BRD-NUT midline carcinoma.  This review gives an overview of the newest developments in the field, with a focus on the biol. of selected bromodomain proteins on the one hand, and on reported pharmacol. inhibitors on the other, including recent examples from the patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-8_ymytCPbVg90H21EOLACvtfcHk0li8xYqtyLFCVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtL4%253D&md5=2ce7c6b5c37001fb8fb901fe04aeb606</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300434%26sid%3Dliteratum%253Aachs%26aulast%3DGallenkamp%26aufirst%3DD.%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DHaendler%26aufirst%3DB.%26aulast%3DWeinmann%26aufirst%3DH.%26atitle%3DBromodomains%2520and%2520Their%2520Pharmacological%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D438%26epage%3D464%26doi%3D10.1002%2Fcmdc.201300434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">The number of bromodomain publications per calendar year was generated from SciFinder using the search term “Bromodomain.” The number of bromodomain publications in 2015 are shown up to November 1.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span><span class="refDoi"> DOI: 10.1021/jm200108t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.-W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.-M.+G.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Cl%C3%A9mentauthor=A.-B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+Characterization+of+Small+Molecule+Inhibitors+of+the+BET+Family+Bromodomains&doi=10.1021%2Fjm200108t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0lhzcfagqys-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.-M.%2BG.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.-B.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520BET%2520Family%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838%26doi%3D10.1021%2Fjm200108t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-Π Interaction</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1002/anie.201402750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fanie.201402750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=6126-6130&author=T.+P.+C.+Rooneyauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=W.+A.+Cortopassiauthor=D.+A.+Hayauthor=S.+Martinauthor=A.+Tumberauthor=C.+M.+Rogersauthor=M.+Philpottauthor=M.+Wangauthor=A.+L.+Thompsonauthor=T.+D.+Heightmanauthor=D.+C.+Prydeauthor=A.+Cookauthor=R.+S.+Patonauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=A+Series+of+Potent+CREBBP+Bromodomain+Ligands+Reveals+an+Induced-Fit+Pocket+Stabilized+by+a+Cation-%CE%A0+Interaction&doi=10.1002%2Fanie.201402750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction</span></div><div class="casAuthors">Rooney, Timothy P. C.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Cortopassi, Wilian A.; Hay, Duncan A.; Martin, Sarah; Tumber, Anthony; Rogers, Catherine M.; Philpott, Martin; Wang, Minghua; Thompson, Amber L.; Heightman, Tom D.; Pryde, David C.; Cook, Andrew; Paton, Robert S.; Mueller, Susanne; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6130</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands.  While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors, e.g., I, of a bromodomain outside the BET family.  Structural and computational studies revealed that an internal hydrogen bond stabilized the protein-bound conformation of the dihydroquinoxalinone series.  The side chain of this series binds in an induced-fit pocket forming a cation-π interaction with R1173 of CREBBP.  Compd. I, the most potent compd., inhibited binding of CREBBP to chromatin in U2OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHFgTVUKe7lrVg90H21EOLACvtfcHk0lhzcfagqys-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D&md5=42b12e1fe855d2af02c49f8e1031d39e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402750%26sid%3Dliteratum%253Aachs%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Series%2520of%2520Potent%2520CREBBP%2520Bromodomain%2520Ligands%2520Reveals%2520an%2520Induced-Fit%2520Pocket%2520Stabilized%2520by%2520a%2520Cation-%25CE%25A0%2520Interaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D6126%26epage%3D6130%26doi%3D10.1002%2Fanie.201402750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Delvecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar-Gurrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panne, D.</span><span> </span><span class="NLM_article-title">Structure of the P300 Catalytic Core and Implications for Chromatin Targeting and HAT Regulation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1038/nsmb.2642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnsmb.2642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23934153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1040-1046&author=M.+Delvecchioauthor=J.+Gaucherauthor=C.+Aguilar-Gurrieriauthor=E.+Ortegaauthor=D.+Panne&title=Structure+of+the+P300+Catalytic+Core+and+Implications+for+Chromatin+Targeting+and+HAT+Regulation&doi=10.1038%2Fnsmb.2642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation</span></div><div class="casAuthors">Delvecchio, Manuela; Gaucher, Jonathan; Aguilar-Gurrieri, Carmen; Ortega, Esther; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1040-1046</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CBP and p300 are histone acetyltransferases (HATs) that assoc. with and acetylate transcriptional regulators and chromatin.  Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer.  Here we present the 2.8-Å crystal structure of the catalytic core of human p300 contg. its bromodomain, CH2 region and HAT domain.  The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain.  The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket.  Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain.  The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYehjRwdhJ7Vg90H21EOLACvtfcHk0lhzcfagqys-bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J&md5=e9352198d513eac6fd93fc2896828d09</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2642%26sid%3Dliteratum%253Aachs%26aulast%3DDelvecchio%26aufirst%3DM.%26aulast%3DGaucher%26aufirst%3DJ.%26aulast%3DAguilar-Gurrieri%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DStructure%2520of%2520the%2520P300%2520Catalytic%2520Core%2520and%2520Implications%2520for%2520Chromatin%2520Targeting%2520and%2520HAT%2520Regulation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1040%26epage%3D1046%26doi%3D10.1038%2Fnsmb.2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeleznik-Le, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structural Mechanism of the Bromodomain of the Coactivator CBP in P53 Transcriptional Activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00528-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2FS1097-2765%2803%2900528-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=14759370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=251-263&author=S.+Mujtabaauthor=Y.+Heauthor=L.+Zengauthor=S.+Yanauthor=O.+Plotnikovaauthor=+Sachchidanandauthor=R.+Sanchezauthor=N.+J.+Zeleznik-Leauthor=Z.+Ronaiauthor=M.+M.+Zhou&title=Structural+Mechanism+of+the+Bromodomain+of+the+Coactivator+CBP+in+P53+Transcriptional+Activation&doi=10.1016%2FS1097-2765%2803%2900528-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation</span></div><div class="casAuthors">Mujtaba, Shiraz; He, Yan; Zeng, Lei; Yan, Sherry; Plotnikova, Olga; Sachchidanand; Sanchez, Roberto; Zeleznik-Le, Nancy J.; Ronai, Ze'ev; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, the authors report that the conserved bromodomain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382.  This bromodomain/acetyllysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest.  The authors further present the three-dimensional NMR structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide.  Using structural and biochem. analyses, the authors define the mol. determinants for the specificity of this mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3g6bC53YUKbVg90H21EOLACvtfcHk0lhY2iAXOT3Ulg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D&md5=10127e2d2ea5165fd8439bf26a6f9241</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900528-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900528-8%26sid%3Dliteratum%253Aachs%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DSachchidanand%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DZeleznik-Le%26aufirst%3DN.%2BJ.%26aulast%3DRonai%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructural%2520Mechanism%2520of%2520the%2520Bromodomain%2520of%2520the%2520Coactivator%2520CBP%2520in%2520P53%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D251%26epage%3D263%26doi%3D10.1016%2FS1097-2765%2803%2900528-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ianculescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallcup, M. R.</span><span> </span><span class="NLM_article-title">Selective Roles for cAMP Response Element-Binding Protein Binding Protein and P300 Protein as Coregulators for Androgen-Regulated Gene Expression in Advanced Prostate Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4013</span><span class="refDoi"> DOI: 10.1074/jbc.M111.300194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M111.300194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22174411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4000-4013&author=I.+Ianculescuauthor=D.+Y.+Wuauthor=K.+D.+Siegmundauthor=M.+R.+Stallcup&title=Selective+Roles+for+cAMP+Response+Element-Binding+Protein+Binding+Protein+and+P300+Protein+as+Coregulators+for+Androgen-Regulated+Gene+Expression+in+Advanced+Prostate+Cancer+Cells&doi=10.1074%2Fjbc.M111.300194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells</span></div><div class="casAuthors">Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4000-4013</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators.  Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer.  CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA.  Global gene expression anal. indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent.  Chromatin immunopptn. anal. after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen.  Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many crit. histone modifications occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uJfPL3B4h7Vg90H21EOLACvtfcHk0lhY2iAXOT3Ulg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D&md5=095ab7582da1b7602e2ab898caa5b094</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.300194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.300194%26sid%3Dliteratum%253Aachs%26aulast%3DIanculescu%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%2BY.%26aulast%3DSiegmund%26aufirst%3DK.%2BD.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520Roles%2520for%2520cAMP%2520Response%2520Element-Binding%2520Protein%2520Binding%2520Protein%2520and%2520P300%2520Protein%2520as%2520Coregulators%2520for%2520Androgen-Regulated%2520Gene%2520Expression%2520in%2520Advanced%2520Prostate%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4000%26epage%3D4013%26doi%3D10.1074%2Fjbc.M111.300194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Iyer, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Özdag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">P300/CBP and Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fsj.onc.1207118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=15156177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4225-4231&author=N.+G.+Iyerauthor=H.+%C3%96zdagauthor=C.+Caldas&title=P300%2FCBP+and+Cancer&doi=10.1038%2Fsj.onc.1207118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">p300/CBP and cancer</span></div><div class="casAuthors">Iyer, Narayanan Gopalakrishna; Oezdag, Hilal; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4231</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P300 and cAMP response element-binding protein (CBP) are adenoviral E1A-binding proteins involved in multiple cellular processes, and function as transcriptional co-factors and histone acetyltransferases.  Germline mutation of CBP results in Rubinstein-Taybi syndrome, which is characterized by an increased predisposition to childhood malignancies.  Furthermore, somatic mutations of p300 and CBP occur in a no. of malignancies.  Chromosome translocations target CBP and, less commonly, p300 in acute myeloid leukemia and treatment-related hematol. disorders.  P300 mutations in solid tumors result in truncated p300 protein products or amino-acid substitutions in crit. protein domains, and these are often assocd. with inactivation of the second allele.  A mouse model confirms that p300 and CBP function as suppressors of hematol. tumor formation.  The involvement of these proteins in crit. tumorigenic pathways (including TGF-β, p53 and Rb) provides a mechanistic route as to how their inactivation could result in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGBLVLWLqkrVg90H21EOLACvtfcHk0lhY2iAXOT3Ulg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D&md5=b68fe6bc258b06515c04a5207410f026</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207118%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DN.%2BG.%26aulast%3D%25C3%2596zdag%26aufirst%3DH.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DP300%252FCBP%2520and%2520Cancer%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4225%26epage%3D4231%26doi%3D10.1038%2Fsj.onc.1207118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Faiola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lymar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E.</span><span> </span><span class="NLM_article-title">Dual Regulation of C-Myc by P300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10220</span><span class="NLM_x">–</span> <span class="NLM_lpage">10234</span><span class="refDoi"> DOI: 10.1128/MCB.25.23.10220-10234.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FMCB.25.23.10220-10234.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=16287840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10220-10234&author=F.+Faiolaauthor=X.+Liuauthor=S.+Loauthor=S.+Panauthor=K.+Zhangauthor=E.+Lymarauthor=A.+Farinaauthor=E.+Martinez&title=Dual+Regulation+of+C-Myc+by+P300+via+Acetylation-Dependent+Control+of+Myc+Protein+Turnover+and+Coactivation+of+Myc-Induced+Transcription&doi=10.1128%2FMCB.25.23.10220-10234.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription</span></div><div class="casAuthors">Faiola, Francesco; Liu, Xiaohui; Lo, Szuying; Pan, Songqin; Zhang, Kangling; Lymar, Elena; Farina, Anthony; Martinez, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10220-10234</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The c-Myc oncoprotein (Myc) controls cell fate by regulating gene transcription in assocn. with a DNA-binding partner, Max.  While Max lacks a transcription regulatory domain, the N-terminus of Myc contains a transcription activation domain (TAD) that recruits cofactor complexes contg. the histone acetyltransferases (HATs) GCN5 and Tip60.  Here, we report a novel functional interaction between Myc TAD and the p300 coactivator-acetyltransferase.  We show that p300 assocs. with Myc in mammalian cells and in vitro through direct interactions with Myc TAD residues 1 to 110 and acetylates Myc in a TAD-dependent manner in vivo at several lysine residues located between the TAD and DNA-binding domain.  Moreover, the Myc:Max complex is differentially acetylated by p300 and GCN5 and is not acetylated by Tip60 in vitro, suggesting distinct functions for these acetyltransferases.  Whereas p300 and CBP can stabilize Myc independently of acetylation, p300-mediated acetylation results in increased Myc turnover.  In addn., p300 functions as a coactivator that is recruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stimulates Myc TAD-dependent transcription in a HAT domain-dependent manner.  Our results suggest dual roles for p300/CBP in Myc regulation: as a Myc coactivator that stabilizes Myc and as an inducer of Myc instability via direct Myc acetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4or2afHXuK7Vg90H21EOLACvtfcHk0ljLUYz4MTflTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL&md5=bbabfb64492444687f048ee59cdc0210</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.23.10220-10234.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.23.10220-10234.2005%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLo%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLymar%26aufirst%3DE.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DE.%26atitle%3DDual%2520Regulation%2520of%2520C-Myc%2520by%2520P300%2520via%2520Acetylation-Dependent%2520Control%2520of%2520Myc%2520Protein%2520Turnover%2520and%2520Coactivation%2520of%2520Myc-Induced%2520Transcription%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10220%26epage%3D10234%26doi%3D10.1128%2FMCB.25.23.10220-10234.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Predina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatti, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindle, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, W. W.</span><span> </span><span class="NLM_article-title">Inhibition of P300 Impairs Foxp3+ T Regulatory Cell Function and Promotes Antitumor Immunity</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.1038/nm.3286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnm.3286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23955711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1173-1177&author=Y.+Liuauthor=L.+Wangauthor=J.+Predinaauthor=R.+Hanauthor=U.+H.+Beierauthor=L.-C.+S.+Wangauthor=V.+Kapoorauthor=T.+R.+Bhattiauthor=T.+Akimovaauthor=S.+Singhalauthor=P.+K.+Brindleauthor=P.+A.+Coleauthor=S.+M.+Albeldaauthor=W.+W.+Hancock&title=Inhibition+of+P300+Impairs+Foxp3%2B+T+Regulatory+Cell+Function+and+Promotes+Antitumor+Immunity&doi=10.1038%2Fnm.3286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity</span></div><div class="casAuthors">Liu, Yujie; Wang, Liqing; Predina, Jarrod; Han, Rongxiang; Beier, Ulf H.; Wang, Liang-Chuan S.; Kapoor, Veena; Bhatti, Tricia R.; Akimova, Tatiana; Singhal, Sunil; Brindle, Paul K.; Cole, Philip A.; Albelda, Steven M.; Hancock, Wayne W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Forkhead box P3 (Foxp3)+ T regulatory (Treg) cells maintain immune homeostasis and limit autoimmunity but can also curtail host immune responses to various types of tumors.  Foxp3+ Treg cells are therefore considered promising targets to enhance antitumor immunity, and approaches for their therapeutic modulation are being developed.  However, although studies showing that exptl. depleting Foxp3+ Treg cells can enhance antitumor responses provide proof of principle, these studies lack clear translational potential and have various shortcomings.  Histone/protein acetyltransferases (HATs) promote chromatin accessibility, gene transcription and the function of multiple transcription factors and nonhistone proteins.  We now report that conditional deletion or pharmacol. inhibition of one HAT, p300 (also known as Ep300 or KAT3B), in Foxp3+ Treg cells increased T cell receptor-induced apoptosis in Treg cells, impaired Treg cell suppressive function and peripheral Treg cell induction, and limited tumor growth in immunocompetent but not in immunodeficient mice.  Our data thereby demonstrate that p300 is important for Foxp3+ Treg cell function and homeostasis in vivo and in vitro, and identify mechanisms by which appropriate small-mol. inhibitors can diminish Treg cell function without overtly impairing T effector cell responses or inducing autoimmunity.  Collectively, these data suggest a new approach for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG1uh9kwBI_rVg90H21EOLACvtfcHk0ljLUYz4MTflTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yks77K&md5=b381e7523f686ed8ea8d54aa38327c41</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnm.3286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3286%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPredina%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DBeier%26aufirst%3DU.%2BH.%26aulast%3DWang%26aufirst%3DL.-C.%2BS.%26aulast%3DKapoor%26aufirst%3DV.%26aulast%3DBhatti%26aufirst%3DT.%2BR.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DBrindle%26aufirst%3DP.%2BK.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520P300%2520Impairs%2520Foxp3%252B%2520T%2520Regulatory%2520Cell%2520Function%2520and%2520Promotes%2520Antitumor%2520Immunity%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1173%26epage%3D1177%26doi%3D10.1038%2Fnm.3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Bellon, S.; Cochran, A.; Cote, A.; Crawford, T.; Fauber, B.; Ghosh, S.; Harmange, J.-C.; Hatzivassiliou, G.; Lora, J. M.; Magnuson, S.; Mellman, I.; Romero, F. A.; Taylor, A. M.; Tsui, V.</span><span> </span><span class="NLM_article-title">Use of CBP/EP300 Bromodomain Inhibitors for Cancer Immunotherapy</span>. WO2015054642A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+K.+Albrecht&author=J.+E.+Audia&author=S.+Bellon&author=A.+Cochran&author=A.+Cote&author=T.+Crawford&author=B.+Fauber&author=S.+Ghosh&author=J.-C.+Harmange&author=G.+Hatzivassiliou&author=J.+M.+Lora&author=S.+Magnuson&author=I.+Mellman&author=F.+A.+Romero&author=A.+M.+Taylor&author=V.+Tsui&title=Use+of+CBP%2FEP300+Bromodomain+Inhibitors+for+Cancer+Immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DUse%2520of%2520CBP%252FEP300%2520Bromodomain%2520Inhibitors%2520for%2520Cancer%2520Immunotherapy%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick-Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutjaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Target Structure-Based Discovery of Small Molecules That Block Human P53 and CREB Binding Protein Association</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2005.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=16426974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsV2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=81-90&author=+Sachchidanandauthor=L.+Resnick-Silvermanauthor=S.+Yanauthor=S.+Mutjabaauthor=W.-J.+Liuauthor=L.+Zengauthor=J.+J.+Manfrediauthor=M.-M.+Zhou&title=Target+Structure-Based+Discovery+of+Small+Molecules+That+Block+Human+P53+and+CREB+Binding+Protein+Association&doi=10.1016%2Fj.chembiol.2005.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein Association</span></div><div class="casAuthors">Sachchidanand; Resnick-Silverman, Lois; Yan, Sherry; Mutjaba, Shiraz; Liu, Wen-jun; Zeng, Lei; Manfredi, James J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of human tumor suppressor p53 in response to cellular stress signals is required for its function as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, we report small mols. that block lysine 382-acetylated p53 assocn. with the bromodomain of the coactivator CBP, an interaction essential for p53-induced transcription of the cell cycle inhibitor p21 in response to DNA damage.  These chems. were discovered in target structure-guided NMR spectroscopy screening of a focused chem. library constructed based on the structural knowledge of CBP bromodomain/p53-AcK382 binding.  Structural characterization shows that these chems. inhibit CBP/p53 assocn. by binding to the acetyl-lysine binding site of the bromodomain.  Cell-based functional assays demonstrate that the lead chems. can modulate p53 stability and function in response to doxorubicin-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrznkGtHkYXCbVg90H21EOLACvtfcHk0ljLUYz4MTflTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsV2qsQ%253D%253D&md5=a88211df5b27a2d2d37cb09a3bc50821</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DSachchidanand%26aulast%3DResnick-Silverman%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMutjaba%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.-J.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DJ.%2BJ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DTarget%2520Structure-Based%2520Discovery%2520of%2520Small%2520Molecules%2520That%2520Block%2520Human%2520P53%2520and%2520CREB%2520Binding%2520Protein%2520Association%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D81%26epage%3D90%26doi%3D10.1016%2Fj.chembiol.2005.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2011.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2011.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21513886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFartL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=495-507&author=T.+Itoauthor=T.+Umeharaauthor=K.+Sasakiauthor=Y.+Nakamuraauthor=N.+Nishinoauthor=T.+Teradaauthor=M.+Shirouzuauthor=B.+Padmanabhanauthor=S.+Yokoyamaauthor=A.+Itoauthor=M.+Yoshida&title=Real-Time+Imaging+of+Histone+H4K12-Specific+Acetylation+Determines+the+Modes+of+Action+of+Histone+Deacetylase+and+Bromodomain+Inhibitors&doi=10.1016%2Fj.chembiol.2011.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors</span></div><div class="casAuthors">Ito, Tamaki; Umehara, Takashi; Sasaki, Kazuki; Nakamura, Yoshihiro; Nishino, Norikazu; Terada, Takaho; Shirouzu, Mikako; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki; Ito, Akihiro; Yoshida, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-507</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone acetylation constitutes an epigenetic mark for transcriptional regulation.  Here we developed a fluorescent probe to visualize acetylation of histone H4 Lys12 (H4K12) in living cells using fluorescence resonance energy transfer (FRET) and the binding of the BRD2 bromodomain to acetylated H4K12.  Using this probe designated as Histac-K12, we demonstrated that histone H4K12 acetylation is retained in mitosis and that some histone deacetylase (HDAC) inhibitors continue to inhibit cellular HDAC activity even after their removal from the culture.  In addn., a small mol. that interferes with ability of the bromodomain to bind to acetylated H4K12 could be assessed using Histac-K12 in cells.  Thus, Histac-K12 will serve as a powerful tool not only to understand the dynamics of H4K12-specific acetylation but also to characterize small mols. that modulate the acetylation or interaction status of histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBoA9RjMb5tLVg90H21EOLACvtfcHk0lifTbYXaE-92A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFartL0%253D&md5=f36a5042c2e9342026884f88f9704954</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DReal-Time%2520Imaging%2520of%2520Histone%2520H4K12-Specific%2520Acetylation%2520Determines%2520the%2520Modes%2520of%2520Action%2520of%2520Histone%2520Deacetylase%2520and%2520Bromodomain%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D495%26epage%3D507%26doi%3D10.1016%2Fj.chembiol.2011.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-Dimethylisoxazoles Act as Acetyl-Lysine-Mimetic Bromodomain Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span><span class="refDoi"> DOI: 10.1021/jm200640v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-Dimethylisoxazoles+Act+as+Acetyl-Lysine-Mimetic+Bromodomain+Ligands&doi=10.1021%2Fjm200640v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Wang, Minghua; Philpott, Martin; Fedorov, Oleg; Uttarkar, Sagar; Filippakopoulos, Panagis; Picaud, Sarah; Vuppusetty, Chaitanya; Marsden, Brian; Knapp, Stefan; Conway, Stuart J.; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6761-6770</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone-lysine acetylation is a vital chromatin post-translational modification involved in the epigenetic regulation of gene transcription.  Bromodomains bind acetylated lysines, acting as readers of the histone-acetylation code.  Competitive inhibitors of this interaction have antiproliferative and anti-inflammatory properties.  With 57 distinct bromodomains known, the discovery of subtype-selective inhibitors of the histone-bromodomain interaction is of great importance.  We have identified the 3,5-dimethylisoxazole moiety as a novel acetyl-lysine bioisostere, which displaces acetylated histone-mimicking peptides from bromodomains.  Using X-ray crystallog. anal., we have detd. the interactions responsible for the activity and selectivity of 4-substituted 3,5-dimethylisoxazoles against a selection of phylogenetically diverse bromodomains.  By exploiting these interactions, we have developed compd. 4d, which has IC50 values of <5 μM for the bromodomain-contg. proteins BRD2(1) and BRD4(1).  These compds. are promising leads for the further development of selective probes for the bromodomain and extra C-terminal domain (BET) family and CREBBP bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzK4xMvJhXrVg90H21EOLACvtfcHk0lifTbYXaE-92A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO&md5=7d6f9eff2735c8a7189dec4fb5c5d13d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-Dimethylisoxazoles%2520Act%2520as%2520Acetyl-Lysine-Mimetic%2520Bromodomain%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770%26doi%3D10.1021%2Fjm200640v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span><span class="refDoi"> DOI: 10.1021/jm301588r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-Dimethylisoxazole+Derivatives+as+Potent+Bromodomain+Ligands&doi=10.1021%2Fjm301588r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Fedorov, Oleg; Filippakopoulos, Panagis; Martin, Sarah; Picaud, Sarah; Tumber, Anthony; Wells, Christopher; Olcina, Monica M.; Freeman, Katherine; Gill, Andrew; Ritchie, Alison J.; Sheppard, David W.; Russell, Angela J.; Hammond, Ester M.; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3217-3227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Isoxazolylphenyl)arylmethanols such as I (R = H; R1 = HO; R2 = H; R3 = Ph), I (R = HO; R1 = H; R2 = H; R3 = Ph), and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = Ph, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4) were prepd. as inhibitors of the bromodomain and extra terminal domain (BET) bromodomain family member BRD4(1) for potential use as antitumor agents.  The structures of I (R = H; R1 = HO; R2 = H; R3 = Ph) and I (R = HO; R1 = H; R2 = H; R3 = Ph) bound to human BRD4(1) were detd. by X-ray crystallog. to det. features useful for selective binding to BRD4(1).  I (R = H, HO; R1 = HO, H; R2 = H, MeCO; R3 = Ph) and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = 3-ClC6H4) inhibited a human acute myeloid leukemia cell line in vitro with 3-4 fold reduced inhibition and reduced toxicity in other human cells compared to a known BRD4(1) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVEQ5OOJGC8bVg90H21EOLACvtfcHk0lifTbYXaE-92A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D&md5=bb4890291db8c3e8d404a75dd9dcbb87</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-Dimethylisoxazole%2520Derivatives%2520as%2520Potent%2520Bromodomain%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227%26doi%3D10.1021%2Fjm301588r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Small-Molecule Ligands for the CBP/P300 Bromodomains</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+Optimization+of+Small-Molecule+Ligands+for+the+CBP%2FP300+Bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0liOsivhte5HWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Small-Molecule%2520Ligands%2520for%2520the%2520CBP%252FP300%2520Bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>SGC-CBP30: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/CBP30" class="extLink">http://www.thesgc.org/chemical-probes/CBP30</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SGC-CBP30%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FCBP30+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSGC-CBP30%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">The Design and Synthesis of 5- and 6-Isoxazolylbenzimidazoles as Selective Inhibitors of the BET Bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1039/C2MD20189E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC2MD20189E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=140-144&author=D.+Hayauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=M.+Philpottauthor=S.+Picaudauthor=D.+S.+Hewingsauthor=S.+Uttakarauthor=T.+D.+Heightmanauthor=S.+J.+Conwayauthor=S.+Knappauthor=P.+E.+Brennan&title=The+Design+and+Synthesis+of+5-+and+6-Isoxazolylbenzimidazoles+as+Selective+Inhibitors+of+the+BET+Bromodomains&doi=10.1039%2FC2MD20189E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FC2MD20189E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20189E%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DUttakar%26aufirst%3DS.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Design%2520and%2520Synthesis%2520of%25205-%2520and%25206-Isoxazolylbenzimidazoles%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520BET%2520Bromodomains%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D140%26epage%3D144%26doi%3D10.1039%2FC2MD20189E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Hammitzsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mossawi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wordsworth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowness, P.</span><span> </span><span class="NLM_article-title">CBP30, a Selective CBP/P300 Bromodomain Inhibitor, Suppresses Human Th17 Responses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">10768</span><span class="NLM_x">–</span> <span class="NLM_lpage">10773</span><span class="refDoi"> DOI: 10.1073/pnas.1501956112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1501956112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26261308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=10768-10773&author=A.+Hammitzschauthor=C.+Tallantauthor=O.+Fedorovauthor=A.+O%E2%80%99Mahonyauthor=P.+E.+Brennanauthor=D.+A.+Hayauthor=F.+O.+Martinezauthor=M.+H.+Al-Mossawiauthor=J.+de+Witauthor=M.+Vecellioauthor=C.+Wellsauthor=P.+Wordsworthauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+Bowness&title=CBP30%2C+a+Selective+CBP%2FP300+Bromodomain+Inhibitor%2C+Suppresses+Human+Th17+Responses&doi=10.1073%2Fpnas.1501956112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses</span></div><div class="casAuthors">Hammitzsch, Ariane; Tallant, Cynthia; Fedorov, Oleg; O'Mahony, Alison; Brennan, Paul E.; Hay, Duncan A.; Martinez, Fernando O.; Al-Mossawi, M. Hussein; de Wit, Jelle; Vecellio, Matteo; Wells, Christopher; Wordsworth, Paul; Muller, Susanne; Knapp, Stefan; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10768-10773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Th17 responses are crit. to a variety of human autoimmune diseases, and therapeutic targeting with monoclonal antibodies against IL-17 and IL-23 has shown considerable promise.  Here, the authors report data to support selective bromodomain blockade of the transcriptional coactivators CBP (CREB binding protein) and p300 as an alternative approach to inhibit human Th17 responses.  The authors show that CBP30 has marked mol. specificity for the bromodomains of CBP and p300, compared with 43 other bromodomains.  In unbiased cellular testing on a diverse panel of cultured primary human cells, CBP30 reduced immune cell prodn. of IL-17A and other proinflammatory cytokines.  CBP30 also inhibited IL-17A secretion by Th17 cells from healthy donors and patients with ankylosing spondylitis and psoriatic arthritis.  Transcriptional profiling of human T cells after CBP30 treatment showed a much more restricted effect on gene expression than that obsd. with the pan-BET (bromo and extraterminal domain protein family) bromodomain inhibitor JQ1.  This selective targeting of the CBP/p300 bromodomain by CBP30 will potentially lead to fewer side effects than with the broadly acting epigenetic inhibitors currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4fYjOUV2xW7Vg90H21EOLACvtfcHk0liOsivhte5HWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI&md5=fb9de88ecdd6441628ae1455ac11b65c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1501956112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1501956112%26sid%3Dliteratum%253Aachs%26aulast%3DHammitzsch%26aufirst%3DA.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DVecellio%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DWordsworth%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBowness%26aufirst%3DP.%26atitle%3DCBP30%252C%2520a%2520Selective%2520CBP%252FP300%2520Bromodomain%2520Inhibitor%252C%2520Suppresses%2520Human%2520Th17%2520Responses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D10768%26epage%3D10773%26doi%3D10.1073%2Fpnas.1501956112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>I-CBP112: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/I-CBP112" class="extLink">http://www.thesgc.org/chemical-probes/I-CBP112</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=I-CBP112%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FI-CBP112+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DI-CBP112%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Xu, M.; Unzue, A.; Dong, J.; Spiliotopoulos, D.; Nevado, C.; Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00171</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Xu&author=A.+Unzue&author=J.+Dong&author=D.+Spiliotopoulos&author=C.+Nevado&author=A.+Caflisch&title=Discovery+of+CREBBP+Bromodomain+Inhibitors+by+High-Throughput+Docking+and+Hit+Optimization+Guided+by+Molecular+Dynamics&doi=10.1021%2Facs.jmedchem.5b00171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00171%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520CREBBP%2520Bromodomain%2520Inhibitors%2520by%2520High-Throughput%2520Docking%2520and%2520Hit%2520Optimization%2520Guided%2520by%2520Molecular%2520Dynamics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Unzue, A.; Xu, M.; Dong, J.; Wiedmer, L.; Spiliotopoulos, D.; Caflisch, A.; Nevado, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Unzue&author=M.+Xu&author=J.+Dong&author=L.+Wiedmer&author=D.+Spiliotopoulos&author=A.+Caflisch&author=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of Methyl Isoxazoleazepines as Inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+Methyl+Isoxazoleazepines+as+Inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0ljuMr1T9MT2dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520Methyl%2520Isoxazoleazepines%2520as%2520Inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Taylor, A. M.; Vaswani, R. G.; Gehling, V. S.; Hewitt, M. C.; Leblanc, Y.; Audia, J. E.; Bellon, S.; Cummings, R. T.; Côté, A.; Harmange, J.-C.; Jayaram, H.; Joshi, S.; Lora, J. M.; Mertz, J. A.; Neiss, A.; Pardo, E.; Nasveschuk, C. G.; Poy, F.; Sandy, P.; Setser, J. W.; Sims, R. J.,  III; Tang, Y.; Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of Benzotriazolo[4,3-<i>D</i>][1,4]Diazepines as Orally Active Inhibitors of BET Bromodomains</span>.  <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/ml500411h</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+M.+Taylor&author=R.+G.+Vaswani&author=V.+S.+Gehling&author=M.+C.+Hewitt&author=Y.+Leblanc&author=J.+E.+Audia&author=S.+Bellon&author=R.+T.+Cummings&author=A.+C%C3%B4t%C3%A9&author=J.-C.+Harmange&author=H.+Jayaram&author=S.+Joshi&author=J.+M.+Lora&author=J.+A.+Mertz&author=A.+Neiss&author=E.+Pardo&author=C.+G.+Nasveschuk&author=F.+Poy&author=P.+Sandy&author=J.+W.+Setser&author=R.+J.+Sims&author=Y.+Tang&author=B.+K.+Albrecht&title=Discovery+of+Benzotriazolo%5B4%2C3-D%5D%5B1%2C4%5DDiazepines+as+Orally+Active+Inhibitors+of+BET+Bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DDiscovery%2520of%2520Benzotriazolo%255B4%252C3-D%255D%255B1%252C4%255DDiazepines%2520as%2520Orally%2520Active%2520Inhibitors%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Strohner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann-Rohrer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummt, I.</span><span> </span><span class="NLM_article-title">NoRC-a Novel Member of Mammalian ISWI-Containing Chromatin Remodeling Machines</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5031</span><span class="refDoi"> DOI: 10.1093/emboj/20.17.4892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Femboj%2F20.17.4892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=4629-5031&author=R.+Strohnerauthor=A.+Nemethauthor=P.+Jansaauthor=U.+Hofmann-Rohrerauthor=R.+Santoroauthor=G.+Langstauthor=I.+Grummt&title=NoRC-a+Novel+Member+of+Mammalian+ISWI-Containing+Chromatin+Remodeling+Machines&doi=10.1093%2Femboj%2F20.17.4892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.17.4892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.17.4892%26sid%3Dliteratum%253Aachs%26aulast%3DStrohner%26aufirst%3DR.%26aulast%3DNemeth%26aufirst%3DA.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DHofmann-Rohrer%26aufirst%3DU.%26aulast%3DSantoro%26aufirst%3DR.%26aulast%3DLangst%26aufirst%3DG.%26aulast%3DGrummt%26aufirst%3DI.%26atitle%3DNoRC-a%2520Novel%2520Member%2520of%2520Mammalian%2520ISWI-Containing%2520Chromatin%2520Remodeling%2520Machines%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D20%26spage%3D4629%26epage%3D5031%26doi%3D10.1093%2Femboj%2F20.17.4892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grupp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerig, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bär, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sültmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provenzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaspo, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brors, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korbel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlomm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eils, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, R.</span><span> </span><span class="NLM_article-title">BAZ2A (TIP5) Is Involved in Epigenetic Alterations in Prostate Cancer and Its Overexpression Predicts Disease Recurrence</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1038/ng.3165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fng.3165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25485837" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=22-30&author=L.+Guauthor=S.+C.+Frommelauthor=C.+C.+Oakesauthor=R.+Simonauthor=K.+Gruppauthor=C.+Y.+Gerigauthor=D.+B%C3%A4rauthor=M.+D.+Robinsonauthor=C.+Baerauthor=M.+Weissauthor=Z.+Guauthor=M.+Schapiraauthor=R.+Kunerauthor=H.+S%C3%BCltmannauthor=M.+Provenzanoauthor=M.-L.+Yaspoauthor=B.+Brorsauthor=J.+Korbelauthor=T.+Schlommauthor=G.+Sauterauthor=R.+Eilsauthor=C.+Plassauthor=R.+Santoro&title=BAZ2A+%28TIP5%29+Is+Involved+in+Epigenetic+Alterations+in+Prostate+Cancer+and+Its+Overexpression+Predicts+Disease+Recurrence&doi=10.1038%2Fng.3165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fng.3165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3165%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DFrommel%26aufirst%3DS.%2BC.%26aulast%3DOakes%26aufirst%3DC.%2BC.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DGrupp%26aufirst%3DK.%26aulast%3DGerig%26aufirst%3DC.%2BY.%26aulast%3DB%25C3%25A4r%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%2BD.%26aulast%3DBaer%26aufirst%3DC.%26aulast%3DWeiss%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DKuner%26aufirst%3DR.%26aulast%3DS%25C3%25BCltmann%26aufirst%3DH.%26aulast%3DProvenzano%26aufirst%3DM.%26aulast%3DYaspo%26aufirst%3DM.-L.%26aulast%3DBrors%26aufirst%3DB.%26aulast%3DKorbel%26aufirst%3DJ.%26aulast%3DSchlomm%26aufirst%3DT.%26aulast%3DSauter%26aufirst%3DG.%26aulast%3DEils%26aufirst%3DR.%26aulast%3DPlass%26aufirst%3DC.%26aulast%3DSantoro%26aufirst%3DR.%26atitle%3DBAZ2A%2520%2528TIP5%2529%2520Is%2520Involved%2520in%2520Epigenetic%2520Alterations%2520in%2520Prostate%2520Cancer%2520and%2520Its%2520Overexpression%2520Predicts%2520Disease%2520Recurrence%26jtitle%3DNat.%2520Genet.%26date%3D2014%26volume%3D47%26spage%3D22%26epage%3D30%26doi%3D10.1038%2Fng.3165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Drouin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhtar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Structure Enabled Design of BAZ2-ICR, a Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2559</span><span class="refDoi"> DOI: 10.1021/jm501963e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501963e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFChtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2553-2559&author=L.+Drouinauthor=S.+McGrathauthor=L.+R.+Vidlerauthor=A.+Chaikuadauthor=O.+Monteiroauthor=C.+Tallantauthor=M.+Philpottauthor=C.+Rogersauthor=O.+Fedorovauthor=M.+Liuauthor=W.+Akhtarauthor=A.+Hayesauthor=F.+Raynaudauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=S.+Hoelder&title=Structure+Enabled+Design+of+BAZ2-ICR%2C+a+Chemical+Probe+Targeting+the+Bromodomains+of+BAZ2A+and+BAZ2B&doi=10.1021%2Fjm501963e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B</span></div><div class="casAuthors">Drouin, Ludovic; McGrath, Sally; Vidler, Lewis R.; Chaikuad, Apirat; Monteiro, Octovia; Tallant, Cynthia; Philpott, Martin; Rogers, Catherine; Fedorov, Oleg; Liu, Manjuan; Akhtar, Wasim; Hayes, Angela; Raynaud, Florence; Muller, Susanne; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2553-2559</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromodomain contg. proteins BAZ2A/B play essential roles in chromatin remodeling and regulation of noncoding RNAs.  The authors present the structure based discovery of a potent, selective, and cell active inhibitor (I) of the BAZ2A/B bromodomains through rapid optimization of a weakly potent starting point.  A key feature of the presented inhibitors is an intramol. arom. stacking interaction that efficiently occupies the shallow bromodomain pockets.  I represents an excellent chem. probe for functional studies of the BAZ2 bromodomains in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfebSuQ4MJm7Vg90H21EOLACvtfcHk0lhPM43STseObg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFChtL4%253D&md5=2147409485bf4b3be9a63046e611e7ba</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm501963e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501963e%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DS.%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DAkhtar%26aufirst%3DW.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DStructure%2520Enabled%2520Design%2520of%2520BAZ2-ICR%252C%2520a%2520Chemical%2520Probe%2520Targeting%2520the%2520Bromodomains%2520of%2520BAZ2A%2520and%2520BAZ2B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2553%26epage%3D2559%26doi%3D10.1021%2Fjm501963e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chen, P.; Chaikuad, A.; Bamborough, P.; Bantscheff, M.; Bountra, C.; Chung, C.-W.; Fedorov, O.; Grandi, P.; Jung, D.; Lesniak, R.; Lindon, M.; Müller, S.; Philpott, M.; Prinjha, R.; Rogers, C.; Selenski, C.; Tallant, C.; Werner, T.; Willson, T. M.; Knapp, S.; Drewry, D. H.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00209</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+Chen&author=A.+Chaikuad&author=P.+Bamborough&author=M.+Bantscheff&author=C.+Bountra&author=C.-W.+Chung&author=O.+Fedorov&author=P.+Grandi&author=D.+Jung&author=R.+Lesniak&author=M.+Lindon&author=S.+M%C3%BCller&author=M.+Philpott&author=R.+Prinjha&author=C.+Rogers&author=C.+Selenski&author=C.+Tallant&author=T.+Werner&author=T.+M.+Willson&author=S.+Knapp&author=D.+H.+Drewry&title=Discovery+and+Characterization+of+GSK2801%2C+a+Selective+Chemical+Probe+for+the+Bromodomains+BAZ2A+and+BAZ2B&doi=10.1021%2Facs.jmedchem.5b00209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00209%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520GSK2801%252C%2520a%2520Selective%2520Chemical%2520Probe%2520for%2520the%2520Bromodomains%2520BAZ2A%2520and%2520BAZ2B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Scotto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandula, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniyam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansukhani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias-Pulido, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murty, V. V.</span><span> </span><span class="NLM_article-title">Integrative Genomics Analysis of Chromosome 5p Gain in Cervical Cancer Reveals Target Over-Expressed Genes, Including Drosha</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1186/1476-4598-7-58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1186%2F1476-4598-7-58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18559093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A280%3ADC%252BD1cvgvFGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=58-10&author=L.+Scottoauthor=G.+Narayanauthor=S.+V.+Nandulaauthor=S.+Subramaniyamauthor=A.+M.+Kaufmannauthor=J.+D.+Wrightauthor=B.+Pothuriauthor=M.+Mansukhaniauthor=A.+Schneiderauthor=H.+Arias-Pulidoauthor=V.+V.+Murty&title=Integrative+Genomics+Analysis+of+Chromosome+5p+Gain+in+Cervical+Cancer+Reveals+Target+Over-Expressed+Genes%2C+Including+Drosha&doi=10.1186%2F1476-4598-7-58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha</span></div><div class="casAuthors">Scotto Luigi; Narayan Gopeshwar; Nandula Subhadra V; Subramaniyam Shivakumar; Kaufmann Andreas M; Wright Jason D; Pothuri Bhavana; Mansukhani Mahesh; Schneider Achim; Arias-Pulido Hugo; Murty Vundavalli V</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Copy number gains and amplifications are characteristic feature of cervical cancer (CC) genomes for which the underlying mechanisms are unclear.  These changes may possess oncogenic properties by deregulating tumor-related genes.  Gain of short arm of chromosome 5 (5p) is the most frequent karyotypic change in CC.  METHODS:  To examine the role of 5p gain, we performed a combination of single nucleotide polymorphism (SNP) array, fluorescence in situ hybridization (FISH), and gene expression analyses on invasive cancer and in various stages of CC progression.  RESULTS:  The SNP and FISH analyses revealed copy number increase (CNI) of 5p in 63% of invasive CC, which arises at later stages of precancerous lesions in CC development.  We integrated chromosome 5 genomic copy number and gene expression data to identify key target over expressed genes as a consequence of 5p gain.  One of the candidates identified was Drosha (RNASEN), a gene that is required in the first step of microRNA (miRNA) processing in the nucleus.  Other 5p genes identified as targets of CNI play a role in DNA repair and cell cycle regulation (BASP1, TARS, PAIP1, BRD9, RAD1, SKP2, and POLS), signal transduction (OSMR), and mitochondrial oxidative phosphorylation (NNT, SDHA, and NDUFS6), suggesting that disruption of pathways involving these genes may contribute to CC progression.  CONCLUSION:  Taken together, we demonstrate the power of integrating genomics data with expression data in deciphering tumor-related targets of CNI.  Identification of 5p gene targets in CC denotes an important step towards biomarker development and forms a framework for testing as molecular therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJ-og-xr-IWuxsqfvU0ziafW6udTcc2ebOksJjZdRo5bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvgvFGktw%253D%253D&md5=9bb25d18ffeaebf79760b3b760c91e15</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-7-58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-7-58%26sid%3Dliteratum%253Aachs%26aulast%3DScotto%26aufirst%3DL.%26aulast%3DNarayan%26aufirst%3DG.%26aulast%3DNandula%26aufirst%3DS.%2BV.%26aulast%3DSubramaniyam%26aufirst%3DS.%26aulast%3DKaufmann%26aufirst%3DA.%2BM.%26aulast%3DWright%26aufirst%3DJ.%2BD.%26aulast%3DPothuri%26aufirst%3DB.%26aulast%3DMansukhani%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DArias-Pulido%26aufirst%3DH.%26aulast%3DMurty%26aufirst%3DV.%2BV.%26atitle%3DIntegrative%2520Genomics%2520Analysis%2520of%2520Chromosome%25205p%2520Gain%2520in%2520Cervical%2520Cancer%2520Reveals%2520Target%2520Over-Expressed%2520Genes%252C%2520Including%2520Drosha%26jtitle%3DMol.%2520Cancer%26date%3D2008%26volume%3D7%26spage%3D58%26epage%3D10%26doi%3D10.1186%2F1476-4598-7-58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Kang, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span> </span><span class="NLM_article-title">Gain at Chromosomal Region 5p15.33, Containing TERT, Is the Most Frequent Genetic Event in Early Stages of Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.cancergencyto.2007.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cancergencyto.2007.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18328944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVWmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2008&pages=1-11&author=J.+U.+Kangauthor=S.+H.+Kooauthor=K.+C.+Kwonauthor=J.+W.+Parkauthor=J.+M.+Kim&title=Gain+at+Chromosomal+Region+5p15.33%2C+Containing+TERT%2C+Is+the+Most+Frequent+Genetic+Event+in+Early+Stages+of+Non-Small+Cell+Lung+Cancer&doi=10.1016%2Fj.cancergencyto.2007.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer</span></div><div class="casAuthors">Kang, Ji Un; Koo, Sun Hoe; Kwon, Kye Chul; Park, Jong Woo; Kim, Jin Man</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genetics and Cytogenetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CGCYDF</span>;
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chromosomal imbalances resulting in altered gene dosage play a role in the mol. pathogenesis of non-small cell lung cancer (NSCLC), but the target genes remain to be identified.  To identify early-stage genetic events that drive progression of NSCLC, we conducted a high-resoln. array comparative genomic hybridization (CGH) study, using an array of 4046 bacterial artificial chromosome clones to screen for DNA copy no. changes assocd. with individual genes in 36 tumors obtained from patients in early stages of NSCLC.  Multiple early genetic events occurring on chromosome 5p were identified, with a minimal detection region at 5p15.33∼12.  The most frequent finding involved gain of 5p15.33, obsd. in 15 of 19 stage I (A+B) cancers (79%) and in 28 of the total 36 NSCLC cases (78%).  This locus harbors the genes TERT, SLC6A19, and SLC6A18 and is a telomeric boundary at bacterial artificial chromosome (BAC) clone 91_J20.  Other potential candidate genes evidencing high nos. of genomic copy no. changes (≥40% of patients) included the following genes, encountered in >50% of 19 stage I (A+B) cancers: CEP72 and TPPP (14 of 19; 74%); AHRR, EXOC3 (previously SEC6L1), SLC9A3, LOC442126, ZDHHC11, BRD9, and TRIP13 (13/19; 68%); and CLPTM1L (alias CRR9), SLC6A3 (previously DAT1), and LOC401169 (10/19; 53%).  Fluorescence in situ hybridization validated the array CGH findings.  The gain of 5p15.33 is thus one of the most consistent alterations in the early stages of lung cancer, and a series of genes in the crit. 5p15.33 region may be used as novel biomarkers for the early detection and classification of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKwLSWMQRnbVg90H21EOLACvtfcHk0lhoyNphUkq6SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVWmt78%253D&md5=514aec6952253ed612003471df40a4ba</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2007.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2007.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BU.%26aulast%3DKoo%26aufirst%3DS.%2BH.%26aulast%3DKwon%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26atitle%3DGain%2520at%2520Chromosomal%2520Region%25205p15.33%252C%2520Containing%2520TERT%252C%2520Is%2520the%2520Most%2520Frequent%2520Genetic%2520Event%2520in%2520Early%2520Stages%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2008%26volume%3D182%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.cancergencyto.2007.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Middeljans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stunnenberg, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logie, C.</span><span> </span><span class="NLM_article-title">SS18 Together with Animal-Specific Factors Defines Human BAF-Type SWI/SNF Complexes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e33834</span><span class="refDoi"> DOI: 10.1371/journal.pone.0033834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0033834" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e33834&author=E.+Middeljansauthor=X.+Wanauthor=P.+W.+Jansenauthor=V.+Sharmaauthor=H.+G.+Stunnenbergauthor=C.+Logie&title=SS18+Together+with+Animal-Specific+Factors+Defines+Human+BAF-Type+SWI%2FSNF+Complexes&doi=10.1371%2Fjournal.pone.0033834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033834%26sid%3Dliteratum%253Aachs%26aulast%3DMiddeljans%26aufirst%3DE.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DJansen%26aufirst%3DP.%2BW.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DStunnenberg%26aufirst%3DH.%2BG.%26aulast%3DLogie%26aufirst%3DC.%26atitle%3DSS18%2520Together%2520with%2520Animal-Specific%2520Factors%2520Defines%2520Human%2520BAF-Type%2520SWI%252FSNF%2520Complexes%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De33834%26doi%3D10.1371%2Fjournal.pone.0033834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kadoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabtree, G. R.</span><span> </span><span class="NLM_article-title">Proteomic and Bioinformatic Analysis of Mammalian SWI/SNF Complexes Identifies Extensive Roles in Human Malignancy</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/ng.2628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fng.2628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23644491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVart7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=592-601&author=C.+Kadochauthor=D.+C.+Hargreavesauthor=C.+Hodgesauthor=L.+Eliasauthor=L.+Hoauthor=J.+Ranishauthor=G.+R.+Crabtree&title=Proteomic+and+Bioinformatic+Analysis+of+Mammalian+SWI%2FSNF+Complexes+Identifies+Extensive+Roles+in+Human+Malignancy&doi=10.1038%2Fng.2628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy</span></div><div class="casAuthors">Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Ranish, Jeff; Crabtree, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">592-601</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Subunits of mammalian SWI/SNF (mSWI/SNF or BAF) complexes have recently been implicated as tumor suppressors in human malignancies.  To understand the full extent of their involvement, we conducted a proteomic anal. of endogenous mSWI/SNF complexes, which identified several new dedicated, stable subunits not found in yeast SWI/SNF complexes, including BCL7A, BCL7B and BCL7C, BCL11A and BCL11B, BRD9 and SS18.  Incorporating these new members, we detd. mSWI/SNF subunit mutation frequency in exome and whole-genome sequencing studies of primary human tumors.  Notably, mSWI/SNF subunits are mutated in 19.6% of all human tumors reported in 44 studies.  Our anal. suggests that specific subunits protect against cancer in specific tissues.  In addn., mutations affecting more than one subunit, defined here as compd. heterozygosity, are prevalent in certain cancers.  Our studies demonstrate that mSWI/SNF is the most frequently mutated chromatin-regulatory complex (CRC) in human cancer, exhibiting a broad mutation pattern, similar to that of TP53.  Thus, proper functioning of polymorphic BAF complexes may constitute a major mechanism of tumor suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP873DCpn7JrVg90H21EOLACvtfcHk0lj530K9vBcdrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVart7s%253D&md5=0f49cf3c59e7bc04b74970fe656b1e17</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fng.2628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2628%26sid%3Dliteratum%253Aachs%26aulast%3DKadoch%26aufirst%3DC.%26aulast%3DHargreaves%26aufirst%3DD.%2BC.%26aulast%3DHodges%26aufirst%3DC.%26aulast%3DElias%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DRanish%26aufirst%3DJ.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26atitle%3DProteomic%2520and%2520Bioinformatic%2520Analysis%2520of%2520Mammalian%2520SWI%252FSNF%2520Complexes%2520Identifies%2520Extensive%2520Roles%2520in%2520Human%2520Malignancy%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D592%26epage%3D601%26doi%3D10.1038%2Fng.2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Kaeser, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. R.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, B. M.</span><span> </span><span class="NLM_article-title">BRD7, a Novel PBAF-Specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32254</span><span class="NLM_x">–</span> <span class="NLM_lpage">32263</span><span class="refDoi"> DOI: 10.1074/jbc.M806061200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M806061200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32254-32263&author=M.+D.+Kaeserauthor=A.+Aslanianauthor=M.+Q.+Dongauthor=J.+R.+Yatesauthor=B.+M.+Emerson&title=BRD7%2C+a+Novel+PBAF-Specific+SWI%2FSNF+Subunit%2C+Is+Required+for+Target+Gene+Activation+and+Repression+in+Embryonic+Stem+Cells&doi=10.1074%2Fjbc.M806061200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806061200%26sid%3Dliteratum%253Aachs%26aulast%3DKaeser%26aufirst%3DM.%2BD.%26aulast%3DAslanian%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DEmerson%26aufirst%3DB.%2BM.%26atitle%3DBRD7%252C%2520a%2520Novel%2520PBAF-Specific%2520SWI%252FSNF%2520Subunit%252C%2520Is%2520Required%2520for%2520Target%2520Gene%2520Activation%2520and%2520Repression%2520in%2520Embryonic%2520Stem%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32254%26epage%3D32263%26doi%3D10.1074%2Fjbc.M806061200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Harte, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkin, D. P.</span><span> </span><span class="NLM_article-title">BRD7, a Subunit of SWI/SNF Complexes, Binds Directly to BRCA1 and Regulates BRCA1-Dependent Transcription</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-09-2089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=2538-2547&author=M.+T.+Harteauthor=G.+J.+O%27Brienauthor=N.+M.+Ryanauthor=J.+J.+Gorskiauthor=K.+I.+Savageauthor=N.+T.+Crawfordauthor=P.+B.+Mullanauthor=D.+P.+Harkin&title=BRD7%2C+a+Subunit+of+SWI%2FSNF+Complexes%2C+Binds+Directly+to+BRCA1+and+Regulates+BRCA1-Dependent+Transcription&doi=10.1158%2F0008-5472.CAN-09-2089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2089%26sid%3Dliteratum%253Aachs%26aulast%3DHarte%26aufirst%3DM.%2BT.%26aulast%3DO%2527Brien%26aufirst%3DG.%2BJ.%26aulast%3DRyan%26aufirst%3DN.%2BM.%26aulast%3DGorski%26aufirst%3DJ.%2BJ.%26aulast%3DSavage%26aufirst%3DK.%2BI.%26aulast%3DCrawford%26aufirst%3DN.%2BT.%26aulast%3DMullan%26aufirst%3DP.%2BB.%26aulast%3DHarkin%26aufirst%3DD.%2BP.%26atitle%3DBRD7%252C%2520a%2520Subunit%2520of%2520SWI%252FSNF%2520Complexes%252C%2520Binds%2520Directly%2520to%2520BRCA1%2520and%2520Regulates%2520BRCA1-Dependent%2520Transcription%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D2538%26epage%3D2547%26doi%3D10.1158%2F0008-5472.CAN-09-2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Drost, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tocco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holstege, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorhoeve, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agami, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Sal, G.</span><span> </span><span class="NLM_article-title">BRD7 Is a Candidate Tumour Suppressor Gene Required for P53 Function</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/ncb2038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fncb2038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20228809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVyjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=380-389&author=J.+Drostauthor=F.+Mantovaniauthor=F.+Toccoauthor=R.+Elkonauthor=A.+Comelauthor=H.+Holstegeauthor=R.+Kerkhovenauthor=J.+Jonkersauthor=P.+M.+Voorhoeveauthor=R.+Agamiauthor=G.+Del+Sal&title=BRD7+Is+a+Candidate+Tumour+Suppressor+Gene+Required+for+P53+Function&doi=10.1038%2Fncb2038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">BRD7 is a candidate tumour suppressor gene required for p53 function</span></div><div class="casAuthors">Drost, Jarno; Mantovani, Fiamma; Tocco, Francesca; Elkon, Ran; Comel, Anna; Holstege, Henne; Kerkhoven, Ron; Jonkers, Jos; Voorhoeve, P. Mathijs; Agami, Reuven; Del Sal, Giannino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">380-389</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene-induced senescence is a p53-dependent defense mechanism against uncontrolled proliferation.  Consequently, many human tumors harbor p53 mutations and others show a dysfunctional p53 pathway, frequently by unknown mechanisms.  Here the authors identify BRD7 (bromodomain-contg. 7) as a protein whose inhibition allows full neoplastic transformation in the presence of wild-type p53.  In human breast tumors harboring wild-type, but not mutant, p53 the BRD7 gene locus was frequently deleted and low BRD7 expression was found in a subgroup of tumors.  Functionally, BRD7 is required for efficient p53-mediated transcription of a subset of target genes.  BRD7 interacts with p53 and p300 and is recruited to target gene promoters, affecting histone acetylation, p53 acetylation and promoter activity.  Thus, BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1grCCyCF9MrVg90H21EOLACvtfcHk0lgucuO-UE-0kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVyjurw%253D&md5=676cb9cbc5a8d157ac85d76c42ba8007</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fncb2038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2038%26sid%3Dliteratum%253Aachs%26aulast%3DDrost%26aufirst%3DJ.%26aulast%3DMantovani%26aufirst%3DF.%26aulast%3DTocco%26aufirst%3DF.%26aulast%3DElkon%26aufirst%3DR.%26aulast%3DComel%26aufirst%3DA.%26aulast%3DHolstege%26aufirst%3DH.%26aulast%3DKerkhoven%26aufirst%3DR.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DVoorhoeve%26aufirst%3DP.%2BM.%26aulast%3DAgami%26aufirst%3DR.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DBRD7%2520Is%2520a%2520Candidate%2520Tumour%2520Suppressor%2520Gene%2520Required%2520for%2520P53%2520Function%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D380%26epage%3D389%26doi%3D10.1038%2Fncb2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strocchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">9 H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2718</span><span class="NLM_x">–</span> <span class="NLM_lpage">2736</span><span class="refDoi"> DOI: 10.1021/jm501893k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501893k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2msLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2718-2736&author=S.+Picaudauthor=M.+Strocchiaauthor=S.+Terraccianoauthor=G.+Lauroauthor=J.+M%C3%A9ndezauthor=D.+L.+Danielsauthor=R.+Riccioauthor=G.+Bifulcoauthor=I.+Brunoauthor=P.+Filippakopoulos&title=9+H-Purine+Scaffold+Reveals+Induced-Fit+Pocket+Plasticity+of+the+BRD9+Bromodomain&doi=10.1021%2Fjm501893k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Strocchia, Maria; Terracciano, Stefania; Lauro, Gianluigi; Mendez, Jacqui; Daniels, Danette L.; Riccio, Raffaele; Bifulco, Giuseppe; Bruno, Ines; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2718-2736</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2-amine-9H-purine scaffold was identified as a weak bromodomain template and was developed via iterative structure based design into a potent nanomolar ligand for the bromodomain of human BRD9 with small residual micromolar affinity toward the bromodomain of BRD4.  Binding of the lead compd. I to the bromodomain of BRD9 results in an unprecedented rearrangement of residues forming the acetyl lysine recognition site, affecting plasticity of the protein in an induced-fit pocket.  The compd. does not exhibit any cytotoxic effect in HEK293 cells and displaces the BRD9 bromodomain from chromatin in bioluminescence proximity assays without affecting the BRD4/histone complex.  The 2-amine-9H-purine scaffold represents a novel template that can be further modified to yield highly potent and selective tool compds. to interrogate the biol. role of BRD9 in diverse cellular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOpXUqzFa-LVg90H21EOLACvtfcHk0lgucuO-UE-0kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2msLc%253D&md5=e5d5f1f622baa9b48f93bb460011ff0b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm501893k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501893k%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DStrocchia%26aufirst%3DM.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DLauro%26aufirst%3DG.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DRiccio%26aufirst%3DR.%26aulast%3DBifulco%26aufirst%3DG.%26aulast%3DBruno%26aufirst%3DI.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3D9%2520H-Purine%2520Scaffold%2520Reveals%2520Induced-Fit%2520Pocket%2520Plasticity%2520of%2520the%2520BRD9%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2718%26epage%3D2736%26doi%3D10.1021%2Fjm501893k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">[1,2,4]Triazolo[4,3- a]Phthalazines: Inhibitors of Diverse Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><span class="refDoi"> DOI: 10.1021/jm401568s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401568s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=462-476&author=O.+Fedorovauthor=H.+Lingardauthor=C.+Wellsauthor=O.+P.+Monteiroauthor=S.+Picaudauthor=T.+Keatesauthor=C.+Yappauthor=M.+Philpottauthor=S.+J.+Martinauthor=I.+Felletarauthor=B.+D.+Marsdenauthor=P.+Filippakopoulosauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennan&title=%5B1%2C2%2C4%5DTriazolo%5B4%2C3-+a%5DPhthalazines%3A+Inhibitors+of+Diverse+Bromodomains&doi=10.1021%2Fjm401568s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm401568s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401568s%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DMarsden%26aufirst%3DB.%2BD.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3D%255B1%252C2%252C4%255DTriazolo%255B4%252C3-%2520a%255DPhthalazines%253A%2520Inhibitors%2520of%2520Diverse%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D462%26epage%3D476%26doi%3D10.1021%2Fjm401568s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Clark, P. G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, L. C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baronio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. J.</span><span> </span><span class="NLM_article-title">LP99: Discovery and Synthesis of the First Selective BRD7/9Bromodomain Inhibitor</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6217</span><span class="NLM_x">–</span> <span class="NLM_lpage">6221</span><span class="refDoi"> DOI: 10.1002/anie.201501394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fanie.201501394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=6217-6221&author=P.+G.+K.+Clarkauthor=L.+C.+C.+Vieiraauthor=C.+Tallantauthor=O.+Fedorovauthor=D.+C.+Singletonauthor=C.+M.+Rogersauthor=O.+P.+Monteiroauthor=J.+M.+Bennettauthor=R.+Baronioauthor=S.+M%C3%BCllerauthor=D.+L.+Danielsauthor=J.+Mendezauthor=S.+Knappauthor=P.+Brennanauthor=D.+J.+Dixon&title=LP99%3A+Discovery+and+Synthesis+of+the+First+Selective+BRD7%2F9Bromodomain+Inhibitor&doi=10.1002%2Fanie.201501394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501394%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DP.%2BG.%2BK.%26aulast%3DVieira%26aufirst%3DL.%2BC.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBaronio%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DMendez%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%26aulast%3DDixon%26aufirst%3DD.%2BJ.%26atitle%3DLP99%253A%2520Discovery%2520and%2520Synthesis%2520of%2520the%2520First%2520Selective%2520BRD7%252F9Bromodomain%2520Inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D6217%26epage%3D6221%26doi%3D10.1002%2Fanie.201501394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent and Selective Inhibitors of BRD7 and BRD9 Bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span><span class="refDoi"> DOI: 10.1039/C5MD00152H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC5MD00152H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1381-1386&author=D.+A.+Hayauthor=C.+M.+Rogersauthor=O.+Fedorovauthor=C.+Tallantauthor=S.+Martinauthor=O.+P.+Monteiroauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Design+and+Synthesis+of+Potent+and+Selective+Inhibitors+of+BRD7+and+BRD9+Bromodomains&doi=10.1039%2FC5MD00152H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2FC5MD00152H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00152H%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520BRD7%2520and%2520BRD9%2520Bromodomains%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1381%26epage%3D1386%26doi%3D10.1039%2FC5MD00152H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span>BI-9564: A Chemical Probe for BRD9 and BRD7; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/BI-9564" class="extLink">http://www.thesgc.org/chemical-probes/BI-9564</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BI-9564%3A+A+Chemical+Probe+for+BRD9+and+BRD7%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FBI-9564+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DBI-9564%253A%2520A%2520Chemical%2520Probe%2520for%2520BRD9%2520and%2520BRD7%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Theodoulou, N. H.; Bamborough, P.; Bannister, A. J.; Becher, I.; Bit, R. A.; Che, K. H.; Chung, C.-W.; Dittmann, A.; Drewes, G.; Drewry, D. H.; Gordon, L.; Grandi, P.; Leveridge, M.; Lindon, M.; Michon, A.-M.; Molnar, J.; Robson, S. C.; Tomkinson, N. C. O.; Kouzarides, T.; Prinjha, R. K.; Humphreys, P. G.</span><span> </span><span class="NLM_article-title">Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00256</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+H.+Theodoulou&author=P.+Bamborough&author=A.+J.+Bannister&author=I.+Becher&author=R.+A.+Bit&author=K.+H.+Che&author=C.-W.+Chung&author=A.+Dittmann&author=G.+Drewes&author=D.+H.+Drewry&author=L.+Gordon&author=P.+Grandi&author=M.+Leveridge&author=M.+Lindon&author=A.-M.+Michon&author=J.+Molnar&author=S.+C.+Robson&author=N.+C.+O.+Tomkinson&author=T.+Kouzarides&author=R.+K.+Prinjha&author=P.+G.+Humphreys&title=Discovery+of+I-BRD9%2C+a+Selective+Cell+Active+Chemical+Probe+for+Bromodomain+Containing+Protein+9+Inhibition&doi=10.1021%2Facs.jmedchem.5b00256"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00256%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoulou%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%2520I-BRD9%252C%2520a%2520Selective%2520Cell%2520Active%2520Chemical%2520Probe%2520for%2520Bromodomain%2520Containing%2520Protein%25209%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Albrecht, B. K.; Cote, A.; Crawford, T.; Fauber, B.; Huang, H. R.; Lora, J. M.; Magnuson, S.; Nasveschuk, C. G.; Salmeron, A.; Sims, R. J.,  III; Taylor, A. M.</span><span> </span><span class="NLM_article-title">Treating TH2-Mediated Diseases by Inhibition of Bromodomains</span>. WO2014144721A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+K.+Albrecht&author=A.+Cote&author=T.+Crawford&author=B.+Fauber&author=H.+R.+Huang&author=J.+M.+Lora&author=S.+Magnuson&author=C.+G.+Nasveschuk&author=A.+Salmeron&author=R.+J.+Sims&author=A.+M.+Taylor&title=Treating+TH2-Mediated+Diseases+by+Inhibition+of+Bromodomains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DTreating%2520TH2-Mediated%2520Diseases%2520by%2520Inhibition%2520of%2520Bromodomains%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Zou, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revenko, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. W.</span><span> </span><span class="NLM_article-title">Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3346</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-3440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-08-3440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=19318566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2hsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=3339-3346&author=J.+X.+Zouauthor=L.+Guoauthor=A.+S.+Revenkoauthor=C.+G.+Tepperauthor=A.+T.+Gemoauthor=H.+J.+Kungauthor=H.+W.+Chen&title=Androgen-Induced+Coactivator+ANCCA+Mediates+Specific+Androgen+Receptor+Signaling+in+Prostate+Cancer&doi=10.1158%2F0008-5472.CAN-08-3440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer</span></div><div class="casAuthors">Zou, June X.; Guo, Linlang; Revenko, Alexey S.; Tepper, Clifford G.; Gemo, Abigael T.; Kung, Hsing-Jien; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3339-3346</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Androgen receptor (AR) plays a pivotal role in prostate cancer, primarily by regulating different gene expression programs elicited by androgen, which is important for cancer cell proliferation, survival, and differentiation.  It is believed that the transcriptional function of AR is mediated largely by distinct nuclear coregulators.  We report here the identification of ANCCA (also known as ATAD2), a new member of the AAA+ ATPase family proteins, as a novel AR coactivator.  ANCCA interacts directly with AR and enhances its transcriptional activity, and is required for androgen-stimulated expression of a specific subgroup of genes including IGF1R, IRS-2, SGK1, and survivin.  Upon androgen stimulation, ANCCA together with AR is recruited to the specific AR target genes.  Suppression of ANCCA expression strongly inhibited the proliferation of androgen-responsive or androgen-independent, AR-pos. prostate cancer cells and caused a significant increase of cellular apoptosis.  Strikingly, the ANCCA gene itself, located at chromosome 8q24, is highly induced by androgen in androgen-dependent prostate cancer cells and xenograft tumors.  Although ANCCA is hardly detected in normal human prostate tissue, high levels of ANCCA are found in hormone-independent prostate cancer cell lines, xenograft tumor, and a subset of prostate cancers with high Gleason scores.  Together, these findings suggest that ANCCA plays an important role in prostate cancer by mediating specific AR functions in cancer cell survival and proliferation.  The possession of ATPase and bromodomain by ANCCA makes it an attractive target for the development of therapeutics for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtieC3cr_jX7Vg90H21EOLACvtfcHk0liSY-VPuMzYhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2hsLY%253D&md5=daa42208c9c7019809bb491e5af1f152</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-3440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-3440%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DTepper%26aufirst%3DC.%2BG.%26aulast%3DGemo%26aufirst%3DA.%2BT.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DH.%2BW.%26atitle%3DAndrogen-Induced%2520Coactivator%2520ANCCA%2520Mediates%2520Specific%2520Androgen%2520Receptor%2520Signaling%2520in%2520Prostate%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D3339%26epage%3D3346%26doi%3D10.1158%2F0008-5472.CAN-08-3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Kalashnikova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revenko, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardiff, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowsky, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. W.</span><span> </span><span class="NLM_article-title">ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells Through Control of B-Myb and EZH2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">9402</span><span class="NLM_x">–</span> <span class="NLM_lpage">9412</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-10-1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20864510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=9402-9412&author=E.+V.+Kalashnikovaauthor=A.+S.+Revenkoauthor=A.+T.+Gemoauthor=N.+P.+Andrewsauthor=C.+G.+Tepperauthor=J.+X.+Zouauthor=R.+D.+Cardiffauthor=A.+D.+Borowskyauthor=H.+W.+Chen&title=ANCCA%2FATAD2+Overexpression+Identifies+Breast+Cancer+Patients+with+Poor+Prognosis%2C+Acting+to+Drive+Proliferation+and+Survival+of+Triple-Negative+Cells+Through+Control+of+B-Myb+and+EZH2&doi=10.1158%2F0008-5472.CAN-10-1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2</span></div><div class="casAuthors">Kalashnikova, Ekaterina V.; Revenko, Alexey S.; Gemo, Abigael T.; Andrews, Nicolas P.; Tepper, Clifford G.; Zou, June X.; Cardiff, Robert D.; Borowsky, Alexander D.; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9402-9412</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chromatin coregulators are important factors in tumorigenesis and cancer progression.  ANCCA is an AAA+ ATPase and a bromodomain-contg. nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells.  In this study, we show that ANCCA is overexpressed in >70% of breast tumors and that its high protein level correlates well with tumor histol. grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence.  Strikingly, high-level ANCCA correlated with triple-neg. tumors that represent highly aggressive disease.  Anal. of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival.  Biol. and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-neg./basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1).  In particular, ANCCA overexpression correlated strongly with EZH2 in tumors.  Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-neg. cancers.  Cancer Res; 70(22); 9402-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-adY-FJac6rVg90H21EOLACvtfcHk0lj7CtPr7D9EwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLnP&md5=d7f74575c9c8cf4ebebdcfa5e3cc45fc</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1199%26sid%3Dliteratum%253Aachs%26aulast%3DKalashnikova%26aufirst%3DE.%2BV.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DGemo%26aufirst%3DA.%2BT.%26aulast%3DAndrews%26aufirst%3DN.%2BP.%26aulast%3DTepper%26aufirst%3DC.%2BG.%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DCardiff%26aufirst%3DR.%2BD.%26aulast%3DBorowsky%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DH.%2BW.%26atitle%3DANCCA%252FATAD2%2520Overexpression%2520Identifies%2520Breast%2520Cancer%2520Patients%2520with%2520Poor%2520Prognosis%252C%2520Acting%2520to%2520Drive%2520Proliferation%2520and%2520Survival%2520of%2520Triple-Negative%2520Cells%2520Through%2520Control%2520of%2520B-Myb%2520and%2520EZH2%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D9402%26epage%3D9412%26doi%3D10.1158%2F0008-5472.CAN-10-1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Ciro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosperini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walfridsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBlane, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucifero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchiana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8491</span><span class="NLM_x">–</span> <span class="NLM_lpage">8498</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-09-2131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=19843847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlantrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8491-8498&author=M.+Ciroauthor=E.+Prosperiniauthor=M.+Quartoauthor=U.+Graziniauthor=J.+Walfridssonauthor=F.+McBlaneauthor=P.+Nuciferoauthor=G.+Pacchianaauthor=M.+Capraauthor=J.+Christensenauthor=K.+Helin&title=ATAD2+Is+a+Novel+Cofactor+for+MYC%2C+Overexpressed+and+Amplified+in+Aggressive+Tumors&doi=10.1158%2F0008-5472.CAN-09-2131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors</span></div><div class="casAuthors">Ciro, Marco; Prosperini, Elena; Quarto, Micaela; Grazini, Ursula; Walfridsson, Julian; McBlane, Fraser; Nucifero, Paolo; Pacchiana, Giovanni; Capra, Maria; Christensen, Jesper; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8491-8498</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The E2F and MYC transcription factors are crit. regulators of cell proliferation and contribute to the development of human cancers.  Here, we report on the identification of a novel E2F target gene, ATAD2, the predicted protein product of which contains both a bromodomain and an ATPase domain.  The pRB-E2F pathway regulates ATAD2 expression, which is limiting for the entry into the S phase of the cell cycle.  We show that ATAD2 binds the MYC oncogene and stimulates its transcriptional activity.  ATAD2 maps to chromosome 8q24, 4.3 Mb distal to MYC, in a region that is frequently found amplified in cancer.  Consistent with this, we show that ATAD2 expression is high in several human tumors and that the expression levels correlate with clin. outcome of breast cancer patients.  We suggest that ATAD2 links the E2F and MYC pathways and contributes to the development of aggressive cancer through the enhancement of MYC-dependent transcription. [Cancer Res 2009;69(21):8491-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-O94KXJv2i7Vg90H21EOLACvtfcHk0lj7CtPr7D9EwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlantrnI&md5=85b462fb8a0c9505d98414ab8d90520b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2131%26sid%3Dliteratum%253Aachs%26aulast%3DCiro%26aufirst%3DM.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DGrazini%26aufirst%3DU.%26aulast%3DWalfridsson%26aufirst%3DJ.%26aulast%3DMcBlane%26aufirst%3DF.%26aulast%3DNucifero%26aufirst%3DP.%26aulast%3DPacchiana%26aufirst%3DG.%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DATAD2%2520Is%2520a%2520Novel%2520Cofactor%2520for%2520MYC%252C%2520Overexpressed%2520and%2520Amplified%2520in%2520Aggressive%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8491%26epage%3D8498%26doi%3D10.1158%2F0008-5472.CAN-09-2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Druggability Analysis and Structural Classification of Bromodomain Acetyl-Lysine Binding Sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7346</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span><span class="refDoi"> DOI: 10.1021/jm300346w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300346w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7346-7359&author=L.+R.+Vidlerauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Druggability+Analysis+and+Structural+Classification+of+Bromodomain+Acetyl-Lysine+Binding+Sites&doi=10.1021%2Fjm300346w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites</span></div><div class="casAuthors">Vidler, Lewis R.; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7346-7359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine contg. recognition sites on proteins.  Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription.  Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability.  Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites.  These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree.  This represents the first anal. of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxYqQyqqj7JrVg90H21EOLACvtfcHk0lhEYKW_6VzcRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN&md5=bfb08154c1964aab5df51cb3513f2c1d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm300346w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300346w%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDruggability%2520Analysis%2520and%2520Structural%2520Classification%2520of%2520Bromodomain%2520Acetyl-Lysine%2520Binding%2520Sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7346%26epage%3D7359%26doi%3D10.1021%2Fjm300346w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Harner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Fragment-Based Screening of the Bromodomain of ATAD2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9687</span><span class="NLM_x">–</span> <span class="NLM_lpage">9692</span><span class="refDoi"> DOI: 10.1021/jm501035j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501035j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9687-9692&author=M.+J.+Harnerauthor=B.+A.+Chauderauthor=J.+Phanauthor=S.+W.+Fesik&title=Fragment-Based+Screening+of+the+Bromodomain+of+ATAD2&doi=10.1021%2Fjm501035j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Screening of the Bromodomain of ATAD2</span></div><div class="casAuthors">Harner, Mary J.; Chauder, Brian A.; Phan, Jason; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9687-9692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cellular and genetic evidence suggest that inhibition of ATAD2 (AAA domain-contg. protein 2) could be a useful strategy to treat several types of cancer.  To discover small-mol. inhibitors of the bromodomain of ATAD2, we used a fragment-based approach.  Fragment hits were identified using NMR spectroscopy, and ATAD2 was crystd. with three of the hits identified in the fragment screen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3781FiAn_x7Vg90H21EOLACvtfcHk0lhEYKW_6VzcRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChtrrE&md5=b3ba9d32e92c8d92b37132214940e9d2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm501035j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501035j%26sid%3Dliteratum%253Aachs%26aulast%3DHarner%26aufirst%3DM.%2BJ.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DFragment-Based%2520Screening%2520of%2520the%2520Bromodomain%2520of%2520ATAD2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9687%26epage%3D9692%26doi%3D10.1021%2Fjm501035j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellaway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karamshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5649</span><span class="NLM_x">–</span> <span class="NLM_lpage">5673</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00772</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00772" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5649-5673&author=E.+H.+Demontauthor=C.-W.+Chungauthor=R.+C.+Furzeauthor=P.+Grandiauthor=A.-M.+Michonauthor=C.+Wellawayauthor=N.+Barrettauthor=A.+M.+Bridgesauthor=P.+D.+Craggsauthor=H.+Dialloauthor=D.+P.+Dixonauthor=C.+Douaultauthor=A.+J.+Emmonsauthor=E.+J.+Jonesauthor=B.+V.+Karamshiauthor=K.+Lockeauthor=D.+J.+Mitchellauthor=B.+H.+Mouzonauthor=R.+K.+Prinjhaauthor=A.+D.+Robertsauthor=R.+J.+Sheppardauthor=R.+J.+Watsonauthor=P.+Bamborough&title=Fragment-Based+Discovery+of+Low-Micromolar+ATAD2+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors</span></div><div class="casAuthors">Demont, Emmanuel H.; Chung, Chun-wa; Furze, Rebecca C.; Grandi, Paola; Michon, Anne-Marie; Wellaway, Chris; Barrett, Nathalie; Bridges, Angela M.; Craggs, Peter D.; Diallo, Hawa; Dixon, David P.; Douault, Clement; Emmons, Amanda J.; Jones, Emma J.; Karamshi, Bhumika V.; Locke, Kelly; Mitchell, Darren J.; Mouzon, Bernadette H.; Prinjha, Rab K.; Roberts, Andy D.; Sheppard, Robert J.; Watson, Robert J.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5649-5673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of ATAD2 (ATPase family, AAA domain contg. 2) has been linked to disease severity and progression in a wide range of cancers, and is implicated in the regulation of several drivers of cancer growth.  Little is known of the dependence of these effects upon the ATAD2 bromodomain, which has been categorized as among the least tractable of its class.  The absence of any potent, selective inhibitors limits clear understanding of the therapeutic potential of the bromodomain.  Here, the authors describe the discovery of a hit from a fragment-based targeted array.  Optimization of this produced the first known micromolar inhibitors of the ATAD2 bromodomain, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5pJPrVexJbVg90H21EOLACvtfcHk0lhEjvVMEgyXpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCrtbbP&md5=c133ce439365cd4e4110230827a7a0a4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00772%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DWellaway%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DN.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DDixon%26aufirst%3DD.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DEmmons%26aufirst%3DA.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DKaramshi%26aufirst%3DB.%2BV.%26aulast%3DLocke%26aufirst%3DK.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DMouzon%26aufirst%3DB.%2BH.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRoberts%26aufirst%3DA.%2BD.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-Based%2520Discovery%2520of%2520Low-Micromolar%2520ATAD2%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5649%26epage%3D5673%26doi%3D10.1021%2Facs.jmedchem.5b00772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karamshi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span> </span><span class="NLM_article-title">Structure-Based Optimization of Naphthyridones Into Potent ATAD2 Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6151</span><span class="NLM_x">–</span> <span class="NLM_lpage">6178</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00773</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00773" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kms7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6151-6178&author=P.+Bamboroughauthor=C.-W.+Chungauthor=R.+C.+Furzeauthor=P.+Grandiauthor=A.-M.+Michonauthor=R.+J.+Sheppardauthor=H.+Barnettauthor=H.+Dialloauthor=D.+P.+Dixonauthor=C.+Douaultauthor=E.+J.+Jonesauthor=B.+Karamshiauthor=D.+J.+Mitchellauthor=R.+K.+Prinjhaauthor=C.+Rauauthor=R.+J.+Watsonauthor=T.+Wernerauthor=E.+H.+Demont&title=Structure-Based+Optimization+of+Naphthyridones+Into+Potent+ATAD2+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors</span></div><div class="casAuthors">Bamborough, Paul; Chung, Chun-wa; Furze, Rebecca C.; Grandi, Paola; Michon, Anne-Marie; Sheppard, Robert J.; Barnett, Heather; Diallo, Hawa; Dixon, David P.; Douault, Clement; Jones, Emma J.; Karamshi, Bhumika; Mitchell, Darren J.; Prinjha, Rab K.; Rau, Christina; Watson, Robert J.; Werner, Thilo; Demont, Emmanuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6151-6178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATAD2 is a bromodomain-contg. protein whose overexpression is linked to poor outcomes in a no. of different cancer types.  To date, no potent and selective inhibitors of the bromodomain have been reported.  This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcCY9tFp5dGbVg90H21EOLACvtfcHk0lhEjvVMEgyXpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kms7jK&md5=c7dcd72fdf4ab1c8557be45085cc68fa</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00773%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DBarnett%26aufirst%3DH.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DDixon%26aufirst%3DD.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DKaramshi%26aufirst%3DB.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26atitle%3DStructure-Based%2520Optimization%2520of%2520Naphthyridones%2520Into%2520Potent%2520ATAD2%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6151%26epage%3D6178%26doi%3D10.1021%2Facs.jmedchem.5b00773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span>NVS-1: A Chemical Probe for CECR2; <span class="NLM_contrib-group">SGC</span><span class="NLM_x">, </span><span class="NLM_x"> (</span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/NVS-1" class="extLink">http://www.thesgc.org/chemical-probes/NVS-1</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=SGC&title=NVS-1%3A+A+Chemical+Probe+for+CECR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNVS-1%253A%2520A%2520Chemical%2520Probe%2520for%2520CECR2%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Medina, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montuenga, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Cespedes, M.</span><span> </span><span class="NLM_article-title">Frequent BRG1/SMARCA4-Inactivating Mutations in Human Lung Cancer Cell Lines</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1002/humu.20730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fhumu.20730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18386774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=617-622&author=P.+P.+Medinaauthor=O.+A.+Romeroauthor=T.+Kohnoauthor=L.+M.+Montuengaauthor=R.+Pioauthor=J.+Yokotaauthor=M.+Sanchez-Cespedes&title=Frequent+BRG1%2FSMARCA4-Inactivating+Mutations+in+Human+Lung+Cancer+Cell+Lines&doi=10.1002%2Fhumu.20730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines</span></div><div class="casAuthors">Medina, Pedro P.; Romero, Octavio A.; Kohno, Takashi; Montuenga, Luis M.; Pio, Ruben; Yokota, Jun; Sanchez-Cespedes, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-622</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Components of the SWI/SNF chromatin-remodeling complex, such as INI1, are inactivated in human cancer and, thus, act as tumor suppressors.  Here we screened for mutations the entire coding sequence of BRG1 (SMARCA4), which encodes the ATPase of the complex, in 59 lung cancer cell lines of the most common histopathol. types.  Mutations were detected in 24% of the cancer cell lines, many of them in cells commonly used for lung cancer research.  All mutations were homozygous and most predicted truncated proteins.  The alterations were significantly more frequent in the non-small-cell lung cancer (NSCLC) type (13/37, 35%) as compared to the small-cell lung cancer (SCLC) type (1/19, 5%) (P < 0.05; Fisher's Exact test) and BRG1 was the fourth most frequently altered gene in NSCLC cell lines.  BRG1 mutations coexisted with mutations/deletions at KRAS, LKB1, NRAS, P16, and P53.  However, alterations at BRG1 always occurred in the absence of MYC amplification, suggesting a common role in lung cancer development.  In conclusion, our data strongly support that BRG1 is a bona fide tumor suppressor and a major factor in lung tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVI5uj5ZXE07Vg90H21EOLACvtfcHk0lhZdYA6zy4LNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOnsr8%253D&md5=cd5a3e9419c52939ea1f922101818684</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fhumu.20730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.20730%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DP.%2BP.%26aulast%3DRomero%26aufirst%3DO.%2BA.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DMontuenga%26aufirst%3DL.%2BM.%26aulast%3DPio%26aufirst%3DR.%26aulast%3DYokota%26aufirst%3DJ.%26aulast%3DSanchez-Cespedes%26aufirst%3DM.%26atitle%3DFrequent%2520BRG1%252FSMARCA4-Inactivating%2520Mutations%2520in%2520Human%2520Lung%2520Cancer%2520Cell%2520Lines%26jtitle%3DHum.%2520Mutat.%26date%3D2008%26volume%3D29%26spage%3D617%26epage%3D622%26doi%3D10.1002%2Fhumu.20730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Romero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Xavier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-López, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villanueva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Cespedes, M.</span><span> </span><span class="NLM_article-title">The Tumour Suppressor and Chromatin-Remodeling Factor BRG1 Antagonizes Myc Activity and Promotes Cell Differentiation in Human Cancer</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1002/emmm.201200236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Femmm.201200236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22407764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=603-616&author=O.+A.+Romeroauthor=F.+Setienauthor=S.+Johnauthor=P.+Gimenez-Xavierauthor=G.+G%C3%B3mez-L%C3%B3pezauthor=D.+Pisanoauthor=E.+Condomauthor=A.+Villanuevaauthor=G.+L.+Hagerauthor=M.+Sanchez-Cespedes&title=The+Tumour+Suppressor+and+Chromatin-Remodeling+Factor+BRG1+Antagonizes+Myc+Activity+and+Promotes+Cell+Differentiation+in+Human+Cancer&doi=10.1002%2Femmm.201200236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer</span></div><div class="casAuthors">Romero, Octavio A.; Setien, Fernando; John, Sam; Gimenez-Xavier, Pol; Gomez-Lopez, Gonzalo; Pisano, David; Condom, Enric; Villanueva, Alberto; Hager, Gordon L.; Sanchez-Cespedes, Montse</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BRG1, a member of the SWI/SNF complex, is mutated in cancer, but it is unclear how it promotes tumorigenesis.  We report that re-expression of BRG1 in lung cancer cells up-regulates lung-specific transcripts, restoring the gene expression signature of normal lung.  Using cell lines from several cancer types we found that those lacking BRG1 do not respond to retinoic acid (RA) or glucocorticoids (GC), while restoration of BRG1 restores sensitivity.  Conversely, in SH-SY5Y cells, a paradigm of RA-dependent differentiation, abrogation of BRG1 prevented the response to RA.  Further, our data suggest an antagonistic functional connection between BRG1 and MYC, whereby, refractoriness to RA and GC by BRG1 inactivation involves deregulation of MYC activity.  Mechanistically, some of these effects are mediated by BRG1 binding to MYC and MYC-target promoters.  The BRG1-MYC antagonism was also evident in primary tumors.  Finally, BRG1 restoration significantly dampened invasion and progression and decreased MYC in lung cancer cells orthotopically implanted in nude mice.  Thus, BRG1 inactivation enables cancer cells to sustain undifferentiated gene expression programs and prevent its response to environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqrAoeW2I6YbVg90H21EOLACvtfcHk0lhZdYA6zy4LNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKls70%253D&md5=098bc5edd376a2d86a938e1a6614b2c5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Femmm.201200236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201200236%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DO.%2BA.%26aulast%3DSetien%26aufirst%3DF.%26aulast%3DJohn%26aufirst%3DS.%26aulast%3DGimenez-Xavier%26aufirst%3DP.%26aulast%3DG%25C3%25B3mez-L%25C3%25B3pez%26aufirst%3DG.%26aulast%3DPisano%26aufirst%3DD.%26aulast%3DCondom%26aufirst%3DE.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DHager%26aufirst%3DG.%2BL.%26aulast%3DSanchez-Cespedes%26aufirst%3DM.%26atitle%3DThe%2520Tumour%2520Suppressor%2520and%2520Chromatin-Remodeling%2520Factor%2520BRG1%2520Antagonizes%2520Myc%2520Activity%2520and%2520Promotes%2520Cell%2520Differentiation%2520in%2520Human%2520Cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D603%26epage%3D616%26doi%3D10.1002%2Femmm.201200236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Garnier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruccelli, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rincon, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">The Novel Arsenical Darinaparsin Circumvents BRG1-Dependent, HO-1-Mediated Cytoprotection in Leukemic Cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2220</span><span class="NLM_x">–</span> <span class="NLM_lpage">2228</span><span class="refDoi"> DOI: 10.1038/leu.2013.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fleu.2013.54" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2220-2228&author=N.+Garnierauthor=L.+A.+Petruccelliauthor=M.+F.+Molinaauthor=M.+Kourelisauthor=S.+Kwanauthor=Z.+Diazauthor=H.+M.+Schipperauthor=A.+Guptaauthor=S.+V.+del+Rinconauthor=K.+K.+Mannauthor=W.+H.+Miller&title=The+Novel+Arsenical+Darinaparsin+Circumvents+BRG1-Dependent%2C+HO-1-Mediated+Cytoprotection+in+Leukemic+Cells&doi=10.1038%2Fleu.2013.54"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.54%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DN.%26aulast%3DPetruccelli%26aufirst%3DL.%2BA.%26aulast%3DMolina%26aufirst%3DM.%2BF.%26aulast%3DKourelis%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DZ.%26aulast%3DSchipper%26aufirst%3DH.%2BM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Ddel%2BRincon%26aufirst%3DS.%2BV.%26aulast%3DMann%26aufirst%3DK.%2BK.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DThe%2520Novel%2520Arsenical%2520Darinaparsin%2520Circumvents%2520BRG1-Dependent%252C%2520HO-1-Mediated%2520Cytoprotection%2520in%2520Leukemic%2520Cells%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2220%26epage%3D2228%26doi%3D10.1038%2Fleu.2013.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span> </span><span class="NLM_article-title">PFI-3: Selective Chemical Probe for SMARCA Bromodomains</span>. <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/PFI-3" class="extLink">http://www.thesgc.org/chemical-probes/PFI-3</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PFI-3%3A+Selective+Chemical+Probe+for+SMARCA+Bromodomains.+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FPFI-3+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPFI-3%253A%2520Selective%2520Chemical%2520Probe%2520for%2520SMARCA%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Vangamudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kost-Alimova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nottebaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadeshwar, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peoples, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marszalek, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toniatti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. N.</span><span> </span><span class="NLM_article-title">The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights From cDNA Rescue and PFI-3 Inhibitor Studies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3865</span><span class="NLM_x">–</span> <span class="NLM_lpage">3878</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-14-3798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26139243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3865-3878&author=B.+Vangamudiauthor=T.+A.+Paulauthor=P.+K.+Shahauthor=M.+Kost-Alimovaauthor=L.+Nottebaumauthor=X.+Shiauthor=Y.+Zhanauthor=E.+Leoauthor=H.+S.+Mahadeshwarauthor=A.+Protopopovauthor=A.+Futrealauthor=T.+N.+Tieuauthor=M.+Peoplesauthor=T.+P.+Heffernanauthor=J.+R.+Marszalekauthor=C.+Toniattiauthor=A.+Petrocchiauthor=D.+Verhelleauthor=D.+R.+Owenauthor=G.+Draettaauthor=P.+Jonesauthor=W.+S.+Palmerauthor=S.+Sharmaauthor=J.+N.+Andersen&title=The+SMARCA2%2F4+ATPase+Domain+Surpasses+the+Bromodomain+as+a+Drug+Target+in+SWI%2FSNF-Mutant+Cancers%3A+Insights+From+cDNA+Rescue+and+PFI-3+Inhibitor+Studies&doi=10.1158%2F0008-5472.CAN-14-3798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies</span></div><div class="casAuthors">Vangamudi, Bhavatarini; Paul, Thomas A.; Shah, Parantu K.; Kost-Alimova, Maria; Nottebaum, Lisa; Shi, Xi; Zhan, Yanai; Leo, Elisabetta; Mahadeshwar, Harshad S.; Protopopov, Alexei; Futreal, Andrew; Tieu, Trang N.; Peoples, Mike; Heffernan, Timothy P.; Marszalek, Joseph R.; Toniatti, Carlo; Petrocchi, Alessia; Verhelle, Dominique; Owen, Dafydd R.; Draetta, Giulio; Jones, Philip; Palmer, Wylie S.; Sharma, Shikhar; Andersen, Jannik N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3865-3878</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SWI/SNF multisubunit complex modulates chromatin structure through the activity of two mutually exclusive catalytic subunits, SMARCA2 and SMARCA4, which both contain a bromodomain and an ATPase domain.  Using RNAi, cancer-specific vulnerabilities have been identified in SWI/SNF-mutant tumors, including SMARCA4-deficient lung cancer; however, the contribution of conserved, druggable protein domains to this anticancer phenotype is unknown.  Here, we functionally deconstruct the SMARCA2/4 paralog dependence of cancer cells using bioinformatics, genetic, and pharmacol. tools.  We evaluate a selective SMARCA2/4 bromodomain inhibitor (PFI-3) and characterize its activity in chromatin-binding and cell-functional assays focusing on cells with altered SWI/SNF complex (e.g., lung, synovial sarcoma, leukemia, and rhabdoid tumors).  We demonstrate that PFI-3 is a potent, cell-permeable probe capable of displacing ectopically expressed, GFP-tagged SMARCA2-bromodomain from chromatin, yet contrary to target knockdown, the inhibitor fails to display an antiproliferative phenotype.  Mechanistically, the lack of pharmacol. efficacy is reconciled by the failure of bromodomain inhibition to displace endogenous, full-length SMARCA2 from chromatin as detd. by in situ cell extn., chromatin immunopptn., and target gene expression studies.  Furthermore, using inducible RNAi and cDNA complementation (bromodomain- and ATPase-dead constructs), we unequivocally identify the ATPase domain, and not the bromodomain of SMARCA2, as the relevant therapeutic target with the catalytic activity suppressing defined transcriptional programs.  Taken together, our complementary genetic and pharmacol. studies exemplify a general strategy for multidomain protein drug-target validation and in case of SMARCA2/4 highlight the potential for drugging the more challenging helicase/ATPase domain to deliver on the promise of synthetic-lethality therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrix1Qe07Ed3LVg90H21EOLACvtfcHk0liaHSKMMmX2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtL7K&md5=bb35d59dabe56c253fef822a9fb337a8</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3798%26sid%3Dliteratum%253Aachs%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DT.%2BA.%26aulast%3DShah%26aufirst%3DP.%2BK.%26aulast%3DKost-Alimova%26aufirst%3DM.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DMahadeshwar%26aufirst%3DH.%2BS.%26aulast%3DProtopopov%26aufirst%3DA.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTieu%26aufirst%3DT.%2BN.%26aulast%3DPeoples%26aufirst%3DM.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DJ.%2BN.%26atitle%3DThe%2520SMARCA2%252F4%2520ATPase%2520Domain%2520Surpasses%2520the%2520Bromodomain%2520as%2520a%2520Drug%2520Target%2520in%2520SWI%252FSNF-Mutant%2520Cancers%253A%2520Insights%2520From%2520cDNA%2520Rescue%2520and%2520PFI-3%2520Inhibitor%2520Studies%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3865%26epage%3D3878%26doi%3D10.1158%2F0008-5472.CAN-14-3798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Avvakumov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, J.</span><span> </span><span class="NLM_article-title">The MYST Family of Histone Acetyltransferases and Their Intimate Links to Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5395</span><span class="NLM_x">–</span> <span class="NLM_lpage">5407</span><span class="refDoi"> DOI: 10.1038/sj.onc.1210608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fsj.onc.1210608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=17694081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFeku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5395-5407&author=N.+Avvakumovauthor=J.+C%C3%B4t%C3%A9&title=The+MYST+Family+of+Histone+Acetyltransferases+and+Their+Intimate+Links+to+Cancer&doi=10.1038%2Fsj.onc.1210608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The MYST family of histone acetyltransferases and their intimate links to cancer</span></div><div class="casAuthors">Avvakumov, N.; Cote, J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5395-5407</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histone acetyltransferases (HATs) of the MYST family are highly conserved in eukaryotes and carry out a significant proportion of all nuclear acetylation.  These enzymes function exclusively in multisubunit protein complexes whose compn. is also evolutionarily conserved.  MYST HATs are involved in a no. of key nuclear processes and play crit. roles in gene-specific transcription regulation, DNA damage response and repair, as well as DNA replication.  This suggests that anomalous activity of these HATs or their assocd. complexes can easily lead to severe cellular malfunction, resulting in cell death or uncontrolled growth and malignancy.  Indeed, the MYST family HATs were implicated in several forms of human cancer.  This review summarizes the current understanding of these enzymes and their normal function, as well as their established and putative links to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJq4AeVS5RZrVg90H21EOLACvtfcHk0liaHSKMMmX2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFeku7g%253D&md5=b5f5ee1db72de5ccecdff00666a2068d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210608%26sid%3Dliteratum%253Aachs%26aulast%3DAvvakumov%26aufirst%3DN.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DJ.%26atitle%3DThe%2520MYST%2520Family%2520of%2520Histone%2520Acetyltransferases%2520and%2520Their%2520Intimate%2520Links%2520to%2520Cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5395%26epage%3D5407%26doi%3D10.1038%2Fsj.onc.1210608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Carlson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, K. C.</span><span> </span><span class="NLM_article-title">The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span><span class="refDoi"> DOI: 10.1002/jcp.24617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fjcp.24617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24633655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1alu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2014&pages=1571-1574&author=S.+Carlsonauthor=K.+C.+Glass&title=The+MOZ+Histone+Acetyltransferase+in+Epigenetic+Signaling+and+Disease&doi=10.1002%2Fjcp.24617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease</span></div><div class="casAuthors">Carlson, Samuel; Glass, Karen C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1571-1574</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The monocytic leukemic zinc finger (MOZ) histone acetyltransferase (HAT) plays a role in acute myeloid leukemia (AML).  It functions as a quaternary complex with the bromodomain PHD finger protein 1 (BRPF1), the human Esa1-assocd. factor 6 homolog (hEAF6), and the inhibitor of growth 5 (ING5).  Each of these subunits contain chromatin reader domains that recognize specific post-translational modifications (PTMs) on histone tails, and this recognition directs the MOZ HAT complex to specific chromatin substrates.  The structure and function of these epigenetic reader modules has now been elucidated, and a model describing how the cooperative action of these domains regulates HAT activity in response to the epigenetic landscape is proposed.  The emerging role of epigenetic reader domains in disease, and their therapeutic potential for many types of cancer is also highlighted.  J. Cell. Physiol. 229: 1571-1574, 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-9bMP8Qp9crVg90H21EOLACvtfcHk0liaHSKMMmX2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1alu7nP&md5=2582999b699ea08ea8d43cd51b411ff2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fjcp.24617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.24617%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DS.%26aulast%3DGlass%26aufirst%3DK.%2BC.%26atitle%3DThe%2520MOZ%2520Histone%2520Acetyltransferase%2520in%2520Epigenetic%2520Signaling%2520and%2520Disease%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2014%26volume%3D229%26spage%3D1571%26epage%3D1574%26doi%3D10.1002%2Fjcp.24617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Qin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Recognition of Unmodified Histone H3 by the First PHD Finger of Bromodomain-PHD Finger Protein 2 Provides Insights Into the Regulation of Histone Acetyltransferases Monocytic Leukemic Zinc-Finger Protein (MOZ) and MOZ-Related Factor (MORF)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">36944</span><span class="NLM_x">–</span> <span class="NLM_lpage">36955</span><span class="refDoi"> DOI: 10.1074/jbc.M111.244400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M111.244400" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=36944-36955&author=S.+Qinauthor=L.+Jinauthor=J.+Zhangauthor=L.+Liuauthor=P.+Jiauthor=M.+Wuauthor=J.+Wuauthor=Y.+Shi&title=Recognition+of+Unmodified+Histone+H3+by+the+First+PHD+Finger+of+Bromodomain-PHD+Finger+Protein+2+Provides+Insights+Into+the+Regulation+of+Histone+Acetyltransferases+Monocytic+Leukemic+Zinc-Finger+Protein+%28MOZ%29+and+MOZ-Related+Factor+%28MORF%29&doi=10.1074%2Fjbc.M111.244400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.244400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.244400%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRecognition%2520of%2520Unmodified%2520Histone%2520H3%2520by%2520the%2520First%2520PHD%2520Finger%2520of%2520Bromodomain-PHD%2520Finger%2520Protein%25202%2520Provides%2520Insights%2520Into%2520the%2520Regulation%2520of%2520Histone%2520Acetyltransferases%2520Monocytic%2520Leukemic%2520Zinc-Finger%2520Protein%2520%2528MOZ%2529%2520and%2520MOZ-Related%2520Factor%2520%2528MORF%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D36944%26epage%3D36955%26doi%3D10.1074%2Fjbc.M111.244400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Vezzoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonadies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiveri, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvinlaug, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göttgens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bycroft, M.</span><span> </span><span class="NLM_article-title">Molecular Basis of Histone H3K36me3 Recognition by the PWWP Domain of Brpf1</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span><span class="refDoi"> DOI: 10.1038/nsmb.1797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnsmb.1797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20400950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVCjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=617-619&author=A.+Vezzoliauthor=N.+Bonadiesauthor=M.+D.+Allenauthor=S.+M.+V.+Freundauthor=C.+M.+Santiveriauthor=B.+T.+Kvinlaugauthor=B.+J.+P.+Huntlyauthor=B.+G%C3%B6ttgensauthor=M.+Bycroft&title=Molecular+Basis+of+Histone+H3K36me3+Recognition+by+the+PWWP+Domain+of+Brpf1&doi=10.1038%2Fnsmb.1797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1</span></div><div class="casAuthors">Vezzoli, Alessandro; Bonadies, Nicolas; Allen, Mark D.; Freund, Stefan M. V.; Santiveri, Clara M.; Kvinlaug, Brynn T.; Huntly, Brian J. P.; Goettgens, Berthold; Bycroft, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-619</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trimethylation of Lys36 in histone H3 (H3K36me3) coordinates events assocd. with the elongation phase of transcription and is also emerging as an important epigenetic regulator of cell growth and differentiation.  We have identified the PWWP domain of bromo and plant homeodomain (PHD) finger-contg. protein 1 (BRPF1) as a H3K36me3 binding module and have detd. the structure of this domain in complex with an H3K36me3-derived peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotHUbg6LZOdbVg90H21EOLACvtfcHk0ljVEMLh5yA_mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVCjtbs%253D&md5=fa97bd4e88b6551c563cd445f9d36bf6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1797%26sid%3Dliteratum%253Aachs%26aulast%3DVezzoli%26aufirst%3DA.%26aulast%3DBonadies%26aufirst%3DN.%26aulast%3DAllen%26aufirst%3DM.%2BD.%26aulast%3DFreund%26aufirst%3DS.%2BM.%2BV.%26aulast%3DSantiveri%26aufirst%3DC.%2BM.%26aulast%3DKvinlaug%26aufirst%3DB.%2BT.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DG%25C3%25B6ttgens%26aufirst%3DB.%26aulast%3DBycroft%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Histone%2520H3K36me3%2520Recognition%2520by%2520the%2520PWWP%2520Domain%2520of%2520Brpf1%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D617%26epage%3D619%26doi%3D10.1038%2Fnsmb.1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Ullah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degerny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahmasebi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayrou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champagne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. J.</span><span> </span><span class="NLM_article-title">Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">6828</span><span class="NLM_x">–</span> <span class="NLM_lpage">6843</span><span class="refDoi"> DOI: 10.1128/MCB.01297-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FMCB.01297-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18794358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSnurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6828-6843&author=M.+Ullahauthor=N.+Pelletierauthor=L.+Xiaoauthor=S.+P.+Zhaoauthor=K.+Wangauthor=C.+Degernyauthor=S.+Tahmasebiauthor=C.+Cayrouauthor=Y.+Doyonauthor=S.+L.+Gohauthor=N.+Champagneauthor=J.+C%C3%B4t%C3%A9author=X.+J.+Yang&title=Molecular+Architecture+of+Quartet+MOZ%2FMORF+Histone+Acetyltransferase+Complexes&doi=10.1128%2FMCB.01297-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes</span></div><div class="casAuthors">Ullah, Mukta; Pelletier, Nadine; Xiao, Lin; Zhao, Song Ping; Wang, Kainan; Degerny, Cindy; Tahmasebi, Soroush; Cayrou, Christelle; Doyon, Yannick; Goh, Siew-Lee; Champagne, Nathalie; Cote, Jacques; Yang, Xiang-Jiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6828-6843</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The monocytic leukemia zinc finger protein MOZ and the related factor MORF form tetrameric complexes with ING5 (inhibitor of growth 5), EAF6 (Esa1-assocd. factor 6 ortholog), and the bromodomain-PHD finger protein BRPF1, -2, or -3.  To gain new insights into the structure, function, and regulation of these complexes, we reconstituted them and performed various mol. analyses.  We found that BRPF proteins bridge the assocn. of MOZ and MORF with ING5 and EAF6.  An N-terminal region of BRPF1 interacts with the acetyltransferases; the enhancer of polycomb (EPc) homol. domain in the middle part binds to ING5 and EAF6.  The assocn. of BRPF1 with EAF6 is weak, but ING5 increases the affinity.  These three proteins form a trimeric core that is conserved from Drosophila melanogaster to humans, although authentic orthologs of MOZ and MORF are absent in invertebrates.  Deletion mapping studies revealed that the acetyltransferase domain of MOZ/MORF is sufficient for BRPF1 interaction.  At the functional level, complex formation with BRPF1 and ING5 drastically stimulates the activity of the acetyltransferase domain in acetylation of nucleosomal histone H3 and free histones H3 and H4.  An unstructured 18-residue region at the C-terminal end of the catalytic domain is required for BRPF1 interaction and may function as an "activation lid.".  Furthermore, BRPF1 enhances the transcriptional potential of MOZ and a leukemic MOZ-TIF2 fusion protein.  These findings thus indicate that BRPF proteins play a key role in assembling and activating MOZ/MORF acetyltransferase complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBMSYP_gcdJrVg90H21EOLACvtfcHk0ljVEMLh5yA_mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSnurfF&md5=3c7cf4abccaf635957b07bb98471329b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1128%2FMCB.01297-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01297-08%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DM.%26aulast%3DPelletier%26aufirst%3DN.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DDegerny%26aufirst%3DC.%26aulast%3DTahmasebi%26aufirst%3DS.%26aulast%3DCayrou%26aufirst%3DC.%26aulast%3DDoyon%26aufirst%3DY.%26aulast%3DGoh%26aufirst%3DS.%2BL.%26aulast%3DChampagne%26aufirst%3DN.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BJ.%26atitle%3DMolecular%2520Architecture%2520of%2520Quartet%2520MOZ%252FMORF%2520Histone%2520Acetyltransferase%2520Complexes%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D6828%26epage%3D6843%26doi%3D10.1128%2FMCB.01297-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Laue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daujat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaster, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehl, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerschmidt, M.</span><span> </span><span class="NLM_article-title">The Multidomain Protein Brpf1 Binds Histones and Is Required for Hox Gene Expression and Segmental Identity</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1242/dev.017160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1242%2Fdev.017160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=1935-1946&author=K.+Laueauthor=S.+Daujatauthor=J.+G.+Crumpauthor=N.+Plasterauthor=H.+H.+Roehlauthor=C.+B.+Kimmelauthor=R.+Schneiderauthor=M.+Hammerschmidt&title=The+Multidomain+Protein+Brpf1+Binds+Histones+and+Is+Required+for+Hox+Gene+Expression+and+Segmental+Identity&doi=10.1242%2Fdev.017160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1242%2Fdev.017160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.017160%26sid%3Dliteratum%253Aachs%26aulast%3DLaue%26aufirst%3DK.%26aulast%3DDaujat%26aufirst%3DS.%26aulast%3DCrump%26aufirst%3DJ.%2BG.%26aulast%3DPlaster%26aufirst%3DN.%26aulast%3DRoehl%26aufirst%3DH.%2BH.%26aulast%3DKimmel%26aufirst%3DC.%2BB.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DHammerschmidt%26aufirst%3DM.%26atitle%3DThe%2520Multidomain%2520Protein%2520Brpf1%2520Binds%2520Histones%2520and%2520Is%2520Required%2520for%2520Hox%2520Gene%2520Expression%2520and%2520Segmental%2520Identity%26jtitle%3DDevelopment%26date%3D2008%26volume%3D135%26spage%3D1935%26epage%3D1946%26doi%3D10.1242%2Fdev.017160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span> </span><span class="NLM_article-title">1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1190</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1021/ml5002932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5002932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1190-1195&author=E.+H.+Demontauthor=P.+Bamboroughauthor=C.-W.+Chungauthor=P.+D.+Craggsauthor=D.+Fallonauthor=L.+J.+Gordonauthor=P.+Grandiauthor=C.+I.+Hobbsauthor=J.+Hussainauthor=E.+J.+Jonesauthor=A.+Le+Gallauthor=A.-M.+Michonauthor=D.+J.+Mitchellauthor=R.+K.+Prinjhaauthor=A.+D.+Robertsauthor=R.+J.+Sheppardauthor=R.+J.+Watson&title=1%2C3-Dimethyl+Benzimidazolones+Are+Potent%2C+Selective+Inhibitors+of+the+BRPF1+Bromodomain&doi=10.1021%2Fml5002932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fml5002932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5002932%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DFallon%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DHussain%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRoberts%26aufirst%3DA.%2BD.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26atitle%3D1%252C3-Dimethyl%2520Benzimidazolones%2520Are%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520the%2520BRPF1%2520Bromodomain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1190%26epage%3D1195%26doi%3D10.1021%2Fml5002932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span>PFI-4: A Chemical Probe for BRPF1B; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/PFI-4" class="extLink">http://www.thesgc.org/chemical-probes/PFI-4</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PFI-4%3A+A+Chemical+Probe+for+BRPF1B%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FPFI-4+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DPFI-4%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF1B%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span>OF-1: A Chemical Probe for BRPF Bromodomains; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/OF-1" class="extLink">http://www.thesgc.org/chemical-probes/OF-1</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=OF-1%3A+A+Chemical+Probe+for+BRPF+Bromodomains%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FOF-1+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DOF-1%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span> </span><span class="NLM_article-title">NI-57: A Chemical Probe for BRPF Bromodomains</span>; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/NI-57" class="extLink">http://www.thesgc.org/chemical-probes/NI-57</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NI-57%3A+A+Chemical+Probe+for+BRPF+Bromodomains%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FNI-57+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DNI-57%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Sweis, R. F.</span><span> </span><span class="NLM_article-title">Target (In)Validation: a Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=618-621&author=R.+F.+Sweis&title=Target+%28In%29Validation%3A+a+Critical%2C+Sometimes+Unheralded%2C+Role+of+Modern+Medicinal+Chemistry&doi=10.1021%2Facsmedchemlett.5b00183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00183%26sid%3Dliteratum%253Aachs%26aulast%3DSweis%26aufirst%3DR.%2BF.%26atitle%3DTarget%2520%2528In%2529Validation%253A%2520a%2520Critical%252C%2520Sometimes%2520Unheralded%252C%2520Role%2520of%2520Modern%2520Medicinal%2520Chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D618%26epage%3D621%26doi%3D10.1021%2Facsmedchemlett.5b00183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Tsai, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdemir, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, M. C.</span><span> </span><span class="NLM_article-title">TRIM24 Links a Non-Canonical Histone Signature to Breast Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1038/nature09542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=927-932&author=W.-W.+Tsaiauthor=Z.+Wangauthor=T.+T.+Yiuauthor=K.+C.+Akdemirauthor=W.+Xiaauthor=S.+Winterauthor=C.-Y.+Tsaiauthor=X.+Shiauthor=D.+Schwarzerauthor=W.+Plunkettauthor=B.+Aronowauthor=O.+Gozaniauthor=W.+Fischleauthor=M.-C.+Hungauthor=D.+J.+Patelauthor=M.+C.+Barton&title=TRIM24+Links+a+Non-Canonical+Histone+Signature+to+Breast+Cancer&doi=10.1038%2Fnature09542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnature09542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09542%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DW.-W.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYiu%26aufirst%3DT.%2BT.%26aulast%3DAkdemir%26aufirst%3DK.%2BC.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWinter%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DC.-Y.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DSchwarzer%26aufirst%3DD.%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DAronow%26aufirst%3DB.%26aulast%3DGozani%26aufirst%3DO.%26aulast%3DFischle%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26aulast%3DBarton%26aufirst%3DM.%2BC.%26atitle%3DTRIM24%2520Links%2520a%2520Non-Canonical%2520Histone%2520Signature%2520to%2520Breast%2520Cancer%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D927%26epage%3D932%26doi%3D10.1038%2Fnature09542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Khetchoumian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teletin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisserand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herquel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouararhni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Losson, R.</span><span> </span><span class="NLM_article-title">TRIM24 (Tif1α): an Essential “Brake” for Retinoic Acid-Induced Transcription to Prevent Liver Cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3647</span><span class="NLM_x">–</span> <span class="NLM_lpage">3652</span><span class="refDoi"> DOI: 10.4161/cc.7.23.7123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.4161%2Fcc.7.23.7123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3647-3652&author=K.+Khetchoumianauthor=M.+Teletinauthor=J.+Tisserandauthor=B.+Herquelauthor=K.+Ouararhniauthor=R.+Losson&title=TRIM24+%28Tif1%CE%B1%29%3A+an+Essential+%E2%80%9CBrake%E2%80%9D+for+Retinoic+Acid-Induced+Transcription+to+Prevent+Liver+Cancer&doi=10.4161%2Fcc.7.23.7123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.23.7123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.23.7123%26sid%3Dliteratum%253Aachs%26aulast%3DKhetchoumian%26aufirst%3DK.%26aulast%3DTeletin%26aufirst%3DM.%26aulast%3DTisserand%26aufirst%3DJ.%26aulast%3DHerquel%26aufirst%3DB.%26aulast%3DOuararhni%26aufirst%3DK.%26aulast%3DLosson%26aufirst%3DR.%26atitle%3DTRIM24%2520%2528Tif1%25CE%25B1%2529%253A%2520an%2520Essential%2520%25E2%2580%259CBrake%25E2%2580%259D%2520for%2520Retinoic%2520Acid-Induced%2520Transcription%2520to%2520Prevent%2520Liver%2520Cancer%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26spage%3D3647%26epage%3D3652%26doi%3D10.4161%2Fcc.7.23.7123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Zhang, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, A.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">TRIM24 Promotes Glioma Progression and Enhances Chemoresistance Through Activation of the PI3K/Akt Signaling Pathway</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1038/onc.2013.593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fonc.2013.593" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=600-610&author=L.-H.+Zhangauthor=A.-A.+Yinauthor=J.-X.+Chengauthor=H.-Y.+Huangauthor=X.-M.+Liauthor=Y.-Q.+Zhangauthor=N.+Hanauthor=X.+Zhang&title=TRIM24+Promotes+Glioma+Progression+and+Enhances+Chemoresistance+Through+Activation+of+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1038%2Fonc.2013.593"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.593%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-H.%26aulast%3DYin%26aufirst%3DA.-A.%26aulast%3DCheng%26aufirst%3DJ.-X.%26aulast%3DHuang%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DHan%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DTRIM24%2520Promotes%2520Glioma%2520Progression%2520and%2520Enhances%2520Chemoresistance%2520Through%2520Activation%2520of%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D600%26epage%3D610%26doi%3D10.1038%2Fonc.2013.593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Overexpression of TRIM24 Is Associated with the Onset and Progress of Human Hepatocellular Carcinoma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e85462</span><span class="refDoi"> DOI: 10.1371/journal.pone.0085462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0085462" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e85462&author=X.+Liuauthor=Y.+Huangauthor=D.+Yangauthor=X.+Liauthor=J.+Liangauthor=L.+Linauthor=M.+Zhangauthor=K.+Zhongauthor=B.+Liangauthor=J.+Li&title=Overexpression+of+TRIM24+Is+Associated+with+the+Onset+and+Progress+of+Human+Hepatocellular+Carcinoma&doi=10.1371%2Fjournal.pone.0085462"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0085462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0085462%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520TRIM24%2520Is%2520Associated%2520with%2520the%2520Onset%2520and%2520Progress%2520of%2520Human%2520Hepatocellular%2520Carcinoma%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De85462%26doi%3D10.1371%2Fjournal.pone.0085462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Bennett, J.; Fedorov, O.; Tallant, C.; Monteiro, O.; Meier, J.; Gamble, V.; Savitsky, P.; Nunez-Alonso, G. A.; Haendler, B.; Rogers, C.; Brennan, P. E.; Müller, S.; Knapp, S.</span><span> </span><span class="NLM_article-title">Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00458</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Bennett&author=O.+Fedorov&author=C.+Tallant&author=O.+Monteiro&author=J.+Meier&author=V.+Gamble&author=P.+Savitsky&author=G.+A.+Nunez-Alonso&author=B.+Haendler&author=C.+Rogers&author=P.+E.+Brennan&author=S.+M%C3%BCller&author=S.+Knapp&title=Discovery+of+a+Chemical+Tool+Inhibitor+Targeting+the+Bromodomains+of+TRIM24+and+BRPF&doi=10.1021%2Facs.jmedchem.5b00458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00458%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Chemical%2520Tool%2520Inhibitor%2520Targeting%2520the%2520Bromodomains%2520of%2520TRIM24%2520and%2520BRPF%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Palmer, W. S.; Poncet-Montange, G.; Liu, G.; Petrocchi, A.; Reyna, N.; Subramanian, G.; Theroff, J.; Yau, A.; Kost-Alimova, M.; Bardenhagen, J. P.; Leo, E.; Shepard, H. E.; Tieu, T. N.; Shi, X.; Zhan, Y.; Zhao, S.; Barton, M. C.; Draetta, G.; Toniatti, C.; Jones, P.; Geck Do, M.; Andersen, J. N.</span><span> </span><span class="NLM_article-title">Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00405</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00405" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+S.+Palmer&author=G.+Poncet-Montange&author=G.+Liu&author=A.+Petrocchi&author=N.+Reyna&author=G.+Subramanian&author=J.+Theroff&author=A.+Yau&author=M.+Kost-Alimova&author=J.+P.+Bardenhagen&author=E.+Leo&author=H.+E.+Shepard&author=T.+N.+Tieu&author=X.+Shi&author=Y.+Zhan&author=S.+Zhao&author=M.+C.+Barton&author=G.+Draetta&author=C.+Toniatti&author=P.+Jones&author=M.+Geck+Do&author=J.+N.+Andersen&title=Structure-Guided+Design+of+IACS-9571%2C+a+Selective+High-Affinity+Dual+TRIM24-BRPF1+Bromodomain+Inhibitor&doi=10.1021%2Facs.jmedchem.5b00405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00405%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26atitle%3DStructure-Guided%2520Design%2520of%2520IACS-9571%252C%2520a%2520Selective%2520High-Affinity%2520Dual%2520TRIM24-BRPF1%2520Bromodomain%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Urick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassel, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, W. C. K.</span><span> </span><span class="NLM_article-title">Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2246</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2246&author=A.+K.+Urickauthor=L.+M.+L.+Hawkauthor=M.+K.+Casselauthor=N.+K.+Mishraauthor=S.+Liuauthor=N.+Adhikariauthor=W.+Zhangauthor=C.+O.+dos+Santosauthor=J.+L.+Hallauthor=W.+C.+K.+Pomerantz&title=Dual+Screening+of+BPTF+and+Brd4+Using+Protein-Observed+Fluorine+NMR+Uncovers+New+Bromodomain+Probe+Molecules&doi=10.1021%2Facschembio.5b00483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules</span></div><div class="casAuthors">Urick, Andrew K.; Hawk, Laura M. L.; Cassel, Melissa K.; Mishra, Neeraj K.; Liu, Shuai; Adhikari, Neeta; Zhang, Wei; dos Santos, Camila O.; Hall, Jennifer L.; Pomerantz, William C. K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2246-2256</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein dysregulation is linked to cancer, diabetes, and inflammation.  Selective inhibition of bromodomain function is a newly proposed therapeutic strategy.  The authors describe a 19F NMR dual screening method for small mol. discovery using fluorinated tryptophan resonances on two bromodomain-contg. proteins.  The chem. shift dispersion of 19F resonances within fluorine-labeled proteins enables the simultaneous anal. of two fluorinated bromodomains by NMR.  A library of 229 small mols. was screened against the first bromodomain of Brd4 and the BPTF bromodomain.  The authors report the first small mol. selective for BPTF over Brd4, termed AU1.  The Kd = 2.8 μM for AU1, which is active in a cell-based reporter assay.  No binding was detected with Brd4.  Three new Brd4 inhibitors with submicromolar affinity were also discovered.  Brd4 hits were validated in a thermal stability assay and potency detd. via fluorescence anisotropy.  The speed, ease of interpretation, and low protein concn. needed for protein-obsd. 19F NMR expts. in a multiprotein format offers a new method to discover and characterize selective ligands for bromodomain-contg. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjhnKasUdNL7Vg90H21EOLACvtfcHk0lhmgULdZ8TsdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCiurfI&md5=584fa6b83f8bfa661f55edb1078e570c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00483%26sid%3Dliteratum%253Aachs%26aulast%3DUrick%26aufirst%3DA.%2BK.%26aulast%3DHawk%26aufirst%3DL.%2BM.%2BL.%26aulast%3DCassel%26aufirst%3DM.%2BK.%26aulast%3DMishra%26aufirst%3DN.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAdhikari%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3Ddos%2BSantos%26aufirst%3DC.%2BO.%26aulast%3DHall%26aufirst%3DJ.%2BL.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%2BK.%26atitle%3DDual%2520Screening%2520of%2520BPTF%2520and%2520Brd4%2520Using%2520Protein-Observed%2520Fluorine%2520NMR%2520Uncovers%2520New%2520Bromodomain%2520Probe%2520Molecules%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2246%26doi%3D10.1021%2Facschembio.5b00483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET Recruitment to Chromatin as an Effective Treatment for MLL-Fusion Leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nature10509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.-I.+Chanauthor=S.+C.+Robsonauthor=C.-W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+P.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+Recruitment+to+Chromatin+as+an+Effective+Treatment+for+MLL-Fusion+Leukaemia&doi=10.1038%2Fnature10509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0lhjDSVoutwqjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.-I.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520Recruitment%2520to%2520Chromatin%2520as%2520an%2520Effective%2520Treatment%2520for%2520MLL-Fusion%2520Leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533%26doi%3D10.1038%2Fnature10509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition Through Optimization of a Fragment-Derived Hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span><span class="refDoi"> DOI: 10.1021/jm3010515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+Chemical+Probe+for+Bromo+and+Extra+C-Terminal+Bromodomain+Inhibition+Through+Optimization+of+a+Fragment-Derived+Hit&doi=10.1021%2Fjm3010515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0lhjDSVoutwqjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520Chemical%2520Probe%2520for%2520Bromo%2520and%2520Extra%2520C-Terminal%2520Bromodomain%2520Inhibition%2520Through%2520Optimization%2520of%2520a%2520Fragment-Derived%2520Hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837%26doi%3D10.1021%2Fjm3010515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Basheer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibitors in Leukemia</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1016/j.exphem.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.exphem.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26163798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCit7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=718-731&author=F.+Basheerauthor=B.+J.+P.+Huntly&title=BET+Bromodomain+Inhibitors+in+Leukemia&doi=10.1016%2Fj.exphem.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibitors in leukemia</span></div><div class="casAuthors">Basheer, Faisal; Huntly, Brian J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-731</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The last few years have seen the identification of bromodomain and extraterminal (BET) proteins as crit. mediators of transcription with effects on its direct control and cisregulation.  This discovery is important in furthering our understanding of the mechanisms of normal transcriptional control.  Subsequent work has shed light on the multiple roles of BET proteins in various aberrant transcriptional pathways that have significant implications across many malignant cell types and other disease processes.  Accordingly, considerable effort has been made to assess the utility of targeting BET proteins with specific small mols. in acute leukemia and across other types of cancer.  In this review, we will discuss the most recent advances in our understanding of the mechanistic actions of BET proteins in normal transcriptional control, both at the gene body and cisregulatory elements; how this is subverted; and its aberrant downstream effects, specifically in the context of acute leukemia and other hematol. cancers.  In particular, we will focus on altered epigenetic programs that have been shown to be central to the development and maintenance of acute myeloid leukemia in preclin. models.  Finally, we will explore how the use of small-mol. BET inhibitors in leukemias has demonstrated significant promise in numerous single-agent and combination therapy preclin. models and will highlight efforts to translate this promise to the therapeutic arena through various clin. trials attempting to validate efficacy and safety.  The considerable opportunities in epigenetically targeting leukemias through BET inhibition will undoubtedly play an important role in improving the management of these conditions in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ0bYdhy9EeLVg90H21EOLACvtfcHk0lhjDSVoutwqjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCit7zM&md5=a2a42b24124463ca946e61cf0663e78d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DBasheer%26aufirst%3DF.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26atitle%3DBET%2520Bromodomain%2520Inhibitors%2520in%2520Leukemia%26jtitle%3DExp.%2520Hematol.%26date%3D2015%26volume%3D43%26spage%3D718%26epage%3D731%26doi%3D10.1016%2Fj.exphem.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Suppresses TH17-Mediated Pathology</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">2181</span><span class="NLM_x">–</span> <span class="NLM_lpage">2190</span><span class="refDoi"> DOI: 10.1084/jem.20130376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1084%2Fjem.20130376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24101376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ygsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2181-2190&author=D.+A.+Meleauthor=A.+Salmeronauthor=S.+Ghoshauthor=H.+R.+Huangauthor=B.+M.+Bryantauthor=J.+M.+Lora&title=BET+Bromodomain+Inhibition+Suppresses+TH17-Mediated+Pathology&doi=10.1084%2Fjem.20130376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibition suppresses TH17-mediated pathology</span></div><div class="casAuthors">Mele, Deanna A.; Salmeron, Andres; Ghosh, Srimoyee; Huang, Hon-Ren; Bryant, Barbara M.; Lora, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2181-2190</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Interleukin (IL) 17-producing T helper (TH17) cells have been selected through evolution for their ability to control fungal and bacterial infections.  It is also firmly established that their aberrant generation and activation results in autoimmune conditions.  Using a characterized potent and selective small mol. inhibitor, we show that the bromodomain and extra-terminal domain (BET) family of chromatin adaptors plays fundamental and selective roles in human and murine TH17 differentiation from naive CD4+ T cells, as well as in the activation of previously differentiated TH17 cells.  We provide evidence that BET controls TH17 differentiation in a bromodomain-dependent manner through a mechanism that includes the direct regulation of multiple effector TH17-assocd. cytokines, including IL17, IL21, and GMCSF.  We also demonstrate that BET family members Brd2 and Brd4 assoc. with the Il17 locus in TH17 cells, and that this assocn. requires bromodomains.  We recapitulate the crit. role of BET bromodomains in TH17 differentiation in vivo and show that therapeutic dosing of the BET inhibitor is efficacious in mouse models of autoimmunity.  Our results identify the BET family of proteins as a fundamental link between chromatin signaling and TH17 biol., and support the notion of BET inhibition as a point of therapeutic intervention in autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBqVtggp2Fa7Vg90H21EOLACvtfcHk0lgbvU11v-YE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ygsLbF&md5=e6822f456cf42cdead9779afa92c05e0</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130376%26sid%3Dliteratum%253Aachs%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DSalmeron%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DH.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Suppresses%2520TH17-Mediated%2520Pathology%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2181%26epage%3D2190%26doi%3D10.1084%2Fjem.20130376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Chaidos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadimitris, A.</span><span> </span><span class="NLM_article-title">Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence</span> <span class="citation_source-journal">Ther. Adv. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span><span class="refDoi"> DOI: 10.1177/2040620715576662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1177%2F2040620715576662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26137204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGhtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=128-141&author=A.+Chaidosauthor=V.+Caputoauthor=A.+Karadimitris&title=Inhibition+of+Bromodomain+and+Extra-Terminal+Proteins+%28BET%29+as+a+Potential+Therapeutic+Approach+in+Haematological+Malignancies%3A+Emerging+Preclinical+and+Clinical+Evidence&doi=10.1177%2F2040620715576662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence</span></div><div class="casAuthors">Chaidos, Aristeidis; Caputo, Valentina; Karadimitris, Anastasios</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Hematology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-141</span>CODEN:
                <span class="NLM_cas:coden">TAHHAT</span>;
        ISSN:<span class="NLM_cas:issn">2040-6207</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of the nucleosomal histone proteins orchestrate chromatin organization and gene expression in normal and cancer cells.  Among them, the acetylation of N-terminal histone tails represents the fundamental epigenetic mark of open structure chromatin and active gene transcription.  The bromodomain and extra-terminal (BET) proteins are epigenetic readers which utilize tandem bromodomains (BRD) modules to recognize and dock themselves on the acetylated lysine tails.  The BET proteins act as scaffolds for the recruitment of transcription factors and chromatin organizers required in transcription initiation and elongation.  The recent discovery of small mols. capable of blocking their Lysine-binding pocket is the first paradigm of successful pharmacol. inhibition of epigenetic readers.  JQ1 is a prototype benzodiazepine mol. and a specific BET inhibitor with antineoplastic activity both in solid tumors and hematol. malignancies.  The quinolone I-BET151 and the suitable for clin. development I-BET762 benzodiazepine were introduced in parallel with J01 and have also shown potent antitumor activity in preclin. studies.  I-BET762 is currently being tested in early phase clin. trials, along with a rapidly growing list of other BET inhibitors.  Unlike older epigenetic therapies, the study of BET inhibitors has offered substantial, context-specific, mechanistic insights of their antitumor activity, which will facilitate optimal therapeutic targeting in future.  Here, we review the development of this novel class of epigenetic drugs, the biol. of BET protein inhibition, the emerging evidence from preclin. work and early phase clin. studies and we discuss their potential role in the treatment of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprChIidUwITLVg90H21EOLACvtfcHk0lgbvU11v-YE4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGhtr%252FP&md5=61a7d6200f0309e76cb4623b7d2bffb5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F2040620715576662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040620715576662%26sid%3Dliteratum%253Aachs%26aulast%3DChaidos%26aufirst%3DA.%26aulast%3DCaputo%26aufirst%3DV.%26aulast%3DKaradimitris%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Bromodomain%2520and%2520Extra-Terminal%2520Proteins%2520%2528BET%2529%2520as%2520a%2520Potential%2520Therapeutic%2520Approach%2520in%2520Haematological%2520Malignancies%253A%2520Emerging%2520Preclinical%2520and%2520Clinical%2520Evidence%26jtitle%3DTher.%2520Adv.%2520Hematol.%26date%3D2015%26volume%3D6%26spage%3D128%26epage%3D141%26doi%3D10.1177%2F2040620715576662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Bertoni, F.; Inghirami, G.</span><span> </span><span class="NLM_article-title">A BET-BRD Inhibitor Represents a Novel Agent for ALK Positive Anaplastic Large Cell Lymphoma</span>. WO2015018520A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=F.+Bertoni&author=G.+Inghirami&title=A+BET-BRD+Inhibitor+Represents+a+Novel+Agent+for+ALK+Positive+Anaplastic+Large+Cell+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertoni%26aufirst%3DF.%26atitle%3DA%2520BET-BRD%2520Inhibitor%2520Represents%2520a%2520Novel%2520Agent%2520for%2520ALK%2520Positive%2520Anaplastic%2520Large%2520Cell%2520Lymphoma%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Harbeson, S. L.</span><span> </span><span class="NLM_article-title">Deuterated Derivatives of a Thienotriazolodiazapine Bromodomain-Containing Protein Inhibitor</span>. WO2015031741A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+L.+Harbeson&title=Deuterated+Derivatives+of+a+Thienotriazolodiazapine+Bromodomain-Containing+Protein+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DDeuterated%2520Derivatives%2520of%2520a%2520Thienotriazolodiazapine%2520Bromodomain-Containing%2520Protein%2520Inhibitor%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.</span><span> </span><span class="NLM_article-title">Pyrrolo- and Pyrazolo-Triazolodiazepines as BET-Protein Inhibitors for Treating Hyperproliferative Diseases</span>. WO2014128070A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&title=Pyrrolo-+and+Pyrazolo-Triazolodiazepines+as+BET-Protein+Inhibitors+for+Treating+Hyperproliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DPyrrolo-%2520and%2520Pyrazolo-Triazolodiazepines%2520as%2520BET-Protein%2520Inhibitors%2520for%2520Treating%2520Hyperproliferative%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">4-Substituted Pyrrolo- and Pyrazolo-Diazepines</span>. WO2014128111A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&author=H.+Rehwinkel&title=4-Substituted+Pyrrolo-+and+Pyrazolo-Diazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3D4-Substituted%2520Pyrrolo-%2520and%2520Pyrazolo-Diazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Schmees, N.; Kuhnke, J.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Siegel, S.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.; Gallenkamp, D.</span><span> </span><span class="NLM_article-title">BET Protein-Inhibiting 5-Aryl Triazole Azepines</span>. WO2014048945A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=J.+Kuhnke&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=S.+Siegel&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&author=D.+Gallenkamp&title=BET+Protein-Inhibiting+5-Aryl+Triazole+Azepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DBET%2520Protein-Inhibiting%25205-Aryl%2520Triazole%2520Azepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Albrecht, B. K.; Hewitt, M. C.; Gehling, V. S.; Vaswani, R. G.</span><span> </span><span class="NLM_article-title">Benzo[C]isoxazoloazepine Bromodomain Inhibitors and Uses Thereof</span>. WO2013184876A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Albrecht&author=M.+C.+Hewitt&author=V.+S.+Gehling&author=R.+G.+Vaswani&title=Benzo%5BC%5Disoxazoloazepine+Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBenzo%255BC%255Disoxazoloazepine%2520Bromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Sims, R.</span><span> </span><span class="NLM_article-title">Discovery of CPI-0610: A novel BET protein bromodomain inhibitor for hematologic malignancies</span>. <span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">April 18–22, 2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sims%2C+R.+Discovery+of+CPI-0610%3A+A+novel+BET+protein+bromodomain+inhibitor+for+hematologic+malignancies.+Annual+Meeting+of+American+Association+for+Cancer+Research%2C+Philadelphia%2C+PA%2C+April+18%E2%80%9322%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520CPI-0610%253A%2520A%2520novel%2520BET%2520protein%2520bromodomain%2520inhibitor%2520for%2520hematologic%2520malignancies" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Côté, A.; Gehling, V. S.; Harmange, J.-C.; Hewitt, M. C.; Naveschuk, C. G.; Taylor, A. M.; Vaswani, R. G.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors and Uses Thereof</span>. WO2012075456A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Albrecht&author=J.+E.+Audia&author=A.+C%C3%B4t%C3%A9&author=V.+S.+Gehling&author=J.-C.+Harmange&author=M.+C.+Hewitt&author=C.+G.+Naveschuk&author=A.+M.+Taylor&author=R.+G.+Vaswani&title=Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Albrecht, B. K.; Harmange, J.-C.; Côté, A.; Taylor, A. M.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors and Uses Thereof</span>. WO2012174487A2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Albrecht&author=J.-C.+Harmange&author=A.+C%C3%B4t%C3%A9&author=A.+M.+Taylor&title=Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Kessler, D.; Reiser, U.; Smethurst, C.; Steffen, A.</span><span> </span><span class="NLM_article-title">Triazolopyridazine</span>. US20140135336A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=D.+Kessler&author=U.+Reiser&author=C.+Smethurst&author=A.+Steffen&title=Triazolopyridazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyridazine%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Wang, H.; Shao, L.; Rodgers, J. D.; Shepard, S.</span><span> </span><span class="NLM_article-title">Tricyclic Heterocycles as BET Protein Inhibitors</span>. WO2015095492A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Wang&author=L.+Shao&author=J.+D.+Rodgers&author=S.+Shepard&title=Tricyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26atitle%3DTricyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Triazolopyrazine Derivatives as BRD4 Inhibitors</span>. WO2015067770A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Triazolopyrazine+Derivatives+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyrazine%2520Derivatives%2520as%2520BRD4%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9019</span><span class="NLM_x">–</span> <span class="NLM_lpage">9027</span><span class="refDoi"> DOI: 10.1021/jm501120z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501120z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9019-9027&author=M.+R.+McKeownauthor=D.+L.+Shawauthor=H.+Fuauthor=S.+Liuauthor=X.+Xuauthor=J.+J.+Marineauauthor=Y.+Huangauthor=X.+Zhangauthor=D.+L.+Buckleyauthor=A.+Kadamauthor=Z.+Zhangauthor=S.+C.+Blacklowauthor=J.+Qiauthor=W.+Zhangauthor=J.+E.+Bradner&title=Biased+Multicomponent+Reactions+to+Develop+Novel+Bromodomain+Inhibitors&doi=10.1021%2Fjm501120z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span></div><div class="casAuthors">McKeown, Michael R.; Shaw, Daniel L.; Fu, Harry; Liu, Shuai; Xu, Xiang; Marineau, Jason J.; Huang, Yibo; Zhang, Xiaofeng; Buckley, Dennis L.; Kadam, Asha; Zhang, Zijuan; Blacklow, Stephen C.; Qi, Jun; Zhang, Wei; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9019-9027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer.  Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function.  Using fluorous-tagged multicomponent reactions, we developed a focused chem. library of bromodomain inhibitors around a 3,5-dimethylisoxazole biasing element with micromolar biochem. IC50.  Iterative synthesis and biochem. assessment allowed optimization of novel BET bromodomain inhibitors based on an imidazo[1,2-a]pyrazine scaffold.  Lead compd. I (UMB-32) binds BRD4 with a Kd of 550 nM and 724 nM cellular potency in BRD4-dependent lines.  Addnl., compd. I shows potency against TAF1, a bromodomain-contg. transcription factor previously unapproached by discovery chem.  Compd. I was cocrystd. with BRD4, yielding a 1.56 Å resoln. crystal structure.  This research showcases new applications of fluorous and multicomponent chem. synthesis for the development of novel epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWEf4LoDJTrVg90H21EOLACvtfcHk0liQgrO0jF5TJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN&md5=a4e20101f5a0b547451814af73c0418f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm501120z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501120z%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DShaw%26aufirst%3DD.%2BL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DKadam%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DBiased%2520Multicomponent%2520Reactions%2520to%2520Develop%2520Novel%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9019%26epage%3D9027%26doi%3D10.1021%2Fjm501120z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Sasmal, S.; Hosahalli, S.</span><span> </span><span class="NLM_article-title">Substituted Imidazo[4,5-<i>c</i>]quinoline Derivatives as Bromodomain Inhibitors</span>. WO2014128655A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Sasmal&author=S.+Hosahalli&title=Substituted+Imidazo%5B4%2C5-c%5Dquinoline+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasmal%26aufirst%3DS.%26atitle%3DSubstituted%2520Imidazo%255B4%252C5-c%255Dquinoline%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Sharma, R.; Kulkarni, S.; Kulkarni, M.; Mukherjee, S.; Yadav, R. K.; Agarwal, M.; Burudkar, S.; Sathe, S.</span><span> </span><span class="NLM_article-title">Imidazoquinoline Compounds as Bromodomain Inhibitors</span>. WO2015049629A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Sharma&author=S.+Kulkarni&author=M.+Kulkarni&author=S.+Mukherjee&author=R.+K.+Yadav&author=M.+Agarwal&author=S.+Burudkar&author=S.+Sathe&title=Imidazoquinoline+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DImidazoquinoline%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Albert, J. S.; Johnstone, S.; Jones, P.</span><span> </span><span class="NLM_article-title">Oxazolo[5,4-<i>c</i>]quinolin-2-One Compounds as Bromodomain Inhibitors</span>. WO2014152029A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+S.+Albert&author=S.+Johnstone&author=P.+Jones&title=Oxazolo%5B5%2C4-c%5Dquinolin-2-One+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DOxazolo%255B5%252C4-c%255Dquinolin-2-One%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Ran, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4927-4939&author=X.+Ranauthor=Y.+Zhaoauthor=L.+Liuauthor=L.+Baiauthor=C.-Y.+Yangauthor=B.+Zhouauthor=J.+L.+Meagherauthor=K.+Chinnaswamyauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-Based+Design+of+%CE%B3-Carboline+Analogues+as+Potent+and+Specific+BET+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span></div><div class="casAuthors">Ran, Xu; Zhao, Yujun; Liu, Liu; Bai, Longchuan; Yang, Chao-Yie; Zhou, Bing; Meagher, Jennifer L.; Chinnaswamy, Krishnapriya; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4927-4939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of bromodomain and extra terminal proteins (BET), including BRD2, BRD3, and BRD4 proteins have therapeutic potential for the treatment of human cancers and other diseases and conditions.  In this paper, the authors report the design, synthesis, and evaluation of γ-carboline-contg. compds. as a new class of small-mol. BET inhibitors.  The most potent inhibitor I (RX-37) obtained from this study binds to BET bromodomain proteins (BRD2, BRD3, and BRD4) with Ki values of 3.2-24.7 nM and demonstrates high selectivity over other non-BET bromodomain-contg. proteins.  Compd. I potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged mixed lineage leukemia 1 gene.  The authors have detd. a cocrystal structure of I in complex with BRD4 BD2 at 1.4 Å resoln., which provides a solid structural basis for the compd.'s high binding affinity and for its further structure-based optimization.  Compd. I represents a promising lead compd. for the development of a new class of therapeutics for the treatment of human cancer and other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-VCfWLBWYLVg90H21EOLACvtfcHk0lgNJYKutsgxGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM&md5=e6e150169812e439c1d7d91416eb3ee9</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00613%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-Based%2520Design%2520of%2520%25CE%25B3-Carboline%2520Analogues%2520as%2520Potent%2520and%2520Specific%2520BET%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4927%26epage%3D4939%26doi%3D10.1021%2Facs.jmedchem.5b00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Wang, S.; Ran, X.; Zhao, Y.; Yang, C.-Y.; Liu, L.; Bai, L.; McEachern, D.; Stuckey, J.; Meagher, J. L.; Sun, D.; Li, X.; Zhou, B.; Karatas, H.; Luo, R.; Chinnaiyan, A.; Asangani, I. A.</span><span> </span><span class="NLM_article-title">Bet Bromodomain Inhibitors and Therapeutic Methods Using the Same</span>. US20140256706A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Wang&author=X.+Ran&author=Y.+Zhao&author=C.-Y.+Yang&author=L.+Liu&author=L.+Bai&author=D.+McEachern&author=J.+Stuckey&author=J.+L.+Meagher&author=D.+Sun&author=X.+Li&author=B.+Zhou&author=H.+Karatas&author=R.+Luo&author=A.+Chinnaiyan&author=I.+A.+Asangani&title=Bet+Bromodomain+Inhibitors+and+Therapeutic+Methods+Using+the+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBet%2520Bromodomain%2520Inhibitors%2520and%2520Therapeutic%2520Methods%2520Using%2520the%2520Same%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Poss, M. A.; Tortolani, D. R.; Dodd, D. S.; Mussari, C. P.; Tokarski, J. S.; Gavai, A. V.; Zhao, Y.; DeLucca, G. V.; OMalley, D.; Norris, D. J.; Gill, P.; Quesnelle, C. A.; Han, W.-C.</span><span> </span><span class="NLM_article-title">Carbazole Compounds Useful as Bromodomain Inhibitors</span>. US20140256700A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Poss&author=D.+R.+Tortolani&author=D.+S.+Dodd&author=C.+P.+Mussari&author=J.+S.+Tokarski&author=A.+V.+Gavai&author=Y.+Zhao&author=G.+V.+DeLucca&author=D.+OMalley&author=D.+J.+Norris&author=P.+Gill&author=C.+A.+Quesnelle&author=W.-C.+Han&title=Carbazole+Compounds+Useful+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DCarbazole%2520Compounds%2520Useful%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Poss, M. A.; Tortolani, D. R.; Purandare, A. V.; Tokarski, J. S.; Mussari, C. P.; Kamau, M. G.; Dodd, D. S.; Gavai, A. V.; OMalley, D.; Huynh, T. N.; Vaccaro, W.; Harikrishnan, L. S.</span><span> </span><span class="NLM_article-title">Carbazole Compounds Useful as Bromodomain Inhibitors</span>. WO2014134267A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Poss&author=D.+R.+Tortolani&author=A.+V.+Purandare&author=J.+S.+Tokarski&author=C.+P.+Mussari&author=M.+G.+Kamau&author=D.+S.+Dodd&author=A.+V.+Gavai&author=D.+OMalley&author=T.+N.+Huynh&author=W.+Vaccaro&author=L.+S.+Harikrishnan&title=Carbazole+Compounds+Useful+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DCarbazole%2520Compounds%2520Useful%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Aktoudianakis, I.; Chin, G.; Corkey, B. K.; Du, J.; Elbel, K.; Jiang, R. H.; Kobayashi, T.; Martinez, R.; Metobo, S. E.; Mish, M.; Shevick, S.; Sperandio, D.; Yang, H.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Benzimidazolone Derivatives as Bromodomain Inhibitors</span>. WO2014160873A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=I.+Aktoudianakis&author=G.+Chin&author=B.+K.+Corkey&author=J.+Du&author=K.+Elbel&author=R.+H.+Jiang&author=T.+Kobayashi&author=R.+Martinez&author=S.+E.+Metobo&author=M.+Mish&author=S.+Shevick&author=D.+Sperandio&author=H.+Yang&author=J.+Zablocki&title=Benzimidazolone+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAktoudianakis%26aufirst%3DI.%26atitle%3DBenzimidazolone%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Babaoglu, K.; Corkey, B. K.; Jiang, R. H.; Sperandio, D.; Yang, H.</span><span> </span><span class="NLM_article-title">Quinoline Derivatives as Bromodomain Inhibitors</span>. US20150148344A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Babaoglu&author=B.+K.+Corkey&author=R.+H.+Jiang&author=D.+Sperandio&author=H.+Yang&title=Quinoline+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBabaoglu%26aufirst%3DK.%26atitle%3DQuinoline%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Duffy, B. C.; Liu, S.; Quinn, J. F.; Wang, R.; Jiang, M. X.; Martin, G. S.; Wagner, G. S.; Young, P. R.</span><span> </span><span class="NLM_article-title">Novel Bicyclic Bromodomain Inhibitors</span>. WO2015002754A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+C.+Duffy&author=S.+Liu&author=J.+F.+Quinn&author=R.+Wang&author=M.+X.+Jiang&author=G.+S.+Martin&author=G.+S.+Wagner&author=P.+R.+Young&title=Novel+Bicyclic+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520Bicyclic%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Liu, S.; Quinn, J. F.; Duffy, B. C.; Wang, R.; Jiang, M. X.; Martin, G. S.; Zhao, H.; Ellis, M.; Wagner, G. S.; Young, P. R.</span><span> </span><span class="NLM_article-title">Novel Substituted Bicyclic Compounds as Bromodomain Inhibitors</span>. WO2015004533A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Liu&author=J.+F.+Quinn&author=B.+C.+Duffy&author=R.+Wang&author=M.+X.+Jiang&author=G.+S.+Martin&author=H.+Zhao&author=M.+Ellis&author=G.+S.+Wagner&author=P.+R.+Young&title=Novel+Substituted+Bicyclic+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DNovel%2520Substituted%2520Bicyclic%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Zhang, J.; Buell, J.; Chan, K.; Ibrahim, P. N.; Lin, J.; Pham, P.; Shi, S.; Spevak, W.; Wu, G.; Wu, J.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds and Uses Thereof</span>. WO2014145051A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Zhang&author=J.+Buell&author=K.+Chan&author=P.+N.+Ibrahim&author=J.+Lin&author=P.+Pham&author=S.+Shi&author=W.+Spevak&author=G.+Wu&author=J.+Wu&title=Heterocyclic+Compounds+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHeterocyclic%2520Compounds%2520and%2520Uses%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Ren, B.; Zhou, C.; Wang, H.</span><span> </span><span class="NLM_article-title">Substituted 5-(3,5-Dimethylisoxazol-4-yl)indoline-2-ones</span>. WO2014173241A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Ren&author=C.+Zhou&author=H.+Wang&title=Substituted+5-%283%2C5-Dimethylisoxazol-4-yl%29indoline-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26atitle%3DSubstituted%25205-%25283%252C5-Dimethylisoxazol-4-yl%2529indoline-2-ones%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Mantoulidis, A.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Indolinone Analogues as BRD4 Inhibitors</span>. WO2014154760A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=A.+Mantoulidis&author=C.+Smethurst&title=Indolinone+Analogues+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DIndolinone%2520Analogues%2520as%2520BRD4%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Smethurst, C.; Engelhardt, H.; Gianni, D.; Reiser, U.</span><span> </span><span class="NLM_article-title">Dihydroquinazolinone Analogues as BRD4 Inhibitors</span>. WO2014154762A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Smethurst&author=H.+Engelhardt&author=D.+Gianni&author=U.+Reiser&title=Dihydroquinazolinone+Analogues+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmethurst%26aufirst%3DC.%26atitle%3DDihydroquinazolinone%2520Analogues%2520as%2520BRD4%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Combs, A. P.; Yue, E. W.; Sparks, R. B.; Maduskuie, J. T. P.</span><span> </span><span class="NLM_article-title">Tricyclic Heterocycles as BET Protein Inhibitors</span>. US20150011540A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+P.+Combs&author=E.+W.+Yue&author=R.+B.+Sparks&author=J.+T.+P.+Maduskuie&title=Tricyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DTricyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Wang, L.; Dai, Y.; Holms, J.; Liu, D.; Mcclellan, W.; Mcdaniel, K.; Hasvold, L.; Fidanze, S. D.; Sheppard, G.; Marjanovic, J.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2014206150A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Wang&author=Y.+Dai&author=J.+Holms&author=D.+Liu&author=W.+Mcclellan&author=K.+Mcdaniel&author=L.+Hasvold&author=S.+D.+Fidanze&author=G.+Sheppard&author=J.+Marjanovic&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Wang, L.; Pratt, J. K.; Mcdaniel, K. F.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2013097052A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+Wang&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Wang, L.; Pratt, J. K.; Mcdaniel, K. F.; Dai, Y.; Fidanze, S. D.; Hasvold, L.; Holms, J. H.; Kati, W. M.; Liu, D.; Mantei, R. A.; Mcclellan, W. J.; Sheppard, G. S.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2013097601A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+Wang&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&author=Y.+Dai&author=S.+D.+Fidanze&author=L.+Hasvold&author=J.+H.+Holms&author=W.+M.+Kati&author=D.+Liu&author=R.+A.+Mantei&author=W.+J.+Mcclellan&author=G.+S.+Sheppard&author=C.+K.+Wada&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Aamans, D.; Bamborough, P.; Barker, M. D.; Bit, R. A.; Brown, J. A.; Campbell, M.; Garton, N. S.; Lindon, M. J.; Shipley, T. J.; Theodoulou, N. H.; Wellaway, C. R.; Westaway, S. M.</span><span> </span><span class="NLM_article-title">Furopyridines as Bromodomain Inhibitors</span>. WO2014140077A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Aamans&author=P.+Bamborough&author=M.+D.+Barker&author=R.+A.+Bit&author=J.+A.+Brown&author=M.+Campbell&author=N.+S.+Garton&author=M.+J.+Lindon&author=T.+J.+Shipley&author=N.+H.+Theodoulou&author=C.+R.+Wellaway&author=S.+M.+Westaway&title=Furopyridines+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAamans%26aufirst%3DD.%26atitle%3DFuropyridines%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Amans, D.; Bamborough, P.; Bit, R. A.; Brown, J. A.; Campbell, M.; Lindon, M. J.; Shipley, T. J.; Theodoulou, N. H.; Wellaway, C. R.; Westaway, S. M.</span><span> </span><span class="NLM_article-title">Thieno[3,2-<i>c</i>]Pyridin-4(5<i>H</i>)-ones as BET Inhibitors</span>. WO2014078257A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=P.+Bamborough&author=R.+A.+Bit&author=J.+A.+Brown&author=M.+Campbell&author=M.+J.+Lindon&author=T.+J.+Shipley&author=N.+H.+Theodoulou&author=C.+R.+Wellaway&author=S.+M.+Westaway&title=Thieno%5B3%2C2-c%5DPyridin-4%285H%29-ones+as+BET+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3DThieno%255B3%252C2-c%255DPyridin-4%25285H%2529-ones%2520as%2520BET%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Bogdan, A.; Kati, W. M.; Mcdaniel, K. F.; Park, C. H.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20150158873A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Bogdan&author=W.+M.+Kati&author=K.+F.+Mcdaniel&author=C.+H.+Park&author=G.+S.+Sheppard&author=L.+Wang&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Wang, L.; Frey, R. R.; Hansen, T. M.; Liu, D.; Mcclellan, W. J.; Mcdaniel, K. F.; Pratt, J. K.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2015085925A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Wang&author=R.+R.+Frey&author=T.+M.+Hansen&author=D.+Liu&author=W.+J.+Mcclellan&author=K.+F.+Mcdaniel&author=J.+K.+Pratt&author=C.+K.+Wada&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Fidanze, S. D.; Liu, D.; Mantei, R. A.; Mcdaniel, K. F.; Pratt, J.; Sheppard, G. S.; Wang, L.; Bogdan, A.; Holms, J. H.; Dietrich, J. D.; Marjanovic, J.; Hasvold, L. A.; Dai, Y.</span><span> </span><span class="NLM_article-title">Tetracyclic Bromodomain Inhibitors</span>. WO2014139324A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+D.+Fidanze&author=D.+Liu&author=R.+A.+Mantei&author=K.+F.+Mcdaniel&author=J.+Pratt&author=G.+S.+Sheppard&author=L.+Wang&author=A.+Bogdan&author=J.+H.+Holms&author=J.+D.+Dietrich&author=J.+Marjanovic&author=L.+A.+Hasvold&author=Y.+Dai&title=Tetracyclic+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26atitle%3DTetracyclic%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Liu, D.; Pratt, J.; Wang, L.; Hasvold, L. A.; Bogdan, A.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20140256710A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Liu&author=J.+Pratt&author=L.+Wang&author=L.+A.+Hasvold&author=A.+Bogdan&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Mcdaniel, K. F.; Pratt, J.; Sheppard, G. S.; Wada, C. K.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20140256705A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=D.+Liu&author=K.+F.+Mcdaniel&author=J.+Pratt&author=G.+S.+Sheppard&author=C.+K.+Wada&author=K.+R.+Woller&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Jutta, B.; Bold, G.; Bordas, V.; Cotesta, S.; Guagnano, V.; Rueger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrrolone Derivatives and Their Use as BET Inhibitors</span>. WO2015075665A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Jutta&author=G.+Bold&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueger&author=A.+Vaupel&title=Pyrrolopyrrolone+Derivatives+and+Their+Use+as+BET+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJutta%26aufirst%3DB.%26atitle%3DPyrrolopyrrolone%2520Derivatives%2520and%2520Their%2520Use%2520as%2520BET%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Yue, E. W.; Combs, A. P.</span><span> </span><span class="NLM_article-title">Bicyclic Heterocycles as BET Protein Inhibitors</span>. US20150148372A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+W.+Yue&author=A.+P.+Combs&title=Bicyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26atitle%3DBicyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Yue, E. W.; Combs, A. P.; Douty, B.</span><span> </span><span class="NLM_article-title">Bicyclic Heterocycles as BET Protein Inhibitors</span>. US20150148342A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+W.+Yue&author=A.+P.+Combs&author=B.+Douty&title=Bicyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26atitle%3DBicyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Engelhardt, H.; Martin, L.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Pyridinones</span>. WO2015022332A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&author=L.+Martin&author=C.+Smethurst&title=Pyridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DPyridinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Bennett, M. J.; Betancort, J. M.; Boloor, A.; Kaldor, S. W.; Stafford, J. A.; Veal, J. M.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2015058160A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+J.+Bennett&author=J.+M.+Betancort&author=A.+Boloor&author=S.+W.+Kaldor&author=J.+A.+Stafford&author=J.+M.+Veal&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Ujjinamatada, R. K.; Hosahalli, S.; Samajdar, S.; Abbineni, C.</span><span> </span><span class="NLM_article-title">Spiro[cyclobutane-1,3′-indolin]-2′-one Derivatives as Bromodomain Inhibitors</span>. WO2015092118A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+K.+Ujjinamatada&author=S.+Hosahalli&author=S.+Samajdar&author=C.+Abbineni&title=Spiro%5Bcyclobutane-1%2C3%E2%80%B2-indolin%5D-2%E2%80%B2-one+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjinamatada%26aufirst%3DR.%2BK.%26atitle%3DSpiro%255Bcyclobutane-1%252C3%25E2%2580%25B2-indolin%255D-2%25E2%2580%25B2-one%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Schmees, N.; Haendler, B.; Stöckigt, D.; Gallenkamp, D.; Bissel, A.; Bouglas, A.</span><span> </span><span class="NLM_article-title">Modified BET-Protein-Inhibiting Dihydroquinoxalinones and Dihydropyridopyrazinones</span>. WO2015004075A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Schmees&author=B.+Haendler&author=D.+St%C3%B6ckigt&author=D.+Gallenkamp&author=A.+Bissel&author=A.+Bouglas&title=Modified+BET-Protein-Inhibiting+Dihydroquinoxalinones+and+Dihydropyridopyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DModified%2520BET-Protein-Inhibiting%2520Dihydroquinoxalinones%2520and%2520Dihydropyridopyrazinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lénárt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronczki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krššák, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gürtler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BI 2536, a Potent and Selective Inhibitor of Polo-Like Kinase 1, Inhibits Tumor Growth in Vivo</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1016/j.cub.2006.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cub.2006.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=17291758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=316-322&author=M.+Steegmaierauthor=M.+Hoffmannauthor=A.+Baumauthor=P.+L%C3%A9n%C3%A1rtauthor=M.+Petronczkiauthor=M.+Kr%C5%A1%C5%A1%C3%A1kauthor=U.+G%C3%BCrtlerauthor=P.+Garin-Chesaauthor=S.+Liebauthor=J.+Quantauthor=M.+Grauertauthor=G.+R.+Adolfauthor=N.+Krautauthor=J.-M.+Petersauthor=W.+J.+Rettig&title=BI+2536%2C+a+Potent+and+Selective+Inhibitor+of+Polo-Like+Kinase+1%2C+Inhibits+Tumor+Growth+in+Vivo&doi=10.1016%2Fj.cub.2006.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo</span></div><div class="casAuthors">Steegmaier, Martin; Hoffmann, Matthias; Baum, Anke; Lenart, Peter; Petronczki, Mark; Krssak, Martin; Guertler, Ulrich; Garin-Chesa, Pilar; Lieb, Simone; Quant, Jens; Grauert, Matthias; Adolf, Guenther R.; Kraut, Norbert; Peters, Jan-Michael; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-322</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fine-mapping of the cell-division cycle, notably the identification of mitotic kinase signaling pathways, provides novel opportunities for cancer-drug discovery.  As a key regulator of multiple steps during mitotic progression across eukaryotic species, the serine/threonine-specific Polo-like kinase 1 (Plk1) is highly expressed in malignant cells and serves as a neg. prognostic marker in specific human cancer types .  Here, we report the discovery of a potent small-mol. inhibitor of mammalian Plk1, BI 2536, which inhibits Plk1 enzyme activity at low nanomolar concns.  The compd. potently causes a mitotic arrest and induces apoptosis in human cancer cell lines of diverse tissue origin and oncogenome signature.  BI 2536 inhibits growth of human tumor xenografts in nude mice and induces regression of large tumors with well-tolerated i.v. dose regimens.  In treated tumors, cells arrest in prometaphase, accumulate phosphohistone H3, and contain aberrant mitotic spindles.  This mitotic arrest is followed by a surge in apoptosis, detectable by immunohistochem. and noninvasive optical and magnetic resonance imaging.  For addressing the therapeutic potential of Plk1 inhibition, BI 2536 has progressed into clin. studies in patients with locally advanced or metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eEWnSYWORbVg90H21EOLACvtfcHk0lhImklBcv8lUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D&md5=49807e335b4ab8cf8209b55597fc7b4e</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DL%25C3%25A9n%25C3%25A1rt%26aufirst%3DP.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DKr%25C5%25A1%25C5%25A1%25C3%25A1k%26aufirst%3DM.%26aulast%3DG%25C3%25BCrtler%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBI%25202536%252C%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Polo-Like%2520Kinase%25201%252C%2520Inhibits%2520Tumor%2520Growth%2520in%2520Vivo%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D316%26epage%3D322%26doi%3D10.1016%2Fj.cub.2006.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Ember, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span> </span><span class="NLM_article-title">Acetyl-Lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/cb500072z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1160-1171&author=S.+W.+J.+Emberauthor=J.-Y.+Zhuauthor=S.+H.+Olesenauthor=M.+P.+Martinauthor=A.+Beckerauthor=N.+Berndtauthor=G.+I.+Georgauthor=E.+Sch%C3%B6nbrunn&title=Acetyl-Lysine+Binding+Site+of+Bromodomain-Containing+Protein+4+%28BRD4%29+Interacts+with+Diverse+Kinase+Inhibitors&doi=10.1021%2Fcb500072z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span></div><div class="casAuthors">Ember, Stuart W. J.; Zhu, Jin-Yi; Olesen, Sanne H.; Martin, Mathew P.; Becker, Andreas; Berndt, Norbert; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1160-1171</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the bromodomain and extra terminal (BET) family of proteins are essential for the recognition of acetylated lysine (KAc) residues in histones and have emerged as promising drug targets in cancer, inflammation, and contraception research.  In co-crystn. screening campaigns using the first bromodomain of BRD4 (BRD4-1) against kinase inhibitor libraries, we identified and characterized 14 kinase inhibitors (10 distinct chem. scaffolds) as ligands of the KAc binding site.  Among these, the PLK1 inhibitor BI2536 and the JAK2 inhibitor TG101209 displayed strongest inhibitory potential against BRD4 (IC50 = 25 nM and 130 nM, resp.) and high selectivity for BET bromodomains.  Comparative structural anal. revealed markedly different binding modes of kinase hinge-binding scaffolds in the KAc binding site, suggesting that BET proteins are potential off-targets of diverse kinase inhibitors.  Combined, these findings provide a new structural framework for the rational design of next-generation BET-selective and dual-activity BET-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0X1hjt7cBbVg90H21EOLACvtfcHk0lhImklBcv8lUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D&md5=5ca37df00cdaa0ba81c0cb4a0f70ba5d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fcb500072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500072z%26sid%3Dliteratum%253Aachs%26aulast%3DEmber%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.-Y.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26atitle%3DAcetyl-Lysine%2520Binding%2520Site%2520of%2520Bromodomain-Containing%2520Protein%25204%2520%2528BRD4%2529%2520Interacts%2520with%2520Diverse%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1160%26epage%3D1171%26doi%3D10.1021%2Fcb500072z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou-Eymard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8111</span><span class="NLM_x">–</span> <span class="NLM_lpage">8131</span><span class="refDoi"> DOI: 10.1021/jm5010539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8111-8131&author=R.+Gosminiauthor=V.-L.+Nguyenauthor=J.+Toumauthor=C.+Simonauthor=J.-M.+G.+Brusqauthor=G.+Krysaauthor=O.+Mirguetauthor=A.+M.+Riou-Eymardauthor=E.+V.+Boursierauthor=L.+Trottetauthor=P.+Bamboroughauthor=H.+Clarkauthor=C.-W.+Chungauthor=L.+Cutlerauthor=E.+H.+Demontauthor=R.+Kaurauthor=A.+J.+Lewisauthor=M.+B.+Schillingauthor=P.+E.+Sodenauthor=S.+Taylorauthor=A.+L.+Walkerauthor=M.+D.+Walkerauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=The+Discovery+of+I-BET726+%28GSK1324726A%29%2C+a+Potent+Tetrahydroquinoline+ApoA1+Up-Regulator+and+Selective+BET+Bromodomain+Inhibitor&doi=10.1021%2Fjm5010539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span></div><div class="casAuthors">Gosmini, Romain; Nguyen, Van Loc; Toum, Jerome; Simon, Christophe; Brusq, Jean-Marie G.; Krysa, Gael; Mirguet, Olivier; Riou-Eymard, Alizon M.; Boursier, Eric V.; Trottet, Lionel; Bamborough, Paul; Clark, Hugh; Chung, Chun-wa; Cutler, Leanne; Demont, Emmanuel H.; Kaur, Rejbinder; Lewis, Antonia J.; Schilling, Mark B.; Soden, Peter E.; Taylor, Simon; Walker, Ann L.; Walker, Matthew D.; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8111-8131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through their function as epigenetic readers of the histone code, the BET family of bromodomain-contg. proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation.  BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncol. and inflammation models, and the first compds. have now progressed into clin. trials.  The exciting biol. of the BETs has led to great interest in the discovery of novel inhibitor classes.  Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compds. active in murine models of septic shock and neuroblastoma.  At the mol. level, these effects are produced by inhibition of BET bromodomains.  X-ray crystallog. reveals the interactions explaining the structure-activity relationships of binding.  The resulting lead mol., I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5OdMn_TjoFLVg90H21EOLACvtfcHk0lhmEcuSVCnwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J&md5=b1c9c9cae73c41252cf73908d561bd9b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm5010539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010539%26sid%3Dliteratum%253Aachs%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.-L.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DBrusq%26aufirst%3DJ.-M.%2BG.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DRiou-Eymard%26aufirst%3DA.%2BM.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DA.%2BJ.%26aulast%3DSchilling%26aufirst%3DM.%2BB.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DThe%2520Discovery%2520of%2520I-BET726%2520%2528GSK1324726A%2529%252C%2520a%2520Potent%2520Tetrahydroquinoline%2520ApoA1%2520Up-Regulator%2520and%2520Selective%2520BET%2520Bromodomain%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8111%26epage%3D8131%26doi%3D10.1021%2Fjm5010539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Amans, D.; Atkinson, S. J.; Harrison, L. A.; Hirst, D. J.; Law, R. P.; Lindon, M.; Preston, A.; Seal, J. T.; Wellaway, C. R.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted 1-Acyl-4-amino-1,2,3,4-tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors</span>. WO2014140076A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=S.+J.+Atkinson&author=L.+A.+Harrison&author=D.+J.+Hirst&author=R.+P.+Law&author=M.+Lindon&author=A.+Preston&author=J.+T.+Seal&author=C.+R.+Wellaway&title=2%2C3-Disubstituted+1-Acyl-4-amino-1%2C2%2C3%2C4-tetrahydroquinoline+Derivatives+and+Their+Use+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3D2%252C3-Disubstituted%25201-Acyl-4-amino-1%252C2%252C3%252C4-tetrahydroquinoline%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. E. R.; Talbot, A. C.; Tebbe, M. J.</span><span> </span><span class="NLM_article-title">Benzopiperazine Compositions as BET Bromodomain Inhibitors</span>. WO2015074081A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+E.+R.+Schiller&author=A.+C.+Talbot&author=M.+J.+Tebbe&title=Benzopiperazine+Compositions+as+BET+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DBenzopiperazine%2520Compositions%2520as%2520BET%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. E. R.; Talbot, A. C.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline Compositions as BET Bromodomain Inhibitors</span>. WO2015074064A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+E.+R.+Schiller&author=A.+C.+Talbot&title=Tetrahydroquinoline+Compositions+as+BET+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DTetrahydroquinoline%2520Compositions%2520as%2520BET%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Siegel, S.; Baurle, S.; Cleve, A.; Haendler, B.; Fernandez-Montalvan, A. E.; Monning, U.; Krause, S.; Lejeune, P.; Busemann, M.; Kuhnke, J.</span><span> </span><span class="NLM_article-title">Bicyclo 2,3-Benzodiazepines and Spirocyclically Substituted 2,3-Benzodiazepines</span>. WO2014128067A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Siegel&author=S.+Baurle&author=A.+Cleve&author=B.+Haendler&author=A.+E.+Fernandez-Montalvan&author=U.+Monning&author=S.+Krause&author=P.+Lejeune&author=M.+Busemann&author=J.+Kuhnke&title=Bicyclo+2%2C3-Benzodiazepines+and+Spirocyclically+Substituted+2%2C3-Benzodiazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DS.%26atitle%3DBicyclo%25202%252C3-Benzodiazepines%2520and%2520Spirocyclically%2520Substituted%25202%252C3-Benzodiazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Pratt, J. K.; Sheppard, G. S.; McDaniel, K. F.; Elmore, S. W.; Hubbard, R. D.</span><span> </span><span class="NLM_article-title">Pyrrole Amide Inhibitors</span>. US20140275079A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=D.+Liu&author=J.+K.+Pratt&author=G.+S.+Sheppard&author=K.+F.+McDaniel&author=S.+W.+Elmore&author=R.+D.+Hubbard&title=Pyrrole+Amide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DPyrrole%2520Amide%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Günther, S.; Lucas, X.; Jung, M.; Einsle, O.; Wohlwend, D.; Gerhardt, S.</span><span> </span><span class="NLM_article-title">Compounds for Use as Bromodomain Inhibitors</span>. WO2014170350A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+G%C3%BCnther&author=X.+Lucas&author=M.+Jung&author=O.+Einsle&author=D.+Wohlwend&author=S.+Gerhardt&title=Compounds+for+Use+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCnther%26aufirst%3DS.%26atitle%3DCompounds%2520for%2520Use%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Zhou, M.-M.; Ohlmeyer, M.; Vincek, A.; Zaware, N.</span><span> </span><span class="NLM_article-title">Cyclic Vinylogous Amides as Bromodomain Inhibitors</span>. WO2015031824A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.-M.+Zhou&author=M.+Ohlmeyer&author=A.+Vincek&author=N.+Zaware&title=Cyclic+Vinylogous+Amides+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DCyclic%2520Vinylogous%2520Amides%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83190</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0083190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24391744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Wju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83190&author=K.+G.+McLureauthor=E.+M.+Gesnerauthor=L.+Tsujikawaauthor=O.+A.+Kharenkoauthor=S.+Attwellauthor=E.+Campeauauthor=S.+Wasiakauthor=A.+Steinauthor=A.+Whiteauthor=E.+Fontanoauthor=R.+K.+Sutoauthor=N.+C.+W.+Wongauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=P.+R.+Young&title=RVX-208%2C+an+Inducer+of+ApoA-I+in+Humans%2C+Is+a+BET+Bromodomain+Antagonist&doi=10.1371%2Fjournal.pone.0083190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist</span></div><div class="casAuthors">McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e83190/1-e83190/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Increased synthesis of Apolipoprotein A-I (ApoA-I) and HDL is believed to provide a new approach to treating atherosclerosis through the stimulation of reverse cholesterol transport.  RVX-208 increases the prodn. of ApoA-I in hepatocytes in vitro and in vivo in monkeys and humans, which results in increased HDL-C, but the mol. target was not previously reported.  Using binding assays and X-ray crystallog., we now show that RVX-208 selectively binds to bromodomains of the BET (Bromodomain and Extra Terminal) family, competing for a site bound by the endogenous ligand, acetylated lysine and that this accounts for its pharmacol. activity. siRNA expts. further suggest that induction of ApoA-I mRNA is mediated by BET family member BRD4.  These data indicate that RVX-208 increases ApoA-I prodn. through an epigenetic mechanism and suggests that BET inhibition may be a promising new approach to the treatment of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLHPlAY0x6NLVg90H21EOLACvtfcHk0lh7S53pDhGp4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Wju78%253D&md5=519ef7ed6d06f97ef8a1359832c11d92</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083190%26sid%3Dliteratum%253Aachs%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DWasiak%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DFontano%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DWong%26aufirst%3DN.%2BC.%2BW.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DRVX-208%252C%2520an%2520Inducer%2520of%2520ApoA-I%2520in%2520Humans%252C%2520Is%2520a%2520BET%2520Bromodomain%2520Antagonist%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83190%26doi%3D10.1371%2Fjournal.pone.0083190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Dacal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">RVX-208, an Inhibitor of BET Transcriptional Regulators with Selectivity for the Second Bromodomain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">19754</span><span class="NLM_x">–</span> <span class="NLM_lpage">19759</span><span class="refDoi"> DOI: 10.1073/pnas.1310658110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1310658110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19754-19759&author=S.+Picaudauthor=C.+Wellsauthor=I.+Felletarauthor=D.+Brothertonauthor=S.+Martinauthor=P.+Savitskyauthor=B.+Diez-Dacalauthor=M.+Philpottauthor=C.+Bountraauthor=H.+Lingardauthor=O.+Fedorovauthor=S.+M%C3%BCllerauthor=P.+E.+Brennanauthor=S.+Knappauthor=P.+Filippakopoulos&title=RVX-208%2C+an+Inhibitor+of+BET+Transcriptional+Regulators+with+Selectivity+for+the+Second+Bromodomain&doi=10.1073%2Fpnas.1310658110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Wells, Christopher; Felletar, Ildiko; Brotherton, Deborah; Martin, Sarah; Savitsky, Pavel; Diez-Dacal, Beatriz; Philpott, Martin; Bountra, Chas; Lingard, Hannah; Fedorov, Oleg; Muller, Susanne; Brennan, Paul E.; Knapp, Stefan; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19754-19759,S19754/1-S19754/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription.  Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models.  However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting.  Here, we report that RVX-208, a compd. currently in phase II clin. trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s).  Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin.  However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription.  Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamW8vnIopKrVg90H21EOLACvtfcHk0lh7S53pDhGp4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN&md5=c918702c9fdb91241bc837732730f7f6</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1310658110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1310658110%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DDiez-Dacal%26aufirst%3DB.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DRVX-208%252C%2520an%2520Inhibitor%2520of%2520BET%2520Transcriptional%2520Regulators%2520with%2520Selectivity%2520for%2520the%2520Second%2520Bromodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19754%26epage%3D19759%26doi%3D10.1073%2Fpnas.1310658110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Noguchi-Yachide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span> </span><span class="NLM_article-title">Discovery and Structure-Activity Relationship Studies of <i>N</i>6-Benzoyladenine Derivatives as Novel BRD4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmc.2015.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25678016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=953-959&author=T.+Noguchi-Yachideauthor=T.+Sakaiauthor=Y.+Hashimotoauthor=T.+Yamaguchi&title=Discovery+and+Structure-Activity+Relationship+Studies+of+N6-Benzoyladenine+Derivatives+as+Novel+BRD4+Inhibitors&doi=10.1016%2Fj.bmc.2015.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span></div><div class="casAuthors">Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-959</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones.  Among them, BRD4 is a candidate target mol. of therapeutic agents for diverse diseases, including cancer and inflammatory disease.  As a part of the continuing structural development studies of thalidomide to obtain a broad spectrum of biol. modifiers based on the 'multitemplate' approach, in this work the authors focused on BRD4-inhibitory activity, and discovered that N6-benzoyladenine derivs. exhibit this activity.  Structure-activity relationship studies led to N6-(2,4,5-trimethoxybenzoyl)adenine I, which exhibits potent BRD4 bromodomain1 inhibitory activity with an IC50 value of 0.427 μM.  N6-Benzoyladenine appears to be a new chem. scaffold for development of BRD4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwaLfpkAET7Vg90H21EOLACvtfcHk0lh7S53pDhGp4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D&md5=889cf81c25fd1e62def22cb2f32dc06e</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi-Yachide%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520of%2520N6-Benzoyladenine%2520Derivatives%2520as%2520Novel%2520BRD4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D953%26epage%3D959%26doi%3D10.1016%2Fj.bmc.2015.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref300"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref300'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit300"><span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9251</span><span class="NLM_x">–</span> <span class="NLM_lpage">9264</span><span class="refDoi"> DOI: 10.1021/jm401334s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401334s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9251-9264&author=G.+Zhangauthor=A.+N.+Plotnikovauthor=E.+Rusinovaauthor=T.+Shenauthor=K.+Morohashiauthor=J.+Joshuaauthor=L.+Zengauthor=S.+Mujtabaauthor=M.+Ohlmeyerauthor=M.-M.+Zhou&title=Structure-Guided+Design+of+Potent+Diazobenzene+Inhibitors+for+the+BET+Bromodomains&doi=10.1021%2Fjm401334s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit300R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span></div><div class="casAuthors">Zhang, Guangtao; Plotnikov, Alexander N.; Rusinova, Elena; Shen, Tong; Morohashi, Keita; Joshua, Jennifer; Zeng, Lei; Mujtaba, Shiraz; Ohlmeyer, Michael; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9251-9264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BRD4, characterized by two acetyl-lysine binding bromodomains and an extra-terminal (ET) domain, is a key chromatin organizer that directs gene activation in chromatin through transcription factor recruitment, enhancer assembly, and pause release of the RNA polymerase II complex for transcription elongation.  BRD4 has been recently validated as a new epigenetic drug target for cancer and inflammation.  Our current knowledge of the functional differences of the two bromodomains of BRD4, however, is limited and is hindered by the lack of selective inhibitors.  Here, we report our structure-guided development of diazobenzene-based small-mol. inhibitors for the BRD4 bromodomains that have over 90% sequence identity at the acetyl-lysine binding site.  Our lead compd., MS436, through a set of water-mediated interactions, exhibits low nanomolar affinity (estd. Ki of 30-50 nM), with preference for the first bromodomain over the second.  We demonstrated that MS436 effectively inhibits BRD4 activity in NF-κB-directed prodn. of nitric oxide and proinflammatory cytokine interleukin-6 in murine macrophages.  MS436 represents a new class of bromodomain inhibitors and will facilitate further investigation of the biol. functions of the two bromodomains of BRD4 in gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlT4IPx_3s7rVg90H21EOLACvtfcHk0ljUBIV9AQT5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO&md5=24c7b50636fc4e0bbbfb80446e4dd23c</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1021%2Fjm401334s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401334s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMorohashi%26aufirst%3DK.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure-Guided%2520Design%2520of%2520Potent%2520Diazobenzene%2520Inhibitors%2520for%2520the%2520BET%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9251%26epage%3D9264%26doi%3D10.1021%2Fjm401334s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Mishra, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ember, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, W. C.</span><span> </span><span class="NLM_article-title">Fluorinated Aromatic Amino Acids Are Sensitive 19F NMR Probes for Bromodomain-Ligand Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2755</span><span class="NLM_x">–</span> <span class="NLM_lpage">2760</span><span class="refDoi"> DOI: 10.1021/cb5007344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2755-2760&author=N.+K.+Mishraauthor=A.+K.+Urickauthor=S.+W.+J.+Emberauthor=E.+Sch%C3%B6nbrunnauthor=W.+C.+Pomerantz&title=Fluorinated+Aromatic+Amino+Acids+Are+Sensitive+19F+NMR+Probes+for+Bromodomain-Ligand+Interactions&doi=10.1021%2Fcb5007344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated Aromatic Amino Acids Are Sensitive 19F NMR Probes for Bromodomain-Ligand Interactions</span></div><div class="casAuthors">Mishra, Neeraj K.; Urick, Andrew K.; Ember, Stuart W. J.; Schonbrunn, Ernst; Pomerantz, William C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2755-2760</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe a 19F NMR method for detecting bromodomain-ligand interactions using fluorine-labeled arom. amino acids due to the conservation of arom. residues in the bromodomain binding site.  The authors test the sensitivity, accuracy, and speed of this method with small mol. ligands (+)-JQ1, BI2536, Dinaciclib, TG101348, and acetaminophen using three bromodomains Brd4, BrdT, and BPTF.  Simplified 19F NMR spectra allowed for simultaneous testing of multiple bromodomains to assess selectivity and identification of a new BPTF ligand.  Fluorine labeling only modestly affected the Brd4 structure and function assessed by isothermal titrn. calorimetry, CD, and x-ray crystallog.  The speed, ease of interpretation, and low concn. of protein needed for binding expts. affords a new method to discover and characterize both native and new ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoejxq3KKVddrVg90H21EOLACvtfcHk0ljUBIV9AQT5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLfP&md5=97f9edadc91cba8670f54bcca57fa03f</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fcb5007344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007344%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DN.%2BK.%26aulast%3DUrick%26aufirst%3DA.%2BK.%26aulast%3DEmber%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%26atitle%3DFluorinated%2520Aromatic%2520Amino%2520Acids%2520Are%2520Sensitive%252019F%2520NMR%2520Probes%2520for%2520Bromodomain-Ligand%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2755%26epage%3D2760%26doi%3D10.1021%2Fcb5007344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of BRD4 Bromodomain Inhibitors by Fragment-Based High-Throughput Docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2014.04.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2493-2496&author=H.+Zhaoauthor=L.+Gartenmannauthor=J.+Dongauthor=D.+Spiliotopoulosauthor=A.+Caflisch&title=Discovery+of+BRD4+Bromodomain+Inhibitors+by+Fragment-Based+High-Throughput+Docking&doi=10.1016%2Fj.bmcl.2014.04.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGartenmann%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520BRD4%2520Bromodomain%2520Inhibitors%2520by%2520Fragment-Based%2520High-Throughput%2520Docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2493%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2014.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8073</span><span class="NLM_x">–</span> <span class="NLM_lpage">8088</span><span class="refDoi"> DOI: 10.1021/jm4011302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8073-8088&author=L.+R.+Vidlerauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=S.+Martinauthor=M.+Tomsettauthor=H.+Woodwardauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Discovery+of+Novel+Small-Molecule+Inhibitors+of+BRD4+Using+Structure-Based+Virtual+Screening&doi=10.1021%2Fjm4011302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span></div><div class="casAuthors">Vidler, Lewis R.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Martin, Sarah; Tomsett, Michael; Woodward, Hannah; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8073-8088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are epigenetic readers that recognize acetylated-lysine (KAc) on proteins and are implicated in a no. of diseases.  We describe a virtual screening approach to identify BRD inhibitors.  Key elements of this approach are the extensive design and use of substructure queries to compile a set of com. available compds. featuring novel putative KAc mimetics and docking this set for final compd. selection.  We describe the validation of this approach by applying it to the first BRD of BRD4.  The selection and testing of 143 compds. lead to the discovery of six novel hits, including four unprecedented KAc mimetics.  We solved the crystal structure of four hits, detd. their binding mode, and improved their potency through synthesis and the purchase of derivs.  This work provides a validated virtual screening approach that is applicable to other BRDs and describes novel KAc mimetics that can be further explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5yj8bnohUbVg90H21EOLACvtfcHk0ljUBIV9AQT5bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI&md5=c1f76e4838713335be7a93ebe4c68701</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm4011302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011302%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTomsett%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Novel%2520Small-Molecule%2520Inhibitors%2520of%2520BRD4%2520Using%2520Structure-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8073%26epage%3D8088%26doi%3D10.1021%2Fjm4011302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1021/jm501504k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501504k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1281-1297&author=L.+Zhaoauthor=Y.+Wangauthor=D.+Caoauthor=T.+Chenauthor=Q.+Wangauthor=Y.+Liauthor=Y.+Xuauthor=N.+Zhangauthor=X.+Wangauthor=D.+Chenauthor=L.+Chenauthor=Y.-L.+Chenauthor=G.+Xiaauthor=Z.+Shiauthor=Y.-C.+Liuauthor=Y.+Linauthor=Z.+Miaoauthor=J.+Shenauthor=B.+Xiong&title=Fragment-Based+Drug+Discovery+of+2-Thiazolidinones+as+BRD4+Inhibitors%3A+2.+Structure-Based+Optimization&doi=10.1021%2Fjm501504k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: Structure-Based Optimization</span></div><div class="casAuthors">Zhao, Lele; Wang, Yingqing; Cao, Danyan; Chen, Tiantian; Wang, Qi; Li, Yanlian; Xu, Yechun; Zhang, Naixia; Wang, Xin; Chen, Danqi; Chen, Lin; Chen, Yue-Lei; Xia, Guangxin; Shi, Zhe; Liu, Yu-Chih; Lin, Yijyun; Miao, Zehong; Shen, Jingkang; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1281-1297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The signal transduction of acetylated histone can be processed through a recognition module, bromodomain.  Several inhibitors targeting BRD4, one of the bromodomain members, are in clin. trials as anticancer drugs.  Hereby, the authors report the efforts on discovery and optimization of a new series of 2-thiazolidinones as BRD4 inhibitors along the previous study.  In this work, guided by crystal structure anal., the authors reversed the sulfonamide group and identified a new binding mode.  A structure-activity relationship study on this new series led to several potent BRD4 inhibitors with IC50 of about 0.05-0.1 μM in FP binding assay and GI50 of 0.1-0.3 μM in cell based assays.  To complete the lead-like assessment of this series, the authors further checked its effects on BRD4 downstream protein c-Myc, investigated its selectivity among five different bromodomain proteins, as well as the metabolic stability test, and reinforced the utility of 2-thiazolidinone scaffold as BET bromodomain inhibitors in novel anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4x-5lE2iPzbVg90H21EOLACvtfcHk0lhkr_OUog--fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D&md5=4056ac1a6d6598dc61be7cc7ef82a3da</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm501504k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501504k%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%25202-Thiazolidinones%2520as%2520BRD4%2520Inhibitors%253A%25202.%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1281%26epage%3D1297%26doi%3D10.1021%2Fjm501504k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Duffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarasimhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a New Chemical Series of BRD4(1) Inhibitors Using Protein-Ligand Docking and Structure-Guided Design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2015.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2818-2823&author=B.+C.+Duffyauthor=S.+Liuauthor=G.+S.+Martinauthor=R.+Wangauthor=M.+M.+Hsiaauthor=H.+Zhaoauthor=C.+Guoauthor=M.+Ellisauthor=J.+F.+Quinnauthor=O.+A.+Kharenkoauthor=K.+Norekauthor=E.+M.+Gesnerauthor=P.+R.+Youngauthor=K.+G.+McLureauthor=G.+S.+Wagnerauthor=D.+Lakshminarasimhanauthor=A.+Whiteauthor=R.+K.+Sutoauthor=H.+C.+Hansenauthor=D.+B.+Kitchen&title=Discovery+of+a+New+Chemical+Series+of+BRD4%281%29+Inhibitors+Using+Protein-Ligand+Docking+and+Structure-Guided+Design&doi=10.1016%2Fj.bmcl.2015.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DHsia%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DLakshminarasimhan%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DKitchen%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Chemical%2520Series%2520of%2520BRD4%25281%2529%2520Inhibitors%2520Using%2520Protein-Ligand%2520Docking%2520and%2520Structure-Guided%2520Design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2818%26epage%3D2823%26doi%3D10.1016%2Fj.bmcl.2015.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain-Damerell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess-Brown, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span> </span><span class="NLM_article-title">Assessing Cellular Efficacy of Bromodomain Inhibitors Using Fluorescence Recovery After Photobleaching</span> <span class="citation_source-journal">Epigenet. Chromatin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1186/1756-8935-7-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1186%2F1756-8935-7-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24393457" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1-12&author=M.+Philpottauthor=C.+M.+Rogersauthor=C.+Yappauthor=C.+Wellsauthor=J.-P.+Lambertauthor=C.+Strain-Damerellauthor=N.+A.+Burgess-Brownauthor=A.-C.+Gingrasauthor=S.+Knappauthor=S.+M%C3%BCller&title=Assessing+Cellular+Efficacy+of+Bromodomain+Inhibitors+Using+Fluorescence+Recovery+After+Photobleaching&doi=10.1186%2F1756-8935-7-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1186%2F1756-8935-7-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8935-7-14%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DJ.-P.%26aulast%3DStrain-Damerell%26aufirst%3DC.%26aulast%3DBurgess-Brown%26aufirst%3DN.%2BA.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26atitle%3DAssessing%2520Cellular%2520Efficacy%2520of%2520Bromodomain%2520Inhibitors%2520Using%2520Fluorescence%2520Recovery%2520After%2520Photobleaching%26jtitle%3DEpigenet.%2520Chromatin%26date%3D2014%26volume%3D7%26spage%3D1%26epage%3D12%26doi%3D10.1186%2F1756-8935-7-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Huang, H.-R.; Sims, R. J.,  III; Bellon, S. F.</span><span> </span><span class="NLM_article-title">Fusion Proteins and Methods for Identifying Bromodomain Inhibiting Compounds</span>. WO2014144303A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.-R.+Huang&author=R.+J.+Sims&author=S.+F.+Bellon&title=Fusion+Proteins+and+Methods+for+Identifying+Bromodomain+Inhibiting+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.-R.%26atitle%3DFusion%2520Proteins%2520and%2520Methods%2520for%2520Identifying%2520Bromodomain%2520Inhibiting%2520Compounds%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodroofe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwinn, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robers, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">NanoBRET—a Novel BRET Platform for the Analysis of Protein–Protein Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1797-1804&author=T.+Machleidtauthor=C.+C.+Woodroofeauthor=M.+K.+Schwinnauthor=J.+M%C3%A9ndezauthor=M.+B.+Robersauthor=K.+Zimmermanauthor=P.+Ottoauthor=D.+L.+Danielsauthor=T.+A.+Kirklandauthor=K.+V.+Wood&title=NanoBRET%E2%80%94a+Novel+BRET+Platform+for+the+Analysis+of+Protein%E2%80%93Protein+Interactions&doi=10.1021%2Facschembio.5b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions</span></div><div class="casAuthors">Machleidt, Thomas; Woodroofe, Carolyn C.; Schwinn, Marie K.; Mendez, Jacqui; Robers, Matthew B.; Zimmerman, Kris; Otto, Paul; Daniels, Danette L.; Kirkland, Thomas A.; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1797-1804</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dynamic interactions between proteins comprise a key mechanism for temporal control of cellular function and thus hold promise for development of novel drug therapies.  It remains tech. challenging, however, to quant. characterize these interactions within the biol. relevant context of living cells.  Although, bioluminescence resonance energy transfer (BRET) has often been used for this purpose, its general applicability has been hindered by limited sensitivity and dynamic range.  We have addressed this by combining an extremely bright luciferase (Nanoluc) with a means for tagging intracellular proteins with a long-wavelength fluorophore (HaloTag).  The small size (19 kDa), high emission intensity, and relatively narrow spectrum (460 nm peak intensity) make Nanoluc luciferase well suited as an energy donor.  By selecting an efficient red-emitting fluorophore (635 nm peak intensity) for attachment onto the HaloTag, an overall spectral sepn. exceeding 175 nm was achieved.  This combination of greater light intensity with improved spectral resoln. results in substantially increased detection sensitivity and dynamic range over current BRET technologies.  Enhanced performance is demonstrated using several established model systems, as well as the ability to image BRET in individual cells.  The capabilities are further exhibited in a novel assay developed for analyzing the interactions of bromodomain proteins with chromatin in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-h9HlReNabVg90H21EOLACvtfcHk0lhgun0nuzhfxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKkt7c%253D&md5=9f5f773b6cd14c40074a2ffbd6472008</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DSchwinn%26aufirst%3DM.%2BK.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DNanoBRET%25E2%2580%2594a%2520Novel%2520BRET%2520Platform%2520for%2520the%2520Analysis%2520of%2520Protein%25E2%2580%2593Protein%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1797%26epage%3D1804%26doi%3D10.1021%2Facschembio.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiske, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Montalvan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, B.</span><span> </span><span class="NLM_article-title">Cell-Based Protein Stabilization Assays for the Detection of Interactions Between Small-Molecule Inhibitors and BRD4</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1177/1087057114552398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1177%2F1087057114552398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25266565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=180-189&author=J.+Schulzeauthor=D.+Moosmayerauthor=J.+Weiskeauthor=A.+Fernandez-Montalvanauthor=C.+Herbstauthor=M.+Jungauthor=B.+Haendlerauthor=B.+Bader&title=Cell-Based+Protein+Stabilization+Assays+for+the+Detection+of+Interactions+Between+Small-Molecule+Inhibitors+and+BRD4&doi=10.1177%2F1087057114552398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4</span></div><div class="casAuthors">Schulze, Jessica; Moosmayer, Dieter; Weiske, Joerg; Fernandez-Montalvan, Amaury; Herbst, Christopher; Jung, Marie; Haendler, Bernard; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-189/1-180-189/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4), a member of the bromodomain and extra-terminal (BET) protein family, acts as a central element in transcriptional elongation and plays essential roles in cell proliferation.  Inhibition of BRD4 binding to acetylated histone tails via its two bromodomains, BD1 and BD2, with small-mol. inhibitors has been shown to be a valid strategy to prevent cancer growth.  We have evaluated and established two novel assays that quantify the interaction of transfected BRD4 BD1 with chem. inhibitors inside cultured cells.  Both methods are based on the principle of ligand-induced protein stabilization by which the binding of a small-mol. inhibitor stabilizes intracellular BRD4 BD1 and protects it from proteolytic degrdn.  We demonstrate the universal character of this principle by using two orthogonal, highly sensitive detection technologies for the quantification of BRD4 BD1 levels in cellular lysates: enzyme fragment complementation and time-resolved fluorescence resonance energy transfer (TR-FRET).  Upon optimization of both assays to a miniaturized high-throughput format, the methods were validated by testing a set of small-mol. BET inhibitors and comparing the results with those from a cell-free binding assay and a biophys. thermal shift assay.  In addn., point mutations were introduced into BRD4 BD1, and the corresponding mutants were characterized in the TR-FRET stabilization assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzgkcUeBYVbVg90H21EOLACvtfcHk0lhgun0nuzhfxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWrurY%253D&md5=283b113f600aa455b6859ef21b7515c1</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1177%2F1087057114552398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114552398%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DHaendler%26aufirst%3DB.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DCell-Based%2520Protein%2520Stabilization%2520Assays%2520for%2520the%2520Detection%2520of%2520Interactions%2520Between%2520Small-Molecule%2520Inhibitors%2520and%2520BRD4%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2015%26volume%3D20%26spage%3D180%26epage%3D189%26doi%3D10.1177%2F1087057114552398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Raab, W.; Wehrman, T. S.</span><span> </span><span class="NLM_article-title">Detection of Intracellular Binding Events by Measuring Protein Abundance</span>. US20130203067A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=W.+Raab&author=T.+S.+Wehrman&title=Detection+of+Intracellular+Binding+Events+by+Measuring+Protein+Abundance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DW.%26atitle%3DDetection%2520of%2520Intracellular%2520Binding%2520Events%2520by%2520Measuring%2520Protein%2520Abundance%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser-Doepner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimshaw, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mader, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Fahrnow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Hagan, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuercher, W. J.</span><span> </span><span class="NLM_article-title">The Promise and Peril of Chemical Probes</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%27Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=B.+Rothauthor=R.+Rossauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+Promise+and+Peril+of+Chemical+Probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lgEskMPR7cU4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%2527Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520Promise%2520and%2520Peril%2520of%2520Chemical%2520Probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Arnold, L. D.; Foreman, K. W.; Werner, D. S.</span><span> </span><span class="NLM_article-title">Bivalent Bromodomain Ligands, and Methods of Using Same</span>. WO2013033268A2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+D.+Arnold&author=K.+W.+Foreman&author=D.+S.+Werner&title=Bivalent+Bromodomain+Ligands%2C+and+Methods+of+Using+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DBivalent%2520Bromodomain%2520Ligands%252C%2520and%2520Methods%2520of%2520Using%2520Same%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Arnold, L. D.; Foreman, K. W.; Jin, M.; Wanner, J.; Werner, D. S.</span><span> </span><span class="NLM_article-title">Bromodomain Ligands Capable of Dimerizing in an Aqueous Solution</span>. WO2015081280A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+D.+Arnold&author=K.+W.+Foreman&author=M.+Jin&author=J.+Wanner&author=D.+S.+Werner&title=Bromodomain+Ligands+Capable+of+Dimerizing+in+an+Aqueous+Solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DBromodomain%2520Ligands%2520Capable%2520of%2520Dimerizing%2520in%2520an%2520Aqueous%2520Solution%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+Ubiquitin+Ligase+Cereblon+to+Efficiently+Target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0ljxMQGbuEf4YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520Ubiquitin%2520Ligase%2520Cereblon%2520to%2520Efficiently%2520Target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a Primary Target of Thalidomide Teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+Primary+Target+of+Thalidomide+Teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0ljxMQGbuEf4YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Primary%2520Target%2520of%2520Thalidomide%2520Teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Phthalimide Conjugation as a Strategy for in Vivo Target Protein Degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=Phthalimide+Conjugation+as+a+Strategy+for+in+Vivo+Target+Protein+Degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0lheuKy7G4mSaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DPhthalimide%2520Conjugation%2520as%2520a%2520Strategy%2520for%2520in%2520Vivo%2520Target%2520Protein%2520Degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&author=M.+Zengerleauthor=K.-H.+Chanauthor=A.+Ciulli&title=Selective+Small+Molecule+Induced+Degradation+of+the+BET+Bromodomain+Protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1α.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0lheuKy7G4mSaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520Small%2520Molecule%2520Induced%2520Degradation%2520of%2520the%2520BET%2520Bromodomain%2520Protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Baud, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Shiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardote, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pschibul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, T. T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">A Bump-and-Hole Approach to Engineer Controlled Selectivity of BET Bromodomain Chemical Probes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1126/science.1249830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1249830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25323695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=638-641&author=M.+G.+J.+Baudauthor=E.+Lin-Shiaoauthor=T.+Cardoteauthor=C.+Tallantauthor=A.+Pschibulauthor=K.-H.+Chanauthor=M.+Zengerleauthor=J.+R.+Garciaauthor=T.+T.+L.+Kwanauthor=F.+M.+Fergusonauthor=A.+Ciulli&title=A+Bump-and-Hole+Approach+to+Engineer+Controlled+Selectivity+of+BET+Bromodomain+Chemical+Probes&doi=10.1126%2Fscience.1249830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span></div><div class="casAuthors">Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T.-L.; Ferguson, Fleur M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6209</span>),
    <span class="NLM_cas:pages">638-641</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. are useful tools for probing the biol. function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins.  The bromodomain and extra-terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer.  The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-mol. inhibitors, but these inhibitors lack selectivity for individual family members.  We developed an Et deriv. of an existing small-mol. inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains.  Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin.  Expansion of this approach could help identify the individual roles of single BET proteins in human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EnzLtvUKwbVg90H21EOLACvtfcHk0lgkW0DwbS2WmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL&md5=04fe967e4681fb4b2b3168f4d5f8ff81</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249830%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DLin-Shiao%26aufirst%3DE.%26aulast%3DCardote%26aufirst%3DT.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPschibul%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DJ.%2BR.%26aulast%3DKwan%26aufirst%3DT.%2BT.%2BL.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DA%2520Bump-and-Hole%2520Approach%2520to%2520Engineer%2520Controlled%2520Selectivity%2520of%2520BET%2520Bromodomain%2520Chemical%2520Probes%26jtitle%3DScience%26date%3D2014%26volume%3D346%26spage%3D638%26epage%3D641%26doi%3D10.1126%2Fscience.1249830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Hett, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piatnitski Chekler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletcher, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Direct Photocapture of Bromodomains Using Tropolone Chemical Probes</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1039/C5MD00070J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC5MD00070J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1018-1023&author=E.+C.+Hettauthor=E.+L.+Piatnitski+Cheklerauthor=A.+Basakauthor=P.+D.+Boninauthor=R.+A.+Dennyauthor=A.+C.+Flickauthor=K.+F.+Geogheganauthor=S.+Liuauthor=M.+T.+Pletcherauthor=P.+Sahasrabudheauthor=S.+C.+Salterauthor=I.+A.+Stockauthor=A.+P.+Taylorauthor=L.+H.+Jones&title=Direct+Photocapture+of+Bromodomains+Using+Tropolone+Chemical+Probes&doi=10.1039%2FC5MD00070J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1039%2FC5MD00070J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00070J%26sid%3Dliteratum%253Aachs%26aulast%3DHett%26aufirst%3DE.%2BC.%26aulast%3DPiatnitski%2BChekler%26aufirst%3DE.%2BL.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DFlick%26aufirst%3DA.%2BC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPletcher%26aufirst%3DM.%2BT.%26aulast%3DSahasrabudhe%26aufirst%3DP.%26aulast%3DSalter%26aufirst%3DS.%2BC.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BP.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520Photocapture%2520of%2520Bromodomains%2520Using%2520Tropolone%2520Chemical%2520Probes%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1018%26epage%3D1023%26doi%3D10.1039%2FC5MD00070J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Anders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenther, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovén, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigova, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span> </span><span class="NLM_article-title">Genome-Wide Localization of Small Molecules</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1038/nbt.2776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnbt.2776" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=92-96&author=L.+Andersauthor=M.+G.+Guentherauthor=J.+Qiauthor=Z.+P.+Fanauthor=J.+J.+Marineauauthor=P.+B.+Rahlauthor=J.+Lov%C3%A9nauthor=A.+A.+Sigovaauthor=W.+B.+Smithauthor=T.+I.+Leeauthor=J.+E.+Bradnerauthor=R.+A.+Young&title=Genome-Wide+Localization+of+Small+Molecules&doi=10.1038%2Fnbt.2776"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2776%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DL.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%2BP.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DLov%25C3%25A9n%26aufirst%3DJ.%26aulast%3DSigova%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DLee%26aufirst%3DT.%2BI.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26atitle%3DGenome-Wide%2520Localization%2520of%2520Small%2520Molecules%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D32%26spage%3D92%26epage%3D96%26doi%3D10.1038%2Fnbt.2776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devaraj, S. G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portier, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span> </span><span class="NLM_article-title">BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F1535-7163.MCT-14-0258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25053825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yisb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2315-2327&author=W.+Fiskusauthor=S.+Sharmaauthor=J.+Qiauthor=B.+Shahauthor=S.+G.+T.+Devarajauthor=C.+Levequeauthor=B.+P.+Portierauthor=S.+Iyerauthor=J.+E.+Bradnerauthor=K.+N.+Bhalla&title=BET+Protein+Antagonist+JQ1+Is+Synergistically+Lethal+with+FLT3+Tyrosine+Kinase+Inhibitor+%28TKI%29+and+Overcomes+Resistance+to+FLT3-TKI+in+AML+Cells+Expressing+FLT-ITD&doi=10.1158%2F1535-7163.MCT-14-0258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD</span></div><div class="casAuthors">Fiskus, Warren; Sharma, Sunil; Qi, Jun; Shah, Bhavin; Devaraj, Santhana G. T.; Leveque, Christopher; Portier, Bryce P.; Iyer, Swaminathan; Bradner, James E.; Bhalla, Kapil N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2315-2327</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recently, treatment with bromodomain and extraterminal protein antagonist (BA) such as JQ1 has been shown to inhibit growth and induce apoptosis of human acute myelogenous leukemia (AML) cells, including those expressing FLT3-ITD.  Here, we demonstrate that cotreatment with JQ1 and the FLT3 tyrosine kinase inhibitor (TKI) ponatinib or AC220 synergistically induce apoptosis of cultured and primary CD34+ human AML blast progenitor cells (BPC) expressing FLT3-ITD.  Concomitantly, as compared with each agent alone, cotreatment with JQ1 and the FLT3-TKI caused greater attenuation of c-MYC, BCL2, and CDK4/6.  Simultaneously, cotreatment with JQ1 and the FLT3-TKI increased the levels of p21, BIM, and cleaved PARP, as well as mediated marked attenuation of p-STAT5, p-AKT, and p-ERK1/2 levels in AML BPCs.  Conversely, cotreatment with JQ1 and FLT3-TKI was significantly less active against CD34+ normal bone marrow progenitor cells.  Knockdown of BRD4 by short hairpin RNA also sensitized AML cells to FLT3-TKI.  JQ1 treatment induced apoptosis of mouse Ba/F3 cells ectopically expressing FLT3-ITD with or without FLT3-TKI-resistant mutations F691L and D835V.  Compared with the parental human AML FLT3-ITD-expressing MOLM13, MOLM13-TKIR cells resistant to AC220 were markedly more sensitive to JQ1-induced apoptosis.  Furthermore, cotreatment with JQ1 and the pan-histone deacetylase inhibitor (HDI) panobinostat synergistically induced apoptosis of FLT3-TKI-resistant MOLM13-TKIR and MV4-11-TKIR cells.  Collectively, these findings support the rationale for detg. the in vivo activity of combined therapy with BA and FLT3-TKI against human AML cells expressing FLT3-ITD or with BA and HDI against AML cells resistant to FLT3-TKI.  Mol Cancer Ther; 13(10); 2315-27. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PTZkTs8dmLVg90H21EOLACvtfcHk0ligkkqAGBwV0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yisb%252FI&md5=86b07b19b740ed314bd042a472507766</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0258%26sid%3Dliteratum%253Aachs%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DB.%26aulast%3DDevaraj%26aufirst%3DS.%2BG.%2BT.%26aulast%3DLeveque%26aufirst%3DC.%26aulast%3DPortier%26aufirst%3DB.%2BP.%26aulast%3DIyer%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DBET%2520Protein%2520Antagonist%2520JQ1%2520Is%2520Synergistically%2520Lethal%2520with%2520FLT3%2520Tyrosine%2520Kinase%2520Inhibitor%2520%2528TKI%2529%2520and%2520Overcomes%2520Resistance%2520to%2520FLT3-TKI%2520in%2520AML%2520Cells%2520Expressing%2520FLT-ITD%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2315%26epage%3D2327%26doi%3D10.1158%2F1535-7163.MCT-14-0258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Stratikopoulos, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dendy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabolcs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaykin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1016/j.ccell.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.ccell.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26058079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVejurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=837-851&author=E.+E.+Stratikopoulosauthor=M.+Dendyauthor=M.+Szabolcsauthor=A.+J.+Khaykinauthor=C.+Lefebvreauthor=M.-M.+Zhouauthor=R.+Parsons&title=Kinase+and+BET+Inhibitors+Together+Clamp+Inhibition+of+PI3K+Signaling+and+Overcome+Resistance+to+Therapy&doi=10.1016%2Fj.ccell.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy</span></div><div class="casAuthors">Stratikopoulos, Elias E.; Dendy, Meaghan; Szabolcs, Matthias; Khaykin, Alan J.; Lefebvre, Celine; Zhou, Ming-Ming; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-851</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Unsustained enzyme inhibition is a barrier to targeted therapy for cancer.  Here, resistance to a class I PI3K inhibitor in a model of metastatic breast cancer driven by PI3K and MYC was assocd. with feedback activation of tyrosine kinase receptors (RTKs), AKT, mTOR, and MYC.  Inhibitors of bromodomain and extra terminal domain (BET) proteins also failed to affect tumor growth.  Interestingly, BET inhibitors lowered PI3K signaling and dissocd. BRD4 from chromatin at regulatory regions of insulin receptor and EGFR family RTKs to reduce their expression.  Combined PI3K and BET inhibition induced cell death, tumor regression, and clamped inhibition of PI3K signaling in a broad range of tumor cell lines to provide a strategy to overcome resistance to kinase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmdX2xaXkHjbVg90H21EOLACvtfcHk0ligkkqAGBwV0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVejurbK&md5=91cca562c9bff9e11e94535916583867</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DStratikopoulos%26aufirst%3DE.%2BE.%26aulast%3DDendy%26aufirst%3DM.%26aulast%3DSzabolcs%26aufirst%3DM.%26aulast%3DKhaykin%26aufirst%3DA.%2BJ.%26aulast%3DLefebvre%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DM.-M.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DKinase%2520and%2520BET%2520Inhibitors%2520Together%2520Clamp%2520Inhibition%2520of%2520PI3K%2520Signaling%2520and%2520Overcome%2520Resistance%2520to%2520Therapy%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D837%26epage%3D851%26doi%3D10.1016%2Fj.ccell.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälth Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/cb400789e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400789e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-502&author=A.+Dittmannauthor=T.+Wernerauthor=C.-W.+Chungauthor=M.+M.+Savitskiauthor=M.+F%C3%A4lth+Savitskiauthor=P.+Grandiauthor=C.+Hopfauthor=M.+Lindonauthor=G.+Neubauerauthor=R.+K.+Prinjhaauthor=M.+Bantscheffauthor=G.+Drewes&title=The+Commonly+Used+PI3-Kinase+Probe+LY294002+Is+an+Inhibitor+of+BET+Bromodomains&doi=10.1021%2Fcb400789e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span></div><div class="casAuthors">Dittmann, Antje; Werner, Thilo; Chung, Chun-Wa; Savitski, Mikhail M.; Faelth Savitski, Maria; Grandi, Paola; Hopf, Carsten; Lindon, Matthew; Neubauer, Gitte; Prinjha, Rabinder K.; Bantscheff, Marcus; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A commonly used small-mol. probe in cell-signaling research is the phosphoinositide 3-kinase inhibitor LY294002.  Quant. chemoproteomic profiling shows that LY294002 and LY303511, a close analog devoid of PI3K activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that comprise a family of targets structurally unrelated to PI3K.  Both compds. competitively inhibit acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell exts.  X-ray crystallog. shows that the chromen-4-one scaffold represents a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the recently discovered BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIVXFQARTKLVg90H21EOLACvtfcHk0ligkkqAGBwV0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO&md5=13435c7d6a6747dc5699e3c3865c8243</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fcb400789e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400789e%26sid%3Dliteratum%253Aachs%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DF%25C3%25A4lth%2BSavitski%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DThe%2520Commonly%2520Used%2520PI3-Kinase%2520Probe%2520LY294002%2520Is%2520an%2520Inhibitor%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D502%26doi%3D10.1021%2Fcb400789e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Dual Kinase-Bromodomain Inhibitors for Rationally Designed Polypharmacology</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nchembio.1471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnchembio.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24584101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=305-312&author=P.+Ciceriauthor=S.+M%C3%BCllerauthor=A.+O%27Mahonyauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=J.+P.+Huntauthor=E.+A.+Lasaterauthor=G.+Pallaresauthor=S.+Picaudauthor=C.+Wellsauthor=S.+Martinauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=D.+K.+Treiberauthor=S.+Knapp&title=Dual+Kinase-Bromodomain+Inhibitors+for+Rationally+Designed+Polypharmacology&doi=10.1038%2Fnchembio.1471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span></div><div class="casAuthors">Ciceri, Pietro; Mueller, Susanne; O'Mahony, Alison; Fedorov, Oleg; Filippakopoulos, Panagis; Hunt, Jeremy P.; Lasater, Elisabeth A.; Pallares, Gabriel; Picaud, Sarah; Wells, Christopher; Martin, Sarah; Wodicka, Lisa M.; Shah, Neil P.; Treiber, Daniel K.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clin. responses to targeted therapies.  The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clin. development challenges.  Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy.  Here the authors report that several clin. kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors.  Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clin. PLK1 and JAK2-FLT3 kinase inhibitors, resp., is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacol. targeting.  Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPedDED4FJLVg90H21EOLACvtfcHk0liwwCJ__sHUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D&md5=a00117db2648ea38dd03750faf3b3cb9</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1471%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%2527Mahony%26aufirst%3DA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DDual%2520Kinase-Bromodomain%2520Inhibitors%2520for%2520Rationally%2520Designed%2520Polypharmacology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnchembio.1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanning, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fountain, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheenstra, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strovel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span> </span><span class="NLM_article-title">BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=764-769&author=L.+Chenauthor=J.+L.+Yapauthor=M.+Yoshiokaauthor=M.+E.+Lanningauthor=R.+N.+Fountainauthor=M.+Rajeauthor=J.+A.+Scheenstraauthor=J.+W.+Strovelauthor=S.+Fletcher&title=BRD4+Structure%E2%80%93Activity+Relationships+of+Dual+PLK1+Kinase%2FBRD4+Bromodomain+Inhibitor+BI-2536&doi=10.1021%2Facsmedchemlett.5b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span></div><div class="casAuthors">Chen, Lijia; Yap, Jeremy L.; Yoshioka, Makoto; Lanning, Maryanna E.; Fountain, Rachel N.; Raje, Mithun; Scheenstra, Jacob A.; Strovel, Jeffrey W.; Fletcher, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A focused library of analogs of the dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536 was prepd. and then analyzed for BRD4 and PLK1 inhibitory activities.  Particularly, replacement of the cyclopentyl group with a 3-bromobenzyl moiety afforded the most potent BRD4 inhibitor of the series (39j) with a Ki = 8.7 nM, which was equipotent against PLK1.  The superior affinity of 39j over the parental compd. to BRD4 possibly derives from improved interactions with the WPF shelf.  Meanwhile, substitution of the pyrimidine NH with an oxygen atom reversed the PLK1/BRD4 selectivity to convert BI-2536 into a BRD4-selective inhibitor, likely owing to the loss of a crit. hydrogen bond in PLK1.  We believe further fine-tuning will furnish a BRD4 "magic bullet" or an even more potent PLK1/BRD4 dual inhibitor toward the expansion and improved efficacy of the chemotherapy arsenal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UnNSmf1L17Vg90H21EOLACvtfcHk0liwwCJ__sHUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D&md5=f39070e652bca20c03a3bc5fe070a7fc</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYap%26aufirst%3DJ.%2BL.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DLanning%26aufirst%3DM.%2BE.%26aulast%3DFountain%26aufirst%3DR.%2BN.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DScheenstra%26aufirst%3DJ.%2BA.%26aulast%3DStrovel%26aufirst%3DJ.%2BW.%26aulast%3DFletcher%26aufirst%3DS.%26atitle%3DBRD4%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Dual%2520PLK1%2520Kinase%252FBRD4%2520Bromodomain%2520Inhibitor%2520BI-2536%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D764%26epage%3D769%26doi%3D10.1021%2Facsmedchemlett.5b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">The Mechanisms Behind the Therapeutic Activity of BET Bromodomain Inhibition</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1016/j.molcel.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.molcel.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24905006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=728-736&author=J.+Shiauthor=C.+R.+Vakoc&title=The+Mechanisms+Behind+the+Therapeutic+Activity+of+BET+Bromodomain+Inhibition&doi=10.1016%2Fj.molcel.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition</span></div><div class="casAuthors">Shi, Junwei; Vakoc, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">728-736</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The bromodomain and extraterminal (BET) protein Brd4 recruits transcriptional regulatory complexes to acetylated chromatin.  While Brd4 is considered to be a general transcriptional regulator, pharmacol. inhibition of BET proteins shows therapeutic activity in a variety of different pathologies, particularly in models of cancer and inflammation.  Such effects have been attributed to a specific set of downstream target genes whose expression is disproportionately sensitive to pharmacol. targeting of BET proteins.  Emerging evidence links the transcriptional consequences of BET inhibition to the assocn. of Brd4 with enhancer elements, which tend to be involved in lineage-specific gene regulation.  Furthermore, Brd4 engages in direct regulatory interactions with several DNA-binding transcription factors to influence their disease-relevant functions.  Here we review the current understanding of mol. mechanisms that underlie the promising therapeutic effects of BET bromodomain inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJpSFRzwcR1rVg90H21EOLACvtfcHk0liwwCJ__sHUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCrtrk%253D&md5=f49bf3524ec378576fb1a25c64a464ae</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Mechanisms%2520Behind%2520the%2520Therapeutic%2520Activity%2520of%2520BET%2520Bromodomain%2520Inhibition%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D728%26epage%3D736%26doi%3D10.1016%2Fj.molcel.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Baratta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhayay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman-Colin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapkin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span> </span><span class="NLM_article-title">An in-Tumor Genetic Screen Reveals That the BET Bromodomain Protein, BRD4, Is a Potential Therapeutic Target in Ovarian Carcinoma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1073/pnas.1422165112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1422165112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=232-237&author=M.+G.+Barattaauthor=A.+C.+Schinzelauthor=Y.+Zwangauthor=P.+Bandopadhayayauthor=C.+Bowman-Colinauthor=J.+Kuttauthor=J.+Curtisauthor=H.+Piaoauthor=L.+C.+Wongauthor=A.+L.+Kungauthor=R.+Beroukhimauthor=J.+E.+Bradnerauthor=R.+Drapkinauthor=W.+C.+Hahnauthor=J.+F.+Liuauthor=D.+M.+Livingston&title=An+in-Tumor+Genetic+Screen+Reveals+That+the+BET+Bromodomain+Protein%2C+BRD4%2C+Is+a+Potential+Therapeutic+Target+in+Ovarian+Carcinoma&doi=10.1073%2Fpnas.1422165112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422165112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422165112%26sid%3Dliteratum%253Aachs%26aulast%3DBaratta%26aufirst%3DM.%2BG.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBowman-Colin%26aufirst%3DC.%26aulast%3DKutt%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DJ.%26aulast%3DPiao%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DL.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520in-Tumor%2520Genetic%2520Screen%2520Reveals%2520That%2520the%2520BET%2520Bromodomain%2520Protein%252C%2520BRD4%252C%2520Is%2520a%2520Potential%2520Therapeutic%2520Target%2520in%2520Ovarian%2520Carcinoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D232%26epage%3D237%26doi%3D10.1073%2Fpnas.1422165112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dommeti, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escara-Wilke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder-Romans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanireddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1038/nature13229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature13229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24759320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=278-282&author=I.+A.+Asanganiauthor=V.+L.+Dommetiauthor=X.+Wangauthor=R.+Malikauthor=M.+Cieslikauthor=R.+Yangauthor=J.+Escara-Wilkeauthor=K.+Wilder-Romansauthor=S.+Dhanireddyauthor=C.+Engelkeauthor=M.+K.+Iyerauthor=X.+Jingauthor=Y.-M.+Wuauthor=X.+Caoauthor=Z.+S.+Qinauthor=S.+Wangauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Therapeutic+Targeting+of+BET+Bromodomain+Proteins+in+Castration-Resistant+Prostate+Cancer&doi=10.1038%2Fnature13229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span></div><div class="casAuthors">Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7504</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the disease.  Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated androgen receptor (AR) signaling.  Despite the success of recently approved therapies targeting AR signaling, such as abiraterone and second-generation anti-androgens including MDV3100 (also known as enzalutamide), durable responses are limited, presumably owing to acquired resistance.  Recently, JQ1 and I-BET762 two selective small-mol. inhibitors that target the N-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies.  AR-signaling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition.  BRD4 phys. interacts with the N-terminal domain of AR and can be disrupted by JQ1 (refs 11, 13).  Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci.  By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity.  In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models.  Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfXutywHDWrVg90H21EOLACvtfcHk0liD92brZy8VwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D&md5=bef4b5faf5d23dc7d125ab1941c3ee39</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1038%2Fnature13229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13229%26sid%3Dliteratum%253Aachs%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DDommeti%26aufirst%3DV.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DCieslik%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DEscara-Wilke%26aufirst%3DJ.%26aulast%3DWilder-Romans%26aufirst%3DK.%26aulast%3DDhanireddy%26aufirst%3DS.%26aulast%3DEngelke%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DM.%2BK.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.-M.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DZ.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DTherapeutic%2520Targeting%2520of%2520BET%2520Bromodomain%2520Proteins%2520in%2520Castration-Resistant%2520Prostate%2520Cancer%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D278%26epage%3D282%26doi%3D10.1038%2Fnature13229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Patel, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, L. Q.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors Through Bim Induction</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.celrep.2013.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24373973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVeq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=81-92&author=A.+J.+Patelauthor=C.-P.+Liaoauthor=Z.+Chenauthor=C.+Liuauthor=Y.+Wangauthor=L.+Q.+Le&title=BET+Bromodomain+Inhibition+Triggers+Apoptosis+of+NF1-Associated+Malignant+Peripheral+Nerve+Sheath+Tumors+Through+Bim+Induction&doi=10.1016%2Fj.celrep.2013.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors through Bim Induction</span></div><div class="casAuthors">Patel, Amish J.; Liao, Chung-Ping; Chen, Zhiguo; Liu, Chiachi; Wang, Yong; Le, Lu Q.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive sarcomas that develop sporadically or in neurofibromatosis type 1 (NF1) patients.  There is no effective treatment for MPNSTs and they are typically fatal.  To gain insights into MPNST pathogenesis, we utilized an MPNST mouse model that allowed us to study the evolution of these tumors at the transcriptome level.  Strikingly, in MPNSTs we found upregulation of a chromatin regulator, Brd4, and show that BRD4 inhibition profoundly suppresses both growth and tumorigenesis.  Our findings reveal roles for BET bromodomains in MPNST development and report a mechanism by which bromodomain inhibition induces apoptosis through induction of proapoptotic Bim, which may represent a paradigm shift in therapy for MPNST patients.  Moreover, these findings indicate epigenetic mechanisms underlying the balance of anti- and proapoptotic mols. and that bromodomain inhibition can shift this balance in favor of cancer cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrH__HnSCqpbVg90H21EOLACvtfcHk0liD92brZy8VwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVeq&md5=dc562b77ccd57d9ff9ad7c4ac8a6133c</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BJ.%26aulast%3DLiao%26aufirst%3DC.-P.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLe%26aufirst%3DL.%2BQ.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Triggers%2520Apoptosis%2520of%2520NF1-Associated%2520Malignant%2520Peripheral%2520Nerve%2520Sheath%2520Tumors%2520Through%2520Bim%2520Induction%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D6%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.celrep.2013.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Gopalakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triche, T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, P. M.</span><span> </span><span class="NLM_article-title">Immunomodulatory Drugs Target IKZF1-IRF4-MYC Axis in Primary Effusion Lymphoma in a Cereblon-Dependent Manner and Display Synergistic Cytotoxicity with BRD4 Inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1038/onc.2015.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fonc.2015.245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1-14&author=R.+Gopalakrishnanauthor=H.+Mattaauthor=B.+Tolaniauthor=T.+Tricheauthor=P.+M.+Chaudhary&title=Immunomodulatory+Drugs+Target+IKZF1-IRF4-MYC+Axis+in+Primary+Effusion+Lymphoma+in+a+Cereblon-Dependent+Manner+and+Display+Synergistic+Cytotoxicity+with+BRD4+Inhibitors&doi=10.1038%2Fonc.2015.245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.245%26sid%3Dliteratum%253Aachs%26aulast%3DGopalakrishnan%26aufirst%3DR.%26aulast%3DMatta%26aufirst%3DH.%26aulast%3DTolani%26aufirst%3DB.%26aulast%3DTriche%26aufirst%3DT.%26aulast%3DChaudhary%26aufirst%3DP.%2BM.%26atitle%3DImmunomodulatory%2520Drugs%2520Target%2520IKZF1-IRF4-MYC%2520Axis%2520in%2520Primary%2520Effusion%2520Lymphoma%2520in%2520a%2520Cereblon-Dependent%2520Manner%2520and%2520Display%2520Synergistic%2520Cytotoxicity%2520with%2520BRD4%2520Inhibitors%26jtitle%3DOncogene%26date%3D2015%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fonc.2015.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Said, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeffler, H. P.</span><span> </span><span class="NLM_article-title">Synergistic Effect of JQ1 and Rapamycin for Treatment of Human Osteosarcoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2064</span><span class="refDoi"> DOI: 10.1002/ijc.29269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fijc.29269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25307878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislegt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=2055-2064&author=D.+H.+Leeauthor=J.+Qiauthor=J.+E.+Bradnerauthor=J.+W.+Saidauthor=N.+B.+Doanauthor=C.+Forscherauthor=H.+Yangauthor=H.+P.+Koeffler&title=Synergistic+Effect+of+JQ1+and+Rapamycin+for+Treatment+of+Human+Osteosarcoma&doi=10.1002%2Fijc.29269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma</span></div><div class="casAuthors">Lee, Dhong Hyun; Qi, Jun; Bradner, James E.; Said, Jonathan W.; Doan, Ngan B.; Forscher, Charles; Yang, Henry; Koeffler, H. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2055-2064</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal domain (BET) proteins are important epigenetic regulators facilitating the transcription of genes in chromatin areas linked to acetylated histones.  JQ1, a BET protein inhibitor, has antiproliferative activity against many cancers, mainly through inhibition of c-MYC and upregulation of p21.  In this research, we investigated the use of JQ1 for human osteosarcoma (OS) treatment.  JQ1 significantly inhibited the proliferation and survival of OS cells inducing G1 cell cycle arrest, premature senescence, but little effect on apoptosis.  Interestingly, c-MYC protein levels in JQ1-treated cells remained unchanged, whereas the upregulation of p21 protein was still observable.  Although effective in vitro, JQ1 alone failed to reduce the size of the MNNG/HOS xenografts in immunocompromised mice.  To overcome the resistance of OS cells to JQ1 treatment, we combined JQ1 with rapamycin, an mammalian target of rapamycin (mTOR) inhibitor.  JQ1 and rapamycin synergistically inhibited the growth and survival of OS cells in vitro and in vivo.  We also identified that RUNX2 is a direct target of bromodomain-contg. protein 4 (BRD4) inhibition by JQ1 in OS cells.  Chromatin immunopptn. (ChIP) showed that enrichment of BRD4 protein around RUNX2 transcription start sites diminished with JQ1 treatment in MNNG/HOS cells.  Overexpression of RUNX2 protected JQ1-sensitive OS cells from the effect of JQ1, and siRNA-mediated inhibition of RUNX2 sensitized the same cells to JQ1.  In conclusion, our findings suggest that JQ1, in combination with rapamycin, is an effective chemotherapeutic option for OS treatment.  We also show that inhibition of RUNX2 expression by JQ1 partly explains the antiproliferative activity of JQ1 in OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0-M1_Sb11LVg90H21EOLACvtfcHk0lgQezR_7BmgKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislegt70%253D&md5=71971e482ce634ae9de6047e94557460</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1002%2Fijc.29269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29269%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSaid%26aufirst%3DJ.%2BW.%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DForscher%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DKoeffler%26aufirst%3DH.%2BP.%26atitle%3DSynergistic%2520Effect%2520of%2520JQ1%2520and%2520Rapamycin%2520for%2520Treatment%2520of%2520Human%2520Osteosarcoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3D2055%26epage%3D2064%26doi%3D10.1002%2Fijc.29269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiha, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, A. L.</span><span> </span><span class="NLM_article-title">Reactivation of Latent HIV-1 by Inhibition of BRD4</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.celrep.2012.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23041316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=807-816&author=J.+Zhuauthor=G.+D.+Gaihaauthor=S.+P.+Johnauthor=T.+Pertelauthor=C.+R.+Chinauthor=G.+Gaoauthor=H.+Quauthor=B.+D.+Walkerauthor=S.+J.+Elledgeauthor=A.+L.+Brass&title=Reactivation+of+Latent+HIV-1+by+Inhibition+of+BRD4&doi=10.1016%2Fj.celrep.2012.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV-1 by inhibition of BRD4</span></div><div class="casAuthors">Zhu, Jian; Gaiha, Gaurav D.; John, Sinu P.; Pertel, Thomas; Chin, Christopher R.; Gao, Geng; Qu, Hongjing; Walker, Bruce D.; Elledge, Stephen J.; Brass, Abraham L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-816</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIV-1 depends on many host factors for propagation.  Other host factors, however, antagonize HIV-1 and may have profound effects on viral activation.  Curing HIV-1 requires the redn. of latent viral reservoirs that remain in the face of antiretroviral therapy.  Using orthologous genetic screens, we identified bromodomain contg. 4 (BRD4) as a neg. regulator of HIV-1 replication.  Antagonism of BRD4, via RNA interference or with a small mol. inhibitor, JQ1, both increased proviral transcriptional elongation and alleviated HIV-1 latency in cell-line models.  In multiple instances, JQ1, when used in combination with the NF-κB activators Prostratin or PHA, enhanced the in vitro reactivation of latent HIV-1 in primary T cells.  These data are consistent with a model wherein BRD4 competes with the virus for HIV-1 dependency factors (HDFs) and suggests that combinatorial therapies that activate HDFs and antagonize HIV-1 competitive factors may be useful for curing HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosSPB0bZraJbVg90H21EOLACvtfcHk0lgQezR_7BmgKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls73E&md5=210b459b66ccf10a84c57ef10b03b684</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGaiha%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DS.%2BP.%26aulast%3DPertel%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DC.%2BR.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DBrass%26aufirst%3DA.%2BL.%26atitle%3DReactivation%2520of%2520Latent%2520HIV-1%2520by%2520Inhibition%2520of%2520BRD4%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D807%26epage%3D816%26doi%3D10.1016%2Fj.celrep.2012.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Gauson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornan, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodily, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, I. M.</span><span> </span><span class="NLM_article-title">Evidence Supporting a Role for TopBP1 and Brd4 in the Initiation but Not Continuation of Human Papillomavirus 16 E1/E2-Mediated DNA Replication</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">4980</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span><span class="refDoi"> DOI: 10.1128/JVI.00335-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FJVI.00335-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25694599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=4980-4991&author=E.+J.+Gausonauthor=M.+M.+Donaldsonauthor=E.+S.+Dornanauthor=X.+Wangauthor=M.+Bristolauthor=J.+M.+Bodilyauthor=I.+M.+Morgan&title=Evidence+Supporting+a+Role+for+TopBP1+and+Brd4+in+the+Initiation+but+Not+Continuation+of+Human+Papillomavirus+16+E1%2FE2-Mediated+DNA+Replication&doi=10.1128%2FJVI.00335-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication</span></div><div class="casAuthors">Gauson, Elaine J.; Donaldson, Mary M.; Dornan, Edward S.; Wang, Xu; Bristol, Molly; Bodily, Jason M.; Morgan, Iain M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4980-4991</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To replicate the double-stranded human papillomavirus 16 (HPV16) DNA genome, viral proteins E1 and E2 assoc. with the viral origin of replication, and E2 can also regulate transcription from adjacent promoters.  E2 interacts with host proteins in order to regulate both transcription and replication; TopBP1 and Brd4 are cellular proteins that interact with HPV16 E2.  Previous work with E2 mutants demonstrated the Brd4 requirement for the transactivation properties of E2, while TopBP1 is required for DNA replication induced by E2 from the viral origin of replication in assocn. with E1.  More-recent studies have also implicated Brd4 in the regulation of DNA replication by E2 and E1.  Here, we demonstrate that both TopBP1 and Brd4 are present at the viral origin of replication and that interaction with E2 is required for optimal initiation of DNA replication.  Both cellular proteins are present in E1-E2-contg. nuclear foci, and the viral origin of replication is required for the efficient formation of these foci.  Short hairpin RNA (shRNA) against either TopBP1 or Brd4 destroys the E1-E2 nuclear bodies but has no effect on E1-E2-mediated levels of DNA replication.  An E2 mutation in the context of the complete HPV16 genome that compromises Brd4 interaction fails to efficiently establish episomes in primary human keratinocytes.  Overall, the results suggest that interactions between TopBP1 and E2 and between Brd4 and E2 are required to correctly initiate DNA replication but are not required for continuing DNA replication, which may be mediated by alternative processes such as rolling circle amplification and/or homologous recombination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCkgSOghorU7Vg90H21EOLACvtfcHk0lgQezR_7BmgKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOns7Y%253D&md5=c98203d833f5b29e2a2c7d3d76361236</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1128%2FJVI.00335-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00335-15%26sid%3Dliteratum%253Aachs%26aulast%3DGauson%26aufirst%3DE.%2BJ.%26aulast%3DDonaldson%26aufirst%3DM.%2BM.%26aulast%3DDornan%26aufirst%3DE.%2BS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBristol%26aufirst%3DM.%26aulast%3DBodily%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DI.%2BM.%26atitle%3DEvidence%2520Supporting%2520a%2520Role%2520for%2520TopBP1%2520and%2520Brd4%2520in%2520the%2520Initiation%2520but%2520Not%2520Continuation%2520of%2520Human%2520Papillomavirus%252016%2520E1%252FE2-Mediated%2520DNA%2520Replication%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D4980%26epage%3D4991%26doi%3D10.1128%2FJVI.00335-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Sverdrup, F. M.</span><span> </span><span class="NLM_article-title">Inhibition of DUX4 Expression Using Bromodomain and Extra-Terminal Domain Protein Inhibitors (BETi)</span>. US20150087636A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=F.+M.+Sverdrup&title=Inhibition+of+DUX4+Expression+Using+Bromodomain+and+Extra-Terminal+Domain+Protein+Inhibitors+%28BETi%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSverdrup%26aufirst%3DF.%2BM.%26atitle%3DInhibition%2520of%2520DUX4%2520Expression%2520Using%2520Bromodomain%2520and%2520Extra-Terminal%2520Domain%2520Protein%2520Inhibitors%2520%2528BETi%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toubai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oravecz-Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathewson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Suppresses Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2728</span><span class="refDoi"> DOI: 10.1182/blood-2014-08-598037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1182%2Fblood-2014-08-598037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=2724-2728&author=Y.+Sunauthor=Y.+Wangauthor=T.+Toubaiauthor=K.+Oravecz-Wilsonauthor=C.+Liuauthor=N.+Mathewsonauthor=J.+Wuauthor=C.+Rossiauthor=E.+Cummingsauthor=D.+Wuauthor=S.+Wangauthor=P.+Reddy&title=BET+Bromodomain+Inhibition+Suppresses+Graft-Versus-Host+Disease+After+Allogeneic+Bone+Marrow+Transplantation+in+Mice&doi=10.1182%2Fblood-2014-08-598037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-08-598037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-08-598037%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DToubai%26aufirst%3DT.%26aulast%3DOravecz-Wilson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMathewson%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Suppresses%2520Graft-Versus-Host%2520Disease%2520After%2520Allogeneic%2520Bone%2520Marrow%2520Transplantation%2520in%2520Mice%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26spage%3D2724%26epage%3D2728%26doi%3D10.1182%2Fblood-2014-08-598037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Herait, P. E.; Berthon, C.; Thieblemont, C.; Raffoux, E.; Magarotto, V.; Stathis, A.; Thomas, X.; Leleu, X.; Gomez-Roca, C.; Odore, E.; Roumier, C.; Bourdel, F.; Quesnel, B.; Zucca, E.; Michallet, M.; Recher, C.; Cvitkovic, E.; Rezai, K.; Preudhomme, C.; Facon, T.; Palumbo, A.; Dombret, H.</span><span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">April 5–9, 2015</span>,  <span class="NLM_fpage">CT231</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Herait%2C+P.+E.%3B+Berthon%2C+C.%3B+Thieblemont%2C+C.%3B+Raffoux%2C+E.%3B+Magarotto%2C+V.%3B+Stathis%2C+A.%3B+Thomas%2C+X.%3B+Leleu%2C+X.%3B+Gomez-Roca%2C+C.%3B+Odore%2C+E.%3B+Roumier%2C+C.%3B+Bourdel%2C+F.%3B+Quesnel%2C+B.%3B+Zucca%2C+E.%3B+Michallet%2C+M.%3B+Recher%2C+C.%3B+Cvitkovic%2C+E.%3B+Rezai%2C+K.%3B+Preudhomme%2C+C.%3B+Facon%2C+T.%3B+Palumbo%2C+A.%3B+Dombret%2C+H.Annual+Meeting+of+American+Association+for+Cancer+Research%2C+San+Diego%2C+CA%2C+April+5%E2%80%939%2C+2015%2C+CT231."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%2BE.%26spage%3DCT231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Dombret, H.; Preudhomme, C.; Berthon, C.; Raffoux, E.; Thoma, X.; Vey, N.; Gomez-Roca, C.; Ethell, M.; Yee, K.; Bourdel, F.; Herait, P.; Michallet, M.; Recher, C.; Roumier, C.; Quesnel, B.</span><span> </span><span class="NLM_article-title">A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia</span>. <span class="NLM_conf-name">56th American Society of Hematology Meeting and Exposition</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">December 6–9, 2014</span>,  <span class="NLM_fpage">117</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dombret%2C+H.%3B+Preudhomme%2C+C.%3B+Berthon%2C+C.%3B+Raffoux%2C+E.%3B+Thoma%2C+X.%3B+Vey%2C+N.%3B+Gomez-Roca%2C+C.%3B+Ethell%2C+M.%3B+Yee%2C+K.%3B+Bourdel%2C+F.%3B+Herait%2C+P.%3B+Michallet%2C+M.%3B+Recher%2C+C.%3B+Roumier%2C+C.%3B+Quesnel%2C+B.+A+Phase+1+Study+of+the+BET-Bromodomain+Inhibitor+OTX015+in+Patients+with+Advanced+Acute+Leukemia.+56th+American+Society+of+Hematology+Meeting+and+Exposition%2C+San+Francisco%2C+CA%2C+December+6%E2%80%939%2C+2014%2C+117."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDombret%26aufirst%3DH.%26atitle%3DA%2520Phase%25201%2520Study%2520of%2520the%2520BET-Bromodomain%2520Inhibitor%2520OTX015%2520in%2520Patients%2520with%2520Advanced%2520Acute%2520Leukemia%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preudhomme, C.</span><span> </span><span class="NLM_article-title">BET-Bromodomain (BRD) Inhibitor OTX015: Final Results of the Dose-Finding Part of a Phase I Study in Hematologic Malignancies</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">ii10</span><span class="NLM_x">–</span> <span class="NLM_lpage">ii11</span><span class="refDoi"> DOI: 10.1093/annonc/mdv085.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Fannonc%2Fmdv085.3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=ii10-ii11&author=P.+Heraitauthor=H.+Dombretauthor=C.+Thieblemontauthor=T.+Faconauthor=A.+Stathisauthor=D.+Cunninghamauthor=A.+Palumboauthor=N.+Veyauthor=M.+Michalletauthor=C.+Recherauthor=K.+Rezaiauthor=C.+Preudhomme&title=BET-Bromodomain+%28BRD%29+Inhibitor+OTX015%3A+Final+Results+of+the+Dose-Finding+Part+of+a+Phase+I+Study+in+Hematologic+Malignancies&doi=10.1093%2Fannonc%2Fmdv085.3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv085.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv085.3%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DThieblemont%26aufirst%3DC.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DVey%26aufirst%3DN.%26aulast%3DMichallet%26aufirst%3DM.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DPreudhomme%26aufirst%3DC.%26atitle%3DBET-Bromodomain%2520%2528BRD%2529%2520Inhibitor%2520OTX015%253A%2520Final%2520Results%2520of%2520the%2520Dose-Finding%2520Part%2520of%2520a%2520Phase%2520I%2520Study%2520in%2520Hematologic%2520Malignancies%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3Dii10%26epage%3Dii11%26doi%3D10.1093%2Fannonc%2Fmdv085.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit196"><span><span> </span><span class="NLM_article-title">BET-Bromodomain (BRD) Inhibitor OTX015: Final Results of the Dose-Finding Part of a Phase I Study in Hematologic Malignancies</span>. <span class="NLM_conf-name">13th International Congress on Targeted Anticancer Therapies</span>, <span class="NLM_conf-loc">Paris, France</span>, <span class="NLM_conf-date">March 2–4, 2015</span>,  <span class="NLM_fpage">O7.3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BET-Bromodomain+%28BRD%29+Inhibitor+OTX015%3A+Final+Results+of+the+Dose-Finding+Part+of+a+Phase+I+Study+in+Hematologic+Malignancies.+13th+International+Congress+on+Targeted+Anticancer+Therapies%2C+Paris%2C+France%2C+March+2%E2%80%934%2C+2015%2C+O7.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26atitle%3DBET-Bromodomain%2520%2528BRD%2529%2520Inhibitor%2520OTX015%253A%2520Final%2520Results%2520of%2520the%2520Dose-Finding%2520Part%2520of%2520a%2520Phase%2520I%2520Study%2520in%2520Hematologic%2520Malignancies%26spage%3DO7.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Odore, E.; Lokiec, F.; Riveiro, M. E.; Bourdel, F.; Kahatt, C.; Herait, P.; Cvitkovic, E.; Rezai, K.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of OTX015 in a Phase Ib Dose-Finding Study of Patients with Hematologic Malignancies: Preliminary Results of a Population PK Analysis</span>. <span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">April 18–22, 2015</span>,  <span class="NLM_fpage">4511</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Odore%2C+E.%3B+Lokiec%2C+F.%3B+Riveiro%2C+M.+E.%3B+Bourdel%2C+F.%3B+Kahatt%2C+C.%3B+Herait%2C+P.%3B+Cvitkovic%2C+E.%3B+Rezai%2C+K.+Pharmacokinetics+of+OTX015+in+a+Phase+Ib+Dose-Finding+Study+of+Patients+with+Hematologic+Malignancies%3A+Preliminary+Results+of+a+Population+PK+Analysis.+Annual+Meeting+of+American+Association+for+Cancer+Research%2C+Philadelphia%2C+PA%2C+April+18%E2%80%9322%2C+2015%2C+4511."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DOdore%26aufirst%3DE.%26atitle%3DPharmacokinetics%2520of%2520OTX015%2520in%2520a%2520Phase%2520Ib%2520Dose-Finding%2520Study%2520of%2520Patients%2520with%2520Hematologic%2520Malignancies%253A%2520Preliminary%2520Results%2520of%2520a%2520Population%2520PK%2520Analysis%26spage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit198"><span>Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority; <span class="NLM_publisher-name">Resverlogix</span>: <span class="NLM_publisher-loc">Calgary, Canada</span>, <span class="NLM_month">June</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.resverlogix.com/media/press-release.html?id=521" class="extLink">http://www.resverlogix.com/media/press-release.html?id=521</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Resverlogix+Officially+Attains+Phase+3+Status+with+a+European+Regulatory+Authority%3B+Resverlogix%3A+Calgary%2C+Canada%2C+June22%2C+2015%3B+http%3A%2F%2Fwww.resverlogix.com%2Fmedia%2Fpress-release.html%3Fid%3D521+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DResverlogix%2520Officially%2520Attains%2520Phase%25203%2520Status%2520with%2520a%2520European%2520Regulatory%2520Authority%26pub%3DResverlogix%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref300':['cit300'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 132 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Michael Brand, James Clayton, Mustafa Moroglu, Matthias Schiedel, Sarah Picaud, Joseph P. Bluck, Anna Skwarska, Hannah Bolland, Anthony K. N. Chan, Corentine M. C. Laurin, Amy R. Scorah, Larissa See, Timothy P. C. Rooney, Katrina H. Andrews, Oleg Fedorov, Gabriella Perell, Prakriti Kalra, Kayla B. Vinh, Wilian A. Cortopassi, Pascal Heitel, Kirsten E. Christensen, Richard I. Cooper, Robert S. Paton, William C. K. Pomerantz, Philip C. Biggin, Ester M. Hammond, Panagis Filippakopoulos, <span class="NLM_string-name hlFld-ContribAuthor">Stuart J. Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 10102-10123. <a href="https://doi.org/10.1021/acs.jmedchem.1c00348" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00348%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DControlling%252BIntramolecular%252BInteractions%252Bin%252Bthe%252BDesign%252Bof%252BSelective%25252C%252BHigh-Affinity%252BLigands%252Bfor%252Bthe%252BCREBBP%252BBromodomain%26aulast%3DBrand%26aufirst%3DMichael%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D25022021%26date%3D13072021%26volume%3D64%26issue%3D14%26spage%3D10102%26epage%3D10123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yi Zhang, Deqin Rong, Bingbing Li, <span class="NLM_string-name hlFld-ContribAuthor">Yuanxiang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7900-7925. <a href="https://doi.org/10.1021/acs.jmedchem.0c02055" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02055%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BEpigenetic%252BRegulators%252Bwith%252BCovalent%252BSmall-Molecule%252BInhibitors%26aulast%3DZhang%26aufirst%3DYi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26112020%26date%3D18022021%26volume%3D64%26issue%3D12%26spage%3D7900%26epage%3D7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lifei Wang, Yan Wang, Zhiyong Yang, Shuobo Xu, <span class="NLM_string-name hlFld-ContribAuthor">Hongyun Li</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Selectivity of Inhibitors toward Bromodomains BAZ2A and BAZ2B Uncovered by Multiple Short Molecular Dynamics Simulations and MM-GBSA Calculations. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (18)
                                     , 12036-12049. <a href="https://doi.org/10.1021/acsomega.1c00687" title="DOI URL">https://doi.org/10.1021/acsomega.1c00687</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c00687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c00687%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DBinding%252BSelectivity%252Bof%252BInhibitors%252Btoward%252BBromodomains%252BBAZ2A%252Band%252BBAZ2B%252BUncovered%252Bby%252BMultiple%252BShort%252BMolecular%252BDynamics%252BSimulations%252Band%252BMM-GBSA%252BCalculations%26aulast%3DWang%26aufirst%3DLifei%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05022021%26date%3D19042021%26date%3D28042021%26volume%3D6%26issue%3D18%26spage%3D12036%26epage%3D12049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Sunil Bhakta, Nicole Blaquiere, Jinhua Chen, Josefa dela Cruz-Chuh, Karen E. Gascoigne, Steven J. Hartman, Mingtao He, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liang Liu, Liling Liu, Qi Liu, Ying Lu, Fanwei Meng, Melinda M. Mulvihill, Aimee O’Donohue, Rebecca K. Rowntree, Leanna R. Staben, Steven T. Staben, John Wai, Jian Wang, BinQing Wei, Catherine Wilson, Jianfeng Xin, Zijin Xu, Hui Yao, Donglu Zhang, Hongyan Zhang, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2534-2575. <a href="https://doi.org/10.1021/acs.jmedchem.0c01845" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01845%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B1%25253A%252BExploration%252Bof%252BAntibody%252BLinker%25252C%252BPayload%252BLoading%25252C%252Band%252BPayload%252BMolecular%252BProperties%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2534%26epage%3D2575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Peter S. Dragovich, Thomas H. Pillow, Robert A. Blake, Jack D. Sadowsky, Emel Adaligil, Pragya Adhikari, Jinhua Chen, Nicholas Corr, Josefa dela Cruz-Chuh, Geoffrey Del Rosario, Aaron Fullerton, Steven J. Hartman, Fan Jiang, Susan Kaufman, Tracy Kleinheinz, Katherine R. Kozak, Liling Liu, Ying Lu, Melinda M. Mulvihill, Jeremy M. Murray, Aimee O’Donohue, Rebecca K. Rowntree, William S. Sawyer, Leanna R. Staben, John Wai, Jian Wang, BinQing Wei, Wentao Wei, Zijin Xu, Hui Yao, Shang-Fan Yu, Donglu Zhang, Hongyan Zhang, Shenhua Zhang, Yongxin Zhao, Hao Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyu Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2576-2607. <a href="https://doi.org/10.1021/acs.jmedchem.0c01846" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01846</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01846%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntibody-Mediated%252BDelivery%252Bof%252BChimeric%252BBRD4%252BDegraders.%252BPart%252B2%25253A%252BImprovement%252Bof%252BIn%252BVitro%252BAntiproliferation%252BActivity%252Band%252BIn%252BVivo%252BAntitumor%252BEfficacy%26aulast%3DDragovich%26aufirst%3DPeter%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21102020%26date%3D17022021%26volume%3D64%26issue%3D5%26spage%3D2576%26epage%3D2607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martin Hügle, Pierre Regenass, Robin Warstat, Mirjam Hau, Karin Schmidtkunz, Xavier Lucas, Daniel Wohlwend, Oliver Einsle, Manfred Jung, Bernhard Breit, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Günther</span>. </span><span class="cited-content_cbyCitation_article-title">4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell Lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15603-15620. <a href="https://doi.org/10.1021/acs.jmedchem.0c00478" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00478%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Acyl%252BPyrroles%252Bas%252BDual%252BBET-BRD7%25252F9%252BBromodomain%252BInhibitors%252BAddress%252BBETi%252BInsensitive%252BHuman%252BCancer%252BCell%252BLines%26aulast%3DH%25C3%25BCgle%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21032020%26date%3D04122020%26volume%3D63%26issue%3D24%26spage%3D15603%26epage%3D15620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Simon C. C. Lucas, Stephen J. Atkinson, Paul Bamborough, Heather Barnett, Chun-wa Chung, Laurie Gordon, Darren J. Mitchell, Alexander Phillipou, Rab K. Prinjha, Robert J. Sheppard, Nicholas C. O. Tomkinson, Robert J. Watson, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel H. Demont</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5212-5241. <a href="https://doi.org/10.1021/acs.jmedchem.0c00021" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00021%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BPotent%252BATAD2%252Band%252BCECR2%252BBromodomain%252BInhibitors%252Bwith%252Ban%252BAtypical%252BBinding%252BMode%26aulast%3DLucas%26aufirst%3DSimon%2BC.%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06012020%26date%3D06052020%26date%3D22042020%26volume%3D63%26issue%3D10%26spage%3D5212%26epage%3D5241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">George S. Sheppard, Le Wang, Steven D. Fidanze, Lisa A. Hasvold, Dachun Liu, John K. Pratt, Chang H. Park, Kenton Longenecker, Wei Qiu, Maricel Torrent, Peter J. Kovar, Mai Bui, Emily Faivre, Xiaoli Huang, Xiaoyu Lin, Denise Wilcox, Lu Zhang, Yu Shen, Daniel H. Albert, Terrance J. Magoc, Ganesh Rajaraman, Warren M. Kati, <span class="NLM_string-name hlFld-ContribAuthor">Keith F. McDaniel</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5585-5623. <a href="https://doi.org/10.1021/acs.jmedchem.0c00628" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00628%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-Ethyl-4-%25255B2-%2525284-fluoro-2%25252C6-dimethyl-phenoxy%252529-5-%2525281-hydroxy-1-methyl-ethyl%252529phenyl%25255D-6-methyl-7-oxo-1H-pyrrolo%25255B2%25252C3-c%25255Dpyridine-2-carboxamide%252B%252528ABBV-744%252529%25252C%252Ba%252BBET%252BBromodomain%252BInhibitor%252Bwith%252BSelectivity%252Bfor%252Bthe%252BSecond%252BBromodomain%26aulast%3DSheppard%26aufirst%3DGeorge%2BS.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16042020%26date%3D07052020%26date%3D23042020%26volume%3D63%26issue%3D10%26spage%3D5585%26epage%3D5623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Noelle M. Olson, Samantha Kroc, Jorden A. Johnson, Huda Zahid, Peter D. Ycas, Alice Chan, Jennifer R. Kimbrough, Prakriti Kalra, Ernst Schönbrunn, <span class="NLM_string-name hlFld-ContribAuthor">William C. K. Pomerantz</span>. </span><span class="cited-content_cbyCitation_article-title">NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2020,</strong> <em>59 </em>
                                    (20)
                                     , 1871-1880. <a href="https://doi.org/10.1021/acs.biochem.0c00159" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00159%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DNMR%252BAnalyses%252Bof%252BAcetylated%252BH2A.Z%252BIsoforms%252BIdentify%252BDifferential%252BBinding%252BInteractions%252Bwith%252Bthe%252BBromodomain%252Bof%252Bthe%252BNURF%252BNucleosome%252BRemodeling%252BComplex%26aulast%3DOlson%26aufirst%3DNoelle%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D25022020%26date%3D30042020%26date%3D11052020%26date%3D01052020%26volume%3D59%26issue%3D20%26spage%3D1871%26epage%3D1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher R. Wellaway, Dominique Amans, Paul Bamborough, Heather Barnett, Rino A. Bit, Jack A. Brown, Neil R. Carlson, Chun-wa Chung, Anthony W. J. Cooper, Peter D. Craggs, Robert P. Davis, Tony W. Dean, John P. Evans, Laurie Gordon, Isobel L. Harada, David J. Hirst, Philip G. Humphreys, Katherine L. Jones, Antonia J. Lewis, Matthew J. Lindon, Dave Lugo, Mahnoor Mahmood, Scott McCleary, Patricia Medeiros, Darren J. Mitchell, Michael O’Sullivan, Armelle Le Gall, Vipulkumar K. Patel, Chris Patten, Darren L. Poole, Rishi R. Shah, Jane E. Smith, Kayleigh A. J. Stafford, Pamela J. Thomas, Mythily Vimal, Ian D. Wall, Robert J. Watson, Natalie Wellaway, Gang Yao, <span class="NLM_string-name hlFld-ContribAuthor">Rab K. Prinjha</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Bromodomain and Extraterminal Inhibitor with a Low Predicted Human Dose through Synergistic Use of Encoded Library Technology and Fragment Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 714-746. <a href="https://doi.org/10.1021/acs.jmedchem.9b01670" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01670%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BBromodomain%252Band%252BExtraterminal%252BInhibitor%252Bwith%252Ba%252BLow%252BPredicted%252BHuman%252BDose%252Bthrough%252BSynergistic%252BUse%252Bof%252BEncoded%252BLibrary%252BTechnology%252Band%252BFragment%252BScreening%26aulast%3DWellaway%26aufirst%3DChristopher%2BR.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08102019%26date%3D06012020%26volume%3D63%26issue%3D2%26spage%3D714%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul Bamborough, Chun-wa Chung, Emmanuel H. Demont, Angela M. Bridges, Peter D. Craggs, David P. Dixon, Peter Francis, Rebecca C. Furze, Paola Grandi, Emma J. Jones, Bhumika Karamshi, Kelly Locke, Simon C. C. Lucas, Anne-Marie Michon, Darren J. Mitchell, Peter Pogány, Rab K. Prinjha, Christina Rau, Ana Maria Roa, Andrew D. Roberts, Robert J. Sheppard, <span class="NLM_string-name hlFld-ContribAuthor">Robert J. Watson</span>. </span><span class="cited-content_cbyCitation_article-title">A Qualified Success: Discovery of a New Series of ATAD2 Bromodomain Inhibitors with a Novel Binding Mode Using High-Throughput Screening and Hit Qualification. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (16)
                                     , 7506-7525. <a href="https://doi.org/10.1021/acs.jmedchem.9b00673" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00673%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BQualified%252BSuccess%25253A%252BDiscovery%252Bof%252Ba%252BNew%252BSeries%252Bof%252BATAD2%252BBromodomain%252BInhibitors%252Bwith%252Ba%252BNovel%252BBinding%252BMode%252BUsing%252BHigh-Throughput%252BScreening%252Band%252BHit%252BQualification%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23042019%26date%3D09082019%26volume%3D62%26issue%3D16%26spage%3D7506%26epage%3D7525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luyi Huang, Hui Li, Linli Li, Lu Niu, Raina Seupel, Chengyong Wu, Wei Cheng, Chong Chen, Bisen Ding, Paul E. Brennan, <span class="NLM_string-name hlFld-ContribAuthor">Shengyong Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyrrolo[3,2-d]pyrimidin-4-one Derivatives as a New Class of Potent and Cell-Active Inhibitors of P300/CBP-Associated Factor Bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4526-4542. <a href="https://doi.org/10.1021/acs.jmedchem.9b00096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyrrolo%25255B3%25252C2-d%25255Dpyrimidin-4-one%252BDerivatives%252Bas%252Ba%252BNew%252BClass%252Bof%252BPotent%252Band%252BCell-Active%252BInhibitors%252Bof%252BP300%25252FCBP-Associated%252BFactor%252BBromodomain%26aulast%3DHuang%26aufirst%3DLuyi%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15012019%26date%3D30042019%26date%3D18042019%26volume%3D62%26issue%3D9%26spage%3D4526%26epage%3D4542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shumei Wang, Vickie Tsui, Terry D. Crawford, James E. Audia, Daniel J. Burdick, Maureen H. Beresini, Alexandre Côté, Richard Cummings, Martin Duplessis, E. Megan Flynn, Michael C. Hewitt, Hon-Ren Huang, Hariharan Jayaram, Ying Jiang, Shivangi Joshi, Jeremy Murray, Christopher G. Nasveschuk, Eneida Pardo, Florence Poy, F. Anthony Romero, Yong Tang, Alexander M. Taylor, Jian Wang, Zhaowu Xu, Laura E. Zawadzke, Xiaoyu Zhu, Brian K. Albrecht, Steven R. Magnuson, Steve Bellon, <span class="NLM_string-name hlFld-ContribAuthor">Andrea G. Cochran</span>. </span><span class="cited-content_cbyCitation_article-title">GNE-371, a Potent and Selective Chemical Probe for the Second Bromodomains of Human Transcription-Initiation-Factor TFIID Subunit 1 and Transcription-Initiation-Factor TFIID Subunit 1-like. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9301-9315. <a href="https://doi.org/10.1021/acs.jmedchem.8b01225" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01225%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGNE-371%25252C%252Ba%252BPotent%252Band%252BSelective%252BChemical%252BProbe%252Bfor%252Bthe%252BSecond%252BBromodomains%252Bof%252BHuman%252BTranscription-Initiation-Factor%252BTFIID%252BSubunit%252B1%252Band%252BTranscription-Initiation-Factor%252BTFIID%252BSubunit%252B1-like%26aulast%3DWang%26aufirst%3DShumei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03082018%26date%3D05102018%26volume%3D61%26issue%3D20%26spage%3D9301%26epage%3D9315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul Bamborough, Chun-wa Chung, Rebecca C. Furze, Paola Grandi, Anne-Marie Michon, Robert J. Watson, Darren J. Mitchell, Heather Barnett, Rab K. Prinjha, Christina Rau, Robert J. Sheppard, Thilo Werner, <span class="NLM_string-name hlFld-ContribAuthor">Emmanuel H. Demont</span>. </span><span class="cited-content_cbyCitation_article-title">Aiming to Miss a Moving Target: Bromo and Extra Terminal Domain (BET) Selectivity in Constrained ATAD2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8321-8336. <a href="https://doi.org/10.1021/acs.jmedchem.8b00862" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAiming%252Bto%252BMiss%252Ba%252BMoving%252BTarget%25253A%252BBromo%252Band%252BExtra%252BTerminal%252BDomain%252B%252528BET%252529%252BSelectivity%252Bin%252BConstrained%252BATAD2%252BInhibitors%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30052018%26date%3D18092018%26volume%3D61%26issue%3D18%26spage%3D8321%26epage%3D8336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zakey
Yusuf Buuh, Zhigang Lyu, <span class="NLM_string-name hlFld-ContribAuthor">Rongsheng E. Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3239-3252. <a href="https://doi.org/10.1021/acs.jmedchem.6b01817" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInterrogating%252Bthe%252BRoles%252Bof%252BPost-Translational%252BModifications%252Bof%252BNon-Histone%252BProteins%26aulast%3DBuuh%26aufirst%3DZakey%2BYusuf%26date%3D2018%26date%3D2017%26date%3D2016%26date%3D11122016%26date%3D24052017%26date%3D15052017%26volume%3D61%26issue%3D8%26spage%3D3239%26epage%3D3252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurent  Batiste</span>, <span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Aymeric  Dolbois</span>, <span class="hlFld-ContribAuthor ">Fabrice  Hassler</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Nicholas  Deerain</span>, <span class="hlFld-ContribAuthor ">Jian  Zhu</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Spiliotopoulos</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>, and <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>  . </span><span class="cited-content_cbyCitation_article-title">Chemical Space Expansion of Bromodomain Ligands Guided by in Silico Virtual Couplings (AutoCouple). </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2018,</strong> <em>4 </em>
                                    (2)
                                     , 180-188. <a href="https://doi.org/10.1021/acscentsci.7b00401" title="DOI URL">https://doi.org/10.1021/acscentsci.7b00401</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.7b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.7b00401%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DChemical%252BSpace%252BExpansion%252Bof%252BBromodomain%252BLigands%252BGuided%252Bby%252Bin%252BSilico%252BVirtual%252BCouplings%252B%252528AutoCouple%252529%26aulast%3DBatiste%26aufirst%3DLaurent%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29082017%26date%3D07022018%26date%3D28022018%26volume%3D4%26issue%3D2%26spage%3D180%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de leon Boenig</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Kevin R.  Clark</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Ruina  Li</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Jonathan  Maher</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Aijun  Zheng</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">A Unique Approach to Design Potent and Selective Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10151-10171. <a href="https://doi.org/10.1021/acs.jmedchem.7b01372" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01372%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BUnique%252BApproach%252Bto%252BDesign%252BPotent%252Band%252BSelective%252BCyclic%252BAdenosine%252BMonophosphate%252BResponse%252BElement%252BBinding%252BProtein%25252C%252BBinding%252BProtein%252B%252528CBP%252529%252BInhibitors%26aulast%3DBronner%26aufirst%3DSarah%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23092017%26date%3D11122017%26date%3D28122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10151%26epage%3D10171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Le  An</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de Leon Boenig</span>, <span class="hlFld-ContribAuthor ">Sarah M.  Bronner</span>, <span class="hlFld-ContribAuthor ">Emily W.  Chan</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Kyle  Clagg</span>, <span class="hlFld-ContribAuthor ">Kevin  Clark</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Patrick  Cyr</span>, <span class="hlFld-ContribAuthor ">Denise  de Almeida Nagata</span>, <span class="hlFld-ContribAuthor ">Karen E.  Gascoigne</span>, <span class="hlFld-ContribAuthor ">Jane L.  Grogan</span>, <span class="hlFld-ContribAuthor ">Georgia  Hatzivassiliou</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Hunsaker</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Koenig</span>, <span class="hlFld-ContribAuthor ">Ruina  Li</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liang</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Jonathan  Maher</span>, <span class="hlFld-ContribAuthor ">Colin  Masui</span>, <span class="hlFld-ContribAuthor ">Mark  Merchant</span>, <span class="hlFld-ContribAuthor ">Yingqing  Ran</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">John  Wai</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaocang  Wei</span>, <span class="hlFld-ContribAuthor ">Dong  Yu</span>, <span class="hlFld-ContribAuthor ">Bing-Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (22)
                                     , 9162-9183. <a href="https://doi.org/10.1021/acs.jmedchem.7b00796" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00796%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGNE-781%25252C%252BA%252BHighly%252BAdvanced%252BPotent%252Band%252BSelective%252BBromodomain%252BInhibitor%252Bof%252BCyclic%252BAdenosine%252BMonophosphate%252BResponse%252BElement%252BBinding%252BProtein%25252C%252BBinding%252BProtein%252B%252528CBP%252529%26aulast%3DRomero%26aufirst%3DF.%2BAnthony%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05062017%26date%3D21092017%26date%3D22112017%26date%3D11092017%26volume%3D60%26issue%3D22%26spage%3D9162%26epage%3D9183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>, <span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">Todd  Soltwedel</span>, <span class="hlFld-ContribAuthor ">Steven D.  Fidanze</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Hasvold</span>, <span class="hlFld-ContribAuthor ">Dachun  Liu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mantei</span>, <span class="hlFld-ContribAuthor ">John K.  Pratt</span>, <span class="hlFld-ContribAuthor ">George S.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Mai H.  Bui</span>, <span class="hlFld-ContribAuthor ">Emily J.  Faivre</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Leiming  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Lin</span>, <span class="hlFld-ContribAuthor ">Rongqi  Wang</span>, <span class="hlFld-ContribAuthor ">Scott E.  Warder</span>, <span class="hlFld-ContribAuthor ">Denise  Wilcox</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Albert</span>, <span class="hlFld-ContribAuthor ">Terrance J.  Magoc</span>, <span class="hlFld-ContribAuthor ">Ganesh  Rajaraman</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Charles W.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Jianwei J.  Shen</span>, <span class="hlFld-ContribAuthor ">Rohinton P.  Edalji</span>, <span class="hlFld-ContribAuthor ">Chaohong C.  Sun</span>, <span class="hlFld-ContribAuthor ">Ruth  Martin</span>, <span class="hlFld-ContribAuthor ">Wenqing  Gao</span>, <span class="hlFld-ContribAuthor ">Shekman  Wong</span>, <span class="hlFld-ContribAuthor ">Guowei  Fang</span>, <span class="hlFld-ContribAuthor ">Steven W.  Elmore</span>, <span class="hlFld-ContribAuthor ">Yu  Shen</span>, and <span class="hlFld-ContribAuthor ">Warren M.  Kati</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8369-8384. <a href="https://doi.org/10.1021/acs.jmedchem.7b00746" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%2525282%25252C4-Difluorophenoxy%252529-3-%2525286-methyl-7-oxo-6%25252C7-dihydro-1H-pyrrolo%25255B2%25252C3-c%25255Dpyridin-4-yl%252529phenyl%252529ethanesulfonamide%252B%252528ABBV-075%25252FMivebresib%252529%25252C%252Ba%252BPotent%252Band%252BOrally%252BAvailable%252BBromodomain%252Band%252BExtraterminal%252BDomain%252B%252528BET%252529%252BFamily%252BBromodomain%252BInhibitor%26aulast%3DMcDaniel%26aufirst%3DKeith%2BF.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19052017%26date%3D12102017%26date%3D26102017%26date%3D26092017%26volume%3D60%26issue%3D20%26spage%3D8369%26epage%3D8384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niall  Igoe</span>, <span class="hlFld-ContribAuthor ">Elliott D.  Bayle</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Julia C.  Meier</span>, <span class="hlFld-ContribAuthor ">Pavel  Savitsky</span>, <span class="hlFld-ContribAuthor ">Catherine  Rogers</span>, <span class="hlFld-ContribAuthor ">Yannick  Morias</span>, <span class="hlFld-ContribAuthor ">Sarah  Scholze</span>, <span class="hlFld-ContribAuthor ">Helen  Boyd</span>, <span class="hlFld-ContribAuthor ">Danen  Cunoosamy</span>, <span class="hlFld-ContribAuthor ">David M.  Andrews</span>, <span class="hlFld-ContribAuthor ">Anne  Cheasty</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Paul V.  Fish</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of a Chemical Probe for the Bromodomain and Plant Homeodomain Finger-Containing (BRPF) Family of Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (16)
                                     , 6998-7011. <a href="https://doi.org/10.1021/acs.jmedchem.7b00611" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00611%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Ba%252BChemical%252BProbe%252Bfor%252Bthe%252BBromodomain%252Band%252BPlant%252BHomeodomain%252BFinger-Containing%252B%252528BRPF%252529%252BFamily%252Bof%252BProteins%26aulast%3DIgoe%26aufirst%3DNiall%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D21042017%26date%3D10082017%26date%3D24082017%26date%3D17072017%26volume%3D60%26issue%3D16%26spage%3D6998%26epage%3D7011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David S.  Millan</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Kayser-Bricker</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Adam C.  Talbot</span>, <span class="hlFld-ContribAuthor ">Shawn E. R.  Schiller</span>, <span class="hlFld-ContribAuthor ">Torsten  Herbertz</span>, <span class="hlFld-ContribAuthor ">Grace L.  Williams</span>, <span class="hlFld-ContribAuthor ">George P.  Luke</span>, <span class="hlFld-ContribAuthor ">Stephen  Hubbs</span>, <span class="hlFld-ContribAuthor ">Monica A.  Alvarez Morales</span>, <span class="hlFld-ContribAuthor ">Daniel  Cardillo</span>, <span class="hlFld-ContribAuthor ">Paul  Troccolo</span>, <span class="hlFld-ContribAuthor ">Rachel L.  Mendes</span>, and <span class="hlFld-ContribAuthor ">Crystal  McKinnon</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (8)
                                     , 847-852. <a href="https://doi.org/10.1021/acsmedchemlett.7b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252BOptimization%252Bof%252BBenzopiperazines%252Bas%252BPotent%252BInhibitors%252Bof%252BBET%252BBromodomains%26aulast%3DMillan%26aufirst%3DDavid%2BS.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04052017%26date%3D14072017%26date%3D19072017%26date%3D10082017%26date%3D14072017%26volume%3D8%26issue%3D8%26spage%3D847%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">James E.  Audia</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Archana  Bommi-Reddy</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Richard T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">E. Megan  Flynn</span>, <span class="hlFld-ContribAuthor ">Michael  Hewitt</span>, <span class="hlFld-ContribAuthor ">Hon-Ren  Huang</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">Shivangi  Joshi</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Nasveschuk</span>, <span class="hlFld-ContribAuthor ">Arianne  Neiss</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Peter  Sandy</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims, III</span>, <span class="hlFld-ContribAuthor ">Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Yongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowu  Xu</span>, <span class="hlFld-ContribAuthor ">Laura  Zawadzke</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Zhu</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, and <span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>  . </span><span class="cited-content_cbyCitation_article-title">GNE-886: A Potent and Selective Inhibitor of the Cat Eye Syndrome Chromosome Region Candidate 2 Bromodomain (CECR2). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (7)
                                     , 737-741. <a href="https://doi.org/10.1021/acsmedchemlett.7b00132" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00132%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DGNE-886%25253A%252BA%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252Bthe%252BCat%252BEye%252BSyndrome%252BChromosome%252BRegion%252BCandidate%252B2%252BBromodomain%252B%252528CECR2%252529%26aulast%3DCrawford%26aufirst%3DTerry%2BD.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23032017%26date%3D01062017%26date%3D13062017%26date%3D13072017%26date%3D01062017%26volume%3D8%26issue%3D7%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Pingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>, and <span class="hlFld-ContribAuthor ">Jia  Zhou</span>  . </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Bromodomain-Containing Protein 4. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (11)
                                     , 4533-4558. <a href="https://doi.org/10.1021/acs.jmedchem.6b01761" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01761</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01761%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BBromodomain-Containing%252BProtein%252B4%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D02122016%26date%3D02032017%26date%3D08062017%26date%3D14022017%26volume%3D60%26issue%3D11%26spage%3D4533%26epage%3D4558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">John K.  Pratt</span>, <span class="hlFld-ContribAuthor ">Todd  Soltwedel</span>, <span class="hlFld-ContribAuthor ">George S.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Steven D.  Fidanze</span>, <span class="hlFld-ContribAuthor ">Dachun  Liu</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Hasvold</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mantei</span>, <span class="hlFld-ContribAuthor ">James H.  Holms</span>, <span class="hlFld-ContribAuthor ">William J.  McClellan</span>, <span class="hlFld-ContribAuthor ">Michael D.  Wendt</span>, <span class="hlFld-ContribAuthor ">Carol  Wada</span>, <span class="hlFld-ContribAuthor ">Robin  Frey</span>, <span class="hlFld-ContribAuthor ">T. Matthew  Hansen</span>, <span class="hlFld-ContribAuthor ">Robert  Hubbard</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Leiming  Li</span>, <span class="hlFld-ContribAuthor ">Terrance J.  Magoc</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Albert</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Lin</span>, <span class="hlFld-ContribAuthor ">Scott E.  Warder</span>, <span class="hlFld-ContribAuthor ">Peter  Kovar</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Denise  Wilcox</span>, <span class="hlFld-ContribAuthor ">Rongqi  Wang</span>, <span class="hlFld-ContribAuthor ">Ganesh  Rajaraman</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Petros</span>, <span class="hlFld-ContribAuthor ">Charles W.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Sanjay C.  Panchal</span>, <span class="hlFld-ContribAuthor ">Chaohong  Sun</span>, <span class="hlFld-ContribAuthor ">Steven W.  Elmore</span>, <span class="hlFld-ContribAuthor ">Yu  Shen</span>, <span class="hlFld-ContribAuthor ">Warren M.  Kati</span>, and <span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3828-3850. <a href="https://doi.org/10.1021/acs.jmedchem.7b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%25252C%252BStructure-Enabled%252BDiscovery%252Bof%252BNovel%252BPyridones%252Band%252BPyridone%252BMacrocycles%252Bas%252BPotent%252BBromodomain%252Band%252BExtra-Terminal%252BDomain%252B%252528BET%252529%252BFamily%252BBromodomain%252BInhibitors%26aulast%3DWang%26aufirst%3DLe%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10012017%26date%3D21042017%26date%3D11052017%26date%3D03042017%26volume%3D60%26issue%3D9%26spage%3D3828%26epage%3D3850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Donna  McEachern</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Xu  Ran</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Yang  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Ting  Zhao</span>, <span class="hlFld-ContribAuthor ">Siwei  Li</span>, <span class="hlFld-ContribAuthor ">Duxin  Sun</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3887-3901. <a href="https://doi.org/10.1021/acs.jmedchem.7b00193" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252B4-%2525286-Methoxy-2-methyl-4-%252528quinolin-4-yl%252529-9H-pyrimido%25255B4%25252C5-b%25255Dindol-7-yl%252529-3%25252C5-dimethylisoxazole%252B%252528CD161%252529%252Bas%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BBET%252BBromodomain%252BInhibitor%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04022017%26date%3D02052017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3887%26epage%3D3901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Léa  Bouché</span>, <span class="hlFld-ContribAuthor ">Clara D.  Christ</span>, <span class="hlFld-ContribAuthor ">Stephan  Siegel</span>, <span class="hlFld-ContribAuthor ">Amaury E.  Fernández-Montalván</span>, <span class="hlFld-ContribAuthor ">Simon J.  Holton</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Antonius  ter Laak</span>, <span class="hlFld-ContribAuthor ">Tatsuo  Sugawara</span>, <span class="hlFld-ContribAuthor ">Detlef  Stöckigt</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">James  Bennett</span>, <span class="hlFld-ContribAuthor ">Octovia  Monteiro</span>, <span class="hlFld-ContribAuthor ">Laura  Díaz-Sáez</span>, <span class="hlFld-ContribAuthor ">Paulina  Siejka</span>, <span class="hlFld-ContribAuthor ">Julia  Meier</span>, <span class="hlFld-ContribAuthor ">Vera  Pütter</span>, <span class="hlFld-ContribAuthor ">Jörg  Weiske</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Kilian V. M.  Huber</span>, <span class="hlFld-ContribAuthor ">Ingo V.  Hartung</span>, and <span class="hlFld-ContribAuthor ">Bernard  Haendler</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 4002-4022. <a href="https://doi.org/10.1021/acs.jmedchem.7b00306" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzoisoquinolinediones%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252BBRPF2%252Band%252BTAF1%25252FTAF1L%252BBromodomains%26aulast%3DBouch%25C3%25A9%26aufirst%3DL%25C3%25A9a%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24022017%26date%3D01052017%26date%3D11052017%26date%3D12042017%26volume%3D60%26issue%3D9%26spage%3D4002%26epage%3D4022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">Paul  Bamborough</span>, <span class="hlFld-ContribAuthor ">Chun-wa  Chung</span>, <span class="hlFld-ContribAuthor ">Peter D.  Craggs</span>, <span class="hlFld-ContribAuthor ">Laurie  Gordon</span>, <span class="hlFld-ContribAuthor ">Paola  Grandi</span>, <span class="hlFld-ContribAuthor ">Thomas G.  Hayhow</span>, <span class="hlFld-ContribAuthor ">Jameed  Hussain</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Jones</span>, <span class="hlFld-ContribAuthor ">Matthew  Lindon</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Michon</span>, <span class="hlFld-ContribAuthor ">Jessica F.  Renaux</span>, <span class="hlFld-ContribAuthor ">Colin J.  Suckling</span>, <span class="hlFld-ContribAuthor ">David F.  Tough</span>, and <span class="hlFld-ContribAuthor ">Rab K.  Prinjha</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 695-709. <a href="https://doi.org/10.1021/acs.jmedchem.6b01566" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01566%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BCell%252BPenetrant%25252C%252Band%252BSelective%252Bp300%25252FCBP-Associated%252BFactor%252B%252528PCAF%252529%25252FGeneral%252BControl%252BNonderepressible%252B5%252B%252528GCN5%252529%252BBromodomain%252BChemical%252BProbe%26aulast%3DHumphreys%26aufirst%3DPhilip%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D27102016%26date%3D09012017%26date%3D26012017%26date%3D21122016%26volume%3D60%26issue%3D2%26spage%3D695%26epage%3D709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niall  Igoe</span>, <span class="hlFld-ContribAuthor ">Elliott D.  Bayle</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Pavel  Savitsky</span>, <span class="hlFld-ContribAuthor ">Catherine  Rogers</span>, <span class="hlFld-ContribAuthor ">Dafydd R.  Owen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deb</span>, <span class="hlFld-ContribAuthor ">Tim C. P.  Somervaille</span>, <span class="hlFld-ContribAuthor ">David M.  Andrews</span>, <span class="hlFld-ContribAuthor ">Neil  Jones</span>, <span class="hlFld-ContribAuthor ">Anne  Cheasty</span>, <span class="hlFld-ContribAuthor ">Hamish  Ryder</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Paul V.  Fish</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 668-680. <a href="https://doi.org/10.1021/acs.jmedchem.6b01583" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01583</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01583%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Ba%252BBiased%252BPotent%252BSmall%252BMolecule%252BInhibitor%252Bof%252Bthe%252BBromodomain%252Band%252BPHD%252BFinger-Containing%252B%252528BRPF%252529%252BProteins%252BSuitable%252Bfor%252BCellular%252Band%252Bin%252BVivo%252BStudies%26aulast%3DIgoe%26aufirst%3DNiall%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D25102016%26date%3D09012017%26date%3D26012017%26volume%3D60%26issue%3D2%26spage%3D668%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Xinzhou  Yang</span>, <span class="hlFld-ContribAuthor ">George D.  Mellick</span>, and <span class="hlFld-ContribAuthor ">Yunjiang  Feng</span>  . </span><span class="cited-content_cbyCitation_article-title">Meeting the Challenge: Using Cytological Profiling to Discover Chemical Probes from Traditional Chinese Medicines against Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (12)
                                     , 1628-1634. <a href="https://doi.org/10.1021/acschemneuro.6b00245" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00245%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMeeting%252Bthe%252BChallenge%25253A%252BUsing%252BCytological%252BProfiling%252Bto%252BDiscover%252BChemical%252BProbes%252Bfrom%252BTraditional%252BChinese%252BMedicines%252Bagainst%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DChao%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D16082016%26date%3D13102016%26date%3D26102016%26date%3D21122016%26date%3D13102016%26volume%3D7%26issue%3D12%26spage%3D1628%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Kwong Wah  Lai</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Gladys  de Leon Boenig</span>, <span class="hlFld-ContribAuthor ">Cameron L.  Noland</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Justin  Ly</span>, <span class="hlFld-ContribAuthor ">Edna F.  Choo</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Hunsaker</span>, <span class="hlFld-ContribAuthor ">Emily W.  Chan</span>, <span class="hlFld-ContribAuthor ">Mark  Merchant</span>, <span class="hlFld-ContribAuthor ">Samir  Kharbanda</span>, <span class="hlFld-ContribAuthor ">Karen E.  Gascoigne</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Jonathan  Maher</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">Florence  Poy</span>, <span class="hlFld-ContribAuthor ">Kerry L.  Spillane</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaocang  Wei</span>, <span class="hlFld-ContribAuthor ">Zhaowu  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongya  Xu</span>, <span class="hlFld-ContribAuthor ">Ivana  Yen</span>, <span class="hlFld-ContribAuthor ">Laura  Zawadzke</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Steven  Bellon</span>, <span class="hlFld-ContribAuthor ">Richard  Cummings</span>, <span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, and <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10549-10563. <a href="https://doi.org/10.1021/acs.jmedchem.6b01022" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01022%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252Bin%252BVivo%252BProbe%252B%252528GNE-272%252529%252Bfor%252Bthe%252BBromodomains%252Bof%252BCBP%25252FEP300%26aulast%3DCrawford%26aufirst%3DTerry%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12072016%26date%3D28092016%26date%3D08122016%26date%3D22092016%26volume%3D59%26issue%3D23%26spage%3D10549%26epage%3D10563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Carlino</span> and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (20)
                                     , 9305-9320. <a href="https://doi.org/10.1021/acs.jmedchem.6b00438" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00438%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BKinase-Bromodomain%252BInhibitors%252Bin%252BAnticancer%252BDrug%252BDiscovery%25253A%252BA%252BStructural%252Band%252BPharmacological%252BPerspective%26aulast%3DCarlino%26aufirst%3DLuca%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D24032016%26date%3D07092016%26date%3D27102016%26date%3D25082016%26volume%3D59%26issue%3D20%26spage%3D9305%26epage%3D9320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vassilios  Myrianthopoulos</span>, <span class="hlFld-ContribAuthor ">Nicolas  Gaboriaud-Kolar</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Michelle-Lynn  Hall</span>, <span class="hlFld-ContribAuthor ">Stylianos  Grigoriou</span>, <span class="hlFld-ContribAuthor ">Peter Moore  Brownlee</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Catherine  Rogers</span>, <span class="hlFld-ContribAuthor ">David  Heidenreich</span>, <span class="hlFld-ContribAuthor ">Marek  Wanior</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Drosos</span>, <span class="hlFld-ContribAuthor ">Nikitia  Mexia</span>, <span class="hlFld-ContribAuthor ">Pavel  Savitsky</span>, <span class="hlFld-ContribAuthor ">Tina  Bagratuni</span>, <span class="hlFld-ContribAuthor ">Efstathios  Kastritis</span>, <span class="hlFld-ContribAuthor ">Evangelos  Terpos</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Alexios-Leandros  Skaltsounis</span>, <span class="hlFld-ContribAuthor ">Jessica Ann  Downs</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, and <span class="hlFld-ContribAuthor ">Emmanuel  Mikros</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8787-8803. <a href="https://doi.org/10.1021/acs.jmedchem.6b00355" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252Ba%252BSelective%252BLigand%252Bfor%252Bthe%252BSwitch%25252FSucrose%252BNonfermenting-Related%252BBromodomains%252Bof%252BPolybromo%252BProtein-1%252Bby%252Bthe%252BUse%252Bof%252BVirtual%252BScreening%252Band%252BHydration%252BAnalysis%26aulast%3DMyrianthopoulos%26aufirst%3DVassilios%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07032016%26date%3D27092016%26date%3D13102016%26date%3D12092016%26volume%3D59%26issue%3D19%26spage%3D8787%26epage%3D8803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">E. Megan  Flynn</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">James E.  Audia</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Richard  Cummings</span>, <span class="hlFld-ContribAuthor ">Les A.  Dakin</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Michael C.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Hon-Ren  Huang</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Ying  Jiang</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Nasveschuk</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">Florence  Poy</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Yong  Tang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowu  Xu</span>, <span class="hlFld-ContribAuthor ">Laura E.  Zawadzke</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Steven R.  Magnuson</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, and <span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>  . </span><span class="cited-content_cbyCitation_article-title">Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5391-5402. <a href="https://doi.org/10.1021/acs.jmedchem.6b00264" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00264%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiving%252Binto%252Bthe%252BWater%25253A%252BInducible%252BBinding%252BConformations%252Bfor%252BBRD4%25252C%252BTAF1%2525282%252529%25252C%252BBRD9%25252C%252Band%252BCECR2%252BBromodomains%26aulast%3DCrawford%26aufirst%3DTerry%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D18022016%26date%3D31052016%26date%3D09062016%26date%3D24052016%26volume%3D59%26issue%3D11%26spage%3D5391%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laetitia J.  Martin</span>, <span class="hlFld-ContribAuthor ">Manfred  Koegl</span>, <span class="hlFld-ContribAuthor ">Gerd  Bader</span>, <span class="hlFld-ContribAuthor ">Xiao-Ling  Cockcroft</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Dennis  Fiegen</span>, <span class="hlFld-ContribAuthor ">Thomas  Gerstberger</span>, <span class="hlFld-ContribAuthor ">Marco H.  Hofmann</span>, <span class="hlFld-ContribAuthor ">Anja F.  Hohmann</span>, <span class="hlFld-ContribAuthor ">Dirk  Kessler</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Petr  Knesl</span>, <span class="hlFld-ContribAuthor ">Stefan  Kornigg</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Herbert  Nar</span>, <span class="hlFld-ContribAuthor ">Catherine  Rogers</span>, <span class="hlFld-ContribAuthor ">Klaus  Rumpel</span>, <span class="hlFld-ContribAuthor ">Otmar  Schaaf</span>, <span class="hlFld-ContribAuthor ">Steffen  Steurer</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Vakoc</span>, <span class="hlFld-ContribAuthor ">Markus  Zeeb</span>, <span class="hlFld-ContribAuthor ">Andreas  Zoephel</span>, <span class="hlFld-ContribAuthor ">Mark  Pearson</span>, <span class="hlFld-ContribAuthor ">Guido  Boehmelt</span>, and <span class="hlFld-ContribAuthor ">Darryl  McConnell</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4462-4475. <a href="https://doi.org/10.1021/acs.jmedchem.5b01865" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01865</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01865%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252Bin%252BVivo%252BActive%252BSelective%252BBRD9%252BInhibitor%26aulast%3DMartin%26aufirst%3DLaetitia%2BJ.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D02122015%26date%3D10032016%26date%3D26052016%26date%3D25022016%26volume%3D59%26issue%3D10%26spage%3D4462%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rezaul M.  Karim</span> and <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>  . </span><span class="cited-content_cbyCitation_article-title">An Advanced Tool To Interrogate BRD9. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4459-4461. <a href="https://doi.org/10.1021/acs.jmedchem.6b00550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252BAdvanced%252BTool%252BTo%252BInterrogate%252BBRD9%26aulast%3DKarim%26aufirst%3DRezaul%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11042016%26date%3D27042016%26date%3D26052016%26volume%3D59%26issue%3D10%26spage%3D4459%26epage%3D4461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Michael C.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Richard  Pastor</span>, <span class="hlFld-ContribAuthor ">Yves  Leblanc</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Nasveschuk</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Terry D.  Crawford</span>, <span class="hlFld-ContribAuthor ">Nico  Cantone</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Jeremy  Setser</span>, <span class="hlFld-ContribAuthor ">Jeremy  Murray</span>, <span class="hlFld-ContribAuthor ">Maureen H.  Beresini</span>, <span class="hlFld-ContribAuthor ">Gladys  de Leon Boenig</span>, <span class="hlFld-ContribAuthor ">Zhongguo  Chen</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Richard T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Leslie A.  Dakin</span>, <span class="hlFld-ContribAuthor ">E. Megan  Flynn</span>, <span class="hlFld-ContribAuthor ">Oscar W.  Huang</span>, <span class="hlFld-ContribAuthor ">Susan  Kaufman</span>, <span class="hlFld-ContribAuthor ">Patricia J.  Keller</span>, <span class="hlFld-ContribAuthor ">James R.  Kiefer</span>, <span class="hlFld-ContribAuthor ">Tommy  Lai</span>, <span class="hlFld-ContribAuthor ">Yingjie  Li</span>, <span class="hlFld-ContribAuthor ">Jiangpeng  Liao</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Henry  Lu</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">Vickie  Tsui</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Yongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaowu  Xu</span>, <span class="hlFld-ContribAuthor ">Fen  Yan</span>, <span class="hlFld-ContribAuthor ">Dong  Yu</span>, <span class="hlFld-ContribAuthor ">Laura  Zawadzke</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims, III</span>, <span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, <span class="hlFld-ContribAuthor ">James E.  Audia</span>, <span class="hlFld-ContribAuthor ">Steven  Magnuson</span>, and <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (5)
                                     , 531-536. <a href="https://doi.org/10.1021/acsmedchemlett.6b00075" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00075%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-Based%252BDiscovery%252Bof%252Ba%252BSelective%252Band%252BCell-Active%252BBenzodiazepinone%252BCBP%25252FEP300%252BBromodomain%252BInhibitor%252B%252528CPI-637%252529%26aulast%3DTaylor%26aufirst%3DAlexander%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19022016%26date%3D15032016%26date%3D25032016%26date%3D12052016%26date%3D15032016%26volume%3D7%26issue%3D5%26spage%3D531%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">Victor S.  Gehling</span>, <span class="hlFld-ContribAuthor ">Michael C.  Hewitt</span>, <span class="hlFld-ContribAuthor ">Rishi G.  Vaswani</span>, <span class="hlFld-ContribAuthor ">Alexandre  Côté</span>, <span class="hlFld-ContribAuthor ">Yves  Leblanc</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Nasveschuk</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, <span class="hlFld-ContribAuthor ">Louise  Bergeron</span>, <span class="hlFld-ContribAuthor ">Robert  Campbell</span>, <span class="hlFld-ContribAuthor ">Nico  Cantone</span>, <span class="hlFld-ContribAuthor ">Michael R.  Cooper</span>, <span class="hlFld-ContribAuthor ">Richard T.  Cummings</span>, <span class="hlFld-ContribAuthor ">Hariharan  Jayaram</span>, <span class="hlFld-ContribAuthor ">Shivangi  Joshi</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Mertz</span>, <span class="hlFld-ContribAuthor ">Adrianne  Neiss</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Normant</span>, <span class="hlFld-ContribAuthor ">Michael  O’Meara</span>, <span class="hlFld-ContribAuthor ">Eneida  Pardo</span>, <span class="hlFld-ContribAuthor ">Florence  Poy</span>, <span class="hlFld-ContribAuthor ">Peter  Sandy</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Supko</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims, III</span>, <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Alexander M.  Taylor</span>, and <span class="hlFld-ContribAuthor ">James E.  Audia</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (4)
                                     , 1330-1339. <a href="https://doi.org/10.1021/acs.jmedchem.5b01882" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BBenzoisoxazoloazepine%252BInhibitor%252B%252528CPI-0610%252529%252Bof%252Bthe%252BBromodomain%252Band%252BExtra-Terminal%252B%252528BET%252529%252BFamily%252Bas%252Ba%252BCandidate%252Bfor%252BHuman%252BClinical%252BTrials%26aulast%3DAlbrecht%26aufirst%3DBrian%2BK.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04122015%26date%3D04022016%26date%3D25022016%26date%3D27012016%26volume%3D59%26issue%3D4%26spage%3D1330%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gang  Zhang</span>, <span class="hlFld-ContribAuthor ">Shan  Li</span>, <span class="hlFld-ContribAuthor ">Kai-Wen  Cheng</span>, <span class="hlFld-ContribAuthor ">Tsui-Fen  Chou</span>. </span><span class="cited-content_cbyCitation_article-title">AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113446. <a href="https://doi.org/10.1016/j.ejmech.2021.113446" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113446%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAAA%252BATPases%252Bas%252Btherapeutic%252Btargets%25253A%252BStructure%25252C%252Bfunctions%25252C%252Band%252Bsmall-molecule%252Binhibitors%26aulast%3DZhang%26aufirst%3DGang%26date%3D2021%26volume%3D219%26spage%3D113446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">Haiquan  Fang</span>, <span class="hlFld-ContribAuthor ">John  Tokarski</span>, <span class="hlFld-ContribAuthor ">Carolynn  Fanslau</span>, <span class="hlFld-ContribAuthor ">Zuzana  Haarhoff</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Melissa  Kramer</span>, <span class="hlFld-ContribAuthor ">Krista  Menard</span>, <span class="hlFld-ContribAuthor ">Laura  Monereau</span>, <span class="hlFld-ContribAuthor ">John  Morrison</span>, <span class="hlFld-ContribAuthor ">Asoka  Ranasinghe</span>, <span class="hlFld-ContribAuthor ">Eric E.  Shields</span>, <span class="hlFld-ContribAuthor ">Ching Kim  Tye</span>, <span class="hlFld-ContribAuthor ">Richard  Westhouse</span>, <span class="hlFld-ContribAuthor ">Gerry  Everlof</span>, <span class="hlFld-ContribAuthor ">Steven  Sheriff</span>, <span class="hlFld-ContribAuthor ">Chunhong  Yan</span>, <span class="hlFld-ContribAuthor ">Frank  Marsilio</span>, <span class="hlFld-ContribAuthor ">Lisa  Zhang</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Francis  Lee</span>, <span class="hlFld-ContribAuthor ">Ashvinikumar V.  Gavai</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Degnan</span>. </span><span class="cited-content_cbyCitation_article-title">Development of BET inhibitors as potential treatments for cancer: A search for structural diversity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>44 </em>, 128108. <a href="https://doi.org/10.1016/j.bmcl.2021.128108" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128108%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252BBET%252Binhibitors%252Bas%252Bpotential%252Btreatments%252Bfor%252Bcancer%25253A%252BA%252Bsearch%252Bfor%252Bstructural%252Bdiversity%26aulast%3DHill%26aufirst%3DMatthew%2BD.%26date%3D2021%26volume%3D44%26spage%3D128108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samuel P.  Boyson</span>, <span class="hlFld-ContribAuthor ">Cong  Gao</span>, <span class="hlFld-ContribAuthor ">Kathleen  Quinn</span>, <span class="hlFld-ContribAuthor ">Joseph  Boyd</span>, <span class="hlFld-ContribAuthor ">Hana  Paculova</span>, <span class="hlFld-ContribAuthor ">Seth  Frietze</span>, <span class="hlFld-ContribAuthor ">Karen C.  Glass</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Roles of Bromodomain Proteins in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (14)
                                     , 3606. <a href="https://doi.org/10.3390/cancers13143606" title="DOI URL">https://doi.org/10.3390/cancers13143606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13143606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13143606%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DFunctional%252BRoles%252Bof%252BBromodomain%252BProteins%252Bin%252BCancer%26aulast%3DBoyson%26aufirst%3DSamuel%2BP.%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D14%26spage%3D3606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhangxu  He</span>, <span class="hlFld-ContribAuthor ">Haomiao  Jiao</span>, <span class="hlFld-ContribAuthor ">Qi  An</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Zengyangzong</span>, <span class="hlFld-ContribAuthor ">Jiale  Xu</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>, <span class="hlFld-ContribAuthor ">Liying  Ma</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>399 </em><a href="https://doi.org/10.1016/j.apsb.2021.07.018" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.07.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.07.018%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDiscovery%252Bof%252Bnovel%252B4-phenylquinazoline-based%252BBRD4%252Binhibitors%252Bfor%252Bcardiac%252Bfibrosis%26aulast%3DHe%26aufirst%3DZhangxu%26date%3D2021%26volume%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daye  Lee</span>, <span class="hlFld-ContribAuthor ">Da-Yeon  Lee</span>, <span class="hlFld-ContribAuthor ">You-Son  Hwang</span>, <span class="hlFld-ContribAuthor ">Hye-Ran  Seo</span>, <span class="hlFld-ContribAuthor ">Shin-Ai  Lee</span>, <span class="hlFld-ContribAuthor ">Jongbum  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">The Bromodomain Inhibitor PFI-3 Sensitizes Cancer Cells to DNA Damage by
                        Targeting SWI/SNF. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2021,</strong> <em>19 </em>
                                    (5)
                                     , 900-912. <a href="https://doi.org/10.1158/1541-7786.MCR-20-0289" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-20-0289</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-20-0289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-20-0289%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DThe%252BBromodomain%252BInhibitor%252BPFI-3%252BSensitizes%252BCancer%252BCells%252Bto%252BDNA%252BDamage%252Bby%252BTargeting%252BSWI%25252FSNF%26aulast%3DLee%26aufirst%3DDaye%26date%3D2021%26date%3D2020%26volume%3D19%26issue%3D5%26spage%3D900%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghua  Ren</span>, <span class="hlFld-ContribAuthor ">Wenqian  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Current status in the discovery of dual BET/HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127829. <a href="https://doi.org/10.1016/j.bmcl.2021.127829" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127829%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCurrent%252Bstatus%252Bin%252Bthe%252Bdiscovery%252Bof%252Bdual%252BBET%25252FHDAC%252Binhibitors%26aulast%3DRen%26aufirst%3DQinghua%26date%3D2021%26volume%3D38%26spage%3D127829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Xin  Mao</span>, <span class="hlFld-ContribAuthor ">Yinping  Guo</span>, <span class="hlFld-ContribAuthor ">Yangli  Zhou</span>, <span class="hlFld-ContribAuthor ">Mingxin  Chen</span>, <span class="hlFld-ContribAuthor ">Pei  Chen</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Linli  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of selective BPTF bromodomain inhibitors by screening and structure-based optimization. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2021,</strong> <em>545 </em>, 125-131. <a href="https://doi.org/10.1016/j.bbrc.2021.01.067" title="DOI URL">https://doi.org/10.1016/j.bbrc.2021.01.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2021.01.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2021.01.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DDiscovery%252Bof%252Bselective%252BBPTF%252Bbromodomain%252Binhibitors%252Bby%252Bscreening%252Band%252Bstructure-based%252Boptimization%26aulast%3DXiong%26aufirst%3DLiang%26date%3D2021%26volume%3D545%26spage%3D125%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Wu</span>, <span class="hlFld-ContribAuthor ">Dan-Qi  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Xia-Juan  Huan</span>, <span class="hlFld-ContribAuthor ">Xu-Bin  Bao</span>, <span class="hlFld-ContribAuthor ">Chang-Qing  Tian</span>, <span class="hlFld-ContribAuthor ">Jianping  Hu</span>, <span class="hlFld-ContribAuthor ">Kai-Kai  Lv</span>, <span class="hlFld-ContribAuthor ">Ying-Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Bing  Xiong</span>, <span class="hlFld-ContribAuthor ">Ze-Hong  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Novel bivalent BET inhibitor N2817 exhibits potent anticancer activity and inhibits TAF1. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>185 </em>, 114435. <a href="https://doi.org/10.1016/j.bcp.2021.114435" title="DOI URL">https://doi.org/10.1016/j.bcp.2021.114435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2021.114435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2021.114435%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DNovel%252Bbivalent%252BBET%252Binhibitor%252BN2817%252Bexhibits%252Bpotent%252Banticancer%252Bactivity%252Band%252Binhibits%252BTAF1%26aulast%3DWu%26aufirst%3DQian%26date%3D2021%26volume%3D185%26spage%3D114435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masanori  Sato</span>, <span class="hlFld-ContribAuthor ">Takekazu  Kondo</span>, <span class="hlFld-ContribAuthor ">Yasushi  Kohno</span>, <span class="hlFld-ContribAuthor ">Shigeki  Seto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of benzo[f]pyrido[4,3-b][1,4]oxazepin-10-one derivatives as orally available bromodomain and extra-terminal domain (BET) inhibitors with efficacy in an in vivo psoriatic animal model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>34 </em>, 116015. <a href="https://doi.org/10.1016/j.bmc.2021.116015" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbenzo%25255Bf%25255Dpyrido%25255B4%25252C3-b%25255D%25255B1%25252C4%25255Doxazepin-10-one%252Bderivatives%252Bas%252Borally%252Bavailable%252Bbromodomain%252Band%252Bextra-terminal%252Bdomain%252B%252528BET%252529%252Binhibitors%252Bwith%252Befficacy%252Bin%252Ban%252Bin%252Bvivo%252Bpsoriatic%252Banimal%252Bmodel%26aulast%3DSato%26aufirst%3DMasanori%26date%3D2021%26volume%3D34%26spage%3D116015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minjin  Yoo</span>, <span class="hlFld-ContribAuthor ">Tae Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Miyoun  Yoo</span>, <span class="hlFld-ContribAuthor ">Yeongrin  Kim</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Kyu Myung  Lee</span>, <span class="hlFld-ContribAuthor ">Seong Eon  Ryu</span>, <span class="hlFld-ContribAuthor ">Byung Il  Lee</span>, <span class="hlFld-ContribAuthor ">Kwan-Young  Jung</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1686. <a href="https://doi.org/10.3390/molecules26061686" title="DOI URL">https://doi.org/10.3390/molecules26061686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061686%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BAristoyagonine%252BDerivatives%252Bas%252BBrd4%252BBromodomain%252BInhibitors%252Bwith%252BX-ray%252BCo-Crystal%252BResearch%26aulast%3DYoo%26aufirst%3DMinjin%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomonaga  Ozawa</span>, <span class="hlFld-ContribAuthor ">Motoyasu  Ozawa</span>. </span><span class="cited-content_cbyCitation_article-title">Application of FMO to Ligand Design: SBDD, FBDD, and Protein–Protein Interaction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 205-251. <a href="https://doi.org/10.1007/978-981-15-9235-5_10" title="DOI URL">https://doi.org/10.1007/978-981-15-9235-5_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-9235-5_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-9235-5_10%26sid%3Dliteratum%253Aachs%26atitle%3DApplication%252Bof%252BFMO%252Bto%252BLigand%252BDesign%25253A%252BSBDD%25252C%252BFBDD%25252C%252Band%252BProtein%2525E2%252580%252593Protein%252BInteraction%26aulast%3DOzawa%26aufirst%3DTomonaga%26date%3D2021%26date%3D2021%26spage%3D205%26epage%3D251%26pub%3DSpringer%2520Singapore%26atitle%3DRecent%252BAdvances%252Bof%252Bthe%252BFragment%252BMolecular%252BOrbital%252BMethod%26aulast%3DMochizuki%26aufirst%3DYuji%26date%3D2021%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinghua  Ren</span>, <span class="hlFld-ContribAuthor ">Wenqian  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Current status in the discovery of dual BET/HDAC inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>31 </em>, 127671. <a href="https://doi.org/10.1016/j.bmcl.2020.127671" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127671</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127671%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCurrent%252Bstatus%252Bin%252Bthe%252Bdiscovery%252Bof%252Bdual%252BBET%25252FHDAC%252Binhibitors%26aulast%3DRen%26aufirst%3DQinghua%26date%3D2021%26volume%3D31%26spage%3D127671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhang-Xu  He</span>, <span class="hlFld-ContribAuthor ">Bing-Fei  Wei</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun-Peng  Gong</span>, <span class="hlFld-ContribAuthor ">Li-Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Wen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Current development of CBP/p300 inhibitors in the last decade. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112861. <a href="https://doi.org/10.1016/j.ejmech.2020.112861" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112861</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112861%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCurrent%252Bdevelopment%252Bof%252BCBP%25252Fp300%252Binhibitors%252Bin%252Bthe%252Blast%252Bdecade%26aulast%3DHe%26aufirst%3DZhang-Xu%26date%3D2021%26volume%3D209%26spage%3D112861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saamanthi  M</span>, <span class="hlFld-ContribAuthor ">Aruna  S</span>, <span class="hlFld-ContribAuthor ">Girija  R</span>, <span class="hlFld-ContribAuthor ">D.  Vinod</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis novel Pyrazolopyridine derivatives and CREBBP bromodomain inhibitors docking and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Materials Today: Proceedings</span><span> <strong>2021,</strong> <em>45 </em>, 7200-7207. <a href="https://doi.org/10.1016/j.matpr.2021.02.416" title="DOI URL">https://doi.org/10.1016/j.matpr.2021.02.416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matpr.2021.02.416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matpr.2021.02.416%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%253A%2520Proceedings%26atitle%3DDesign%25252C%252Bsynthesis%252Bnovel%252BPyrazolopyridine%252Bderivatives%252Band%252BCREBBP%252Bbromodomain%252Binhibitors%252Bdocking%252Band%252Bmolecular%252Bdynamics%26aulast%3DM%26aufirst%3DSaamanthi%26date%3D2021%26volume%3D45%26spage%3D7200%26epage%3D7207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun  Padmanabhan</span>, <span class="hlFld-ContribAuthor ">Michael  Alexanian</span>, <span class="hlFld-ContribAuthor ">Ricardo  Linares-Saldana</span>, <span class="hlFld-ContribAuthor ">Bárbara  González-Terán</span>, <span class="hlFld-ContribAuthor ">Gaia  Andreoletti</span>, <span class="hlFld-ContribAuthor ">Yu  Huang</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Connolly</span>, <span class="hlFld-ContribAuthor ">Wonho  Kim</span>, <span class="hlFld-ContribAuthor ">Austin  Hsu</span>, <span class="hlFld-ContribAuthor ">Qiming  Duan</span>, <span class="hlFld-ContribAuthor ">Sarah A.B.  Winchester</span>, <span class="hlFld-ContribAuthor ">Franco  Felix</span>, <span class="hlFld-ContribAuthor ">Juan A.  Perez-Bermejo</span>, <span class="hlFld-ContribAuthor ">Qiaohong  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Parisha P.  Shah</span>, <span class="hlFld-ContribAuthor ">Saptarsi M.  Haldar</span>, <span class="hlFld-ContribAuthor ">Rajan  Jain</span>, <span class="hlFld-ContribAuthor ">Deepak  Srivastava</span>. </span><span class="cited-content_cbyCitation_article-title">BRD4 (Bromodomain-Containing Protein 4) Interacts with GATA4 (GATA Binding Protein 4) to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes. </span><span class="cited-content_cbyCitation_journal-name">Circulation</span><span> <strong>2020,</strong> <em>142 </em>
                                    (24)
                                     , 2338-2355. <a href="https://doi.org/10.1161/CIRCULATIONAHA.120.047753" title="DOI URL">https://doi.org/10.1161/CIRCULATIONAHA.120.047753</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/CIRCULATIONAHA.120.047753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FCIRCULATIONAHA.120.047753%26sid%3Dliteratum%253Aachs%26jtitle%3DCirculation%26atitle%3DBRD4%252B%252528Bromodomain-Containing%252BProtein%252B4%252529%252BInteracts%252Bwith%252BGATA4%252B%252528GATA%252BBinding%252BProtein%252B4%252529%252Bto%252BGovern%252BMitochondrial%252BHomeostasis%252Bin%252BAdult%252BCardiomyocytes%26aulast%3DPadmanabhan%26aufirst%3DArun%26date%3D2020%26volume%3D142%26issue%3D24%26spage%3D2338%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seul Gi  Park</span>, <span class="hlFld-ContribAuthor ">Daye  Lee</span>, <span class="hlFld-ContribAuthor ">Hye-Ran  Seo</span>, <span class="hlFld-ContribAuthor ">Shin-Ai  Lee</span>, <span class="hlFld-ContribAuthor ">Jongbum  Kwon</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-73500-7" title="DOI URL">https://doi.org/10.1038/s41598-020-73500-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-73500-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-73500-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCytotoxic%252Bactivity%252Bof%252Bbromodomain%252Binhibitor%252BNVS-CECR2-1%252Bon%252Bhuman%252Bcancer%252Bcells%26aulast%3DPark%26aufirst%3DSeul%2BGi%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Huang</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Zhao</span>, <span class="hlFld-ContribAuthor ">Wootae  Kim</span>, <span class="hlFld-ContribAuthor ">Xinyi  Tu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Somaira  Nowsheen</span>, <span class="hlFld-ContribAuthor ">Qian  Zhu</span>, <span class="hlFld-ContribAuthor ">Min  Deng</span>, <span class="hlFld-ContribAuthor ">Yuping  Chen</span>, <span class="hlFld-ContribAuthor ">Bo  Qin</span>, <span class="hlFld-ContribAuthor ">Kuntian  Luo</span>, <span class="hlFld-ContribAuthor ">Baohua  Liu</span>, <span class="hlFld-ContribAuthor ">Zhenkun  Lou</span>, <span class="hlFld-ContribAuthor ">Robert W.  Mutter</span>, <span class="hlFld-ContribAuthor ">Jian  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">The bromodomain containing protein BRD-9 orchestrates RAD51–RAD54 complex formation and regulates homologous recombination-mediated repair. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-16443-x" title="DOI URL">https://doi.org/10.1038/s41467-020-16443-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-16443-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-16443-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Bbromodomain%252Bcontaining%252Bprotein%252BBRD-9%252Borchestrates%252BRAD51%2525E2%252580%252593RAD54%252Bcomplex%252Bformation%252Band%252Bregulates%252Bhomologous%252Brecombination-mediated%252Brepair%26aulast%3DZhou%26aufirst%3DQin%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linghua  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanshuang  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaopeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrazolone fused benzodiazepines
              via
              Rh(
              iii
              )-catalyzed [4 + 3] annulation of 1-phenylpyrazolidinones with propargyl alcohols. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2020,</strong> <em>7 </em>
                                    (16)
                                     , 2284-2290. <a href="https://doi.org/10.1039/D0QO00657B" title="DOI URL">https://doi.org/10.1039/D0QO00657B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0QO00657B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0QO00657B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Bof%252Bpyrazolone%252Bfused%252Bbenzodiazepines%252Bvia%252BRh%252528%252Biii%252B%252529-catalyzed%252B%25255B4%252B%25252B%252B3%25255D%252Bannulation%252Bof%252B1-phenylpyrazolidinones%252Bwith%252Bpropargyl%252Balcohols%26aulast%3DZhang%26aufirst%3DLinghua%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D16%26spage%3D2284%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ehab  Ghazy</span>, <span class="hlFld-ContribAuthor ">Patrik  Zeyen</span>, <span class="hlFld-ContribAuthor ">Daniel  Herp</span>, <span class="hlFld-ContribAuthor ">Martin  Hügle</span>, <span class="hlFld-ContribAuthor ">Karin  Schmidtkunz</span>, <span class="hlFld-ContribAuthor ">Frank  Erdmann</span>, <span class="hlFld-ContribAuthor ">Dina  Robaa</span>, <span class="hlFld-ContribAuthor ">Matthias  Schmidt</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Morales</span>, <span class="hlFld-ContribAuthor ">Christophe  Romier</span>, <span class="hlFld-ContribAuthor ">Stefan  Günther</span>, <span class="hlFld-ContribAuthor ">Manfred  Jung</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112338. <a href="https://doi.org/10.1016/j.ejmech.2020.112338" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112338%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bdual%252Btargeting%252Binhibitors%252Bof%252Bhistone%252Bdeacetylase%252B6%25252F8%252Band%252Bbromodomain%252BBRPF1%26aulast%3DGhazy%26aufirst%3DEhab%26date%3D2020%26volume%3D200%26spage%3D112338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dailin  Liang</span>, <span class="hlFld-ContribAuthor ">Yifan  Yu</span>, <span class="hlFld-ContribAuthor ">Zonghui  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112426. <a href="https://doi.org/10.1016/j.ejmech.2020.112426" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112426%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bstrategies%252Btargeting%252Bbromodomain-containing%252Bprotein%252B4%252B%252528BRD4%252529%252Bfor%252Bcancer%252Bdrug%252Bdiscovery%26aulast%3DLiang%26aufirst%3DDailin%26date%3D2020%26volume%3D200%26spage%3D112426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijun  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Li</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Lixun  Huang</span>, <span class="hlFld-ContribAuthor ">Yuying  Yao</span>, <span class="hlFld-ContribAuthor ">Liuyou  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Chen</span>, <span class="hlFld-ContribAuthor ">Rongxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Lijing  Wang</span>, <span class="hlFld-ContribAuthor ">Qian-Qian  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.01043" title="DOI URL">https://doi.org/10.3389/fphar.2020.01043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.01043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.01043%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BBromodomain-Containing%252BProtein%252B4%252B%252528BRD4%252529%252BInhibitor%252BSuppresses%252BAngiogenesis%252Bby%252BRegulating%252BAP-1%252BExpression%26aulast%3DZhou%26aufirst%3DZijun%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Mandell</span>, <span class="hlFld-ContribAuthor ">Bhaskar  Saha</span>, <span class="hlFld-ContribAuthor ">Todd A.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00308" title="DOI URL">https://doi.org/10.3389/fphar.2020.00308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00308%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BTripartite%252BNexus%25253A%252BAutophagy%25252C%252BCancer%25252C%252Band%252BTripartite%252BMotif-Containing%252BProtein%252BFamily%252BMembers%26aulast%3DMandell%26aufirst%3DMichael%2BA.%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoel  Rodríguez</span>, <span class="hlFld-ContribAuthor ">Guillermo  Gerona‐Navarro</span>, <span class="hlFld-ContribAuthor ">Roman  Osman</span>, <span class="hlFld-ContribAuthor ">Ming‐Ming  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2020,</strong> <em>88 </em>
                                    (3)
                                     , 414-430. <a href="https://doi.org/10.1002/prot.25818" title="DOI URL">https://doi.org/10.1002/prot.25818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25818%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DIn%252Bsilico%252Bdesign%252Band%252Bmolecular%252Bbasis%252Bfor%252Bthe%252Bselectivity%252Bof%252BOlinone%252Btoward%252Bthe%252Bfirst%252Bover%252Bthe%252Bsecond%252Bbromodomain%252Bof%252BBRD4%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DYoel%26date%3D2020%26date%3D2019%26volume%3D88%26issue%3D3%26spage%3D414%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Wisniewski</span>, <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>. </span><span class="cited-content_cbyCitation_article-title">BET proteins: Investigating BRDT as a potential target for male contraception. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (6)
                                     , 126958. <a href="https://doi.org/10.1016/j.bmcl.2020.126958" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126958</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126958%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBET%252Bproteins%25253A%252BInvestigating%252BBRDT%252Bas%252Ba%252Bpotential%252Btarget%252Bfor%252Bmale%252Bcontraception%26aulast%3DWisniewski%26aufirst%3DAndrea%26date%3D2020%26volume%3D30%26issue%3D6%26spage%3D126958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng-cai  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhong-ya  Sun</span>, <span class="hlFld-ContribAuthor ">Li-ping  Liao</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Dan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-tao  Chen</span>, <span class="hlFld-ContribAuthor ">Sen-hao  Xiao</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Li-yan  Yue</span>, <span class="hlFld-ContribAuthor ">Dao-hai  Du</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Chuan-peng  Liu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (2)
                                     , 286-292. <a href="https://doi.org/10.1038/s41401-019-0256-2" title="DOI URL">https://doi.org/10.1038/s41401-019-0256-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-019-0256-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-019-0256-2%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DDiscovery%252Bof%252Bnovel%252BCBP%252Bbromodomain%252Binhibitors%252Bthrough%252BTR-FRET-based%252Bhigh-throughput%252Bscreening%26aulast%3DZhang%26aufirst%3DFeng-cai%26date%3D2020%26date%3D2019%26volume%3D41%26issue%3D2%26spage%3D286%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huihui  Zhu</span>, <span class="hlFld-ContribAuthor ">Tao  Wei</span>, <span class="hlFld-ContribAuthor ">Yong  Cai</span>, <span class="hlFld-ContribAuthor ">Jingji  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecules Targeting the Specific Domains of Histone-Mark Readers in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (3)
                                     , 578. <a href="https://doi.org/10.3390/molecules25030578" title="DOI URL">https://doi.org/10.3390/molecules25030578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25030578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25030578%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSmall%252BMolecules%252BTargeting%252Bthe%252BSpecific%252BDomains%252Bof%252BHistone-Mark%252BReaders%252Bin%252BCancer%252BTherapy%26aulast%3DZhu%26aufirst%3DHuihui%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D3%26spage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iwona A.  Ciechomska</span>, <span class="hlFld-ContribAuthor ">Chinchu  Jayaprakash</span>, <span class="hlFld-ContribAuthor ">Marta  Maleszewska</span>, <span class="hlFld-ContribAuthor ">Bozena  Kaminska</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Modifying Enzymes and Chromatin Modifiers in Glioma Pathobiology and Therapy Responses. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 259-279. <a href="https://doi.org/10.1007/978-3-030-30651-9_13" title="DOI URL">https://doi.org/10.1007/978-3-030-30651-9_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-30651-9_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-30651-9_13%26sid%3Dliteratum%253Aachs%26atitle%3DHistone%252BModifying%252BEnzymes%252Band%252BChromatin%252BModifiers%252Bin%252BGlioma%252BPathobiology%252Band%252BTherapy%252BResponses%26aulast%3DCiechomska%26aufirst%3DIwona%2BA.%26date%3D2020%26date%3D2020%26spage%3D259%26epage%3D279%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DGlioma%252BSignaling%26aulast%3DBara%25C5%2584ska%26aufirst%3DJolanta%26date%3D2020%26volume%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Utpala Nanda  Chowdhury</span>, <span class="hlFld-ContribAuthor ">M. Babul  Islam</span>, <span class="hlFld-ContribAuthor ">Shamim  Ahmad</span>, <span class="hlFld-ContribAuthor ">Mohammad Ali  Moni</span>. </span><span class="cited-content_cbyCitation_article-title">Network-based identification of genetic factors in ageing, lifestyle and type 2 diabetes that influence to the progression of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Informatics in Medicine Unlocked</span><span> <strong>2020,</strong> <em>19 </em>, 100309. <a href="https://doi.org/10.1016/j.imu.2020.100309" title="DOI URL">https://doi.org/10.1016/j.imu.2020.100309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.imu.2020.100309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.imu.2020.100309%26sid%3Dliteratum%253Aachs%26jtitle%3DInformatics%2520in%2520Medicine%2520Unlocked%26atitle%3DNetwork-based%252Bidentification%252Bof%252Bgenetic%252Bfactors%252Bin%252Bageing%25252C%252Blifestyle%252Band%252Btype%252B2%252Bdiabetes%252Bthat%252Binfluence%252Bto%252Bthe%252Bprogression%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DChowdhury%26aufirst%3DUtpala%2BNanda%26date%3D2020%26volume%3D19%26spage%3D100309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Homa  Rahnamoun</span>, <span class="hlFld-ContribAuthor ">Paola  Orozco</span>, <span class="hlFld-ContribAuthor ">Shannon M.  Lauberth</span>. </span><span class="cited-content_cbyCitation_article-title">The role of enhancer RNAs in epigenetic regulation of gene expression. </span><span class="cited-content_cbyCitation_journal-name">Transcription</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 19-25. <a href="https://doi.org/10.1080/21541264.2019.1698934" title="DOI URL">https://doi.org/10.1080/21541264.2019.1698934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21541264.2019.1698934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21541264.2019.1698934%26sid%3Dliteratum%253Aachs%26jtitle%3DTranscription%26atitle%3DThe%252Brole%252Bof%252Benhancer%252BRNAs%252Bin%252Bepigenetic%252Bregulation%252Bof%252Bgene%252Bexpression%26aulast%3DRahnamoun%26aufirst%3DHoma%26date%3D2020%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Wang</span>, <span class="hlFld-ContribAuthor ">Dabo  Pan</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 713-725. <a href="https://doi.org/10.1080/14756366.2020.1740924" title="DOI URL">https://doi.org/10.1080/14756366.2020.1740924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1740924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1740924%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BATAD2%252Bbromodomain%252Binhibitors%252Bthat%252Btrigger%252Bapoptosis%252Band%252Bautophagy%252Bin%252Bbreast%252Bcells%252Bby%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DYao%26aufirst%3DDahong%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D713%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliet O.  Obi</span>, <span class="hlFld-ContribAuthor ">Mulu Y.  Lubula</span>, <span class="hlFld-ContribAuthor ">Gabriel  Cornilescu</span>, <span class="hlFld-ContribAuthor ">Amy  Henrickson</span>, <span class="hlFld-ContribAuthor ">Kara  McGuire</span>, <span class="hlFld-ContribAuthor ">Chiara M.  Evans</span>, <span class="hlFld-ContribAuthor ">Margaret  Phillips</span>, <span class="hlFld-ContribAuthor ">Samuel P.  Boyson</span>, <span class="hlFld-ContribAuthor ">Borries  Demeler</span>, <span class="hlFld-ContribAuthor ">John L.  Markley</span>, <span class="hlFld-ContribAuthor ">Karen C.  Glass</span>. </span><span class="cited-content_cbyCitation_article-title">The BRPF1 bromodomain is a molecular reader of di-acetyllysine. </span><span class="cited-content_cbyCitation_journal-name">Current Research in Structural Biology</span><span> <strong>2020,</strong> <em>2 </em>, 104-115. <a href="https://doi.org/10.1016/j.crstbi.2020.05.001" title="DOI URL">https://doi.org/10.1016/j.crstbi.2020.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crstbi.2020.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crstbi.2020.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Research%2520in%2520Structural%2520Biology%26atitle%3DThe%252BBRPF1%252Bbromodomain%252Bis%252Ba%252Bmolecular%252Breader%252Bof%252Bdi-acetyllysine%26aulast%3DObi%26aufirst%3DJuliet%2BO.%26date%3D2020%26volume%3D2%26spage%3D104%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">Mustafa  Moroglu</span>, <span class="hlFld-ContribAuthor ">David M. H.  Ascough</span>, <span class="hlFld-ContribAuthor ">Anna E. R.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Jos J. A. G.  Kamps</span>, <span class="hlFld-ContribAuthor ">Angelina R.  Sekirnik</span>, <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Chemische Epigenetik: der Einfluss chemischer und chemo‐biologischer Techniken auf die Zielstruktur‐Validierung von Bromodomänen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (50)
                                     , 18096-18120. <a href="https://doi.org/10.1002/ange.201812164" title="DOI URL">https://doi.org/10.1002/ange.201812164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201812164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201812164%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemische%252BEpigenetik%25253A%252Bder%252BEinfluss%252Bchemischer%252Bund%252Bchemo%2525E2%252580%252590biologischer%252BTechniken%252Bauf%252Bdie%252BZielstruktur%2525E2%252580%252590Validierung%252Bvon%252BBromodom%2525C3%2525A4nen%26aulast%3DSchiedel%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D50%26spage%3D18096%26epage%3D18120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">Mustafa  Moroglu</span>, <span class="hlFld-ContribAuthor ">David M. H.  Ascough</span>, <span class="hlFld-ContribAuthor ">Anna E. R.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Jos J. A. G.  Kamps</span>, <span class="hlFld-ContribAuthor ">Angelina R.  Sekirnik</span>, <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Epigenetics: The Impact of Chemical and Chemical Biology Techniques on Bromodomain Target Validation. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (50)
                                     , 17930-17952. <a href="https://doi.org/10.1002/anie.201812164" title="DOI URL">https://doi.org/10.1002/anie.201812164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201812164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201812164%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemical%252BEpigenetics%25253A%252BThe%252BImpact%252Bof%252BChemical%252Band%252BChemical%252BBiology%252BTechniques%252Bon%252BBromodomain%252BTarget%252BValidation%26aulast%3DSchiedel%26aufirst%3DMatthias%26date%3D2019%26volume%3D58%26issue%3D50%26spage%3D17930%26epage%3D17952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.P.  Hilton-Proctor</span>, <span class="hlFld-ContribAuthor ">O.  Ilyichova</span>, <span class="hlFld-ContribAuthor ">Z.  Zheng</span>, <span class="hlFld-ContribAuthor ">I.G.  Jennings</span>, <span class="hlFld-ContribAuthor ">R.W.  Johnstone</span>, <span class="hlFld-ContribAuthor ">J.  Shortt</span>, <span class="hlFld-ContribAuthor ">S.J.  Mountford</span>, <span class="hlFld-ContribAuthor ">M.J.  Scanlon</span>, <span class="hlFld-ContribAuthor ">P.E.  Thompson</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and elaboration of N-methylpyrrolidone as an acetamide fragment substitute in bromodomain inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (24)
                                     , 115157. <a href="https://doi.org/10.1016/j.bmc.2019.115157" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115157</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115157%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Belaboration%252Bof%252BN-methylpyrrolidone%252Bas%252Ban%252Bacetamide%252Bfragment%252Bsubstitute%252Bin%252Bbromodomain%252Binhibition%26aulast%3DHilton-Proctor%26aufirst%3DJ.P.%26date%3D2019%26volume%3D27%26issue%3D24%26spage%3D115157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Cai  He</span>, <span class="hlFld-ContribAuthor ">Manni  Wang</span>, <span class="hlFld-ContribAuthor ">Xuelei  Ma</span>, <span class="hlFld-ContribAuthor ">Fei  Mo</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Junhong  Han</span>, <span class="hlFld-ContribAuthor ">Xiawei  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-019-0095-0" title="DOI URL">https://doi.org/10.1038/s41392-019-0095-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-019-0095-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-019-0095-0%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DTargeting%252Bepigenetic%252Bregulators%252Bfor%252Bcancer%252Btherapy%25253A%252Bmechanisms%252Band%252Badvances%252Bin%252Bclinical%252Btrials%26aulast%3DCheng%26aufirst%3DYuan%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deheng  Chen</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Ziqin  Yan</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Feilong  Zhou</span>, <span class="hlFld-ContribAuthor ">Xilin  Lyu</span>, <span class="hlFld-ContribAuthor ">Biling  Xu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111633. <a href="https://doi.org/10.1016/j.ejmech.2019.111633" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111633%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252Bstructural%252Binsight%25252C%252Band%252Bbioactivities%252Bof%252BBY27%252Bas%252Ba%252Bselective%252Binhibitor%252Bof%252Bthe%252Bsecond%252Bbromodomains%252Bof%252BBET%252Bproteins%26aulast%3DChen%26aufirst%3DDeheng%26date%3D2019%26volume%3D182%26spage%3D111633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Rong</span>, <span class="hlFld-ContribAuthor ">Zhan-Zhan  Feng</span>, <span class="hlFld-ContribAuthor ">Yao-Jie  Shi</span>, <span class="hlFld-ContribAuthor ">Jing  Ren</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>, <span class="hlFld-ContribAuthor ">Ning-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Qiang  Xue</span>, <span class="hlFld-ContribAuthor ">Kun-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Shu-Yan  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Luo-Ting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (19)
                                     , 126577. <a href="https://doi.org/10.1016/j.bmcl.2019.07.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C5-dimethylisoxazole%252Band%252Bpyridone%252Bderivatives%252Bas%252BBRD4%252Binhibitors%26aulast%3DRong%26aufirst%3DJuan%26date%3D2019%26volume%3D29%26issue%3D19%26spage%3D126577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franca-Maria  Klingler</span>, <span class="hlFld-ContribAuthor ">Marcus  Gastreich</span>, <span class="hlFld-ContribAuthor ">Oleksandr  Grygorenko</span>, <span class="hlFld-ContribAuthor ">Olena  Savych</span>, <span class="hlFld-ContribAuthor ">Petro  Borysko</span>, <span class="hlFld-ContribAuthor ">Anastasia  Griniukova</span>, <span class="hlFld-ContribAuthor ">Kateryna  Gubina</span>, <span class="hlFld-ContribAuthor ">Christian  Lemmen</span>, <span class="hlFld-ContribAuthor ">Yurii  Moroz</span>. </span><span class="cited-content_cbyCitation_article-title">SAR by Space: Enriching Hit Sets from the Chemical Space. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (17)
                                     , 3096. <a href="https://doi.org/10.3390/molecules24173096" title="DOI URL">https://doi.org/10.3390/molecules24173096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24173096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24173096%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSAR%252Bby%252BSpace%25253A%252BEnriching%252BHit%252BSets%252Bfrom%252Bthe%252BChemical%252BSpace%26aulast%3DKlingler%26aufirst%3DFranca-Maria%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D17%26spage%3D3096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Speck-Planche</span>, <span class="hlFld-ContribAuthor ">Marcus T.  Scotti</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 555-572. <a href="https://doi.org/10.1007/s11030-018-9890-8" title="DOI URL">https://doi.org/10.1007/s11030-018-9890-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9890-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9890-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DBET%252Bbromodomain%252Binhibitors%25253A%252Bfragment-based%252Bin%252Bsilico%252Bdesign%252Busing%252Bmulti-target%252BQSAR%252Bmodels%26aulast%3DSpeck-Planche%26aufirst%3DAlejandro%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D555%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea G.  Cochran</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Conery</span>, <span class="hlFld-ContribAuthor ">Robert J.  Sims</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomains: a new target class for drug development. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2019,</strong> <em>18 </em>
                                    (8)
                                     , 609-628. <a href="https://doi.org/10.1038/s41573-019-0030-7" title="DOI URL">https://doi.org/10.1038/s41573-019-0030-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41573-019-0030-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41573-019-0030-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBromodomains%25253A%252Ba%252Bnew%252Btarget%252Bclass%252Bfor%2525C2%2525A0drug%252Bdevelopment%26aulast%3DCochran%26aufirst%3DAndrea%2BG.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D8%26spage%3D609%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li Ting  Song</span>, <span class="hlFld-ContribAuthor ">Jing  Tu</span>, <span class="hlFld-ContribAuthor ">Rui Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Min  Zhu</span>, <span class="hlFld-ContribAuthor ">Ya Jie  Meng</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism study of several inhibitors binding to BRD9 bromodomain based on molecular simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (11)
                                     , 2970-2979. <a href="https://doi.org/10.1080/07391102.2018.1502097" title="DOI URL">https://doi.org/10.1080/07391102.2018.1502097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1502097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1502097%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bmechanism%252Bstudy%252Bof%252Bseveral%252Binhibitors%252Bbinding%252Bto%252BBRD9%252Bbromodomain%252Bbased%252Bon%252Bmolecular%252Bsimulations%26aulast%3DSong%26aufirst%3DLi%2BTing%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D11%26spage%3D2970%26epage%3D2979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Han</span>, <span class="hlFld-ContribAuthor ">Wenchao  Lu</span>, <span class="hlFld-ContribAuthor ">Fulin  Lian</span>, <span class="hlFld-ContribAuthor ">Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Tian  Lu</span>, <span class="hlFld-ContribAuthor ">Hongru  Tao</span>, <span class="hlFld-ContribAuthor ">Senhao  Xiao</span>, <span class="hlFld-ContribAuthor ">Fengcai  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Chih  Liu</span>, <span class="hlFld-ContribAuthor ">Rongfeng  Liu</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Chunshen  Zhao</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 494-500. <a href="https://doi.org/10.1016/j.bioorg.2019.01.035" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Balkoxy%252Bbenzamide%252Bderivatives%252Bas%252Bnovel%252BBPTF%252Bbromodomain%252Binhibitors%252Bvia%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DZhang%26aufirst%3DDan%26date%3D2019%26volume%3D86%26spage%3D494%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyh-Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Makoto  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Strovel</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Urban</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Ajit  Jadhav</span>, <span class="hlFld-ContribAuthor ">David J.  Maloney</span>. </span><span class="cited-content_cbyCitation_article-title">Lead optimization and efficacy evaluation of quinazoline-based BET family inhibitors for potential treatment of cancer and inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (10)
                                     , 1220-1226. <a href="https://doi.org/10.1016/j.bmcl.2019.03.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.03.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.03.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLead%252Boptimization%252Band%252Befficacy%252Bevaluation%252Bof%252Bquinazoline-based%252BBET%252Bfamily%252Binhibitors%252Bfor%252Bpotential%252Btreatment%252Bof%252Bcancer%252Band%252Binflammatory%252Bdiseases%26aulast%3DYang%26aufirst%3DShyh-Ming%26date%3D2019%26volume%3D29%26issue%3D10%26spage%3D1220%26epage%3D1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Valenti</span>, <span class="hlFld-ContribAuthor ">Stanimira  Hristeva</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Tzalis</span>, <span class="hlFld-ContribAuthor ">Christian  Ottmann</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical candidates modulating protein-protein interactions: The fragment-based experience. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 76-95. <a href="https://doi.org/10.1016/j.ejmech.2019.01.084" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.084%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DClinical%252Bcandidates%252Bmodulating%252Bprotein-protein%252Binteractions%25253A%252BThe%252Bfragment-based%252Bexperience%26aulast%3DValenti%26aufirst%3DDario%26date%3D2019%26volume%3D167%26spage%3D76%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy  Donner</span>, <span class="hlFld-ContribAuthor ">Heather  King</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>, <span class="hlFld-ContribAuthor ">Moses  Moustakim</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Probes. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 133-152. <a href="https://doi.org/10.1002/9783527809257.ch6" title="DOI URL">https://doi.org/10.1002/9783527809257.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527809257.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527809257.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DChemical%252BProbes%26aulast%3DDonner%26aufirst%3DAmy%26date%3D2019%26date%3D2019%26spage%3D133%26epage%3D152%26pub%3DWiley%26atitle%3DEpigenetic%252BDrug%252BDiscovery%26aulast%3DSippl%26aufirst%3DWolfgang%26date%3D2019%26date%3D2019%26volume%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie C.  Gay</span>, <span class="hlFld-ContribAuthor ">Brian E.  Eckenroth</span>, <span class="hlFld-ContribAuthor ">Chiara M.  Evans</span>, <span class="hlFld-ContribAuthor ">Cassiano  Langini</span>, <span class="hlFld-ContribAuthor ">Samuel  Carlson</span>, <span class="hlFld-ContribAuthor ">Jonathan T.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, <span class="hlFld-ContribAuthor ">Karen C.  Glass</span>. </span><span class="cited-content_cbyCitation_article-title">Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2019,</strong> <em>87 </em>
                                    (2)
                                     , 157-167. <a href="https://doi.org/10.1002/prot.25636" title="DOI URL">https://doi.org/10.1002/prot.25636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25636%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DDisulfide%252Bbridge%252Bformation%252Binfluences%252Bligand%252Brecognition%252Bby%252Bthe%252BATAD2%252Bbromodomain%26aulast%3DGay%26aufirst%3DJamie%2BC.%26date%3D2019%26date%3D2018%26volume%3D87%26issue%3D2%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomomi  Noguchi-Yachide</span>. </span><span class="cited-content_cbyCitation_article-title">Regulators of Histone Acetylation: Bromodomain Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 463-473. <a href="https://doi.org/10.1016/B978-0-12-813939-4.00010-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-813939-4.00010-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813939-4.00010-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813939-4.00010-3%26sid%3Dliteratum%253Aachs%26atitle%3DRegulators%252Bof%252BHistone%252BAcetylation%25253A%252BBromodomain%252BInhibitors%26aulast%3DNoguchi-Yachide%26aufirst%3DTomomi%26date%3D2019%26spage%3D463%26epage%3D473%26pub%3DElsevier%26atitle%3DPharmacoepigenetics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan J.  Dupper</span>, <span class="hlFld-ContribAuthor ">Yingsheng  Zhou</span>, <span class="hlFld-ContribAuthor ">Jérôme  Govin</span>, <span class="hlFld-ContribAuthor ">Charles E.  McKenna</span>. </span><span class="cited-content_cbyCitation_article-title">Bromodomain Inhibition and Its Application to Human Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 475-492. <a href="https://doi.org/10.1016/B978-0-12-813939-4.00011-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-813939-4.00011-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813939-4.00011-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813939-4.00011-5%26sid%3Dliteratum%253Aachs%26atitle%3DBromodomain%252BInhibition%252Band%252BIts%252BApplication%252Bto%252BHuman%252BDisease%26aulast%3DDupper%26aufirst%3DNathan%2BJ.%26date%3D2019%26spage%3D475%26epage%3D492%26pub%3DElsevier%26atitle%3DPharmacoepigenetics%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Gu</span>, <span class="hlFld-ContribAuthor ">Beibei  Wang</span>, <span class="hlFld-ContribAuthor ">Wenhai  Huang</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen  Ma</span>, <span class="hlFld-ContribAuthor ">Shenxin  Zeng</span>, <span class="hlFld-ContribAuthor ">Zhengrong  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel coumarin derivatives as potent and orally bioavailable BRD4 inhibitors based on scaffold hopping. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 808-817. <a href="https://doi.org/10.1080/14756366.2019.1587417" title="DOI URL">https://doi.org/10.1080/14756366.2019.1587417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1587417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1587417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bcoumarin%252Bderivatives%252Bas%252Bpotent%252Band%252Borally%252Bbioavailable%252BBRD4%252Binhibitors%252Bbased%252Bon%252Bscaffold%252Bhopping%26aulast%3DZhang%26aufirst%3DZhimin%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D808%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical Protein Degradation Approach and its Application to Epigenetic Targets. </span><span class="cited-content_cbyCitation_journal-name">The Chemical Record</span><span> <strong>2018,</strong> <em>18 </em>
                                    (12)
                                     , 1681-1700. <a href="https://doi.org/10.1002/tcr.201800032" title="DOI URL">https://doi.org/10.1002/tcr.201800032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/tcr.201800032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ftcr.201800032%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Chemical%2520Record%26atitle%3DChemical%252BProtein%252BDegradation%252BApproach%252Band%252Bits%252BApplication%252Bto%252BEpigenetic%252BTargets%26aulast%3DItoh%26aufirst%3DYukihiro%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D12%26spage%3D1681%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju  Dash</span>, <span class="hlFld-ContribAuthor ">Sarmistha  Mitra</span>, <span class="hlFld-ContribAuthor ">Md.  Arifuzzaman</span>, <span class="hlFld-ContribAuthor ">S. M.  Zahid Hosen</span>. </span><span class="cited-content_cbyCitation_article-title">In silico quest of selective naphthyl-based CREBBP bromodomain inhibitor. </span><span class="cited-content_cbyCitation_journal-name">In Silico Pharmacology</span><span> <strong>2018,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40203-018-0038-4" title="DOI URL">https://doi.org/10.1007/s40203-018-0038-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40203-018-0038-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40203-018-0038-4%26sid%3Dliteratum%253Aachs%26jtitle%3DIn%2520Silico%2520Pharmacology%26atitle%3DIn%252Bsilico%252Bquest%252Bof%252Bselective%252Bnaphthyl-based%252BCREBBP%252Bbromodomain%252Binhibitor%26aulast%3DDash%26aufirst%3DRaju%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kavitha  Ramaswamy</span>, <span class="hlFld-ContribAuthor ">Lauren  Forbes</span>, <span class="hlFld-ContribAuthor ">Gerard  Minuesa</span>, <span class="hlFld-ContribAuthor ">Tatyana  Gindin</span>, <span class="hlFld-ContribAuthor ">Fiona  Brown</span>, <span class="hlFld-ContribAuthor ">Michael G.  Kharas</span>, <span class="hlFld-ContribAuthor ">Andrei V.  Krivtsov</span>, <span class="hlFld-ContribAuthor ">Scott A.  Armstrong</span>, <span class="hlFld-ContribAuthor ">Eric  Still</span>, <span class="hlFld-ContribAuthor ">Elisa  de Stanchina</span>, <span class="hlFld-ContribAuthor ">Birgit  Knoechel</span>, <span class="hlFld-ContribAuthor ">Richard  Koche</span>, <span class="hlFld-ContribAuthor ">Alex  Kentsis</span>. </span><span class="cited-content_cbyCitation_article-title">Peptidomimetic blockade of MYB in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02618-6" title="DOI URL">https://doi.org/10.1038/s41467-017-02618-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02618-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02618-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DPeptidomimetic%252Bblockade%252Bof%252BMYB%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DRamaswamy%26aufirst%3DKavitha%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyh-Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Urban</span>, <span class="hlFld-ContribAuthor ">Makoto  Yoshioka</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Strovel</span>, <span class="hlFld-ContribAuthor ">Steven  Fletcher</span>, <span class="hlFld-ContribAuthor ">Amy Q.  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Xu</span>, <span class="hlFld-ContribAuthor ">Pranav  Shah</span>, <span class="hlFld-ContribAuthor ">Xin  Hu</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hall</span>, <span class="hlFld-ContribAuthor ">Ajit  Jadhav</span>, <span class="hlFld-ContribAuthor ">David J.  Maloney</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and lead identification of quinazoline-based BRD4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (21)
                                     , 3483-3488. <a href="https://doi.org/10.1016/j.bmcl.2018.08.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Blead%252Bidentification%252Bof%252Bquinazoline-based%252BBRD4%252Binhibitors%26aulast%3DYang%26aufirst%3DShyh-Ming%26date%3D2018%26volume%3D28%26issue%3D21%26spage%3D3483%26epage%3D3488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Hun  Kim</span>, <span class="hlFld-ContribAuthor ">Minsung  Kim</span>, <span class="hlFld-ContribAuthor ">Miyoun  Yoo</span>, <span class="hlFld-ContribAuthor ">Ji Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Heung Kyoung  Lee</span>, <span class="hlFld-ContribAuthor ">Jung-Nyoung  Heo</span>, <span class="hlFld-ContribAuthor ">Chong Ock  Lee</span>, <span class="hlFld-ContribAuthor ">Minjin  Yoo</span>, <span class="hlFld-ContribAuthor ">Kwan-Young  Jung</span>, <span class="hlFld-ContribAuthor ">Chang-Soo  Yun</span>, <span class="hlFld-ContribAuthor ">Sung Woong  Moon</span>, <span class="hlFld-ContribAuthor ">Hye Kyung  Chang</span>, <span class="hlFld-ContribAuthor ">Chul-Woong  Chung</span>, <span class="hlFld-ContribAuthor ">Suhkneung  Pyo</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>. </span><span class="cited-content_cbyCitation_article-title">A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2018,</strong> <em>503 </em>
                                    (2)
                                     , 882-887. <a href="https://doi.org/10.1016/j.bbrc.2018.06.091" title="DOI URL">https://doi.org/10.1016/j.bbrc.2018.06.091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2018.06.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2018.06.091%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DA%252Bnatural%252Bcompound%25252C%252Baristoyagonine%25252C%252Bis%252Bidentified%252Bas%252Ba%252Bpotent%252Bbromodomain%252Binhibitor%252Bby%252Bmid-throughput%252Bscreening%26aulast%3DKim%26aufirst%3DYoung%2BHun%26date%3D2018%26volume%3D503%26issue%3D2%26spage%3D882%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Prieto-Martínez</span>, <span class="hlFld-ContribAuthor ">José  Medina-Franco</span>. </span><span class="cited-content_cbyCitation_article-title">Flavonoids as Putative Epi-Modulators: Insight into Their Binding Mode with BRD4 Bromodomains Using Molecular Docking and Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2018,</strong> <em>8 </em>
                                    (3)
                                     , 61. <a href="https://doi.org/10.3390/biom8030061" title="DOI URL">https://doi.org/10.3390/biom8030061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom8030061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom8030061%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DFlavonoids%252Bas%252BPutative%252BEpi-Modulators%25253A%252BInsight%252Binto%252BTheir%252BBinding%252BMode%252Bwith%252BBRD4%252BBromodomains%252BUsing%252BMolecular%252BDocking%252Band%252BDynamics%26aulast%3DPrieto-Mart%25C3%25ADnez%26aufirst%3DFernando%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D3%26spage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meghan E  Breen</span>, <span class="hlFld-ContribAuthor ">Anna K  Mapp</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating the masters: chemical tools to dissect CBP and p300 function. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2018,</strong> <em>45 </em>, 195-203. <a href="https://doi.org/10.1016/j.cbpa.2018.06.005" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DModulating%252Bthe%252Bmasters%25253A%252Bchemical%252Btools%252Bto%252Bdissect%252BCBP%252Band%252Bp300%252Bfunction%26aulast%3DBreen%26aufirst%3DMeghan%2BE%26date%3D2018%26volume%3D45%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">Stuart J  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules as tools to study the chemical epigenetics of lysine acetylation. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2018,</strong> <em>45 </em>, 166-178. <a href="https://doi.org/10.1016/j.cbpa.2018.06.015" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DSmall%252Bmolecules%252Bas%252Btools%252Bto%252Bstudy%252Bthe%252Bchemical%252Bepigenetics%252Bof%252Blysine%252Bacetylation%26aulast%3DSchiedel%26aufirst%3DMatthias%26date%3D2018%26volume%3D45%26spage%3D166%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura E.  Jennings</span>, <span class="hlFld-ContribAuthor ">Matthias  Schiedel</span>, <span class="hlFld-ContribAuthor ">David S.  Hewings</span>, <span class="hlFld-ContribAuthor ">Sarah  Picaud</span>, <span class="hlFld-ContribAuthor ">Corentine M.C.  Laurin</span>, <span class="hlFld-ContribAuthor ">Paul A.  Bruno</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Bluck</span>, <span class="hlFld-ContribAuthor ">Amy R.  Scorah</span>, <span class="hlFld-ContribAuthor ">Larissa  See</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Reynolds</span>, <span class="hlFld-ContribAuthor ">Mustafa  Moroglu</span>, <span class="hlFld-ContribAuthor ">Ishna N.  Mistry</span>, <span class="hlFld-ContribAuthor ">Amy  Hicks</span>, <span class="hlFld-ContribAuthor ">Pavel  Guzanov</span>, <span class="hlFld-ContribAuthor ">James  Clayton</span>, <span class="hlFld-ContribAuthor ">Charles N.G.  Evans</span>, <span class="hlFld-ContribAuthor ">Giulia  Stazi</span>, <span class="hlFld-ContribAuthor ">Philip C.  Biggin</span>, <span class="hlFld-ContribAuthor ">Anna K.  Mapp</span>, <span class="hlFld-ContribAuthor ">Ester M.  Hammond</span>, <span class="hlFld-ContribAuthor ">Philip G.  Humphreys</span>, <span class="hlFld-ContribAuthor ">Panagis  Filippakopoulos</span>, <span class="hlFld-ContribAuthor ">Stuart J.  Conway</span>. </span><span class="cited-content_cbyCitation_article-title">BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 2937-2957. <a href="https://doi.org/10.1016/j.bmc.2018.05.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBET%252Bbromodomain%252Bligands%25253A%252BProbing%252Bthe%252BWPF%252Bshelf%252Bto%252Bimprove%252BBRD4%252Bbromodomain%252Baffinity%252Band%252Bmetabolic%252Bstability%26aulast%3DJennings%26aufirst%3DLaura%2BE.%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D2937%26epage%3D2957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Bennett</span>, <span class="hlFld-ContribAuthor ">Yiqin  Wu</span>, <span class="hlFld-ContribAuthor ">Amogh  Boloor</span>, <span class="hlFld-ContribAuthor ">Jennifer  Matuszkiewicz</span>, <span class="hlFld-ContribAuthor ">Shawn M.  O'Connell</span>, <span class="hlFld-ContribAuthor ">Lihong  Shi</span>, <span class="hlFld-ContribAuthor ">Ryan K.  Stansfield</span>, <span class="hlFld-ContribAuthor ">Joselyn R.  Del Rosario</span>, <span class="hlFld-ContribAuthor ">James M.  Veal</span>, <span class="hlFld-ContribAuthor ">David J.  Hosfield</span>, <span class="hlFld-ContribAuthor ">Jiangchun  Xu</span>, <span class="hlFld-ContribAuthor ">Stephen W.  Kaldor</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Stafford</span>, <span class="hlFld-ContribAuthor ">Juan M.  Betancort</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1811-1816. <a href="https://doi.org/10.1016/j.bmcl.2018.04.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B4-phenylisoquinolinone%252BBET%252Bbromodomain%252Binhibitors%26aulast%3DBennett%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1811%26epage%3D1816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven D.  Fidanze</span>, <span class="hlFld-ContribAuthor ">Dachun  Liu</span>, <span class="hlFld-ContribAuthor ">Robert A.  Mantei</span>, <span class="hlFld-ContribAuthor ">Lisa A.  Hasvold</span>, <span class="hlFld-ContribAuthor ">John K.  Pratt</span>, <span class="hlFld-ContribAuthor ">George S.  Sheppard</span>, <span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">James H.  Holms</span>, <span class="hlFld-ContribAuthor ">Yujia  Dai</span>, <span class="hlFld-ContribAuthor ">Ana  Aguirre</span>, <span class="hlFld-ContribAuthor ">Andrew  Bogdan</span>, <span class="hlFld-ContribAuthor ">Justin D.  Dietrich</span>, <span class="hlFld-ContribAuthor ">Jasmina  Marjanovic</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Charles W.  Hutchins</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Lin</span>, <span class="hlFld-ContribAuthor ">Mai H.  Bui</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Huang</span>, <span class="hlFld-ContribAuthor ">Denise  Wilcox</span>, <span class="hlFld-ContribAuthor ">Leiming  Li</span>, <span class="hlFld-ContribAuthor ">Rongqi  Wang</span>, <span class="hlFld-ContribAuthor ">Peter  Kovar</span>, <span class="hlFld-ContribAuthor ">Terrance J.  Magoc</span>, <span class="hlFld-ContribAuthor ">Ganesh  Rajaraman</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Albert</span>, <span class="hlFld-ContribAuthor ">Yu  Shen</span>, <span class="hlFld-ContribAuthor ">Warren M.  Kati</span>, <span class="hlFld-ContribAuthor ">Keith F.  McDaniel</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of novel constrained pyrrolopyridone BET family inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (10)
                                     , 1804-1810. <a href="https://doi.org/10.1016/j.bmcl.2018.04.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.04.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.04.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bconstrained%252Bpyrrolopyridone%252BBET%252Bfamily%252Binhibitors%26aulast%3DFidanze%26aufirst%3DSteven%2BD.%26date%3D2018%26volume%3D28%26issue%3D10%26spage%3D1804%26epage%3D1810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Bowkett</span>, <span class="hlFld-ContribAuthor ">Romain  Talon</span>, <span class="hlFld-ContribAuthor ">Cynthia  Tallant</span>, <span class="hlFld-ContribAuthor ">Chris  Schofield</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Gordon  Bruton</span>, <span class="hlFld-ContribAuthor ">Paul E.  Brennan</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying Small-Molecule Binding Sites for Epigenetic Proteins at Domain-Domain Interfaces. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (10)
                                     , 1051-1057. <a href="https://doi.org/10.1002/cmdc.201800030" title="DOI URL">https://doi.org/10.1002/cmdc.201800030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800030%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIdentifying%252BSmall-Molecule%252BBinding%252BSites%252Bfor%252BEpigenetic%252BProteins%252Bat%252BDomain-Domain%252BInterfaces%26aulast%3DBowkett%26aufirst%3DDavid%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3D1051%26epage%3D1057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Pingyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Allan R.  Brasier</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent and selective BRD4 inhibitors capable of blocking TLR3-induced acute airway inflammation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 450-461. <a href="https://doi.org/10.1016/j.ejmech.2018.04.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Band%252Bselective%252BBRD4%252Binhibitors%252Bcapable%252Bof%252Bblocking%252BTLR3-induced%252Bacute%252Bairway%252Binflammation%26aulast%3DLiu%26aufirst%3DZhiqing%26date%3D2018%26volume%3D151%26spage%3D450%26epage%3D461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan T.  Lloyd</span>, <span class="hlFld-ContribAuthor ">Karen C.  Glass</span>. </span><span class="cited-content_cbyCitation_article-title">Biological function and histone recognition of family IV bromodomain-containing proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2018,</strong> <em>233 </em>
                                    (3)
                                     , 1877-1886. <a href="https://doi.org/10.1002/jcp.26010" title="DOI URL">https://doi.org/10.1002/jcp.26010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.26010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.26010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DBiological%252Bfunction%252Band%252Bhistone%252Brecognition%252Bof%252Bfamily%252BIV%252Bbromodomain-containing%252Bproteins%26aulast%3DLloyd%26aufirst%3DJonathan%2BT.%26date%3D2018%26date%3D2017%26volume%3D233%26issue%3D3%26spage%3D1877%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.5b01514&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-4%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01514%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=132&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> (JQ1) and <b>2</b> (I-BET762).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Number of bromodomain publications per calendar year.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Overview of the bromodomain binding site. Compound <b>3</b> is shown in complex with BRD4(1) (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q">4Z1Q</a>). (A) Structure of compound <b>3</b>. (B) Cartoon representation of chain A of the bromodomain, showing the 4-helix bundle and the ligand-binding site. (C) Close-up view of the binding site: the ligand is shown in beige, and the protein is depicted as a ribbon covered with a gray molecular surface. Key amino acid side chains are shown; these and important structural features are labeled.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structure of <b>4</b> bound to CBP (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYW">4NYW</a>). (A) Structure of compound <b>4</b>. (B) Chain A is shown in cyan, with its bound ligand shown in beige. The neighboring symmetry mate, as generated by PyMol (Schrodinger, Inc.), is shown in gray. The interactions between two glutamic acids (both direct and water-mediated) from the symmetry mate and Arg1173 of the parent subunit are depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of some of the first reported CBP inhibitors (<b>5</b>–<b>8</b>) with their reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Recently developed potent CBP inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>. Initial starting points for the optimization of these inhibitors (when known) are shown at left of arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. BAZ2A/B bromodomain inhibitors and their reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Recently developed, potent BRD9 inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>. Initial starting points for the optimization of these inhibitors are shown left of arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Co-crystal structures comparing the binding mode of BRD7/9 bromodomain inhibitors. (A) <b>19</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z6I">4Z6I</a>], (B) <b>22</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9V">5E9V</a>], and (C) <b>24</b> [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UIW">4UIW</a>].</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. ATAD2 inhibitors and their reported IC<sub>50</sub>. Initial starting point and progression to potent compounds is shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Co-crystal structure of <b>28</b> (gray) with ATAD2 (teal) [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A83">5A83</a>]; the apo structure of BRD4(1) [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LYI">4LYI</a>] is overlaid in brown. Distances are shown between the sulfone of <b>28</b> and residues in BRD4(1) that may result in steric clashing.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SMARCA4 (BRG1) bromodomain inhibitor and its reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. BRPF bromodomain inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Comparison of BRPF1/<b>31</b> (yellow, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UYE">4UYE</a>) co-crystal structure with the apo structure of BRPF2 (teal, PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RCW">3RCW</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Dual TRIM24/BRPF bromodomain inhibitors and their reported IC<sub>50</sub> or <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Crystal structure of <b>37</b> bound to TRIM24 [PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YBM">4YBM</a>] showing different crystal contacts and inhibitor conformations for the two copies of TRIM24 in the asymmetric unit. (A) Structure of <b>37</b>. (B) Chain A is depicted in gray, with the “upper pocket” shaded orange. In pink is the surface of TRIM24 from chain B in the asymmetric subunit. The ZA channel is purple. (C) Chain B is depicted in gray, with the “upper pocket” shaded orange. In green is the symmetry mate closest to chain B. The ZA channel is purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. BPTF bromodomain inhibitor and its reported <i>K</i><sub>d</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Seminal BET bromodomain inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Key interactions for (A) triazole <b>2</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3P5O">3P5O</a>), (B) dimethylisoxazole <b>39</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZYU">3ZYU</a>), and (C) pyridone-like <b>40</b> (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E96">4E96</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Selected recently reported triazole-derived BET inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Selected recently reported dimethylisoxazole-based BET inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0023.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Recently reported BET inhibitors with pyridone-derived KAc mimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0024.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Recently reported BET inhibitors with less common KAc binding motifs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0025.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Schematic representation of the (A) dot assay and (B) BRET assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0026.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Compound <b>41</b> (blue) tethered to pomalidomide (red).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/medium/jm-2015-01514u_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Some reported BET bromodomain/kinase dual inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-4/acs.jmedchem.5b01514/20160219/images/large/jm-2015-01514u_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01514&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 199 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Verdone, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caserta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, E. D.</span><span> </span><span class="NLM_article-title">Role of Histone Acetylation in the Control of Gene Expression</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">344</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span><span class="refDoi"> DOI: 10.1139/o05-041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1139%2Fo05-041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=15959560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXntFClsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2005&pages=344-353&author=L.+Verdoneauthor=M.+Casertaauthor=E.+D.+Mauro&title=Role+of+Histone+Acetylation+in+the+Control+of+Gene+Expression&doi=10.1139%2Fo05-041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Role of histone acetylation in the control of gene expression</span></div><div class="casAuthors">Verdone, Loredana; Caserta, Micaela; Di Mauro, Ernesto</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">344-353</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Histone proteins play structural and functional roles in all nuclear processes.  They undergo different types of covalent modifications, defined in their ensemble as epigenetic because changes in DNA sequences are not involved.  Histone acetylation emerges as a central switch that allows interconversion between permissive and repressive chromatin domains in terms of transcriptional competence.  The mechanisms underlying the histone acetylation-dependent control of gene expression include a direct effect on the stability of nucleosomal arrays and the creation of docking sites for the binding of regulatory proteins.  Histone acetyltransferases and deacetylases are, resp., the enzymes devoted to the addn. and removal of acetyl groups from lysine residues on the histone N-terminal tails.  The enzymes exert fundamental roles in developmental processes and their deregulation has been linked to the progression of diverse human disorders, including cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra07s9zdBpF7Vg90H21EOLACvtfcHk0ljurmC25e9hpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXntFClsbo%253D&md5=4f3d8b79f8cac35e7b0b553028ce96c5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1139%2Fo05-041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fo05-041%26sid%3Dliteratum%253Aachs%26aulast%3DVerdone%26aufirst%3DL.%26aulast%3DCaserta%26aufirst%3DM.%26aulast%3DMauro%26aufirst%3DE.%2BD.%26atitle%3DRole%2520of%2520Histone%2520Acetylation%2520in%2520the%2520Control%2520of%2520Gene%2520Expression%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2005%26volume%3D83%26spage%3D344%26epage%3D353%26doi%3D10.1139%2Fo05-041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Workman, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingston, R. E.</span><span> </span><span class="NLM_article-title">Alteration of Nucleosome Structure as a Mechanism of Transcriptional Regulation</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">579</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.67.1.545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1146%2Fannurev.biochem.67.1.545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=9759497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFOmsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=545-579&author=J.+L.+Workmanauthor=R.+E.+Kingston&title=Alteration+of+Nucleosome+Structure+as+a+Mechanism+of+Transcriptional+Regulation&doi=10.1146%2Fannurev.biochem.67.1.545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of nucleosome structure as a mechanism of transcriptional regulation</span></div><div class="casAuthors">Workman, J. L.; Kingston, R. E.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">545-579</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 270 refs.  The nucleosome, which is the primary building block of chromatin, is not a static structure: It can adopt alternative conformations.  Changes in soln. conditions or changes in histone acetylation state cause nucleosomes and nucleosomal arrays to behave with altered biophys. properties.  Distinct subpopulations of nucleosomes isolated from cells have chromatog. properties and nuclease sensitivity different from those of bulk nucleosomes.  Recently, proteins that were initially identified as necessary for transcriptional regulation have been shown to alter nucleosomal structure.  These proteins are found in three types of multiprotein complexes that can acetylate nucleosomes, deacetylate nucleosomes, or alter nucleosome structure in an ATP-dependent manner.  The direct modification of nucleosome structure by these complexes is likely to play a central role in appropriate regulation of eukaryotic genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpflCcssvuburVg90H21EOLACvtfcHk0lhgJxDYGI872Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFOmsbw%253D&md5=6dceb9de82a66dd5360a1183b33a3365</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.67.1.545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.67.1.545%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DJ.%2BL.%26aulast%3DKingston%26aufirst%3DR.%2BE.%26atitle%3DAlteration%2520of%2520Nucleosome%2520Structure%2520as%2520a%2520Mechanism%2520of%2520Transcriptional%2520Regulation%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D1998%26volume%3D67%26spage%3D545%26epage%3D579%26doi%3D10.1146%2Fannurev.biochem.67.1.545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Allfrey, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faulkner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirsky, A. E.</span><span> </span><span class="NLM_article-title">Acetylation and Methylation of Histones and Their Possible Role in the Regulation of RNA Synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">786</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.1073/pnas.51.5.786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.51.5.786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=14172992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaF2cXktlekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1964&pages=786-794&author=V.+G.+Allfreyauthor=R.+Faulknerauthor=A.+E.+Mirsky&title=Acetylation+and+Methylation+of+Histones+and+Their+Possible+Role+in+the+Regulation+of+RNA+Synthesis&doi=10.1073%2Fpnas.51.5.786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylation and methylation of histones and their possible role in the regulation of ribonucleic acid (RNA) synthesis</span></div><div class="casAuthors">Allfrey, V. G.; Faulkner, R.; Mirsky, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1964</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">786-94</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Isolated calf thymus nuclei was incubated with 14C-labeled Na acetate.  Evidence that acetate was incorporated as acetyl groups attached to histones included: (1) following chromatography the label was eluted together with basic proteins; (2) acetyl-labeled histones were sepd. by electrophoresis; (3) acetate-14C was not removed from histones by org. solvents; (4) over 75% of the label remained after histones were treated with trichloroacetic acid.  Most extensive acetate uptake occurred with arginine-rich histones.  Puromycin did not inhibit the acetylation, indicating histones were modified by acetylation after completion of the polypeptide chain.  Acetylation lowered the histone effectiveness as inhibitor of the RNA polymerase reaction, and a dynamic and reversible mechanism was suggested for activation as well as repression of RNA synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL5QIm_JdO1bVg90H21EOLACvtfcHk0lhgJxDYGI872Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXktlekurg%253D&md5=7a80f7a8a12636d4bc47930ee5eff217</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.51.5.786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.51.5.786%26sid%3Dliteratum%253Aachs%26aulast%3DAllfrey%26aufirst%3DV.%2BG.%26aulast%3DFaulkner%26aufirst%3DR.%26aulast%3DMirsky%26aufirst%3DA.%2BE.%26atitle%3DAcetylation%2520and%2520Methylation%2520of%2520Histones%2520and%2520Their%2520Possible%2520Role%2520in%2520the%2520Regulation%2520of%2520RNA%2520Synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1964%26volume%3D51%26spage%3D786%26epage%3D794%26doi%3D10.1073%2Fpnas.51.5.786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Jenuwein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">Translating the Histone Code</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">293</span><span class="NLM_x">, </span> <span class="NLM_fpage">1074</span><span class="NLM_x">–</span> <span class="NLM_lpage">1080</span><span class="refDoi"> DOI: 10.1126/science.1063127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1063127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=11498575" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=1074-1080&author=T.+Jenuweinauthor=C.+D.+Allis&title=Translating+the+Histone+Code&doi=10.1126%2Fscience.1063127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Translating the histone code</span></div><div class="casAuthors">Jenuwein, Thomas; Allis, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5532</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The review.  Chromatin, the physiol. template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone amino termini, thereby regulating access to the underlying DNA.  Distinct histone amino-terminal modifications can generate synergistic or antagonistic interaction affinities for chromatin-assocd. proteins, which in turn dictate dynamic transitions between transcriptionally active or transcriptionally silent chromatin states.  The combinatorial nature of histone amino-terminal modifications thus reveals a "histone code" that considerably extends the information potential of the genetic code.  We propose that this epigenetic marking system represents a fundamental regulatory mechanism that has an impact on most, if not all; chromatin-templated processes, with far-reaching consequences for cell fate decisions and both normal and pathol. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUFyHNepKcUbVg90H21EOLACvtfcHk0lg9pNtuQPPBPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmtVWltro%253D&md5=021dcd98a5e5bf2ed7eedef1897b2269</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1063127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1063127%26sid%3Dliteratum%253Aachs%26aulast%3DJenuwein%26aufirst%3DT.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DTranslating%2520the%2520Histone%2520Code%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D1074%26epage%3D1080%26doi%3D10.1126%2Fscience.1063127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The Language of Covalent Histone Modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1038/47412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+Language+of+Covalent+Histone+Modifications&doi=10.1038%2F47412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eYTo1w8vvR7JLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520Language%2520of%2520Covalent%2520Histone%2520Modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45%26doi%3D10.1038%2F47412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Dhalluin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure and Ligand of a Histone Acetyltransferase Bromodomain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">399</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">496</span><span class="refDoi"> DOI: 10.1038/20974</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2F20974" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10365964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=491-496&author=C.+Dhalluinauthor=J.+E.+Carlsonauthor=L.+Zengauthor=C.+Heauthor=A.+K.+Aggarwalauthor=M.-M.+Zhou&title=Structure+and+Ligand+of+a+Histone+Acetyltransferase+Bromodomain&doi=10.1038%2F20974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and ligand of a histone acetyltransferase bromodomain</span></div><div class="casAuthors">Dhalluin, Christophe; Carlson, Justin E.; Zeng, Lei; He, Cheng; Aggarwal, Aneel K.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6735</span>),
    <span class="NLM_cas:pages">491-496</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone acetylation is important in chromatin remodelling and gene activation.  Nearly all known histone-acetyltransferase (HAT)-assocd. transcriptional co-activators contain bromodomains, which are ∼110-amino-acid modules found in many chromatin-assocd. proteins.  Despite the wide occurrence of these bromodomains, their three-dimensional structure and binding partners remain unknown.  Here we report the soln. structure of the bromodomain of the HAT co-activator P/CAF (p300/CBP-assocd. factor).  The structure reveals an unusual left-handed up-and-down four-helix bundle.  In addn., we show by a combination of structural and site-directed mutagenesis studies that bromodomains can interact specifically with acetylated lysine, making them the first known protein modules to do so.  The nature of the recognition of acetyl-lysine by the P/CAF bromodomain is similar to that of acetyl-CoA by histone acetyltransferase.  Thus, the bromodomain is functionally linked to the HAT activity of co-activators in the regulation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsTbwcjeBG_rVg90H21EOLACvtfcHk0lg9pNtuQPPBPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvV2isLo%253D&md5=ff1063ba81d81b431065dd6e3751ba79</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F20974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20974%26sid%3Dliteratum%253Aachs%26aulast%3DDhalluin%26aufirst%3DC.%26aulast%3DCarlson%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DC.%26aulast%3DAggarwal%26aufirst%3DA.%2BK.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure%2520and%2520Ligand%2520of%2520a%2520Histone%2520Acetyltransferase%2520Bromodomain%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D491%26epage%3D496%26doi%3D10.1038%2F20974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Targeting Bromodomains: Epigenetic Readers of Lysine Acetylation</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nrd4286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnrd4286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24751816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=337-356&author=P.+Filippakopoulosauthor=S.+Knapp&title=Targeting+Bromodomains%3A+Epigenetic+Readers+of+Lysine+Acetylation&doi=10.1038%2Fnrd4286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bromodomains: epigenetic readers of lysine acetylation</span></div><div class="casAuthors">Filippakopoulos, Panagis; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">337-356</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Lysine acetylation is a key mechanism that regulates chromatin structure; aberrant acetylation levels have been linked to the development of several diseases.  Acetyl-lysine modifications create docking sites for bromodomains, which are small interaction modules found on diverse proteins, some of which have a key role in the acetylation-dependent assembly of transcriptional regulator complexes.  These complexes can then initiate transcriptional programs that result in phenotypic changes.  The recent discovery of potent and highly specific inhibitors for the BET (bromodomain and extra-terminal) family of bromodomains has stimulated intensive research activity in diverse therapeutic areas, particularly in oncol., where BET proteins regulate the expression of key oncogenes and anti-apoptotic proteins.  In addn., targeting BET bromodomains could hold potential for the treatment of inflammation and viral infection.  Here, we highlight recent progress in the development of bromodomain inhibitors, and their potential applications in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOSIcwBJKj4LVg90H21EOLACvtfcHk0lh1sfwD1CmP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFalsr4%253D&md5=77049c82ce6a19b4685e3b7950399a07</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4286%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DTargeting%2520Bromodomains%253A%2520Epigenetic%2520Readers%2520of%2520Lysine%2520Acetylation%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D337%26epage%3D356%26doi%3D10.1038%2Fnrd4286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lange, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaynak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonjes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlesinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunkel, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrach, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lurz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottbauer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdelilah-Seyfried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, S.</span><span> </span><span class="NLM_article-title">Regulation of Muscle Development by DPF3, a Novel Histone Acetylation and Methylation Reader of the BAF Chromatin Remodeling Complex</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">–</span> <span class="NLM_lpage">2384</span><span class="refDoi"> DOI: 10.1101/gad.471408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1101%2Fgad.471408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18765789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=2370-2384&author=M.+Langeauthor=B.+Kaynakauthor=U.+B.+Forsterauthor=M.+Tonjesauthor=J.+J.+Fischerauthor=C.+Grimmauthor=J.+Schlesingerauthor=S.+Justauthor=I.+Dunkelauthor=T.+Kruegerauthor=S.+Mebusauthor=H.+Lehrachauthor=R.+Lurzauthor=J.+Gobomauthor=W.+Rottbauerauthor=S.+Abdelilah-Seyfriedauthor=S.+Sperling&title=Regulation+of+Muscle+Development+by+DPF3%2C+a+Novel+Histone+Acetylation+and+Methylation+Reader+of+the+BAF+Chromatin+Remodeling+Complex&doi=10.1101%2Fgad.471408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of muscle development by DPF3, a novel histone acetylation and methylation reader of the BAF chromatin remodeling complex</span></div><div class="casAuthors">Lange, Martin; Kaynak, Bogac; Forster, Ulrike B.; Toenjes, Martje; Fischer, Jenny J.; Grimm, Christina; Schlesinger, Jenny; Just, Steffen; Dunkel, Ilona; Krueger, Tammo; Mebus, Siegrun; Lehrach, Hans; Lurz, Rudi; Gobom, Johan; Rottbauer, Wolfgang; Abdelilah-Seyfried, Salim; Sperling, Silke</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2370-2384</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Chromatin remodeling and histone modifications facilitate access of transcription factors to DNA by promoting the unwinding and destabilization of histone-DNA interactions.  We present DPF3, a new epigenetic key factor for heart and muscle development characterized by a double PHD finger.  DPF3 is assocd. with the BAF chromatin remodeling complex and binds methylated and acetylated lysine residues of histone 3 and 4.  Thus, DPF3 may represent the first plant homeodomains that bind acetylated lysines, a feature previously only shown for the bromodomain.  During development Dpf3 is expressed in the heart and somites of mouse, chicken, and zebrafish.  Morpholino knockdown of dpf3 in zebrafish leads to incomplete cardiac looping and severely reduced ventricular contractility, with disassembled muscular fibers caused by transcriptional deregulation of structural and regulatory proteins.  Promoter anal. identified Dpf3 as a novel downstream target of Mef2a.  Taken together, DPF3 adds a further layer of complexity to the BAF complex by representing a tissue-specific anchor between histone acetylations as well as methylations and chromatin remodeling.  Furthermore, this shows that plant homeodomain proteins play a yet unexplored role in recruiting chromatin remodeling complexes to acetylated histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFKDUoXByUL7Vg90H21EOLACvtfcHk0lh1sfwD1CmP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSrs7zI&md5=173473acf1587d33492b8cee1fa16f88</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1101%2Fgad.471408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.471408%26sid%3Dliteratum%253Aachs%26aulast%3DLange%26aufirst%3DM.%26aulast%3DKaynak%26aufirst%3DB.%26aulast%3DForster%26aufirst%3DU.%2BB.%26aulast%3DTonjes%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DJ.%2BJ.%26aulast%3DGrimm%26aufirst%3DC.%26aulast%3DSchlesinger%26aufirst%3DJ.%26aulast%3DJust%26aufirst%3DS.%26aulast%3DDunkel%26aufirst%3DI.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DMebus%26aufirst%3DS.%26aulast%3DLehrach%26aufirst%3DH.%26aulast%3DLurz%26aufirst%3DR.%26aulast%3DGobom%26aufirst%3DJ.%26aulast%3DRottbauer%26aufirst%3DW.%26aulast%3DAbdelilah-Seyfried%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Muscle%2520Development%2520by%2520DPF3%252C%2520a%2520Novel%2520Histone%2520Acetylation%2520and%2520Methylation%2520Reader%2520of%2520the%2520BAF%2520Chromatin%2520Remodeling%2520Complex%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D2370%26epage%3D2384%26doi%3D10.1101%2Fgad.471408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Mechanism and Regulation of Acetylated Histone Binding by the Tandem PHD Finger of DPF3b</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">466</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span><span class="refDoi"> DOI: 10.1038/nature09139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20613843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=466&publication_year=2010&pages=258-262&author=L.+Zengauthor=Q.+Zhangauthor=S.+Liauthor=A.+N.+Plotnikovauthor=M.+J.+Walshauthor=M.-M.+Zhou&title=Mechanism+and+Regulation+of+Acetylated+Histone+Binding+by+the+Tandem+PHD+Finger+of+DPF3b&doi=10.1038%2Fnature09139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b</span></div><div class="casAuthors">Zeng, Lei; Zhang, Qiang; Li, SiDe; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">466</span>
        (<span class="NLM_cas:issue">7303</span>),
    <span class="NLM_cas:pages">258-262</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context.  Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains.  Recently, a tandem plant homeodomain (PHD) finger (PHD1-PHD2, or PHD12) of human DPF3b, which functions in assocn. with the BAF chromatin remodeling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner, making it the first alternative to bromodomains for acetyl-lysine binding.  Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b.  Our three-dimensional soln. structures and biochem. anal. of DPF3b highlight the mol. basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac).  Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c.  Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIs304GNjB0LVg90H21EOLACvtfcHk0lh1sfwD1CmP1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKht7o%253D&md5=48807136d91002d7454db72c56ece898</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature09139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09139%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DWalsh%26aufirst%3DM.%2BJ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DMechanism%2520and%2520Regulation%2520of%2520Acetylated%2520Histone%2520Binding%2520by%2520the%2520Tandem%2520PHD%2520Finger%2520of%2520DPF3b%26jtitle%3DNature%26date%3D2010%26volume%3D466%26spage%3D258%26epage%3D262%26doi%3D10.1038%2Fnature09139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Su, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botuyan, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mer, G.</span><span> </span><span class="NLM_article-title">Structural Basis for Recognition of H3K56-Acetylated Histone H3-H4 by the Chaperone Rtt106</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1038/nature10861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature10861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=104-107&author=D.+Suauthor=Q.+Huauthor=Q.+Liauthor=J.+R.+Thompsonauthor=G.+Cuiauthor=A.+Fazlyauthor=B.+A.+Daviesauthor=M.+V.+Botuyanauthor=Z.+Zhangauthor=G.+Mer&title=Structural+Basis+for+Recognition+of+H3K56-Acetylated+Histone+H3-H4+by+the+Chaperone+Rtt106&doi=10.1038%2Fnature10861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10861%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DThompson%26aufirst%3DJ.%2BR.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DFazly%26aufirst%3DA.%26aulast%3DDavies%26aufirst%3DB.%2BA.%26aulast%3DBotuyan%26aufirst%3DM.%2BV.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DMer%26aufirst%3DG.%26atitle%3DStructural%2520Basis%2520for%2520Recognition%2520of%2520H3K56-Acetylated%2520Histone%2520H3-H4%2520by%2520the%2520Chaperone%2520Rtt106%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D104%26epage%3D107%26doi%3D10.1038%2Fnature10861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsyte-Lovejoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.cell.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cell.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22464331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=214-231&author=P.+Filippakopoulosauthor=S.+Picaudauthor=M.+Mangosauthor=T.+Keatesauthor=J.-P.+Lambertauthor=D.+Barsyte-Lovejoyauthor=I.+Felletarauthor=R.+Volkmerauthor=S.+M%C3%BCllerauthor=T.+Pawsonauthor=A.-C.+Gingrasauthor=C.+H.+Arrowsmithauthor=S.+Knapp&title=Histone+Recognition+and+Large-Scale+Structural+Analysis+of+the+Human+Bromodomain+Family&doi=10.1016%2Fj.cell.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family</span></div><div class="casAuthors">Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Muller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">214-231</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks.  The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity.  Here, we present 29 high-resoln. crystal structures, covering all BRD families.  These proteins are: ASH1L, ATAD2, BAZ2B, BPTF, BRD1, BRD3(1), BRD3(2), BRD4(1), BRD4(2), BRD9, BRDT(1), CECR2, EP300, CREBBP, GCN5L2, KIAA1240, PB1(1), PB1(2), PB1(3), PB1(4), PB1(5), PB1(6), PCAF, PHIP(2), TAF1(2), WDR9(2), BRD4(1).  Comprehensive crossfamily structural anal. identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition.  Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences.  We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-contg. peptides by BRD4.  These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK2FSIcPoXZLVg90H21EOLACvtfcHk0ljsyUAGEiTUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVamurs%253D&md5=05583a01a1cd4c3b59fc59c00e4c4777</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMangos%26aufirst%3DM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DLambert%26aufirst%3DJ.-P.%26aulast%3DBarsyte-Lovejoy%26aufirst%3DD.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DVolkmer%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DHistone%2520Recognition%2520and%2520Large-Scale%2520Structural%2520Analysis%2520of%2520the%2520Human%2520Bromodomain%2520Family%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D214%26epage%3D231%26doi%3D10.1016%2Fj.cell.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tamkun, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deuring, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kissinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattatucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennison, J. A.</span><span> </span><span class="NLM_article-title">Brahma: a Regulator of Drosophila Homeotic Genes Structurally Related to the Yeast Transcriptional Activator SNF2/SWl2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">572</span><span class="refDoi"> DOI: 10.1016/0092-8674(92)90191-E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2F0092-8674%2892%2990191-E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1992&pages=561-572&author=J.+W.+Tamkunauthor=R.+Deuringauthor=M.+P.+Scottauthor=M.+Kissingerauthor=A.+M.+Pattatucciauthor=T.+C.+Kaufmanauthor=J.+A.+Kennison&title=Brahma%3A+a+Regulator+of+Drosophila+Homeotic+Genes+Structurally+Related+to+the+Yeast+Transcriptional+Activator+SNF2%2FSWl2&doi=10.1016%2F0092-8674%2892%2990191-E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2892%2990191-E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252892%252990191-E%26sid%3Dliteratum%253Aachs%26aulast%3DTamkun%26aufirst%3DJ.%2BW.%26aulast%3DDeuring%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DM.%2BP.%26aulast%3DKissinger%26aufirst%3DM.%26aulast%3DPattatucci%26aufirst%3DA.%2BM.%26aulast%3DKaufman%26aufirst%3DT.%2BC.%26aulast%3DKennison%26aufirst%3DJ.%2BA.%26atitle%3DBrahma%253A%2520a%2520Regulator%2520of%2520Drosophila%2520Homeotic%2520Genes%2520Structurally%2520Related%2520to%2520the%2520Yeast%2520Transcriptional%2520Activator%2520SNF2%252FSWl2%26jtitle%3DCell%26date%3D1992%26volume%3D68%26spage%3D561%26epage%3D572%26doi%3D10.1016%2F0092-8674%2892%2990191-E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Haynes, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winston, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trowsdale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawid, I. B.</span><span> </span><span class="NLM_article-title">The Bromodomain: a Conserved Sequence Found in Human, <i>Drosophila</i> And Yeast Proteins</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="refDoi"> DOI: 10.1093/nar/20.10.2603</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Fnar%2F20.10.2603" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1992&pages=2603&author=S.+R.+Haynesauthor=C.+Dollardauthor=F.+Winstonauthor=S.+Beckauthor=J.+Trowsdaleauthor=I.+B.+Dawid&title=The+Bromodomain%3A+a+Conserved+Sequence+Found+in+Human%2C+Drosophila+And+Yeast+Proteins&doi=10.1093%2Fnar%2F20.10.2603"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F20.10.2603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F20.10.2603%26sid%3Dliteratum%253Aachs%26aulast%3DHaynes%26aufirst%3DS.%2BR.%26aulast%3DDollard%26aufirst%3DC.%26aulast%3DWinston%26aufirst%3DF.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DTrowsdale%26aufirst%3DJ.%26aulast%3DDawid%26aufirst%3DI.%2BB.%26atitle%3DThe%2520Bromodomain%253A%2520a%2520Conserved%2520Sequence%2520Found%2520in%2520Human%252C%2520Drosophila%2520And%2520Yeast%2520Proteins%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1992%26volume%3D20%26spage%3D2603%26doi%3D10.1093%2Fnar%2F20.10.2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span> </span><span class="NLM_article-title">Epigenetic Protein Families: a New Frontier for Drug Discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span><span class="refDoi"> DOI: 10.1038/nrd3674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnrd3674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22498752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=384-400&author=C.+H.+Arrowsmithauthor=C.+Bountraauthor=P.+V.+Fishauthor=K.+Leeauthor=M.+Schapira&title=Epigenetic+Protein+Families%3A+a+New+Frontier+for+Drug+Discovery&doi=10.1038%2Fnrd3674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic protein families: a new frontier for drug discovery</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V.; Lee, Kevin; Schapira, Matthieu</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">384-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases.  At the mol. level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones.  Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-contg. proteins and proteins that bind to methylated histones.  These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains.  In this article, we discuss the known links with disease, basic mol. mechanisms of action and recent progress in the pharmacol. modulation of each class of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcD99eCigNtLVg90H21EOLACvtfcHk0ljsyUAGEiTUCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlsFWjsbs%253D&md5=eb82034466a43107aa74a18ccf6d29f5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd3674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3674%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSchapira%26aufirst%3DM.%26atitle%3DEpigenetic%2520Protein%2520Families%253A%2520a%2520New%2520Frontier%2520for%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D384%26epage%3D400%26doi%3D10.1038%2Fnrd3674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Thangue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiest, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Selective Inhibition of BET Bromodomains</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span><span class="refDoi"> DOI: 10.1038/nature09504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20871596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1067-1073&author=P.+Filippakopoulosauthor=J.+Qiauthor=S.+Picaudauthor=Y.+Shenauthor=W.+B.+Smithauthor=O.+Fedorovauthor=E.+M.+Morseauthor=T.+Keatesauthor=T.+T.+Hickmanauthor=I.+Felletarauthor=M.+Philpottauthor=S.+Munroauthor=M.+R.+McKeownauthor=Y.+Wangauthor=A.+L.+Christieauthor=N.+Westauthor=M.+J.+Cameronauthor=B.+Schwartzauthor=T.+D.+Heightmanauthor=N.+La+Thangueauthor=C.+A.+Frenchauthor=O.+Wiestauthor=A.+L.+Kungauthor=S.+Knappauthor=J.+E.+Bradner&title=Selective+Inhibition+of+BET+Bromodomains&doi=10.1038%2Fnature09504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of BET bromodomains</span></div><div class="casAuthors">Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shongah; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1067-1073</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epigenetic proteins are intently pursued targets in ligand discovery.  So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'.  Potent inhibitors of histone binding modules have not yet been described.  Here the authors report a cell-permeable small mol. (I,JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains.  High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity.  Recurrent translocation of BRD4 is obsd. in a genetically-defined, incurable subtype of human squamous carcinoma.  Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models.  These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chem. scaffold for the development of chem. probes more broadly throughout the bromodomain family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2ZbtmZM8m_LVg90H21EOLACvtfcHk0lhv5AR7DJd-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlGmtA%253D%253D&md5=bd9cadac86124d2c6c3cd5b2a92d68c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature09504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09504%26sid%3Dliteratum%253Aachs%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMorse%26aufirst%3DE.%2BM.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DHickman%26aufirst%3DT.%2BT.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMunro%26aufirst%3DS.%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DWest%26aufirst%3DN.%26aulast%3DCameron%26aufirst%3DM.%2BJ.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DLa%2BThangue%26aufirst%3DN.%26aulast%3DFrench%26aufirst%3DC.%2BA.%26aulast%3DWiest%26aufirst%3DO.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DSelective%2520Inhibition%2520of%2520BET%2520Bromodomains%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1067%26epage%3D1073%26doi%3D10.1038%2Fnature09504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sueoka, H.; Ehara, S.; Kobayashi, H.; Arichi, T.; Komatsu, T.</span><span> </span><span class="NLM_article-title">Thienotraizolodiazepine Compounds and Their Pharmaceutical Use</span>. US5712274,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Sueoka&author=S.+Ehara&author=H.+Kobayashi&author=T.+Arichi&author=T.+Komatsu&title=Thienotraizolodiazepine+Compounds+and+Their+Pharmaceutical+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSueoka%26aufirst%3DH.%26atitle%3DThienotraizolodiazepine%2520Compounds%2520and%2520Their%2520Pharmaceutical%2520Use%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nicodeme, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandwani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marazzi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span> </span><span class="NLM_article-title">Suppression of Inflammation by a Synthetic Histone Mimic</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">1119</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1038/nature09589</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21068722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=1119-1123&author=E.+Nicodemeauthor=K.+L.+Jeffreyauthor=U.+Schaeferauthor=S.+Beinkeauthor=S.+Dewellauthor=C.-W.+Chungauthor=R.+Chandwaniauthor=I.+Marazziauthor=P.+Wilsonauthor=H.+Costeauthor=J.+Whiteauthor=J.+Kirilovskyauthor=C.+M.+Riceauthor=J.+M.+Loraauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=A.+Tarakhovsky&title=Suppression+of+Inflammation+by+a+Synthetic+Histone+Mimic&doi=10.1038%2Fnature09589"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of inflammation by a synthetic histone mimic</span></div><div class="casAuthors">Nicodeme, Edwige; Jeffrey, Kate L.; Schaefer, Uwe; Beinke, Soren; Dewell, Scott; Chung, Chun-wa; Chandwani, Rohit; Marazzi, Ivan; Wilson, Paul; Coste, Herve; White, Julia; Kirilovsky, Jorge; Rice, Charles M.; Lora, Jose M.; Prinjha, Rab K.; Lee, Kevin; Tarakhovsky, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">468</span>
        (<span class="NLM_cas:issue">7327</span>),
    <span class="NLM_cas:pages">1119-1123</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interaction of pathogens with cells of the immune system results in activation of inflammatory gene expression.  This response, although vital for immune defense, is frequently deleterious to the host due to the exaggerated prodn. of inflammatory proteins.  The scope of inflammatory responses reflects the activation state of signaling proteins upstream of inflammatory genes as well as signal-induced assembly of nuclear chromatin complexes that support mRNA expression.  Recognition of post-translationally modified histones by nuclear proteins that initiate mRNA transcription and support mRNA elongation is a crit. step in the regulation of gene expression.  Here we present a novel pharmacol. approach that targets inflammatory gene expression by interfering with the recognition of acetylated histones by the bromodomain and extra terminal domain (BET) family of proteins.  We describe a synthetic compd. (I-BET) that by mimicking' acetylated histones disrupts chromatin complexes responsible for the expression of key inflammatory genes in activated macrophages, and confers protection against lipopolysaccharide-induced endotoxic shock and bacteria-induced sepsis.  Our findings suggest that synthetic compds. specifically targeting proteins that recognize post-translationally modified histones can serve as a new generation of immunomodulatory drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxc3_PNaiuKLVg90H21EOLACvtfcHk0lhv5AR7DJd-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2rtb%252FP&md5=0dfccd9d01b87859512bf591e1c5a93c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnature09589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09589%26sid%3Dliteratum%253Aachs%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DK.%2BL.%26aulast%3DSchaefer%26aufirst%3DU.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DDewell%26aufirst%3DS.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DChandwani%26aufirst%3DR.%26aulast%3DMarazzi%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DP.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DRice%26aufirst%3DC.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520Inflammation%2520by%2520a%2520Synthetic%2520Histone%2520Mimic%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D1119%26epage%3D1123%26doi%3D10.1038%2Fnature09589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span> </span><span class="NLM_article-title">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">776</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span><span class="refDoi"> DOI: 10.2174/1568026615666150302110135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.2174%2F1568026615666150302110135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25732788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=776-794&author=L.+Yuauthor=Z.+Wangauthor=Z.+Zhangauthor=X.+Renauthor=X.+Luauthor=K.+Ding&title=Small-Molecule+BET+Inhibitors+in+Clinical+and+Preclinical+Development+and+Their+Therapeutic+Potential&doi=10.2174%2F1568026615666150302110135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule BET Inhibitors in Clinical and Preclinical Development and Their Therapeutic Potential</span></div><div class="casAuthors">Yu, Lei; Wang, Zhen; Zhang, Zhang; Ren, Xiaomei; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">776-794</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Lysine acetylation is a pivotal mechanism in chromatin processes and the regulation of gene transcription.  The acetylated lysine residues of histones are exclusively recognized by bromodomains (BRDs) known as epigenetic reader.  Proteins contg. BRDs undergo a post-translational modification (PTM) with development of cellular signaling and disease biol.  The bromo and extra-terminal (BET) proteins are the second subfamily, which play important roles in cellular proliferation, cell cycle progression and chromatin compaction.  Recently, a variety of small mols. have been reported to interact with the BET family proteins and accelerate the validation of BET proteins as druggable targets for treatment of cancers, inflammation and related diseases.  In this review, we will summarize the small-mol. inhibitors in clin. and preclin. studies of the BET family bromodomains and their medicinal implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk52FOUPlX8bVg90H21EOLACvtfcHk0lhv5AR7DJd-EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXks1ynurs%253D&md5=802bf7b832d46c2b18ef6ac77eda1445</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2174%2F1568026615666150302110135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026615666150302110135%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DSmall-Molecule%2520BET%2520Inhibitors%2520in%2520Clinical%2520and%2520Preclinical%2520Development%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26spage%3D776%26epage%3D794%26doi%3D10.2174%2F1568026615666150302110135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain–Acetyl-Lysine Interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9393</span><span class="NLM_x">–</span> <span class="NLM_lpage">9413</span><span class="refDoi"> DOI: 10.1021/jm300915b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300915b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9393-9413&author=D.+S.+Hewingsauthor=T.+P.+C.+Rooneyauthor=L.+E.+Jenningsauthor=D.+A.+Hayauthor=C.+J.+Schofieldauthor=P.+E.+Brennanauthor=S.+Knappauthor=S.+J.+Conway&title=Progress+in+the+Development+and+Application+of+Small+Molecule+Inhibitors+of+Bromodomain%E2%80%93Acetyl-Lysine+Interactions&doi=10.1021%2Fjm300915b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Hewings, David S.; Rooney, Timothy P. C.; Jennings, Laura E.; Hay, Duncan A.; Schofield, Christopher J.; Brennan, Paul E.; Knapp, Stefan; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9393-9413</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery.  These acetyl-lysine (KAc) reader domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information.  By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners.  There has been intense activity in developing potent and selective small mol. probes that disrupt the interaction between a given bromodomain and KAc.  Rapid success has been achieved with the BET family of bromodomains, and a no. of potent and selective probes have been reported.  These compds. have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets.  Herein, we review the biol. of the bromodomains and discuss the SAR for the existing small mol. probes.  The biol. that has been enabled by these compds. is summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8pl0pnLXruLVg90H21EOLACvtfcHk0likv59zqwzlrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FJ&md5=486a87abb406c4c833404ccce61c1389</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm300915b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300915b%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DJennings%26aufirst%3DL.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DProgress%2520in%2520the%2520Development%2520and%2520Application%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520Bromodomain%25E2%2580%2593Acetyl-Lysine%2520Interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9393%26epage%3D9413%26doi%3D10.1021%2Fjm300915b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Brand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Measures, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of Bromodomain–Acetyl-Lysine Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1021/cb500996u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500996u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFGktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=22-39&author=M.+Brandauthor=A.+M.+Measuresauthor=B.+G.+Wilsonauthor=W.+A.+Cortopassiauthor=R.+Alexanderauthor=M.+H%C3%B6ssauthor=D.+S.+Hewingsauthor=T.+P.+C.+Rooneyauthor=R.+S.+Patonauthor=S.+J.+Conway&title=Small+Molecule+Inhibitors+of+Bromodomain%E2%80%93Acetyl-Lysine+Interactions&doi=10.1021%2Fcb500996u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions</span></div><div class="casAuthors">Brand, Michael; Measures, Angelina R.; Wilson, Brian G.; Cortopassi, Wilian A.; Alexander, Rikki; Hoss, Matthias; Hewings, David S.; Rooney, Timothy P. C.; Paton, Robert S.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-39</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bromodomains are protein modules that bind to acetylated lysine residues.  Their interaction with histone proteins suggests that they function as "readers" of histone lysine acetylation, a component of the proposed "histone code".  Bromodomain-contg. proteins are often found as components of larger protein complexes with roles in fundamental cellular process including transcription.  The publication of two potent ligands for the BET bromodomains in 2010 demonstrated that small mols. can inhibit the bromodomain-acetyl-lysine protein-protein interaction.  These mols. display strong phenotypic effects in a no. of cell lines and affect a range of cancers in vivo.  This work stimulated intense interest in developing further ligands for the BET bromodomains and the design of ligands for non-BET bromodomains.  Here we review the recent progress in the field with particular attention paid to ligand design, the assays employed in early ligand discovery, and the use of computational approaches to inform ligand design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1JZtWpBpqS7Vg90H21EOLACvtfcHk0likv59zqwzlrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFGktQ%253D%253D&md5=e40e85fc300109654712a00de400c8ba</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fcb500996u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500996u%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DM.%26aulast%3DMeasures%26aufirst%3DA.%2BM.%26aulast%3DWilson%26aufirst%3DB.%2BG.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DH%25C3%25B6ss%26aufirst%3DM.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520Bromodomain%25E2%2580%2593Acetyl-Lysine%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D22%26epage%3D39%26doi%3D10.1021%2Fcb500996u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Gallenkamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelato, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinmann, H.</span><span> </span><span class="NLM_article-title">Bromodomains and Their Pharmacological Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1002/cmdc.201300434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fcmdc.201300434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24497428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=438-464&author=D.+Gallenkampauthor=K.+A.+Gelatoauthor=B.+Haendlerauthor=H.+Weinmann&title=Bromodomains+and+Their+Pharmacological+Inhibitors&doi=10.1002%2Fcmdc.201300434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Bromodomains and Their Pharmacological Inhibitors</span></div><div class="casAuthors">Gallenkamp, Daniel; Gelato, Kathy A.; Haendler, Bernard; Weinmann, Hilmar</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">438-464</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Over 60 bromodomains belonging to proteins with very different functions have been identified in humans.  Several of them interact with acetylated lysine residues, leading to the recruitment and stabilization of protein complexes.  The bromodomain and extra-terminal domain (BET) proteins contain tandem bromodomains which bind to acetylated histones and are thereby implicated in a no. of DNA-centered processes, including the regulation of gene expression.  The recent identification of inhibitors of BET and non-BET bromodomains is one of the few examples in which effective blockade of a protein-protein interaction can be achieved with a small mol.  This has led to major strides in the understanding of the function of bromodomain-contg. proteins and their involvement in diseases such as cancer and inflammation.  Indeed, BET bromodomain inhibitors are now being clin. evaluated for the treatment of hematol. tumors and have also been tested in clin. trials for the relatively rare BRD-NUT midline carcinoma.  This review gives an overview of the newest developments in the field, with a focus on the biol. of selected bromodomain proteins on the one hand, and on reported pharmacol. inhibitors on the other, including recent examples from the patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-8_ymytCPbVg90H21EOLACvtfcHk0likv59zqwzlrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsl2gtL4%253D&md5=2ce7c6b5c37001fb8fb901fe04aeb606</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300434%26sid%3Dliteratum%253Aachs%26aulast%3DGallenkamp%26aufirst%3DD.%26aulast%3DGelato%26aufirst%3DK.%2BA.%26aulast%3DHaendler%26aufirst%3DB.%26aulast%3DWeinmann%26aufirst%3DH.%26atitle%3DBromodomains%2520and%2520Their%2520Pharmacological%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D438%26epage%3D464%26doi%3D10.1002%2Fcmdc.201300434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">The number of bromodomain publications per calendar year was generated from SciFinder using the search term “Bromodomain.” The number of bromodomain publications in 2015 are shown up to November 1.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coste, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosmini, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delves, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magny, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillot, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uings, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clément, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, A.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimley, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blandel, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirilovsky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3827</span><span class="NLM_x">–</span> <span class="NLM_lpage">3838</span><span class="refDoi"> DOI: 10.1021/jm200108t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200108t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3827-3838&author=C.-W.+Chungauthor=H.+Costeauthor=J.+H.+Whiteauthor=O.+Mirguetauthor=J.+Wildeauthor=R.+L.+Gosminiauthor=C.+Delvesauthor=S.+M.+Magnyauthor=R.+Woodwardauthor=S.+A.+Hughesauthor=E.+V.+Boursierauthor=H.+Flynnauthor=A.+M.+Bouillotauthor=P.+Bamboroughauthor=J.-M.+G.+Brusqauthor=F.+J.+Gellibertauthor=E.+J.+Jonesauthor=A.+M.+Riouauthor=P.+Homesauthor=S.+L.+Martinauthor=I.+J.+Uingsauthor=J.+Toumauthor=C.+A.+Cl%C3%A9mentauthor=A.-B.+Boullayauthor=R.+L.+Grimleyauthor=F.+M.+Blandelauthor=R.+K.+Prinjhaauthor=K.+Leeauthor=J.+Kirilovskyauthor=E.+Nicodeme&title=Discovery+and+Characterization+of+Small+Molecule+Inhibitors+of+the+BET+Family+Bromodomains&doi=10.1021%2Fjm200108t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of small molecule inhibitors of the BET family bromodomains</span></div><div class="casAuthors">Chung, Chun-wa; Coste, Herve; White, Julia H.; Mirguet, Olivier; Wilde, Jonathan; Gosmini, Romain L.; Delves, Chris; Magny, Sylvie M.; Woodward, Robert; Hughes, Stephen A.; Boursier, Eric V.; Flynn, Helen; Bouillot, Anne M.; Bamborough, Paul; Brusq, Jean-Marie G.; Gellibert, Francoise J.; Jones, Emma J.; Riou, Alizon M.; Homes, Paul; Martin, Sandrine L.; Uings, Iain J.; Toum, Jerome; Clement, Catherine A.; Boullay, Anne-Benedicte; Grimley, Rachel L.; Blandel, Florence M.; Prinjha, Rab K.; Lee, Kevin; Kirilovsky, Jorge; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3827-3838</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epigenetic mechanisms of gene regulation have a profound role in normal development and disease processes.  An integral part of this mechanism occurs through lysine acetylation of histone tails which are recognized by bromodomains.  While the biol. and structural characterization of many bromodomain contg. proteins has advanced considerably, the therapeutic tractability of this protein family is only now becoming understood.  This paper describes the discovery and mol. characterization of potent (nM) small mol. inhibitors that disrupt the function of the BET family of bromodomains (Brd2, Brd3, and Brd4).  By using a combination of phenotypic screening, chemoproteomics, and biophys. studies, we have discovered that the protein-protein interactions between bromodomains and acetylated histones can be antagonized by selective small mols. that bind at the acetylated lysine recognition pocket.  X-ray crystal structures of compds. bound into bromodomains of Brd2 and Brd4 elucidate the mol. interactions of binding and explain the precisely defined stereochem. required for activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8VauuYkT5YLVg90H21EOLACvtfcHk0li_fnX7IjZQNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVWnurs%253D&md5=ebc0f6062321dece877259d775f1c19b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm200108t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200108t%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DWhite%26aufirst%3DJ.%2BH.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DWilde%26aufirst%3DJ.%26aulast%3DGosmini%26aufirst%3DR.%2BL.%26aulast%3DDelves%26aufirst%3DC.%26aulast%3DMagny%26aufirst%3DS.%2BM.%26aulast%3DWoodward%26aufirst%3DR.%26aulast%3DHughes%26aufirst%3DS.%2BA.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DFlynn%26aufirst%3DH.%26aulast%3DBouillot%26aufirst%3DA.%2BM.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrusq%26aufirst%3DJ.-M.%2BG.%26aulast%3DGellibert%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DRiou%26aufirst%3DA.%2BM.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%2BL.%26aulast%3DUings%26aufirst%3DI.%2BJ.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DC.%2BA.%26aulast%3DBoullay%26aufirst%3DA.-B.%26aulast%3DGrimley%26aufirst%3DR.%2BL.%26aulast%3DBlandel%26aufirst%3DF.%2BM.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520BET%2520Family%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3827%26epage%3D3838%26doi%3D10.1021%2Fjm200108t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortopassi, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryde, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paton, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-Π Interaction</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">6126</span><span class="NLM_x">–</span> <span class="NLM_lpage">6130</span><span class="refDoi"> DOI: 10.1002/anie.201402750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fanie.201402750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=6126-6130&author=T.+P.+C.+Rooneyauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=W.+A.+Cortopassiauthor=D.+A.+Hayauthor=S.+Martinauthor=A.+Tumberauthor=C.+M.+Rogersauthor=M.+Philpottauthor=M.+Wangauthor=A.+L.+Thompsonauthor=T.+D.+Heightmanauthor=D.+C.+Prydeauthor=A.+Cookauthor=R.+S.+Patonauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=A+Series+of+Potent+CREBBP+Bromodomain+Ligands+Reveals+an+Induced-Fit+Pocket+Stabilized+by+a+Cation-%CE%A0+Interaction&doi=10.1002%2Fanie.201402750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction</span></div><div class="casAuthors">Rooney, Timothy P. C.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Cortopassi, Wilian A.; Hay, Duncan A.; Martin, Sarah; Tumber, Anthony; Rogers, Catherine M.; Philpott, Martin; Wang, Minghua; Thompson, Amber L.; Heightman, Tom D.; Pryde, David C.; Cook, Andrew; Paton, Robert S.; Mueller, Susanne; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6126-6130</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Benzoxazinone and dihydroquinoxalinone fragments were employed as novel acetyl lysine mimics in the development of CREBBP bromodomain ligands.  While the benzoxazinone series showed low affinity for the CREBBP bromodomain, expansion of the dihydroquinoxalinone series resulted in the first potent inhibitors, e.g., I, of a bromodomain outside the BET family.  Structural and computational studies revealed that an internal hydrogen bond stabilized the protein-bound conformation of the dihydroquinoxalinone series.  The side chain of this series binds in an induced-fit pocket forming a cation-π interaction with R1173 of CREBBP.  Compd. I, the most potent compd., inhibited binding of CREBBP to chromatin in U2OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHFgTVUKe7lrVg90H21EOLACvtfcHk0li_fnX7IjZQNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvFWgsb0%253D&md5=42b12e1fe855d2af02c49f8e1031d39e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402750%26sid%3Dliteratum%253Aachs%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DCortopassi%26aufirst%3DW.%2BA.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DA.%2BL.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DPryde%26aufirst%3DD.%2BC.%26aulast%3DCook%26aufirst%3DA.%26aulast%3DPaton%26aufirst%3DR.%2BS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DA%2520Series%2520of%2520Potent%2520CREBBP%2520Bromodomain%2520Ligands%2520Reveals%2520an%2520Induced-Fit%2520Pocket%2520Stabilized%2520by%2520a%2520Cation-%25CE%25A0%2520Interaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D6126%26epage%3D6130%26doi%3D10.1002%2Fanie.201402750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Delvecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaucher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguilar-Gurrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panne, D.</span><span> </span><span class="NLM_article-title">Structure of the P300 Catalytic Core and Implications for Chromatin Targeting and HAT Regulation</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1040</span><span class="NLM_x">–</span> <span class="NLM_lpage">1046</span><span class="refDoi"> DOI: 10.1038/nsmb.2642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnsmb.2642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23934153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1040-1046&author=M.+Delvecchioauthor=J.+Gaucherauthor=C.+Aguilar-Gurrieriauthor=E.+Ortegaauthor=D.+Panne&title=Structure+of+the+P300+Catalytic+Core+and+Implications+for+Chromatin+Targeting+and+HAT+Regulation&doi=10.1038%2Fnsmb.2642"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation</span></div><div class="casAuthors">Delvecchio, Manuela; Gaucher, Jonathan; Aguilar-Gurrieri, Carmen; Ortega, Esther; Panne, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1040-1046</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CBP and p300 are histone acetyltransferases (HATs) that assoc. with and acetylate transcriptional regulators and chromatin.  Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer.  Here we present the 2.8-Å crystal structure of the catalytic core of human p300 contg. its bromodomain, CH2 region and HAT domain.  The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain.  The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket.  Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain.  The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlYehjRwdhJ7Vg90H21EOLACvtfcHk0lg6UbA3PkI_kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cgtr3J&md5=e9352198d513eac6fd93fc2896828d09</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2642%26sid%3Dliteratum%253Aachs%26aulast%3DDelvecchio%26aufirst%3DM.%26aulast%3DGaucher%26aufirst%3DJ.%26aulast%3DAguilar-Gurrieri%26aufirst%3DC.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DPanne%26aufirst%3DD.%26atitle%3DStructure%2520of%2520the%2520P300%2520Catalytic%2520Core%2520and%2520Implications%2520for%2520Chromatin%2520Targeting%2520and%2520HAT%2520Regulation%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D1040%26epage%3D1046%26doi%3D10.1038%2Fnsmb.2642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeleznik-Le, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M. M.</span><span> </span><span class="NLM_article-title">Structural Mechanism of the Bromodomain of the Coactivator CBP in P53 Transcriptional Activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span><span class="refDoi"> DOI: 10.1016/S1097-2765(03)00528-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2FS1097-2765%2803%2900528-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=14759370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=251-263&author=S.+Mujtabaauthor=Y.+Heauthor=L.+Zengauthor=S.+Yanauthor=O.+Plotnikovaauthor=+Sachchidanandauthor=R.+Sanchezauthor=N.+J.+Zeleznik-Leauthor=Z.+Ronaiauthor=M.+M.+Zhou&title=Structural+Mechanism+of+the+Bromodomain+of+the+Coactivator+CBP+in+P53+Transcriptional+Activation&doi=10.1016%2FS1097-2765%2803%2900528-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation</span></div><div class="casAuthors">Mujtaba, Shiraz; He, Yan; Zeng, Lei; Yan, Sherry; Plotnikova, Olga; Sachchidanand; Sanchez, Roberto; Zeleznik-Le, Nancy J.; Ronai, Ze'ev; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-263</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of the tumor suppressor protein p53 in response to a wide variety of cellular stress signals is required for its activation as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, the authors report that the conserved bromodomain of the transcriptional coactivator CBP (CREB binding protein) binds specifically to p53 at the C-terminal acetylated lysine 382.  This bromodomain/acetyllysine binding is responsible for p53 acetylation-dependent coactivator recruitment after DNA damage, a step essential for p53-induced transcriptional activation of the cyclin-dependent kinase inhibitor p21 in G1 cell cycle arrest.  The authors further present the three-dimensional NMR structure of the CBP bromodomain in complex with a lysine 382-acetylated p53 peptide.  Using structural and biochem. analyses, the authors define the mol. determinants for the specificity of this mol. recognition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3g6bC53YUKbVg90H21EOLACvtfcHk0lg6UbA3PkI_kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFOhsr0%253D&md5=10127e2d2ea5165fd8439bf26a6f9241</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900528-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900528-8%26sid%3Dliteratum%253Aachs%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DSachchidanand%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DZeleznik-Le%26aufirst%3DN.%2BJ.%26aulast%3DRonai%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DM.%2BM.%26atitle%3DStructural%2520Mechanism%2520of%2520the%2520Bromodomain%2520of%2520the%2520Coactivator%2520CBP%2520in%2520P53%2520Transcriptional%2520Activation%26jtitle%3DMol.%2520Cell%26date%3D2004%26volume%3D13%26spage%3D251%26epage%3D263%26doi%3D10.1016%2FS1097-2765%2803%2900528-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ianculescu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegmund, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallcup, M. R.</span><span> </span><span class="NLM_article-title">Selective Roles for cAMP Response Element-Binding Protein Binding Protein and P300 Protein as Coregulators for Androgen-Regulated Gene Expression in Advanced Prostate Cancer Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4013</span><span class="refDoi"> DOI: 10.1074/jbc.M111.300194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M111.300194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22174411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=4000-4013&author=I.+Ianculescuauthor=D.+Y.+Wuauthor=K.+D.+Siegmundauthor=M.+R.+Stallcup&title=Selective+Roles+for+cAMP+Response+Element-Binding+Protein+Binding+Protein+and+P300+Protein+as+Coregulators+for+Androgen-Regulated+Gene+Expression+in+Advanced+Prostate+Cancer+Cells&doi=10.1074%2Fjbc.M111.300194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells</span></div><div class="casAuthors">Ianculescu, Irina; Wu, Dai-Ying; Siegmund, Kimberly D.; Stallcup, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4000-4013</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The protein acetyltransferases p300 and cAMP response element-binding protein binding protein (CBP) are homologous, ubiquitously expressed proteins that interact with hundreds of proteins involved in transcriptional regulation and are involved globally as transcriptional coregulators.  Although these two proteins acetylate and interact with overlapping sets of proteins, we found that p300 and CBP contribute to androgen-induced regulation of distinct sets of genes in C4-2B prostate cancer cells, a model of advanced prostate cancer.  CBP cannot compensate for the loss of p300 to support androgen-induced expression of many genes, such as TMPRSS2 and PSA.  Global gene expression anal. indicated that 47% of androgen-regulated genes are p300-dependent in these cells, whereas, surprisingly, only 0.3% of them are CBP-dependent.  Chromatin immunopptn. anal. after depletion of cellular p300 indicated that p300 is required for androgen-induced acetylation of histones H3 and H4, methylation of histone H3 at Lys-4, and recruitment of TATA box binding protein (TBP) and RNA polymerase II, but not recruitment of the androgen receptor, on the TMPRSS2 gene in response to androgen.  Thus, p300 is the dominant coregulator of the CBP/p300 pair for androgen-regulated gene expression in C4-2B cells. p300 is required at an early stage of chromatin remodeling and transcription complex assembly after binding of androgen receptor to the gene but before many crit. histone modifications occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7uJfPL3B4h7Vg90H21EOLACvtfcHk0lg6UbA3PkI_kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSjtLg%253D&md5=095ab7582da1b7602e2ab898caa5b094</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.300194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.300194%26sid%3Dliteratum%253Aachs%26aulast%3DIanculescu%26aufirst%3DI.%26aulast%3DWu%26aufirst%3DD.%2BY.%26aulast%3DSiegmund%26aufirst%3DK.%2BD.%26aulast%3DStallcup%26aufirst%3DM.%2BR.%26atitle%3DSelective%2520Roles%2520for%2520cAMP%2520Response%2520Element-Binding%2520Protein%2520Binding%2520Protein%2520and%2520P300%2520Protein%2520as%2520Coregulators%2520for%2520Androgen-Regulated%2520Gene%2520Expression%2520in%2520Advanced%2520Prostate%2520Cancer%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D4000%26epage%3D4013%26doi%3D10.1074%2Fjbc.M111.300194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Iyer, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Özdag, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">P300/CBP and Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4225</span><span class="NLM_x">–</span> <span class="NLM_lpage">4231</span><span class="refDoi"> DOI: 10.1038/sj.onc.1207118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fsj.onc.1207118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=15156177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=4225-4231&author=N.+G.+Iyerauthor=H.+%C3%96zdagauthor=C.+Caldas&title=P300%2FCBP+and+Cancer&doi=10.1038%2Fsj.onc.1207118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">p300/CBP and cancer</span></div><div class="casAuthors">Iyer, Narayanan Gopalakrishna; Oezdag, Hilal; Caldas, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4231</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  P300 and cAMP response element-binding protein (CBP) are adenoviral E1A-binding proteins involved in multiple cellular processes, and function as transcriptional co-factors and histone acetyltransferases.  Germline mutation of CBP results in Rubinstein-Taybi syndrome, which is characterized by an increased predisposition to childhood malignancies.  Furthermore, somatic mutations of p300 and CBP occur in a no. of malignancies.  Chromosome translocations target CBP and, less commonly, p300 in acute myeloid leukemia and treatment-related hematol. disorders.  P300 mutations in solid tumors result in truncated p300 protein products or amino-acid substitutions in crit. protein domains, and these are often assocd. with inactivation of the second allele.  A mouse model confirms that p300 and CBP function as suppressors of hematol. tumor formation.  The involvement of these proteins in crit. tumorigenic pathways (including TGF-β, p53 and Rb) provides a mechanistic route as to how their inactivation could result in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKGBLVLWLqkrVg90H21EOLACvtfcHk0liTRTXIj_wKvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVChtrc%253D&md5=b68fe6bc258b06515c04a5207410f026</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1207118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1207118%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DN.%2BG.%26aulast%3D%25C3%2596zdag%26aufirst%3DH.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DP300%252FCBP%2520and%2520Cancer%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D4225%26epage%3D4231%26doi%3D10.1038%2Fsj.onc.1207118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Faiola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lymar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, E.</span><span> </span><span class="NLM_article-title">Dual Regulation of C-Myc by P300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10220</span><span class="NLM_x">–</span> <span class="NLM_lpage">10234</span><span class="refDoi"> DOI: 10.1128/MCB.25.23.10220-10234.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FMCB.25.23.10220-10234.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=16287840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10220-10234&author=F.+Faiolaauthor=X.+Liuauthor=S.+Loauthor=S.+Panauthor=K.+Zhangauthor=E.+Lymarauthor=A.+Farinaauthor=E.+Martinez&title=Dual+Regulation+of+C-Myc+by+P300+via+Acetylation-Dependent+Control+of+Myc+Protein+Turnover+and+Coactivation+of+Myc-Induced+Transcription&doi=10.1128%2FMCB.25.23.10220-10234.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription</span></div><div class="casAuthors">Faiola, Francesco; Liu, Xiaohui; Lo, Szuying; Pan, Songqin; Zhang, Kangling; Lymar, Elena; Farina, Anthony; Martinez, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10220-10234</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The c-Myc oncoprotein (Myc) controls cell fate by regulating gene transcription in assocn. with a DNA-binding partner, Max.  While Max lacks a transcription regulatory domain, the N-terminus of Myc contains a transcription activation domain (TAD) that recruits cofactor complexes contg. the histone acetyltransferases (HATs) GCN5 and Tip60.  Here, we report a novel functional interaction between Myc TAD and the p300 coactivator-acetyltransferase.  We show that p300 assocs. with Myc in mammalian cells and in vitro through direct interactions with Myc TAD residues 1 to 110 and acetylates Myc in a TAD-dependent manner in vivo at several lysine residues located between the TAD and DNA-binding domain.  Moreover, the Myc:Max complex is differentially acetylated by p300 and GCN5 and is not acetylated by Tip60 in vitro, suggesting distinct functions for these acetyltransferases.  Whereas p300 and CBP can stabilize Myc independently of acetylation, p300-mediated acetylation results in increased Myc turnover.  In addn., p300 functions as a coactivator that is recruited by Myc to the promoter of the human telomerase reverse transcriptase gene, and p300/CBP stimulates Myc TAD-dependent transcription in a HAT domain-dependent manner.  Our results suggest dual roles for p300/CBP in Myc regulation: as a Myc coactivator that stabilizes Myc and as an inducer of Myc instability via direct Myc acetylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4or2afHXuK7Vg90H21EOLACvtfcHk0liTRTXIj_wKvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Ons7fL&md5=bbabfb64492444687f048ee59cdc0210</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.23.10220-10234.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.23.10220-10234.2005%26sid%3Dliteratum%253Aachs%26aulast%3DFaiola%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLo%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLymar%26aufirst%3DE.%26aulast%3DFarina%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DE.%26atitle%3DDual%2520Regulation%2520of%2520C-Myc%2520by%2520P300%2520via%2520Acetylation-Dependent%2520Control%2520of%2520Myc%2520Protein%2520Turnover%2520and%2520Coactivation%2520of%2520Myc-Induced%2520Transcription%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D10220%26epage%3D10234%26doi%3D10.1128%2FMCB.25.23.10220-10234.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Predina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beier, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatti, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akimova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singhal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brindle, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albelda, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, W. W.</span><span> </span><span class="NLM_article-title">Inhibition of P300 Impairs Foxp3+ T Regulatory Cell Function and Promotes Antitumor Immunity</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1177</span><span class="refDoi"> DOI: 10.1038/nm.3286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnm.3286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23955711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1173-1177&author=Y.+Liuauthor=L.+Wangauthor=J.+Predinaauthor=R.+Hanauthor=U.+H.+Beierauthor=L.-C.+S.+Wangauthor=V.+Kapoorauthor=T.+R.+Bhattiauthor=T.+Akimovaauthor=S.+Singhalauthor=P.+K.+Brindleauthor=P.+A.+Coleauthor=S.+M.+Albeldaauthor=W.+W.+Hancock&title=Inhibition+of+P300+Impairs+Foxp3%2B+T+Regulatory+Cell+Function+and+Promotes+Antitumor+Immunity&doi=10.1038%2Fnm.3286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p300 impairs Foxp3+ T regulatory cell function and promotes antitumor immunity</span></div><div class="casAuthors">Liu, Yujie; Wang, Liqing; Predina, Jarrod; Han, Rongxiang; Beier, Ulf H.; Wang, Liang-Chuan S.; Kapoor, Veena; Bhatti, Tricia R.; Akimova, Tatiana; Singhal, Sunil; Brindle, Paul K.; Cole, Philip A.; Albelda, Steven M.; Hancock, Wayne W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Forkhead box P3 (Foxp3)+ T regulatory (Treg) cells maintain immune homeostasis and limit autoimmunity but can also curtail host immune responses to various types of tumors.  Foxp3+ Treg cells are therefore considered promising targets to enhance antitumor immunity, and approaches for their therapeutic modulation are being developed.  However, although studies showing that exptl. depleting Foxp3+ Treg cells can enhance antitumor responses provide proof of principle, these studies lack clear translational potential and have various shortcomings.  Histone/protein acetyltransferases (HATs) promote chromatin accessibility, gene transcription and the function of multiple transcription factors and nonhistone proteins.  We now report that conditional deletion or pharmacol. inhibition of one HAT, p300 (also known as Ep300 or KAT3B), in Foxp3+ Treg cells increased T cell receptor-induced apoptosis in Treg cells, impaired Treg cell suppressive function and peripheral Treg cell induction, and limited tumor growth in immunocompetent but not in immunodeficient mice.  Our data thereby demonstrate that p300 is important for Foxp3+ Treg cell function and homeostasis in vivo and in vitro, and identify mechanisms by which appropriate small-mol. inhibitors can diminish Treg cell function without overtly impairing T effector cell responses or inducing autoimmunity.  Collectively, these data suggest a new approach for cancer immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG1uh9kwBI_rVg90H21EOLACvtfcHk0liTRTXIj_wKvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1yks77K&md5=b381e7523f686ed8ea8d54aa38327c41</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnm.3286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3286%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPredina%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DR.%26aulast%3DBeier%26aufirst%3DU.%2BH.%26aulast%3DWang%26aufirst%3DL.-C.%2BS.%26aulast%3DKapoor%26aufirst%3DV.%26aulast%3DBhatti%26aufirst%3DT.%2BR.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DSinghal%26aufirst%3DS.%26aulast%3DBrindle%26aufirst%3DP.%2BK.%26aulast%3DCole%26aufirst%3DP.%2BA.%26aulast%3DAlbelda%26aufirst%3DS.%2BM.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26atitle%3DInhibition%2520of%2520P300%2520Impairs%2520Foxp3%252B%2520T%2520Regulatory%2520Cell%2520Function%2520and%2520Promotes%2520Antitumor%2520Immunity%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1173%26epage%3D1177%26doi%3D10.1038%2Fnm.3286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Bellon, S.; Cochran, A.; Cote, A.; Crawford, T.; Fauber, B.; Ghosh, S.; Harmange, J.-C.; Hatzivassiliou, G.; Lora, J. M.; Magnuson, S.; Mellman, I.; Romero, F. A.; Taylor, A. M.; Tsui, V.</span><span> </span><span class="NLM_article-title">Use of CBP/EP300 Bromodomain Inhibitors for Cancer Immunotherapy</span>. WO2015054642A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+K.+Albrecht&author=J.+E.+Audia&author=S.+Bellon&author=A.+Cochran&author=A.+Cote&author=T.+Crawford&author=B.+Fauber&author=S.+Ghosh&author=J.-C.+Harmange&author=G.+Hatzivassiliou&author=J.+M.+Lora&author=S.+Magnuson&author=I.+Mellman&author=F.+A.+Romero&author=A.+M.+Taylor&author=V.+Tsui&title=Use+of+CBP%2FEP300+Bromodomain+Inhibitors+for+Cancer+Immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DUse%2520of%2520CBP%252FEP300%2520Bromodomain%2520Inhibitors%2520for%2520Cancer%2520Immunotherapy%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sachchidanand</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick-Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutjaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Target Structure-Based Discovery of Small Molecules That Block Human P53 and CREB Binding Protein Association</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2005.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2005.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=16426974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsV2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=81-90&author=+Sachchidanandauthor=L.+Resnick-Silvermanauthor=S.+Yanauthor=S.+Mutjabaauthor=W.-J.+Liuauthor=L.+Zengauthor=J.+J.+Manfrediauthor=M.-M.+Zhou&title=Target+Structure-Based+Discovery+of+Small+Molecules+That+Block+Human+P53+and+CREB+Binding+Protein+Association&doi=10.1016%2Fj.chembiol.2005.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Target Structure-Based Discovery of Small Molecules that Block Human p53 and CREB Binding Protein Association</span></div><div class="casAuthors">Sachchidanand; Resnick-Silverman, Lois; Yan, Sherry; Mutjaba, Shiraz; Liu, Wen-jun; Zeng, Lei; Manfredi, James J.; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-90</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Lysine acetylation of human tumor suppressor p53 in response to cellular stress signals is required for its function as a transcription factor that regulates cell cycle arrest, senescence, or apoptosis.  Here, we report small mols. that block lysine 382-acetylated p53 assocn. with the bromodomain of the coactivator CBP, an interaction essential for p53-induced transcription of the cell cycle inhibitor p21 in response to DNA damage.  These chems. were discovered in target structure-guided NMR spectroscopy screening of a focused chem. library constructed based on the structural knowledge of CBP bromodomain/p53-AcK382 binding.  Structural characterization shows that these chems. inhibit CBP/p53 assocn. by binding to the acetyl-lysine binding site of the bromodomain.  Cell-based functional assays demonstrate that the lead chems. can modulate p53 stability and function in response to doxorubicin-induced DNA damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrznkGtHkYXCbVg90H21EOLACvtfcHk0liEkOJHk9nUyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsV2qsQ%253D%253D&md5=a88211df5b27a2d2d37cb09a3bc50821</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DSachchidanand%26aulast%3DResnick-Silverman%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DMutjaba%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.-J.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DManfredi%26aufirst%3DJ.%2BJ.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DTarget%2520Structure-Based%2520Discovery%2520of%2520Small%2520Molecules%2520That%2520Block%2520Human%2520P53%2520and%2520CREB%2520Binding%2520Protein%2520Association%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D81%26epage%3D90%26doi%3D10.1016%2Fj.chembiol.2005.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirouzu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2011.02.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2011.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21513886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFartL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=495-507&author=T.+Itoauthor=T.+Umeharaauthor=K.+Sasakiauthor=Y.+Nakamuraauthor=N.+Nishinoauthor=T.+Teradaauthor=M.+Shirouzuauthor=B.+Padmanabhanauthor=S.+Yokoyamaauthor=A.+Itoauthor=M.+Yoshida&title=Real-Time+Imaging+of+Histone+H4K12-Specific+Acetylation+Determines+the+Modes+of+Action+of+Histone+Deacetylase+and+Bromodomain+Inhibitors&doi=10.1016%2Fj.chembiol.2011.02.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors</span></div><div class="casAuthors">Ito, Tamaki; Umehara, Takashi; Sasaki, Kazuki; Nakamura, Yoshihiro; Nishino, Norikazu; Terada, Takaho; Shirouzu, Mikako; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki; Ito, Akihiro; Yoshida, Minoru</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-507</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone acetylation constitutes an epigenetic mark for transcriptional regulation.  Here we developed a fluorescent probe to visualize acetylation of histone H4 Lys12 (H4K12) in living cells using fluorescence resonance energy transfer (FRET) and the binding of the BRD2 bromodomain to acetylated H4K12.  Using this probe designated as Histac-K12, we demonstrated that histone H4K12 acetylation is retained in mitosis and that some histone deacetylase (HDAC) inhibitors continue to inhibit cellular HDAC activity even after their removal from the culture.  In addn., a small mol. that interferes with ability of the bromodomain to bind to acetylated H4K12 could be assessed using Histac-K12 in cells.  Thus, Histac-K12 will serve as a powerful tool not only to understand the dynamics of H4K12-specific acetylation but also to characterize small mols. that modulate the acetylation or interaction status of histones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBoA9RjMb5tLVg90H21EOLACvtfcHk0liEkOJHk9nUyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFartL0%253D&md5=f36a5042c2e9342026884f88f9704954</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DUmehara%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DPadmanabhan%26aufirst%3DB.%26aulast%3DYokoyama%26aufirst%3DS.%26aulast%3DIto%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DReal-Time%2520Imaging%2520of%2520Histone%2520H4K12-Specific%2520Acetylation%2520Determines%2520the%2520Modes%2520of%2520Action%2520of%2520Histone%2520Deacetylase%2520and%2520Bromodomain%2520Inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D495%26epage%3D507%26doi%3D10.1016%2Fj.chembiol.2011.02.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttarkar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuppusetty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span> </span><span class="NLM_article-title">3,5-Dimethylisoxazoles Act as Acetyl-Lysine-Mimetic Bromodomain Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6761</span><span class="NLM_x">–</span> <span class="NLM_lpage">6770</span><span class="refDoi"> DOI: 10.1021/jm200640v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200640v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6761-6770&author=D.+S.+Hewingsauthor=M.+Wangauthor=M.+Philpottauthor=O.+Fedorovauthor=S.+Uttarkarauthor=P.+Filippakopoulosauthor=S.+Picaudauthor=C.+Vuppusettyauthor=B.+Marsdenauthor=S.+Knappauthor=S.+J.+Conwayauthor=T.+D.+Heightman&title=3%2C5-Dimethylisoxazoles+Act+as+Acetyl-Lysine-Mimetic+Bromodomain+Ligands&doi=10.1021%2Fjm200640v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Wang, Minghua; Philpott, Martin; Fedorov, Oleg; Uttarkar, Sagar; Filippakopoulos, Panagis; Picaud, Sarah; Vuppusetty, Chaitanya; Marsden, Brian; Knapp, Stefan; Conway, Stuart J.; Heightman, Tom D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6761-6770</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Histone-lysine acetylation is a vital chromatin post-translational modification involved in the epigenetic regulation of gene transcription.  Bromodomains bind acetylated lysines, acting as readers of the histone-acetylation code.  Competitive inhibitors of this interaction have antiproliferative and anti-inflammatory properties.  With 57 distinct bromodomains known, the discovery of subtype-selective inhibitors of the histone-bromodomain interaction is of great importance.  We have identified the 3,5-dimethylisoxazole moiety as a novel acetyl-lysine bioisostere, which displaces acetylated histone-mimicking peptides from bromodomains.  Using X-ray crystallog. anal., we have detd. the interactions responsible for the activity and selectivity of 4-substituted 3,5-dimethylisoxazoles against a selection of phylogenetically diverse bromodomains.  By exploiting these interactions, we have developed compd. 4d, which has IC50 values of <5 μM for the bromodomain-contg. proteins BRD2(1) and BRD4(1).  These compds. are promising leads for the further development of selective probes for the bromodomain and extra C-terminal domain (BET) family and CREBBP bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzK4xMvJhXrVg90H21EOLACvtfcHk0liEkOJHk9nUyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaks7rO&md5=7d6f9eff2735c8a7189dec4fb5c5d13d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm200640v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200640v%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DUttarkar%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DVuppusetty%26aufirst%3DC.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26atitle%3D3%252C5-Dimethylisoxazoles%2520Act%2520as%2520Acetyl-Lysine-Mimetic%2520Bromodomain%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6761%26epage%3D6770%26doi%3D10.1021%2Fjm200640v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olcina, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span> </span><span class="NLM_article-title">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3217</span><span class="NLM_x">–</span> <span class="NLM_lpage">3227</span><span class="refDoi"> DOI: 10.1021/jm301588r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301588r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3217-3227&author=D.+S.+Hewingsauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=S.+Picaudauthor=A.+Tumberauthor=C.+Wellsauthor=M.+M.+Olcinaauthor=K.+Freemanauthor=A.+Gillauthor=A.+J.+Ritchieauthor=D.+W.+Sheppardauthor=A.+J.+Russellauthor=E.+M.+Hammondauthor=S.+Knappauthor=P.+E.+Brennanauthor=S.+J.+Conway&title=Optimization+of+3%2C5-Dimethylisoxazole+Derivatives+as+Potent+Bromodomain+Ligands&doi=10.1021%2Fjm301588r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands</span></div><div class="casAuthors">Hewings, David S.; Fedorov, Oleg; Filippakopoulos, Panagis; Martin, Sarah; Picaud, Sarah; Tumber, Anthony; Wells, Christopher; Olcina, Monica M.; Freeman, Katherine; Gill, Andrew; Ritchie, Alison J.; Sheppard, David W.; Russell, Angela J.; Hammond, Ester M.; Knapp, Stefan; Brennan, Paul E.; Conway, Stuart J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3217-3227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(Isoxazolylphenyl)arylmethanols such as I (R = H; R1 = HO; R2 = H; R3 = Ph), I (R = HO; R1 = H; R2 = H; R3 = Ph), and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = Ph, 3-FC6H4, 4-FC6H4, 3-ClC6H4, 4-ClC6H4) were prepd. as inhibitors of the bromodomain and extra terminal domain (BET) bromodomain family member BRD4(1) for potential use as antitumor agents.  The structures of I (R = H; R1 = HO; R2 = H; R3 = Ph) and I (R = HO; R1 = H; R2 = H; R3 = Ph) bound to human BRD4(1) were detd. by X-ray crystallog. to det. features useful for selective binding to BRD4(1).  I (R = H, HO; R1 = HO, H; R2 = H, MeCO; R3 = Ph) and I (R = H, HO; R1 = HO, H; R2 = Et; R3 = 3-ClC6H4) inhibited a human acute myeloid leukemia cell line in vitro with 3-4 fold reduced inhibition and reduced toxicity in other human cells compared to a known BRD4(1) inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVEQ5OOJGC8bVg90H21EOLACvtfcHk0ljfZdwxDuYq7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktlekuro%253D&md5=bb4890291db8c3e8d404a75dd9dcbb87</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm301588r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301588r%26sid%3Dliteratum%253Aachs%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DOlcina%26aufirst%3DM.%2BM.%26aulast%3DFreeman%26aufirst%3DK.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DRitchie%26aufirst%3DA.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DRussell%26aufirst%3DA.%2BJ.%26aulast%3DHammond%26aufirst%3DE.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26atitle%3DOptimization%2520of%25203%252C5-Dimethylisoxazole%2520Derivatives%2520as%2520Potent%2520Bromodomain%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3217%26epage%3D3227%26doi%3D10.1021%2Fjm301588r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, T. P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Discovery and Optimization of Small-Molecule Ligands for the CBP/P300 Bromodomains</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">9308</span><span class="NLM_x">–</span> <span class="NLM_lpage">9319</span><span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+Optimization+of+Small-Molecule+Ligands+for+the+CBP%2FP300+Bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0ljfZdwxDuYq7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520Small-Molecule%2520Ligands%2520for%2520the%2520CBP%252FP300%2520Bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>SGC-CBP30: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/CBP30" class="extLink">http://www.thesgc.org/chemical-probes/CBP30</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SGC-CBP30%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FCBP30+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DSGC-CBP30%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewings, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uttakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">The Design and Synthesis of 5- and 6-Isoxazolylbenzimidazoles as Selective Inhibitors of the BET Bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1039/C2MD20189E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC2MD20189E" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=140-144&author=D.+Hayauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=S.+Martinauthor=M.+Philpottauthor=S.+Picaudauthor=D.+S.+Hewingsauthor=S.+Uttakarauthor=T.+D.+Heightmanauthor=S.+J.+Conwayauthor=S.+Knappauthor=P.+E.+Brennan&title=The+Design+and+Synthesis+of+5-+and+6-Isoxazolylbenzimidazoles+as+Selective+Inhibitors+of+the+BET+Bromodomains&doi=10.1039%2FC2MD20189E"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1039%2FC2MD20189E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC2MD20189E%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DHewings%26aufirst%3DD.%2BS.%26aulast%3DUttakar%26aufirst%3DS.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DThe%2520Design%2520and%2520Synthesis%2520of%25205-%2520and%25206-Isoxazolylbenzimidazoles%2520as%2520Selective%2520Inhibitors%2520of%2520the%2520BET%2520Bromodomains%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D140%26epage%3D144%26doi%3D10.1039%2FC2MD20189E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Hammitzsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, F. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Mossawi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecellio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wordsworth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowness, P.</span><span> </span><span class="NLM_article-title">CBP30, a Selective CBP/P300 Bromodomain Inhibitor, Suppresses Human Th17 Responses</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">10768</span><span class="NLM_x">–</span> <span class="NLM_lpage">10773</span><span class="refDoi"> DOI: 10.1073/pnas.1501956112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1501956112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26261308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=10768-10773&author=A.+Hammitzschauthor=C.+Tallantauthor=O.+Fedorovauthor=A.+O%E2%80%99Mahonyauthor=P.+E.+Brennanauthor=D.+A.+Hayauthor=F.+O.+Martinezauthor=M.+H.+Al-Mossawiauthor=J.+de+Witauthor=M.+Vecellioauthor=C.+Wellsauthor=P.+Wordsworthauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+Bowness&title=CBP30%2C+a+Selective+CBP%2FP300+Bromodomain+Inhibitor%2C+Suppresses+Human+Th17+Responses&doi=10.1073%2Fpnas.1501956112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses</span></div><div class="casAuthors">Hammitzsch, Ariane; Tallant, Cynthia; Fedorov, Oleg; O'Mahony, Alison; Brennan, Paul E.; Hay, Duncan A.; Martinez, Fernando O.; Al-Mossawi, M. Hussein; de Wit, Jelle; Vecellio, Matteo; Wells, Christopher; Wordsworth, Paul; Muller, Susanne; Knapp, Stefan; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10768-10773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Th17 responses are crit. to a variety of human autoimmune diseases, and therapeutic targeting with monoclonal antibodies against IL-17 and IL-23 has shown considerable promise.  Here, the authors report data to support selective bromodomain blockade of the transcriptional coactivators CBP (CREB binding protein) and p300 as an alternative approach to inhibit human Th17 responses.  The authors show that CBP30 has marked mol. specificity for the bromodomains of CBP and p300, compared with 43 other bromodomains.  In unbiased cellular testing on a diverse panel of cultured primary human cells, CBP30 reduced immune cell prodn. of IL-17A and other proinflammatory cytokines.  CBP30 also inhibited IL-17A secretion by Th17 cells from healthy donors and patients with ankylosing spondylitis and psoriatic arthritis.  Transcriptional profiling of human T cells after CBP30 treatment showed a much more restricted effect on gene expression than that obsd. with the pan-BET (bromo and extraterminal domain protein family) bromodomain inhibitor JQ1.  This selective targeting of the CBP/p300 bromodomain by CBP30 will potentially lead to fewer side effects than with the broadly acting epigenetic inhibitors currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4fYjOUV2xW7Vg90H21EOLACvtfcHk0lgLn7TyCFNmxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSit7jI&md5=fb9de88ecdd6441628ae1455ac11b65c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1501956112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1501956112%26sid%3Dliteratum%253Aachs%26aulast%3DHammitzsch%26aufirst%3DA.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Mahony%26aufirst%3DA.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DMartinez%26aufirst%3DF.%2BO.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DVecellio%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DWordsworth%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBowness%26aufirst%3DP.%26atitle%3DCBP30%252C%2520a%2520Selective%2520CBP%252FP300%2520Bromodomain%2520Inhibitor%252C%2520Suppresses%2520Human%2520Th17%2520Responses%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D10768%26epage%3D10773%26doi%3D10.1073%2Fpnas.1501956112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>I-CBP112: A CREBBP/EP300-Selective Chemical Probe; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/I-CBP112" class="extLink">http://www.thesgc.org/chemical-probes/I-CBP112</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=I-CBP112%3A+A+CREBBP%2FEP300-Selective+Chemical+Probe%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FI-CBP112+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DI-CBP112%253A%2520A%2520CREBBP%252FEP300-Selective%2520Chemical%2520Probe%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Xu, M.; Unzue, A.; Dong, J.; Spiliotopoulos, D.; Nevado, C.; Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00171</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+Xu&author=A.+Unzue&author=J.+Dong&author=D.+Spiliotopoulos&author=C.+Nevado&author=A.+Caflisch&title=Discovery+of+CREBBP+Bromodomain+Inhibitors+by+High-Throughput+Docking+and+Hit+Optimization+Guided+by+Molecular+Dynamics&doi=10.1021%2Facs.jmedchem.5b00171"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00171%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520CREBBP%2520Bromodomain%2520Inhibitors%2520by%2520High-Throughput%2520Docking%2520and%2520Hit%2520Optimization%2520Guided%2520by%2520Molecular%2520Dynamics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Unzue, A.; Xu, M.; Dong, J.; Wiedmer, L.; Spiliotopoulos, D.; Caflisch, A.; Nevado, C.</span><span> </span><span class="NLM_article-title">Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00172</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Unzue&author=M.+Xu&author=J.+Dong&author=L.+Wiedmer&author=D.+Spiliotopoulos&author=A.+Caflisch&author=C.+Nevado&title=Fragment-Based+Design+of+Selective+Nanomolar+Ligands+of+the+CREBBP+Bromodomain&doi=10.1021%2Facs.jmedchem.5b00172"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DUnzue%26aufirst%3DA.%26atitle%3DFragment-Based%2520Design%2520of%2520Selective%2520Nanomolar%2520Ligands%2520of%2520the%2520CREBBP%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hewitt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehling, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaswani, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasveschuk, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, R. J.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Development of Methyl Isoxazoleazepines as Inhibitors of BET</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1842</span><span class="NLM_x">–</span> <span class="NLM_lpage">1848</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.03.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2015.03.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25851940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1842-1848&author=M.+C.+Hewittauthor=Y.+Leblancauthor=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=A.+C%C3%B4t%C3%A9author=C.+G.+Nasveschukauthor=A.+M.+Taylorauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=E.+Pardoauthor=R.+Cummingsauthor=S.+Joshiauthor=P.+Sandyauthor=J.+A.+Mertzauthor=R.+J.+Simsauthor=L.+Bergeronauthor=B.+M.+Bryantauthor=S.+Bellonauthor=F.+Poyauthor=H.+Jayaramauthor=Y.+Tangauthor=B.+K.+Albrecht&title=Development+of+Methyl+Isoxazoleazepines+as+Inhibitors+of+BET&doi=10.1016%2Fj.bmcl.2015.03.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Development of methyl isoxazoleazepines as inhibitors of BET</span></div><div class="casAuthors">Hewitt, Michael C.; Leblanc, Yves; Gehling, Victor S.; Vaswani, Rishi G.; Cote, Alexandre; Nasveschuk, Christopher G.; Taylor, Alexander M.; Harmange, Jean-Christophe; Audia, James E.; Pardo, Eneida; Cummings, Rich; Joshi, Shivangi; Sandy, Peter; Mertz, Jennifer A.; Sims, Robert J.; Bergeron, Louise; Bryant, Barbara M.; Bellon, Steve; Poy, Florence; Jayaran, Hariharan; Tang, Yong; Albrecht, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1842-1848</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the Me isoxazoleazepine chemotype) exemplified by carboxamide 23.  The Me isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrdQuVhIoU1rVg90H21EOLACvtfcHk0lgLn7TyCFNmxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKrsL8%253D&md5=fb9a78528287f82ccf004e751e491ee4</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.03.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.03.045%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DA.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DCummings%26aufirst%3DR.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDevelopment%2520of%2520Methyl%2520Isoxazoleazepines%2520as%2520Inhibitors%2520of%2520BET%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1842%26epage%3D1848%26doi%3D10.1016%2Fj.bmcl.2015.03.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Taylor, A. M.; Vaswani, R. G.; Gehling, V. S.; Hewitt, M. C.; Leblanc, Y.; Audia, J. E.; Bellon, S.; Cummings, R. T.; Côté, A.; Harmange, J.-C.; Jayaram, H.; Joshi, S.; Lora, J. M.; Mertz, J. A.; Neiss, A.; Pardo, E.; Nasveschuk, C. G.; Poy, F.; Sandy, P.; Setser, J. W.; Sims, R. J.,  III; Tang, Y.; Albrecht, B. K.</span><span> </span><span class="NLM_article-title">Discovery of Benzotriazolo[4,3-<i>D</i>][1,4]Diazepines as Orally Active Inhibitors of BET Bromodomains</span>.  <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/ml500411h</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/ml500411h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+M.+Taylor&author=R.+G.+Vaswani&author=V.+S.+Gehling&author=M.+C.+Hewitt&author=Y.+Leblanc&author=J.+E.+Audia&author=S.+Bellon&author=R.+T.+Cummings&author=A.+C%C3%B4t%C3%A9&author=J.-C.+Harmange&author=H.+Jayaram&author=S.+Joshi&author=J.+M.+Lora&author=J.+A.+Mertz&author=A.+Neiss&author=E.+Pardo&author=C.+G.+Nasveschuk&author=F.+Poy&author=P.+Sandy&author=J.+W.+Setser&author=R.+J.+Sims&author=Y.+Tang&author=B.+K.+Albrecht&title=Discovery+of+Benzotriazolo%5B4%2C3-D%5D%5B1%2C4%5DDiazepines+as+Orally+Active+Inhibitors+of+BET+Bromodomains&doi=10.1021%2Fml500411h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fml500411h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500411h%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26atitle%3DDiscovery%2520of%2520Benzotriazolo%255B4%252C3-D%255D%255B1%252C4%255DDiazepines%2520as%2520Orally%2520Active%2520Inhibitors%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26doi%3D10.1021%2Fml500411h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Strohner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann-Rohrer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummt, I.</span><span> </span><span class="NLM_article-title">NoRC-a Novel Member of Mammalian ISWI-Containing Chromatin Remodeling Machines</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4629</span><span class="NLM_x">–</span> <span class="NLM_lpage">5031</span><span class="refDoi"> DOI: 10.1093/emboj/20.17.4892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Femboj%2F20.17.4892" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=4629-5031&author=R.+Strohnerauthor=A.+Nemethauthor=P.+Jansaauthor=U.+Hofmann-Rohrerauthor=R.+Santoroauthor=G.+Langstauthor=I.+Grummt&title=NoRC-a+Novel+Member+of+Mammalian+ISWI-Containing+Chromatin+Remodeling+Machines&doi=10.1093%2Femboj%2F20.17.4892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F20.17.4892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F20.17.4892%26sid%3Dliteratum%253Aachs%26aulast%3DStrohner%26aufirst%3DR.%26aulast%3DNemeth%26aufirst%3DA.%26aulast%3DJansa%26aufirst%3DP.%26aulast%3DHofmann-Rohrer%26aufirst%3DU.%26aulast%3DSantoro%26aufirst%3DR.%26aulast%3DLangst%26aufirst%3DG.%26aulast%3DGrummt%26aufirst%3DI.%26atitle%3DNoRC-a%2520Novel%2520Member%2520of%2520Mammalian%2520ISWI-Containing%2520Chromatin%2520Remodeling%2520Machines%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D20%26spage%3D4629%26epage%3D5031%26doi%3D10.1093%2Femboj%2F20.17.4892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grupp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerig, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bär, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sültmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Provenzano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaspo, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brors, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korbel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlomm, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eils, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, R.</span><span> </span><span class="NLM_article-title">BAZ2A (TIP5) Is Involved in Epigenetic Alterations in Prostate Cancer and Its Overexpression Predicts Disease Recurrence</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1038/ng.3165</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fng.3165" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25485837" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2014&pages=22-30&author=L.+Guauthor=S.+C.+Frommelauthor=C.+C.+Oakesauthor=R.+Simonauthor=K.+Gruppauthor=C.+Y.+Gerigauthor=D.+B%C3%A4rauthor=M.+D.+Robinsonauthor=C.+Baerauthor=M.+Weissauthor=Z.+Guauthor=M.+Schapiraauthor=R.+Kunerauthor=H.+S%C3%BCltmannauthor=M.+Provenzanoauthor=M.-L.+Yaspoauthor=B.+Brorsauthor=J.+Korbelauthor=T.+Schlommauthor=G.+Sauterauthor=R.+Eilsauthor=C.+Plassauthor=R.+Santoro&title=BAZ2A+%28TIP5%29+Is+Involved+in+Epigenetic+Alterations+in+Prostate+Cancer+and+Its+Overexpression+Predicts+Disease+Recurrence&doi=10.1038%2Fng.3165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fng.3165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3165%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DL.%26aulast%3DFrommel%26aufirst%3DS.%2BC.%26aulast%3DOakes%26aufirst%3DC.%2BC.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DGrupp%26aufirst%3DK.%26aulast%3DGerig%26aufirst%3DC.%2BY.%26aulast%3DB%25C3%25A4r%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%2BD.%26aulast%3DBaer%26aufirst%3DC.%26aulast%3DWeiss%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DZ.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DKuner%26aufirst%3DR.%26aulast%3DS%25C3%25BCltmann%26aufirst%3DH.%26aulast%3DProvenzano%26aufirst%3DM.%26aulast%3DYaspo%26aufirst%3DM.-L.%26aulast%3DBrors%26aufirst%3DB.%26aulast%3DKorbel%26aufirst%3DJ.%26aulast%3DSchlomm%26aufirst%3DT.%26aulast%3DSauter%26aufirst%3DG.%26aulast%3DEils%26aufirst%3DR.%26aulast%3DPlass%26aufirst%3DC.%26aulast%3DSantoro%26aufirst%3DR.%26atitle%3DBAZ2A%2520%2528TIP5%2529%2520Is%2520Involved%2520in%2520Epigenetic%2520Alterations%2520in%2520Prostate%2520Cancer%2520and%2520Its%2520Overexpression%2520Predicts%2520Disease%2520Recurrence%26jtitle%3DNat.%2520Genet.%26date%3D2014%26volume%3D47%26spage%3D22%26epage%3D30%26doi%3D10.1038%2Fng.3165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Drouin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhtar, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Structure Enabled Design of BAZ2-ICR, a Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2553</span><span class="NLM_x">–</span> <span class="NLM_lpage">2559</span><span class="refDoi"> DOI: 10.1021/jm501963e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501963e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFChtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2553-2559&author=L.+Drouinauthor=S.+McGrathauthor=L.+R.+Vidlerauthor=A.+Chaikuadauthor=O.+Monteiroauthor=C.+Tallantauthor=M.+Philpottauthor=C.+Rogersauthor=O.+Fedorovauthor=M.+Liuauthor=W.+Akhtarauthor=A.+Hayesauthor=F.+Raynaudauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=S.+Hoelder&title=Structure+Enabled+Design+of+BAZ2-ICR%2C+a+Chemical+Probe+Targeting+the+Bromodomains+of+BAZ2A+and+BAZ2B&doi=10.1021%2Fjm501963e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B</span></div><div class="casAuthors">Drouin, Ludovic; McGrath, Sally; Vidler, Lewis R.; Chaikuad, Apirat; Monteiro, Octovia; Tallant, Cynthia; Philpott, Martin; Rogers, Catherine; Fedorov, Oleg; Liu, Manjuan; Akhtar, Wasim; Hayes, Angela; Raynaud, Florence; Muller, Susanne; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2553-2559</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The bromodomain contg. proteins BAZ2A/B play essential roles in chromatin remodeling and regulation of noncoding RNAs.  The authors present the structure based discovery of a potent, selective, and cell active inhibitor (I) of the BAZ2A/B bromodomains through rapid optimization of a weakly potent starting point.  A key feature of the presented inhibitors is an intramol. arom. stacking interaction that efficiently occupies the shallow bromodomain pockets.  I represents an excellent chem. probe for functional studies of the BAZ2 bromodomains in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfebSuQ4MJm7Vg90H21EOLACvtfcHk0lhCFjqPLv6dLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFChtL4%253D&md5=2147409485bf4b3be9a63046e611e7ba</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm501963e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501963e%26sid%3Dliteratum%253Aachs%26aulast%3DDrouin%26aufirst%3DL.%26aulast%3DMcGrath%26aufirst%3DS.%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DMonteiro%26aufirst%3DO.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DAkhtar%26aufirst%3DW.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DRaynaud%26aufirst%3DF.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DStructure%2520Enabled%2520Design%2520of%2520BAZ2-ICR%252C%2520a%2520Chemical%2520Probe%2520Targeting%2520the%2520Bromodomains%2520of%2520BAZ2A%2520and%2520BAZ2B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2553%26epage%3D2559%26doi%3D10.1021%2Fjm501963e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chen, P.; Chaikuad, A.; Bamborough, P.; Bantscheff, M.; Bountra, C.; Chung, C.-W.; Fedorov, O.; Grandi, P.; Jung, D.; Lesniak, R.; Lindon, M.; Müller, S.; Philpott, M.; Prinjha, R.; Rogers, C.; Selenski, C.; Tallant, C.; Werner, T.; Willson, T. M.; Knapp, S.; Drewry, D. H.</span><span> </span><span class="NLM_article-title">Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00209</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00209" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=P.+Chen&author=A.+Chaikuad&author=P.+Bamborough&author=M.+Bantscheff&author=C.+Bountra&author=C.-W.+Chung&author=O.+Fedorov&author=P.+Grandi&author=D.+Jung&author=R.+Lesniak&author=M.+Lindon&author=S.+M%C3%BCller&author=M.+Philpott&author=R.+Prinjha&author=C.+Rogers&author=C.+Selenski&author=C.+Tallant&author=T.+Werner&author=T.+M.+Willson&author=S.+Knapp&author=D.+H.+Drewry&title=Discovery+and+Characterization+of+GSK2801%2C+a+Selective+Chemical+Probe+for+the+Bromodomains+BAZ2A+and+BAZ2B&doi=10.1021%2Facs.jmedchem.5b00209"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00209%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520GSK2801%252C%2520a%2520Selective%2520Chemical%2520Probe%2520for%2520the%2520Bromodomains%2520BAZ2A%2520and%2520BAZ2B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Scotto, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandula, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramaniyam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pothuri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansukhani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arias-Pulido, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murty, V. V.</span><span> </span><span class="NLM_article-title">Integrative Genomics Analysis of Chromosome 5p Gain in Cervical Cancer Reveals Target Over-Expressed Genes, Including Drosha</span> <span class="citation_source-journal">Mol. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span><span class="refDoi"> DOI: 10.1186/1476-4598-7-58</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1186%2F1476-4598-7-58" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18559093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A280%3ADC%252BD1cvgvFGktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=58-10&author=L.+Scottoauthor=G.+Narayanauthor=S.+V.+Nandulaauthor=S.+Subramaniyamauthor=A.+M.+Kaufmannauthor=J.+D.+Wrightauthor=B.+Pothuriauthor=M.+Mansukhaniauthor=A.+Schneiderauthor=H.+Arias-Pulidoauthor=V.+V.+Murty&title=Integrative+Genomics+Analysis+of+Chromosome+5p+Gain+in+Cervical+Cancer+Reveals+Target+Over-Expressed+Genes%2C+Including+Drosha&doi=10.1186%2F1476-4598-7-58"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha</span></div><div class="casAuthors">Scotto Luigi; Narayan Gopeshwar; Nandula Subhadra V; Subramaniyam Shivakumar; Kaufmann Andreas M; Wright Jason D; Pothuri Bhavana; Mansukhani Mahesh; Schneider Achim; Arias-Pulido Hugo; Murty Vundavalli V</div><div class="citationInfo"><span class="NLM_cas:title">Molecular cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Copy number gains and amplifications are characteristic feature of cervical cancer (CC) genomes for which the underlying mechanisms are unclear.  These changes may possess oncogenic properties by deregulating tumor-related genes.  Gain of short arm of chromosome 5 (5p) is the most frequent karyotypic change in CC.  METHODS:  To examine the role of 5p gain, we performed a combination of single nucleotide polymorphism (SNP) array, fluorescence in situ hybridization (FISH), and gene expression analyses on invasive cancer and in various stages of CC progression.  RESULTS:  The SNP and FISH analyses revealed copy number increase (CNI) of 5p in 63% of invasive CC, which arises at later stages of precancerous lesions in CC development.  We integrated chromosome 5 genomic copy number and gene expression data to identify key target over expressed genes as a consequence of 5p gain.  One of the candidates identified was Drosha (RNASEN), a gene that is required in the first step of microRNA (miRNA) processing in the nucleus.  Other 5p genes identified as targets of CNI play a role in DNA repair and cell cycle regulation (BASP1, TARS, PAIP1, BRD9, RAD1, SKP2, and POLS), signal transduction (OSMR), and mitochondrial oxidative phosphorylation (NNT, SDHA, and NDUFS6), suggesting that disruption of pathways involving these genes may contribute to CC progression.  CONCLUSION:  Taken together, we demonstrate the power of integrating genomics data with expression data in deciphering tumor-related targets of CNI.  Identification of 5p gene targets in CC denotes an important step towards biomarker development and forms a framework for testing as molecular therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJ-og-xr-IWuxsqfvU0ziafW6udTcc2ebBevzkFwOA_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvgvFGktw%253D%253D&md5=9bb25d18ffeaebf79760b3b760c91e15</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1186%2F1476-4598-7-58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1476-4598-7-58%26sid%3Dliteratum%253Aachs%26aulast%3DScotto%26aufirst%3DL.%26aulast%3DNarayan%26aufirst%3DG.%26aulast%3DNandula%26aufirst%3DS.%2BV.%26aulast%3DSubramaniyam%26aufirst%3DS.%26aulast%3DKaufmann%26aufirst%3DA.%2BM.%26aulast%3DWright%26aufirst%3DJ.%2BD.%26aulast%3DPothuri%26aufirst%3DB.%26aulast%3DMansukhani%26aufirst%3DM.%26aulast%3DSchneider%26aufirst%3DA.%26aulast%3DArias-Pulido%26aufirst%3DH.%26aulast%3DMurty%26aufirst%3DV.%2BV.%26atitle%3DIntegrative%2520Genomics%2520Analysis%2520of%2520Chromosome%25205p%2520Gain%2520in%2520Cervical%2520Cancer%2520Reveals%2520Target%2520Over-Expressed%2520Genes%252C%2520Including%2520Drosha%26jtitle%3DMol.%2520Cancer%26date%3D2008%26volume%3D7%26spage%3D58%26epage%3D10%26doi%3D10.1186%2F1476-4598-7-58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Kang, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. M.</span><span> </span><span class="NLM_article-title">Gain at Chromosomal Region 5p15.33, Containing TERT, Is the Most Frequent Genetic Event in Early Stages of Non-Small Cell Lung Cancer</span> <span class="citation_source-journal">Cancer Genet. Cytogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">182</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span><span class="refDoi"> DOI: 10.1016/j.cancergencyto.2007.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cancergencyto.2007.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18328944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtVWmt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2008&pages=1-11&author=J.+U.+Kangauthor=S.+H.+Kooauthor=K.+C.+Kwonauthor=J.+W.+Parkauthor=J.+M.+Kim&title=Gain+at+Chromosomal+Region+5p15.33%2C+Containing+TERT%2C+Is+the+Most+Frequent+Genetic+Event+in+Early+Stages+of+Non-Small+Cell+Lung+Cancer&doi=10.1016%2Fj.cancergencyto.2007.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer</span></div><div class="casAuthors">Kang, Ji Un; Koo, Sun Hoe; Kwon, Kye Chul; Park, Jong Woo; Kim, Jin Man</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Genetics and Cytogenetics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-11</span>CODEN:
                <span class="NLM_cas:coden">CGCYDF</span>;
        ISSN:<span class="NLM_cas:issn">0165-4608</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Chromosomal imbalances resulting in altered gene dosage play a role in the mol. pathogenesis of non-small cell lung cancer (NSCLC), but the target genes remain to be identified.  To identify early-stage genetic events that drive progression of NSCLC, we conducted a high-resoln. array comparative genomic hybridization (CGH) study, using an array of 4046 bacterial artificial chromosome clones to screen for DNA copy no. changes assocd. with individual genes in 36 tumors obtained from patients in early stages of NSCLC.  Multiple early genetic events occurring on chromosome 5p were identified, with a minimal detection region at 5p15.33∼12.  The most frequent finding involved gain of 5p15.33, obsd. in 15 of 19 stage I (A+B) cancers (79%) and in 28 of the total 36 NSCLC cases (78%).  This locus harbors the genes TERT, SLC6A19, and SLC6A18 and is a telomeric boundary at bacterial artificial chromosome (BAC) clone 91_J20.  Other potential candidate genes evidencing high nos. of genomic copy no. changes (≥40% of patients) included the following genes, encountered in >50% of 19 stage I (A+B) cancers: CEP72 and TPPP (14 of 19; 74%); AHRR, EXOC3 (previously SEC6L1), SLC9A3, LOC442126, ZDHHC11, BRD9, and TRIP13 (13/19; 68%); and CLPTM1L (alias CRR9), SLC6A3 (previously DAT1), and LOC401169 (10/19; 53%).  Fluorescence in situ hybridization validated the array CGH findings.  The gain of 5p15.33 is thus one of the most consistent alterations in the early stages of lung cancer, and a series of genes in the crit. 5p15.33 region may be used as novel biomarkers for the early detection and classification of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvKwLSWMQRnbVg90H21EOLACvtfcHk0liQ4cl2e0AgWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtVWmt78%253D&md5=514aec6952253ed612003471df40a4ba</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.cancergencyto.2007.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cancergencyto.2007.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DJ.%2BU.%26aulast%3DKoo%26aufirst%3DS.%2BH.%26aulast%3DKwon%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26atitle%3DGain%2520at%2520Chromosomal%2520Region%25205p15.33%252C%2520Containing%2520TERT%252C%2520Is%2520the%2520Most%2520Frequent%2520Genetic%2520Event%2520in%2520Early%2520Stages%2520of%2520Non-Small%2520Cell%2520Lung%2520Cancer%26jtitle%3DCancer%2520Genet.%2520Cytogenet.%26date%3D2008%26volume%3D182%26spage%3D1%26epage%3D11%26doi%3D10.1016%2Fj.cancergencyto.2007.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Middeljans, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stunnenberg, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logie, C.</span><span> </span><span class="NLM_article-title">SS18 Together with Animal-Specific Factors Defines Human BAF-Type SWI/SNF Complexes</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e33834</span><span class="refDoi"> DOI: 10.1371/journal.pone.0033834</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0033834" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e33834&author=E.+Middeljansauthor=X.+Wanauthor=P.+W.+Jansenauthor=V.+Sharmaauthor=H.+G.+Stunnenbergauthor=C.+Logie&title=SS18+Together+with+Animal-Specific+Factors+Defines+Human+BAF-Type+SWI%2FSNF+Complexes&doi=10.1371%2Fjournal.pone.0033834"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0033834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0033834%26sid%3Dliteratum%253Aachs%26aulast%3DMiddeljans%26aufirst%3DE.%26aulast%3DWan%26aufirst%3DX.%26aulast%3DJansen%26aufirst%3DP.%2BW.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DStunnenberg%26aufirst%3DH.%2BG.%26aulast%3DLogie%26aufirst%3DC.%26atitle%3DSS18%2520Together%2520with%2520Animal-Specific%2520Factors%2520Defines%2520Human%2520BAF-Type%2520SWI%252FSNF%2520Complexes%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De33834%26doi%3D10.1371%2Fjournal.pone.0033834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kadoch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elias, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crabtree, G. R.</span><span> </span><span class="NLM_article-title">Proteomic and Bioinformatic Analysis of Mammalian SWI/SNF Complexes Identifies Extensive Roles in Human Malignancy</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span><span class="refDoi"> DOI: 10.1038/ng.2628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fng.2628" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23644491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVart7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2013&pages=592-601&author=C.+Kadochauthor=D.+C.+Hargreavesauthor=C.+Hodgesauthor=L.+Eliasauthor=L.+Hoauthor=J.+Ranishauthor=G.+R.+Crabtree&title=Proteomic+and+Bioinformatic+Analysis+of+Mammalian+SWI%2FSNF+Complexes+Identifies+Extensive+Roles+in+Human+Malignancy&doi=10.1038%2Fng.2628"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy</span></div><div class="casAuthors">Kadoch, Cigall; Hargreaves, Diana C.; Hodges, Courtney; Elias, Laura; Ho, Lena; Ranish, Jeff; Crabtree, Gerald R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">592-601</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Subunits of mammalian SWI/SNF (mSWI/SNF or BAF) complexes have recently been implicated as tumor suppressors in human malignancies.  To understand the full extent of their involvement, we conducted a proteomic anal. of endogenous mSWI/SNF complexes, which identified several new dedicated, stable subunits not found in yeast SWI/SNF complexes, including BCL7A, BCL7B and BCL7C, BCL11A and BCL11B, BRD9 and SS18.  Incorporating these new members, we detd. mSWI/SNF subunit mutation frequency in exome and whole-genome sequencing studies of primary human tumors.  Notably, mSWI/SNF subunits are mutated in 19.6% of all human tumors reported in 44 studies.  Our anal. suggests that specific subunits protect against cancer in specific tissues.  In addn., mutations affecting more than one subunit, defined here as compd. heterozygosity, are prevalent in certain cancers.  Our studies demonstrate that mSWI/SNF is the most frequently mutated chromatin-regulatory complex (CRC) in human cancer, exhibiting a broad mutation pattern, similar to that of TP53.  Thus, proper functioning of polymorphic BAF complexes may constitute a major mechanism of tumor suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP873DCpn7JrVg90H21EOLACvtfcHk0li0Go2XSmzvsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVart7s%253D&md5=0f49cf3c59e7bc04b74970fe656b1e17</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fng.2628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.2628%26sid%3Dliteratum%253Aachs%26aulast%3DKadoch%26aufirst%3DC.%26aulast%3DHargreaves%26aufirst%3DD.%2BC.%26aulast%3DHodges%26aufirst%3DC.%26aulast%3DElias%26aufirst%3DL.%26aulast%3DHo%26aufirst%3DL.%26aulast%3DRanish%26aufirst%3DJ.%26aulast%3DCrabtree%26aufirst%3DG.%2BR.%26atitle%3DProteomic%2520and%2520Bioinformatic%2520Analysis%2520of%2520Mammalian%2520SWI%252FSNF%2520Complexes%2520Identifies%2520Extensive%2520Roles%2520in%2520Human%2520Malignancy%26jtitle%3DNat.%2520Genet.%26date%3D2013%26volume%3D45%26spage%3D592%26epage%3D601%26doi%3D10.1038%2Fng.2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Kaeser, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aslanian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, M. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. R.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, B. M.</span><span> </span><span class="NLM_article-title">BRD7, a Novel PBAF-Specific SWI/SNF Subunit, Is Required for Target Gene Activation and Repression in Embryonic Stem Cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32254</span><span class="NLM_x">–</span> <span class="NLM_lpage">32263</span><span class="refDoi"> DOI: 10.1074/jbc.M806061200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M806061200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32254-32263&author=M.+D.+Kaeserauthor=A.+Aslanianauthor=M.+Q.+Dongauthor=J.+R.+Yatesauthor=B.+M.+Emerson&title=BRD7%2C+a+Novel+PBAF-Specific+SWI%2FSNF+Subunit%2C+Is+Required+for+Target+Gene+Activation+and+Repression+in+Embryonic+Stem+Cells&doi=10.1074%2Fjbc.M806061200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M806061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M806061200%26sid%3Dliteratum%253Aachs%26aulast%3DKaeser%26aufirst%3DM.%2BD.%26aulast%3DAslanian%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DM.%2BQ.%26aulast%3DYates%26aufirst%3DJ.%2BR.%26aulast%3DEmerson%26aufirst%3DB.%2BM.%26atitle%3DBRD7%252C%2520a%2520Novel%2520PBAF-Specific%2520SWI%252FSNF%2520Subunit%252C%2520Is%2520Required%2520for%2520Target%2520Gene%2520Activation%2520and%2520Repression%2520in%2520Embryonic%2520Stem%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32254%26epage%3D32263%26doi%3D10.1074%2Fjbc.M806061200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Harte, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullan, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harkin, D. P.</span><span> </span><span class="NLM_article-title">BRD7, a Subunit of SWI/SNF Complexes, Binds Directly to BRCA1 and Regulates BRCA1-Dependent Transcription</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2538</span><span class="NLM_x">–</span> <span class="NLM_lpage">2547</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-09-2089" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=2538-2547&author=M.+T.+Harteauthor=G.+J.+O%27Brienauthor=N.+M.+Ryanauthor=J.+J.+Gorskiauthor=K.+I.+Savageauthor=N.+T.+Crawfordauthor=P.+B.+Mullanauthor=D.+P.+Harkin&title=BRD7%2C+a+Subunit+of+SWI%2FSNF+Complexes%2C+Binds+Directly+to+BRCA1+and+Regulates+BRCA1-Dependent+Transcription&doi=10.1158%2F0008-5472.CAN-09-2089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2089%26sid%3Dliteratum%253Aachs%26aulast%3DHarte%26aufirst%3DM.%2BT.%26aulast%3DO%2527Brien%26aufirst%3DG.%2BJ.%26aulast%3DRyan%26aufirst%3DN.%2BM.%26aulast%3DGorski%26aufirst%3DJ.%2BJ.%26aulast%3DSavage%26aufirst%3DK.%2BI.%26aulast%3DCrawford%26aufirst%3DN.%2BT.%26aulast%3DMullan%26aufirst%3DP.%2BB.%26aulast%3DHarkin%26aufirst%3DD.%2BP.%26atitle%3DBRD7%252C%2520a%2520Subunit%2520of%2520SWI%252FSNF%2520Complexes%252C%2520Binds%2520Directly%2520to%2520BRCA1%2520and%2520Regulates%2520BRCA1-Dependent%2520Transcription%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D2538%26epage%3D2547%26doi%3D10.1158%2F0008-5472.CAN-09-2089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Drost, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantovani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tocco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elkon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holstege, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonkers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voorhoeve, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agami, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Sal, G.</span><span> </span><span class="NLM_article-title">BRD7 Is a Candidate Tumour Suppressor Gene Required for P53 Function</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span><span class="refDoi"> DOI: 10.1038/ncb2038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fncb2038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20228809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVyjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=380-389&author=J.+Drostauthor=F.+Mantovaniauthor=F.+Toccoauthor=R.+Elkonauthor=A.+Comelauthor=H.+Holstegeauthor=R.+Kerkhovenauthor=J.+Jonkersauthor=P.+M.+Voorhoeveauthor=R.+Agamiauthor=G.+Del+Sal&title=BRD7+Is+a+Candidate+Tumour+Suppressor+Gene+Required+for+P53+Function&doi=10.1038%2Fncb2038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">BRD7 is a candidate tumour suppressor gene required for p53 function</span></div><div class="casAuthors">Drost, Jarno; Mantovani, Fiamma; Tocco, Francesca; Elkon, Ran; Comel, Anna; Holstege, Henne; Kerkhoven, Ron; Jonkers, Jos; Voorhoeve, P. Mathijs; Agami, Reuven; Del Sal, Giannino</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">380-389</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oncogene-induced senescence is a p53-dependent defense mechanism against uncontrolled proliferation.  Consequently, many human tumors harbor p53 mutations and others show a dysfunctional p53 pathway, frequently by unknown mechanisms.  Here the authors identify BRD7 (bromodomain-contg. 7) as a protein whose inhibition allows full neoplastic transformation in the presence of wild-type p53.  In human breast tumors harboring wild-type, but not mutant, p53 the BRD7 gene locus was frequently deleted and low BRD7 expression was found in a subgroup of tumors.  Functionally, BRD7 is required for efficient p53-mediated transcription of a subset of target genes.  BRD7 interacts with p53 and p300 and is recruited to target gene promoters, affecting histone acetylation, p53 acetylation and promoter activity.  Thus, BRD7 suppresses tumorigenicity by serving as a p53 cofactor required for the efficient induction of p53-dependent oncogene-induced senescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1grCCyCF9MrVg90H21EOLACvtfcHk0li0Go2XSmzvsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVyjurw%253D&md5=676cb9cbc5a8d157ac85d76c42ba8007</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fncb2038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb2038%26sid%3Dliteratum%253Aachs%26aulast%3DDrost%26aufirst%3DJ.%26aulast%3DMantovani%26aufirst%3DF.%26aulast%3DTocco%26aufirst%3DF.%26aulast%3DElkon%26aufirst%3DR.%26aulast%3DComel%26aufirst%3DA.%26aulast%3DHolstege%26aufirst%3DH.%26aulast%3DKerkhoven%26aufirst%3DR.%26aulast%3DJonkers%26aufirst%3DJ.%26aulast%3DVoorhoeve%26aufirst%3DP.%2BM.%26aulast%3DAgami%26aufirst%3DR.%26aulast%3DDel%2BSal%26aufirst%3DG.%26atitle%3DBRD7%2520Is%2520a%2520Candidate%2520Tumour%2520Suppressor%2520Gene%2520Required%2520for%2520P53%2520Function%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2010%26volume%3D12%26spage%3D380%26epage%3D389%26doi%3D10.1038%2Fncb2038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strocchia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracciano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lauro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riccio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifulco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">9 H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2718</span><span class="NLM_x">–</span> <span class="NLM_lpage">2736</span><span class="refDoi"> DOI: 10.1021/jm501893k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501893k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtV2msLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2718-2736&author=S.+Picaudauthor=M.+Strocchiaauthor=S.+Terraccianoauthor=G.+Lauroauthor=J.+M%C3%A9ndezauthor=D.+L.+Danielsauthor=R.+Riccioauthor=G.+Bifulcoauthor=I.+Brunoauthor=P.+Filippakopoulos&title=9+H-Purine+Scaffold+Reveals+Induced-Fit+Pocket+Plasticity+of+the+BRD9+Bromodomain&doi=10.1021%2Fjm501893k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Strocchia, Maria; Terracciano, Stefania; Lauro, Gianluigi; Mendez, Jacqui; Daniels, Danette L.; Riccio, Raffaele; Bifulco, Giuseppe; Bruno, Ines; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2718-2736</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The 2-amine-9H-purine scaffold was identified as a weak bromodomain template and was developed via iterative structure based design into a potent nanomolar ligand for the bromodomain of human BRD9 with small residual micromolar affinity toward the bromodomain of BRD4.  Binding of the lead compd. I to the bromodomain of BRD9 results in an unprecedented rearrangement of residues forming the acetyl lysine recognition site, affecting plasticity of the protein in an induced-fit pocket.  The compd. does not exhibit any cytotoxic effect in HEK293 cells and displaces the BRD9 bromodomain from chromatin in bioluminescence proximity assays without affecting the BRD4/histone complex.  The 2-amine-9H-purine scaffold represents a novel template that can be further modified to yield highly potent and selective tool compds. to interrogate the biol. role of BRD9 in diverse cellular systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFOpXUqzFa-LVg90H21EOLACvtfcHk0li0Go2XSmzvsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtV2msLc%253D&md5=e5d5f1f622baa9b48f93bb460011ff0b</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm501893k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501893k%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DStrocchia%26aufirst%3DM.%26aulast%3DTerracciano%26aufirst%3DS.%26aulast%3DLauro%26aufirst%3DG.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DRiccio%26aufirst%3DR.%26aulast%3DBifulco%26aufirst%3DG.%26aulast%3DBruno%26aufirst%3DI.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3D9%2520H-Purine%2520Scaffold%2520Reveals%2520Induced-Fit%2520Pocket%2520Plasticity%2520of%2520the%2520BRD9%2520Bromodomain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2718%26epage%3D2736%26doi%3D10.1021%2Fjm501893k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keates, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">[1,2,4]Triazolo[4,3- a]Phthalazines: Inhibitors of Diverse Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span><span class="refDoi"> DOI: 10.1021/jm401568s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401568s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=462-476&author=O.+Fedorovauthor=H.+Lingardauthor=C.+Wellsauthor=O.+P.+Monteiroauthor=S.+Picaudauthor=T.+Keatesauthor=C.+Yappauthor=M.+Philpottauthor=S.+J.+Martinauthor=I.+Felletarauthor=B.+D.+Marsdenauthor=P.+Filippakopoulosauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=P.+E.+Brennan&title=%5B1%2C2%2C4%5DTriazolo%5B4%2C3-+a%5DPhthalazines%3A+Inhibitors+of+Diverse+Bromodomains&doi=10.1021%2Fjm401568s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm401568s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401568s%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DKeates%26aufirst%3DT.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMartin%26aufirst%3DS.%2BJ.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DMarsden%26aufirst%3DB.%2BD.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3D%255B1%252C2%252C4%255DTriazolo%255B4%252C3-%2520a%255DPhthalazines%253A%2520Inhibitors%2520of%2520Diverse%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D462%26epage%3D476%26doi%3D10.1021%2Fjm401568s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Clark, P. G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, L. C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singleton, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baronio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. J.</span><span> </span><span class="NLM_article-title">LP99: Discovery and Synthesis of the First Selective BRD7/9Bromodomain Inhibitor</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6217</span><span class="NLM_x">–</span> <span class="NLM_lpage">6221</span><span class="refDoi"> DOI: 10.1002/anie.201501394</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fanie.201501394" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=6217-6221&author=P.+G.+K.+Clarkauthor=L.+C.+C.+Vieiraauthor=C.+Tallantauthor=O.+Fedorovauthor=D.+C.+Singletonauthor=C.+M.+Rogersauthor=O.+P.+Monteiroauthor=J.+M.+Bennettauthor=R.+Baronioauthor=S.+M%C3%BCllerauthor=D.+L.+Danielsauthor=J.+Mendezauthor=S.+Knappauthor=P.+Brennanauthor=D.+J.+Dixon&title=LP99%3A+Discovery+and+Synthesis+of+the+First+Selective+BRD7%2F9Bromodomain+Inhibitor&doi=10.1002%2Fanie.201501394"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501394%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DP.%2BG.%2BK.%26aulast%3DVieira%26aufirst%3DL.%2BC.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DBaronio%26aufirst%3DR.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DMendez%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%26aulast%3DDixon%26aufirst%3DD.%2BJ.%26atitle%3DLP99%253A%2520Discovery%2520and%2520Synthesis%2520of%2520the%2520First%2520Selective%2520BRD7%252F9Bromodomain%2520Inhibitor%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D6217%26epage%3D6221%26doi%3D10.1002%2Fanie.201501394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Hay, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteiro, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schofield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Potent and Selective Inhibitors of BRD7 and BRD9 Bromodomains</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span><span class="refDoi"> DOI: 10.1039/C5MD00152H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC5MD00152H" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1381-1386&author=D.+A.+Hayauthor=C.+M.+Rogersauthor=O.+Fedorovauthor=C.+Tallantauthor=S.+Martinauthor=O.+P.+Monteiroauthor=S.+M%C3%BCllerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Design+and+Synthesis+of+Potent+and+Selective+Inhibitors+of+BRD7+and+BRD9+Bromodomains&doi=10.1039%2FC5MD00152H"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1039%2FC5MD00152H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00152H%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520BRD7%2520and%2520BRD9%2520Bromodomains%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1381%26epage%3D1386%26doi%3D10.1039%2FC5MD00152H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span>BI-9564: A Chemical Probe for BRD9 and BRD7; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/BI-9564" class="extLink">http://www.thesgc.org/chemical-probes/BI-9564</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BI-9564%3A+A+Chemical+Probe+for+BRD9+and+BRD7%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FBI-9564+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DBI-9564%253A%2520A%2520Chemical%2520Probe%2520for%2520BRD9%2520and%2520BRD7%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Theodoulou, N. H.; Bamborough, P.; Bannister, A. J.; Becher, I.; Bit, R. A.; Che, K. H.; Chung, C.-W.; Dittmann, A.; Drewes, G.; Drewry, D. H.; Gordon, L.; Grandi, P.; Leveridge, M.; Lindon, M.; Michon, A.-M.; Molnar, J.; Robson, S. C.; Tomkinson, N. C. O.; Kouzarides, T.; Prinjha, R. K.; Humphreys, P. G.</span><span> </span><span class="NLM_article-title">Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00256</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+H.+Theodoulou&author=P.+Bamborough&author=A.+J.+Bannister&author=I.+Becher&author=R.+A.+Bit&author=K.+H.+Che&author=C.-W.+Chung&author=A.+Dittmann&author=G.+Drewes&author=D.+H.+Drewry&author=L.+Gordon&author=P.+Grandi&author=M.+Leveridge&author=M.+Lindon&author=A.-M.+Michon&author=J.+Molnar&author=S.+C.+Robson&author=N.+C.+O.+Tomkinson&author=T.+Kouzarides&author=R.+K.+Prinjha&author=P.+G.+Humphreys&title=Discovery+of+I-BRD9%2C+a+Selective+Cell+Active+Chemical+Probe+for+Bromodomain+Containing+Protein+9+Inhibition&doi=10.1021%2Facs.jmedchem.5b00256"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00256%26sid%3Dliteratum%253Aachs%26aulast%3DTheodoulou%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%2520I-BRD9%252C%2520a%2520Selective%2520Cell%2520Active%2520Chemical%2520Probe%2520for%2520Bromodomain%2520Containing%2520Protein%25209%2520Inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Albrecht, B. K.; Cote, A.; Crawford, T.; Fauber, B.; Huang, H. R.; Lora, J. M.; Magnuson, S.; Nasveschuk, C. G.; Salmeron, A.; Sims, R. J.,  III; Taylor, A. M.</span><span> </span><span class="NLM_article-title">Treating TH2-Mediated Diseases by Inhibition of Bromodomains</span>. WO2014144721A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+K.+Albrecht&author=A.+Cote&author=T.+Crawford&author=B.+Fauber&author=H.+R.+Huang&author=J.+M.+Lora&author=S.+Magnuson&author=C.+G.+Nasveschuk&author=A.+Salmeron&author=R.+J.+Sims&author=A.+M.+Taylor&title=Treating+TH2-Mediated+Diseases+by+Inhibition+of+Bromodomains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DTreating%2520TH2-Mediated%2520Diseases%2520by%2520Inhibition%2520of%2520Bromodomains%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Zou, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revenko, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. W.</span><span> </span><span class="NLM_article-title">Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">3339</span><span class="NLM_x">–</span> <span class="NLM_lpage">3346</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-3440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-08-3440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=19318566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksV2hsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=3339-3346&author=J.+X.+Zouauthor=L.+Guoauthor=A.+S.+Revenkoauthor=C.+G.+Tepperauthor=A.+T.+Gemoauthor=H.+J.+Kungauthor=H.+W.+Chen&title=Androgen-Induced+Coactivator+ANCCA+Mediates+Specific+Androgen+Receptor+Signaling+in+Prostate+Cancer&doi=10.1158%2F0008-5472.CAN-08-3440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer</span></div><div class="casAuthors">Zou, June X.; Guo, Linlang; Revenko, Alexey S.; Tepper, Clifford G.; Gemo, Abigael T.; Kung, Hsing-Jien; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3339-3346</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Androgen receptor (AR) plays a pivotal role in prostate cancer, primarily by regulating different gene expression programs elicited by androgen, which is important for cancer cell proliferation, survival, and differentiation.  It is believed that the transcriptional function of AR is mediated largely by distinct nuclear coregulators.  We report here the identification of ANCCA (also known as ATAD2), a new member of the AAA+ ATPase family proteins, as a novel AR coactivator.  ANCCA interacts directly with AR and enhances its transcriptional activity, and is required for androgen-stimulated expression of a specific subgroup of genes including IGF1R, IRS-2, SGK1, and survivin.  Upon androgen stimulation, ANCCA together with AR is recruited to the specific AR target genes.  Suppression of ANCCA expression strongly inhibited the proliferation of androgen-responsive or androgen-independent, AR-pos. prostate cancer cells and caused a significant increase of cellular apoptosis.  Strikingly, the ANCCA gene itself, located at chromosome 8q24, is highly induced by androgen in androgen-dependent prostate cancer cells and xenograft tumors.  Although ANCCA is hardly detected in normal human prostate tissue, high levels of ANCCA are found in hormone-independent prostate cancer cell lines, xenograft tumor, and a subset of prostate cancers with high Gleason scores.  Together, these findings suggest that ANCCA plays an important role in prostate cancer by mediating specific AR functions in cancer cell survival and proliferation.  The possession of ATPase and bromodomain by ANCCA makes it an attractive target for the development of therapeutics for the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtieC3cr_jX7Vg90H21EOLACvtfcHk0lgsFV1fvvWUlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksV2hsLY%253D&md5=daa42208c9c7019809bb491e5af1f152</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-3440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-3440%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DGuo%26aufirst%3DL.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DTepper%26aufirst%3DC.%2BG.%26aulast%3DGemo%26aufirst%3DA.%2BT.%26aulast%3DKung%26aufirst%3DH.%2BJ.%26aulast%3DChen%26aufirst%3DH.%2BW.%26atitle%3DAndrogen-Induced%2520Coactivator%2520ANCCA%2520Mediates%2520Specific%2520Androgen%2520Receptor%2520Signaling%2520in%2520Prostate%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D3339%26epage%3D3346%26doi%3D10.1158%2F0008-5472.CAN-08-3440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Kalashnikova, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revenko, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gemo, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardiff, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borowsky, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. W.</span><span> </span><span class="NLM_article-title">ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells Through Control of B-Myb and EZH2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">9402</span><span class="NLM_x">–</span> <span class="NLM_lpage">9412</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-10-1199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20864510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=9402-9412&author=E.+V.+Kalashnikovaauthor=A.+S.+Revenkoauthor=A.+T.+Gemoauthor=N.+P.+Andrewsauthor=C.+G.+Tepperauthor=J.+X.+Zouauthor=R.+D.+Cardiffauthor=A.+D.+Borowskyauthor=H.+W.+Chen&title=ANCCA%2FATAD2+Overexpression+Identifies+Breast+Cancer+Patients+with+Poor+Prognosis%2C+Acting+to+Drive+Proliferation+and+Survival+of+Triple-Negative+Cells+Through+Control+of+B-Myb+and+EZH2&doi=10.1158%2F0008-5472.CAN-10-1199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">ANCCA/ATAD2 Overexpression Identifies Breast Cancer Patients with Poor Prognosis, Acting to Drive Proliferation and Survival of Triple-Negative Cells through Control of B-Myb and EZH2</span></div><div class="casAuthors">Kalashnikova, Ekaterina V.; Revenko, Alexey S.; Gemo, Abigael T.; Andrews, Nicolas P.; Tepper, Clifford G.; Zou, June X.; Cardiff, Robert D.; Borowsky, Alexander D.; Chen, Hong-Wu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9402-9412</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chromatin coregulators are important factors in tumorigenesis and cancer progression.  ANCCA is an AAA+ ATPase and a bromodomain-contg. nuclear coactivator for the estrogen and androgen receptors that is crucial for assembly of chromatin-modifying complexes and proliferation of hormone-responsive cancer cells.  In this study, we show that ANCCA is overexpressed in >70% of breast tumors and that its high protein level correlates well with tumor histol. grades (P < 0.0001), highlighting ANCCA as a prognostic factor for poor overall survival and disease recurrence.  Strikingly, high-level ANCCA correlated with triple-neg. tumors that represent highly aggressive disease.  Anal. of ANCCA transcript levels in multiple expression profiles of breast cancer identified ANCCA as a common signature gene, indicating that elevated transcripts also strongly correlate with tumor metastasis and poor survival.  Biol. and mechanistic investigations revealed that ANCCA is crucial for proliferation and survival of triple-neg./basal-like cancer cells and that it controls the expression of B-Myb, histone methyltransferase EZH2, and an Rb-E2F core program for proliferation, along with a subset of key mitotic kinesins and cell survival genes (IRS2, VEGF, and Akt1).  In particular, ANCCA overexpression correlated strongly with EZH2 in tumors.  Our results suggest that ANCCA may integrate multiple oncogenic programs in breast cancer, serving in particular as a prognostic marker and a therapeutic target for triple-neg. cancers.  Cancer Res; 70(22); 9402-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-adY-FJac6rVg90H21EOLACvtfcHk0lgsFV1fvvWUlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWmsLnP&md5=d7f74575c9c8cf4ebebdcfa5e3cc45fc</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1199%26sid%3Dliteratum%253Aachs%26aulast%3DKalashnikova%26aufirst%3DE.%2BV.%26aulast%3DRevenko%26aufirst%3DA.%2BS.%26aulast%3DGemo%26aufirst%3DA.%2BT.%26aulast%3DAndrews%26aufirst%3DN.%2BP.%26aulast%3DTepper%26aufirst%3DC.%2BG.%26aulast%3DZou%26aufirst%3DJ.%2BX.%26aulast%3DCardiff%26aufirst%3DR.%2BD.%26aulast%3DBorowsky%26aufirst%3DA.%2BD.%26aulast%3DChen%26aufirst%3DH.%2BW.%26atitle%3DANCCA%252FATAD2%2520Overexpression%2520Identifies%2520Breast%2520Cancer%2520Patients%2520with%2520Poor%2520Prognosis%252C%2520Acting%2520to%2520Drive%2520Proliferation%2520and%2520Survival%2520of%2520Triple-Negative%2520Cells%2520Through%2520Control%2520of%2520B-Myb%2520and%2520EZH2%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D9402%26epage%3D9412%26doi%3D10.1158%2F0008-5472.CAN-10-1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Ciro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosperini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grazini, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walfridsson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBlane, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucifero, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacchiana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helin, K.</span><span> </span><span class="NLM_article-title">ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">8491</span><span class="NLM_x">–</span> <span class="NLM_lpage">8498</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-2131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-09-2131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=19843847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlantrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=8491-8498&author=M.+Ciroauthor=E.+Prosperiniauthor=M.+Quartoauthor=U.+Graziniauthor=J.+Walfridssonauthor=F.+McBlaneauthor=P.+Nuciferoauthor=G.+Pacchianaauthor=M.+Capraauthor=J.+Christensenauthor=K.+Helin&title=ATAD2+Is+a+Novel+Cofactor+for+MYC%2C+Overexpressed+and+Amplified+in+Aggressive+Tumors&doi=10.1158%2F0008-5472.CAN-09-2131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors</span></div><div class="casAuthors">Ciro, Marco; Prosperini, Elena; Quarto, Micaela; Grazini, Ursula; Walfridsson, Julian; McBlane, Fraser; Nucifero, Paolo; Pacchiana, Giovanni; Capra, Maria; Christensen, Jesper; Helin, Kristian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8491-8498</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The E2F and MYC transcription factors are crit. regulators of cell proliferation and contribute to the development of human cancers.  Here, we report on the identification of a novel E2F target gene, ATAD2, the predicted protein product of which contains both a bromodomain and an ATPase domain.  The pRB-E2F pathway regulates ATAD2 expression, which is limiting for the entry into the S phase of the cell cycle.  We show that ATAD2 binds the MYC oncogene and stimulates its transcriptional activity.  ATAD2 maps to chromosome 8q24, 4.3 Mb distal to MYC, in a region that is frequently found amplified in cancer.  Consistent with this, we show that ATAD2 expression is high in several human tumors and that the expression levels correlate with clin. outcome of breast cancer patients.  We suggest that ATAD2 links the E2F and MYC pathways and contributes to the development of aggressive cancer through the enhancement of MYC-dependent transcription. [Cancer Res 2009;69(21):8491-8].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-O94KXJv2i7Vg90H21EOLACvtfcHk0lgsFV1fvvWUlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlantrnI&md5=85b462fb8a0c9505d98414ab8d90520b</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-2131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-2131%26sid%3Dliteratum%253Aachs%26aulast%3DCiro%26aufirst%3DM.%26aulast%3DProsperini%26aufirst%3DE.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DGrazini%26aufirst%3DU.%26aulast%3DWalfridsson%26aufirst%3DJ.%26aulast%3DMcBlane%26aufirst%3DF.%26aulast%3DNucifero%26aufirst%3DP.%26aulast%3DPacchiana%26aufirst%3DG.%26aulast%3DCapra%26aufirst%3DM.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DHelin%26aufirst%3DK.%26atitle%3DATAD2%2520Is%2520a%2520Novel%2520Cofactor%2520for%2520MYC%252C%2520Overexpressed%2520and%2520Amplified%2520in%2520Aggressive%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D8491%26epage%3D8498%26doi%3D10.1158%2F0008-5472.CAN-09-2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Druggability Analysis and Structural Classification of Bromodomain Acetyl-Lysine Binding Sites</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7346</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span><span class="refDoi"> DOI: 10.1021/jm300346w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300346w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7346-7359&author=L.+R.+Vidlerauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Druggability+Analysis+and+Structural+Classification+of+Bromodomain+Acetyl-Lysine+Binding+Sites&doi=10.1021%2Fjm300346w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites</span></div><div class="casAuthors">Vidler, Lewis R.; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7346-7359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains are readers of the epigenetic code that specifically bind acetyl-lysine contg. recognition sites on proteins.  Recently the BET family of bromodomains has been demonstrated to be druggable through the discovery of potent inhibitors, sparking an interest in protein-protein interaction inhibitors that directly target gene transcription.  Here, we assess the druggability of diverse members of the bromodomain family using SiteMap and show that there are significant differences in predicted druggability.  Furthermore, we trace these differences in druggability back to unique amino acid signatures in the bromodomain acetyl-lysine binding sites.  These signatures were then used to generate a new classification of the bromodomain family, visualized as a classification tree.  This represents the first anal. of this type for the bromodomain family and can prove useful in the discovery of inhibitors, particularly for anticipating screening hit rates, identifying inhibitors that can be explored for lead hopping approaches, and selecting proteins for selectivity screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxYqQyqqj7JrVg90H21EOLACvtfcHk0lhNb1LjUEeOtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVWht7fN&md5=bfb08154c1964aab5df51cb3513f2c1d</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm300346w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300346w%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDruggability%2520Analysis%2520and%2520Structural%2520Classification%2520of%2520Bromodomain%2520Acetyl-Lysine%2520Binding%2520Sites%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7346%26epage%3D7359%26doi%3D10.1021%2Fjm300346w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Harner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauder, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Fragment-Based Screening of the Bromodomain of ATAD2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9687</span><span class="NLM_x">–</span> <span class="NLM_lpage">9692</span><span class="refDoi"> DOI: 10.1021/jm501035j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501035j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9687-9692&author=M.+J.+Harnerauthor=B.+A.+Chauderauthor=J.+Phanauthor=S.+W.+Fesik&title=Fragment-Based+Screening+of+the+Bromodomain+of+ATAD2&doi=10.1021%2Fjm501035j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Screening of the Bromodomain of ATAD2</span></div><div class="casAuthors">Harner, Mary J.; Chauder, Brian A.; Phan, Jason; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9687-9692</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cellular and genetic evidence suggest that inhibition of ATAD2 (AAA domain-contg. protein 2) could be a useful strategy to treat several types of cancer.  To discover small-mol. inhibitors of the bromodomain of ATAD2, we used a fragment-based approach.  Fragment hits were identified using NMR spectroscopy, and ATAD2 was crystd. with three of the hits identified in the fragment screen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3781FiAn_x7Vg90H21EOLACvtfcHk0lhNb1LjUEeOtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChtrrE&md5=b3ba9d32e92c8d92b37132214940e9d2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm501035j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501035j%26sid%3Dliteratum%253Aachs%26aulast%3DHarner%26aufirst%3DM.%2BJ.%26aulast%3DChauder%26aufirst%3DB.%2BA.%26aulast%3DPhan%26aufirst%3DJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DFragment-Based%2520Screening%2520of%2520the%2520Bromodomain%2520of%2520ATAD2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9687%26epage%3D9692%26doi%3D10.1021%2Fjm501035j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellaway, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karamshi, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locke, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouzon, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5649</span><span class="NLM_x">–</span> <span class="NLM_lpage">5673</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00772</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00772" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCrtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5649-5673&author=E.+H.+Demontauthor=C.-W.+Chungauthor=R.+C.+Furzeauthor=P.+Grandiauthor=A.-M.+Michonauthor=C.+Wellawayauthor=N.+Barrettauthor=A.+M.+Bridgesauthor=P.+D.+Craggsauthor=H.+Dialloauthor=D.+P.+Dixonauthor=C.+Douaultauthor=A.+J.+Emmonsauthor=E.+J.+Jonesauthor=B.+V.+Karamshiauthor=K.+Lockeauthor=D.+J.+Mitchellauthor=B.+H.+Mouzonauthor=R.+K.+Prinjhaauthor=A.+D.+Robertsauthor=R.+J.+Sheppardauthor=R.+J.+Watsonauthor=P.+Bamborough&title=Fragment-Based+Discovery+of+Low-Micromolar+ATAD2+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors</span></div><div class="casAuthors">Demont, Emmanuel H.; Chung, Chun-wa; Furze, Rebecca C.; Grandi, Paola; Michon, Anne-Marie; Wellaway, Chris; Barrett, Nathalie; Bridges, Angela M.; Craggs, Peter D.; Diallo, Hawa; Dixon, David P.; Douault, Clement; Emmons, Amanda J.; Jones, Emma J.; Karamshi, Bhumika V.; Locke, Kelly; Mitchell, Darren J.; Mouzon, Bernadette H.; Prinjha, Rab K.; Roberts, Andy D.; Sheppard, Robert J.; Watson, Robert J.; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5649-5673</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of ATAD2 (ATPase family, AAA domain contg. 2) has been linked to disease severity and progression in a wide range of cancers, and is implicated in the regulation of several drivers of cancer growth.  Little is known of the dependence of these effects upon the ATAD2 bromodomain, which has been categorized as among the least tractable of its class.  The absence of any potent, selective inhibitors limits clear understanding of the therapeutic potential of the bromodomain.  Here, the authors describe the discovery of a hit from a fragment-based targeted array.  Optimization of this produced the first known micromolar inhibitors of the ATAD2 bromodomain, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql5pJPrVexJbVg90H21EOLACvtfcHk0lhNb1LjUEeOtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCrtbbP&md5=c133ce439365cd4e4110230827a7a0a4</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00772%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DWellaway%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DN.%26aulast%3DBridges%26aufirst%3DA.%2BM.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DDixon%26aufirst%3DD.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DEmmons%26aufirst%3DA.%2BJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DKaramshi%26aufirst%3DB.%2BV.%26aulast%3DLocke%26aufirst%3DK.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DMouzon%26aufirst%3DB.%2BH.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRoberts%26aufirst%3DA.%2BD.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DFragment-Based%2520Discovery%2520of%2520Low-Micromolar%2520ATAD2%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5649%26epage%3D5673%26doi%3D10.1021%2Facs.jmedchem.5b00772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furze, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diallo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douault, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karamshi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span> </span><span class="NLM_article-title">Structure-Based Optimization of Naphthyridones Into Potent ATAD2 Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6151</span><span class="NLM_x">–</span> <span class="NLM_lpage">6178</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00773</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00773" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kms7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6151-6178&author=P.+Bamboroughauthor=C.-W.+Chungauthor=R.+C.+Furzeauthor=P.+Grandiauthor=A.-M.+Michonauthor=R.+J.+Sheppardauthor=H.+Barnettauthor=H.+Dialloauthor=D.+P.+Dixonauthor=C.+Douaultauthor=E.+J.+Jonesauthor=B.+Karamshiauthor=D.+J.+Mitchellauthor=R.+K.+Prinjhaauthor=C.+Rauauthor=R.+J.+Watsonauthor=T.+Wernerauthor=E.+H.+Demont&title=Structure-Based+Optimization+of+Naphthyridones+Into+Potent+ATAD2+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors</span></div><div class="casAuthors">Bamborough, Paul; Chung, Chun-wa; Furze, Rebecca C.; Grandi, Paola; Michon, Anne-Marie; Sheppard, Robert J.; Barnett, Heather; Diallo, Hawa; Dixon, David P.; Douault, Clement; Jones, Emma J.; Karamshi, Bhumika; Mitchell, Darren J.; Prinjha, Rab K.; Rau, Christina; Watson, Robert J.; Werner, Thilo; Demont, Emmanuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6151-6178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">ATAD2 is a bromodomain-contg. protein whose overexpression is linked to poor outcomes in a no. of different cancer types.  To date, no potent and selective inhibitors of the bromodomain have been reported.  This article describes the structure-based optimization of a series of naphthyridones from micromolar leads with no selectivity over the BET bromodomains to inhibitors with sub-100 nM ATAD2 potency and 100-fold BET selectivity, e.g. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcCY9tFp5dGbVg90H21EOLACvtfcHk0lg9m5IaFstKDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kms7jK&md5=c7dcd72fdf4ab1c8557be45085cc68fa</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00773%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DFurze%26aufirst%3DR.%2BC.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DBarnett%26aufirst%3DH.%26aulast%3DDiallo%26aufirst%3DH.%26aulast%3DDixon%26aufirst%3DD.%2BP.%26aulast%3DDouault%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DKaramshi%26aufirst%3DB.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26atitle%3DStructure-Based%2520Optimization%2520of%2520Naphthyridones%2520Into%2520Potent%2520ATAD2%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6151%26epage%3D6178%26doi%3D10.1021%2Facs.jmedchem.5b00773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span>NVS-1: A Chemical Probe for CECR2; <span class="NLM_contrib-group">SGC</span><span class="NLM_x">, </span><span class="NLM_x"> (</span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/NVS-1" class="extLink">http://www.thesgc.org/chemical-probes/NVS-1</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=SGC&title=NVS-1%3A+A+Chemical+Probe+for+CECR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNVS-1%253A%2520A%2520Chemical%2520Probe%2520for%2520CECR2%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Medina, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montuenga, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Cespedes, M.</span><span> </span><span class="NLM_article-title">Frequent BRG1/SMARCA4-Inactivating Mutations in Human Lung Cancer Cell Lines</span> <span class="citation_source-journal">Hum. Mutat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1002/humu.20730</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fhumu.20730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18386774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVOnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=617-622&author=P.+P.+Medinaauthor=O.+A.+Romeroauthor=T.+Kohnoauthor=L.+M.+Montuengaauthor=R.+Pioauthor=J.+Yokotaauthor=M.+Sanchez-Cespedes&title=Frequent+BRG1%2FSMARCA4-Inactivating+Mutations+in+Human+Lung+Cancer+Cell+Lines&doi=10.1002%2Fhumu.20730"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines</span></div><div class="casAuthors">Medina, Pedro P.; Romero, Octavio A.; Kohno, Takashi; Montuenga, Luis M.; Pio, Ruben; Yokota, Jun; Sanchez-Cespedes, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Human Mutation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-622</span>CODEN:
                <span class="NLM_cas:coden">HUMUE3</span>;
        ISSN:<span class="NLM_cas:issn">1059-7794</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Components of the SWI/SNF chromatin-remodeling complex, such as INI1, are inactivated in human cancer and, thus, act as tumor suppressors.  Here we screened for mutations the entire coding sequence of BRG1 (SMARCA4), which encodes the ATPase of the complex, in 59 lung cancer cell lines of the most common histopathol. types.  Mutations were detected in 24% of the cancer cell lines, many of them in cells commonly used for lung cancer research.  All mutations were homozygous and most predicted truncated proteins.  The alterations were significantly more frequent in the non-small-cell lung cancer (NSCLC) type (13/37, 35%) as compared to the small-cell lung cancer (SCLC) type (1/19, 5%) (P < 0.05; Fisher's Exact test) and BRG1 was the fourth most frequently altered gene in NSCLC cell lines.  BRG1 mutations coexisted with mutations/deletions at KRAS, LKB1, NRAS, P16, and P53.  However, alterations at BRG1 always occurred in the absence of MYC amplification, suggesting a common role in lung cancer development.  In conclusion, our data strongly support that BRG1 is a bona fide tumor suppressor and a major factor in lung tumorigenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVI5uj5ZXE07Vg90H21EOLACvtfcHk0lg9m5IaFstKDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVOnsr8%253D&md5=cd5a3e9419c52939ea1f922101818684</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1002%2Fhumu.20730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhumu.20730%26sid%3Dliteratum%253Aachs%26aulast%3DMedina%26aufirst%3DP.%2BP.%26aulast%3DRomero%26aufirst%3DO.%2BA.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DMontuenga%26aufirst%3DL.%2BM.%26aulast%3DPio%26aufirst%3DR.%26aulast%3DYokota%26aufirst%3DJ.%26aulast%3DSanchez-Cespedes%26aufirst%3DM.%26atitle%3DFrequent%2520BRG1%252FSMARCA4-Inactivating%2520Mutations%2520in%2520Human%2520Lung%2520Cancer%2520Cell%2520Lines%26jtitle%3DHum.%2520Mutat.%26date%3D2008%26volume%3D29%26spage%3D617%26epage%3D622%26doi%3D10.1002%2Fhumu.20730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Romero, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Xavier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gómez-López, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condom, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villanueva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Cespedes, M.</span><span> </span><span class="NLM_article-title">The Tumour Suppressor and Chromatin-Remodeling Factor BRG1 Antagonizes Myc Activity and Promotes Cell Differentiation in Human Cancer</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">603</span><span class="NLM_x">–</span> <span class="NLM_lpage">616</span><span class="refDoi"> DOI: 10.1002/emmm.201200236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Femmm.201200236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=22407764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsFKls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=603-616&author=O.+A.+Romeroauthor=F.+Setienauthor=S.+Johnauthor=P.+Gimenez-Xavierauthor=G.+G%C3%B3mez-L%C3%B3pezauthor=D.+Pisanoauthor=E.+Condomauthor=A.+Villanuevaauthor=G.+L.+Hagerauthor=M.+Sanchez-Cespedes&title=The+Tumour+Suppressor+and+Chromatin-Remodeling+Factor+BRG1+Antagonizes+Myc+Activity+and+Promotes+Cell+Differentiation+in+Human+Cancer&doi=10.1002%2Femmm.201200236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer</span></div><div class="casAuthors">Romero, Octavio A.; Setien, Fernando; John, Sam; Gimenez-Xavier, Pol; Gomez-Lopez, Gonzalo; Pisano, David; Condom, Enric; Villanueva, Alberto; Hager, Gordon L.; Sanchez-Cespedes, Montse</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">603-616</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">BRG1, a member of the SWI/SNF complex, is mutated in cancer, but it is unclear how it promotes tumorigenesis.  We report that re-expression of BRG1 in lung cancer cells up-regulates lung-specific transcripts, restoring the gene expression signature of normal lung.  Using cell lines from several cancer types we found that those lacking BRG1 do not respond to retinoic acid (RA) or glucocorticoids (GC), while restoration of BRG1 restores sensitivity.  Conversely, in SH-SY5Y cells, a paradigm of RA-dependent differentiation, abrogation of BRG1 prevented the response to RA.  Further, our data suggest an antagonistic functional connection between BRG1 and MYC, whereby, refractoriness to RA and GC by BRG1 inactivation involves deregulation of MYC activity.  Mechanistically, some of these effects are mediated by BRG1 binding to MYC and MYC-target promoters.  The BRG1-MYC antagonism was also evident in primary tumors.  Finally, BRG1 restoration significantly dampened invasion and progression and decreased MYC in lung cancer cells orthotopically implanted in nude mice.  Thus, BRG1 inactivation enables cancer cells to sustain undifferentiated gene expression programs and prevent its response to environmental stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqrAoeW2I6YbVg90H21EOLACvtfcHk0lg9m5IaFstKDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsFKls70%253D&md5=098bc5edd376a2d86a938e1a6614b2c5</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1002%2Femmm.201200236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201200236%26sid%3Dliteratum%253Aachs%26aulast%3DRomero%26aufirst%3DO.%2BA.%26aulast%3DSetien%26aufirst%3DF.%26aulast%3DJohn%26aufirst%3DS.%26aulast%3DGimenez-Xavier%26aufirst%3DP.%26aulast%3DG%25C3%25B3mez-L%25C3%25B3pez%26aufirst%3DG.%26aulast%3DPisano%26aufirst%3DD.%26aulast%3DCondom%26aufirst%3DE.%26aulast%3DVillanueva%26aufirst%3DA.%26aulast%3DHager%26aufirst%3DG.%2BL.%26aulast%3DSanchez-Cespedes%26aufirst%3DM.%26atitle%3DThe%2520Tumour%2520Suppressor%2520and%2520Chromatin-Remodeling%2520Factor%2520BRG1%2520Antagonizes%2520Myc%2520Activity%2520and%2520Promotes%2520Cell%2520Differentiation%2520in%2520Human%2520Cancer%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2012%26volume%3D4%26spage%3D603%26epage%3D616%26doi%3D10.1002%2Femmm.201200236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Garnier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petruccelli, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Rincon, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. H.</span><span> </span><span class="NLM_article-title">The Novel Arsenical Darinaparsin Circumvents BRG1-Dependent, HO-1-Mediated Cytoprotection in Leukemic Cells</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">2220</span><span class="NLM_x">–</span> <span class="NLM_lpage">2228</span><span class="refDoi"> DOI: 10.1038/leu.2013.54</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fleu.2013.54" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=2220-2228&author=N.+Garnierauthor=L.+A.+Petruccelliauthor=M.+F.+Molinaauthor=M.+Kourelisauthor=S.+Kwanauthor=Z.+Diazauthor=H.+M.+Schipperauthor=A.+Guptaauthor=S.+V.+del+Rinconauthor=K.+K.+Mannauthor=W.+H.+Miller&title=The+Novel+Arsenical+Darinaparsin+Circumvents+BRG1-Dependent%2C+HO-1-Mediated+Cytoprotection+in+Leukemic+Cells&doi=10.1038%2Fleu.2013.54"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.54%26sid%3Dliteratum%253Aachs%26aulast%3DGarnier%26aufirst%3DN.%26aulast%3DPetruccelli%26aufirst%3DL.%2BA.%26aulast%3DMolina%26aufirst%3DM.%2BF.%26aulast%3DKourelis%26aufirst%3DM.%26aulast%3DKwan%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DZ.%26aulast%3DSchipper%26aufirst%3DH.%2BM.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Ddel%2BRincon%26aufirst%3DS.%2BV.%26aulast%3DMann%26aufirst%3DK.%2BK.%26aulast%3DMiller%26aufirst%3DW.%2BH.%26atitle%3DThe%2520Novel%2520Arsenical%2520Darinaparsin%2520Circumvents%2520BRG1-Dependent%252C%2520HO-1-Mediated%2520Cytoprotection%2520in%2520Leukemic%2520Cells%26jtitle%3DLeukemia%26date%3D2013%26volume%3D27%26spage%3D2220%26epage%3D2228%26doi%3D10.1038%2Fleu.2013.54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span> </span><span class="NLM_article-title">PFI-3: Selective Chemical Probe for SMARCA Bromodomains</span>. <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/PFI-3" class="extLink">http://www.thesgc.org/chemical-probes/PFI-3</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PFI-3%3A+Selective+Chemical+Probe+for+SMARCA+Bromodomains.+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FPFI-3+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPFI-3%253A%2520Selective%2520Chemical%2520Probe%2520for%2520SMARCA%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Vangamudi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kost-Alimova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nottebaum, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadeshwar, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tieu, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peoples, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffernan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marszalek, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toniatti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhelle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Draetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. N.</span><span> </span><span class="NLM_article-title">The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights From cDNA Rescue and PFI-3 Inhibitor Studies</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3865</span><span class="NLM_x">–</span> <span class="NLM_lpage">3878</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-3798</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F0008-5472.CAN-14-3798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26139243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=3865-3878&author=B.+Vangamudiauthor=T.+A.+Paulauthor=P.+K.+Shahauthor=M.+Kost-Alimovaauthor=L.+Nottebaumauthor=X.+Shiauthor=Y.+Zhanauthor=E.+Leoauthor=H.+S.+Mahadeshwarauthor=A.+Protopopovauthor=A.+Futrealauthor=T.+N.+Tieuauthor=M.+Peoplesauthor=T.+P.+Heffernanauthor=J.+R.+Marszalekauthor=C.+Toniattiauthor=A.+Petrocchiauthor=D.+Verhelleauthor=D.+R.+Owenauthor=G.+Draettaauthor=P.+Jonesauthor=W.+S.+Palmerauthor=S.+Sharmaauthor=J.+N.+Andersen&title=The+SMARCA2%2F4+ATPase+Domain+Surpasses+the+Bromodomain+as+a+Drug+Target+in+SWI%2FSNF-Mutant+Cancers%3A+Insights+From+cDNA+Rescue+and+PFI-3+Inhibitor+Studies&doi=10.1158%2F0008-5472.CAN-14-3798"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies</span></div><div class="casAuthors">Vangamudi, Bhavatarini; Paul, Thomas A.; Shah, Parantu K.; Kost-Alimova, Maria; Nottebaum, Lisa; Shi, Xi; Zhan, Yanai; Leo, Elisabetta; Mahadeshwar, Harshad S.; Protopopov, Alexei; Futreal, Andrew; Tieu, Trang N.; Peoples, Mike; Heffernan, Timothy P.; Marszalek, Joseph R.; Toniatti, Carlo; Petrocchi, Alessia; Verhelle, Dominique; Owen, Dafydd R.; Draetta, Giulio; Jones, Philip; Palmer, Wylie S.; Sharma, Shikhar; Andersen, Jannik N.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3865-3878</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SWI/SNF multisubunit complex modulates chromatin structure through the activity of two mutually exclusive catalytic subunits, SMARCA2 and SMARCA4, which both contain a bromodomain and an ATPase domain.  Using RNAi, cancer-specific vulnerabilities have been identified in SWI/SNF-mutant tumors, including SMARCA4-deficient lung cancer; however, the contribution of conserved, druggable protein domains to this anticancer phenotype is unknown.  Here, we functionally deconstruct the SMARCA2/4 paralog dependence of cancer cells using bioinformatics, genetic, and pharmacol. tools.  We evaluate a selective SMARCA2/4 bromodomain inhibitor (PFI-3) and characterize its activity in chromatin-binding and cell-functional assays focusing on cells with altered SWI/SNF complex (e.g., lung, synovial sarcoma, leukemia, and rhabdoid tumors).  We demonstrate that PFI-3 is a potent, cell-permeable probe capable of displacing ectopically expressed, GFP-tagged SMARCA2-bromodomain from chromatin, yet contrary to target knockdown, the inhibitor fails to display an antiproliferative phenotype.  Mechanistically, the lack of pharmacol. efficacy is reconciled by the failure of bromodomain inhibition to displace endogenous, full-length SMARCA2 from chromatin as detd. by in situ cell extn., chromatin immunopptn., and target gene expression studies.  Furthermore, using inducible RNAi and cDNA complementation (bromodomain- and ATPase-dead constructs), we unequivocally identify the ATPase domain, and not the bromodomain of SMARCA2, as the relevant therapeutic target with the catalytic activity suppressing defined transcriptional programs.  Taken together, our complementary genetic and pharmacol. studies exemplify a general strategy for multidomain protein drug-target validation and in case of SMARCA2/4 highlight the potential for drugging the more challenging helicase/ATPase domain to deliver on the promise of synthetic-lethality therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrix1Qe07Ed3LVg90H21EOLACvtfcHk0lh-l8P1NjLrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2gtL7K&md5=bb35d59dabe56c253fef822a9fb337a8</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-3798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-3798%26sid%3Dliteratum%253Aachs%26aulast%3DVangamudi%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DT.%2BA.%26aulast%3DShah%26aufirst%3DP.%2BK.%26aulast%3DKost-Alimova%26aufirst%3DM.%26aulast%3DNottebaum%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DZhan%26aufirst%3DY.%26aulast%3DLeo%26aufirst%3DE.%26aulast%3DMahadeshwar%26aufirst%3DH.%2BS.%26aulast%3DProtopopov%26aufirst%3DA.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTieu%26aufirst%3DT.%2BN.%26aulast%3DPeoples%26aufirst%3DM.%26aulast%3DHeffernan%26aufirst%3DT.%2BP.%26aulast%3DMarszalek%26aufirst%3DJ.%2BR.%26aulast%3DToniatti%26aufirst%3DC.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DDraetta%26aufirst%3DG.%26aulast%3DJones%26aufirst%3DP.%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAndersen%26aufirst%3DJ.%2BN.%26atitle%3DThe%2520SMARCA2%252F4%2520ATPase%2520Domain%2520Surpasses%2520the%2520Bromodomain%2520as%2520a%2520Drug%2520Target%2520in%2520SWI%252FSNF-Mutant%2520Cancers%253A%2520Insights%2520From%2520cDNA%2520Rescue%2520and%2520PFI-3%2520Inhibitor%2520Studies%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D3865%26epage%3D3878%26doi%3D10.1158%2F0008-5472.CAN-14-3798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Avvakumov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, J.</span><span> </span><span class="NLM_article-title">The MYST Family of Histone Acetyltransferases and Their Intimate Links to Cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5395</span><span class="NLM_x">–</span> <span class="NLM_lpage">5407</span><span class="refDoi"> DOI: 10.1038/sj.onc.1210608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fsj.onc.1210608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=17694081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFeku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5395-5407&author=N.+Avvakumovauthor=J.+C%C3%B4t%C3%A9&title=The+MYST+Family+of+Histone+Acetyltransferases+and+Their+Intimate+Links+to+Cancer&doi=10.1038%2Fsj.onc.1210608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">The MYST family of histone acetyltransferases and their intimate links to cancer</span></div><div class="casAuthors">Avvakumov, N.; Cote, J.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5395-5407</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The histone acetyltransferases (HATs) of the MYST family are highly conserved in eukaryotes and carry out a significant proportion of all nuclear acetylation.  These enzymes function exclusively in multisubunit protein complexes whose compn. is also evolutionarily conserved.  MYST HATs are involved in a no. of key nuclear processes and play crit. roles in gene-specific transcription regulation, DNA damage response and repair, as well as DNA replication.  This suggests that anomalous activity of these HATs or their assocd. complexes can easily lead to severe cellular malfunction, resulting in cell death or uncontrolled growth and malignancy.  Indeed, the MYST family HATs were implicated in several forms of human cancer.  This review summarizes the current understanding of these enzymes and their normal function, as well as their established and putative links to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJq4AeVS5RZrVg90H21EOLACvtfcHk0lh-l8P1NjLrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFeku7g%253D&md5=b5f5ee1db72de5ccecdff00666a2068d</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210608%26sid%3Dliteratum%253Aachs%26aulast%3DAvvakumov%26aufirst%3DN.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DJ.%26atitle%3DThe%2520MYST%2520Family%2520of%2520Histone%2520Acetyltransferases%2520and%2520Their%2520Intimate%2520Links%2520to%2520Cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5395%26epage%3D5407%26doi%3D10.1038%2Fsj.onc.1210608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Carlson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, K. C.</span><span> </span><span class="NLM_article-title">The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1574</span><span class="refDoi"> DOI: 10.1002/jcp.24617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fjcp.24617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24633655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1alu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2014&pages=1571-1574&author=S.+Carlsonauthor=K.+C.+Glass&title=The+MOZ+Histone+Acetyltransferase+in+Epigenetic+Signaling+and+Disease&doi=10.1002%2Fjcp.24617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease</span></div><div class="casAuthors">Carlson, Samuel; Glass, Karen C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">229</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1571-1574</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The monocytic leukemic zinc finger (MOZ) histone acetyltransferase (HAT) plays a role in acute myeloid leukemia (AML).  It functions as a quaternary complex with the bromodomain PHD finger protein 1 (BRPF1), the human Esa1-assocd. factor 6 homolog (hEAF6), and the inhibitor of growth 5 (ING5).  Each of these subunits contain chromatin reader domains that recognize specific post-translational modifications (PTMs) on histone tails, and this recognition directs the MOZ HAT complex to specific chromatin substrates.  The structure and function of these epigenetic reader modules has now been elucidated, and a model describing how the cooperative action of these domains regulates HAT activity in response to the epigenetic landscape is proposed.  The emerging role of epigenetic reader domains in disease, and their therapeutic potential for many types of cancer is also highlighted.  J. Cell. Physiol. 229: 1571-1574, 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-9bMP8Qp9crVg90H21EOLACvtfcHk0lg3WVSUb29Row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1alu7nP&md5=2582999b699ea08ea8d43cd51b411ff2</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1002%2Fjcp.24617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.24617%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DS.%26aulast%3DGlass%26aufirst%3DK.%2BC.%26atitle%3DThe%2520MOZ%2520Histone%2520Acetyltransferase%2520in%2520Epigenetic%2520Signaling%2520and%2520Disease%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2014%26volume%3D229%26spage%3D1571%26epage%3D1574%26doi%3D10.1002%2Fjcp.24617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Qin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Recognition of Unmodified Histone H3 by the First PHD Finger of Bromodomain-PHD Finger Protein 2 Provides Insights Into the Regulation of Histone Acetyltransferases Monocytic Leukemic Zinc-Finger Protein (MOZ) and MOZ-Related Factor (MORF)</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">36944</span><span class="NLM_x">–</span> <span class="NLM_lpage">36955</span><span class="refDoi"> DOI: 10.1074/jbc.M111.244400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1074%2Fjbc.M111.244400" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=36944-36955&author=S.+Qinauthor=L.+Jinauthor=J.+Zhangauthor=L.+Liuauthor=P.+Jiauthor=M.+Wuauthor=J.+Wuauthor=Y.+Shi&title=Recognition+of+Unmodified+Histone+H3+by+the+First+PHD+Finger+of+Bromodomain-PHD+Finger+Protein+2+Provides+Insights+Into+the+Regulation+of+Histone+Acetyltransferases+Monocytic+Leukemic+Zinc-Finger+Protein+%28MOZ%29+and+MOZ-Related+Factor+%28MORF%29&doi=10.1074%2Fjbc.M111.244400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.244400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.244400%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DRecognition%2520of%2520Unmodified%2520Histone%2520H3%2520by%2520the%2520First%2520PHD%2520Finger%2520of%2520Bromodomain-PHD%2520Finger%2520Protein%25202%2520Provides%2520Insights%2520Into%2520the%2520Regulation%2520of%2520Histone%2520Acetyltransferases%2520Monocytic%2520Leukemic%2520Zinc-Finger%2520Protein%2520%2528MOZ%2529%2520and%2520MOZ-Related%2520Factor%2520%2528MORF%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D36944%26epage%3D36955%26doi%3D10.1074%2Fjbc.M111.244400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Vezzoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonadies, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S. M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santiveri, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kvinlaug, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göttgens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bycroft, M.</span><span> </span><span class="NLM_article-title">Molecular Basis of Histone H3K36me3 Recognition by the PWWP Domain of Brpf1</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">617</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span><span class="refDoi"> DOI: 10.1038/nsmb.1797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnsmb.1797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20400950" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVCjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=617-619&author=A.+Vezzoliauthor=N.+Bonadiesauthor=M.+D.+Allenauthor=S.+M.+V.+Freundauthor=C.+M.+Santiveriauthor=B.+T.+Kvinlaugauthor=B.+J.+P.+Huntlyauthor=B.+G%C3%B6ttgensauthor=M.+Bycroft&title=Molecular+Basis+of+Histone+H3K36me3+Recognition+by+the+PWWP+Domain+of+Brpf1&doi=10.1038%2Fnsmb.1797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1</span></div><div class="casAuthors">Vezzoli, Alessandro; Bonadies, Nicolas; Allen, Mark D.; Freund, Stefan M. V.; Santiveri, Clara M.; Kvinlaug, Brynn T.; Huntly, Brian J. P.; Goettgens, Berthold; Bycroft, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-619</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Trimethylation of Lys36 in histone H3 (H3K36me3) coordinates events assocd. with the elongation phase of transcription and is also emerging as an important epigenetic regulator of cell growth and differentiation.  We have identified the PWWP domain of bromo and plant homeodomain (PHD) finger-contg. protein 1 (BRPF1) as a H3K36me3 binding module and have detd. the structure of this domain in complex with an H3K36me3-derived peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotHUbg6LZOdbVg90H21EOLACvtfcHk0lg3WVSUb29Row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVCjtbs%253D&md5=fa97bd4e88b6551c563cd445f9d36bf6</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1797%26sid%3Dliteratum%253Aachs%26aulast%3DVezzoli%26aufirst%3DA.%26aulast%3DBonadies%26aufirst%3DN.%26aulast%3DAllen%26aufirst%3DM.%2BD.%26aulast%3DFreund%26aufirst%3DS.%2BM.%2BV.%26aulast%3DSantiveri%26aufirst%3DC.%2BM.%26aulast%3DKvinlaug%26aufirst%3DB.%2BT.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DG%25C3%25B6ttgens%26aufirst%3DB.%26aulast%3DBycroft%26aufirst%3DM.%26atitle%3DMolecular%2520Basis%2520of%2520Histone%2520H3K36me3%2520Recognition%2520by%2520the%2520PWWP%2520Domain%2520of%2520Brpf1%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D17%26spage%3D617%26epage%3D619%26doi%3D10.1038%2Fnsmb.1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Ullah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelletier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Degerny, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahmasebi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cayrou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyon, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Champagne, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Côté, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. J.</span><span> </span><span class="NLM_article-title">Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">6828</span><span class="NLM_x">–</span> <span class="NLM_lpage">6843</span><span class="refDoi"> DOI: 10.1128/MCB.01297-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FMCB.01297-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=18794358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVSnurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=6828-6843&author=M.+Ullahauthor=N.+Pelletierauthor=L.+Xiaoauthor=S.+P.+Zhaoauthor=K.+Wangauthor=C.+Degernyauthor=S.+Tahmasebiauthor=C.+Cayrouauthor=Y.+Doyonauthor=S.+L.+Gohauthor=N.+Champagneauthor=J.+C%C3%B4t%C3%A9author=X.+J.+Yang&title=Molecular+Architecture+of+Quartet+MOZ%2FMORF+Histone+Acetyltransferase+Complexes&doi=10.1128%2FMCB.01297-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes</span></div><div class="casAuthors">Ullah, Mukta; Pelletier, Nadine; Xiao, Lin; Zhao, Song Ping; Wang, Kainan; Degerny, Cindy; Tahmasebi, Soroush; Cayrou, Christelle; Doyon, Yannick; Goh, Siew-Lee; Champagne, Nathalie; Cote, Jacques; Yang, Xiang-Jiao</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6828-6843</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The monocytic leukemia zinc finger protein MOZ and the related factor MORF form tetrameric complexes with ING5 (inhibitor of growth 5), EAF6 (Esa1-assocd. factor 6 ortholog), and the bromodomain-PHD finger protein BRPF1, -2, or -3.  To gain new insights into the structure, function, and regulation of these complexes, we reconstituted them and performed various mol. analyses.  We found that BRPF proteins bridge the assocn. of MOZ and MORF with ING5 and EAF6.  An N-terminal region of BRPF1 interacts with the acetyltransferases; the enhancer of polycomb (EPc) homol. domain in the middle part binds to ING5 and EAF6.  The assocn. of BRPF1 with EAF6 is weak, but ING5 increases the affinity.  These three proteins form a trimeric core that is conserved from Drosophila melanogaster to humans, although authentic orthologs of MOZ and MORF are absent in invertebrates.  Deletion mapping studies revealed that the acetyltransferase domain of MOZ/MORF is sufficient for BRPF1 interaction.  At the functional level, complex formation with BRPF1 and ING5 drastically stimulates the activity of the acetyltransferase domain in acetylation of nucleosomal histone H3 and free histones H3 and H4.  An unstructured 18-residue region at the C-terminal end of the catalytic domain is required for BRPF1 interaction and may function as an "activation lid.".  Furthermore, BRPF1 enhances the transcriptional potential of MOZ and a leukemic MOZ-TIF2 fusion protein.  These findings thus indicate that BRPF proteins play a key role in assembling and activating MOZ/MORF acetyltransferase complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBMSYP_gcdJrVg90H21EOLACvtfcHk0lg3WVSUb29Row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVSnurfF&md5=3c7cf4abccaf635957b07bb98471329b</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1128%2FMCB.01297-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.01297-08%26sid%3Dliteratum%253Aachs%26aulast%3DUllah%26aufirst%3DM.%26aulast%3DPelletier%26aufirst%3DN.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DS.%2BP.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DDegerny%26aufirst%3DC.%26aulast%3DTahmasebi%26aufirst%3DS.%26aulast%3DCayrou%26aufirst%3DC.%26aulast%3DDoyon%26aufirst%3DY.%26aulast%3DGoh%26aufirst%3DS.%2BL.%26aulast%3DChampagne%26aufirst%3DN.%26aulast%3DC%25C3%25B4t%25C3%25A9%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%2BJ.%26atitle%3DMolecular%2520Architecture%2520of%2520Quartet%2520MOZ%252FMORF%2520Histone%2520Acetyltransferase%2520Complexes%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2008%26volume%3D28%26spage%3D6828%26epage%3D6843%26doi%3D10.1128%2FMCB.01297-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Laue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daujat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plaster, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roehl, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerschmidt, M.</span><span> </span><span class="NLM_article-title">The Multidomain Protein Brpf1 Binds Histones and Is Required for Hox Gene Expression and Segmental Identity</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1946</span><span class="refDoi"> DOI: 10.1242/dev.017160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1242%2Fdev.017160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=1935-1946&author=K.+Laueauthor=S.+Daujatauthor=J.+G.+Crumpauthor=N.+Plasterauthor=H.+H.+Roehlauthor=C.+B.+Kimmelauthor=R.+Schneiderauthor=M.+Hammerschmidt&title=The+Multidomain+Protein+Brpf1+Binds+Histones+and+Is+Required+for+Hox+Gene+Expression+and+Segmental+Identity&doi=10.1242%2Fdev.017160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1242%2Fdev.017160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.017160%26sid%3Dliteratum%253Aachs%26aulast%3DLaue%26aufirst%3DK.%26aulast%3DDaujat%26aufirst%3DS.%26aulast%3DCrump%26aufirst%3DJ.%2BG.%26aulast%3DPlaster%26aufirst%3DN.%26aulast%3DRoehl%26aufirst%3DH.%2BH.%26aulast%3DKimmel%26aufirst%3DC.%2BB.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DHammerschmidt%26aufirst%3DM.%26atitle%3DThe%2520Multidomain%2520Protein%2520Brpf1%2520Binds%2520Histones%2520and%2520Is%2520Required%2520for%2520Hox%2520Gene%2520Expression%2520and%2520Segmental%2520Identity%26jtitle%3DDevelopment%26date%3D2008%26volume%3D135%26spage%3D1935%26epage%3D1946%26doi%3D10.1242%2Fdev.017160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craggs, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fallon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Gall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R. J.</span><span> </span><span class="NLM_article-title">1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1190</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1021/ml5002932</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml5002932" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1190-1195&author=E.+H.+Demontauthor=P.+Bamboroughauthor=C.-W.+Chungauthor=P.+D.+Craggsauthor=D.+Fallonauthor=L.+J.+Gordonauthor=P.+Grandiauthor=C.+I.+Hobbsauthor=J.+Hussainauthor=E.+J.+Jonesauthor=A.+Le+Gallauthor=A.-M.+Michonauthor=D.+J.+Mitchellauthor=R.+K.+Prinjhaauthor=A.+D.+Robertsauthor=R.+J.+Sheppardauthor=R.+J.+Watson&title=1%2C3-Dimethyl+Benzimidazolones+Are+Potent%2C+Selective+Inhibitors+of+the+BRPF1+Bromodomain&doi=10.1021%2Fml5002932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fml5002932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml5002932%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DFallon%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DHussain%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DE.%2BJ.%26aulast%3DLe%2BGall%26aufirst%3DA.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DMitchell%26aufirst%3DD.%2BJ.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DRoberts%26aufirst%3DA.%2BD.%26aulast%3DSheppard%26aufirst%3DR.%2BJ.%26aulast%3DWatson%26aufirst%3DR.%2BJ.%26atitle%3D1%252C3-Dimethyl%2520Benzimidazolones%2520Are%2520Potent%252C%2520Selective%2520Inhibitors%2520of%2520the%2520BRPF1%2520Bromodomain%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1190%26epage%3D1195%26doi%3D10.1021%2Fml5002932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span>PFI-4: A Chemical Probe for BRPF1B; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/PFI-4" class="extLink">http://www.thesgc.org/chemical-probes/PFI-4</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PFI-4%3A+A+Chemical+Probe+for+BRPF1B%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FPFI-4+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DPFI-4%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF1B%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span>OF-1: A Chemical Probe for BRPF Bromodomains; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/OF-1" class="extLink">http://www.thesgc.org/chemical-probes/OF-1</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=OF-1%3A+A+Chemical+Probe+for+BRPF+Bromodomains%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FOF-1+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DOF-1%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span> </span><span class="NLM_article-title">NI-57: A Chemical Probe for BRPF Bromodomains</span>; <span class="NLM_publisher-name">SGC</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.thesgc.org/chemical-probes/NI-57" class="extLink">http://www.thesgc.org/chemical-probes/NI-57</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=NI-57%3A+A+Chemical+Probe+for+BRPF+Bromodomains%3B+SGC%2C+2015%3B+http%3A%2F%2Fwww.thesgc.org%2Fchemical-probes%2FNI-57+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DNI-57%253A%2520A%2520Chemical%2520Probe%2520for%2520BRPF%2520Bromodomains%26pub%3DSGC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Sweis, R. F.</span><span> </span><span class="NLM_article-title">Target (In)Validation: a Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">621</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00183</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=618-621&author=R.+F.+Sweis&title=Target+%28In%29Validation%3A+a+Critical%2C+Sometimes+Unheralded%2C+Role+of+Modern+Medicinal+Chemistry&doi=10.1021%2Facsmedchemlett.5b00183"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00183%26sid%3Dliteratum%253Aachs%26aulast%3DSweis%26aufirst%3DR.%2BF.%26atitle%3DTarget%2520%2528In%2529Validation%253A%2520a%2520Critical%252C%2520Sometimes%2520Unheralded%252C%2520Role%2520of%2520Modern%2520Medicinal%2520Chemistry%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D618%26epage%3D621%26doi%3D10.1021%2Facsmedchemlett.5b00183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Tsai, W.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiu, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akdemir, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plunkett, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronow, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozani, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barton, M. C.</span><span> </span><span class="NLM_article-title">TRIM24 Links a Non-Canonical Histone Signature to Breast Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">468</span><span class="NLM_x">, </span> <span class="NLM_fpage">927</span><span class="NLM_x">–</span> <span class="NLM_lpage">932</span><span class="refDoi"> DOI: 10.1038/nature09542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature09542" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=468&publication_year=2010&pages=927-932&author=W.-W.+Tsaiauthor=Z.+Wangauthor=T.+T.+Yiuauthor=K.+C.+Akdemirauthor=W.+Xiaauthor=S.+Winterauthor=C.-Y.+Tsaiauthor=X.+Shiauthor=D.+Schwarzerauthor=W.+Plunkettauthor=B.+Aronowauthor=O.+Gozaniauthor=W.+Fischleauthor=M.-C.+Hungauthor=D.+J.+Patelauthor=M.+C.+Barton&title=TRIM24+Links+a+Non-Canonical+Histone+Signature+to+Breast+Cancer&doi=10.1038%2Fnature09542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1038%2Fnature09542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature09542%26sid%3Dliteratum%253Aachs%26aulast%3DTsai%26aufirst%3DW.-W.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DYiu%26aufirst%3DT.%2BT.%26aulast%3DAkdemir%26aufirst%3DK.%2BC.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DWinter%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DC.-Y.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DSchwarzer%26aufirst%3DD.%26aulast%3DPlunkett%26aufirst%3DW.%26aulast%3DAronow%26aufirst%3DB.%26aulast%3DGozani%26aufirst%3DO.%26aulast%3DFischle%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DM.-C.%26aulast%3DPatel%26aufirst%3DD.%2BJ.%26aulast%3DBarton%26aufirst%3DM.%2BC.%26atitle%3DTRIM24%2520Links%2520a%2520Non-Canonical%2520Histone%2520Signature%2520to%2520Breast%2520Cancer%26jtitle%3DNature%26date%3D2010%26volume%3D468%26spage%3D927%26epage%3D932%26doi%3D10.1038%2Fnature09542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Khetchoumian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teletin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tisserand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herquel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouararhni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Losson, R.</span><span> </span><span class="NLM_article-title">TRIM24 (Tif1α): an Essential “Brake” for Retinoic Acid-Induced Transcription to Prevent Liver Cancer</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">3647</span><span class="NLM_x">–</span> <span class="NLM_lpage">3652</span><span class="refDoi"> DOI: 10.4161/cc.7.23.7123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.4161%2Fcc.7.23.7123" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3647-3652&author=K.+Khetchoumianauthor=M.+Teletinauthor=J.+Tisserandauthor=B.+Herquelauthor=K.+Ouararhniauthor=R.+Losson&title=TRIM24+%28Tif1%CE%B1%29%3A+an+Essential+%E2%80%9CBrake%E2%80%9D+for+Retinoic+Acid-Induced+Transcription+to+Prevent+Liver+Cancer&doi=10.4161%2Fcc.7.23.7123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.23.7123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.23.7123%26sid%3Dliteratum%253Aachs%26aulast%3DKhetchoumian%26aufirst%3DK.%26aulast%3DTeletin%26aufirst%3DM.%26aulast%3DTisserand%26aufirst%3DJ.%26aulast%3DHerquel%26aufirst%3DB.%26aulast%3DOuararhni%26aufirst%3DK.%26aulast%3DLosson%26aufirst%3DR.%26atitle%3DTRIM24%2520%2528Tif1%25CE%25B1%2529%253A%2520an%2520Essential%2520%25E2%2580%259CBrake%25E2%2580%259D%2520for%2520Retinoic%2520Acid-Induced%2520Transcription%2520to%2520Prevent%2520Liver%2520Cancer%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26spage%3D3647%26epage%3D3652%26doi%3D10.4161%2Fcc.7.23.7123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Zhang, L.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, A.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">TRIM24 Promotes Glioma Progression and Enhances Chemoresistance Through Activation of the PI3K/Akt Signaling Pathway</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">600</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span><span class="refDoi"> DOI: 10.1038/onc.2013.593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fonc.2013.593" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=600-610&author=L.-H.+Zhangauthor=A.-A.+Yinauthor=J.-X.+Chengauthor=H.-Y.+Huangauthor=X.-M.+Liauthor=Y.-Q.+Zhangauthor=N.+Hanauthor=X.+Zhang&title=TRIM24+Promotes+Glioma+Progression+and+Enhances+Chemoresistance+Through+Activation+of+the+PI3K%2FAkt+Signaling+Pathway&doi=10.1038%2Fonc.2013.593"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fonc.2013.593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2013.593%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.-H.%26aulast%3DYin%26aufirst%3DA.-A.%26aulast%3DCheng%26aufirst%3DJ.-X.%26aulast%3DHuang%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DX.-M.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DHan%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DTRIM24%2520Promotes%2520Glioma%2520Progression%2520and%2520Enhances%2520Chemoresistance%2520Through%2520Activation%2520of%2520the%2520PI3K%252FAkt%2520Signaling%2520Pathway%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D600%26epage%3D610%26doi%3D10.1038%2Fonc.2013.593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Overexpression of TRIM24 Is Associated with the Onset and Progress of Human Hepatocellular Carcinoma</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e85462</span><span class="refDoi"> DOI: 10.1371/journal.pone.0085462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0085462" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e85462&author=X.+Liuauthor=Y.+Huangauthor=D.+Yangauthor=X.+Liauthor=J.+Liangauthor=L.+Linauthor=M.+Zhangauthor=K.+Zhongauthor=B.+Liangauthor=J.+Li&title=Overexpression+of+TRIM24+Is+Associated+with+the+Onset+and+Progress+of+Human+Hepatocellular+Carcinoma&doi=10.1371%2Fjournal.pone.0085462"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0085462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0085462%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhong%26aufirst%3DK.%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DOverexpression%2520of%2520TRIM24%2520Is%2520Associated%2520with%2520the%2520Onset%2520and%2520Progress%2520of%2520Human%2520Hepatocellular%2520Carcinoma%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De85462%26doi%3D10.1371%2Fjournal.pone.0085462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Bennett, J.; Fedorov, O.; Tallant, C.; Monteiro, O.; Meier, J.; Gamble, V.; Savitsky, P.; Nunez-Alonso, G. A.; Haendler, B.; Rogers, C.; Brennan, P. E.; Müller, S.; Knapp, S.</span><span> </span><span class="NLM_article-title">Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00458</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00458" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Bennett&author=O.+Fedorov&author=C.+Tallant&author=O.+Monteiro&author=J.+Meier&author=V.+Gamble&author=P.+Savitsky&author=G.+A.+Nunez-Alonso&author=B.+Haendler&author=C.+Rogers&author=P.+E.+Brennan&author=S.+M%C3%BCller&author=S.+Knapp&title=Discovery+of+a+Chemical+Tool+Inhibitor+Targeting+the+Bromodomains+of+TRIM24+and+BRPF&doi=10.1021%2Facs.jmedchem.5b00458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00458%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Chemical%2520Tool%2520Inhibitor%2520Targeting%2520the%2520Bromodomains%2520of%2520TRIM24%2520and%2520BRPF%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Palmer, W. S.; Poncet-Montange, G.; Liu, G.; Petrocchi, A.; Reyna, N.; Subramanian, G.; Theroff, J.; Yau, A.; Kost-Alimova, M.; Bardenhagen, J. P.; Leo, E.; Shepard, H. E.; Tieu, T. N.; Shi, X.; Zhan, Y.; Zhao, S.; Barton, M. C.; Draetta, G.; Toniatti, C.; Jones, P.; Geck Do, M.; Andersen, J. N.</span><span> </span><span class="NLM_article-title">Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00405</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00405" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=W.+S.+Palmer&author=G.+Poncet-Montange&author=G.+Liu&author=A.+Petrocchi&author=N.+Reyna&author=G.+Subramanian&author=J.+Theroff&author=A.+Yau&author=M.+Kost-Alimova&author=J.+P.+Bardenhagen&author=E.+Leo&author=H.+E.+Shepard&author=T.+N.+Tieu&author=X.+Shi&author=Y.+Zhan&author=S.+Zhao&author=M.+C.+Barton&author=G.+Draetta&author=C.+Toniatti&author=P.+Jones&author=M.+Geck+Do&author=J.+N.+Andersen&title=Structure-Guided+Design+of+IACS-9571%2C+a+Selective+High-Affinity+Dual+TRIM24-BRPF1+Bromodomain+Inhibitor&doi=10.1021%2Facs.jmedchem.5b00405"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00405&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00405%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DW.%2BS.%26atitle%3DStructure-Guided%2520Design%2520of%2520IACS-9571%252C%2520a%2520Selective%2520High-Affinity%2520Dual%2520TRIM24-BRPF1%2520Bromodomain%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26doi%3D10.1021%2Facs.jmedchem.5b00405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Urick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawk, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassel, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">dos Santos, C. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, W. C. K.</span><span> </span><span class="NLM_article-title">Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2246</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2246&author=A.+K.+Urickauthor=L.+M.+L.+Hawkauthor=M.+K.+Casselauthor=N.+K.+Mishraauthor=S.+Liuauthor=N.+Adhikariauthor=W.+Zhangauthor=C.+O.+dos+Santosauthor=J.+L.+Hallauthor=W.+C.+K.+Pomerantz&title=Dual+Screening+of+BPTF+and+Brd4+Using+Protein-Observed+Fluorine+NMR+Uncovers+New+Bromodomain+Probe+Molecules&doi=10.1021%2Facschembio.5b00483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules</span></div><div class="casAuthors">Urick, Andrew K.; Hawk, Laura M. L.; Cassel, Melissa K.; Mishra, Neeraj K.; Liu, Shuai; Adhikari, Neeta; Zhang, Wei; dos Santos, Camila O.; Hall, Jennifer L.; Pomerantz, William C. K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2246-2256</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomain-contg. protein dysregulation is linked to cancer, diabetes, and inflammation.  Selective inhibition of bromodomain function is a newly proposed therapeutic strategy.  The authors describe a 19F NMR dual screening method for small mol. discovery using fluorinated tryptophan resonances on two bromodomain-contg. proteins.  The chem. shift dispersion of 19F resonances within fluorine-labeled proteins enables the simultaneous anal. of two fluorinated bromodomains by NMR.  A library of 229 small mols. was screened against the first bromodomain of Brd4 and the BPTF bromodomain.  The authors report the first small mol. selective for BPTF over Brd4, termed AU1.  The Kd = 2.8 μM for AU1, which is active in a cell-based reporter assay.  No binding was detected with Brd4.  Three new Brd4 inhibitors with submicromolar affinity were also discovered.  Brd4 hits were validated in a thermal stability assay and potency detd. via fluorescence anisotropy.  The speed, ease of interpretation, and low protein concn. needed for protein-obsd. 19F NMR expts. in a multiprotein format offers a new method to discover and characterize selective ligands for bromodomain-contg. proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjhnKasUdNL7Vg90H21EOLACvtfcHk0lhG6NmPTDkmHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCiurfI&md5=584fa6b83f8bfa661f55edb1078e570c</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00483%26sid%3Dliteratum%253Aachs%26aulast%3DUrick%26aufirst%3DA.%2BK.%26aulast%3DHawk%26aufirst%3DL.%2BM.%2BL.%26aulast%3DCassel%26aufirst%3DM.%2BK.%26aulast%3DMishra%26aufirst%3DN.%2BK.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DAdhikari%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3Ddos%2BSantos%26aufirst%3DC.%2BO.%26aulast%3DHall%26aufirst%3DJ.%2BL.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%2BK.%26atitle%3DDual%2520Screening%2520of%2520BPTF%2520and%2520Brd4%2520Using%2520Protein-Observed%2520Fluorine%2520NMR%2520Uncovers%2520New%2520Bromodomain%2520Probe%2520Molecules%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2246%26doi%3D10.1021%2Facschembio.5b00483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Dawson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giotopoulos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudgin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lugo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beinke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doehner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delwel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouzarides, T.</span><span> </span><span class="NLM_article-title">Inhibition of BET Recruitment to Chromatin as an Effective Treatment for MLL-Fusion Leukaemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">478</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span><span class="refDoi"> DOI: 10.1038/nature10509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature10509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=21964340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=478&publication_year=2011&pages=529-533&author=M.+A.+Dawsonauthor=R.+K.+Prinjhaauthor=A.+Dittmannauthor=G.+Giotopoulosauthor=M.+Bantscheffauthor=W.-I.+Chanauthor=S.+C.+Robsonauthor=C.-W.+Chungauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=C.+Huthmacherauthor=E.+Gudginauthor=D.+Lugoauthor=S.+Beinkeauthor=T.+D.+Chapmanauthor=E.+J.+Robertsauthor=P.+E.+Sodenauthor=K.+R.+Augerauthor=O.+Mirguetauthor=K.+Doehnerauthor=R.+Delwelauthor=A.+K.+Burnettauthor=P.+Jeffreyauthor=G.+Drewesauthor=K.+Leeauthor=B.+J.+P.+Huntlyauthor=T.+Kouzarides&title=Inhibition+of+BET+Recruitment+to+Chromatin+as+an+Effective+Treatment+for+MLL-Fusion+Leukaemia&doi=10.1038%2Fnature10509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia</span></div><div class="casAuthors">Dawson, Mark A.; Prinjha, Rab K.; Dittman, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">478</span>
        (<span class="NLM_cas:issue">7370</span>),
    <span class="NLM_cas:pages">529-533</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent chromosomal translocations involving the mixed lineage leukemia (MLL) gene initiate aggressive forms of leukemia, which are often refractory to conventional therapies.  Many MLL-fusion partners are members of the super elongation complex (SEC), a crit. regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukemia induction.  Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC and the polymerase-assocd. factor complex (PAFc), are assocd. with the BET family of acetyl-lysine recognizing, chromatin adaptor' proteins.  These data provided the basis for therapeutic intervention in MLL-fusion leukemia, via the displacement of the BET family of proteins from chromatin.  We show that a novel small mol. inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukemic cell lines, through the induction of early cell cycle arrest and apoptosis.  I-BET151 treatment in two human leukemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes.  The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin.  In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukemia.  Finally, the efficacy of I-BET151 against human leukemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential.  These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukemias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4FbgJpjftv7Vg90H21EOLACvtfcHk0lhTqy1QWKc0xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GqsL%252FO&md5=dffb4b81da4ca8291c27139d0df86324</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1038%2Fnature10509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10509%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DM.%2BA.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGiotopoulos%26aufirst%3DG.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DW.-I.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DGudgin%26aufirst%3DE.%26aulast%3DLugo%26aufirst%3DD.%26aulast%3DBeinke%26aufirst%3DS.%26aulast%3DChapman%26aufirst%3DT.%2BD.%26aulast%3DRoberts%26aufirst%3DE.%2BJ.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DAuger%26aufirst%3DK.%2BR.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DDoehner%26aufirst%3DK.%26aulast%3DDelwel%26aufirst%3DR.%26aulast%3DBurnett%26aufirst%3DA.%2BK.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26aulast%3DKouzarides%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520BET%2520Recruitment%2520to%2520Chromatin%2520as%2520an%2520Effective%2520Treatment%2520for%2520MLL-Fusion%2520Leukaemia%26jtitle%3DNature%26date%3D2011%26volume%3D478%26spage%3D529%26epage%3D533%26doi%3D10.1038%2Fnature10509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Fish, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bish, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerstenberger, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nocka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Primiano, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralph, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciammetta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trzupek, J. D.</span><span> </span><span class="NLM_article-title">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition Through Optimization of a Fragment-Derived Hit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9831</span><span class="NLM_x">–</span> <span class="NLM_lpage">9837</span><span class="refDoi"> DOI: 10.1021/jm3010515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3010515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9831-9837&author=P.+V.+Fishauthor=P.+Filippakopoulosauthor=G.+Bishauthor=P.+E.+Brennanauthor=M.+E.+Bunnageauthor=A.+S.+Cookauthor=O.+Federovauthor=B.+S.+Gerstenbergerauthor=H.+Jonesauthor=S.+Knappauthor=B.+Marsdenauthor=K.+Nockaauthor=D.+R.+Owenauthor=M.+Philpottauthor=S.+Picaudauthor=M.+J.+Primianoauthor=M.+J.+Ralphauthor=N.+Sciammettaauthor=J.+D.+Trzupek&title=Identification+of+a+Chemical+Probe+for+Bromo+and+Extra+C-Terminal+Bromodomain+Inhibition+Through+Optimization+of+a+Fragment-Derived+Hit&doi=10.1021%2Fjm3010515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit</span></div><div class="casAuthors">Fish, Paul V.; Filippakopoulos, Panagis; Bish, Gerwyn; Brennan, Paul E.; Bunnage, Mark E.; Cook, Andrew S.; Federov, Oleg; Gerstenberger, Brian S.; Jones, Hannah; Knapp, Stefan; Marsden, Brian; Nocka, Karl; Owen, Dafydd R.; Philpott, Martin; Picaud, Sarah; Primiano, Michael J.; Ralph, Michael J.; Sciammetta, Nunzio; Trzupek, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9831-9837</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The posttranslational modification of chromatin through acetylation at selected histone lysine residues is governed by histone acetyltransferases (HATs) and histone deacetylases (HDACs).  The significance of this subset of the epigenetic code is interrogated and interpreted by an acetyllysine-specific protein-protein interaction with bromodomain reader modules.  Selective inhibition of the bromo and extra C-terminal domain (BET) family of bromodomains with a small mol. is feasible, and this may represent an opportunity for disease intervention through the recently disclosed antiproliferative and anti-inflammatory properties of such inhibitors.  Herein, we describe the discovery and structure-activity relationship (SAR) of a novel, small-mol. chem. probe for BET family inhibition that was identified through the application of structure-based fragment assessment and optimization techniques.  This has yielded a potent, selective compd. with cell-based activity (PFI-1) that may further add to the understanding of BET family function within the bromodomains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphzpWnuXoLdrVg90H21EOLACvtfcHk0lhTqy1QWKc0xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtLnE&md5=ba864f3916bea5f793dd0b26732784f0</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm3010515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3010515%26sid%3Dliteratum%253Aachs%26aulast%3DFish%26aufirst%3DP.%2BV.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBish%26aufirst%3DG.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DFederov%26aufirst%3DO.%26aulast%3DGerstenberger%26aufirst%3DB.%2BS.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DNocka%26aufirst%3DK.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPrimiano%26aufirst%3DM.%2BJ.%26aulast%3DRalph%26aufirst%3DM.%2BJ.%26aulast%3DSciammetta%26aufirst%3DN.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26atitle%3DIdentification%2520of%2520a%2520Chemical%2520Probe%2520for%2520Bromo%2520and%2520Extra%2520C-Terminal%2520Bromodomain%2520Inhibition%2520Through%2520Optimization%2520of%2520a%2520Fragment-Derived%2520Hit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9831%26epage%3D9837%26doi%3D10.1021%2Fjm3010515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Basheer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huntly, B. J. P.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibitors in Leukemia</span> <span class="citation_source-journal">Exp. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">731</span><span class="refDoi"> DOI: 10.1016/j.exphem.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.exphem.2015.06.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26163798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCit7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=718-731&author=F.+Basheerauthor=B.+J.+P.+Huntly&title=BET+Bromodomain+Inhibitors+in+Leukemia&doi=10.1016%2Fj.exphem.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibitors in leukemia</span></div><div class="casAuthors">Basheer, Faisal; Huntly, Brian J. P.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Hematology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-731</span>CODEN:
                <span class="NLM_cas:coden">EXHMA6</span>;
        ISSN:<span class="NLM_cas:issn">0301-472X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The last few years have seen the identification of bromodomain and extraterminal (BET) proteins as crit. mediators of transcription with effects on its direct control and cisregulation.  This discovery is important in furthering our understanding of the mechanisms of normal transcriptional control.  Subsequent work has shed light on the multiple roles of BET proteins in various aberrant transcriptional pathways that have significant implications across many malignant cell types and other disease processes.  Accordingly, considerable effort has been made to assess the utility of targeting BET proteins with specific small mols. in acute leukemia and across other types of cancer.  In this review, we will discuss the most recent advances in our understanding of the mechanistic actions of BET proteins in normal transcriptional control, both at the gene body and cisregulatory elements; how this is subverted; and its aberrant downstream effects, specifically in the context of acute leukemia and other hematol. cancers.  In particular, we will focus on altered epigenetic programs that have been shown to be central to the development and maintenance of acute myeloid leukemia in preclin. models.  Finally, we will explore how the use of small-mol. BET inhibitors in leukemias has demonstrated significant promise in numerous single-agent and combination therapy preclin. models and will highlight efforts to translate this promise to the therapeutic arena through various clin. trials attempting to validate efficacy and safety.  The considerable opportunities in epigenetically targeting leukemias through BET inhibition will undoubtedly play an important role in improving the management of these conditions in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ0bYdhy9EeLVg90H21EOLACvtfcHk0lhTqy1QWKc0xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCit7zM&md5=a2a42b24124463ca946e61cf0663e78d</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2Fj.exphem.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exphem.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DBasheer%26aufirst%3DF.%26aulast%3DHuntly%26aufirst%3DB.%2BJ.%2BP.%26atitle%3DBET%2520Bromodomain%2520Inhibitors%2520in%2520Leukemia%26jtitle%3DExp.%2520Hematol.%26date%3D2015%26volume%3D43%26spage%3D718%26epage%3D731%26doi%3D10.1016%2Fj.exphem.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Mele, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmeron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lora, J. M.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Suppresses TH17-Mediated Pathology</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">210</span><span class="NLM_x">, </span> <span class="NLM_fpage">2181</span><span class="NLM_x">–</span> <span class="NLM_lpage">2190</span><span class="refDoi"> DOI: 10.1084/jem.20130376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1084%2Fjem.20130376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24101376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ygsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2181-2190&author=D.+A.+Meleauthor=A.+Salmeronauthor=S.+Ghoshauthor=H.+R.+Huangauthor=B.+M.+Bryantauthor=J.+M.+Lora&title=BET+Bromodomain+Inhibition+Suppresses+TH17-Mediated+Pathology&doi=10.1084%2Fjem.20130376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">BET bromodomain inhibition suppresses TH17-mediated pathology</span></div><div class="casAuthors">Mele, Deanna A.; Salmeron, Andres; Ghosh, Srimoyee; Huang, Hon-Ren; Bryant, Barbara M.; Lora, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2181-2190</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Interleukin (IL) 17-producing T helper (TH17) cells have been selected through evolution for their ability to control fungal and bacterial infections.  It is also firmly established that their aberrant generation and activation results in autoimmune conditions.  Using a characterized potent and selective small mol. inhibitor, we show that the bromodomain and extra-terminal domain (BET) family of chromatin adaptors plays fundamental and selective roles in human and murine TH17 differentiation from naive CD4+ T cells, as well as in the activation of previously differentiated TH17 cells.  We provide evidence that BET controls TH17 differentiation in a bromodomain-dependent manner through a mechanism that includes the direct regulation of multiple effector TH17-assocd. cytokines, including IL17, IL21, and GMCSF.  We also demonstrate that BET family members Brd2 and Brd4 assoc. with the Il17 locus in TH17 cells, and that this assocn. requires bromodomains.  We recapitulate the crit. role of BET bromodomains in TH17 differentiation in vivo and show that therapeutic dosing of the BET inhibitor is efficacious in mouse models of autoimmunity.  Our results identify the BET family of proteins as a fundamental link between chromatin signaling and TH17 biol., and support the notion of BET inhibition as a point of therapeutic intervention in autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBqVtggp2Fa7Vg90H21EOLACvtfcHk0ljbFChe-2kVgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ygsLbF&md5=e6822f456cf42cdead9779afa92c05e0</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1084%2Fjem.20130376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20130376%26sid%3Dliteratum%253Aachs%26aulast%3DMele%26aufirst%3DD.%2BA.%26aulast%3DSalmeron%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DH.%2BR.%26aulast%3DBryant%26aufirst%3DB.%2BM.%26aulast%3DLora%26aufirst%3DJ.%2BM.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Suppresses%2520TH17-Mediated%2520Pathology%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2181%26epage%3D2190%26doi%3D10.1084%2Fjem.20130376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Chaidos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caputo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karadimitris, A.</span><span> </span><span class="NLM_article-title">Inhibition of Bromodomain and Extra-Terminal Proteins (BET) as a Potential Therapeutic Approach in Haematological Malignancies: Emerging Preclinical and Clinical Evidence</span> <span class="citation_source-journal">Ther. Adv. Hematol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span><span class="refDoi"> DOI: 10.1177/2040620715576662</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1177%2F2040620715576662" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26137204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGhtr%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=128-141&author=A.+Chaidosauthor=V.+Caputoauthor=A.+Karadimitris&title=Inhibition+of+Bromodomain+and+Extra-Terminal+Proteins+%28BET%29+as+a+Potential+Therapeutic+Approach+in+Haematological+Malignancies%3A+Emerging+Preclinical+and+Clinical+Evidence&doi=10.1177%2F2040620715576662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of bromodomain and extra-terminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence</span></div><div class="casAuthors">Chaidos, Aristeidis; Caputo, Valentina; Karadimitris, Anastasios</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Hematology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-141</span>CODEN:
                <span class="NLM_cas:coden">TAHHAT</span>;
        ISSN:<span class="NLM_cas:issn">2040-6207</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Post-translational modifications of the nucleosomal histone proteins orchestrate chromatin organization and gene expression in normal and cancer cells.  Among them, the acetylation of N-terminal histone tails represents the fundamental epigenetic mark of open structure chromatin and active gene transcription.  The bromodomain and extra-terminal (BET) proteins are epigenetic readers which utilize tandem bromodomains (BRD) modules to recognize and dock themselves on the acetylated lysine tails.  The BET proteins act as scaffolds for the recruitment of transcription factors and chromatin organizers required in transcription initiation and elongation.  The recent discovery of small mols. capable of blocking their Lysine-binding pocket is the first paradigm of successful pharmacol. inhibition of epigenetic readers.  JQ1 is a prototype benzodiazepine mol. and a specific BET inhibitor with antineoplastic activity both in solid tumors and hematol. malignancies.  The quinolone I-BET151 and the suitable for clin. development I-BET762 benzodiazepine were introduced in parallel with J01 and have also shown potent antitumor activity in preclin. studies.  I-BET762 is currently being tested in early phase clin. trials, along with a rapidly growing list of other BET inhibitors.  Unlike older epigenetic therapies, the study of BET inhibitors has offered substantial, context-specific, mechanistic insights of their antitumor activity, which will facilitate optimal therapeutic targeting in future.  Here, we review the development of this novel class of epigenetic drugs, the biol. of BET protein inhibition, the emerging evidence from preclin. work and early phase clin. studies and we discuss their potential role in the treatment of hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprChIidUwITLVg90H21EOLACvtfcHk0ljbFChe-2kVgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGhtr%252FP&md5=61a7d6200f0309e76cb4623b7d2bffb5</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F2040620715576662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F2040620715576662%26sid%3Dliteratum%253Aachs%26aulast%3DChaidos%26aufirst%3DA.%26aulast%3DCaputo%26aufirst%3DV.%26aulast%3DKaradimitris%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Bromodomain%2520and%2520Extra-Terminal%2520Proteins%2520%2528BET%2529%2520as%2520a%2520Potential%2520Therapeutic%2520Approach%2520in%2520Haematological%2520Malignancies%253A%2520Emerging%2520Preclinical%2520and%2520Clinical%2520Evidence%26jtitle%3DTher.%2520Adv.%2520Hematol.%26date%3D2015%26volume%3D6%26spage%3D128%26epage%3D141%26doi%3D10.1177%2F2040620715576662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Bertoni, F.; Inghirami, G.</span><span> </span><span class="NLM_article-title">A BET-BRD Inhibitor Represents a Novel Agent for ALK Positive Anaplastic Large Cell Lymphoma</span>. WO2015018520A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=F.+Bertoni&author=G.+Inghirami&title=A+BET-BRD+Inhibitor+Represents+a+Novel+Agent+for+ALK+Positive+Anaplastic+Large+Cell+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBertoni%26aufirst%3DF.%26atitle%3DA%2520BET-BRD%2520Inhibitor%2520Represents%2520a%2520Novel%2520Agent%2520for%2520ALK%2520Positive%2520Anaplastic%2520Large%2520Cell%2520Lymphoma%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Harbeson, S. L.</span><span> </span><span class="NLM_article-title">Deuterated Derivatives of a Thienotriazolodiazapine Bromodomain-Containing Protein Inhibitor</span>. WO2015031741A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+L.+Harbeson&title=Deuterated+Derivatives+of+a+Thienotriazolodiazapine+Bromodomain-Containing+Protein+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26atitle%3DDeuterated%2520Derivatives%2520of%2520a%2520Thienotriazolodiazapine%2520Bromodomain-Containing%2520Protein%2520Inhibitor%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.</span><span> </span><span class="NLM_article-title">Pyrrolo- and Pyrazolo-Triazolodiazepines as BET-Protein Inhibitors for Treating Hyperproliferative Diseases</span>. WO2014128070A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&title=Pyrrolo-+and+Pyrazolo-Triazolodiazepines+as+BET-Protein+Inhibitors+for+Treating+Hyperproliferative+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DPyrrolo-%2520and%2520Pyrazolo-Triazolodiazepines%2520as%2520BET-Protein%2520Inhibitors%2520for%2520Treating%2520Hyperproliferative%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Schmees, N.; Buchmann, B.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.; Rehwinkel, H.</span><span> </span><span class="NLM_article-title">4-Substituted Pyrrolo- and Pyrazolo-Diazepines</span>. WO2014128111A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=B.+Buchmann&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&author=H.+Rehwinkel&title=4-Substituted+Pyrrolo-+and+Pyrazolo-Diazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3D4-Substituted%2520Pyrrolo-%2520and%2520Pyrazolo-Diazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Schmees, N.; Kuhnke, J.; Haendler, B.; Neuhaus, R.; Lejeune, P.; Siegel, S.; Krüger, M.; Fernandez-Montalvan, A. E.; Künzer, H.; Gallenkamp, D.</span><span> </span><span class="NLM_article-title">BET Protein-Inhibiting 5-Aryl Triazole Azepines</span>. WO2014048945A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=N.+Schmees&author=J.+Kuhnke&author=B.+Haendler&author=R.+Neuhaus&author=P.+Lejeune&author=S.+Siegel&author=M.+Kr%C3%BCger&author=A.+E.+Fernandez-Montalvan&author=H.+K%C3%BCnzer&author=D.+Gallenkamp&title=BET+Protein-Inhibiting+5-Aryl+Triazole+Azepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DBET%2520Protein-Inhibiting%25205-Aryl%2520Triazole%2520Azepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Albrecht, B. K.; Hewitt, M. C.; Gehling, V. S.; Vaswani, R. G.</span><span> </span><span class="NLM_article-title">Benzo[C]isoxazoloazepine Bromodomain Inhibitors and Uses Thereof</span>. WO2013184876A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+K.+Albrecht&author=M.+C.+Hewitt&author=V.+S.+Gehling&author=R.+G.+Vaswani&title=Benzo%5BC%5Disoxazoloazepine+Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBenzo%255BC%255Disoxazoloazepine%2520Bromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Sims, R.</span><span> </span><span class="NLM_article-title">Discovery of CPI-0610: A novel BET protein bromodomain inhibitor for hematologic malignancies</span>. <span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">April 18–22, 2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sims%2C+R.+Discovery+of+CPI-0610%3A+A+novel+BET+protein+bromodomain+inhibitor+for+hematologic+malignancies.+Annual+Meeting+of+American+Association+for+Cancer+Research%2C+Philadelphia%2C+PA%2C+April+18%E2%80%9322%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSims%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520CPI-0610%253A%2520A%2520novel%2520BET%2520protein%2520bromodomain%2520inhibitor%2520for%2520hematologic%2520malignancies" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Albrecht, B. K.; Audia, J. E.; Côté, A.; Gehling, V. S.; Harmange, J.-C.; Hewitt, M. C.; Naveschuk, C. G.; Taylor, A. M.; Vaswani, R. G.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors and Uses Thereof</span>. WO2012075456A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Albrecht&author=J.+E.+Audia&author=A.+C%C3%B4t%C3%A9&author=V.+S.+Gehling&author=J.-C.+Harmange&author=M.+C.+Hewitt&author=C.+G.+Naveschuk&author=A.+M.+Taylor&author=R.+G.+Vaswani&title=Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Albrecht, B. K.; Harmange, J.-C.; Côté, A.; Taylor, A. M.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors and Uses Thereof</span>. WO2012174487A2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=B.+K.+Albrecht&author=J.-C.+Harmange&author=A.+C%C3%B4t%C3%A9&author=A.+M.+Taylor&title=Bromodomain+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DBromodomain%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Kessler, D.; Reiser, U.; Smethurst, C.; Steffen, A.</span><span> </span><span class="NLM_article-title">Triazolopyridazine</span>. US20140135336A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=D.+Kessler&author=U.+Reiser&author=C.+Smethurst&author=A.+Steffen&title=Triazolopyridazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyridazine%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Wang, H.; Shao, L.; Rodgers, J. D.; Shepard, S.</span><span> </span><span class="NLM_article-title">Tricyclic Heterocycles as BET Protein Inhibitors</span>. WO2015095492A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Wang&author=L.+Shao&author=J.+D.+Rodgers&author=S.+Shepard&title=Tricyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26atitle%3DTricyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Engelhardt, H.</span><span> </span><span class="NLM_article-title">Triazolopyrazine Derivatives as BRD4 Inhibitors</span>. WO2015067770A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&title=Triazolopyrazine+Derivatives+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DTriazolopyrazine%2520Derivatives%2520as%2520BRD4%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">McKeown, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklow, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9019</span><span class="NLM_x">–</span> <span class="NLM_lpage">9027</span><span class="refDoi"> DOI: 10.1021/jm501120z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501120z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9019-9027&author=M.+R.+McKeownauthor=D.+L.+Shawauthor=H.+Fuauthor=S.+Liuauthor=X.+Xuauthor=J.+J.+Marineauauthor=Y.+Huangauthor=X.+Zhangauthor=D.+L.+Buckleyauthor=A.+Kadamauthor=Z.+Zhangauthor=S.+C.+Blacklowauthor=J.+Qiauthor=W.+Zhangauthor=J.+E.+Bradner&title=Biased+Multicomponent+Reactions+to+Develop+Novel+Bromodomain+Inhibitors&doi=10.1021%2Fjm501120z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors</span></div><div class="casAuthors">McKeown, Michael R.; Shaw, Daniel L.; Fu, Harry; Liu, Shuai; Xu, Xiang; Marineau, Jason J.; Huang, Yibo; Zhang, Xiaofeng; Buckley, Dennis L.; Kadam, Asha; Zhang, Zijuan; Blacklow, Stephen C.; Qi, Jun; Zhang, Wei; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9019-9027</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BET bromodomain inhibition has contributed new insights into gene regulation and emerged as a promising therapeutic strategy in cancer.  Structural analogy of early methyl-triazolo BET inhibitors has prompted a need for structurally dissimilar ligands as probes of bromodomain function.  Using fluorous-tagged multicomponent reactions, we developed a focused chem. library of bromodomain inhibitors around a 3,5-dimethylisoxazole biasing element with micromolar biochem. IC50.  Iterative synthesis and biochem. assessment allowed optimization of novel BET bromodomain inhibitors based on an imidazo[1,2-a]pyrazine scaffold.  Lead compd. I (UMB-32) binds BRD4 with a Kd of 550 nM and 724 nM cellular potency in BRD4-dependent lines.  Addnl., compd. I shows potency against TAF1, a bromodomain-contg. transcription factor previously unapproached by discovery chem.  Compd. I was cocrystd. with BRD4, yielding a 1.56 Å resoln. crystal structure.  This research showcases new applications of fluorous and multicomponent chem. synthesis for the development of novel epigenetic inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocWEf4LoDJTrVg90H21EOLACvtfcHk0lggCqqIEW1nQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslChsbbN&md5=a4e20101f5a0b547451814af73c0418f</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Fjm501120z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501120z%26sid%3Dliteratum%253Aachs%26aulast%3DMcKeown%26aufirst%3DM.%2BR.%26aulast%3DShaw%26aufirst%3DD.%2BL.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DKadam%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DBiased%2520Multicomponent%2520Reactions%2520to%2520Develop%2520Novel%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9019%26epage%3D9027%26doi%3D10.1021%2Fjm501120z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Sasmal, S.; Hosahalli, S.</span><span> </span><span class="NLM_article-title">Substituted Imidazo[4,5-<i>c</i>]quinoline Derivatives as Bromodomain Inhibitors</span>. WO2014128655A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Sasmal&author=S.+Hosahalli&title=Substituted+Imidazo%5B4%2C5-c%5Dquinoline+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSasmal%26aufirst%3DS.%26atitle%3DSubstituted%2520Imidazo%255B4%252C5-c%255Dquinoline%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Sharma, R.; Kulkarni, S.; Kulkarni, M.; Mukherjee, S.; Yadav, R. K.; Agarwal, M.; Burudkar, S.; Sathe, S.</span><span> </span><span class="NLM_article-title">Imidazoquinoline Compounds as Bromodomain Inhibitors</span>. WO2015049629A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Sharma&author=S.+Kulkarni&author=M.+Kulkarni&author=S.+Mukherjee&author=R.+K.+Yadav&author=M.+Agarwal&author=S.+Burudkar&author=S.+Sathe&title=Imidazoquinoline+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26atitle%3DImidazoquinoline%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Albert, J. S.; Johnstone, S.; Jones, P.</span><span> </span><span class="NLM_article-title">Oxazolo[5,4-<i>c</i>]quinolin-2-One Compounds as Bromodomain Inhibitors</span>. WO2014152029A2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+S.+Albert&author=S.+Johnstone&author=P.+Jones&title=Oxazolo%5B5%2C4-c%5Dquinolin-2-One+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26atitle%3DOxazolo%255B5%252C4-c%255Dquinolin-2-One%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Ran, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaswamy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4927</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00613</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4927-4939&author=X.+Ranauthor=Y.+Zhaoauthor=L.+Liuauthor=L.+Baiauthor=C.-Y.+Yangauthor=B.+Zhouauthor=J.+L.+Meagherauthor=K.+Chinnaswamyauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Structure-Based+Design+of+%CE%B3-Carboline+Analogues+as+Potent+and+Specific+BET+Bromodomain+Inhibitors&doi=10.1021%2Facs.jmedchem.5b00613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors</span></div><div class="casAuthors">Ran, Xu; Zhao, Yujun; Liu, Liu; Bai, Longchuan; Yang, Chao-Yie; Zhou, Bing; Meagher, Jennifer L.; Chinnaswamy, Krishnapriya; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4927-4939</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of bromodomain and extra terminal proteins (BET), including BRD2, BRD3, and BRD4 proteins have therapeutic potential for the treatment of human cancers and other diseases and conditions.  In this paper, the authors report the design, synthesis, and evaluation of γ-carboline-contg. compds. as a new class of small-mol. BET inhibitors.  The most potent inhibitor I (RX-37) obtained from this study binds to BET bromodomain proteins (BRD2, BRD3, and BRD4) with Ki values of 3.2-24.7 nM and demonstrates high selectivity over other non-BET bromodomain-contg. proteins.  Compd. I potently and selectively inhibits cell growth in human acute leukemia cell lines harboring the rearranged mixed lineage leukemia 1 gene.  The authors have detd. a cocrystal structure of I in complex with BRD4 BD2 at 1.4 Å resoln., which provides a solid structural basis for the compd.'s high binding affinity and for its further structure-based optimization.  Compd. I represents a promising lead compd. for the development of a new class of therapeutics for the treatment of human cancer and other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-VCfWLBWYLVg90H21EOLACvtfcHk0lgL4DLSXNVgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVagu7rM&md5=e6e150169812e439c1d7d91416eb3ee9</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00613%26sid%3Dliteratum%253Aachs%26aulast%3DRan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-Based%2520Design%2520of%2520%25CE%25B3-Carboline%2520Analogues%2520as%2520Potent%2520and%2520Specific%2520BET%2520Bromodomain%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4927%26epage%3D4939%26doi%3D10.1021%2Facs.jmedchem.5b00613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Wang, S.; Ran, X.; Zhao, Y.; Yang, C.-Y.; Liu, L.; Bai, L.; McEachern, D.; Stuckey, J.; Meagher, J. L.; Sun, D.; Li, X.; Zhou, B.; Karatas, H.; Luo, R.; Chinnaiyan, A.; Asangani, I. A.</span><span> </span><span class="NLM_article-title">Bet Bromodomain Inhibitors and Therapeutic Methods Using the Same</span>. US20140256706A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Wang&author=X.+Ran&author=Y.+Zhao&author=C.-Y.+Yang&author=L.+Liu&author=L.+Bai&author=D.+McEachern&author=J.+Stuckey&author=J.+L.+Meagher&author=D.+Sun&author=X.+Li&author=B.+Zhou&author=H.+Karatas&author=R.+Luo&author=A.+Chinnaiyan&author=I.+A.+Asangani&title=Bet+Bromodomain+Inhibitors+and+Therapeutic+Methods+Using+the+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26atitle%3DBet%2520Bromodomain%2520Inhibitors%2520and%2520Therapeutic%2520Methods%2520Using%2520the%2520Same%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Poss, M. A.; Tortolani, D. R.; Dodd, D. S.; Mussari, C. P.; Tokarski, J. S.; Gavai, A. V.; Zhao, Y.; DeLucca, G. V.; OMalley, D.; Norris, D. J.; Gill, P.; Quesnelle, C. A.; Han, W.-C.</span><span> </span><span class="NLM_article-title">Carbazole Compounds Useful as Bromodomain Inhibitors</span>. US20140256700A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Poss&author=D.+R.+Tortolani&author=D.+S.+Dodd&author=C.+P.+Mussari&author=J.+S.+Tokarski&author=A.+V.+Gavai&author=Y.+Zhao&author=G.+V.+DeLucca&author=D.+OMalley&author=D.+J.+Norris&author=P.+Gill&author=C.+A.+Quesnelle&author=W.-C.+Han&title=Carbazole+Compounds+Useful+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DCarbazole%2520Compounds%2520Useful%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Poss, M. A.; Tortolani, D. R.; Purandare, A. V.; Tokarski, J. S.; Mussari, C. P.; Kamau, M. G.; Dodd, D. S.; Gavai, A. V.; OMalley, D.; Huynh, T. N.; Vaccaro, W.; Harikrishnan, L. S.</span><span> </span><span class="NLM_article-title">Carbazole Compounds Useful as Bromodomain Inhibitors</span>. WO2014134267A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+A.+Poss&author=D.+R.+Tortolani&author=A.+V.+Purandare&author=J.+S.+Tokarski&author=C.+P.+Mussari&author=M.+G.+Kamau&author=D.+S.+Dodd&author=A.+V.+Gavai&author=D.+OMalley&author=T.+N.+Huynh&author=W.+Vaccaro&author=L.+S.+Harikrishnan&title=Carbazole+Compounds+Useful+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPoss%26aufirst%3DM.%2BA.%26atitle%3DCarbazole%2520Compounds%2520Useful%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Aktoudianakis, I.; Chin, G.; Corkey, B. K.; Du, J.; Elbel, K.; Jiang, R. H.; Kobayashi, T.; Martinez, R.; Metobo, S. E.; Mish, M.; Shevick, S.; Sperandio, D.; Yang, H.; Zablocki, J.</span><span> </span><span class="NLM_article-title">Benzimidazolone Derivatives as Bromodomain Inhibitors</span>. WO2014160873A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=I.+Aktoudianakis&author=G.+Chin&author=B.+K.+Corkey&author=J.+Du&author=K.+Elbel&author=R.+H.+Jiang&author=T.+Kobayashi&author=R.+Martinez&author=S.+E.+Metobo&author=M.+Mish&author=S.+Shevick&author=D.+Sperandio&author=H.+Yang&author=J.+Zablocki&title=Benzimidazolone+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAktoudianakis%26aufirst%3DI.%26atitle%3DBenzimidazolone%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Babaoglu, K.; Corkey, B. K.; Jiang, R. H.; Sperandio, D.; Yang, H.</span><span> </span><span class="NLM_article-title">Quinoline Derivatives as Bromodomain Inhibitors</span>. US20150148344A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Babaoglu&author=B.+K.+Corkey&author=R.+H.+Jiang&author=D.+Sperandio&author=H.+Yang&title=Quinoline+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBabaoglu%26aufirst%3DK.%26atitle%3DQuinoline%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Duffy, B. C.; Liu, S.; Quinn, J. F.; Wang, R.; Jiang, M. X.; Martin, G. S.; Wagner, G. S.; Young, P. R.</span><span> </span><span class="NLM_article-title">Novel Bicyclic Bromodomain Inhibitors</span>. WO2015002754A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+C.+Duffy&author=S.+Liu&author=J.+F.+Quinn&author=R.+Wang&author=M.+X.+Jiang&author=G.+S.+Martin&author=G.+S.+Wagner&author=P.+R.+Young&title=Novel+Bicyclic+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26atitle%3DNovel%2520Bicyclic%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Liu, S.; Quinn, J. F.; Duffy, B. C.; Wang, R.; Jiang, M. X.; Martin, G. S.; Zhao, H.; Ellis, M.; Wagner, G. S.; Young, P. R.</span><span> </span><span class="NLM_article-title">Novel Substituted Bicyclic Compounds as Bromodomain Inhibitors</span>. WO2015004533A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Liu&author=J.+F.+Quinn&author=B.+C.+Duffy&author=R.+Wang&author=M.+X.+Jiang&author=G.+S.+Martin&author=H.+Zhao&author=M.+Ellis&author=G.+S.+Wagner&author=P.+R.+Young&title=Novel+Substituted+Bicyclic+Compounds+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DNovel%2520Substituted%2520Bicyclic%2520Compounds%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Zhang, J.; Buell, J.; Chan, K.; Ibrahim, P. N.; Lin, J.; Pham, P.; Shi, S.; Spevak, W.; Wu, G.; Wu, J.</span><span> </span><span class="NLM_article-title">Heterocyclic Compounds and Uses Thereof</span>. WO2014145051A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+Zhang&author=J.+Buell&author=K.+Chan&author=P.+N.+Ibrahim&author=J.+Lin&author=P.+Pham&author=S.+Shi&author=W.+Spevak&author=G.+Wu&author=J.+Wu&title=Heterocyclic+Compounds+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26atitle%3DHeterocyclic%2520Compounds%2520and%2520Uses%2520Thereof%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Ren, B.; Zhou, C.; Wang, H.</span><span> </span><span class="NLM_article-title">Substituted 5-(3,5-Dimethylisoxazol-4-yl)indoline-2-ones</span>. WO2014173241A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+Ren&author=C.+Zhou&author=H.+Wang&title=Substituted+5-%283%2C5-Dimethylisoxazol-4-yl%29indoline-2-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DB.%26atitle%3DSubstituted%25205-%25283%252C5-Dimethylisoxazol-4-yl%2529indoline-2-ones%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Engelhardt, H.; Gianni, D.; Mantoulidis, A.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Indolinone Analogues as BRD4 Inhibitors</span>. WO2014154760A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.+Engelhardt&author=D.+Gianni&author=A.+Mantoulidis&author=C.+Smethurst&title=Indolinone+Analogues+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DIndolinone%2520Analogues%2520as%2520BRD4%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Smethurst, C.; Engelhardt, H.; Gianni, D.; Reiser, U.</span><span> </span><span class="NLM_article-title">Dihydroquinazolinone Analogues as BRD4 Inhibitors</span>. WO2014154762A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Smethurst&author=H.+Engelhardt&author=D.+Gianni&author=U.+Reiser&title=Dihydroquinazolinone+Analogues+as+BRD4+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmethurst%26aufirst%3DC.%26atitle%3DDihydroquinazolinone%2520Analogues%2520as%2520BRD4%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Combs, A. P.; Yue, E. W.; Sparks, R. B.; Maduskuie, J. T. P.</span><span> </span><span class="NLM_article-title">Tricyclic Heterocycles as BET Protein Inhibitors</span>. US20150011540A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+P.+Combs&author=E.+W.+Yue&author=R.+B.+Sparks&author=J.+T.+P.+Maduskuie&title=Tricyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DTricyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Wang, L.; Dai, Y.; Holms, J.; Liu, D.; Mcclellan, W.; Mcdaniel, K.; Hasvold, L.; Fidanze, S. D.; Sheppard, G.; Marjanovic, J.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2014206150A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Wang&author=Y.+Dai&author=J.+Holms&author=D.+Liu&author=W.+Mcclellan&author=K.+Mcdaniel&author=L.+Hasvold&author=S.+D.+Fidanze&author=G.+Sheppard&author=J.+Marjanovic&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Wang, L.; Pratt, J. K.; Mcdaniel, K. F.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2013097052A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+Wang&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Wang, L.; Pratt, J. K.; Mcdaniel, K. F.; Dai, Y.; Fidanze, S. D.; Hasvold, L.; Holms, J. H.; Kati, W. M.; Liu, D.; Mantei, R. A.; Mcclellan, W. J.; Sheppard, G. S.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2013097601A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+Wang&author=J.+K.+Pratt&author=K.+F.+Mcdaniel&author=Y.+Dai&author=S.+D.+Fidanze&author=L.+Hasvold&author=J.+H.+Holms&author=W.+M.+Kati&author=D.+Liu&author=R.+A.+Mantei&author=W.+J.+Mcclellan&author=G.+S.+Sheppard&author=C.+K.+Wada&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Aamans, D.; Bamborough, P.; Barker, M. D.; Bit, R. A.; Brown, J. A.; Campbell, M.; Garton, N. S.; Lindon, M. J.; Shipley, T. J.; Theodoulou, N. H.; Wellaway, C. R.; Westaway, S. M.</span><span> </span><span class="NLM_article-title">Furopyridines as Bromodomain Inhibitors</span>. WO2014140077A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Aamans&author=P.+Bamborough&author=M.+D.+Barker&author=R.+A.+Bit&author=J.+A.+Brown&author=M.+Campbell&author=N.+S.+Garton&author=M.+J.+Lindon&author=T.+J.+Shipley&author=N.+H.+Theodoulou&author=C.+R.+Wellaway&author=S.+M.+Westaway&title=Furopyridines+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAamans%26aufirst%3DD.%26atitle%3DFuropyridines%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Amans, D.; Bamborough, P.; Bit, R. A.; Brown, J. A.; Campbell, M.; Lindon, M. J.; Shipley, T. J.; Theodoulou, N. H.; Wellaway, C. R.; Westaway, S. M.</span><span> </span><span class="NLM_article-title">Thieno[3,2-<i>c</i>]Pyridin-4(5<i>H</i>)-ones as BET Inhibitors</span>. WO2014078257A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=P.+Bamborough&author=R.+A.+Bit&author=J.+A.+Brown&author=M.+Campbell&author=M.+J.+Lindon&author=T.+J.+Shipley&author=N.+H.+Theodoulou&author=C.+R.+Wellaway&author=S.+M.+Westaway&title=Thieno%5B3%2C2-c%5DPyridin-4%285H%29-ones+as+BET+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3DThieno%255B3%252C2-c%255DPyridin-4%25285H%2529-ones%2520as%2520BET%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Bogdan, A.; Kati, W. M.; Mcdaniel, K. F.; Park, C. H.; Sheppard, G. S.; Wang, L.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20150158873A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Bogdan&author=W.+M.+Kati&author=K.+F.+Mcdaniel&author=C.+H.+Park&author=G.+S.+Sheppard&author=L.+Wang&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Wang, L.; Frey, R. R.; Hansen, T. M.; Liu, D.; Mcclellan, W. J.; Mcdaniel, K. F.; Pratt, J. K.; Wada, C. K.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2015085925A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Wang&author=R.+R.+Frey&author=T.+M.+Hansen&author=D.+Liu&author=W.+J.+Mcclellan&author=K.+F.+Mcdaniel&author=J.+K.+Pratt&author=C.+K.+Wada&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Fidanze, S. D.; Liu, D.; Mantei, R. A.; Mcdaniel, K. F.; Pratt, J.; Sheppard, G. S.; Wang, L.; Bogdan, A.; Holms, J. H.; Dietrich, J. D.; Marjanovic, J.; Hasvold, L. A.; Dai, Y.</span><span> </span><span class="NLM_article-title">Tetracyclic Bromodomain Inhibitors</span>. WO2014139324A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+D.+Fidanze&author=D.+Liu&author=R.+A.+Mantei&author=K.+F.+Mcdaniel&author=J.+Pratt&author=G.+S.+Sheppard&author=L.+Wang&author=A.+Bogdan&author=J.+H.+Holms&author=J.+D.+Dietrich&author=J.+Marjanovic&author=L.+A.+Hasvold&author=Y.+Dai&title=Tetracyclic+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26atitle%3DTetracyclic%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Liu, D.; Pratt, J.; Wang, L.; Hasvold, L. A.; Bogdan, A.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20140256710A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Liu&author=J.+Pratt&author=L.+Wang&author=L.+A.+Hasvold&author=A.+Bogdan&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Mcdaniel, K. F.; Pratt, J.; Sheppard, G. S.; Wada, C. K.; Woller, K. R.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. US20140256705A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=D.+Liu&author=K.+F.+Mcdaniel&author=J.+Pratt&author=G.+S.+Sheppard&author=C.+K.+Wada&author=K.+R.+Woller&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Jutta, B.; Bold, G.; Bordas, V.; Cotesta, S.; Guagnano, V.; Rueger, H.; Vaupel, A.</span><span> </span><span class="NLM_article-title">Pyrrolopyrrolone Derivatives and Their Use as BET Inhibitors</span>. WO2015075665A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=B.+Jutta&author=G.+Bold&author=V.+Bordas&author=S.+Cotesta&author=V.+Guagnano&author=H.+Rueger&author=A.+Vaupel&title=Pyrrolopyrrolone+Derivatives+and+Their+Use+as+BET+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJutta%26aufirst%3DB.%26atitle%3DPyrrolopyrrolone%2520Derivatives%2520and%2520Their%2520Use%2520as%2520BET%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Yue, E. W.; Combs, A. P.</span><span> </span><span class="NLM_article-title">Bicyclic Heterocycles as BET Protein Inhibitors</span>. US20150148372A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+W.+Yue&author=A.+P.+Combs&title=Bicyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26atitle%3DBicyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Yue, E. W.; Combs, A. P.; Douty, B.</span><span> </span><span class="NLM_article-title">Bicyclic Heterocycles as BET Protein Inhibitors</span>. US20150148342A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+W.+Yue&author=A.+P.+Combs&author=B.+Douty&title=Bicyclic+Heterocycles+as+BET+Protein+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYue%26aufirst%3DE.%2BW.%26atitle%3DBicyclic%2520Heterocycles%2520as%2520BET%2520Protein%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Engelhardt, H.; Martin, L.; Smethurst, C.</span><span> </span><span class="NLM_article-title">Pyridinones</span>. WO2015022332A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Engelhardt&author=L.+Martin&author=C.+Smethurst&title=Pyridinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DEngelhardt%26aufirst%3DH.%26atitle%3DPyridinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Bennett, M. J.; Betancort, J. M.; Boloor, A.; Kaldor, S. W.; Stafford, J. A.; Veal, J. M.</span><span> </span><span class="NLM_article-title">Bromodomain Inhibitors</span>. WO2015058160A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.+J.+Bennett&author=J.+M.+Betancort&author=A.+Boloor&author=S.+W.+Kaldor&author=J.+A.+Stafford&author=J.+M.+Veal&title=Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DM.%2BJ.%26atitle%3DBromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Ujjinamatada, R. K.; Hosahalli, S.; Samajdar, S.; Abbineni, C.</span><span> </span><span class="NLM_article-title">Spiro[cyclobutane-1,3′-indolin]-2′-one Derivatives as Bromodomain Inhibitors</span>. WO2015092118A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+K.+Ujjinamatada&author=S.+Hosahalli&author=S.+Samajdar&author=C.+Abbineni&title=Spiro%5Bcyclobutane-1%2C3%E2%80%B2-indolin%5D-2%E2%80%B2-one+Derivatives+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUjjinamatada%26aufirst%3DR.%2BK.%26atitle%3DSpiro%255Bcyclobutane-1%252C3%25E2%2580%25B2-indolin%255D-2%25E2%2580%25B2-one%2520Derivatives%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Schmees, N.; Haendler, B.; Stöckigt, D.; Gallenkamp, D.; Bissel, A.; Bouglas, A.</span><span> </span><span class="NLM_article-title">Modified BET-Protein-Inhibiting Dihydroquinoxalinones and Dihydropyridopyrazinones</span>. WO2015004075A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=N.+Schmees&author=B.+Haendler&author=D.+St%C3%B6ckigt&author=D.+Gallenkamp&author=A.+Bissel&author=A.+Bouglas&title=Modified+BET-Protein-Inhibiting+Dihydroquinoxalinones+and+Dihydropyridopyrazinones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchmees%26aufirst%3DN.%26atitle%3DModified%2520BET-Protein-Inhibiting%2520Dihydroquinoxalinones%2520and%2520Dihydropyridopyrazinones%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Steegmaier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lénárt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petronczki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krššák, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gürtler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garin-Chesa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grauert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adolf, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraut, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rettig, W. J.</span><span> </span><span class="NLM_article-title">BI 2536, a Potent and Selective Inhibitor of Polo-Like Kinase 1, Inhibits Tumor Growth in Vivo</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span><span class="refDoi"> DOI: 10.1016/j.cub.2006.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.cub.2006.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=17291758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=316-322&author=M.+Steegmaierauthor=M.+Hoffmannauthor=A.+Baumauthor=P.+L%C3%A9n%C3%A1rtauthor=M.+Petronczkiauthor=M.+Kr%C5%A1%C5%A1%C3%A1kauthor=U.+G%C3%BCrtlerauthor=P.+Garin-Chesaauthor=S.+Liebauthor=J.+Quantauthor=M.+Grauertauthor=G.+R.+Adolfauthor=N.+Krautauthor=J.-M.+Petersauthor=W.+J.+Rettig&title=BI+2536%2C+a+Potent+and+Selective+Inhibitor+of+Polo-Like+Kinase+1%2C+Inhibits+Tumor+Growth+in+Vivo&doi=10.1016%2Fj.cub.2006.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo</span></div><div class="casAuthors">Steegmaier, Martin; Hoffmann, Matthias; Baum, Anke; Lenart, Peter; Petronczki, Mark; Krssak, Martin; Guertler, Ulrich; Garin-Chesa, Pilar; Lieb, Simone; Quant, Jens; Grauert, Matthias; Adolf, Guenther R.; Kraut, Norbert; Peters, Jan-Michael; Rettig, Wolfgang J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">316-322</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Fine-mapping of the cell-division cycle, notably the identification of mitotic kinase signaling pathways, provides novel opportunities for cancer-drug discovery.  As a key regulator of multiple steps during mitotic progression across eukaryotic species, the serine/threonine-specific Polo-like kinase 1 (Plk1) is highly expressed in malignant cells and serves as a neg. prognostic marker in specific human cancer types .  Here, we report the discovery of a potent small-mol. inhibitor of mammalian Plk1, BI 2536, which inhibits Plk1 enzyme activity at low nanomolar concns.  The compd. potently causes a mitotic arrest and induces apoptosis in human cancer cell lines of diverse tissue origin and oncogenome signature.  BI 2536 inhibits growth of human tumor xenografts in nude mice and induces regression of large tumors with well-tolerated i.v. dose regimens.  In treated tumors, cells arrest in prometaphase, accumulate phosphohistone H3, and contain aberrant mitotic spindles.  This mitotic arrest is followed by a surge in apoptosis, detectable by immunohistochem. and noninvasive optical and magnetic resonance imaging.  For addressing the therapeutic potential of Plk1 inhibition, BI 2536 has progressed into clin. studies in patients with locally advanced or metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eEWnSYWORbVg90H21EOLACvtfcHk0lhrzc1FBfoXGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjtbg%253D&md5=49807e335b4ab8cf8209b55597fc7b4e</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2006.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2006.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DSteegmaier%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DBaum%26aufirst%3DA.%26aulast%3DL%25C3%25A9n%25C3%25A1rt%26aufirst%3DP.%26aulast%3DPetronczki%26aufirst%3DM.%26aulast%3DKr%25C5%25A1%25C5%25A1%25C3%25A1k%26aufirst%3DM.%26aulast%3DG%25C3%25BCrtler%26aufirst%3DU.%26aulast%3DGarin-Chesa%26aufirst%3DP.%26aulast%3DLieb%26aufirst%3DS.%26aulast%3DQuant%26aufirst%3DJ.%26aulast%3DGrauert%26aufirst%3DM.%26aulast%3DAdolf%26aufirst%3DG.%2BR.%26aulast%3DKraut%26aufirst%3DN.%26aulast%3DPeters%26aufirst%3DJ.-M.%26aulast%3DRettig%26aufirst%3DW.%2BJ.%26atitle%3DBI%25202536%252C%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Polo-Like%2520Kinase%25201%252C%2520Inhibits%2520Tumor%2520Growth%2520in%2520Vivo%26jtitle%3DCurr.%2520Biol.%26date%3D2007%26volume%3D17%26spage%3D316%26epage%3D322%26doi%3D10.1016%2Fj.cub.2006.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Ember, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olesen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berndt, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georg, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span> </span><span class="NLM_article-title">Acetyl-Lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span><span class="refDoi"> DOI: 10.1021/cb500072z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500072z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1160-1171&author=S.+W.+J.+Emberauthor=J.-Y.+Zhuauthor=S.+H.+Olesenauthor=M.+P.+Martinauthor=A.+Beckerauthor=N.+Berndtauthor=G.+I.+Georgauthor=E.+Sch%C3%B6nbrunn&title=Acetyl-Lysine+Binding+Site+of+Bromodomain-Containing+Protein+4+%28BRD4%29+Interacts+with+Diverse+Kinase+Inhibitors&doi=10.1021%2Fcb500072z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors</span></div><div class="casAuthors">Ember, Stuart W. J.; Zhu, Jin-Yi; Olesen, Sanne H.; Martin, Mathew P.; Becker, Andreas; Berndt, Norbert; Georg, Gunda I.; Schonbrunn, Ernst</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1160-1171</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the bromodomain and extra terminal (BET) family of proteins are essential for the recognition of acetylated lysine (KAc) residues in histones and have emerged as promising drug targets in cancer, inflammation, and contraception research.  In co-crystn. screening campaigns using the first bromodomain of BRD4 (BRD4-1) against kinase inhibitor libraries, we identified and characterized 14 kinase inhibitors (10 distinct chem. scaffolds) as ligands of the KAc binding site.  Among these, the PLK1 inhibitor BI2536 and the JAK2 inhibitor TG101209 displayed strongest inhibitory potential against BRD4 (IC50 = 25 nM and 130 nM, resp.) and high selectivity for BET bromodomains.  Comparative structural anal. revealed markedly different binding modes of kinase hinge-binding scaffolds in the KAc binding site, suggesting that BET proteins are potential off-targets of diverse kinase inhibitors.  Combined, these findings provide a new structural framework for the rational design of next-generation BET-selective and dual-activity BET-kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf0X1hjt7cBbVg90H21EOLACvtfcHk0likxEhKhpC_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1ymt7g%253D&md5=5ca37df00cdaa0ba81c0cb4a0f70ba5d</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1021%2Fcb500072z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500072z%26sid%3Dliteratum%253Aachs%26aulast%3DEmber%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.-Y.%26aulast%3DOlesen%26aufirst%3DS.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DBecker%26aufirst%3DA.%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DGeorg%26aufirst%3DG.%2BI.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26atitle%3DAcetyl-Lysine%2520Binding%2520Site%2520of%2520Bromodomain-Containing%2520Protein%25204%2520%2528BRD4%2529%2520Interacts%2520with%2520Diverse%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1160%26epage%3D1171%26doi%3D10.1021%2Fcb500072z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Gosmini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J.-M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riou-Eymard, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursier, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trottet, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soden, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicodeme, E.</span><span> </span><span class="NLM_article-title">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8111</span><span class="NLM_x">–</span> <span class="NLM_lpage">8131</span><span class="refDoi"> DOI: 10.1021/jm5010539</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5010539" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8111-8131&author=R.+Gosminiauthor=V.-L.+Nguyenauthor=J.+Toumauthor=C.+Simonauthor=J.-M.+G.+Brusqauthor=G.+Krysaauthor=O.+Mirguetauthor=A.+M.+Riou-Eymardauthor=E.+V.+Boursierauthor=L.+Trottetauthor=P.+Bamboroughauthor=H.+Clarkauthor=C.-W.+Chungauthor=L.+Cutlerauthor=E.+H.+Demontauthor=R.+Kaurauthor=A.+J.+Lewisauthor=M.+B.+Schillingauthor=P.+E.+Sodenauthor=S.+Taylorauthor=A.+L.+Walkerauthor=M.+D.+Walkerauthor=R.+K.+Prinjhaauthor=E.+Nicodeme&title=The+Discovery+of+I-BET726+%28GSK1324726A%29%2C+a+Potent+Tetrahydroquinoline+ApoA1+Up-Regulator+and+Selective+BET+Bromodomain+Inhibitor&doi=10.1021%2Fjm5010539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of I-BET726 (GSK1324726A), a Potent Tetrahydroquinoline ApoA1 Up-Regulator and Selective BET Bromodomain Inhibitor</span></div><div class="casAuthors">Gosmini, Romain; Nguyen, Van Loc; Toum, Jerome; Simon, Christophe; Brusq, Jean-Marie G.; Krysa, Gael; Mirguet, Olivier; Riou-Eymard, Alizon M.; Boursier, Eric V.; Trottet, Lionel; Bamborough, Paul; Clark, Hugh; Chung, Chun-wa; Cutler, Leanne; Demont, Emmanuel H.; Kaur, Rejbinder; Lewis, Antonia J.; Schilling, Mark B.; Soden, Peter E.; Taylor, Simon; Walker, Ann L.; Walker, Matthew D.; Prinjha, Rab K.; Nicodeme, Edwige</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8111-8131</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through their function as epigenetic readers of the histone code, the BET family of bromodomain-contg. proteins regulate expression of multiple genes of therapeutic relevance, including those involved in tumor cell growth and inflammation.  BET bromodomain inhibitors have profound antiproliferative and anti-inflammatory effects which translate into efficacy in oncol. and inflammation models, and the first compds. have now progressed into clin. trials.  The exciting biol. of the BETs has led to great interest in the discovery of novel inhibitor classes.  Here we describe the identification of a novel tetrahydroquinoline series through up-regulation of apolipoprotein A1 and the optimization into potent compds. active in murine models of septic shock and neuroblastoma.  At the mol. level, these effects are produced by inhibition of BET bromodomains.  X-ray crystallog. reveals the interactions explaining the structure-activity relationships of binding.  The resulting lead mol., I-BET726, represents a new, potent, and selective class of tetrahydroquinoline-based BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5OdMn_TjoFLVg90H21EOLACvtfcHk0likxEhKhpC_dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wlur7J&md5=b1c9c9cae73c41252cf73908d561bd9b</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm5010539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5010539%26sid%3Dliteratum%253Aachs%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DNguyen%26aufirst%3DV.-L.%26aulast%3DToum%26aufirst%3DJ.%26aulast%3DSimon%26aufirst%3DC.%26aulast%3DBrusq%26aufirst%3DJ.-M.%2BG.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DRiou-Eymard%26aufirst%3DA.%2BM.%26aulast%3DBoursier%26aufirst%3DE.%2BV.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DCutler%26aufirst%3DL.%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DKaur%26aufirst%3DR.%26aulast%3DLewis%26aufirst%3DA.%2BJ.%26aulast%3DSchilling%26aufirst%3DM.%2BB.%26aulast%3DSoden%26aufirst%3DP.%2BE.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWalker%26aufirst%3DM.%2BD.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DNicodeme%26aufirst%3DE.%26atitle%3DThe%2520Discovery%2520of%2520I-BET726%2520%2528GSK1324726A%2529%252C%2520a%2520Potent%2520Tetrahydroquinoline%2520ApoA1%2520Up-Regulator%2520and%2520Selective%2520BET%2520Bromodomain%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8111%26epage%3D8131%26doi%3D10.1021%2Fjm5010539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Amans, D.; Atkinson, S. J.; Harrison, L. A.; Hirst, D. J.; Law, R. P.; Lindon, M.; Preston, A.; Seal, J. T.; Wellaway, C. R.</span><span> </span><span class="NLM_article-title">2,3-Disubstituted 1-Acyl-4-amino-1,2,3,4-tetrahydroquinoline Derivatives and Their Use as Bromodomain Inhibitors</span>. WO2014140076A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+Amans&author=S.+J.+Atkinson&author=L.+A.+Harrison&author=D.+J.+Hirst&author=R.+P.+Law&author=M.+Lindon&author=A.+Preston&author=J.+T.+Seal&author=C.+R.+Wellaway&title=2%2C3-Disubstituted+1-Acyl-4-amino-1%2C2%2C3%2C4-tetrahydroquinoline+Derivatives+and+Their+Use+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmans%26aufirst%3DD.%26atitle%3D2%252C3-Disubstituted%25201-Acyl-4-amino-1%252C2%252C3%252C4-tetrahydroquinoline%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. E. R.; Talbot, A. C.; Tebbe, M. J.</span><span> </span><span class="NLM_article-title">Benzopiperazine Compositions as BET Bromodomain Inhibitors</span>. WO2015074081A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+E.+R.+Schiller&author=A.+C.+Talbot&author=M.+J.+Tebbe&title=Benzopiperazine+Compositions+as+BET+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DBenzopiperazine%2520Compositions%2520as%2520BET%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Bair, K. W.; Herbertz, T.; Kauffman, G. S.; Kayser-Bricker, K. J.; Luke, G. P.; Martin, M. W.; Millan, D. S.; Schiller, S. E. R.; Talbot, A. C.</span><span> </span><span class="NLM_article-title">Tetrahydroquinoline Compositions as BET Bromodomain Inhibitors</span>. WO2015074064A2,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+W.+Bair&author=T.+Herbertz&author=G.+S.+Kauffman&author=K.+J.+Kayser-Bricker&author=G.+P.+Luke&author=M.+W.+Martin&author=D.+S.+Millan&author=S.+E.+R.+Schiller&author=A.+C.+Talbot&title=Tetrahydroquinoline+Compositions+as+BET+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBair%26aufirst%3DK.%2BW.%26atitle%3DTetrahydroquinoline%2520Compositions%2520as%2520BET%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Siegel, S.; Baurle, S.; Cleve, A.; Haendler, B.; Fernandez-Montalvan, A. E.; Monning, U.; Krause, S.; Lejeune, P.; Busemann, M.; Kuhnke, J.</span><span> </span><span class="NLM_article-title">Bicyclo 2,3-Benzodiazepines and Spirocyclically Substituted 2,3-Benzodiazepines</span>. WO2014128067A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Siegel&author=S.+Baurle&author=A.+Cleve&author=B.+Haendler&author=A.+E.+Fernandez-Montalvan&author=U.+Monning&author=S.+Krause&author=P.+Lejeune&author=M.+Busemann&author=J.+Kuhnke&title=Bicyclo+2%2C3-Benzodiazepines+and+Spirocyclically+Substituted+2%2C3-Benzodiazepines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DS.%26atitle%3DBicyclo%25202%252C3-Benzodiazepines%2520and%2520Spirocyclically%2520Substituted%25202%252C3-Benzodiazepines%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Hasvold, L. A.; Liu, D.; Pratt, J. K.; Sheppard, G. S.; McDaniel, K. F.; Elmore, S. W.; Hubbard, R. D.</span><span> </span><span class="NLM_article-title">Pyrrole Amide Inhibitors</span>. US20140275079A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+A.+Hasvold&author=D.+Liu&author=J.+K.+Pratt&author=G.+S.+Sheppard&author=K.+F.+McDaniel&author=S.+W.+Elmore&author=R.+D.+Hubbard&title=Pyrrole+Amide+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26atitle%3DPyrrole%2520Amide%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Günther, S.; Lucas, X.; Jung, M.; Einsle, O.; Wohlwend, D.; Gerhardt, S.</span><span> </span><span class="NLM_article-title">Compounds for Use as Bromodomain Inhibitors</span>. WO2014170350A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+G%C3%BCnther&author=X.+Lucas&author=M.+Jung&author=O.+Einsle&author=D.+Wohlwend&author=S.+Gerhardt&title=Compounds+for+Use+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25BCnther%26aufirst%3DS.%26atitle%3DCompounds%2520for%2520Use%2520as%2520Bromodomain%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Zhou, M.-M.; Ohlmeyer, M.; Vincek, A.; Zaware, N.</span><span> </span><span class="NLM_article-title">Cyclic Vinylogous Amides as Bromodomain Inhibitors</span>. WO2015031824A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=M.-M.+Zhou&author=M.+Ohlmeyer&author=A.+Vincek&author=N.+Zaware&title=Cyclic+Vinylogous+Amides+as+Bromodomain+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DCyclic%2520Vinylogous%2520Amides%2520as%2520Bromodomain%2520Inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujikawa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fontano, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, N. C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span> </span><span class="NLM_article-title">RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e83190</span><span class="refDoi"> DOI: 10.1371/journal.pone.0083190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1371%2Fjournal.pone.0083190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24391744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Wju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e83190&author=K.+G.+McLureauthor=E.+M.+Gesnerauthor=L.+Tsujikawaauthor=O.+A.+Kharenkoauthor=S.+Attwellauthor=E.+Campeauauthor=S.+Wasiakauthor=A.+Steinauthor=A.+Whiteauthor=E.+Fontanoauthor=R.+K.+Sutoauthor=N.+C.+W.+Wongauthor=G.+S.+Wagnerauthor=H.+C.+Hansenauthor=P.+R.+Young&title=RVX-208%2C+an+Inducer+of+ApoA-I+in+Humans%2C+Is+a+BET+Bromodomain+Antagonist&doi=10.1371%2Fjournal.pone.0083190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist</span></div><div class="casAuthors">McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e83190/1-e83190/12, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Increased synthesis of Apolipoprotein A-I (ApoA-I) and HDL is believed to provide a new approach to treating atherosclerosis through the stimulation of reverse cholesterol transport.  RVX-208 increases the prodn. of ApoA-I in hepatocytes in vitro and in vivo in monkeys and humans, which results in increased HDL-C, but the mol. target was not previously reported.  Using binding assays and X-ray crystallog., we now show that RVX-208 selectively binds to bromodomains of the BET (Bromodomain and Extra Terminal) family, competing for a site bound by the endogenous ligand, acetylated lysine and that this accounts for its pharmacol. activity. siRNA expts. further suggest that induction of ApoA-I mRNA is mediated by BET family member BRD4.  These data indicate that RVX-208 increases ApoA-I prodn. through an epigenetic mechanism and suggests that BET inhibition may be a promising new approach to the treatment of atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLHPlAY0x6NLVg90H21EOLACvtfcHk0ljOU3oH30gtaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Wju78%253D&md5=519ef7ed6d06f97ef8a1359832c11d92</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0083190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0083190%26sid%3Dliteratum%253Aachs%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DTsujikawa%26aufirst%3DL.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DAttwell%26aufirst%3DS.%26aulast%3DCampeau%26aufirst%3DE.%26aulast%3DWasiak%26aufirst%3DS.%26aulast%3DStein%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DFontano%26aufirst%3DE.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DWong%26aufirst%3DN.%2BC.%2BW.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26atitle%3DRVX-208%252C%2520an%2520Inducer%2520of%2520ApoA-I%2520in%2520Humans%252C%2520Is%2520a%2520BET%2520Bromodomain%2520Antagonist%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De83190%26doi%3D10.1371%2Fjournal.pone.0083190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felletar, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotherton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez-Dacal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span> </span><span class="NLM_article-title">RVX-208, an Inhibitor of BET Transcriptional Regulators with Selectivity for the Second Bromodomain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">19754</span><span class="NLM_x">–</span> <span class="NLM_lpage">19759</span><span class="refDoi"> DOI: 10.1073/pnas.1310658110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1310658110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24248379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19754-19759&author=S.+Picaudauthor=C.+Wellsauthor=I.+Felletarauthor=D.+Brothertonauthor=S.+Martinauthor=P.+Savitskyauthor=B.+Diez-Dacalauthor=M.+Philpottauthor=C.+Bountraauthor=H.+Lingardauthor=O.+Fedorovauthor=S.+M%C3%BCllerauthor=P.+E.+Brennanauthor=S.+Knappauthor=P.+Filippakopoulos&title=RVX-208%2C+an+Inhibitor+of+BET+Transcriptional+Regulators+with+Selectivity+for+the+Second+Bromodomain&doi=10.1073%2Fpnas.1310658110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain</span></div><div class="casAuthors">Picaud, Sarah; Wells, Christopher; Felletar, Ildiko; Brotherton, Deborah; Martin, Sarah; Savitsky, Pavel; Diez-Dacal, Beatriz; Philpott, Martin; Bountra, Chas; Lingard, Hannah; Fedorov, Oleg; Muller, Susanne; Brennan, Paul E.; Knapp, Stefan; Filippakopoulos, Panagis</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19754-19759,S19754/1-S19754/10</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bromodomains have emerged as attractive candidates for the development of inhibitors targeting gene transcription.  Inhibitors of the bromo and extraterminal (BET) family recently showed promising activity in diverse disease models.  However, the pleiotropic nature of BET proteins regulating tissue-specific transcription has raised safety concerns and suggested that attempts should be made for domain-specific targeting.  Here, we report that RVX-208, a compd. currently in phase II clin. trials, is a BET bromodomain inhibitor specific for second bromodomains (BD2s).  Cocrystal structures revealed binding modes of RVX-208 and its synthetic precursor, and fluorescent recovery after photobleaching demonstrated that RVX-208 displaces BET proteins from chromatin.  However, gene-expression data showed that BD2 inhibition only modestly affects BET-dependent gene transcription.  Our data demonstrate the feasibility of specific targeting within the BET family resulting in different transcriptional outcomes and highlight the importance of BD1 in transcriptional regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqamW8vnIopKrVg90H21EOLACvtfcHk0ljOU3oH30gtaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKms7zN&md5=c918702c9fdb91241bc837732730f7f6</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1310658110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1310658110%26sid%3Dliteratum%253Aachs%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DFelletar%26aufirst%3DI.%26aulast%3DBrotherton%26aufirst%3DD.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSavitsky%26aufirst%3DP.%26aulast%3DDiez-Dacal%26aufirst%3DB.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DLingard%26aufirst%3DH.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26atitle%3DRVX-208%252C%2520an%2520Inhibitor%2520of%2520BET%2520Transcriptional%2520Regulators%2520with%2520Selectivity%2520for%2520the%2520Second%2520Bromodomain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19754%26epage%3D19759%26doi%3D10.1073%2Fpnas.1310658110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Noguchi-Yachide, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span> </span><span class="NLM_article-title">Discovery and Structure-Activity Relationship Studies of <i>N</i>6-Benzoyladenine Derivatives as Novel BRD4 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.01.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmc.2015.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25678016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=953-959&author=T.+Noguchi-Yachideauthor=T.+Sakaiauthor=Y.+Hashimotoauthor=T.+Yamaguchi&title=Discovery+and+Structure-Activity+Relationship+Studies+of+N6-Benzoyladenine+Derivatives+as+Novel+BRD4+Inhibitors&doi=10.1016%2Fj.bmc.2015.01.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors</span></div><div class="casAuthors">Noguchi-Yachide, Tomomi; Sakai, Taki; Hashimoto, Yuichi; Yamaguchi, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">953-959</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that bind to acetylated lysines in histones.  Among them, BRD4 is a candidate target mol. of therapeutic agents for diverse diseases, including cancer and inflammatory disease.  As a part of the continuing structural development studies of thalidomide to obtain a broad spectrum of biol. modifiers based on the 'multitemplate' approach, in this work the authors focused on BRD4-inhibitory activity, and discovered that N6-benzoyladenine derivs. exhibit this activity.  Structure-activity relationship studies led to N6-(2,4,5-trimethoxybenzoyl)adenine I, which exhibits potent BRD4 bromodomain1 inhibitory activity with an IC50 value of 0.427 μM.  N6-Benzoyladenine appears to be a new chem. scaffold for development of BRD4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDwaLfpkAET7Vg90H21EOLACvtfcHk0liMiQ_Eak2W2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslertLs%253D&md5=889cf81c25fd1e62def22cb2f32dc06e</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi-Yachide%26aufirst%3DT.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520and%2520Structure-Activity%2520Relationship%2520Studies%2520of%2520N6-Benzoyladenine%2520Derivatives%2520as%2520Novel%2520BRD4%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D953%26epage%3D959%26doi%3D10.1016%2Fj.bmc.2015.01.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref300"><div class="reference"><strong class="refLabel"><a href="#ref300" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit300"><span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikov, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusinova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morohashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshua, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mujtaba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span> </span><span class="NLM_article-title">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9251</span><span class="NLM_x">–</span> <span class="NLM_lpage">9264</span><span class="refDoi"> DOI: 10.1021/jm401334s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401334s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref300/cit300&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9251-9264&author=G.+Zhangauthor=A.+N.+Plotnikovauthor=E.+Rusinovaauthor=T.+Shenauthor=K.+Morohashiauthor=J.+Joshuaauthor=L.+Zengauthor=S.+Mujtabaauthor=M.+Ohlmeyerauthor=M.-M.+Zhou&title=Structure-Guided+Design+of+Potent+Diazobenzene+Inhibitors+for+the+BET+Bromodomains&doi=10.1021%2Fjm401334s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit300R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains</span></div><div class="casAuthors">Zhang, Guangtao; Plotnikov, Alexander N.; Rusinova, Elena; Shen, Tong; Morohashi, Keita; Joshua, Jennifer; Zeng, Lei; Mujtaba, Shiraz; Ohlmeyer, Michael; Zhou, Ming-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9251-9264</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BRD4, characterized by two acetyl-lysine binding bromodomains and an extra-terminal (ET) domain, is a key chromatin organizer that directs gene activation in chromatin through transcription factor recruitment, enhancer assembly, and pause release of the RNA polymerase II complex for transcription elongation.  BRD4 has been recently validated as a new epigenetic drug target for cancer and inflammation.  Our current knowledge of the functional differences of the two bromodomains of BRD4, however, is limited and is hindered by the lack of selective inhibitors.  Here, we report our structure-guided development of diazobenzene-based small-mol. inhibitors for the BRD4 bromodomains that have over 90% sequence identity at the acetyl-lysine binding site.  Our lead compd., MS436, through a set of water-mediated interactions, exhibits low nanomolar affinity (estd. Ki of 30-50 nM), with preference for the first bromodomain over the second.  We demonstrated that MS436 effectively inhibits BRD4 activity in NF-κB-directed prodn. of nitric oxide and proinflammatory cytokine interleukin-6 in murine macrophages.  MS436 represents a new class of bromodomain inhibitors and will facilitate further investigation of the biol. functions of the two bromodomains of BRD4 in gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlT4IPx_3s7rVg90H21EOLACvtfcHk0liMiQ_Eak2W2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Ckt7jO&md5=24c7b50636fc4e0bbbfb80446e4dd23c</span></div><a href="/servlet/linkout?suffix=cit300&amp;dbid=16384&amp;doi=10.1021%2Fjm401334s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401334s%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DPlotnikov%26aufirst%3DA.%2BN.%26aulast%3DRusinova%26aufirst%3DE.%26aulast%3DShen%26aufirst%3DT.%26aulast%3DMorohashi%26aufirst%3DK.%26aulast%3DJoshua%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DMujtaba%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DM.-M.%26atitle%3DStructure-Guided%2520Design%2520of%2520Potent%2520Diazobenzene%2520Inhibitors%2520for%2520the%2520BET%2520Bromodomains%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9251%26epage%3D9264%26doi%3D10.1021%2Fjm401334s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Mishra, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urick, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ember, S. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schönbrunn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, W. C.</span><span> </span><span class="NLM_article-title">Fluorinated Aromatic Amino Acids Are Sensitive 19F NMR Probes for Bromodomain-Ligand Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2755</span><span class="NLM_x">–</span> <span class="NLM_lpage">2760</span><span class="refDoi"> DOI: 10.1021/cb5007344</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5007344" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=2755-2760&author=N.+K.+Mishraauthor=A.+K.+Urickauthor=S.+W.+J.+Emberauthor=E.+Sch%C3%B6nbrunnauthor=W.+C.+Pomerantz&title=Fluorinated+Aromatic+Amino+Acids+Are+Sensitive+19F+NMR+Probes+for+Bromodomain-Ligand+Interactions&doi=10.1021%2Fcb5007344"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated Aromatic Amino Acids Are Sensitive 19F NMR Probes for Bromodomain-Ligand Interactions</span></div><div class="casAuthors">Mishra, Neeraj K.; Urick, Andrew K.; Ember, Stuart W. J.; Schonbrunn, Ernst; Pomerantz, William C.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2755-2760</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe a 19F NMR method for detecting bromodomain-ligand interactions using fluorine-labeled arom. amino acids due to the conservation of arom. residues in the bromodomain binding site.  The authors test the sensitivity, accuracy, and speed of this method with small mol. ligands (+)-JQ1, BI2536, Dinaciclib, TG101348, and acetaminophen using three bromodomains Brd4, BrdT, and BPTF.  Simplified 19F NMR spectra allowed for simultaneous testing of multiple bromodomains to assess selectivity and identification of a new BPTF ligand.  Fluorine labeling only modestly affected the Brd4 structure and function assessed by isothermal titrn. calorimetry, CD, and x-ray crystallog.  The speed, ease of interpretation, and low concn. of protein needed for binding expts. affords a new method to discover and characterize both native and new ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoejxq3KKVddrVg90H21EOLACvtfcHk0liMiQ_Eak2W2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12gtLfP&md5=97f9edadc91cba8670f54bcca57fa03f</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fcb5007344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5007344%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DN.%2BK.%26aulast%3DUrick%26aufirst%3DA.%2BK.%26aulast%3DEmber%26aufirst%3DS.%2BW.%2BJ.%26aulast%3DSch%25C3%25B6nbrunn%26aufirst%3DE.%26aulast%3DPomerantz%26aufirst%3DW.%2BC.%26atitle%3DFluorinated%2520Aromatic%2520Amino%2520Acids%2520Are%2520Sensitive%252019F%2520NMR%2520Probes%2520for%2520Bromodomain-Ligand%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D2755%26epage%3D2760%26doi%3D10.1021%2Fcb5007344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gartenmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiliotopoulos, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span> </span><span class="NLM_article-title">Discovery of BRD4 Bromodomain Inhibitors by Fragment-Based High-Throughput Docking</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2493</span><span class="NLM_x">–</span> <span class="NLM_lpage">2496</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2014.04.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2493-2496&author=H.+Zhaoauthor=L.+Gartenmannauthor=J.+Dongauthor=D.+Spiliotopoulosauthor=A.+Caflisch&title=Discovery+of+BRD4+Bromodomain+Inhibitors+by+Fragment-Based+High-Throughput+Docking&doi=10.1016%2Fj.bmcl.2014.04.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.017%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGartenmann%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DSpiliotopoulos%26aufirst%3DD.%26aulast%3DCaflisch%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520BRD4%2520Bromodomain%2520Inhibitors%2520by%2520Fragment-Based%2520High-Throughput%2520Docking%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2493%26epage%3D2496%26doi%3D10.1016%2Fj.bmcl.2014.04.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Vidler, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomsett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">8073</span><span class="NLM_x">–</span> <span class="NLM_lpage">8088</span><span class="refDoi"> DOI: 10.1021/jm4011302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4011302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8073-8088&author=L.+R.+Vidlerauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+Picaudauthor=S.+Martinauthor=M.+Tomsettauthor=H.+Woodwardauthor=N.+Brownauthor=S.+Knappauthor=S.+Hoelder&title=Discovery+of+Novel+Small-Molecule+Inhibitors+of+BRD4+Using+Structure-Based+Virtual+Screening&doi=10.1021%2Fjm4011302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small-Molecule Inhibitors of BRD4 Using Structure-Based Virtual Screening</span></div><div class="casAuthors">Vidler, Lewis R.; Filippakopoulos, Panagis; Fedorov, Oleg; Picaud, Sarah; Martin, Sarah; Tomsett, Michael; Woodward, Hannah; Brown, Nathan; Knapp, Stefan; Hoelder, Swen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8073-8088</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bromodomains (BRDs) are epigenetic readers that recognize acetylated-lysine (KAc) on proteins and are implicated in a no. of diseases.  We describe a virtual screening approach to identify BRD inhibitors.  Key elements of this approach are the extensive design and use of substructure queries to compile a set of com. available compds. featuring novel putative KAc mimetics and docking this set for final compd. selection.  We describe the validation of this approach by applying it to the first BRD of BRD4.  The selection and testing of 143 compds. lead to the discovery of six novel hits, including four unprecedented KAc mimetics.  We solved the crystal structure of four hits, detd. their binding mode, and improved their potency through synthesis and the purchase of derivs.  This work provides a validated virtual screening approach that is applicable to other BRDs and describes novel KAc mimetics that can be further explored to design more potent inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow5yj8bnohUbVg90H21EOLACvtfcHk0lhIa9LPArgu2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOjurrI&md5=c1f76e4838713335be7a93ebe4c68701</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1021%2Fjm4011302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4011302%26sid%3Dliteratum%253Aachs%26aulast%3DVidler%26aufirst%3DL.%2BR.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DTomsett%26aufirst%3DM.%26aulast%3DWoodward%26aufirst%3DH.%26aulast%3DBrown%26aufirst%3DN.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Novel%2520Small-Molecule%2520Inhibitors%2520of%2520BRD4%2520Using%2520Structure-Based%2520Virtual%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D8073%26epage%3D8088%26doi%3D10.1021%2Fjm4011302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Zhao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, B.</span><span> </span><span class="NLM_article-title">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: 2. Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1297</span><span class="refDoi"> DOI: 10.1021/jm501504k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501504k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=1281-1297&author=L.+Zhaoauthor=Y.+Wangauthor=D.+Caoauthor=T.+Chenauthor=Q.+Wangauthor=Y.+Liauthor=Y.+Xuauthor=N.+Zhangauthor=X.+Wangauthor=D.+Chenauthor=L.+Chenauthor=Y.-L.+Chenauthor=G.+Xiaauthor=Z.+Shiauthor=Y.-C.+Liuauthor=Y.+Linauthor=Z.+Miaoauthor=J.+Shenauthor=B.+Xiong&title=Fragment-Based+Drug+Discovery+of+2-Thiazolidinones+as+BRD4+Inhibitors%3A+2.+Structure-Based+Optimization&doi=10.1021%2Fjm501504k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors: Structure-Based Optimization</span></div><div class="casAuthors">Zhao, Lele; Wang, Yingqing; Cao, Danyan; Chen, Tiantian; Wang, Qi; Li, Yanlian; Xu, Yechun; Zhang, Naixia; Wang, Xin; Chen, Danqi; Chen, Lin; Chen, Yue-Lei; Xia, Guangxin; Shi, Zhe; Liu, Yu-Chih; Lin, Yijyun; Miao, Zehong; Shen, Jingkang; Xiong, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1281-1297</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The signal transduction of acetylated histone can be processed through a recognition module, bromodomain.  Several inhibitors targeting BRD4, one of the bromodomain members, are in clin. trials as anticancer drugs.  Hereby, the authors report the efforts on discovery and optimization of a new series of 2-thiazolidinones as BRD4 inhibitors along the previous study.  In this work, guided by crystal structure anal., the authors reversed the sulfonamide group and identified a new binding mode.  A structure-activity relationship study on this new series led to several potent BRD4 inhibitors with IC50 of about 0.05-0.1 μM in FP binding assay and GI50 of 0.1-0.3 μM in cell based assays.  To complete the lead-like assessment of this series, the authors further checked its effects on BRD4 downstream protein c-Myc, investigated its selectivity among five different bromodomain proteins, as well as the metabolic stability test, and reinforced the utility of 2-thiazolidinone scaffold as BET bromodomain inhibitors in novel anticancer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4x-5lE2iPzbVg90H21EOLACvtfcHk0lhIa9LPArgu2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivFSqtw%253D%253D&md5=4056ac1a6d6598dc61be7cc7ef82a3da</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm501504k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501504k%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DB.%26atitle%3DFragment-Based%2520Drug%2520Discovery%2520of%25202-Thiazolidinones%2520as%2520BRD4%2520Inhibitors%253A%25202.%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D1281%26epage%3D1297%26doi%3D10.1021%2Fjm501504k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Duffy, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsia, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharenko, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLure, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakshminarasimhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suto, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitchen, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a New Chemical Series of BRD4(1) Inhibitors Using Protein-Ligand Docking and Structure-Guided Design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">2818</span><span class="NLM_x">–</span> <span class="NLM_lpage">2823</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.bmcl.2015.04.107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2818-2823&author=B.+C.+Duffyauthor=S.+Liuauthor=G.+S.+Martinauthor=R.+Wangauthor=M.+M.+Hsiaauthor=H.+Zhaoauthor=C.+Guoauthor=M.+Ellisauthor=J.+F.+Quinnauthor=O.+A.+Kharenkoauthor=K.+Norekauthor=E.+M.+Gesnerauthor=P.+R.+Youngauthor=K.+G.+McLureauthor=G.+S.+Wagnerauthor=D.+Lakshminarasimhanauthor=A.+Whiteauthor=R.+K.+Sutoauthor=H.+C.+Hansenauthor=D.+B.+Kitchen&title=Discovery+of+a+New+Chemical+Series+of+BRD4%281%29+Inhibitors+Using+Protein-Ligand+Docking+and+Structure-Guided+Design&doi=10.1016%2Fj.bmcl.2015.04.107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.107%26sid%3Dliteratum%253Aachs%26aulast%3DDuffy%26aufirst%3DB.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DG.%2BS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DHsia%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DM.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKharenko%26aufirst%3DO.%2BA.%26aulast%3DNorek%26aufirst%3DK.%26aulast%3DGesner%26aufirst%3DE.%2BM.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DMcLure%26aufirst%3DK.%2BG.%26aulast%3DWagner%26aufirst%3DG.%2BS.%26aulast%3DLakshminarasimhan%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DSuto%26aufirst%3DR.%2BK.%26aulast%3DHansen%26aufirst%3DH.%2BC.%26aulast%3DKitchen%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520New%2520Chemical%2520Series%2520of%2520BRD4%25281%2529%2520Inhibitors%2520Using%2520Protein-Ligand%2520Docking%2520and%2520Structure-Guided%2520Design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2818%26epage%3D2823%26doi%3D10.1016%2Fj.bmcl.2015.04.107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Philpott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yapp, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strain-Damerell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess-Brown, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span> </span><span class="NLM_article-title">Assessing Cellular Efficacy of Bromodomain Inhibitors Using Fluorescence Recovery After Photobleaching</span> <span class="citation_source-journal">Epigenet. Chromatin</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1186/1756-8935-7-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1186%2F1756-8935-7-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24393457" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1-12&author=M.+Philpottauthor=C.+M.+Rogersauthor=C.+Yappauthor=C.+Wellsauthor=J.-P.+Lambertauthor=C.+Strain-Damerellauthor=N.+A.+Burgess-Brownauthor=A.-C.+Gingrasauthor=S.+Knappauthor=S.+M%C3%BCller&title=Assessing+Cellular+Efficacy+of+Bromodomain+Inhibitors+Using+Fluorescence+Recovery+After+Photobleaching&doi=10.1186%2F1756-8935-7-14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1186%2F1756-8935-7-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-8935-7-14%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DJ.-P.%26aulast%3DStrain-Damerell%26aufirst%3DC.%26aulast%3DBurgess-Brown%26aufirst%3DN.%2BA.%26aulast%3DGingras%26aufirst%3DA.-C.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26atitle%3DAssessing%2520Cellular%2520Efficacy%2520of%2520Bromodomain%2520Inhibitors%2520Using%2520Fluorescence%2520Recovery%2520After%2520Photobleaching%26jtitle%3DEpigenet.%2520Chromatin%26date%3D2014%26volume%3D7%26spage%3D1%26epage%3D12%26doi%3D10.1186%2F1756-8935-7-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Huang, H.-R.; Sims, R. J.,  III; Bellon, S. F.</span><span> </span><span class="NLM_article-title">Fusion Proteins and Methods for Identifying Bromodomain Inhibiting Compounds</span>. WO2014144303A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=H.-R.+Huang&author=R.+J.+Sims&author=S.+F.+Bellon&title=Fusion+Proteins+and+Methods+for+Identifying+Bromodomain+Inhibiting+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.-R.%26atitle%3DFusion%2520Proteins%2520and%2520Methods%2520for%2520Identifying%2520Bromodomain%2520Inhibiting%2520Compounds%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodroofe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwinn, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Méndez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robers, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daniels, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkland, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. V.</span><span> </span><span class="NLM_article-title">NanoBRET—a Novel BRET Platform for the Analysis of Protein–Protein Interactions</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1797</span><span class="NLM_x">–</span> <span class="NLM_lpage">1804</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1797-1804&author=T.+Machleidtauthor=C.+C.+Woodroofeauthor=M.+K.+Schwinnauthor=J.+M%C3%A9ndezauthor=M.+B.+Robersauthor=K.+Zimmermanauthor=P.+Ottoauthor=D.+L.+Danielsauthor=T.+A.+Kirklandauthor=K.+V.+Wood&title=NanoBRET%E2%80%94a+Novel+BRET+Platform+for+the+Analysis+of+Protein%E2%80%93Protein+Interactions&doi=10.1021%2Facschembio.5b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions</span></div><div class="casAuthors">Machleidt, Thomas; Woodroofe, Carolyn C.; Schwinn, Marie K.; Mendez, Jacqui; Robers, Matthew B.; Zimmerman, Kris; Otto, Paul; Daniels, Danette L.; Kirkland, Thomas A.; Wood, Keith V.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1797-1804</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dynamic interactions between proteins comprise a key mechanism for temporal control of cellular function and thus hold promise for development of novel drug therapies.  It remains tech. challenging, however, to quant. characterize these interactions within the biol. relevant context of living cells.  Although, bioluminescence resonance energy transfer (BRET) has often been used for this purpose, its general applicability has been hindered by limited sensitivity and dynamic range.  We have addressed this by combining an extremely bright luciferase (Nanoluc) with a means for tagging intracellular proteins with a long-wavelength fluorophore (HaloTag).  The small size (19 kDa), high emission intensity, and relatively narrow spectrum (460 nm peak intensity) make Nanoluc luciferase well suited as an energy donor.  By selecting an efficient red-emitting fluorophore (635 nm peak intensity) for attachment onto the HaloTag, an overall spectral sepn. exceeding 175 nm was achieved.  This combination of greater light intensity with improved spectral resoln. results in substantially increased detection sensitivity and dynamic range over current BRET technologies.  Enhanced performance is demonstrated using several established model systems, as well as the ability to image BRET in individual cells.  The capabilities are further exhibited in a novel assay developed for analyzing the interactions of bromodomain proteins with chromatin in living cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6-h9HlReNabVg90H21EOLACvtfcHk0ljkiQY_RoQhKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKkt7c%253D&md5=9f5f773b6cd14c40074a2ffbd6472008</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DWoodroofe%26aufirst%3DC.%2BC.%26aulast%3DSchwinn%26aufirst%3DM.%2BK.%26aulast%3DM%25C3%25A9ndez%26aufirst%3DJ.%26aulast%3DRobers%26aufirst%3DM.%2BB.%26aulast%3DZimmerman%26aufirst%3DK.%26aulast%3DOtto%26aufirst%3DP.%26aulast%3DDaniels%26aufirst%3DD.%2BL.%26aulast%3DKirkland%26aufirst%3DT.%2BA.%26aulast%3DWood%26aufirst%3DK.%2BV.%26atitle%3DNanoBRET%25E2%2580%2594a%2520Novel%2520BRET%2520Platform%2520for%2520the%2520Analysis%2520of%2520Protein%25E2%2580%2593Protein%2520Interactions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1797%26epage%3D1804%26doi%3D10.1021%2Facschembio.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Schulze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosmayer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiske, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Montalvan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbst, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haendler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bader, B.</span><span> </span><span class="NLM_article-title">Cell-Based Protein Stabilization Assays for the Detection of Interactions Between Small-Molecule Inhibitors and BRD4</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span><span class="refDoi"> DOI: 10.1177/1087057114552398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1177%2F1087057114552398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25266565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislWrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=180-189&author=J.+Schulzeauthor=D.+Moosmayerauthor=J.+Weiskeauthor=A.+Fernandez-Montalvanauthor=C.+Herbstauthor=M.+Jungauthor=B.+Haendlerauthor=B.+Bader&title=Cell-Based+Protein+Stabilization+Assays+for+the+Detection+of+Interactions+Between+Small-Molecule+Inhibitors+and+BRD4&doi=10.1177%2F1087057114552398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4</span></div><div class="casAuthors">Schulze, Jessica; Moosmayer, Dieter; Weiske, Joerg; Fernandez-Montalvan, Amaury; Herbst, Christopher; Jung, Marie; Haendler, Bernard; Bader, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">180-189/1-180-189/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Bromodomain protein 4 (BRD4), a member of the bromodomain and extra-terminal (BET) protein family, acts as a central element in transcriptional elongation and plays essential roles in cell proliferation.  Inhibition of BRD4 binding to acetylated histone tails via its two bromodomains, BD1 and BD2, with small-mol. inhibitors has been shown to be a valid strategy to prevent cancer growth.  We have evaluated and established two novel assays that quantify the interaction of transfected BRD4 BD1 with chem. inhibitors inside cultured cells.  Both methods are based on the principle of ligand-induced protein stabilization by which the binding of a small-mol. inhibitor stabilizes intracellular BRD4 BD1 and protects it from proteolytic degrdn.  We demonstrate the universal character of this principle by using two orthogonal, highly sensitive detection technologies for the quantification of BRD4 BD1 levels in cellular lysates: enzyme fragment complementation and time-resolved fluorescence resonance energy transfer (TR-FRET).  Upon optimization of both assays to a miniaturized high-throughput format, the methods were validated by testing a set of small-mol. BET inhibitors and comparing the results with those from a cell-free binding assay and a biophys. thermal shift assay.  In addn., point mutations were introduced into BRD4 BD1, and the corresponding mutants were characterized in the TR-FRET stabilization assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzgkcUeBYVbVg90H21EOLACvtfcHk0ljkiQY_RoQhKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislWrurY%253D&md5=283b113f600aa455b6859ef21b7515c1</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1177%2F1087057114552398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114552398%26sid%3Dliteratum%253Aachs%26aulast%3DSchulze%26aufirst%3DJ.%26aulast%3DMoosmayer%26aufirst%3DD.%26aulast%3DWeiske%26aufirst%3DJ.%26aulast%3DFernandez-Montalvan%26aufirst%3DA.%26aulast%3DHerbst%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DHaendler%26aufirst%3DB.%26aulast%3DBader%26aufirst%3DB.%26atitle%3DCell-Based%2520Protein%2520Stabilization%2520Assays%2520for%2520the%2520Detection%2520of%2520Interactions%2520Between%2520Small-Molecule%2520Inhibitors%2520and%2520BRD4%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2015%26volume%3D20%26spage%3D180%26epage%3D189%26doi%3D10.1177%2F1087057114552398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Raab, W.; Wehrman, T. S.</span><span> </span><span class="NLM_article-title">Detection of Intracellular Binding Events by Measuring Protein Abundance</span>. US20130203067A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=W.+Raab&author=T.+S.+Wehrman&title=Detection+of+Intracellular+Binding+Events+by+Measuring+Protein+Abundance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaab%26aufirst%3DW.%26atitle%3DDetection%2520of%2520Intracellular%2520Binding%2520Events%2520by%2520Measuring%2520Protein%2520Abundance%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Arrowsmith, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunnage, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser-Doepner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanak, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederiksen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimshaw, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepworth, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, K. V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruger, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mader, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsden, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller-Fahrnow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Hagan, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Superti-Furga, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo-Sherman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuercher, W. J.</span><span> </span><span class="NLM_article-title">The Promise and Peril of Chemical Probes</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">536</span><span class="NLM_x">–</span> <span class="NLM_lpage">541</span><span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%27Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=B.+Rothauthor=R.+Rossauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+Promise+and+Peril+of+Chemical+Probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lhhjxT96VtBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%2527Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520Promise%2520and%2520Peril%2520of%2520Chemical%2520Probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Arnold, L. D.; Foreman, K. W.; Werner, D. S.</span><span> </span><span class="NLM_article-title">Bivalent Bromodomain Ligands, and Methods of Using Same</span>. WO2013033268A2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=L.+D.+Arnold&author=K.+W.+Foreman&author=D.+S.+Werner&title=Bivalent+Bromodomain+Ligands%2C+and+Methods+of+Using+Same"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DBivalent%2520Bromodomain%2520Ligands%252C%2520and%2520Methods%2520of%2520Using%2520Same%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Arnold, L. D.; Foreman, K. W.; Jin, M.; Wanner, J.; Werner, D. S.</span><span> </span><span class="NLM_article-title">Bromodomain Ligands Capable of Dimerizing in an Aqueous Solution</span>. WO2015081280A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+D.+Arnold&author=K.+W.+Foreman&author=M.+Jin&author=J.+Wanner&author=D.+S.+Werner&title=Bromodomain+Ligands+Capable+of+Dimerizing+in+an+Aqueous+Solution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26atitle%3DBromodomain%2520Ligands%2520Capable%2520of%2520Dimerizing%2520in%2520an%2520Aqueous%2520Solution%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altieri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crews, C. M.</span><span> </span><span class="NLM_article-title">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2015.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.chembiol.2015.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26051217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=755-763&author=J.+Luauthor=Y.+Qianauthor=M.+Altieriauthor=H.+Dongauthor=J.+Wangauthor=K.+Rainaauthor=J.+Hinesauthor=J.+D.+Winklerauthor=A.+P.+Crewauthor=K.+Colemanauthor=C.+M.+Crews&title=Hijacking+the+E3+Ubiquitin+Ligase+Cereblon+to+Efficiently+Target+BRD4&doi=10.1016%2Fj.chembiol.2015.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4</span></div><div class="casAuthors">Lu, Jing; Qian, Yimin; Altieri, Martha; Dong, Hanqing; Wang, Jing; Raina, Kanak; Hines, John; Winkler, James D.; Crew, Andrew P.; Coleman, Kevin; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">755-763</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">BRD4, a bromodomain and extraterminal domain (BET) family member, is an attractive target in multiple pathol. settings, particularly cancer.  While BRD4 inhibitors have shown some promise in MYC-driven malignancies such as Burkitt's lymphoma (BL), we show that BRD4 inhibitors lead to robust BRD4 protein accumulation, which may account for their limited suppression of MYC expression, modest antiproliferative activity, and lack of apoptotic induction.  To address these limitations we designed ARV-825, a hetero-bifunctional PROTAC (Proteolysis Targeting Chimera) that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degrdn. of BRD4 in all BL cell lines tested.  Consequently, ARV-825 more effectively suppresses c-MYC levels and downstream signaling than small-mol. BRD4 inhibitors, resulting in more effective cell proliferation inhibition and apoptosis induction in BL.  Our findings provide strong evidence that cereblon-based PROTACs provide a better and more efficient strategy in targeting BRD4 than traditional small-mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6Ol4grCG2RbVg90H21EOLACvtfcHk0lhhjxT96VtBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVWrtbrM&md5=a64675e7a0cd006a8737be9730f447e3</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2015.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2015.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DY.%26aulast%3DAltieri%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DRaina%26aufirst%3DK.%26aulast%3DHines%26aufirst%3DJ.%26aulast%3DWinkler%26aufirst%3DJ.%2BD.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DColeman%26aufirst%3DK.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DHijacking%2520the%2520E3%2520Ubiquitin%2520Ligase%2520Cereblon%2520to%2520Efficiently%2520Target%2520BRD4%26jtitle%3DChem.%2520Biol.%26date%3D2015%26volume%3D22%26spage%3D755%26epage%3D763%26doi%3D10.1016%2Fj.chembiol.2015.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hotta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handa, H.</span><span> </span><span class="NLM_article-title">Identification of a Primary Target of Thalidomide Teratogenicity</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1345</span><span class="NLM_x">–</span> <span class="NLM_lpage">1350</span><span class="refDoi"> DOI: 10.1126/science.1177319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1177319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=20223979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2010&pages=1345-1350&author=T.+Itoauthor=H.+Andoauthor=T.+Suzukiauthor=T.+Oguraauthor=K.+Hottaauthor=Y.+Imamuraauthor=Y.+Yamaguchiauthor=H.+Handa&title=Identification+of+a+Primary+Target+of+Thalidomide+Teratogenicity&doi=10.1126%2Fscience.1177319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Primary Target of Thalidomide Teratogenicity</span></div><div class="casAuthors">Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">327</span>
        (<span class="NLM_cas:issue">5971</span>),
    <span class="NLM_cas:pages">1345-1350</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects.  Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown.  Here, we identified cereblon (CRBN) as a thalidomide-binding protein.  CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks.  Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the assocd. ubiquitin ligase activity.  This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivs. without teratogenic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPC_7RXLkfabVg90H21EOLACvtfcHk0ljdyrG4u5QdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFensrs%253D&md5=4565a67837e0ec34ede2c93c1036f312</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1126%2Fscience.1177319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1177319%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DOgura%26aufirst%3DT.%26aulast%3DHotta%26aufirst%3DK.%26aulast%3DImamura%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DHanda%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520a%2520Primary%2520Target%2520of%2520Thalidomide%2520Teratogenicity%26jtitle%3DScience%26date%3D2010%26volume%3D327%26spage%3D1345%26epage%3D1350%26doi%3D10.1126%2Fscience.1177319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Winter, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulk, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span> </span><span class="NLM_article-title">Phthalimide Conjugation as a Strategy for in Vivo Target Protein Degradation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">348</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1381</span><span class="refDoi"> DOI: 10.1126/science.aab1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.aab1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25999370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=348&publication_year=2015&pages=1376-1381&author=G.+E.+Winterauthor=D.+L.+Buckleyauthor=J.+Paulkauthor=J.+M.+Robertsauthor=A.+Souzaauthor=S.+Dhe-Paganonauthor=J.+E.+Bradner&title=Phthalimide+Conjugation+as+a+Strategy+for+in+Vivo+Target+Protein+Degradation&doi=10.1126%2Fscience.aab1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalimide conjugation as a strategy for in vivo target protein degradation</span></div><div class="casAuthors">Winter, Georg E.; Buckley, Dennis L.; Paulk, Joshiawa; Roberts, Justin M.; Souza, Amanda; Dhe-Paganon, Sirano; Bradner, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">348</span>
        (<span class="NLM_cas:issue">6241</span>),
    <span class="NLM_cas:pages">1376-1381</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The development of effective pharmacol. inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem.  In part, this is because many small-mol. antagonists disrupt the activity of only one domain in the target protein.  The authors devised a chem. strategy that promotes ligand-dependent target protein degrdn. using as an example the transcriptional coactivator BRD4, a protein crit. for cancer cell growth and survival.  The authors appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex.  The resultant compd., dBET1, induced highly selective cereblon-dependent BET protein degrdn. in vitro and in vivo and delayed leukemia progression in mice.  A second series of probes resulted in selective degrdn. of the cytosolic protein FKBP12.  This chem. strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ZW4zjRjXi7Vg90H21EOLACvtfcHk0ljdyrG4u5QdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFansLk%253D&md5=b0277cc95d318d926b96e7a119066e3b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1126%2Fscience.aab1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aab1433%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%2BE.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DPaulk%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DJ.%2BM.%26aulast%3DSouza%26aufirst%3DA.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26atitle%3DPhthalimide%2520Conjugation%2520as%2520a%2520Strategy%2520for%2520in%2520Vivo%2520Target%2520Protein%2520Degradation%26jtitle%3DScience%26date%3D2015%26volume%3D348%26spage%3D1376%26epage%3D1381%26doi%3D10.1126%2Fscience.aab1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1770</span><span class="NLM_x">–</span> <span class="NLM_lpage">1777</span><span class="refDoi"> DOI: 10.1021/acschembio.5b00216</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00216" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1770-1777&author=M.+Zengerleauthor=K.-H.+Chanauthor=A.+Ciulli&title=Selective+Small+Molecule+Induced+Degradation+of+the+BET+Bromodomain+Protein+BRD4&doi=10.1021%2Facschembio.5b00216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4</span></div><div class="casAuthors">Zengerle, Michael; Chan, Kwok-Ho; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1770-1777</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Bromo- and Extra-Terminal (BET) proteins BRD2, BRD3, and BRD4 play important roles in transcriptional regulation, epigenetics, and cancer and are the targets of pan-BET selective bromodomain inhibitor JQ1.  However, the lack of intra-BET selectivity limits the scope of current inhibitors as probes for target validation and could lead to unwanted side effects or toxicity in a therapeutic setting.  We designed Proteolysis Targeted Chimeras (PROTACs) that tether JQ1 to a ligand for the E3 ubiquitin ligase VHL, aimed at triggering the intracellular destruction of BET proteins.  Compd. MZ1 potently and rapidly induces reversible, long-lasting, and unexpectedly selective removal of BRD4 over BRD2 and BRD3.  The activity of MZ1 is dependent on binding to VHL but is achieved at a sufficiently low concn. not to induce stabilization of HIF-1α.  Gene expression profiles of selected cancer-related genes responsive to JQ1 reveal distinct and more limited transcriptional responses induced by MZ1, consistent with selective suppression of BRD4.  Our discovery opens up new opportunities to elucidate the cellular phenotypes and therapeutic implications assocd. with selective targeting of BRD4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEmSv7p9MZOrVg90H21EOLACvtfcHk0ljdyrG4u5QdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlOgu70%253D&md5=b7514fd274eff8e4bb6a771f5aaf9ab5</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00216%26sid%3Dliteratum%253Aachs%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSelective%2520Small%2520Molecule%2520Induced%2520Degradation%2520of%2520the%2520BET%2520Bromodomain%2520Protein%2520BRD4%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D1770%26epage%3D1777%26doi%3D10.1021%2Facschembio.5b00216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Baud, M. G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin-Shiao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardote, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pschibul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zengerle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwan, T. T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciulli, A.</span><span> </span><span class="NLM_article-title">A Bump-and-Hole Approach to Engineer Controlled Selectivity of BET Bromodomain Chemical Probes</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1126/science.1249830</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1126%2Fscience.1249830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25323695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2014&pages=638-641&author=M.+G.+J.+Baudauthor=E.+Lin-Shiaoauthor=T.+Cardoteauthor=C.+Tallantauthor=A.+Pschibulauthor=K.-H.+Chanauthor=M.+Zengerleauthor=J.+R.+Garciaauthor=T.+T.+L.+Kwanauthor=F.+M.+Fergusonauthor=A.+Ciulli&title=A+Bump-and-Hole+Approach+to+Engineer+Controlled+Selectivity+of+BET+Bromodomain+Chemical+Probes&doi=10.1126%2Fscience.1249830"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes</span></div><div class="casAuthors">Baud, Matthias G. J.; Lin-Shiao, Enrique; Cardote, Teresa; Tallant, Cynthia; Pschibul, Annica; Chan, Kwok-Ho; Zengerle, Michael; Garcia, Jordi R.; Kwan, Terence T.-L.; Ferguson, Fleur M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">6209</span>),
    <span class="NLM_cas:pages">638-641</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Small mols. are useful tools for probing the biol. function and therapeutic potential of individual proteins, but achieving selectivity is challenging when the target protein shares structural domains with other proteins.  The bromodomain and extra-terminal (BET) proteins have attracted interest because of their roles in transcriptional regulation, epigenetics, and cancer.  The BET bromodomains (protein interaction modules that bind acetyl-lysine) have been targeted by potent small-mol. inhibitors, but these inhibitors lack selectivity for individual family members.  We developed an Et deriv. of an existing small-mol. inhibitor, I-BET/JQ1, and showed that it binds leucine/alanine mutant bromodomains with nanomolar affinity and achieves up to 540-fold selectivity relative to wild-type bromodomains.  Cell culture studies showed that blockade of the first bromodomain alone is sufficient to displace a specific BET protein, Brd4, from chromatin.  Expansion of this approach could help identify the individual roles of single BET proteins in human physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9EnzLtvUKwbVg90H21EOLACvtfcHk0ljdyrG4u5QdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWlt7nL&md5=04fe967e4681fb4b2b3168f4d5f8ff81</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1126%2Fscience.1249830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1249830%26sid%3Dliteratum%253Aachs%26aulast%3DBaud%26aufirst%3DM.%2BG.%2BJ.%26aulast%3DLin-Shiao%26aufirst%3DE.%26aulast%3DCardote%26aufirst%3DT.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DPschibul%26aufirst%3DA.%26aulast%3DChan%26aufirst%3DK.-H.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DJ.%2BR.%26aulast%3DKwan%26aufirst%3DT.%2BT.%2BL.%26aulast%3DFerguson%26aufirst%3DF.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DA%2520Bump-and-Hole%2520Approach%2520to%2520Engineer%2520Controlled%2520Selectivity%2520of%2520BET%2520Bromodomain%2520Chemical%2520Probes%26jtitle%3DScience%26date%3D2014%26volume%3D346%26spage%3D638%26epage%3D641%26doi%3D10.1126%2Fscience.1249830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Hett, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piatnitski Chekler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flick, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pletcher, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahasrabudhe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">Direct Photocapture of Bromodomains Using Tropolone Chemical Probes</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1018</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1039/C5MD00070J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1039%2FC5MD00070J" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1018-1023&author=E.+C.+Hettauthor=E.+L.+Piatnitski+Cheklerauthor=A.+Basakauthor=P.+D.+Boninauthor=R.+A.+Dennyauthor=A.+C.+Flickauthor=K.+F.+Geogheganauthor=S.+Liuauthor=M.+T.+Pletcherauthor=P.+Sahasrabudheauthor=S.+C.+Salterauthor=I.+A.+Stockauthor=A.+P.+Taylorauthor=L.+H.+Jones&title=Direct+Photocapture+of+Bromodomains+Using+Tropolone+Chemical+Probes&doi=10.1039%2FC5MD00070J"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1039%2FC5MD00070J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00070J%26sid%3Dliteratum%253Aachs%26aulast%3DHett%26aufirst%3DE.%2BC.%26aulast%3DPiatnitski%2BChekler%26aufirst%3DE.%2BL.%26aulast%3DBasak%26aufirst%3DA.%26aulast%3DBonin%26aufirst%3DP.%2BD.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DFlick%26aufirst%3DA.%2BC.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPletcher%26aufirst%3DM.%2BT.%26aulast%3DSahasrabudhe%26aufirst%3DP.%26aulast%3DSalter%26aufirst%3DS.%2BC.%26aulast%3DStock%26aufirst%3DI.%2BA.%26aulast%3DTaylor%26aufirst%3DA.%2BP.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DDirect%2520Photocapture%2520of%2520Bromodomains%2520Using%2520Tropolone%2520Chemical%2520Probes%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26spage%3D1018%26epage%3D1023%26doi%3D10.1039%2FC5MD00070J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Anders, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenther, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marineau, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahl, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovén, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigova, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. A.</span><span> </span><span class="NLM_article-title">Genome-Wide Localization of Small Molecules</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">92</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span><span class="refDoi"> DOI: 10.1038/nbt.2776</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnbt.2776" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=92-96&author=L.+Andersauthor=M.+G.+Guentherauthor=J.+Qiauthor=Z.+P.+Fanauthor=J.+J.+Marineauauthor=P.+B.+Rahlauthor=J.+Lov%C3%A9nauthor=A.+A.+Sigovaauthor=W.+B.+Smithauthor=T.+I.+Leeauthor=J.+E.+Bradnerauthor=R.+A.+Young&title=Genome-Wide+Localization+of+Small+Molecules&doi=10.1038%2Fnbt.2776"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2776%26sid%3Dliteratum%253Aachs%26aulast%3DAnders%26aufirst%3DL.%26aulast%3DGuenther%26aufirst%3DM.%2BG.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%2BP.%26aulast%3DMarineau%26aufirst%3DJ.%2BJ.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DLov%25C3%25A9n%26aufirst%3DJ.%26aulast%3DSigova%26aufirst%3DA.%2BA.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26aulast%3DLee%26aufirst%3DT.%2BI.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26atitle%3DGenome-Wide%2520Localization%2520of%2520Small%2520Molecules%26jtitle%3DNat.%2520Biotechnol.%26date%3D2013%26volume%3D32%26spage%3D92%26epage%3D96%26doi%3D10.1038%2Fnbt.2776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devaraj, S. G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Portier, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K. N.</span><span> </span><span class="NLM_article-title">BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2315</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-0258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1158%2F1535-7163.MCT-14-0258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25053825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1yisb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=2315-2327&author=W.+Fiskusauthor=S.+Sharmaauthor=J.+Qiauthor=B.+Shahauthor=S.+G.+T.+Devarajauthor=C.+Levequeauthor=B.+P.+Portierauthor=S.+Iyerauthor=J.+E.+Bradnerauthor=K.+N.+Bhalla&title=BET+Protein+Antagonist+JQ1+Is+Synergistically+Lethal+with+FLT3+Tyrosine+Kinase+Inhibitor+%28TKI%29+and+Overcomes+Resistance+to+FLT3-TKI+in+AML+Cells+Expressing+FLT-ITD&doi=10.1158%2F1535-7163.MCT-14-0258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD</span></div><div class="casAuthors">Fiskus, Warren; Sharma, Sunil; Qi, Jun; Shah, Bhavin; Devaraj, Santhana G. T.; Leveque, Christopher; Portier, Bryce P.; Iyer, Swaminathan; Bradner, James E.; Bhalla, Kapil N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2315-2327</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Recently, treatment with bromodomain and extraterminal protein antagonist (BA) such as JQ1 has been shown to inhibit growth and induce apoptosis of human acute myelogenous leukemia (AML) cells, including those expressing FLT3-ITD.  Here, we demonstrate that cotreatment with JQ1 and the FLT3 tyrosine kinase inhibitor (TKI) ponatinib or AC220 synergistically induce apoptosis of cultured and primary CD34+ human AML blast progenitor cells (BPC) expressing FLT3-ITD.  Concomitantly, as compared with each agent alone, cotreatment with JQ1 and the FLT3-TKI caused greater attenuation of c-MYC, BCL2, and CDK4/6.  Simultaneously, cotreatment with JQ1 and the FLT3-TKI increased the levels of p21, BIM, and cleaved PARP, as well as mediated marked attenuation of p-STAT5, p-AKT, and p-ERK1/2 levels in AML BPCs.  Conversely, cotreatment with JQ1 and FLT3-TKI was significantly less active against CD34+ normal bone marrow progenitor cells.  Knockdown of BRD4 by short hairpin RNA also sensitized AML cells to FLT3-TKI.  JQ1 treatment induced apoptosis of mouse Ba/F3 cells ectopically expressing FLT3-ITD with or without FLT3-TKI-resistant mutations F691L and D835V.  Compared with the parental human AML FLT3-ITD-expressing MOLM13, MOLM13-TKIR cells resistant to AC220 were markedly more sensitive to JQ1-induced apoptosis.  Furthermore, cotreatment with JQ1 and the pan-histone deacetylase inhibitor (HDI) panobinostat synergistically induced apoptosis of FLT3-TKI-resistant MOLM13-TKIR and MV4-11-TKIR cells.  Collectively, these findings support the rationale for detg. the in vivo activity of combined therapy with BA and FLT3-TKI against human AML cells expressing FLT3-ITD or with BA and HDI against AML cells resistant to FLT3-TKI.  Mol Cancer Ther; 13(10); 2315-27. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PTZkTs8dmLVg90H21EOLACvtfcHk0lggefHHalEHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1yisb%252FI&md5=86b07b19b740ed314bd042a472507766</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-0258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-0258%26sid%3Dliteratum%253Aachs%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DB.%26aulast%3DDevaraj%26aufirst%3DS.%2BG.%2BT.%26aulast%3DLeveque%26aufirst%3DC.%26aulast%3DPortier%26aufirst%3DB.%2BP.%26aulast%3DIyer%26aufirst%3DS.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%2BN.%26atitle%3DBET%2520Protein%2520Antagonist%2520JQ1%2520Is%2520Synergistically%2520Lethal%2520with%2520FLT3%2520Tyrosine%2520Kinase%2520Inhibitor%2520%2528TKI%2529%2520and%2520Overcomes%2520Resistance%2520to%2520FLT3-TKI%2520in%2520AML%2520Cells%2520Expressing%2520FLT-ITD%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2014%26volume%3D13%26spage%3D2315%26epage%3D2327%26doi%3D10.1158%2F1535-7163.MCT-14-0258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Stratikopoulos, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dendy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szabolcs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaykin, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R.</span><span> </span><span class="NLM_article-title">Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">851</span><span class="refDoi"> DOI: 10.1016/j.ccell.2015.05.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.ccell.2015.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=26058079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVejurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2015&pages=837-851&author=E.+E.+Stratikopoulosauthor=M.+Dendyauthor=M.+Szabolcsauthor=A.+J.+Khaykinauthor=C.+Lefebvreauthor=M.-M.+Zhouauthor=R.+Parsons&title=Kinase+and+BET+Inhibitors+Together+Clamp+Inhibition+of+PI3K+Signaling+and+Overcome+Resistance+to+Therapy&doi=10.1016%2Fj.ccell.2015.05.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy</span></div><div class="casAuthors">Stratikopoulos, Elias E.; Dendy, Meaghan; Szabolcs, Matthias; Khaykin, Alan J.; Lefebvre, Celine; Zhou, Ming-Ming; Parsons, Ramon</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-851</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Unsustained enzyme inhibition is a barrier to targeted therapy for cancer.  Here, resistance to a class I PI3K inhibitor in a model of metastatic breast cancer driven by PI3K and MYC was assocd. with feedback activation of tyrosine kinase receptors (RTKs), AKT, mTOR, and MYC.  Inhibitors of bromodomain and extra terminal domain (BET) proteins also failed to affect tumor growth.  Interestingly, BET inhibitors lowered PI3K signaling and dissocd. BRD4 from chromatin at regulatory regions of insulin receptor and EGFR family RTKs to reduce their expression.  Combined PI3K and BET inhibition induced cell death, tumor regression, and clamped inhibition of PI3K signaling in a broad range of tumor cell lines to provide a strategy to overcome resistance to kinase inhibitor therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmdX2xaXkHjbVg90H21EOLACvtfcHk0lggefHHalEHdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVejurbK&md5=91cca562c9bff9e11e94535916583867</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2015.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DStratikopoulos%26aufirst%3DE.%2BE.%26aulast%3DDendy%26aufirst%3DM.%26aulast%3DSzabolcs%26aufirst%3DM.%26aulast%3DKhaykin%26aufirst%3DA.%2BJ.%26aulast%3DLefebvre%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DM.-M.%26aulast%3DParsons%26aufirst%3DR.%26atitle%3DKinase%2520and%2520BET%2520Inhibitors%2520Together%2520Clamp%2520Inhibition%2520of%2520PI3K%2520Signaling%2520and%2520Overcome%2520Resistance%2520to%2520Therapy%26jtitle%3DCancer%2520Cell%26date%3D2015%26volume%3D27%26spage%3D837%26epage%3D851%26doi%3D10.1016%2Fj.ccell.2015.05.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälth Savitski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinjha, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span><span class="refDoi"> DOI: 10.1021/cb400789e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400789e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=495-502&author=A.+Dittmannauthor=T.+Wernerauthor=C.-W.+Chungauthor=M.+M.+Savitskiauthor=M.+F%C3%A4lth+Savitskiauthor=P.+Grandiauthor=C.+Hopfauthor=M.+Lindonauthor=G.+Neubauerauthor=R.+K.+Prinjhaauthor=M.+Bantscheffauthor=G.+Drewes&title=The+Commonly+Used+PI3-Kinase+Probe+LY294002+Is+an+Inhibitor+of+BET+Bromodomains&doi=10.1021%2Fcb400789e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">The Commonly Used PI3-Kinase Probe LY294002 Is an Inhibitor of BET Bromodomains</span></div><div class="casAuthors">Dittmann, Antje; Werner, Thilo; Chung, Chun-Wa; Savitski, Mikhail M.; Faelth Savitski, Maria; Grandi, Paola; Hopf, Carsten; Lindon, Matthew; Neubauer, Gitte; Prinjha, Rabinder K.; Bantscheff, Marcus; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A commonly used small-mol. probe in cell-signaling research is the phosphoinositide 3-kinase inhibitor LY294002.  Quant. chemoproteomic profiling shows that LY294002 and LY303511, a close analog devoid of PI3K activity, inhibit the BET bromodomain proteins BRD2, BRD3, and BRD4 that comprise a family of targets structurally unrelated to PI3K.  Both compds. competitively inhibit acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell exts.  X-ray crystallog. shows that the chromen-4-one scaffold represents a new bromodomain pharmacophore and establishes LY294002 as a dual kinase and BET-bromodomain inhibitor, whereas LY303511 exhibits anti-inflammatory and antiproliferative effects similar to the recently discovered BET inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIVXFQARTKLVg90H21EOLACvtfcHk0lhxPdfO9gtuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGnt7nO&md5=13435c7d6a6747dc5699e3c3865c8243</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Fcb400789e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400789e%26sid%3Dliteratum%253Aachs%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DC.-W.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DF%25C3%25A4lth%2BSavitski%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DLindon%26aufirst%3DM.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DPrinjha%26aufirst%3DR.%2BK.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DThe%2520Commonly%2520Used%2520PI3-Kinase%2520Probe%2520LY294002%2520Is%2520an%2520Inhibitor%2520of%2520BET%2520Bromodomains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D495%26epage%3D502%26doi%3D10.1021%2Fcb400789e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Mahony, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasater, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picaud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Dual Kinase-Bromodomain Inhibitors for Rationally Designed Polypharmacology</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">312</span><span class="refDoi"> DOI: 10.1038/nchembio.1471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnchembio.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24584101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=305-312&author=P.+Ciceriauthor=S.+M%C3%BCllerauthor=A.+O%27Mahonyauthor=O.+Fedorovauthor=P.+Filippakopoulosauthor=J.+P.+Huntauthor=E.+A.+Lasaterauthor=G.+Pallaresauthor=S.+Picaudauthor=C.+Wellsauthor=S.+Martinauthor=L.+M.+Wodickaauthor=N.+P.+Shahauthor=D.+K.+Treiberauthor=S.+Knapp&title=Dual+Kinase-Bromodomain+Inhibitors+for+Rationally+Designed+Polypharmacology&doi=10.1038%2Fnchembio.1471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Dual kinase-bromodomain inhibitors for rationally designed polypharmacology</span></div><div class="casAuthors">Ciceri, Pietro; Mueller, Susanne; O'Mahony, Alison; Fedorov, Oleg; Filippakopoulos, Panagis; Hunt, Jeremy P.; Lasater, Elisabeth A.; Pallares, Gabriel; Picaud, Sarah; Wells, Christopher; Martin, Sarah; Wodicka, Lisa M.; Shah, Neil P.; Treiber, Daniel K.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-312</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Concomitant inhibition of multiple cancer-driving kinases is an established strategy to improve the durability of clin. responses to targeted therapies.  The difficulty of discovering kinase inhibitors with an appropriate multitarget profile has, however, necessitated the application of combination therapies, which can pose major clin. development challenges.  Epigenetic reader domains of the bromodomain family have recently emerged as new targets for cancer therapy.  Here the authors report that several clin. kinase inhibitors also inhibit bromodomains with therapeutically relevant potencies and are best classified as dual kinase-bromodomain inhibitors.  Nanomolar activity on BRD4 by BI-2536 and TG-101348, which are clin. PLK1 and JAK2-FLT3 kinase inhibitors, resp., is particularly noteworthy as these combinations of activities on independent oncogenic pathways exemplify a new strategy for rational single-agent polypharmacol. targeting.  Furthermore, structure-activity relationships and co-crystal structures identify design features that enable a general platform for the rational design of dual kinase-bromodomain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotPedDED4FJLVg90H21EOLACvtfcHk0lhxPdfO9gtuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtl2itro%253D&md5=a00117db2648ea38dd03750faf3b3cb9</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1471%26sid%3Dliteratum%253Aachs%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%2527Mahony%26aufirst%3DA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLasater%26aufirst%3DE.%2BA.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DDual%2520Kinase-Bromodomain%2520Inhibitors%2520for%2520Rationally%2520Designed%2520Polypharmacology%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D305%26epage%3D312%26doi%3D10.1038%2Fnchembio.1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yap, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshioka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanning, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fountain, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheenstra, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strovel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span> </span><span class="NLM_article-title">BRD4 Structure–Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">764</span><span class="NLM_x">–</span> <span class="NLM_lpage">769</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=764-769&author=L.+Chenauthor=J.+L.+Yapauthor=M.+Yoshiokaauthor=M.+E.+Lanningauthor=R.+N.+Fountainauthor=M.+Rajeauthor=J.+A.+Scheenstraauthor=J.+W.+Strovelauthor=S.+Fletcher&title=BRD4+Structure%E2%80%93Activity+Relationships+of+Dual+PLK1+Kinase%2FBRD4+Bromodomain+Inhibitor+BI-2536&doi=10.1021%2Facsmedchemlett.5b00084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536</span></div><div class="casAuthors">Chen, Lijia; Yap, Jeremy L.; Yoshioka, Makoto; Lanning, Maryanna E.; Fountain, Rachel N.; Raje, Mithun; Scheenstra, Jacob A.; Strovel, Jeffrey W.; Fletcher, Steven</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">764-769</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A focused library of analogs of the dual PLK1 kinase/BRD4 bromodomain inhibitor BI-2536 was prepd. and then analyzed for BRD4 and PLK1 inhibitory activities.  Particularly, replacement of the cyclopentyl group with a 3-bromobenzyl moiety afforded the most potent BRD4 inhibitor of the series (39j) with a Ki = 8.7 nM, which was equipotent against PLK1.  The superior affinity of 39j over the parental compd. to BRD4 possibly derives from improved interactions with the WPF shelf.  Meanwhile, substitution of the pyrimidine NH with an oxygen atom reversed the PLK1/BRD4 selectivity to convert BI-2536 into a BRD4-selective inhibitor, likely owing to the loss of a crit. hydrogen bond in PLK1.  We believe further fine-tuning will furnish a BRD4 "magic bullet" or an even more potent PLK1/BRD4 dual inhibitor toward the expansion and improved efficacy of the chemotherapy arsenal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5UnNSmf1L17Vg90H21EOLACvtfcHk0lhxPdfO9gtuhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVChtb0%253D&md5=f39070e652bca20c03a3bc5fe070a7fc</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00084%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYap%26aufirst%3DJ.%2BL.%26aulast%3DYoshioka%26aufirst%3DM.%26aulast%3DLanning%26aufirst%3DM.%2BE.%26aulast%3DFountain%26aufirst%3DR.%2BN.%26aulast%3DRaje%26aufirst%3DM.%26aulast%3DScheenstra%26aufirst%3DJ.%2BA.%26aulast%3DStrovel%26aufirst%3DJ.%2BW.%26aulast%3DFletcher%26aufirst%3DS.%26atitle%3DBRD4%2520Structure%25E2%2580%2593Activity%2520Relationships%2520of%2520Dual%2520PLK1%2520Kinase%252FBRD4%2520Bromodomain%2520Inhibitor%2520BI-2536%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D764%26epage%3D769%26doi%3D10.1021%2Facsmedchemlett.5b00084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Shi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vakoc, C. R.</span><span> </span><span class="NLM_article-title">The Mechanisms Behind the Therapeutic Activity of BET Bromodomain Inhibition</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span><span class="refDoi"> DOI: 10.1016/j.molcel.2014.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.molcel.2014.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24905006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslCrtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2014&pages=728-736&author=J.+Shiauthor=C.+R.+Vakoc&title=The+Mechanisms+Behind+the+Therapeutic+Activity+of+BET+Bromodomain+Inhibition&doi=10.1016%2Fj.molcel.2014.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition</span></div><div class="casAuthors">Shi, Junwei; Vakoc, Christopher R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">728-736</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The bromodomain and extraterminal (BET) protein Brd4 recruits transcriptional regulatory complexes to acetylated chromatin.  While Brd4 is considered to be a general transcriptional regulator, pharmacol. inhibition of BET proteins shows therapeutic activity in a variety of different pathologies, particularly in models of cancer and inflammation.  Such effects have been attributed to a specific set of downstream target genes whose expression is disproportionately sensitive to pharmacol. targeting of BET proteins.  Emerging evidence links the transcriptional consequences of BET inhibition to the assocn. of Brd4 with enhancer elements, which tend to be involved in lineage-specific gene regulation.  Furthermore, Brd4 engages in direct regulatory interactions with several DNA-binding transcription factors to influence their disease-relevant functions.  Here we review the current understanding of mol. mechanisms that underlie the promising therapeutic effects of BET bromodomain inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJpSFRzwcR1rVg90H21EOLACvtfcHk0liHJ82mZnMKHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslCrtrk%253D&md5=f49bf3524ec378576fb1a25c64a464ae</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2014.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2014.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DVakoc%26aufirst%3DC.%2BR.%26atitle%3DThe%2520Mechanisms%2520Behind%2520the%2520Therapeutic%2520Activity%2520of%2520BET%2520Bromodomain%2520Inhibition%26jtitle%3DMol.%2520Cell%26date%3D2014%26volume%3D54%26spage%3D728%26epage%3D736%26doi%3D10.1016%2Fj.molcel.2014.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Baratta, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinzel, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandopadhayay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman-Colin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drapkin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livingston, D. M.</span><span> </span><span class="NLM_article-title">An in-Tumor Genetic Screen Reveals That the BET Bromodomain Protein, BRD4, Is a Potential Therapeutic Target in Ovarian Carcinoma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1073/pnas.1422165112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1073%2Fpnas.1422165112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=232-237&author=M.+G.+Barattaauthor=A.+C.+Schinzelauthor=Y.+Zwangauthor=P.+Bandopadhayayauthor=C.+Bowman-Colinauthor=J.+Kuttauthor=J.+Curtisauthor=H.+Piaoauthor=L.+C.+Wongauthor=A.+L.+Kungauthor=R.+Beroukhimauthor=J.+E.+Bradnerauthor=R.+Drapkinauthor=W.+C.+Hahnauthor=J.+F.+Liuauthor=D.+M.+Livingston&title=An+in-Tumor+Genetic+Screen+Reveals+That+the+BET+Bromodomain+Protein%2C+BRD4%2C+Is+a+Potential+Therapeutic+Target+in+Ovarian+Carcinoma&doi=10.1073%2Fpnas.1422165112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1422165112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1422165112%26sid%3Dliteratum%253Aachs%26aulast%3DBaratta%26aufirst%3DM.%2BG.%26aulast%3DSchinzel%26aufirst%3DA.%2BC.%26aulast%3DZwang%26aufirst%3DY.%26aulast%3DBandopadhayay%26aufirst%3DP.%26aulast%3DBowman-Colin%26aufirst%3DC.%26aulast%3DKutt%26aufirst%3DJ.%26aulast%3DCurtis%26aufirst%3DJ.%26aulast%3DPiao%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DL.%2BC.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DDrapkin%26aufirst%3DR.%26aulast%3DHahn%26aufirst%3DW.%2BC.%26aulast%3DLiu%26aufirst%3DJ.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520in-Tumor%2520Genetic%2520Screen%2520Reveals%2520That%2520the%2520BET%2520Bromodomain%2520Protein%252C%2520BRD4%252C%2520Is%2520a%2520Potential%2520Therapeutic%2520Target%2520in%2520Ovarian%2520Carcinoma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D232%26epage%3D237%26doi%3D10.1073%2Fpnas.1422165112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Asangani, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dommeti, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cieslik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escara-Wilke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilder-Romans, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhanireddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, Z. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, F. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Therapeutic Targeting of BET Bromodomain Proteins in Castration-Resistant Prostate Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">510</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span><span class="refDoi"> DOI: 10.1038/nature13229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fnature13229" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24759320" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=510&publication_year=2014&pages=278-282&author=I.+A.+Asanganiauthor=V.+L.+Dommetiauthor=X.+Wangauthor=R.+Malikauthor=M.+Cieslikauthor=R.+Yangauthor=J.+Escara-Wilkeauthor=K.+Wilder-Romansauthor=S.+Dhanireddyauthor=C.+Engelkeauthor=M.+K.+Iyerauthor=X.+Jingauthor=Y.-M.+Wuauthor=X.+Caoauthor=Z.+S.+Qinauthor=S.+Wangauthor=F.+Y.+Fengauthor=A.+M.+Chinnaiyan&title=Therapeutic+Targeting+of+BET+Bromodomain+Proteins+in+Castration-Resistant+Prostate+Cancer&doi=10.1038%2Fnature13229"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer</span></div><div class="casAuthors">Asangani, Irfan A.; Dommeti, Vijaya L.; Wang, Xiaoju; Malik, Rohit; Cieslik, Marcin; Yang, Rendong; Escara-Wilke, June; Wilder-Romans, Kari; Dhanireddy, Sudheer; Engelke, Carl; Iyer, Mathew K.; Jing, Xiaojun; Wu, Yi-Mi; Cao, Xuhong; Qin, Zhaohui S.; Wang, Shaomeng; Feng, Felix Y.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">510</span>
        (<span class="NLM_cas:issue">7504</span>),
    <span class="NLM_cas:pages">278-282</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the disease.  Progression to CRPC after androgen ablation therapy is predominantly driven by deregulated androgen receptor (AR) signaling.  Despite the success of recently approved therapies targeting AR signaling, such as abiraterone and second-generation anti-androgens including MDV3100 (also known as enzalutamide), durable responses are limited, presumably owing to acquired resistance.  Recently, JQ1 and I-BET762 two selective small-mol. inhibitors that target the N-terminal bromodomains of BRD4, have been shown to exhibit anti-proliferative effects in a range of malignancies.  AR-signaling-competent human CRPC cell lines are preferentially sensitive to bromodomain and extraterminal (BET) inhibition.  BRD4 phys. interacts with the N-terminal domain of AR and can be disrupted by JQ1 (refs 11, 13).  Like the direct AR antagonist MDV3100, JQ1 disrupted AR recruitment to target gene loci.  By contrast with MDV3100, JQ1 functions downstream of AR, and more potently abrogated BRD4 localization to AR target loci and AR-mediated gene transcription, including induction of the TMPRSS2-ERG gene fusion and its oncogenic activity.  In vivo, BET bromodomain inhibition was more efficacious than direct AR antagonism in CRPC xenograft mouse models.  Taken together, these studies provide a novel epigenetic approach for the concerted blockade of oncogenic drivers in advanced prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfXutywHDWrVg90H21EOLACvtfcHk0liHJ82mZnMKHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXps1WmtLo%253D&md5=bef4b5faf5d23dc7d125ab1941c3ee39</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1038%2Fnature13229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13229%26sid%3Dliteratum%253Aachs%26aulast%3DAsangani%26aufirst%3DI.%2BA.%26aulast%3DDommeti%26aufirst%3DV.%2BL.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DCieslik%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DEscara-Wilke%26aufirst%3DJ.%26aulast%3DWilder-Romans%26aufirst%3DK.%26aulast%3DDhanireddy%26aufirst%3DS.%26aulast%3DEngelke%26aufirst%3DC.%26aulast%3DIyer%26aufirst%3DM.%2BK.%26aulast%3DJing%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DY.-M.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DQin%26aufirst%3DZ.%2BS.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DF.%2BY.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DTherapeutic%2520Targeting%2520of%2520BET%2520Bromodomain%2520Proteins%2520in%2520Castration-Resistant%2520Prostate%2520Cancer%26jtitle%3DNature%26date%3D2014%26volume%3D510%26spage%3D278%26epage%3D282%26doi%3D10.1038%2Fnature13229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Patel, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, L. Q.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors Through Bim Induction</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">92</span><span class="refDoi"> DOI: 10.1016/j.celrep.2013.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.celrep.2013.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=24373973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVeq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=81-92&author=A.+J.+Patelauthor=C.-P.+Liaoauthor=Z.+Chenauthor=C.+Liuauthor=Y.+Wangauthor=L.+Q.+Le&title=BET+Bromodomain+Inhibition+Triggers+Apoptosis+of+NF1-Associated+Malignant+Peripheral+Nerve+Sheath+Tumors+Through+Bim+Induction&doi=10.1016%2Fj.celrep.2013.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">BET Bromodomain Inhibition Triggers Apoptosis of NF1-Associated Malignant Peripheral Nerve Sheath Tumors through Bim Induction</span></div><div class="casAuthors">Patel, Amish J.; Liao, Chung-Ping; Chen, Zhiguo; Liu, Chiachi; Wang, Yong; Le, Lu Q.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive sarcomas that develop sporadically or in neurofibromatosis type 1 (NF1) patients.  There is no effective treatment for MPNSTs and they are typically fatal.  To gain insights into MPNST pathogenesis, we utilized an MPNST mouse model that allowed us to study the evolution of these tumors at the transcriptome level.  Strikingly, in MPNSTs we found upregulation of a chromatin regulator, Brd4, and show that BRD4 inhibition profoundly suppresses both growth and tumorigenesis.  Our findings reveal roles for BET bromodomains in MPNST development and report a mechanism by which bromodomain inhibition induces apoptosis through induction of proapoptotic Bim, which may represent a paradigm shift in therapy for MPNST patients.  Moreover, these findings indicate epigenetic mechanisms underlying the balance of anti- and proapoptotic mols. and that bromodomain inhibition can shift this balance in favor of cancer cell apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrH__HnSCqpbVg90H21EOLACvtfcHk0liMQ1llnlGD5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVeq&md5=dc562b77ccd57d9ff9ad7c4ac8a6133c</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2013.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2013.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DA.%2BJ.%26aulast%3DLiao%26aufirst%3DC.-P.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLe%26aufirst%3DL.%2BQ.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Triggers%2520Apoptosis%2520of%2520NF1-Associated%2520Malignant%2520Peripheral%2520Nerve%2520Sheath%2520Tumors%2520Through%2520Bim%2520Induction%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D6%26spage%3D81%26epage%3D92%26doi%3D10.1016%2Fj.celrep.2013.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Gopalakrishnan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Triche, T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, P. M.</span><span> </span><span class="NLM_article-title">Immunomodulatory Drugs Target IKZF1-IRF4-MYC Axis in Primary Effusion Lymphoma in a Cereblon-Dependent Manner and Display Synergistic Cytotoxicity with BRD4 Inhibitors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span><span class="refDoi"> DOI: 10.1038/onc.2015.245</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1038%2Fonc.2015.245" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=1-14&author=R.+Gopalakrishnanauthor=H.+Mattaauthor=B.+Tolaniauthor=T.+Tricheauthor=P.+M.+Chaudhary&title=Immunomodulatory+Drugs+Target+IKZF1-IRF4-MYC+Axis+in+Primary+Effusion+Lymphoma+in+a+Cereblon-Dependent+Manner+and+Display+Synergistic+Cytotoxicity+with+BRD4+Inhibitors&doi=10.1038%2Fonc.2015.245"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1038%2Fonc.2015.245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2015.245%26sid%3Dliteratum%253Aachs%26aulast%3DGopalakrishnan%26aufirst%3DR.%26aulast%3DMatta%26aufirst%3DH.%26aulast%3DTolani%26aufirst%3DB.%26aulast%3DTriche%26aufirst%3DT.%26aulast%3DChaudhary%26aufirst%3DP.%2BM.%26atitle%3DImmunomodulatory%2520Drugs%2520Target%2520IKZF1-IRF4-MYC%2520Axis%2520in%2520Primary%2520Effusion%2520Lymphoma%2520in%2520a%2520Cereblon-Dependent%2520Manner%2520and%2520Display%2520Synergistic%2520Cytotoxicity%2520with%2520BRD4%2520Inhibitors%26jtitle%3DOncogene%26date%3D2015%26spage%3D1%26epage%3D14%26doi%3D10.1038%2Fonc.2015.245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Said, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeffler, H. P.</span><span> </span><span class="NLM_article-title">Synergistic Effect of JQ1 and Rapamycin for Treatment of Human Osteosarcoma</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">2055</span><span class="NLM_x">–</span> <span class="NLM_lpage">2064</span><span class="refDoi"> DOI: 10.1002/ijc.29269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1002%2Fijc.29269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25307878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislegt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=2055-2064&author=D.+H.+Leeauthor=J.+Qiauthor=J.+E.+Bradnerauthor=J.+W.+Saidauthor=N.+B.+Doanauthor=C.+Forscherauthor=H.+Yangauthor=H.+P.+Koeffler&title=Synergistic+Effect+of+JQ1+and+Rapamycin+for+Treatment+of+Human+Osteosarcoma&doi=10.1002%2Fijc.29269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma</span></div><div class="casAuthors">Lee, Dhong Hyun; Qi, Jun; Bradner, James E.; Said, Jonathan W.; Doan, Ngan B.; Forscher, Charles; Yang, Henry; Koeffler, H. Phillip</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2055-2064</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Bromodomain and extra terminal domain (BET) proteins are important epigenetic regulators facilitating the transcription of genes in chromatin areas linked to acetylated histones.  JQ1, a BET protein inhibitor, has antiproliferative activity against many cancers, mainly through inhibition of c-MYC and upregulation of p21.  In this research, we investigated the use of JQ1 for human osteosarcoma (OS) treatment.  JQ1 significantly inhibited the proliferation and survival of OS cells inducing G1 cell cycle arrest, premature senescence, but little effect on apoptosis.  Interestingly, c-MYC protein levels in JQ1-treated cells remained unchanged, whereas the upregulation of p21 protein was still observable.  Although effective in vitro, JQ1 alone failed to reduce the size of the MNNG/HOS xenografts in immunocompromised mice.  To overcome the resistance of OS cells to JQ1 treatment, we combined JQ1 with rapamycin, an mammalian target of rapamycin (mTOR) inhibitor.  JQ1 and rapamycin synergistically inhibited the growth and survival of OS cells in vitro and in vivo.  We also identified that RUNX2 is a direct target of bromodomain-contg. protein 4 (BRD4) inhibition by JQ1 in OS cells.  Chromatin immunopptn. (ChIP) showed that enrichment of BRD4 protein around RUNX2 transcription start sites diminished with JQ1 treatment in MNNG/HOS cells.  Overexpression of RUNX2 protected JQ1-sensitive OS cells from the effect of JQ1, and siRNA-mediated inhibition of RUNX2 sensitized the same cells to JQ1.  In conclusion, our findings suggest that JQ1, in combination with rapamycin, is an effective chemotherapeutic option for OS treatment.  We also show that inhibition of RUNX2 expression by JQ1 partly explains the antiproliferative activity of JQ1 in OS cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc0-M1_Sb11LVg90H21EOLACvtfcHk0liMQ1llnlGD5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislegt70%253D&md5=71971e482ce634ae9de6047e94557460</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1002%2Fijc.29269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.29269%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DSaid%26aufirst%3DJ.%2BW.%26aulast%3DDoan%26aufirst%3DN.%2BB.%26aulast%3DForscher%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DKoeffler%26aufirst%3DH.%2BP.%26atitle%3DSynergistic%2520Effect%2520of%2520JQ1%2520and%2520Rapamycin%2520for%2520Treatment%2520of%2520Human%2520Osteosarcoma%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3D2055%26epage%3D2064%26doi%3D10.1002%2Fijc.29269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiha, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, A. L.</span><span> </span><span class="NLM_article-title">Reactivation of Latent HIV-1 by Inhibition of BRD4</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span><span class="refDoi"> DOI: 10.1016/j.celrep.2012.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1016%2Fj.celrep.2012.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=23041316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCls73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=807-816&author=J.+Zhuauthor=G.+D.+Gaihaauthor=S.+P.+Johnauthor=T.+Pertelauthor=C.+R.+Chinauthor=G.+Gaoauthor=H.+Quauthor=B.+D.+Walkerauthor=S.+J.+Elledgeauthor=A.+L.+Brass&title=Reactivation+of+Latent+HIV-1+by+Inhibition+of+BRD4&doi=10.1016%2Fj.celrep.2012.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Reactivation of latent HIV-1 by inhibition of BRD4</span></div><div class="casAuthors">Zhu, Jian; Gaiha, Gaurav D.; John, Sinu P.; Pertel, Thomas; Chin, Christopher R.; Gao, Geng; Qu, Hongjing; Walker, Bruce D.; Elledge, Stephen J.; Brass, Abraham L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">807-816</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIV-1 depends on many host factors for propagation.  Other host factors, however, antagonize HIV-1 and may have profound effects on viral activation.  Curing HIV-1 requires the redn. of latent viral reservoirs that remain in the face of antiretroviral therapy.  Using orthologous genetic screens, we identified bromodomain contg. 4 (BRD4) as a neg. regulator of HIV-1 replication.  Antagonism of BRD4, via RNA interference or with a small mol. inhibitor, JQ1, both increased proviral transcriptional elongation and alleviated HIV-1 latency in cell-line models.  In multiple instances, JQ1, when used in combination with the NF-κB activators Prostratin or PHA, enhanced the in vitro reactivation of latent HIV-1 in primary T cells.  These data are consistent with a model wherein BRD4 competes with the virus for HIV-1 dependency factors (HDFs) and suggests that combinatorial therapies that activate HDFs and antagonize HIV-1 competitive factors may be useful for curing HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosSPB0bZraJbVg90H21EOLACvtfcHk0liMQ1llnlGD5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCls73E&md5=210b459b66ccf10a84c57ef10b03b684</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2012.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2012.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGaiha%26aufirst%3DG.%2BD.%26aulast%3DJohn%26aufirst%3DS.%2BP.%26aulast%3DPertel%26aufirst%3DT.%26aulast%3DChin%26aufirst%3DC.%2BR.%26aulast%3DGao%26aufirst%3DG.%26aulast%3DQu%26aufirst%3DH.%26aulast%3DWalker%26aufirst%3DB.%2BD.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DBrass%26aufirst%3DA.%2BL.%26atitle%3DReactivation%2520of%2520Latent%2520HIV-1%2520by%2520Inhibition%2520of%2520BRD4%26jtitle%3DCell%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D807%26epage%3D816%26doi%3D10.1016%2Fj.celrep.2012.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Gauson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donaldson, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dornan, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodily, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, I. M.</span><span> </span><span class="NLM_article-title">Evidence Supporting a Role for TopBP1 and Brd4 in the Initiation but Not Continuation of Human Papillomavirus 16 E1/E2-Mediated DNA Replication</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">4980</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span><span class="refDoi"> DOI: 10.1128/JVI.00335-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1128%2FJVI.00335-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=25694599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFOns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2015&pages=4980-4991&author=E.+J.+Gausonauthor=M.+M.+Donaldsonauthor=E.+S.+Dornanauthor=X.+Wangauthor=M.+Bristolauthor=J.+M.+Bodilyauthor=I.+M.+Morgan&title=Evidence+Supporting+a+Role+for+TopBP1+and+Brd4+in+the+Initiation+but+Not+Continuation+of+Human+Papillomavirus+16+E1%2FE2-Mediated+DNA+Replication&doi=10.1128%2FJVI.00335-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence supporting a role for TopBP1 and Brd4 in the initiation but not continuation of human papillomavirus 16 E1/E2-mediated DNA replication</span></div><div class="casAuthors">Gauson, Elaine J.; Donaldson, Mary M.; Dornan, Edward S.; Wang, Xu; Bristol, Molly; Bodily, Jason M.; Morgan, Iain M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4980-4991</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">To replicate the double-stranded human papillomavirus 16 (HPV16) DNA genome, viral proteins E1 and E2 assoc. with the viral origin of replication, and E2 can also regulate transcription from adjacent promoters.  E2 interacts with host proteins in order to regulate both transcription and replication; TopBP1 and Brd4 are cellular proteins that interact with HPV16 E2.  Previous work with E2 mutants demonstrated the Brd4 requirement for the transactivation properties of E2, while TopBP1 is required for DNA replication induced by E2 from the viral origin of replication in assocn. with E1.  More-recent studies have also implicated Brd4 in the regulation of DNA replication by E2 and E1.  Here, we demonstrate that both TopBP1 and Brd4 are present at the viral origin of replication and that interaction with E2 is required for optimal initiation of DNA replication.  Both cellular proteins are present in E1-E2-contg. nuclear foci, and the viral origin of replication is required for the efficient formation of these foci.  Short hairpin RNA (shRNA) against either TopBP1 or Brd4 destroys the E1-E2 nuclear bodies but has no effect on E1-E2-mediated levels of DNA replication.  An E2 mutation in the context of the complete HPV16 genome that compromises Brd4 interaction fails to efficiently establish episomes in primary human keratinocytes.  Overall, the results suggest that interactions between TopBP1 and E2 and between Brd4 and E2 are required to correctly initiate DNA replication but are not required for continuing DNA replication, which may be mediated by alternative processes such as rolling circle amplification and/or homologous recombination.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCkgSOghorU7Vg90H21EOLACvtfcHk0lhQLvwnztcx2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFOns7Y%253D&md5=c98203d833f5b29e2a2c7d3d76361236</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1128%2FJVI.00335-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00335-15%26sid%3Dliteratum%253Aachs%26aulast%3DGauson%26aufirst%3DE.%2BJ.%26aulast%3DDonaldson%26aufirst%3DM.%2BM.%26aulast%3DDornan%26aufirst%3DE.%2BS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DBristol%26aufirst%3DM.%26aulast%3DBodily%26aufirst%3DJ.%2BM.%26aulast%3DMorgan%26aufirst%3DI.%2BM.%26atitle%3DEvidence%2520Supporting%2520a%2520Role%2520for%2520TopBP1%2520and%2520Brd4%2520in%2520the%2520Initiation%2520but%2520Not%2520Continuation%2520of%2520Human%2520Papillomavirus%252016%2520E1%252FE2-Mediated%2520DNA%2520Replication%26jtitle%3DJ.%2520Virol.%26date%3D2015%26volume%3D89%26spage%3D4980%26epage%3D4991%26doi%3D10.1128%2FJVI.00335-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Sverdrup, F. M.</span><span> </span><span class="NLM_article-title">Inhibition of DUX4 Expression Using Bromodomain and Extra-Terminal Domain Protein Inhibitors (BETi)</span>. US20150087636A1,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=F.+M.+Sverdrup&title=Inhibition+of+DUX4+Expression+Using+Bromodomain+and+Extra-Terminal+Domain+Protein+Inhibitors+%28BETi%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSverdrup%26aufirst%3DF.%2BM.%26atitle%3DInhibition%2520of%2520DUX4%2520Expression%2520Using%2520Bromodomain%2520and%2520Extra-Terminal%2520Domain%2520Protein%2520Inhibitors%2520%2528BETi%2529%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toubai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oravecz-Wilson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathewson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span> </span><span class="NLM_article-title">BET Bromodomain Inhibition Suppresses Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2728</span><span class="refDoi"> DOI: 10.1182/blood-2014-08-598037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1182%2Fblood-2014-08-598037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2015&pages=2724-2728&author=Y.+Sunauthor=Y.+Wangauthor=T.+Toubaiauthor=K.+Oravecz-Wilsonauthor=C.+Liuauthor=N.+Mathewsonauthor=J.+Wuauthor=C.+Rossiauthor=E.+Cummingsauthor=D.+Wuauthor=S.+Wangauthor=P.+Reddy&title=BET+Bromodomain+Inhibition+Suppresses+Graft-Versus-Host+Disease+After+Allogeneic+Bone+Marrow+Transplantation+in+Mice&doi=10.1182%2Fblood-2014-08-598037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1182%2Fblood-2014-08-598037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2014-08-598037%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DToubai%26aufirst%3DT.%26aulast%3DOravecz-Wilson%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMathewson%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DRossi%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DReddy%26aufirst%3DP.%26atitle%3DBET%2520Bromodomain%2520Inhibition%2520Suppresses%2520Graft-Versus-Host%2520Disease%2520After%2520Allogeneic%2520Bone%2520Marrow%2520Transplantation%2520in%2520Mice%26jtitle%3DBlood%26date%3D2015%26volume%3D125%26spage%3D2724%26epage%3D2728%26doi%3D10.1182%2Fblood-2014-08-598037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Herait, P. E.; Berthon, C.; Thieblemont, C.; Raffoux, E.; Magarotto, V.; Stathis, A.; Thomas, X.; Leleu, X.; Gomez-Roca, C.; Odore, E.; Roumier, C.; Bourdel, F.; Quesnel, B.; Zucca, E.; Michallet, M.; Recher, C.; Cvitkovic, E.; Rezai, K.; Preudhomme, C.; Facon, T.; Palumbo, A.; Dombret, H.</span><span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">April 5–9, 2015</span>,  <span class="NLM_fpage">CT231</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Herait%2C+P.+E.%3B+Berthon%2C+C.%3B+Thieblemont%2C+C.%3B+Raffoux%2C+E.%3B+Magarotto%2C+V.%3B+Stathis%2C+A.%3B+Thomas%2C+X.%3B+Leleu%2C+X.%3B+Gomez-Roca%2C+C.%3B+Odore%2C+E.%3B+Roumier%2C+C.%3B+Bourdel%2C+F.%3B+Quesnel%2C+B.%3B+Zucca%2C+E.%3B+Michallet%2C+M.%3B+Recher%2C+C.%3B+Cvitkovic%2C+E.%3B+Rezai%2C+K.%3B+Preudhomme%2C+C.%3B+Facon%2C+T.%3B+Palumbo%2C+A.%3B+Dombret%2C+H.Annual+Meeting+of+American+Association+for+Cancer+Research%2C+San+Diego%2C+CA%2C+April+5%E2%80%939%2C+2015%2C+CT231."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%2BE.%26spage%3DCT231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Dombret, H.; Preudhomme, C.; Berthon, C.; Raffoux, E.; Thoma, X.; Vey, N.; Gomez-Roca, C.; Ethell, M.; Yee, K.; Bourdel, F.; Herait, P.; Michallet, M.; Recher, C.; Roumier, C.; Quesnel, B.</span><span> </span><span class="NLM_article-title">A Phase 1 Study of the BET-Bromodomain Inhibitor OTX015 in Patients with Advanced Acute Leukemia</span>. <span class="NLM_conf-name">56th American Society of Hematology Meeting and Exposition</span>, <span class="NLM_conf-loc">San Francisco, CA</span>, <span class="NLM_conf-date">December 6–9, 2014</span>,  <span class="NLM_fpage">117</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Dombret%2C+H.%3B+Preudhomme%2C+C.%3B+Berthon%2C+C.%3B+Raffoux%2C+E.%3B+Thoma%2C+X.%3B+Vey%2C+N.%3B+Gomez-Roca%2C+C.%3B+Ethell%2C+M.%3B+Yee%2C+K.%3B+Bourdel%2C+F.%3B+Herait%2C+P.%3B+Michallet%2C+M.%3B+Recher%2C+C.%3B+Roumier%2C+C.%3B+Quesnel%2C+B.+A+Phase+1+Study+of+the+BET-Bromodomain+Inhibitor+OTX015+in+Patients+with+Advanced+Acute+Leukemia.+56th+American+Society+of+Hematology+Meeting+and+Exposition%2C+San+Francisco%2C+CA%2C+December+6%E2%80%939%2C+2014%2C+117."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DDombret%26aufirst%3DH.%26atitle%3DA%2520Phase%25201%2520Study%2520of%2520the%2520BET-Bromodomain%2520Inhibitor%2520OTX015%2520in%2520Patients%2520with%2520Advanced%2520Acute%2520Leukemia%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Herait, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombret, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thieblemont, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stathis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palumbo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vey, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michallet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preudhomme, C.</span><span> </span><span class="NLM_article-title">BET-Bromodomain (BRD) Inhibitor OTX015: Final Results of the Dose-Finding Part of a Phase I Study in Hematologic Malignancies</span> <span class="citation_source-journal">Ann. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">ii10</span><span class="NLM_x">–</span> <span class="NLM_lpage">ii11</span><span class="refDoi"> DOI: 10.1093/annonc/mdv085.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;key=10.1093%2Fannonc%2Fmdv085.3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=ii10-ii11&author=P.+Heraitauthor=H.+Dombretauthor=C.+Thieblemontauthor=T.+Faconauthor=A.+Stathisauthor=D.+Cunninghamauthor=A.+Palumboauthor=N.+Veyauthor=M.+Michalletauthor=C.+Recherauthor=K.+Rezaiauthor=C.+Preudhomme&title=BET-Bromodomain+%28BRD%29+Inhibitor+OTX015%3A+Final+Results+of+the+Dose-Finding+Part+of+a+Phase+I+Study+in+Hematologic+Malignancies&doi=10.1093%2Fannonc%2Fmdv085.3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdv085.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdv085.3%26sid%3Dliteratum%253Aachs%26aulast%3DHerait%26aufirst%3DP.%26aulast%3DDombret%26aufirst%3DH.%26aulast%3DThieblemont%26aufirst%3DC.%26aulast%3DFacon%26aufirst%3DT.%26aulast%3DStathis%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DPalumbo%26aufirst%3DA.%26aulast%3DVey%26aufirst%3DN.%26aulast%3DMichallet%26aufirst%3DM.%26aulast%3DRecher%26aufirst%3DC.%26aulast%3DRezai%26aufirst%3DK.%26aulast%3DPreudhomme%26aufirst%3DC.%26atitle%3DBET-Bromodomain%2520%2528BRD%2529%2520Inhibitor%2520OTX015%253A%2520Final%2520Results%2520of%2520the%2520Dose-Finding%2520Part%2520of%2520a%2520Phase%2520I%2520Study%2520in%2520Hematologic%2520Malignancies%26jtitle%3DAnn.%2520Oncol.%26date%3D2015%26volume%3D26%26spage%3Dii10%26epage%3Dii11%26doi%3D10.1093%2Fannonc%2Fmdv085.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span> </span><span class="NLM_article-title">BET-Bromodomain (BRD) Inhibitor OTX015: Final Results of the Dose-Finding Part of a Phase I Study in Hematologic Malignancies</span>. <span class="NLM_conf-name">13th International Congress on Targeted Anticancer Therapies</span>, <span class="NLM_conf-loc">Paris, France</span>, <span class="NLM_conf-date">March 2–4, 2015</span>,  <span class="NLM_fpage">O7.3</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=BET-Bromodomain+%28BRD%29+Inhibitor+OTX015%3A+Final+Results+of+the+Dose-Finding+Part+of+a+Phase+I+Study+in+Hematologic+Malignancies.+13th+International+Congress+on+Targeted+Anticancer+Therapies%2C+Paris%2C+France%2C+March+2%E2%80%934%2C+2015%2C+O7.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26atitle%3DBET-Bromodomain%2520%2528BRD%2529%2520Inhibitor%2520OTX015%253A%2520Final%2520Results%2520of%2520the%2520Dose-Finding%2520Part%2520of%2520a%2520Phase%2520I%2520Study%2520in%2520Hematologic%2520Malignancies%26spage%3DO7.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Odore, E.; Lokiec, F.; Riveiro, M. E.; Bourdel, F.; Kahatt, C.; Herait, P.; Cvitkovic, E.; Rezai, K.</span><span> </span><span class="NLM_article-title">Pharmacokinetics of OTX015 in a Phase Ib Dose-Finding Study of Patients with Hematologic Malignancies: Preliminary Results of a Population PK Analysis</span>. <span class="NLM_conf-name">Annual Meeting of American Association for Cancer Research</span>, <span class="NLM_conf-loc">Philadelphia, PA</span>, <span class="NLM_conf-date">April 18–22, 2015</span>,  <span class="NLM_fpage">4511</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Odore%2C+E.%3B+Lokiec%2C+F.%3B+Riveiro%2C+M.+E.%3B+Bourdel%2C+F.%3B+Kahatt%2C+C.%3B+Herait%2C+P.%3B+Cvitkovic%2C+E.%3B+Rezai%2C+K.+Pharmacokinetics+of+OTX015+in+a+Phase+Ib+Dose-Finding+Study+of+Patients+with+Hematologic+Malignancies%3A+Preliminary+Results+of+a+Population+PK+Analysis.+Annual+Meeting+of+American+Association+for+Cancer+Research%2C+Philadelphia%2C+PA%2C+April+18%E2%80%9322%2C+2015%2C+4511."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DOdore%26aufirst%3DE.%26atitle%3DPharmacokinetics%2520of%2520OTX015%2520in%2520a%2520Phase%2520Ib%2520Dose-Finding%2520Study%2520of%2520Patients%2520with%2520Hematologic%2520Malignancies%253A%2520Preliminary%2520Results%2520of%2520a%2520Population%2520PK%2520Analysis%26spage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit198"><span>Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority; <span class="NLM_publisher-name">Resverlogix</span>: <span class="NLM_publisher-loc">Calgary, Canada</span>, <span class="NLM_month">June</span><span class="NLM_day">22</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.resverlogix.com/media/press-release.html?id=521" class="extLink">http://www.resverlogix.com/media/press-release.html?id=521</a> (accessed July 17, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Resverlogix+Officially+Attains+Phase+3+Status+with+a+European+Regulatory+Authority%3B+Resverlogix%3A+Calgary%2C+Canada%2C+June22%2C+2015%3B+http%3A%2F%2Fwww.resverlogix.com%2Fmedia%2Fpress-release.html%3Fid%3D521+%28accessed+July+17%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DResverlogix%2520Officially%2520Attains%2520Phase%25203%2520Status%2520with%2520a%2520European%2520Regulatory%2520Authority%26pub%3DResverlogix%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z1Q','PDB','4Z1Q'); return false;">PDB: 4Z1Q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NYW','PDB','4NYW'); return false;">PDB: 4NYW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NR6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NR6','PDB','4NR6'); return false;">PDB: 4NR6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z6I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Z6I','PDB','4Z6I'); return false;">PDB: 4Z6I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E9V','PDB','5E9V'); return false;">PDB: 5E9V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UIW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UIW','PDB','4UIW'); return false;">PDB: 4UIW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A83" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5A83','PDB','5A83'); return false;">PDB: 5A83</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LYI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LYI','PDB','4LYI'); return false;">PDB: 4LYI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UYE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4UYE','PDB','4UYE'); return false;">PDB: 4UYE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RCW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3RCW','PDB','3RCW'); return false;">PDB: 3RCW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YBM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YBM','PDB','4YBM'); return false;">PDB: 4YBM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3P5O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3P5O','PDB','3P5O'); return false;">PDB: 3P5O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZYU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ZYU','PDB','3ZYU'); return false;">PDB: 3ZYU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4E96','PDB','4E96'); return false;">PDB: 4E96</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01514&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-4%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01514%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01514" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ab51d1a812254","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
